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. ?;'''ISS222SS2S^ a/a-:/!>/-’'v?-; <
/-<J' 1'ho young roooavoh worker 1% a oliuietU Hold a-
commonAy ndvlood to make u dooe etudy of 'a am all number ■
of daa?oa of the dlocoao in which ho io interested. Trie .", ./ 
advioo la nouod if the omul! aammlo roprcneutativo of all
ems of the ddeouso or " f a partie ular aspect Iv being 
.atudtfceiTf.i'pr- which tho coaoe haw 'boon specially ooloo tod» -
' in ithpe Work -d'dgcMbod -hexo- •-•the- - m©cba‘hf©fm■•• f ■•my^Othapiib -■ ; ' 
woaknena hna boon studied in thio way on a roprooentotlve ■ 
e/ample of tho clinical material® Even this anpplo
la onongh W ohov/ that the current idea of rnyaothonia gravies • 
00 a dioordor of function of tho uonropusouaax' junction of
ololotn! rnnoXo in only part'of tho truth® ,
' On tho other’ hnnd X nm cornedneed fchot thoro io a till •
amah to bo looavnod about dine coo by a study of n large ?
population® it la only in this way that- Itging-'pb^siblo ,;to
ra^c^iogni-ao tho loan,-ooppon rmaifcatavionGi especially where • ■
the ,ecbwirenop'L#f those . MgnifiScW t' *4 V'y'
/The.. w,«op'fih.-'Mplogioai ■roopapeb. 'Aa/Wshow e;■1
whether the assooiatit^n bo twoon phenomena might have occurred
by ch&iKiOi Tho ability to recognise whan'tMs Io mniikciy/-;
iiB,o£"■.'obvious ..vaiuK* there ia a common but musiaken . b
i.iipr^^o'O^/^^x^ .that tho conclusion that two phenomena could have 
boon onnooinbod by chance necessarily Implies that they swut 
hove douo so* / Ah alternative method unod in other branokeo 
of natural science is to asaoei&to certain phenomona within a 
hypothoteia and then? to . .extrapolate/ . the hype It'll obis ■±xtt0-: fields? 
where it can be tested* Thin method has ol&o boon wood in
the present work. •• / ;, ‘ . ,’ A/«. -g’aaA'p'/kf >
The ’concept grow out of a study of a large series of 
patients;/ •’ ‘" -■
■Apakt.onis /$ray£©'.wd©r at the ••hvitaiion .of .•/ ,, . ..
■ : --DxA .Arnold HatiomX Hospital for - NeryouB y .. '
■••-?/"■ Mae&eoAiAQuo,on, S'qtuareA Landon* with' thA mMuA purpose of -/■... ./ /.*•••/
"/A- ^v&iLU^ing iho • role, of thymeet'prny in the treatment - of the • ' • ,
' ' •'••itmoe which wan. at that ' tira©; .aoHtswor&i&Xv- W the ■ '.. Y; ... Y ••
••A- -previous --yeare -j' had, otidied'’ the 'offeetA'of. oo^tl^optoraido - . .•'. -■.
Y 't 'on 'myasthenia gravia-in- the ••Gardiner'- XhbiiiuoY’ef''Medioitt'e*" - : /
. •;...•• Western' XnfimOryA .Glasgow anti had - hogrna yio-work ••on. ' '-■ - A/--. , ■ '
;■.■ -oXeo trwypgr&phy through /the.-’kindne©® -of'. Professor S'ir. John . ;.,-... .■
•.. - KeKoe.A ': A Tho/'r^iemxyjpjmnne to ppnMotmo w .not ' such\no to '“ /A-V Y
A •"'•■' oownd itself ' for ..therUpouile- pmrpoaMi hh&A'iir was olear < -..A
. • that -this'' drug: woe ’oble to -influence "tho- eoured.'ofYa .disease.. -A .
' A which, wnr.afc- that - time oon’Md'eodd-. to "he a AA&oohowicai/ loolw* - .
- -.-of the?- neuromas© ular? jiincMon#/----The ...only-- rationale- for its • -.-A -
• .use appeared /to - .he Athe. -thymoXytio adMeni of'tlw-steroid /yet''' '
'A'/’ the nature of the relationship,'WWoKnn, theYthymuq-'glandf and '■/• - .
’ • the gtttseol&r disease •-.was; obscure/and 'oven the- normal- function Y. ,
-• • . • rpf - the -. thymus was umkiww ' . A ' AA ,'.... -. .,--- ' - A/- . . '.-••• '- '“ '
-;A/-.' '-A. ..MhW’'there/ word AaAtony xnkiwmsA1Adoel'dad to 'ignore A 
' the Cutremt cono'epi.te of myae frhonia-.'gravis% 'including the -/ . ... _
// aosumptione WaV the'r.e.’were. no-.- sensory---symptoms -mid. no mating ’ ,
■ ’.off, musoXo., ' and .'to/ invest! $ateA the? patients -won - at' the . -■ • ■
'■ ' ;- •;Rational- Hospital as though.••.they’ fHAsuffering f*ra«&as:-'a. now /
'and .undeedribed ' dfseaeev'. A/.- -/'-*'. ' A.A’-A' '/A'- -„ A-■' ' " --A -..:' ’;•
■ ,'-/,. • ■ ThG.daae- poeordm of.vthe' National no©pita! mm- . . -'A-.-' -
-onrutib^ta^xl - 'from the year ’ igM -WdA.tlw -. 'fate . of -.wox\y.,.oaseA ,: '"
‘ di&in»G«dd:Aaa by, thewd;aff'- df .that hospital ' •.
‘Wsua /cxiStCe'ptj'a^dLx^^o^d- by '•cOr?.£’;0'dpOmlohlOc?/ withr -the YpOti^nt» his td’oc.fcosy
, . .other - t honfp.tpiXs' or ' Wr Reigie trar "•'GomeraX <AW. au$o frey Koymeb Aw
,;. ' kindly'permitted mo to-XnoXudo _al^L-'the-dsais.e^/Aioen by.Mm:-ah. . . .
/:.A:;8t. • JtetholoraOw ^/Hoh pi tai; ond- • taxdon<r ..-■ -in . "//
















,this"A<Sy-.s. lhGhAQa'$oo wan ^vailahXppfOrAptudyVa' ' . / A>A
VHHipvo death wac not known to- have occurred tho patiente wrro 
invited to the National hospital fO-i*.■:ewt«inaMh&% *,/% id A
Thli'typutter»fco oou.^^«] not i>be-tra,ood9 129 wove domd And 2hy.
were knov/n to be alive* They were invited ./to 'at<e^nd;\Ui<A;? rci
Natl oral ■ Kocp! tai for exuni nt Hon # :. IX was. nblcAto \rikamifee.:'% ' ' 
X8t/ d fAthene /.PHddt&aoMithe •',6 'thfor.'-.Shvwho,‘.wore 'dhabld 'to'y -a ' yi 
attend the hospital (mainly oluO--tOyOo®M'd»«3e ahri.e&d5;'omra YA/' ■/­
asked' XO’A00h$ne$e a: detasiXed' ' .questionnaire wi^Hythe,..A•';', / '= 7 A'.
an.sinfcnne© of their family doctor* • ■ \ • /? ;:'v\'? o - -A'.
, fall, .caao hintoricw wore taken from the 24-5 known ,.
survivors and the entire ’ncrvono aynton mo cxominod in the 
;na4fet;onV,o-9w^_o-attended• ’for .examination*''aTho information--"'wap
ree0rees'■i■0a & nr6Afcr#a&;’ aneAWae--suppXeW»t0.e ley '■ddiaiXa" 
rd’o'3rd.e^d: 'in th$ onoo records* The Info nun. fcih roeordod owo
des ignod ' ' 'tC '•'ph.ow •. th o sex amd/ @® .of’o^hset$/crdarAo f . ;/■
muscle- invoIvoRh t,_ otate of ro flexes $ miiwle .atrophy /response 
io neontig-ine9 and rospouse to thyweotorny if thia wuj dono^ A. 
Iri aiddilon? a Areoord /was m^de of . 'faqtors whipfi' aggravated'' -or • 1 
ImprovedAj«ympt©ma$;- faiotorn'’ Tiieh • preeipittneexnho "origimot - A : - 
aitackA&hdsr®XtpuaBV -;of menmitruamion ..arid different
periods of pregiurncy, and tho nature of 'amyArs'ridiated . .di;©e®0'&4 
./• :Ay'Tho '' data ■ provided '' th#, .material ' for ' tho evaluation 'of 'the
'role /of■ 'thyohwtomy - '( Appendix c) hat while this work ,.was ';bein$'
.pa^^ppa%**c^c^-\fei^/Y^^^hl^ioattO/rii;/ X ■r<^^<aile^s3af;/^liiat aswtalnA’faatriVes - Y' -y 
’reourred?lb'"thw histories*.'/ On-my relnm© to Glasgow in 1953- 
si', conceived' ■ the , ideaAthat ' 'instead of rqjeeting-th'e 'data - aa ■ i ; - 
/'Irrelevant? it would ho worth eonsiderink whether thoro was , 
aemp- oorroiatt^o3n■-'•h0tw©e'n /them. ■ ; It '.immodiatoxy , seemed ' < !AA 
appropriate to regard, the pathological features from the? same 
■point, ■ 9T-'vliW.u Apiis^XQ^wI ©adages ..in/■tfhsoio ,'arid ■ other , "■ • ■
Grggw/'A '••• W Y A/;vA.fA'A,. . pAAA/yAy , . .
.’’Organa had .been..described' '.for.-many-years .'.buty.were always.'.. / •' ' - 
"''dXhnjbQBe&A'as' '*n#n~AppG'i£i.cJ on" the ' grounds -'that. • similar :'A
'YhaOighs occurred/In " Other diseases A ' /" ih they. aamOyway the, ./ •• ".
recent'description '/of myasthenic syndromes 'in' some' muscular.// .
‘diseases/had given'- rise to' the-■opinion in ' the 1950*8 that ' .. ■'■'
. myastheni'a/'wah, a bype/’ofvmusouiar reaction note Coif fined to .
’ 'one disease and ;so myasthenia- gravis, -might'hot ;bo/a clinical/- 
hntity» '' ' As ' .'abj^^m-/aar.. the conc.opt/of a/dis ease . which' could -
occasionally' be ' 'geher’ai^.ioid'd./-and which had' pathological a-■ y■ -■■■•' - 
" 'features-, in ' Common/ wi/th'/he' connec.tiv'e tisuu'e/diseases' was y y.'
.- consi'dex’edthe.- hypothesis/"of 'ah,itmm*hQ 1 bridal''disorder ' ' ' ' ./
resembling' systemic -lupus erythematosus' suggested itself'*/". ' 
-'-The. .lymphoid nature 'of /the / thymus then ^^e^e’d mbfc important ,
.,-'-JhaAn..' any. ' possiblc'/function'/as ;'a; -ductless /gland V- ' ' For., the’/' ,
/firs/time' the ■vwba'Oseemed/ opon to. ;ay theory' -of iiyaathenia/ ' ' : -,
gravis 'which' would comprehend 'all t.He/known 'facts* - ' /-"// ' /. / - 
, . /'/'On ,my /’return' 'to "Glasgow in'-. 1955' A obtained.-the y'' /'//
, '•cooo'p'eeation' of Dr,. John.'- Anderson in an attempt to ' "produce' /
an' /aut^omomiune-'.mraasiiK’en4^£x/In miceebylhoculating ' them with 
an, emnleion/ 'of,’ homologous• musclo ' with •''XFeeihdds adjuvant* ';,'/-'
/Tht©Tpdit3-ts.r .which wcx*'' .unsuccessful*',•wore' hot reported /in/'- •• 
'my' Lecture '- ( Appe^'^^'d:^.?^ D7,d ,’becaube -the ' ' "<<■■-■­
.'-lecturer 'la' forbidden to /discuss' experimenta' on anirn&ao.' ' :
Dr. Anderson also collaborated' in ' a ' search for. antibodies 
" against muscle 'in 1956 ' and 1957 but we discontinued ' the .. /,. //
■ -experiments' because ' of ' negative' 'results, , , ; '' -.'
/ ■'Won i 'moved ' to,. the ' .Northern General -Hospital/'Edinburgh
in 1956 1 '•contimued' with ./the clinical and ' electromyographic- 
studios /but when N&stuk ot .a! (1959) ' reported ’-/the ' /.presence. of 
a ' cytolytic, ' ef fee t ■ bf myasthe'nic serum.the ac'arch. for . ' //
.'•antibodies'.against = was reeumbd with the help o'f/ //
Dr*/’\. / ' . /-' ' /’ • /// A '/'’:/ ’ ’ . ’''/./'/'/.' '
■ 'Dr, W Ri k,7 Al exdnder . 'of .the .Rhouma tic. -Uni t.. - in,., the.. Nor th om' •/• ... •
General Hospital'./ -. Oux; results were again- -negative.- -but/by - /, ■'
Y.-pthis,timei-I was'■ the - clinical and/ ■ ?-■..
, ..; pathological data, to iSlmul&ie; the, iatttoinjmune'.'.hypothesis * • '•. .
Lecture delivered in. the' University'/ ■,'■
,-. :of Edinburgh in Aprils ,- ..Coinciding piih/ith ' appearance ,
.; in print’ (Appendix Y) Strauss . etial'.(i960). announced the ,
. . discovery. of aniibp.'diespagatnet' muscle' in-.-the -aerum-of ■■... .Y.V,
. -myasthenic ‘pationta, .- -Though- he has. used tthe-’arHie techniques;
' as . these-.authors, Alexander 'io'- still, unable,/to confirm'- 'their Y 
■ -.resuliisV ,YAA' possaible/rearao.. for the -'diSerepdncy. Sv 3.1 be ■' ■ .
‘ . g’iveh-'in a'later .chiipter./p '.. ' , -’'/" -y ."'.a. =
.’.''•'•7 •’• / /The '-publication, of -..my-•hypothcsis -was -jnstiff:Jx'd by a ‘ Y.
.• quo.tptionr-from -Jiugglings- Jackson (SirnjpQbsa, 1960a)., . •• ■
V .••••// y';Tn3'',,iwa^^;Aff:h;^;p<^^‘bhe£^e^e^^.-.lY-;- the. metho'dabf • •science.' ' To- -•-/ ' 
'.'/ 7 -.•<•• ■ aup.’pnSe/We--.can 'maae; .discoveries by they- Baconian method - -'/••
Is a delusion. •••.'.'A hypothesis ' or supposition -is not a /
Y '/" -■'/YeWnluafons it. -ip yoniy; a starting point. /for; methodical 
?'/’•■- //;. observation and. experiment,, the endeavour . being xot< only
• 7 ■'/’■ ■; to/ prove ; it* but to/disprove .it, * - ’.-- y /7y• .. ;■ -/-,,/* . '■>
• 7AI'f-th© . hypothesis is va3.id^tne■■• would 'expect to find..-. >
...pre viously .unsuspected- correlations.between my as then!a- ,;gtav:Le y 
' and other-diseasea - associated 1 =with' ' -abnormal ' immun60'oS.ix5aX , ' '
- toioranoep . a The - thymus should have an important role /in 
;umm.un>logy' and '.antibodies' against - various- organo' might/be .
found - in the .blood of myasthenic patients, \ .
. In ' the following year - Miller (1961) published .his ,
Pp/pnoliiaiaar/-,atc0u^lt7tn the -function ' -of - the - ’thymus- as :an . ' -,•/-/ 
/■' immunooogical organ* thud -confirming the - theoretical basis /' '
which ' had been ' speculative in- my :hypothoeisi'- ; In' this Thesis 
are-., described- the further investigations -'which I have made - in 
Edinburgh/ // ■ y: : -/ '7/-< - • ... a’ ' A- .
 6*
Edinburgh -showing luireuspootod correlations . 'between .,■ '
myasthenia gravis and rheumatoid arthritis, pernicious •
anaemia,'and Uaehirnoto*a disease and'confirming tho presence . 
of various organ-specific antibodies' in the blood of many 
myasthenic patients* Now for the first time a rational’ 
basis is provided, for the operation of thymectomy and some 
obscure points are clarified such as the ’necessity to operate 
within a certain, period and the latency of the improvement '■ 
which may result* Light is thrmm on tho nature of
neonatal "nyaathojnia* A possible '.genetic and hormonal .
.control of tho imminnlogioal mechanism is suggested# .
In the second part-.-of the Thesis the -mechanism of 
transmission failure is re-examined in the light of my own ' 
work' and a now concept is outlined Wich. reconciles the 
electrophysiologicalpharmacological and^/for’ the first’' ' ■
time, the histological . abuorramlities ' of: myasthenic muscle* , 
This lead©'to some■ personal studies on the drug treatment of ■ 
the disease and tho .nature of neaatigmiae^resistnnee and death 
in myasthenic patients*-' . Those -have ' n.ot ./boon -published - .
jpL.gWJeniso but -arphoeosaary for a proper understanding ■ -of 
the nature‘of tho disease# ,
- ■ Tho whole Thees-a iis# then# a monograph on all aspects ■
#of myasthenia grav-is*' 1 have contributed to them all except'
tho pathological, buVthe reason for presemting.tho work aa a
whole instead of a selected part is that it la exactly thia 
sectarian approach to myasthenia gravis which has obscured the 
fact; that, ■ far from' being a unique •biochemioaX* disorder, it 
is part of a widespread'■irnmnunooggeal disorder and so its' true• 
position is in the mainstream of modern medicine. -
AKNOtLEgGMgro *
The clinical and electromyographic work is my own' but
x/ ■ ' • , '
7I ami indebted to Dr. $.A* Carmichael and thie' Medical staff 
of tho National Hospital, Sir Geoffrey Keypea of 
St* . Bartholomew" £ Hoo.pl tai, . London Profossor .Sir John- Me No o 
and - Profossor -E.J. -Wayne, of "the Department of Meedc-ino, •
Glasgow University,.Di* J*B. Saylor, Dr* J*D. -Stanton,
Dr.:‘J.K. Slater and.other colleagues for permission to 
examine their cases. Miss-Joyce Mayo wao invaluable in -
helping to trace tho London cases-. All thyme atomies in.
the series -of 90. cases, soon in Edinburgh have been carried 
out by' Mr. ’Andrew I.og&n to whom I am most grateful for* 
enabling me to continue my researches into the operating 
theatre itself- • • ’ • .
Pathology in the Edinburgh series was carried out by 
Dr* A.F.J. Maloney, biochemistry' by Dr. S*L. Torappeet, and 
immunology, by Dr. J*,.-Anderson, -Dr. yMAlexander and 
Dr. W.J.: Irvine. ' To them 1 extend my -deepest gratitude and 
I take full responsibility for the interpretation of their 
results. Most of.-the- photographic work - is ..my, own but I have
had the assistance of the . Department Of .Medical Photogiaphy, 
Edinburgh University,,., -and Dr. ID* Sanderson .and Mr. A Folkarde 
of the' Neurological ■
-’<• ■ ''' ' 1 . ■ • ■ • ■ . '
... . •' "•? '• - ;" • : - '
".. '-.'_ /Myasthenia .gravie wae not recognised 'as . a /clinical.. •
• entity .Until -late'In fehe'.19fch'eenWy$ but It-lo now '' <
/©c'deptod't is in Co Guthrie/ (1903) -drew attention; to lte that ' 
this was the probable - disorder In .a, patient • described in .. •/•. -.
.{great'detail by .Thomas '.Wills • (,1672),*' -The- next recorded .. 
ob'be'ryafci'o.n ws also in . England ' by the' .London' ’physician ,, ■ ■ ■
Samuel Uilks ClS?/). and .'foe'w^ the' flro’t/to/ notice the- - ... .
-jstriU-iig^^.i^^^^e^e^noe of gross •.pathology in the -nervous system* •
: '• • The disease • then became better known in the .German '
'schools ••'.W.th• thie^^'m.e^g^n-iirieH'JX^.b'.contrilbutiPcnio?-' Of *Brb-"(-l879;) '.and ' • 
Gold fXma (1&93')* .Mhoufo --li. aoeme certain■: that -.cases; were ' . ’ 
observed by Bypom"-Bfamw©Xi and others-(Simpson* I960 'g 'Fig* 1,Mj ■
- 'the disease .was not .clearly .weognisod 'until the review, by'
CamPbei and/-bramwil '('1900) ' -of t^e^-fe'abu^'-rbpojrt^ed up' to 
that -date.'• . '•>•■' "•*" * - ••. .•■"•" • ■, -■ - -".-'V \ .
"- - gbb -twaln ' contribution made 'by ferb/was :'tbo -ewtdKLish-'
.smofot -.of tho clinical- picture* ''Though her' was -on early ' - . . ' . 
"exponent -of ' wWectrcdiagnosi© he apparently failed to ..notion ' ■
- ' tho '.typical myasthenic. 'venotioi''tG/.ff^ral±c current applied '' . .
-to a motor nerve. Some -of the symptoms he noted- (such aa ■ .
•lOTerac'u0is"' in ' hla first -two eawee)h&ve been forgotten- lint!! '
the .present' writer .drew atten^^on. '^o. sen8oyy--'ph©nora0ndfl ■ . / 
feimpsosayj9$0)* ' 4 " ', " ; ''/.-.' . W '* ': '‘r '
. ■- .. 'Goldflam (1893)'.particularly emphasised the rapid
exhaustion of .affected mue3ie©..dttd’'.the abort /term 
■ which is-;' so ' -striking as well as longer ’ term remissions '-and 
/exacerbatione* He-alsa drew attention. to .the.normal 'or ' 







•• ..which.■ will .. .be? Commented '. oh/iii-< ]at@r"-.;< .. ■
; bhhptbp, ' . 'but Woted. Cthat 'the knee ' jerk, Wmld1;be?/exhausted ''" 
'.by . ’.repeated ' stimulation. •"; -The clinic &X' -picture, was -now -so v 
..compo-teXy;.do^;c3pi.bed' as ?to. mere' than, justify. t4e • -eponym - - .■
GooUflamcdLs'eaae * . 'kiiXV used./ . l^b^Al^xr^pp#n;Xi'berai^bii^e^* >
' ■■• ' A/', ’?■%e . Y#«ftb • .-ifflyas theniavgrayi# -pseudo^<ap.@iytiea Vr-toma- 
dfirst'-gi^v^e^n .by-Jol-ly -(1895) '* . ■ He noted' that-When"'’the.mmeeXes
were stimulated ‘rCpe&tedly\<hX-fa^adis#** ..a.re&ofci0nAb-f“ " - ;
asthenia wan prompt] y/ .demoxistrbted .-yet" When’-the'.muU€?X©‘v'nx' \ ? 
longer, responded- to ; this - type" Af. . .stimulus ’it would, respond- '■ 
TmmddWeXy 'to • galyfimima* a-’Tiia ,fUndaimje^1;£^:i...oosCrv^s^tt-on/-^^-e '• "
Aftill the basis - of 'all . test© -’(.ChapteA.-15)<
-Jolly termed '!V '’the Yay&sShhhlc .reaction1../?Y^eiSlIX&^’• - '
• " ' 1 '?'.■■ iti/ji ) " > A . '.. .’A--' - i -
- aUggX^t'x'd;i•the ruse -Af -phy®os$Xgmine,,,pB; " .a-Aorm^ogtre&tra.  out ■ •
but: . there .is ".no record . -that "'he ever used it, . ’’ a iA1
A ..-/’'•' In "the. .-next five, years oaseS/War© repo'rie&ffrdmk all ’
.....oy<r" :Europe " includsug* Ybifm in and from the bnlbcd -Staten . 
and those "have been wall rovi.owed by yief] (1953)* .Xt/ma*" '.
, -however C^s^mpre^®e^®s'Ve review ' sof • -Campbell and' BramvWli
. (1900) .' that made- Xmrnstheaia- gravis' . a .weXlUreeogni&ed ' *'
diagnostic entity to British and American nourooogists.
AkA ; \ Campbell' • and!brawm©I.X ^(1909’)’ '-described ''Ml-.the ' ---'
- -f.eaturre.s' "Which •• arednow- well-- 'r^boogsiisod. mid.-many which1 .-..were'
'• ®e4isc0yeri’d ’ by my ;owii ... survey*-. including ihe - /age - .and sox 
/incidence; •■ -the. variability*.: the-, dife1^3i'tiAntionmihd‘-the,- . A' ' 1
•oecnsionpi-ioCcuArnhO'Apf retraction of tho uppor eyelids - 
•. (PagelTl ). ‘One symptom (also described by' Bu»sard.1900) :- 
'which":].’ have • '.not encountered •.3,0?'' •©pont^a^j^^^c^^^s;;clonie • ' .; .-•... - ;•
"■movement#.of' limbs orjiww.... Ti^iey. ..st;'at©'(:u:it.©e'^ii^iaiyAbhat■ no ‘







io• . ••• -
'* account of quoqo dnocoibod ’b;y oovoral author# Wtioh/had
' transient OonY o f oohumtioa In wrn o© ot hex' part b fathe••..• 
body* Altec reviewing the essential!;/ negative .. . •
, pathological finOMgs they read a (mnolnwippm which -/ie - '
worth quoting in iulVoinoo it le so similar xto ..tho-s ■■ / .
oonul union which will bo reached io thio thos:un<&" nwo .-, •. . •
view vfo ourselvos put forward Iss that.■tho ■■ •• ■■--•• ■
. dicoaao ie duo to a pol/oxo probably ox' mleroblir ■. '"
forigi.n acting noon ,tho hewer motor ronrqhhB:':'dsM'•• .•/ ’. . 
interfering with their fttY»eti.onnX activity ■•'• ■- .••. ,
■ "y\.' ’-^v^thont neeosRariiyi^roOnelhg-dnCoVernhio.  ' ohaugc
• in structure#, Wo that the oo?:’a^on oots upon' “
- tho motor flbro (% /won) or ehd**p.^.at^o«$ a# to ,.
' Wether 3 t also notn upon the c elite body (In bulbar ';, ...
■\ 'houel ai „ or ', anterior■ bohnWH tew/dto: form . ho • ’ W
opinion »'««« The poison nay conceivably act upon ■ •■ • ' •,
tho motor norvous aystom9 or upon tho mvusslcarz •■•
1 thorns clvcrH» - ; . .;
. Though some of the analogies? with’ which they/’ llluotrate '
■ Osjithiria&gttmin.t'■ AtfW^i■‘note0bg@r■iO>WeoOt£hXe thoix* general.., •
conclusion in favour of ten atteHuetod toxin? aacooiatte .
with infoctioon i# oaiontnally. /similar. 'to m,.‘town .concluslon-sy..' 
The rxionco of iwrmnll0g,y had yot to o omr# " ... • >•.- te;'
■ • Tho■ concept Of a "Myasthenic toxin * remained 1% the - ■-
Horanur??© from that ■ date. ■ • ten 1901 lacuer and VWegcri 9
reported a cooc of Myasthenia gravin' aa so ci at ed wl th a - ,
thymie tumour® Vwigeri (l^OlJj reporting the prc^ac^JitW' of 
round ■ e<rll infiltration In,the muuoloa. though t that ,ihey '•
wore mh tastusoa from .a thymie tumour but Burxard (1905) • '
.: soon, disproved.■ ■ thiu and termed ,hhy© ’Xymoh0irhfhM1■•? beonnoo - ■ 
they appeared .to look fromm ■ blood, we-welro* "Ho (onnd them in - 
tho adrenal and other organa’^nelidBug a oqet>er:’Ooo‘ ^rpet ,•
ganglion and conelddddnfchat *lt Is’ neoesshary. to arsuMe. ■
avtlibakYhH' : - toxic’-' agen-t:'--!#'' capable • of„ 'exerting;.; an -Infl'Afthe; .on- 








? X? ■ tW tKep-Xismes ‘ besides •• muscle-/ in or^d^e^s^'r-t'O-
s.. > ;A^cdount.ffd'k#© sensooryg’.'/mmiaX) - VsoQ&oto/ aOSBeeee.tt'T/'' X- :
•“‘-Liti6s^j^‘er^-yC')x5«asionMXX't'•'msfcoaii,>^ in .the -d’ieoagoX - M® ;-;-/':" •’
', . - ' advocated' morap&Wm&iMaa' being; dir©oted to th-^e? condition ,
' -lof. ' ;th‘e. ..blood#-'the -marrow, - the -lymphatic - ay©tern- and - the - ,' ■ '. “
• ., ;Wtiy/and‘'WqeOciiy© xila.ettestaa - -#olylng.. / ••
. - .'-■'myasthenip74^aTlai?';-7-', •'’ X- .. . - . :.,
X. X, ,- . -"ifeOhher amC.-SWauss - (1927);'giw--a:'-adMaahio review-'- • 
„,.' ’'-. of"the Xis&aoe - before ‘ tK-iinfcro&uot&toi. 6 Sophie holibe s t©3ra$$e-X 
1 . twatiemt* ' In -their opinion -••?the - 'symiptoma - 'of - the . dia.ease , . ■. ' 
•' '©re'$©©'t'-- e%p3«aiihea,by Whenming ‘ ‘the -prononootoi' somo- tootle & - •-.- ’
posai hly nntotoxio# n$tni rhXX hoa a special inflnwwe 'Qh -‘X-- 
,7- • thCXpretopl^ 'of vblUUiaryXuselo end -a- loss'---.
gX;7 0peolalised. influence- -on.- We/tuhC tien.oi- other ttiattbs XXX-/ 
jX Xli-- would oeem*.' they comment lator* ’that in all ? ■ X -- . “ ‘
’probability -tho . - ’thymus - -iX - of . ..Slgniticm,neC- in : the ' phyelologic-
•X and pathologic proco&#on merely by virtue of it# 'lymphoid- '
' ” •';h/:^B.a:r.a<G,t|e3^-V#.-:.andi-ltba pdriph’orml; aite.of'drigin of tho/. j ' ,
' %a #t then!" roac tloa,,, is- - moat - iil;oXy. '•-fetus. 'poPi terminal- network • - • # -
/Tie- concept of 'an su^^^^O[te^st^^■ar|aa^5.gohe/\■'^tv' of/favour - ' •
until ' replaced- by ’-'he . - modern - the-ry of -automtihodiee* .-'i-f'. -
.m-y those - three -' - GOnc^U0i’on© woro footated la-Wodorn term'tX-.-jixey^. . 
o ■-•■■, wuld. - admirably- sum up my owm-pPiuX'ef’yiow, ''- •- ..,X X • •• • ■ 
yg XXg;/-- . xt;hao b>e/Xwahee4XyXOfi^MMtd tthai'thymi6't/‘ -. - 
' .■ '•tW^<^t^ra 'oo.aiar. in - of - caeca 'of . - myV©tthmia'-
.' Xthat-. -in-tho-'oth®r®/'th'®;tHymua is. ‘abnor'lltin7that it-. ' •.• - • •’
■ . -contains - agerminal controa'T#- . Swarodi© - - aitempts to treat - ..’ ...
' mya'sthen'ia gravis - by .irradiation of.'' the’-/t.hymue/' or - by - ' ' / -
, thyt/eottomy - ^110^X1^ _ the -beneficial- ' ‘roeulta - claimed - -by .• -
:- " - aomo- Tonggeona. CKeyhea -1949, ot aeq*)- ‘.were - 'hotly diapnied - by 
' X- \',othpUb/,’\:; ' ” • X"; ' 7.- XX'. Xg '-■ - X * XX ■- '7 ■ .•-• . ' '
 * others! .' vAg;- analysis /by-/ the . ■ writer- ■ (Simpson* • ^958)"YoOn firmed ,
■./iheYvalue/of "/thymectomy: in/ certain’ types 'of oa&WYand-A ■■ ... • 
Vresolvedy-the/ apparent; ' dipcrepanc i.esyof other. '.wrfeer.©/*.'' This.-,-
Us described; isf'"0hapter; W'YnePin" Appendik'Uh’ - There can "
A now/he " no /doubt that '/the /thymus.; le Yln'-sexas -way Important " ■ ’
■';; ih/ 'the /pat^h^£^ge^n^^^s^'ie^abf?;m^^^33?theh:ia' gravid . ' /// iYaY.//■ - ':
Yy?Y ■■' /-" , Early' mO/rkors:';lhcludihg/.OppPhhelW . ;(1887" )" and;.. Jolly „ - 
YY (18.95) ' recognised, a? resemblance'/between:.myasthenia" graVls-
^and. cnras"(5“^};KxLGonxggY y;nd. euggeatf^d .iU3:Lng ^Piv^o£a;xgiiinc3'i , • .
' - 'the"/antidote" <tG'.'our&re4,/,ln 'the -treatment"/of/" myasthenia* "■- -
Y /Appaehtly" 11' "was ' use&Y'but .abandoned as' ihpf f©c'tiy >Y.. - '■//,. ' -
. Many Walker •$ demonGtrafionY -Of thia/drarndtic Yr■lie.fyafforded
hy/phyy0of:igm±ne$./and./lbier of its analogue neostigmine,-,
. .* (Mlker 1934 Yi5b.iI cdimeldihgYhlth '.Palo •andYFeidberg/’/oy "(1934) 
confirmation,- of the • role "of /acetylcholine • inyneurpmuscular' , 
transmission turned all thinking ’towards the •C0neeptYefA& Y
y" biocHemical/les^ion Ye&u&'iW " a"-bibbk" ?of" -trPnSmlaslon. at the/ .
‘ neuromuscular•'junctipom' . #, .InYtho/YbPkt "a23",*year©$■/thOYy apid ■■, .
... . /adyance/ Of ' /heu yd physiology/ and/, of" /pharmacology .suggested- ' ". ’/
••;Y; ;eeVeyai"Ym§ehhntsme for’- such aiblookv. ..leading /to -mmy" Yy .. ...
■ ■ argument.,;- With/ f aw'-exception©'. all -' of/ these,’/ighdrPd - Yth©.a' , \
' ' y£a0/t/ that ./the thymus/'wain- ^Invariably; abnormal- and that; Its ..
; ', removal 'would effect"Yi^tprovemeht in" the -myasthenic "' ©bate.’ YY.'
'Tho"trend- ' of t^hdught ;^<oo;f?;^a^mpbdi1 and; fiymjweli 119QQ1»;y. .? ' ;,
. :‘ •Btoaard" 'fX9®5)" $/ WO/Keschner and Straus© (1927) was '
■forgotten 'while all '-in torep t • -p ontred"; oh: " a ’..presumed "
• .’biochemical, lesoon-* at •the... neuromuscular-iunctloh/ " - -a ■ "
- a'A" Y /The way.-'put of " this."impasse .was flr.ttY/duggested by .
•; thoYwiter. ^l^^lYa;/^^phym^&^(^:tllL.'<^^^lp;ie. Lecture; on " 2$ihY'pyil's - 1960
' • at- the/ ..University' -of ■-'Ediybnrgh''( 5impepn,-... i960- - ' . XtYwap - -'/•'

















FF <F '---'F.f "U* ? ' -f •• - • F-F" \ ; v
, d'A’sugge&tH /that - -^as an/endo'crino glandACas; _
' '■'\'Xia<lFbeoFPwV©wXy ,as©um@dj., ©Xppipt'.j&ft “so'"-far as it -regulated
- tho - formmtioxA of .blood. ceild/Wdy- iknd&re£tiy| ;df plasm// / •
.'.' •-. proteins*-2'it- wad/anggedted ‘'that-' vny&sthenia-'Was .the 'result.' •
' F ■;Qf Van. . ■.abnOrmal,: imWmooibicaX reaction - i n ''which /an an tibody •
-• A./, was VfPr&Wd ‘'"iggainiSt. the ; protein;. of ' the. end-platea . of- muscle,
- .;• Tihl© /oOcep.'V droseAornt - offal review, of'- the- largest aeripa/iof '
V '.case© -V^eeBntyvFnF^ingXe author which suggested '•that ■ they ,i.
' - mispMw IXaioha; pphld yujcasiwaxiy • he- .associated, with ../,' 'F •
■ p disorders -of --other AtleguW 'in a.. auanooiaXo3®Xy resembling
•. '. eyptorn,a''lupus erythematOBdiA '; Suit'd independently dirausCA •• 
a et al (i960) reported that amtibodioo against muscle could '
-.' occasionally be found in tho blood of myaathenio; patient©, .-.
x • -1 ''h4y©AmMggei3tb& aXpo'esiblerSechldtem' by which '"meh-/an ' ■■
m. mMtadyviouM--'a<eeoumtnfpr ' 'tho ''/physiolp'gic' ai /and - '.• ' - / - , /a /.„
V "y. /pharmacological change© in myasthenia/gravis (Simpson i960 a.
. Appendix D), but this -is not an essential part o£ Vbc '
•hypd'thesi^j^/aj '^ -other; possible -.mechanisms;Wll '"bo/described' •
';.; ..--in dhaBier --16* --.. Tils conclusion-■’confiM®',,'^n. i A'-•'-' .'
sophistic at ed ' Way, the /au^fgeiB.-fciosam-' 'of- 'Campbel . and 'Bramwell- .
- and, of :3BiW#ad ,(1905) , in the following year -the 
: ,5 ;ouWfcandin&--. ;work of -Hiller, C-XS6X) cM firmed ‘-the magor F- -
'AA - ‘^mppr^^^^mcc,.. of / the. '-thymus .as -an immuhoi ugioal organ* ;/ - a
This- thesis provide© a -fuller / ©Mount of./thie", •/£-•-
/, -‘rWrloaa -forpreaching/thib/conolusioa. -ahd- rcpdxFs.-.ext'en&ed' ;
ob'Sorvationis,' 'Which.- now- ©digest - thlt-‘'there-i# .sometimes '
,pA’ ‘ciinical .and serolOglCal - ;©ver3^cip .heiW€m;nmryatt^m^^^n„a - .gravis, - 
and "other- disorder's of -'the type- discri bed-at-th'©' time - of "
, ••••.-..iwitihg- as idutommmuno" diseases', -.'AIM. closing chapters ,..•
,. / -give - an - account of - 1 personal - studies - /on -thi nature - ©fAthe •
, //. failure. if - ',»edC’a>mu^^Cul^s^x*■Ax^C^l^^t^i•£^g^^lon- .andpoh' ' the- ‘treatment'-
of the mynothonio patient* * .The thesis • ©n#s. with a survey 
of evidence which suggests .that. •..lafuiy. of .the .-deaths arc 
&uos;to, usweGOgnised' overdosage --with antioholine.steraco
dru gf.5 « /
;.■-■■ . ■ ,-i- . ‘
■'i'i , /l
that myasthenia
■■Kennedy --and. y ;
y-gAfflftAE .-SlbTOig
fee eg , ’' " * t ‘ ’
■ . The majority oY tho putienta xn this aeries dr©
CaucasiancyihclH&ing patients from Ireland in the ..West/ 
(Case F/N7766) to Oreeoe and Turkey in the Middle .East 
(Camea O&S3&5i WWOh One Asiatic *(Gase W3«5O) 
wao studied closely* ' Other Indian caooe and African 
negroes known to me have‘not been included’ because of 
insufficient data but there is no doubt
gravis affects all race©.-(Hdrvwy, -ijW.t 
Moersoh, 1957) • - ■ ' -
JPrevai«wac©M ’ ’ *i . ’
The population from whrich the present ©erica in ,
drawn does 'not permit an estimate of prevalence# lestimaxto© 
Which have been made ini thio country and in K’exwwy arc off 
the order of 1 in 40.000 (Ferguson at nl, 19555 Garland mad
Clark, 1,9.56* Pennington and Wiloon, 19615 Storrn-IMathis©si, 
.l96.id® y'^KttrXWd; and .Alter. . (1961) awabneed the inaid one.© Lin " 
■the L&ited; B Mtbs of, America as 1 in X0~20,000 of 'the■•;• y;C-' 
£opulati©a*‘ ' - \ ?•..';
Wfe^JBtheiiaiAsrS^viOv':!.^Wore ebAibl i< ‘Woiei y.' 
©especially in 'the .first half of life, but When the first 
mianifestatioa ecf the disona© is in latbr life, men are’
more frequently affected# In o&rlior reviews 0f part; of 
■thia- .Itbrial’ it7wag?.-tpuad. JhkAt"females^Were affected,' - • •' - '' 
twice ao often aa males (Simpson 1956a, 1958), In the
first deoade of life the number of girls affected was ##5 
times the numbex’ of boys but the disproportion deereasod, ' . 
•in later yeara and was r0versed in later Hfe* The 











expanded oerios uow reported confirms the main trends; '
previously reported but; in the age group ever 50 the 
disease is equally common in both sescem* • Figurc ‘2.,1 
ahowo --the ago aad':e?q^af;{-:i£rb©tl3ut:t.ou of caaoa with and .
wi thout a known thymio tumour* These‘are shown separately 
bee uuse, as.will appear Inter# -the natural history of ''. 
myasthenia i e different' in the .presence of a,- thymoma*
Figr.ro 2,1 and TalbLe 2,1 show that thymie 
tumours occur with equal frequency- lit eaoh ae#:* . h’t^o .:
mcodaX'/agp©;7&t'; thef time ;/of - phoc-ta ■(.©©' judged/ byfihe 2f wisest- 
recognisable symptoms of myasthenia) are shown in 'Table -2/1 
Thesc figures - show that the modal ago at the, on©o t of .
symptoms is virtually the same for bohh ex-ess although the 
•pre dominance of females in the younger group makes the 
moam ages different for each sex* A thymoma is equally .
common in either sez but the modal age is 25 years older*
In -earlier reviews of part of :WdaX,/ag4
■for '.male patients - - and/'the'/RpPper t£6h;,.,pf/mulM: in ■ theioider -/ 
age - •: group©/; ww©/ both -'liighWpf -With - ,the /larger ebrie© -'itM 22 
.Ms now apparent that the om.y difference Bo two on We sescos 
id th# higher incidence of eases in women, under W years of 
ng©*;. - ' -"' *,22'' ' • • ’ '"'. 2 - ■ -2--1’2'-‘ •
It will be seen from Figure'2,1 can'd --Table 2*1 .that/
■bBou' /ihbVfiW^/b • appear"''afte.r •-'
■'the ,,/ago - of ho there is vs 50% ehance that the patient -has a
'thymic - -tumour* - '.2^i^^^^nds^'\.(195S;)-rhUi2 -remarked .-■ qn tho-^absence ■/
of oases - of nya ©then ia gravi o vitirn thymoma under 20 /years
’of age and, the .low incidence hud or 50-'(.4 per cent)* - - '
/ 12'*</ iThe:mgo :distribution, of - ■ thb/.202 '--.female ' ‘Caseo' ; ■;" • 
reported by Bohwab and loland (1955) io similar to 2th©;,,- , - 




the rndaa*age of their 167 male patilcmte wao 61. years';ThO 
mneh-'W^lW/ZQ^riespbi-^aK and Harvey <19551- and .of ’• • . ’
-’ s 4 “ ’ J- ■ ' . ,...■' ”1 X • ■
(1963.) show n mimilm- trend to my enecu* ‘
fte .latter .author -roccrd®. Similar ..results from .■ earlier > - :' 
waiter® (Me Table 2) but It must bo remembered that none 
ox . tho go authors? have given separate figure® for patients -
with and without thymic turnonrr* Tko;'. statement , by Garland 
and Clark 0-956) that ■lacs disease occur® with equal -
frequency in ea« h oox below,the- age of 30 can only bo based-. • 
on tho omni! sijse of tho:lr sorio?# , t /comparison is -
’iwpoesiblM. aa’other autboro have used moan ag® as a - , .•
measure of central tendency* This is’/tmfdrtWaia 'booaUoe .,■■ 
of the showed distribution and the relatively ©moll number® 
of.mny aeries)* . .••... . . - . .
fho fcignWesonae. uC tho sox and age distribution .alii 
bo diocuoeod dm Chapter 3.4, At this point it 1© desirable to 
point out that the ago distribution curve© for each aex are 
regular ''and mo nemo .dal ’though nfcowad, Tho distribution i© *. 
certainly not ram&om nor ia .thoro any suggoation of a •:
^multiplicity of disease© related by a common symptom complex, 
(Bimipaon* 1960a)# . . ' ■ ■ ' ,
2 A benign typo p% myasthenia gray!©-'whiah''is; virtually 
eonfihed -to ' the ‘cxtraocular muscles'is more common',in ’males , ' 
(Orobi 1933)0 In my aerie's the incidence warn 1,6% of 
female cases and 9% of m^!.es* ' Rono of those patient*! 'had ’
’a :khymoya' % 1958) a Despite thfr Orob (1953 ) states
.that the prognosis la worse in male© than 1n females* • M
Btorm-Mthison (I96X) agrees with. Grob but only When he io 
aumlysing tho case© treated with anticholinesterase drugo* 
Untreated male case© appeared, to have a much bettor prognosis 
and ho was unable to account for this'diocrepauacy* My own. - 
finding© which are detailed in Chapter 10* are the ,9 ■ '©9y©







converse (Gimpuoa* 19550) and Hoof ox* ot nl (X955) found -
no difference in the eonrso o& the diso&se Wmn .the 
noxea* , * , ' .’ - . '< ■_.. ,
Ko do of onwota ' .
> The onset of symptom© may %o imeldiOmo 00 %% /.'. •/ .'. 
tho patient 1© only oueMouaOy aware of disability*
TMr nay oausa dHTlcmlty in oBkasXSWMag tho time of ...
onaotp duo patient© Insist that they have always boon
weak but X have not been able to confirm thin frbi , ■
independoht-sources® ; • ' ■ . . . t /
.' Cawo HU55H5 had wolsnogrn of one aide of the faoo at . :
the ago of Dtlng ’tic nortt 18 yoara she had four 
' more nttweka of facial pal^y on one or other aide* ewh
lassbiag for • about ©Az montha* With some of thoo ■
■ episodes her toa-uo ’felt *mnnb* but there “wd#‘ •&© ‘ipse '
- of tpeW no* j^ation* 8he kuew that pho had a ’lofty eye’
■. \ to the'Inf bit donied dlpXopla me atep;W Mid had not
noticed any other oonkuotG* . ' •
■ Wlwn #bo wr# .14* there was a brief $peH when ©ho
■ ■ nuld not hold ihinno in her loft • K>.ndc Wiou uho was
HI ahe attoudod tho Northern ucnortl •■WH.nburghh
with a complaint of bllntoral facial wmhnosy whlph had 
star cod four mouth© prr/loualy (Fin* 2*2)» Almost
eojonlote faecal : palmy warn noted?. M% An addd.tiou oho was
<•-; ’ftmW to..hMyu ,twaka'0ta‘-oo"'tW© t^h^o*' ’ -thp loft #ldo of
tho palaho, mud tho fluxor 'mwelen of tho nook* Trua#
- mud limb mwsXoo wro powerful until osho-rleed ’ aamlnet 
. rrooiotanco who# the right triceps* loft finger flexors,
‘ flexor# of both hips•"Wl'1<thO’ X<fft7&umstrA«g mu'mXno wore 
4 found to *£aUguo9 ra*rAdly* Ml tendon ref leases worn
'.brisk cabbtho*plautar refXexea were flcwor * Bmioation
vwn ^^imp’io To fmvthor qttGStionhufs oho stated that oho
f ' .7 V
' . < . / /s-,-/'1t.'A > J ■ '-j /f
hadncvtiocda£;lightgoitrGOH.eweoksarI;U?re ' . - ' 1.
,‘ ; ' p.‘:‘.;-lA'y«^^Hgat^^oii' 'eomirmisd 'that-ske/lisd; .myasthemia ,; /.;
'■•'•/..• <;/g£&VI&;»■ -- •'■ - There' /yds.' an 1 ©xbe3~Xon 't;/response -to %. y■■-::' ■ ■', ■ ' - ’
-. --■'/pycpOdGotigmino In 'OX!'', muscles. 'except'•-.’•the ' facial; and ■■. _ ■ ,
■ ; <■ h‘are~remminmn'&d-'iMMn*Fig3‘^-■ - /' -'''-. . '• • • .'•' '■
■ - ■ -•■-' - ■>ac3®: MBgg769 '- had- ■ double ' - vision'/for-the' : first-..time 'at . ' . -
• - „ -her/ ^wedding-.w&e»;-.ishe■ /waas-'agsO • 20» - 1 She -later developed■
'•■:■'- < '••-■ gen eral'ised ; m^aat.hemi a-'.gravis# '- '-'She's tated ' that' ahe ■■•-had/
'been' : •a'fr£v_Llehij^d®i^iHntiLage.'of .'14*-." ' .; .?. ...
‘1:.’ -■4ase/MBjQ5j4. (Flgf'./2#86) fell'■while ■ skating -at the, ■ .age /of
J i. 2.4$ ;,!"\/Fd/ the fO'iiwiW" month'/both'• 1 egw -were-..weak -Wien -.
• / ' --'•■■ running', / - - ./SW - ■ them', ■ remained -.'well-.;ua'tii/ Weaknessa - of /the -' .
, ‘ -. siOga' ■- reinrned;/in ■ the ''last ■“ trimester '/of '"her ’fourth-' ,' ••'./ . / .
-,. . - 'pregnancy -■/ffurte'Sh' "years--later*/'/ This '-imh'' followed. by • - - 
. . - -- . .difficulty. -bolding .her 'rms/iij> ' tb. dress' 'her ■ /hair«-., A ' ': '
-'. - - -/:Vdiagia£©Ls - of ' mtwOniar : dystrophy .was' -'mad© - elsewhere *s ' I • ’■ 
, ••' -/-saw./ her/ in S&ihhnrglt; at' the, ;agg-‘’o£ - ' She had ■ typical
, ■ ■ -'yaethehia ‘-gravis '/atr ‘that ■ time '‘and '•©ubwo^UOntly;/ - ' '1.
'—p developed '-‘mild' thyrotoxic sgoitre*' ' ■ ■'She-has remained - 
■-' n-iOll. fox* six •yearsSon' pyyi&o.s.ti’imi'nS'^mSdeatioh-i/i: t /
■ ••■ -" •- Y'-.-z/it;- 13 ' ■ possible /that ••som©'-•iaees\6f'';t'b±®' ..type■ • have' ' had-, 
/mtild' myasthenic weakness-si'nca .early ''©hild-hoo'd .but in view '■ ,
, '.Of' 'the' / f&iXibility 'Of' ' memory "/and ' .th# "‘natural /tendency/ to, ' 
extrapolate backwardOr /bnly-tW. 'Sariieb t /kn'owh; date ■ of//- .. , '
• definite ■ 'fatigu'able , * Weakness;has•been'naed' in /establishing -
■ the''Wth/this /type of■•olhset-.- the ..
patient’ iO/aware' >0f o»rphhsioal exer&iae' (Cases '. -
HH?X5?'/IWI939.)» ‘ The‘Onset■ '-is '.mOsre --.often suddoh,' “. Ih ' 'tbi© ■'- •
•• type- -it., is ,;rar©v for- /physio al exercise /.to --be -the ■ ,.pr ooipi t a ting. ■ 
■'fao'ti'^>'■/t:hong,h ■ .'this' ' was/:nb'tbd? 'by/-some ■ /patients t ,, ' 110329 '
/ and. ' ■ H-Hl'ggk^.vror© ■ hUfying' '/for '/a •,- A0ase' I^K6XXS>B/'fF&t - - .
harvesting9 .Case. HH42788f//laying -.football'■-•-and ''-'X^a^ise 'GK/DB and 
' MTO&?/.- / ' •'t'; /./■/:/tf. ■'//’/; , /
ME7343 •Wexr.o/;pi&3r:hgg< tehni®'--wh©h - -they -/noticed. Walendaa for, ' - ■'-’ • e- ,
'■..■-the,-firSt'/fliaeV’..-•-7-77/7 7s-’7-‘ ; ■ “• 7-/-7\ / v7'7y ' ' .
. 7-7-7 /1 ..--In 'my- ?-exp&irIehce "WomoOioyM. /upset ■'•haa - .been,' -ah Y-. ’• - '
-//■.more- .common - precipitating- fac tor* • - .The --i’at'en'-t"-period - -stay .. . , 
b© 'but I ■-'have- - not .-been - able- to. Obtain ",
• •.• ind©pendent- c onfl^sm^IJi^on of. .-the.' - intervals- "described. by-- •,/
.,, pat:u^sit/^o?-';'/- ^motional; ,th©, onset- - • ' - - ■„, f '
; 'of ^^lo\-flisks/^\;Qmn23-tom.-v^©ee/'--!^^ ‘^be*d-'i^ll•'r’■eaGaes^tl^55^-/Wl.S9u'; -andy-;-''■ '. .
/ /-Stoneb (19.44)-.and- thiB-.-wa's^Wi^;i/ kho#1 /to/oarlioy ,■ writers-, /-- . ••
- • (Gamphe©! and - .Bramwell, ; 19OO)* 7-/ --Three- /patients 4a the ■■■•-/--.--' ;■--,. 
.■ present'-' aeries’.-attributed . the--'sud&on -'onsat'-Cob - a .p’©-^^©©!/. ’-%;,
•;.bdy,?Sh’o'$t:#/during- the 'ihoma^h^3rdmfl©t?-oe’-:^e^(^^:n '($a$ea:.-teL7?.6.ji'.' 7 '
■./-, W0$£/.and v#b48883),"> ./ Gao #Ii4&883iw$©., throw - to,y.tho ■' '' 7 ' ' '' 
-••‘'gy^c^u^^jid-'.'-’b;^.;..b'^(^^t---andyas^^;u^a^t)i<© .;fcd/-piae;'HgaiiU;- . /..The. Initial '' .-
• diagnosis-- of;-;hh^yS^<^;i?i^ea^■'1^^aJralys3^ss/AWseiat^e^xa■ changed''' to ■ - ■ ■. - - ■
'•'- -gravis* 7'----Other c'mi.se.s- have:-been the-suddenv .; /• .
. ...death.of a.near/ relative/COno©’-;M4584»-.#h62047$, M88?f ’ ' -" ’ - - - 
■ ■hlB9505)/or- . an3^i.ety/-S^bo^t;d,^3h©ss--of-a child .ox//,'-, ’<
; W2345®s /.■Mi449S3 s TO$S0j-X*)/>- •.% - discovery.- of' - - - - = '-
•. h - .husband ’s. infidelity (Oase -W43986 ) - .•op-\a'divorce - (Oa©e •■ ' " . .'-'•
-.- 7BH61463) » ' ,On#-- patient - -.(Oms# OT6X9QS)-- was" - certain that- -,he - 
t,, .was -’about to bo killed In .an accident" .involving the/crane ' ’-•
- ’• which- %e was/driving*'>'-Ee . was -pnhvriY' -.but/hi® firat --- - / , - -
■'“ '‘symptoms -of " myasthenia /started -'-in '•’•fcH@-/i^e:Xt/-jfew ;&ayyu77 - ' - -•-.
/.../ -- ‘ - 7 The offiootonal reaction- may a-lsp"-ao©b,uat--for -'onset-■'■ - . •
'/ - of •myasthenia./ on -the - day. following 7 de a tai -- e’x'tb ao -t'i oh- 7 -. -.'
«. ■ 1 (Oss©” HEX,$369- ,/wHfer - ',^;h^e;- oeuiax* which- ' started '
777ivo" 7-weks - -after a blow -on -.the .©ye/i-h/ a' patient-With W- /■-- . . .
/family - history- of7thyxo»id,disease -'-(^^e-■'MBHlJ.O'O).*-- Cane #1133170 
- 'developed generaXisod pyaSthenib. ’-gravis - - sis'-months" after’; a" :
- erttah /‘ln-|J^J?y/•^,f- th©- -.chest - and- > later - - no$ed - --that • relapses- ,i - ,.. .- ' -
'' -wore '-usually.caused -by ..worry'.or••'"aspcloty p pPtosi^ 'first ■.■ ■ / p 
developed at:.a partjpi-(Gas0©)M917Y pud761^15J or during- -
■ - YYthe .’wadding..',ceremonyX'0as©©. GK/S.jS and PhS076’9) * • Q&P©'- W>i4a$ - 
. •'■p^had-' diffiloulty ■rtn.'^swsi:!!.owing■' for ;the ...'first - tim© .during on ; . ... - • 
;''.''Y examine time.-1 ' ;pY'.-Y"- . ' . • p.Y -...'. p,-,'Y. , ,■ 1',-p ,*'-.Y. - Y
..--/’On 'thpppther'/hm^h -Oase >EfEG</W'had a;'.remission - .. • 
When-.she.was bipwiet; up.' by .' a 9dopdle-.'.'bpmh'*; during ■ the-war;. , ...--; - ,
.'p vahd'pdas© $H25X$6 -tel' an' immediate' .ronisoibn •.vhssi'i/^^^dcnosjs-’ Y
. ■ of her- hands ..■caused her pto-drpp. a 'hot; water pbottlo*,-'; '.'She . '
;•;• . had ■ a . severe burn . and .no. wyaethe.nie ' symptom© Wore ' .present ,, ' 
Y.'.:/ for the. nojdf i^wotweeks ■ despite. x^bfydraWal' of, .neostigmine ».. .. .; ■ .. 
. . Case M26672- had -O remission', when.'hop husband, Was 'injured:'' ' 'p
• ■ -by'failing, from.-Ja, poof / '// . .y" .." ; p. ., , ■.
,. - .Only? a’ little IpsopsenwlGhpas a -pree;lpi^at3^ng factor '-••'• .
" .•.' is ..apfebrile disease$ • .usually Yon '.'upper .: resplr&tp ry, Inf potion* .'’
• ',;/XQ^aso©;>!/p-E/M^p.NI0a7iu '^6^8X•.$$7X95^8l9Xv Wp36O/'?p -
Y •■ .m725$r'^H178?^,>^33?Ot. f26?85'? nH265^6;' f
.; Y-^^6l^S^\.pM6i454i-^H$aO32'r ^OTa'&SG.and. W^W)--*
.. . -■•. Me Ypr®woo-korp©© -spates?:' lh Oases Wh/HO/GS . p'/
: .." anO^MC/AW#/'yyV Y dpj’Y ' pY/pY"
. - . .'.' -p p /.. .. .Symptoms'- may.' .appear -'during, pregnaaoy X'$a©p.3 Y
ait/pn GK/E1, pW3$9% - «6ixa7? - 0®O^.' MM5912,; , W5S7 j'< ;•
.;, ttns pmenjK^r’inm or ;Ln the lie:vt ?3Je: month,o (0aooo GK/$Sy;p :.->' -■
- ,W5683:>n<t.’WT79)^ y>y©nU<n .
■i. ■ after • pregnancy. was 'more likely - If.-the ehll# :Wa&l. uhwhietupp'. ••
- . Otherbeganpa£b.$x<a/ ffilsoarrl-agp’-X00' - p-'’"> .'.
' - ' .' p. ' •' i iMKdiagnosis^waspn&de in .’spb© eases •after 7'they -''' •;...
' -“.../had ■ shown an-abnormal "response -io /at relaxant -drug ;uspd-.?p-? ■'.• "’•
' ■. 'during ' .anaestheaia9'-as . described '.InpCh&pter 17* ^-Vhf.ort-unafcely
Reason fer pbiducinp.''anaesthesia ;was sprnptimes• io-'-'permit.- ' , 
-•...'.. - ‘ -o tplar;M$GiG£i6 al... Investigation; •, for; dysp&oala { Case GK/dB)... p ’..,
! ' .or, dyspii^la XGases GK/BK -and'-W62039).;when 'the true ’,cause . Y
• • • ofY/'y'p ■ Y ,'■. Y •• p : '■ •■' ' -- YYY „ • /,-Y • Y -
 as.
o f -thete''aympt oms 'had not -•-beea;vrQQ'ogn:i^s^<^fl^; ' _; I ■'' '.;7. '
\Y '- "'■' ' -. \;Xn’ - "some -.'.cases .'.ihereiwa's -- no - obvious-- .ppfedipitailng' '.;
■ factor and . ■the xunturo- '6f - Wo '-disease. remained- imfeoogniaed 
h eoaUme'-/..of • tho''.unusual/’sita? if-'■ - theYaffee ted muscles* ;7' .Thus - 
oight ,'cases ''preshnted - as -unilateral or - .bilateral, 'facial*'; ■ •/ '■ 
palsy'■fG^ea-WZWW^ wW~St. -
»539y fe^?YW776UY ':YY/y J;-/-'//' *. .. Y'-\Y
'.' / 7 ’ /- A;-' It - kill' be - pointed out • in. ■ a ' later ' section. . that!. the • 
imueXe'©'-.of '•.'r’eSp:lrati^on"..^:r'e, usUaXly!, ©pared, until Ythe'-disease - '­
is -''Midespread. ..•rthz^ougha.utij: the. -’mmseuXiatur'o# '. /'-Hverrhei'esa . ■• ’ 
one -•' patiept/-presented; with :-acute-'-'dyspnoea - -Without obvious. •.'• • 
.cause. ’-
' - '--/..Gase ME.382V A/map" aged 47 - suddenly-.- beesmiQ.'ektf ©mely' • •• .• • <'^i|y;,i1. \ '■ ' ■ - • .... ' ' , . . ' • “ ?.  ......... . -- ' , - ‘ " '
. ' - '-.J'shppY-if--.breath- 'while'- -at his -work# - ' W' collapsed' -but - , /--: •
' -;k''©-©onnrdoovered'k ..7 Six weeks. later- he - developed' doiuTblle' a - 
-! ; vision - /and'in - /another--'foup - weeks 'he..zsgain/-e©XXsp©ed ...-’. -
- . . •; suddenly7 w!thhiid&bi 11 by- / tpwinff ate - his . iuhg©*-7 ! ' The. ■ - ■ -.- - 
■ ' ••• initial/diagmoaia 'at :£^-i3a©s^u^a^,ty;. department - was 'I hysteria ■ 
■- ': op - 'disseminated.... sbieposisl'*'•, .' Be- iiok -has ...typical -. -'/. -■ -7 7-:
, .;7"7•^1/5m^fmS^^3eii^''-grav:^,f3''£ClcB^^yHs^u^^"^cV^©; syndrome<' - - 77-. .7" -. .' ' •.•• 
' - ' - •' ' •• There'-is a graphic /abodunt - of a -similar case- in.- - a ’■' - . .
'.•pepprt-.by'Sbwmpeil'Jf-I896)*. ' /.Such -a -dramatic - -oh©et -of ae'rious- 
syfeiptors ' without ’obvious" oau©b\©dwoany’ /leader to a /diagnosis 
'oxYj^pss^y^jh^in^ge^^uro^is^-^,/.- . -Thi0 - diagnosis;i© --.■pWiioularly -likely 
where -the onset' of - symptoms: -follow© an : emotional 'disturbance^-
- ^:tns^*-'’X7^f-,i:-thepatient- entop©-’the : - ■.
'"©o^^uli^^:^;x^f^-\^^oc^^.7af1^<53?.''-’^©yplri0d-, ofTrest/Zin;the. doctor*© /' . - /
waiting, room 1© ■ in : striking 'contrast’' to the' .dramatic - symptoms - 
.■described - by - the "patient* .. /-If - the - latter - - are ...relat e'd-.;-.to-'.ah / ' 
unhappy: love-- affair- 7.(/Case ---^Bpl^h, -?. - /quarrel© 'with'- wife.,
..relatives^ -.or’ negghbour©' /(Oases MPX906'70M35466 ’MB4G84 and - "• /. -' .
\.23*X •• '? ,.'-/j ...
./'W4l$6)' /ox* to similar. ’a'psychopathologtCaX \
■ o.<exM'Masi®n may ‘inCScapablef 'Y/These' /• fao tor© , added ' to■•. ,
’ .-'a-. lardt of •; alerthC©©' W the -pGSsibiXiiylof imry-stlh^jadLatgra^;!©, ■; 
';'' accbuht• ••’for'the ’ 'fact’ that meot'-ratieftfcS vfitbYthat'diabase -/• --• ;. 
. are' treated as ’-1 hysterica’ ® for •many '-month© • O'. years' ' before : 
:.;.:ih8• trad diagnosis ./f©-,' e.ptabi’ishedr •/ V ' 3 ••. /- ' - - ' - - - .­
v , - • XOase' HH3343’ ' had •■•’double . 'vision in • 1931 • and 'this returned' .•
' • at.intervals ' w th '.ptosis ' and ' facial/Weakneas?"•always’:’- " ■
/ ■ y- precipitated by .emotional-/upset. The' •diagnosis -of p ' 
.• ' 'V' myasthenia • gravi.©"Was'/n'ot established -until- '/’ ■ ,
• -'-'/ y. • in/January^ 1959 this/19;; year "bid -"-gr! ’;• / /
■' ' -''• •,was’-unable .to’ -speWc/after- a •long- .ride • : on • •&.’-'motor' ' ■
■ :/ ””.©dc>6.ter.£ ' 'Her ' jaw ’ 'was ’stiff3« . '■" This -Was• attributed; . / 
’/,".' ' to /cold but ’"it ''persisted- ’and .-•■■’'she • began ’to".\Gbmpl&in' of ’ • '/
. '• •?. Severe ’ -physical, tiredness*//. 'Her•'eyelids'closed -.though •. '
•.../';//'she• .was/hot sleepy*/ •'■•’Shetbuld -open • them • .for a./few . ' ,-••/’
'.• ”•" • - 'in two "months' '■•©ihe:-' kasyuhable • to • .support. '
■'** -; ””her-head yor‘..'to’stand w tWut•'assistance' *" 'We had - ' 
■/-// . ■ 'difficnQty .in.• ©hewing? /©wallowing’ an'd--'speaking. and'was .
' ' •’ 'unable''to/cough#-•• ■ -' /' . ’••' ' '// '■'•'.,' ’ ”- ’ ■■
., " .-, - in jth'e ’. following;10 months "'she,. Vma-in; three • .''" // - ” /
/ •' ' • pey<^l^a,ivt:^"3^c'iK^©a^iitaX© aid one large .tesching/hospitai •'.'.'
Y -/ - •* in /London/ ' ‘She’ 'was/put -in/ ’solitary -confinement;5 '. and .
• ■" ev<mtUaiiy•'shesattempted:' miitide*" • - Finally'ahe - was- /• ” ••. ■. 
'•''e©'eh?fey ”a psychhatehst who. • had'previousXywbrked• in ' ' ’ •''
- . Hew-End- HoapitaXy • YLadon»-,iaa<d.who iecognis©d ’''the • true,- ■ ■
• '/-natur,”” Of - the' - 'd’I'soy&er., jTh’Grejwas immeddab© .improvement -
. •. Y after- thymectomy.. In’ i960 ’though .'We still-requires ’to'~ •
"'r■taky'loyrindddt5^1^^ma^ne3'' ’ '. •/.”•,,• '.^V - . ’, /<•-• . * .
'.' SurtherYsdurse"" ''” r • ■ - xt,;. ■ , ■
, ’• .’-Mie ./.further tourse 'of /the tXIne©© is •.equally/'. • ' 
variable*- ’ • -Many ca'se© have /a -rapid, if 'not' .©imultanieou’s.-






the ...skeletal..musculature,* , ; -Thef'7, ' . 
p'©gno®i-/iss loss’ favourable in'- , those * earned# ,' .Stormy:' - • , / ■ ■ - 
Mathison ', XiMl )/ 'found' ,that'-' ,60$"f,' males *'(%rt,'paly ' $Q%,''of/ '/;'; \ 
'emaX0g0vWho'-develop generalLieei' sigmi/in the*'course;of '" .,
fa/mOntth '' dle/within 'seven years#-' ' /,'lA other cases* the, '/ /*'’. ' 
.spread' occurs*/gradually or, sporadically 'over 'a , period-.'.Of , ••■
months'', or , years# •• -, / ' - '• •'..' .• •**.-,.' „ .- . /- •
/ ,-• Lees'/often. the , initial ,/symptoma 'subside ' .and *no /•• t . •'•/ *'. 
•further --weakness '.ia.' noted - 'for- .a, long, ,period* ' . . The. ' . , '
longest-remission, of, this,type, in ,t>Ji€'t series/.was /-•' • ■
•ik' yO.ars' (Case described - on i ' Pa®e/ TO/PS/t^B
had/•©nd: remission', of. 10'years -and A. second ' of years ,. /'.'
but '• tbi.e'.-waO '/exceptional.#- . • "Ac Cdingfto-' 'th e, -descriptions .:. ■' 
'-in; current /textbooks, ; remissions ' of itbis 'type , are ' •.• ;• '-/ ■ •. ■ 
chnsrnisterits'ticYtof the disease but ••Ytiic^ES^s;• authors •'/with'Wide ,’/ . 
personal -experience '-report -'that • % significant ■remission/ ■' •• , ■ 
-occurs ..in-'only ;2.0*4O5#/.of ' all /puses; .(Kenuedy/And ./Moersoli19>?
■ FergusOn/• et • al^ /X93& 1' ■.Crop,•■ 1998y . pse©iman;,*.1958.) */ .-. / ;Th> ■ ■ ' " 
' higher; figures . are, from those- ’authors; who include -/remissions :' 
of one-'moo tt^s'Anu a lionif aiperiod of . -three -months •• ' *• • • 
complete 'freedom from symptoms• • la,-specified the Incidence of -, 
remissions’lie about .'220% '.'of■■'eases /{St^^o:rm*tl£ ,^tlii(sen, 1901 ) 0 ' ...'* 
if.- / ■../ /..-//Xii/tho-, present ;series . ;*valuable l/though not ■ ■ ■
nebehs&rily. -'Complete'. remissions/of snore •; than,, a mpnth'-• .•* J. '
'' occurred /In - fW/ex*>th®n‘.:h’ajL f' of the patients ■ and • usually 
only; In the • early /years -of- the - illness • <• unless the .'-natural • 
hist or y; waA;aXtered.-.by* removal'' of • the/-.thymus/ gland'"' ■. , v . ‘
•'• (.Chapter' 10}>•. ■ • EeMssions /'hpOasrts Xless:''ff©quest - M,d -ieo’s - 
prolonged -•&£?. -tim©'. Wnt • on *; /-.VMoy © ..than.' one ’..long ■reiiilssion 
/was.toew^- and .'the •^re@mi:t''^er:lee5/,.Bu'gges'ts /that if ■; . .'• •'• .. 
■ myasthenic' symptomsr return after. an;;-i£ib)i3/enc^^r//©f /a’ or • ,




















■ ■ : / . .
■■ mte-Uejrttsuatl# .•■..?
. KoXapaea ■ are' precipitated /by -.tbe same . factors ft© 
the fixusf attack©, principally by emotional -strain why .
■' infootion©'(-‘Hylaxid, X93&3/ - Thdrosiotiqnal strain • need ■ not. .■ 
■.••baewm«: For' in© tamo® many -.patient© with myaathonia 
■'- gravis aro 'troubled with -'ptaeto 'or dyaex^tbriu only. when ■ .•
..they enter-:‘a ox^wded room- or area otheuviao eratwr&QgtGtf ...--.
- .(.Gaae® &H9X7*h.I-JH6X50M» ‘ Ws was roeo^hiaod by;
T» ’ Buarawd' (X900) -but hue been-neglected& •■'•It-to' stressed'
- -here because of-- its .import-aneO'.An aoaeeGiug.-.-tbe. Vylfcer ■ '
• effect’(Ghaptoy i6): ahd"because'of-1-ta'praoMenX 
•importance 'to.-the manegount of -a'caa'o of myaatb.enixx' gravio*
•• - .Other.-4au©oa:;of-'temporary aggravation.- of nymptoms 
are menstruation and’, pregnancy ^Chapter ;8'5): and. oxtuomos- 
of cold or boat* • • A. stuffy atmbapli'ere or a hot hath are.
-. particuXas*!:/ drtetnubtog-to some 'patient®- (Caoos KRX08t
'-ni$388». wssa 8832972,WiUp- awf irofeo^y.
Thi'e- IntoXeranee of.climatic extreme© has- boon reported by -
■ftdg?eworth 0-9X0 -and MXsoa-a»d Stew; 09^3*
MX&psoo appeared to be-induced hytoociiluMon
•'■'•against typhoid (Casa OT6$O50)<>'.'' Case hod a '.wlapqo
after Connor 1 an vaccination and Ca©o©':S'?H/l?8/t*B mid. TiH5?O69"
had attack© px’uelpitatod by /oat'tog . shellfish- to which they
aloe' showed ©kin. allergy 4., Th^vanard-.'et al" 09^9) -described
.. the onset, jo £ 'myasthenia* 'gravia in association with, ©©rum
aiokne'©© .duo- to. injection of.. anti tc terms i&exnua six woeka
previously#'.-;• On -the other hand JSfcosm <X<&3) reported- two .
eases .wlutoh- ’appeared 'to improve after/'anaphylaotio shook..
Mg attx'ibuted the improwmonfe.Jo' diMnntion of ’permeability
of- theBvseie membrane* ■ • ;.'-'
Many patients were weaker- aftor•oleeplea©.nights -on 














.W620te^. MB62O^0^ MB29XMV . .It has W„been . possible _to
■decide' , Whether -:-these,!'.-ahd' the•, other5 factor's" just’' domribed . . .. 
are •'genuine/first• Wder< , offoot© .,:<0r: die-;to -a psychological 'Y. - 
ro^phasO'fco" -but. it/ihould%be'noted, , that "
• transitory.' deterioration ' ;is'.spneMmes.oanisOdhj' the same ■•-■■■ ••
"faetora -4^ . 'disseminated seXePeeiWtip;which. the ;pafchogohesia 
".may be paidtod , to' bhatypos’tnX&tdd' foy.myWthhmia gravis in
jhiis'.tiooiigY'••’ : /-- -. ?;-'Y’Y" ' - ' - . '•: '' ••■• '
'Y ;Y••'•/Jh'hf ' , role', ,of bright sunliigh't • • la .'equally ' pivajlng* . •','
TM©i-'■O‘ften.’eMuse^B , ptoad^a and blurring, of?vl©ioa# - - - /Xh.' , . / ; /,-■
'might-be , that , aorm'aX? people' have'/an '••ever'a«fciv£iy'- of the ; -- '
•XeV&tor©' paxpobrarummusole©'••to. o'ohj^'t'orab.ta -reflex • eye« -; ,
• •'bX'o&ttre, -in, these , cireumdtauce© '.and , that •;/this,, resp.onso ... . ■ • t
■ ^fatigues*. ’ in : thpY^ya© theuiO', - but - it"'’!" ' dlf f iouXt' .to /aoo oimi’ ' 
•■for the statement:''-Of ■ some /patients; (0*g*- /Gaae/ WA923) ./that
L -bright - ©anight , made , 4hem , • feel ,.•gshr&iXy /vernier ' ..oven , • when - • . 
■• it ■ w^s^'-'in^’t/ioso^cmpanl^^cl'' by; ennegniw’ warmth* -'.. This' has' ' been -’•/;•'• 
. no'tedrprevieuaXy'by •'WXXS^oa';and; Stoner (1944}*, • •/_ - •.
/ • /■'■/ ' Th 'fao tor© :i^i^^ft^^^;'hierO"’^^mvo^n’btJ^^l3^jg'-t.n oomm«m:Y' • . ,
except, that '.they reproseai^.: tho /extremes of~ the normal , - ,.
^environments - It 'would be a fair summay'Qf the opinion ; \ ,
■ ©XprSase&;/b .eshy ehpa'rtnre from-'the : ' • . •' ■
''norma:! routine? bo it:'temperature?' Xigllt>Y o.xoitomeot-er \ ' _ -
'.worry,- 'may oawde'increased,.weakne!!* •'■• •■•' '/ ' • .'•-' .
■• Yhe \av^tivet^and /?* , /. '■■' ///' ‘ ■
•. ' ./?"-. 'Ytl '' h&vX'fgrrned- a- strong'••impression-/that theloXinieal 
' abate .io•■ moat’- labile _ during - the ■ first • year© -after; which 
: there-' is- less''fluctuation, / Major'^.eiulSseic^iigs-ax’e most ? 
'•oomrnoa-within years /of the onset-and-it is much rarer .-■ 
"’/for ©'long reraiaMoh-.to/occur' after the /disease has '’"been '■.. 
©atablishod/ •' ' ;/■"•-/ •-' ••' Y' ;• '-.•-.' ■ • '• .Y ..; - •. ■• ’
■2?
for 'mope; -than- 5 years-'if ,/the,thymu© -.is .hot
-\.’removed/'(©imp sou?.-iBS?").**/ .' -As the presenee of --a ..thymic-- .
■ 'tumour- may/.adyerseiy.-'affect the pouiose, .oofth© -disease ? •
- ■- oases - without -a- thymoma wlll/be ooih5i^d<e-[’eti-sepai^jateXy; ib "-' /" ■ • 
Chapter ,3-/abd'/ln-MX '..statistics^ •'* -■ >•;. ; "/; '••'.> -••'.’/; •■//.
..• ■■'-,?/ ■ '•-Table" 2&2 'shows .the .'duration .of ilia©© before • '•'" * . . 
•..death- ;due' - to-.m^£lS^C^^^^;iriC'-^^^ixav:^s "-(excluding- /deaths- -dire©tly ;
a '•. attributable, .to -mirgepy or - to " incidental' disease)*.:/.:%t7 - ■ v .
• 7/will- ' he seen, that'-mooi --.of ' the -•deaths; occur in-the; - first- _// ■ .
■ ' year «. ' / Thi.© - /expert emee;-. is In'- ' agreement-. with - that- --of; - Grob. ,• ■
/ - ■••and • Harvey - - (1933)$, Bow! and et -'•al ;'(X956J -and /Storm'—iathiaenis •:
7 (1961 ", ■/ -.'-Heath - 'usua/tly- ..oeehrred ;4?7, /-year© - after -the/onset '
,'... of.•the';dis'©&S©y.wh.ether - thyieeo/tomy7v£s•oarrie.d-out.-'or' not ’ •
../Deaths from myasthenia- (gravi©- • per.ce/rarely •bpcitrred-'iaore-. ’ ■'
,.•.. -'. than ten./years sifter - the "pis'bt'"wf symptoms*- .There m'&y/b.e 
•-.- / persistent, weakness;-, of the / muscles. of' /expiration ‘ - • /•.•' '' - 7 ' '•
:./ '■■■ constituting - a - a on© tant hazard' ,.of 'death/ - from- a.sphyxidt io n /• <’
<•' ..-by inhalation if fox•T©ign'-*b©dies*- -/This 'may-' pause- suddon-'-; '. •■
//.'.death/lb - ivpaiionhwho' .doe©; 'notshow slgas/o-i-' -’.active.*' ■• ' ■
, j./ disease'*/*' Hovland /eVal. -(19365 .report/a; similar' experience, ■'
* ..of -the -^brittle-A. nature of the" -'expiratory reserve in 'some - ’
.'b'Xai©;.oases*-..C/ - /■-■///;./;-/•-/; /.//.<; .•••;•; ;■ . „/' y;./- 7-.V "
/• "1 7; g^g./M9933.e-: /This- young' -woman. hed- ptosi^'/ and ' diplopia./ '. ‘
.7 .-, ' .-when she" was.aged ' 21*• ■' -Lator/she developed •gb'neqrCliGed. /- ... 
/ . but it .was 'not-unduly-severe and w©re ■
■ - - /;sevbral.''remissions;bf/up'107X8 month©--du^Mon, //Fob -' '
"" ;. /--many. year©-shb ..led \a-'full- ,li fe - W--y8 ••tablets-.of/- ■.- Z/ ■;
1 ' //' '.neost^l^^^^i].^€^^/<lbi'3^:y*. . •Eighteen' .'years-'after-'the ’onget '
•.• ' she- choked 'wShie- L eating .eh oro^^^^<3-"je^id/-^he - 'wa© '.unabie:"-to
. cough " -up" e.; ''segment/ - which/Aas:'- -impacted' in -- her 'glottis* • '
.;/.•Beat^!i;'LP^Cp^d;ly,;<^^^CJCci3xrc^t^'' '^^s^^i^^SKa^Bph'yix^ai^oLoii-/^/// - /I ■■ '
-yCase/-//'' < . ' '. '•/ / ’' .■ ' /•. 7 ' 7 . 7 7 ■ ■ .
28 *
Case jINgglgZ-B,.' a boy.-aged 18, was very-well and without
..symptoms -while ' ' taking ? ' tablets of neostigmine daily 
/eighte'cii months. after . /thymectomy®' One. day. he,;stepped' .
out of a bath? gave -a sigh and died ineiediately* • ••
' Undoubtedly some.cases' continue to advance for many
‘.'years, but .in the average.' case'- the ^active'-..stage of-the- . • 
disease . is limited to a period of-4-?..: years and 'the' - . ■ 
subsequent course depends on the extent ' of the damage .'
" sustained during ' that ' period* 'In• Cha/ptex* 10 it will- 'be\
-.'shown that 'if - thymectomy ' is '' to • be /beneficial the .epei’ation 
must as a ' rule be.carried' out during• ’this -periodicSimpson,.
. 1958,' ' 1960a)* ■ •/; •;' , -.- V -- • • I- <• \ .-■- ■ , «
; . ' ' The c oux'se ;;o f '' th e; ' illness': may .be b enign-and 'the,. ' p
' affection may-' remain limited to ' a few muscles# - 'Grob (1933) 
stated that 20'“30% of cases show only ' extraOcular'-muscle _ •
■ involvement- Ho considered -that '-the 'further- -prognosis is.
'good "if there ' is' ho wider /spread ih ' thio.-'next;' -two years*? ..-.'- '-• .­
Ferguson ot' al (1953) ' agreed with' this -'conclusion in general 
but- reported that 3.6% of such cases.did show extension to - 
'other muscles.-after 3<iL3 years* -• Only' 36% of-'the-ocular ’ 
cases in the. series ' de.scrib'ed by Qsserman (1958) and? none 
of the series' of Storni-Math'ison (1961) failed to spread*
' Case.. •G{/QG-hha--rmyashenic diplopia 'and ptosis- ■ from-\ .
• 1923 He did not .develop gene rails e'd symptoms'until-
/ 194.3 o' ' These'were' '-yiofc , affected -by- thymectomy in that ■ ■
. year and he 'died ' ..three month's' -later. ' . .
■■■' .- '.." In my experience restrieiion-oo-- the ocular mumeles . 
has .been found’ An 6f ' '% of male patients. and in' only 1^2% 
of fomalx-s* -.This ' difference in ineidenco .from the other -
series quoted' above 'was' at' ' first..-believed' /to' be due' to ' the 






















; . 2?- ■ ' ' •'' • • ■ , " .
• ; 'BoOpxfctii for Hor/^.ad ao;may-Wvo/ bocni.a-Y’,' •"•• - ‘ ' :
.•selected;group as ' thore 'are Wo ' •largo. ■Departments of •• >
. Ophfchnaumloggr' •nearby. .which mightWciXeot■• the, purely • " ■
.ocular baeoer (Gijmmn9-•1953J<••. X now. thijxWthat thi©. • .
could not asodunt fofih2'’apparent’' differenco In/' '. '•<•'< * .' •• ' 
-e'xjuot'ioice■ Gince ? during the laaf oigf'b y'bhra? X have ' • . .'
/-seen (90 .o'aaes of myasthoala gravis--in /'Edinburgh ' including.. •
'- all .'■ those/ roferred'-to ' Ytho ■•Dop&rfcmnt ' 'ox* Oppthh/Walogy. at
.Wthe -Royal* -Xnfx:ma3yy«'-/' :Xn -no have /1\ failed -to db.toot / .'■■
.. iavol vembnfe 'of '•nook.' or 'limb mmolea.' ■ '! hollow that thie ■ '
ie due' to 'certain teohnlquos :of dxawiuation. whioh. will bo
■ /deGeribod'in ''"-the next '.ohapWri ••/•••" yd. .' •'•-> •
- .'-. •. ’• • • Tie Finch’lower iioi&'ewO'-.of' MduXaa•'oyosthmxa: -'•" ' '
' in .women# who •constitute thio groat'or .-part-of .this aeries# • ' • 
may, account, for ' dl^s^iif^xoat^monta. regarding-/prognosis*. -.Grab .•
/-/- -.(1958) oonmlders <thuttmwn/ hayo ‘SY-wow .proisaeG© tnan^wBen .,.
; 'Wherea-a /ih'jny oxpori'bao woman haver, had a potorer prognGMa • ,- 
than men unless treated by thymectomy ; (Simpson#. dl.958).*-- : •
,'flio basiD^- for ’thio, conclusion in. oot ■ out in Chapter1 10* ■ .
'-■' ■ ■ Hm p'rognemio IS# -cm-the whole# poorer if •■■ ••>• < /■ .
; jywi© -'is. n©s^Kate^^^c\d■'-td^■th■-' R-mthysRo tumour?, ••• .. . '
• •-Ruocnl'aj'- wdk'oQ .is ■ .uenally oovore •and -difficult te . '. .
control Wth neostigmine# ■ Newrthelosaa although / those •
•.■/ ■- gone realisations '&re,-MW ' guide /'tco prognoGia#- it ,1s imposMblo
•••'. to• predict/'•the 'oourne '•of., .any individual case#.- A .patient' ‘ •• \ 
..•• with rapidly ' -a’dv^a^^rdl.8ag ttay;^stho^sayxr^<lxuLxring high dosago of '
.' Gnt;^ehol:nuntcer?ase ' drug'A during the ■ "firat ■ year may. ... - . ,
,' • " have yMwprlaingXy'. little. disability' ■ 'when. the. .
•" •' Hines a -''enters the.. * burned .out* ; pimG© <C<oeoa, isW.32 9 $'.' 1112648$ .
; ■ ? • W26672 XBAoiX&# • . Oa iM . other
• ■. hand a: patient who..has ’had. many years .of /r<u^looiO'n .may . ••'
•••; ■nevcrtheX©© • enter*' a .rapidly advancing phase with, danger ■
to/fi’fe (Case NHHWsO .:' : ; , 7 ■ ./ ■
-•’//'. ■ • ' GHAPTEB 3. '/
...- . ' ■ S5!HPT0MS-AMD SIGHS.. ' . /'/'.'-'', ' i mW i i r rn xilIm-ll :iT~1niiiji^nwwriiwnwiiwwi ' "
A feature .of‘-'myasthenia .gravis .is. '.the--• variabilityi - 
/ in ••'aiuso.ulhr'-', strength,-/from-'day" to' 'day' -or even ./front-hour/ to”; ' ■ 
;\\hou>y1:?\!Phese\-eh'ah^es-';in';mttseula3? 'strength 'may be dnel'to ..
: physical exertion' but^/W'in the .long terra relapses^-the-;
'-. emotional, state- is; an --impo^tant:.'-'f dot or •'/-.■-• ’The cheerful/- ,, •• /
-patient;'who. ls?de.tex,Miii0d:‘'^€> '.get-.-WlX ,;ofteh has a .smooth'-;’ : ,
’'• dourse• - and•:is- • able ?.td>reduce--bis./medication' progressiyely #. '; '
Emotional/disturbance"Will-.'oause-increased-‘.weakness with.'- - 
■'diminished '.response' to•••ahtiohpiin©stea*a.S@«-medication' ,ahd;.--<;. ' ' •' 
-.-this. •'de.terios>ation‘.’m4y-.. occur, within.- hours 'of. the. trauma tier, ■
-/event♦;•••••?'Vory occasionally sudden stress.-may.-'initiate -a'
• remission;CCases ; WH£667£'’ and 'WKC/1HF-cite.a?in .
-Chapter//21* . '- ■ 'i/'" ? ' ..
- .Myasthenie.<v‘ -,.'•//• •••" - -• '/... ■
... •- ' .-. Bia-symptom..which-.differentiate©'-.the- myasthenia;
diseases, "from.; all' others causes of muscular weakness 'and ....
■ 'to -whi© hr the term ;?my asthenia is'".npw^ .pea trie ted’ inf the •'/ ..
•/■ &hgiiBhnspeakihg’: countries -»•'is;-rap,idly’•progressive, loss' ■ -
of povjer of Skeletal; muscle ,if - it. is. 'contracted repeatedly .
. without:'-rest or;if-a contraction is maintained^ • The >. .... 
. contracting-mttseieanhy-' lengthen-■.gradually if-it "is •;
'-"supporting;'a 'loadr-©if &• course- tremor-' develops*-, , This is' ••..
', interruptod’ by’ 'brief .rest //per iod a wliidh booome ..more and.-"more""■
frequent.until■ the. attempt to .sustain.’..the..oontrae-tioh"'’-ceases"'.'
(Fig*/3si'l.#-;:/-This' ia/often; described •''as. muscular .fatigue * *
-. It -.'is--., entirely- different- in, .nature  ^from /normal?- fatigue-', but . ■
•' .the’ termwill • suffice-,for •descriptive' purpose©.'since', there
’is-.-hd,' convenient/Knglish term*. Gradual- tfatigue* is.not’ •
. always, seen and'.'failure of -contraction '‘may be- midden,!<.f
■ -. . •- Because/-' . -■ > /f ; ,
31.
. '■ Because of' the .undoubted "effect .of-'physical." --, ' . ' 
exercise most - myasthenic/ "patients become -"weaker as the. 
day progresses » .This ' is -'®a textbook .symptom’? yet " some 
patients"-. arc, at their" weakest soon after '.walking in th© - 
morning - (C.ases"H.#E0/H8, mH474?j - MK9174, KIA2883, W5766) * 
This'cannot be, accounted for by lack of 'nocturnal treatment 
sineo - i t has - b.e en noted by several patients before -the- .
- ■ . diagnosis ' was - -made . and - • indeed -' this - , wee.... reported; before •. - 
the introduction of- anticholinesterase/-treatment .
(Auerbach?, 19Q2§ Boethby? 193M®, w With".dung. treatment 
some .patients ar^e very weak. i^ti. th©. morning » rapidlyt , . 
improye.-twards theLfimddle of "-the- day--and -deteriorate-. •. • 
again -towards,..the;'O4^<^t^ilng(/(U5?nent,■ 1953Y: - ' "' ;;
'Muscular atrophysY. - - ,
..' Recovery 'with, rest or full" medication is often
■ ■' ihcompieto *, -,a, point - which is "a’pp&xrently/ unknown. to -somo .
■ authors who have tried - to.account for myasthenic gravis. .
entirely - on the " basis of, a disorder of transmission.- at
the neuromuscular-..Junction* . The practical - importance .
, of ' this' is.. that ' full-: restoration - of - - power - should / not' always- 
"be 'expected 'from 'anticholinesterase^i'eddeht:!l0n-or*. from ' - . 
thymectomy.',.; -A. patient/may,, pps^from'/matthenic'to.' :. ■,
’cholinergic ® weakness* wi.thout-. an- intervening s t&ge- of -
' nori&X,:m^st'uXar.; power {0hapter,.'-L9)* ....... - , ..,. •' - " ..
.."..• , . GtvpbolT - end Bramwell "/ (190O" - ".empilasisG.d the. - rbsence 
of - muscular - atrophy " .in iya/thenir. -gravis '"though it -Was - .. 
mentioned -in - 10 of -the.. 60 case^. reviewed. by them mid ' -this '• 
statement/is.-,reported- by.most- authors..;wbo' have "written-.•.• • 
about the disease since, then<" .Permanent weakness with ■
wasting; of muse lee, (myasthenic • myopathy*/) is probably 
more common- than ;generally -believed, particularly in . the
■. .extrcoeular/• • •" •., '• ■ :..' ■ ■ ■. •’ ' ■
 extraoculaa* ..muscles$ ■ tricei?© • toaobli, iliopsoas $ .- .^nadrice'p6
ferncri© and '.tongue:. (in that••order)*..,; in' -this series;
• atrophy'.was present in 10%-of female and 20% of male,-.
- 'case© -(Simpson; -1953j. t; WaotlxMs of the-tongue occurred
in' 12 patients'in the. characteristic;distribution which.. - ■ -. 
causes three parallel '--longitudinal furrow© (Fig® 3,2}®
/.; (Oases. KH/EC/DH, KHW5?O9 nH6l^9^» MJ&269* MN29V' W19Q6,
' W252?<;MH3251» ^6993,:.'W738)< . The. ;.
' tripl'e^fnrrowetV tongue - is sometimes named-after Kinnier; 
Wilson (195*0 hut was previously-described-by Erb '(1879) 
and F®. BuKK&rd- (19Q5)>> and-other writers of that era.
. (Campbell and Bramwell> 1900)®. The treason- for this , . 
selective wasting is unknown*
J 'have previously deaci’ibed. a woman -who had a 
benign myapathywith myasthenic features -(Walton, et al/. 1956) 
As its -nosol'dgicai position- is.- uncertain-, consideration of
. this case will .be deferred until - Chapter -.8 which, deals with ■ 
congenitalmyasthenic.syndromes#■ ;. "
Some 'patients with persistent weakness but,'without / 
the -.’.fatigue s phenomenon and without; further .response to
' neostigmine 'in ' the 9 burned out stage of-the; disease 9 / 
show a pai'adpxical -improvement -with moderate'- exercise . and .-
. are- at. their -weakest' aftex^ a- period of physical rest*
Most of -those .' patients--have boon males® : (Cases GK/HA, BH/BC/ 
NH/FG/KW;--WX95o' W3i629 N06Wo8 J3H615G5'9 NH62041)
This paradoxical phenomenon has been-/referred to by the 
writer (Simpson,. 196tb) but has not been -described by other
- workers• ;. .. -. . - . . >
,. Effect of thymomag ■ ■ f
There is no distinctive clinical sign of the
-presence of a thymoma® ■ It.is often accompanied .by a 
particularly 'sever© and progressive type;-of-myasthenia
■'■-'with/ ■ ■ •- '' .
- ' ■' . , ///■//33. : ; : •< . •,
with -p'o’o.r-r espouse. io. BeoftifineVV'iY-h&y© hoW 'fouhdn/ • ' .- ../ 
a " :"thymoma " in patjUmt© " who. have had myasthenic weakness .
roe trie ted to the' ocular" muscles nor has such a case ..' . .
been -reported - by -others (Simpson? " 19585 #/ /Neostigmine.. .
"requirements averaged 50% more-than .IhaV-o-ihott* tumour, ," < •• . . 
.cases and the' -incidence - of •,vaa\iuolrhigh©r'., ."'■"/ .
- .'(X0% in - " and 22% in".men? Simpson? '.1958) « ' 'Thyroid" . . .
" disease-occurred--with similar frequency.i'n both- grdups % ' . . .. ,
and. ' there was ,.no special " tendency for-hompliee.tioho ' -'■.■•'
described- in' later' chapters io be -associated with - at-' ; ,
thymoma - with the exception -of. -.aplastic anaemia -'.(Chapter 7) - ■. 
end•/the//pre©enc'e;.-oi. a'iireulatinv. antibody against 'mode' .
;(-Chapfeer'':/i5)* :JM®weddtie.has ' be.eh'-- reported by other '• "•'' "
' workers .only in cases -with a -thymoma .(Mendelow -and . Genkins» •• 
.19541 Chapter11)# ' " • ' . . " '.’;//" ‘
• .••- Sopc 'ppeienid with .a'.-thymic. ■'.tumpur’’ have =a,/ benign •" ' ■ -
course’-‘and/" may .respond "/well" top thymectomy -- ( Chapt er -.10), ' ,. '• -/v
but -os the whole the " prognosis Is -much worse when :a-\iimottir
; is present in - the. glamd. For this " reason it - is - id visible • -
to hav-e' lateral • as;" veil. as poat'ero-ernttexicr - radiographs9 . • - ;
With 'wll -clpaeat■' plLrbts , it is ".■,rpr,e '.io-"-a ■ thymoma.,■■ , -
. < Fig*" 3 ? 5) <. -.' Many - experienced; radiologists - ( Good, 1947 )
’.'do- not consider..-thait ."there' 'is any" advantage in using , .
tomography,./Kemp Harper?- 1952)-, .. . s<£toulfer.'es-. et- al;, (1934) . .
'and Hare/>nd-Mekay?( 1965) ‘outline. the 'thymus" -by- ' ;/' ..;. ?
insufflation of 'oxygon - into "the ‘mediastinum,An example - . ;
of this technique - (for which X am indebted to Dr. M- SuBiirling) "
, is shown in-litg# 3$4> . It -is-of’ doubtful /value - as a routine' . /, /
' procedure' since thymic turAOxurs are -u^sua3-iy identifiable • '■ .' ,
without the injection' e.nd the sine /of;" th'e;'nonAneppl&8tic 
gland is. 'not closely reiated to- the' "severity of the disease. ’ 
Calcification may be seen -in- ,i -thymomai / '-.Itis- .never;.. 
present/
present •in ■ th© • ■ 'hyperplastic * ' •’ of, /thymic'-' enlargement';/ •
' . Muse 3.es af f ec ted § ' _ '. ' \ ‘ ". .-■•' - • •/. '. , '■' ■', •. •' '
Myasthenia gravis affects only striated muscle- 
' and never the smooth-/muscle.’of the - /viscera.' The ' ' .
possibility of affection of cardiac muscle will be '
discussed in- Chapter 11. In some cases a single muscle
. .may' -be affect'eU'' ' Rarely-'extension' of "a;'single finger .may ■'
be weak' suggesting' that ' the; pathological change . may be. V
. confined to .part .- of a - muscle. . Any ' skeletal muscle may' ' ' . 
i /be-; involved? usually 'several.. at -a time^but some .are -'more'.
; frequently involved '-.than' o there ..... Fig. 3# 5 - - from. Simpson ? 
(1964c) shows the' frequency with which -muscles may be .. 
affec lied - a). as -the . ; ini 'tial.. symptom, and b). at-any -, s t age • . 
of - the. disease up to -the moot. recent time: I'.have; examined ■" 
each patient;(10-15 years for the majority of - eases)- .
. Spread to previously ..unaffected- muscle's is. rare after- the -• ;■ 
4-7 year ’active* period. ■ It will be; seen -that -the'--//, 
relative incidence of' involvement of/-muscles -at some -time 
■during.-'the course of -;a - large - series'.'of -cases follows • '
' closely -the probability that - .--these - muscles will be 'the . ■
• first- to show myasthenic signs (0 inrpson? -1960a) « The '
distribution in - this series closely resembles -those of 
■ '-Kennedy andMoersck (1937) -and Oeaorman (1958).. /
. .‘.The - ext.raocular muscles -and -ievatoi’oa palpebrarum .
are -.most--- frequently involved /.being .affected at. some time •. ,
in more than 90% of.oasos*- Transient -ptosis or diplopia
.- are by. - far- the most frequent presenting symptoms .('Fig. 3$$)» 
Unlike neurogenic disease causing these symptoms the ..paresis 
ofextx'aocnlar- muscles or of a levator-•paXpebrae, is •usually-.
. associated with weakness' of orbicularis -ocxxli on one or 
bo tH‘‘sides. . ' / ' ■■ ' . ..
' .- ■';••;. - ? The/ • / ' ■. .. /<•.,'■ /'1 ' ' /.. • ; •'
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. The -next most commonly affected muscles are. the- -• ••
flexors and extensors of - the - neck? the shoulder girdle : ,-. 
muscles and -hip flexors In that order’? closely - followed.
•" by. - the .muscles' fox* facial expression. ..(Figi/3??)? mastication? 
swallowing and speech? ■ There Is a strong tendency for-
''..the -proximal -muscles of - the limbs to -toe more severely -
affected than - - the distal, - a distrlbu.tibn-.more characteristic - 
of -.a myopathy - than of a neuropathy* "..T^e upper -limbs art 1 
more- .often involved than the - lower and Indeed the average - 
patient -is'unaware -of leg' until this- -is-elicited '••'•
/ by clinical .oscaminatibn,. In the upper limbs' the extensor 
• • muscles’-.'are more-'.severely affected-than the .flexors?,: In ■. ,
the, lower limbs« oh - the;contrary,:, the-flexors are.-moreo?’’ . , , 
.Of tea --affected than the extensors.- ahd..-wbatvtGas. is often:
■ confined - to.- the .hip flexors* ' • - p. /■.. •' -’- '
.The erector, spinae -group ■is;"£re$ueatly. involved 
but other - 'tnunk- muscles- usually-oacape in the milder. < 
eases* Respiratory  - -.and - abdominal muscles - are? fox*ci^ui.n?.tely?
' usually only.involved - in the most aevere cases though they . . 
may sometimes be^among the -/.earliest affected* - One example
; of a case’ prosedting as sovero'inspiratory.dyspnoea of- - .
sudden, .onset Is'dsfcprbbc’d ’.in .Chapter "'2 - (Case W38S)*..
• 'Symptoms - and signs s . ' • '' ... •' - - -
' Symptoms are '.usually - confined .to-. the results -of . .
' weakness /of 'muse.l'ea-.whieh-- are- ’ fatigued ' .by - normal everyday
use or - by-a 'particular jaoyemmat'- - required- -by the patient'® s ■ -
. work or :by a daily -.activity such as -.'typing-or playing, the .. 
'-piano (Cases NH33&539 /H62026? MH809O)#- -This -'nfay lead to
•• a wrong .-diagnosis of-.'a craft palsy --'or cramp- ( Simpson ?- 1964b) » 
\ Systematic examination may -.reveal . Unsuspected' -weakness or
fatlgnabllity of other - muscles? but examination must be .
. 'thorough// • •. ■ • "" ■ ••' ’ .- ■. . •• -
3& •
thorough .and . include contraction maintained against 
X’.ooistance; for an '.adequate period* ; This .’point;-ie:- stressed 
because failure to . observe, it may account for the ';/'. 
discrepancy between .this series and.others- in the 
literature rogax'ding the proportion of cases with- 
myasthenia. confined to the ocular muscles* ' - Many/patients 
referred .to-me. as bases of. ’pure ocular, myasthenia9. were . 
shown to have, involvement;..of obhcarmuscres-v;h©». tested to 
■ fatigue.9usually- of' neck-.flexion and-'abduction-of the//,'.-/•'•
: shoulders >"(Simpa.ons. 1960a)*. /’’ On. the other hand, many, 
experienced physicians refuse’’ ‘to •diagnose myasthenia 
gravis in the absence of.ocular or .bulbar symptoms. •
Fig * -3 3 o on f i rms 
for this point o f
that ••’there? is statistical’ .'justification - 
view,, .- but there is no doubt- that .
'• severe myasthenia may spare these muscles and .present 
•in-unusual • ways* -
"/ptosis'may be- unilateral or bilateral (Fig*
It. commonly changes from; one eyelid to the other .without-
apparent cause* Ptosis may be brought on'by bright , 
sunlight or by looking fixedly at.an object above eye/’•■'•• 
level• This manoeuvre provides a ’useful/’diagnostic test 
(Chapter 17)< • It is equally often precipitated by 
emotional disturbance such as- the ..entry, into a crowded 
room of -a pati exit/ lacking., self-confidence ( Simp's on d 1964b)« - 
’■■•-. ''.Double vision-may • dlso be induced■by embarrassment 
as well as by directing- the ga2se-...as-..in reading*. The two 
;-images raay.--separate<. steadily or„- very..charactfn”ist3^c'ally, •.- 
one image may appeal*, to islip® 'suddenly (Simpson* 1966a)«
■ The unusual and-variable;nature of the/diplopia may. cause 
.diagnostic difficulty since analysis' will.show- that' 'some 
-.but .not all muscles supplied by one.-or store of':th’e--III* • XV ' •
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or Vlth. cranial' norv© .on one -or both sid'OB is weak* • This 
-very ••fact should immediately make -the 'ophthalmpoogist • ,
■ think of myasthenia gravis and -suspicion is increased. .if 
there is also ptosis5 and weakness .of orbicularis, o.culi*- •..•
.-...The separation-. of''the .visual. 'images increases if the. , -,
. patient*s gase is-‘/fixed -on an object at the 'periphery 'of
the visual ' field and one or both • eyes may be soon to drift
■ ' back '.towards . thO primary 'position of ga%e *.. '-.Sometimes • -.this''
. is corrected' by-an . .'extra-voluntary 'effort* .-This' 'causes • a—-.
coarse nystagmus which may be monocular \or binocular* • .
'The• most •severely 'affected .rnuudles are/the' 'elevatox’s •'.and
■ abductors . of ‘the eyeballs, but • commonly .all'. extraoc.uiar
: muscles/are affected* There -may be • severe strabssrnus but 
more often' the'- eyes' are<in the' . primary< position with only 
5-10 °/of voluntary movement in each .Mseo/tien.*: . - /
'■ , ■■ ••. . i have never ' personally ' seen 'convincing evidonco ■
of 7 fatiguabili tyf ' of the pupil ' reflexes 'but ' it was 
recorded in the eas^‘li.er -case i'ocords of Casej A/h 6131 ' 
and' has. been ' described'- previously ' by Mark©!off • (1912) r. -
. Fatigue./of visual ' accomodation may bo' 'more ct^m^o'n ■
. (Font&±ho?'19'52? Rabinowitoh/'and F©ngrjehbvsky» 1935)* .
'■' Franc ole ot al ' (1955) ' consider ihab/there is;.' no ''definite • 
..evidence of ' ’pupillary' abnormalities in myaathenia gravis*
. - ••'• . Weakuess/of - the' muscles; of the face ,may ' not bo , '
noticed' “at/ firs t-'"by the/.patient-.but' in 10 ' oases -of'. the ' 
present/', 'series it was sufficiently -s'ev’ere' to. be/'diagnosed ,
■ as- 'Bell'©' palsy until -'-the‘further course'revealed ito .true, 
nature* ' /The correct /diagnosis,'may. be;suggested by some- '
•. anomalous' features *. ■;//■ ■' ■' / ■. ".'. ; ' .• '. ...
. Case MB8088* ' ' Tints' '.young woman was referred :as a-case
, of 'Boll s-s palsy of' -.the right side ' of the face but
•. remarked/ ,, - • '• .. .. ' .. .
thmiv soap '.entered: her' left/ ey©*?' \ The.- right ?. - - ■ 
lower/face was ' weak/but' the, left ' palpebral' fissure Was'- 
•the larger ‘'and. .'elosur'G bf both, ‘©yes. ema' 'slightly weak# .■
. Furthere examination.• pf neck flexion
and; of ■both ' deltoid?', muscles# ' •?./•’ '.•,//■"-. ’■'. "’
' './■/' i%o. patient may ‘/not be . avax'd of' facial ..weakness but
friends' 
'snarl9 '
notice ‘that the. ’.smile i'e distorted into : a. Vertical 
(Figs.- 3 Whistling may.be "•impossible' and .■' ' ■
women -'find difficulty in; applying lipstick -because' of ' : .
failure to/paut/the lips'and .to 'r'olJ.i'-teal.'in 'the ..customary 
manner#■■ ■■ /. . ... • .'/?.; y.'.'//-. ■ . ■ ■ ■ '
. ■ ‘Veekness of the .. maoeoterb Is ' common .but may, only ..
•be 'ho tie ©able. when chewing . tough meat* ‘ -?/:?It - should . always 
be ' tested -for.;-'by -asking, the patient ' 'to, hold -hie 'jaw open/' 
and ‘-closed' against' resistance 'for at 'least' 3Q ' seconds./ 
Weakness may - be ' so great - that ■ the ' .patient may bo? forced , 
to sit with ..a .hand supporting lier1 'jaw? especially? if'/the - . 
posterior 'ntiehal imiscles are also ..'weak* ?,.:‘ Tie posture is '
eo .typical; as. to- ‘suggest myasthenia gravis‘ when, ke'ea. .to be 
hakltua!
/'i ’■?; Involvement ‘ of the striated muscle of the pharynx 
•leads to dysphagia» ' S.wallowiug• /miay' be normal 'at .the . .'
beginning of. a meal 'but 'becomes;-' impossible after w few / '■-■• " 
mouthfuls* -If. the tongue is./&feected- there is ‘ progressive 
thickening of spoeohy• and;'if; laryngeal and 'respiratory 
muscles 'are affected thex'e, is /c Impac t oris tic ‘ - fading ‘of the'
voice ‘ after speaking- for a short time* : ' .- ■ -. ••
' Weakness of the limb muscles may? surprisinglyy be
ignored by the ‘ patient -'until it /becomes olfiant'./ Quute i . 
COfiBnonly inspection ^.ev.e'als.; unsuspec ted keeikwjssg but ' only 
if .the patient,is exhorted to maintain muscular contraction
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- agadniV^roMs-taiea ■ /.for. a ' 'suf f ici'shtly Ylengthy plr£0^!'w; if 
ho- -repeated' maximal -contractions. -for- tho .a^iam©:^^p^2?:i^^ocl*'
Kor’. instance women 'often. notice'Yft&piahllity . of the .‘deltoid . 
muscics' .'••as-they .are ...forced ' to •.. stop . .-for . a/ rest -when, .discing. . , 
.theii*' hair ."or . doing-work above .©boulder-'/ level . su<?hTa© -■< .-. . 
‘ hanging'.out/. eIith©s on 'a -line# If a. ..patient with these ', ■
symptoms.. -is asked'to hold the .arme.'ontstretched they • .
.■ gra.dua4y‘?sag in ./1©©s .' than a ;pW_iiwte » •'.•'-.. A,';coarsc' • tremor may • 
.’■develop/.’(Fig*-- .,3$1)< ■'.•Th© arms' arc 'dropped .for 'a 'Second. • "
then ' 'raised again ' .iwwlet©iatoly$ ' '/only'. -‘to .be '.dropped .ohoo 
more* The' cycle, becpmea ah or to 3; and ;iahQrier.' until .-further
amn» raising -‘is/. impossibiet - -t The-'sudden, drop of the /arms .''• - 
and ■. the' renewed ".‘effort ' .has .the ' • appearance., to • the '•: • ■
ttn'acluatowed. eye ?' of' a ' hya terical phenomenon* It is ' a 
genuine. paresis and . the -prompt rest oration is due to pos t« 
tetanic facilita-ioon, (Chapter 15.)'*:'''-":• . ■. ’’
' . ' Y ' <.Weakness •'•Qf,•,.•thi triceps ' may' not' be Y evident/to. -a ; 
patient .unless his. ..work requires its’ us.s as 'in sawing?, 
slrttVbing" or "pushing a. load# . It is/-.in /.fact? one of . the
'■c^OlwwGle©t' muscles H 'undergo...permanent.’ 'myopathic ® change ' 
yet ' . .‘the patient '-is' often, '.unaware ' :iY-' (illQSO» -11917.4-$' \ /
NHM1759 Mt61'4-3i? MH62038). Wea/Wess of' the muscles’'of '
• the forearm -and hand. 'cause d^lp^Y.wi,st and' weakness of .the. 
grip* Y The patient/' 'having' .••.started' -a-task with.-normal - .' ■
' strength/■unexpe.e.tJ^cljiy' drops •••ihat©ver.•.hd is holding* . - It 
will' be' observed.. from Fig. 3»9‘ that the forearm and . hand 
muscles' are spared in more. than half of . the -cases#' . ITis
".is -'an ant '. fact '' to ' 'remember,; since many conventional. ,
oi»glgyaph:^c.-J^)3S’•./elec)^3ilip^c^gSX*iap]^llc^^. tee sts utilise these. .,- . ■• 
muscle©#' • ’ . . '-/./ YY , .. y yY:''' '“'••; :
■ ,Y..'-• The mostYcommonly affected muscles of tho ' lower - 
Yli'rnbs/Y * . ■ Y Y,'Y''.'.... Y'••. '- Y/Y .... ' ' ' ' • •
 liiw&b&Se v'-tii©/'iliq^soa® \ and/quadfibePeh. Y. TheY patient .
\,; may" -only '■ hotio e,.'diff stottO^'-dli^na makingstnp'M& -on ' ■
; '7enMingn^\&:;bu3/ but " 'eVnm^WJiiy/';^eg^^^yn^y ifoitire • *6h Y/tMWy /"*- 
'; /being' Unable fo cosvrolete. the :;^a^©en^h;# ^.t'xezxta; /?/.'■- /' ■
.. oomplscthed. ■ qf' sudden" / the ■ ' / // :.'
.„ Xeg©.nrlH^6utYwW*>jr^nig'grati^^<5t^e^* " ■■/ ’A'UBeibXyMt^d--<of ■ "^©tihg; ■
'and " •&ddtie tian'" ’ 6'f .• the . • thigh® ? is. ' to ' ask .'the ■ -'patient ' ' 
•:- : tor ©ftyon .tho/; edge/pf a "/tablo " -and ''theh" ho/djr'dSs 'each1 /leg..
;' owr /■fho/'.qohqr: in , thrgi'..for" onia' miaUtO., oO/ uhtiii tihe.' gequenoe 
• . is' /tersiiaa ted//bywyeakhhsss*//. /• \:g‘ ? ‘ I / /•'•''//•" • ' ■'' /■ >' \
’ • >•.; '■’■■';■> '..in /yery'-'sey-ere. oasee1 ■ WL1;liibihyyiyem«^^ih^;, of the' " . ■'
- pelyinmusouXature. -therq/may be ■ stress■• incontinence /of • ■ ., 
g■ they^c^o^#i;/ooyb:^£d^c^c^3?;:n^30555vy^W^»4^^W^*^; Thin is- :
/duo' t^^o.•• Yakkess, of. , the. . external / sphiqo ■ ters ';Out ' smooth , •• '
; mthslexta-sieVer; affteetodl/' " >' ' . • '••
■• Heflexess %.•/''' /'■'• ••’•'. - - ■ ■ ••/ ;. •'.•■'•-•'••■.
•;, •. •;;?•? Tondcnyi.reflexes’. ''are/ .usually’,/ present -despi t'©.- //•,' •
"i /. s t&'temqnt/'- toyth©.o/mrt'.r&ry ' in "-the"/mW ori ty ' of Y. textbooks;# / / , 
?’ In ■ fao i'"they are. 'usually -brisk and’ gay ' "even. be elenio/ •'' '/:
. - ' (Campbeli/ ■andaBq&raw©$< 1900 s.YYimppon». 1960'd.) .* '. ©leY / i /
.. - observation'/ha'Syhe©©^^/.previously•’-■by -Shaw, <1890): . Wd.,' '
. G;o!,dfl£m f1893 )* " a’If . /a " tehdph; reflex La elLLaited
■,, /, r epe'^i tively - the • j ©xkf ’ may deer ease’? pro gr e ssiy-ely am til - / ''', . . .' 
,/v . i/t' ’.'disapp,e&3?s«./" ■Ybbe.iws'e. ofv" a'/single,tondpa jerk •. may? be Y"
, Y/aY/L'nMli^^^t;^ron '©'myopathic ohab^g^e^'$/ "' . "-'It moy/00c'ur 'quite ’• ■ ■
> ; YeearLyYfn. :the-lhLs'tc^:^3i^'0^^y^/;ti^.diieasas^^vbut/i® u/^su/Hy" ay../,'- '•'.,
■ ;late" riani fes tatiohk". ,.. Pex’siateht ■ abaehco’- "of '•many-. roflcXes ' ?
' ' ‘.shouLd/ .suggest/that/'the ".Ywefakness" is ’ /due ’to''. oarG±•no®ahousi' .■ "
■ ’ ' ■ - rathef ./.than?,.myas.fche&ia gravis :■ (Chapter 9) # "/•.-'•" /■
, •, • T^e .■ plantar f ©'fl/exes''. are "' usually phy'htologioal "■ in / /, .'. =;' •
. //, ii'hepmplieat© /myasthenia"/gra-vis$/. ■ '/'•■- , '': / '■'
//.'"■/ /•" /<.'' Severely ill, patients - of ten? produce - excessive •.'.'. •
- i'•quantities/ <•, i". . • ■-•.; ./ . - /. / •• . , :. '.i’-
pnanblMas s.oX‘ frothy; secretion in;;iheir, wmhh_• /• . itM •'/ . 
source■ is.’u:»e.e2’.tain< ’. When 'it. is-,associaibdfwith -the '- 
use; of"’n'cosiigsiine" or,;similar*-.•drugs'. i1. ifeipf ten.;salivary7in 
origin^.but'",thick; glairy., .mucoid,.seerebi on -.was-•neperted .’ '•;■ , 
many ;yeaps .-before the,use' of-.'anticholinasfeerase driigs/-.'. ' 
C^hawii-lSSP');*"- >?I'b ;'i& ..sometimes the,,cause' of; death; by'.;; '••■ 
asphyxiation ••and;,, at post/-mortem examination-'if..-some times .., 
appears;•£ft. haye.'ox’iginatod . frOm ..the. bronchial ;muc.oits -- 
glands^ ,-;. - .' ... --; ■' \
; ;.';■. ;,-.■, ‘ ^ceseiye;; sweating;^©.'" also'/-noted'; by ••teany’ .patients ' 
in ? the present- series', even. he ford; they/started treatment'* . 
Xt ,is possible .-’that,some.of. these patients ,had. ■unrecognised 
thyppioxL bps is; but X- hayd^nof/eyidene'e' on ...this, point - '■' ;' 
i’dasps; WH5S2'jNHliiOg ,< 5/ HH35131 i-i NH3371Q , ;NH4551S,
;nte^02)y '; lf;,ia;ihtereptinf?;to' note 




. , Vheh:this study was commenced.I accepted the 
conventional' idea that. myasthenia gravis Iwas -due to .a •
defect' of neuromuscular . transmission*■ «’ Hovertholess ? - in 
accordance with. the policy of recording without prejudiGe 
aXi'syinptoes,-. described .by', the patients examined? the ... 
foioowihg Lni^fo:LLiaaL^5,nJ^--wa3 'noted'*-. ' ■ •••'••- .
Pains -
.. Pain in and around the eyoa? the back of the. 
neck and. the/shoulders • waa. commonly .reported*It was’ ' 
"aching- ini-type* /A. few patients ' mentioned .similar' pain 
Ln other - muscles after. an -.attempt to' -prolong a. weakening 
contraction* This suggests that the pain is'associated
‘.With the extra effort - required - ;to maintain posture* Some 
patients also, described pain'in the ' shoulder girdle at the 
•onset of the . illness' before . weakness Was noticeable* From 
•their. descriptions it 'appeared; to be similar - in type to ' ; 
that which is . of ten - -found in polymyositis# • . . ..'
: ' , . Oases'GU/MO* Kni6?l'$ "ilHWbo? Nh^^4?69^» WH53369 
and-..W332 described -.brief'attacks qf 8utostornal pain, ' ’
especially, while. stooping# -The .Gause Of .this is■ niUcnown#
Hone of then had . a thymoma and. -the pain/did no t 'appear .to 
be of . m;>yx;aj;diui or ..pericax'dia.1 -origin* ; it was sometimes
' associated with palpitations* .-Pain - of this type ; iss ‘ ' . .. 
mentioned xwithoutcomiaraen't by .'Hyland (1936) and Russoli (1955)
Par’&esthesia and anaesthesias ' ■
lHr,'r]P'.n>TlinWu»M f.-i»iiii*>Arrt»n.>u»ir>«r^Kj;’«H»,-er> .
. . . '• A .sensation of p®S±fi'xxoni® ® of affected muscles is . 
more common.than • pain* - This is . not uncommon in motor , 
disorders/ '• ' ■ - • ' ’ ' . 'Y -•. .
disorder'©.' owing..’.totthe' 'lack., of a.''Suitable .terminology - for-;.'- ‘ ■' 
the 'Idyrndn ;t,b .-'d.escribe /the'• sensations; '/^jxj^exrleneod whenia•, ' 
limb/ iiS'/Wealki^-'-"^b:' thia <cohtsx:t/-*humbhe&e>/Ouitf. wPtoxY-1 .-•< '- •.'. •' . 
implies .inability to .'move ’ the/ phrt#. -•' -Acroparaesthesis' duo- - ' •. ‘
' also .' -/// /<
case© .pMofePs mbs't' • '
W082$:. rn2>7f «Q93Ymi45W$ W09*.abcm.
MM??:£O ..■'ail mentioned ,tiaasient parses thesis©/ of the hands • *■ 
or ••••thighs* These'., oonld; W accounted /for- . by -tr&otioa orl •;.. . . 
•pressuro. 'oh jporipheraX ''nerves- .Oh';- by .- unrelated disorders ./'"hl/ ■ ' 
shell hs: cervical spondylosis* .-.'Some 'may. have •'•been. of the/ : •'. 
.oamo nature •. as l-the -parses thesis-• which'\ is/Sometimeshno'ted'.t •*' ' . 
by patients-,.with.%wehlab• 'dystrophy .who 'have ' to/, lie for 
lohg .periods',.i-h''bed without' being.’ able efco'fehangditposi'bio.n*5 / . 
Othe'rs'. 'may have been • associated with’.' hyfperr^entilatd^on# .• . , - '
JHeverth.eless ‘when. tall ' these causes of abnormal sens&'ticms ';/. " 
.were ' excluded •/there. remained; .a. -small, number of eases 'with'' ■ 
u:mieE^lnx:^nied;;i3fiir<aesihesia -"or actual. aehs'ory lossi . -Before . • • /. 
describing these '’some disorders of/hearing Will .be. /described» 
Though;; net ' generally. • recognised». these .'can be 'accounted .for •■ ' ' 
in terms '-of -a • mechanical. .disorder due’. tip muscular • weakness #
- '. ' Case GK/MF noticed''weakness of ..her arms while dancing ' .
' i iih .19430 ■ in the following; year . myasthenia,. gravis! ■ '• . '
. ; ‘. - became ; generalised *; When; dysphagia' developed/.she/
; •■"'., 7 became ' deaf '-and/this fluctuated : in* ./severity ' '/■’,//’/' •■ '
■ :■ / Case. HH.3122 became'.  '.deaf at ihe.eame; time as. she1. .....< .
./ . .experienced.'difflenity. in 'chewing "when . aged .'.24# ./ This..'. .
. -.was : shown io; bo -..•due; to myastheniagrayisi* . •' Tuning'' fork .gt - ■
.;■ •,/ tests were /thought'7tp indicate/perceptive deafness but. . .
; -she. stated that .-.her/hearing :-also improved with . .: /' ' .
■' ••: ;.nebs;M,gm±n'a'$' : ;. \ - •• • '•"••; ' •














■■ --be Qase-bit that -her/eara ‘werebblbo&M and -.'...that T>b - 
she, could blow - them out when. shetwas fatigued* . -. . , '
-. ,0ae© MN-S01*-.; -t 0<AW6lmmat$:r$'-h'a&- int'©rmittoat - deafnesa - . - 
fea ho is; -tlred»\ ? . ’ / ' -/ /I'yeb. _ •• ■ '• ■ /,■" '•
.- ' .casee!. ,M??78,.‘aa<J ’ W?8l •"-..
had -deafness -•which '-wa'rosittent_a%d-pannot..ho . '■ .■■
. /;-,.‘wlaiod . tc^\ ...-%• '■ b b' . -J
■ '■’■ •.'; t ;#he , onset : of ' deafness ;’oae- or ' both Tears' ' '. ... _ . •
slmuitaneomsly iW.tlvaa^aeuto mysaStftento- relapse. and ■ ■ ‘-.. .■
soffleMmess^miitlng 'with-tretmffiomt' may,/he- - acoownted for ■ ' •
by obatrua-i-lo^h. of-''the' 'eustachian .tubes - asso.elated. With . ' ■.
.pharyngeal paresis* ..BULeaberg (I89S) /dee'cribed a " L - 
myetetheaio - .-patient L&th -••do4^:fne©s -for ’low - frequency tones •■ ••■•
-.only.) --attributed; this--to' - -"parsis-*6f 'the'- -tensor ' ' '
tympani ' musclee# ' ' The ■ following - - ease ••.•appeaashto' sbo similar .
though - the -diagnosis of - ^$—^11011:1— -gravis has ’.not - been. ■. , 
fully substantiated*■ ;•.' ■-:■ bi. b.T , ' . .
' ••• ---CaBe- M4583>.-.. T1t1^s, :j^a,a^t.ent ;wpp described -by , ' • • ;. b ..?’•.
• .- b.Bppstdw^j^i^'X and -MoHHrg ( 1953) #'■’—- .apM -of - “AmyorPphie- ! - 
. '- '. ..Lateral B^le'rosi© odmmplLoated-by -progressive-. ■ ' ' -
. b -- - lipodystrophyft-'b, - ph Ahad -been ,.adnm.tted'.to- --the _ - ".
-.'.Edinburgh - Hospital! for ’and- Nervoda '■'Disorders ■ '
’ bon - 26/11/48 at the -age of 24 - years with.- 'A -‘com^Xx^^aLnt.
•..of .deafness* - "poor -• eyesight and w^sme.ss- of the hands . :
b ' 'whieh caueed her to drop things)-t-Xn - addition.--she •'•■
•b . ■; described - seme difficulty - .with. speech, . >n inability. '
weakness and - ; ■
Across the - .cheat, .
- and
was- 15# ’Sometimes
aecordingMb.■B08towski .and'MeHprg* ’she - would .hear-’.; ;
'OG??tain/' \ ■' • hC ' • b,-.' b' '
to - wri:n;Xe,,’.her- f'Or©lLe^€l; and/; aagenpr&l 
-tiredness - with-, feelings of - discernfort-- 
- in the .meek-.and - 'in the. lumbar region*- 
• .'’tiredness9', had both ’started Mien - she
' #5.
.• Pertain voices -. especially high pitched voices - 
better than others*. Her hearing was changeable, 
being better at certain times than at others*
Sometimes she said .she could hear the birds swinging*
’It>was' also thought' that she could hear better 
against 'a background of noise.
Because of the fluctuating nature of the deafness 
and the paucity of objective fLui.dings the consultant 
otologist at first considered that deafness was. 
hysterical but in 194? audiometry showed an almost 
complete deafness with retention of only a few of tho 
high notes. (This is the converse of the usual 
finding in nerve deafness). Deafness, and later
blindness, wore considered hysterical, but the
. development of muscle atrophy of .-limbs and tongue was 
evidence of organic disease (confirmed by an illustration), 
Her legs became co•rpletely'pared yse.' .and ' loss of body 
fat was attributed to tlipodya trophy *, Though plantar
reflexes were normal, the waasing ■nsssocdated with brisk
■ reflexes ■ land ' * fibrillary 'twitching*'':of- ■ the forehead,
•••tongue and hand mu sole s which developed after atrophy
was already, severe vere.. considered to indicate a 
dia'gnosife of '♦atypical amyotrophic- lateral sclerosis* 
though the. duration of . illness (11‘years) and tho , 
partial. recovery before discharge from hospital must 
thxow doubt ob that diagnosis.
She remained extremely tired and weighed only 6st, 
from 1949 to 1931 but gradually regained strength-.
After influenaa in 1933 she again became very weak but 
recovered . again so that w^^n 1 saw hex* in March I960 all 
.musales were powerful except the wasted hand, muscles and 
the right facial muscles. Reflexes were normal and
conduction velocity. of the left ulnar . nerve was within 
nor'mmi limits. A study of hex’ earlier case record
rGve«aled/ ;
• ' revealed ‘ that 'on tho.'daypof • admission 'she go it " U|> ' . . ",
' • . in ? the morning.*••.-'packed • her ■ e.ultOase? ■ ©teed • 'in - the' hue., '
',’' • • '. . '.oarried ^'hef vowA 'ease© and. discussed •details • -Including ••'
-'I. her,sweet ratoon* •’but • her •voice .was -'going and • going! 1
• and she was getting down '-In'spirits '-by; the time she ■
’•■arrived *•* \.,.Tho tongue ■ was. wasted but -not -fascleulatlng ‘ 
-; .• . - andshe •stated -that • she had -not /noticedf aseioulatioh' ■
••? ' -.-In; -the 26 years of' her -illne©©* ••-,//',■•' • •/ ' l:"i.., "/’ P ' • ; "'
• '•.• : ' ’’ The ‘history is •'most , ©ngg-ejBitive.ef/fo^^it^^iKla gravis«
.;-“. - /'■■• Her conditipn/ini960 whe-.oharao toristio of -the•'^burned..
- . . '■out.', •type '(•’myasthenic '.-‘myopathy *•).«'/ At.-'-•this stage..' •, .' i-'­
. ' '■ -neostigmine .responsiveness • is- lost; '(Chapter ’18) . so the. - 
, >’ • • ' " lack .of response..fonhd in 'I960 .does not ..controvert• -that •;
' - ; .' DpjroX^^s^si<p:^.y/it.do©^_ Ic^iayolan■■•ex-meni <of -■,'
••'/>.. Ildoubt' reg'ardli»$./the”-true'diaga0aiag<iAl'? 1 ■ ' ■ ' - . -
- J:..’’The .first /two .."laees described'by Erb'(1879) la his''-
lolassical paper“,on .myasthenia';,gravis-iomplained -of• ...
hyperaetisid {a'nd./he /atprilmte<X. thia'to paresis-of "the' ’ . ,
. • / aetapedlhs'' ''muscle • ofthe middle -ear©). - Giddiness mid '. tinnitus 
,.<•' aref recently -meniiened in eax*ly'ease, records (Campbell .and 
, '.’'.Bramwell*'-X9.O0)•-’and • auditory* , visual -and '-other;©ensory ’..... - _
’ ■■ '•'diet^ua^^lotincses,. are. referred 'to ' .by-Keschhed van’d• - Strauss ?(1927) * •
•• -Harvey (194-8) ' -found / ©ehspry.--symptoms in.19% of Jiie oases — ’
In • the trigeminal-area* / tingling \of :ihe4faee*- -lips and- '/.
' .'/tongue •or -'uailateraX• /sensory- 1'os.s. •of "'the '/face with •■-.• ' ' . ,
' ^diminished, pome al' .reflexes • .hav© .boon described ,by Harvey ''
‘ ‘A'- yj;' $uaaeXV(X993and, Alajowaihe^t^dl" (Wi«. ; '' ' ' ’
, ' • ’ Transitory • •..bilateral,;'womia follow'd by /.parosmia way ' - “/.-
-•• recorded , by Berkeley•.,(1897) .and -'Alajouanine• et &!■ (-1997)$/• ■
• Los©' •..pf•■/taste• sensailon •oGfiurred-in - the 'cases repox’ted by -•
1'. KojeWikov/(X'896) and Symon^e• (X922>.$. •- ' •. • ; '
:••--'-■ d ..case/;' ••'/'■''■ '' 1 ’ . '/ . '
■ '■‘W?
' ■ r':''-:Cas*’Mt298&-loe i ■ her’' oenae of ■ smell- an^ - taste completely 
CX forChs*0®:'br -four'.Weeks* • This . was. the 'onsetCf/her ,
X/.//mya©ihCW-illness'ahd. these ;s^ptp«is .could have, been ,
' du© to:' theWreapi^aOory. infection 'which preaipl/ta.ted'-itt# ■,' 
■'•’'• Case-W5625 .had '-/transient'-nurmbness"thb" t^ongue*•• (Xt
V ip {necessary, 'toXappreci&b©.. that ©com • patients : cannot'
'•■ . ?0i©arlLy'-?di^j3ii^fjii:i®h• between' 9? numbness Wdue/'to loss of •’ •
‘ ©ens'atlon/and{ the Reeling ./associated’ 'with .inability. .to
' ''contract-'.a muscle}* '-’C '/./ / .■/\X'/'-X /• _
- • 'St^OUWlSSSS'• dove'l^^<>pod:'msrs^£3^&jbe'nita.'gravi©/in'." 19^8 *X- •• . • . 
/Radiology' revealed a t thymoma-. which was notxbompl'etbiy. .
•' -“'removed ,atX thymectomy because of/operative' difficulties 
- :‘: -'and so. radiotherapy •.was given*., ...Prom /'lW3 to .I960, the - 
■•’;{Wyat-thhJSii^'were.\<itt33;^v5iwt*X- •controlAd by A' . ' -
, • .■ Wostigftithe',. though-. tbe/dose'-w©/'r&iOod /progressively ■
-.. ' - to 6O0rng*-/orally in' M- hour© * -From 1958 ;to '<1960 speech ’ ■ 
9/••. ./"ahd'''swallowing became difficult*-9••During. the ' same., period 
' • " lie complained “Of ' and" numbness 'in hie
'■'••• -legs and "in 'the'’middle * ..ring" shdriit’tle fd^ngers/'of' both - 
: '. ' / hands* /‘a sensation -'like water ••iln'his left ''ear*'.'and’loss- 
i,/•./,'■ of '-'-taste sensation*';X'.Xt;. was ' oonfirmed by , examination .
■X:-/that• he 'could ,■ not • ’taste-wi.th; /’ohy''.■part • "of -.hiC "toUgtib * '/ '{ .
'■' - ' -' The' - tongue, was ' ©mooth'- ('Fig*"$*R), d&d■ he later developed
' ".megaloblastic -anaemia ■ which X© 'further desoribed'/ih' -
/ - /./Chapter ?*/ Bis -death from9^cholinergic Crisis9' /is/also, 
■’-■recounted , in - Chapter: X9»' .- .lot- view of/the possibility •' ■?'
vthpt - ho - had cernipious '' anaemia it is - uu-f optuna to '-.that' - 
- the /spinal ; bord was-.not. cxs^?ntm^d. 'at/autopsy* ', .. :/.- .. .,
••-.a '' /•/Symond©• (1922)-described two" cases ' of: myasthenia/-, -', 
.gravis ;-ih‘. a oilnical.lecture© ' One ''of ,,the©Cais©/..hadX anosmia 





















v -r 7■ ;--7 . - . . , \ - ?i ’■ /
and ■'the'.other; - had - •'phdryhgeal -anaesthesia* 'SEv9n allowing - •- ■ 
for - ‘.-the '' possible: - hysterica. ‘'nature "of/ihe - latter' sigh’, .‘it - ; > 
■is'into resting' to ' 'amOe./tthai: in-'■1922, /before' ' the '"neurbmiH'oular 
.theory-of- myasthenia-wag 'established,' •■.Symonda<wrote; 7*1-' ' . ,
think there -are some- argument's which ’ favour the •• theory ' ■'. 
that - - the?-disease is ••hervoug ••±a‘ origin* ■ ■ One- la 'the -'not . 
'unibommohtGooohpoooedf senaory ‘ '•aymptems in - -the form - of 577 -7 •.­
.pain's- -or' mirbheoaH, . /Busaard - ( 1905) - - had- .already. objected ;• i ■ ■. 
•to -the 'summary /diemispal:;©f sOwery' 'Symptoms by Campbell-•' ; - 
and ■.Brdmmwoi- -(19Q0)^and wa©-w117- •; y-
r’eooghisod thataehebry- •iie'turbanceB were : occasionally ; 
'preaent-‘Until -the - ‘attention .-of phyBieAaws ;.vhs directed - 7' I
.•exclusively to - . the fraaSmi^BMon .at; the neui*omuueular, ■ , i'
'jurne-tibit*/ ' -■■/On -ef/.the oases/ deecribed':byt-ussara- /C1905)- - ' '•''•
.had'-loas-Of -pain-''©.enasutibh 'in the. logs/'ulnar , border.; ..of/. - '-■­
the -'upper limba* '.Bulraese-'- region •of -the.-Chest tahd -''round •-•■/ ■
the /nOGee - Tie '-'history- suggests /& 'diagnosis- of - tabes ..-I; 
dorsalis1 1p1;/nb7:lI^^^Ja^^lib©/d^;'Syph^;i,asfg^iI"‘ 'found '.'at; poet '• , ' '•
.mdrtbm- examination'*-.-"’ There arc- surprising .resemblances:-■7 5, _ 
between'- -'this- case - and - MH5595- described above'» .Another-" 'of
’.Bna&&rd*8 oasea had'' -d- -••XooaXised area of -‘-ah&©eth@©ia-and.•'•' . '
after -.'death was -■found- -'to/ have 7tlypphbi^hsgeS's - ■ in - ;th© -' - ■' 
appropri&tel&Qrs&a'Frot';$&»lgidn*5• /•'•'•;•/.-•' . 1 .77. '•'.;'." ..
- J' ■' '' - • AnaesthesiUWf ' the - -pharynx - 'and - larynx wa© - reported ' - 
by- Wemii^^Ick^^'(l893,)»; Sohwab and /•Viets (1958I .report similar
symptoms.;in 'edg'd of- •tsubgidipg- .peripheral neuritis*''''in ■■ 
-ivhom- - a. - diagnosis.- of :Oo^sLsab^^Si'e^*’i^a^^^1V^.s^-had - been -''made.-' but 7' y
/'';7-'•/• '" / - '/';'/■''' " ..; ' "' 7' ,
• ? 'Qas©'- EH3.2S7 a' ' 32--year/aM' 'University •'Leo'tuuerr>had’.a
7 - -'■dor.e. throat/ln .‘December-, 71957:« ' it •■•Cleared up -with y&n -.
. • - 7'oral- '.aatibio tie - .but - headao.he-.perO^^6tld - for - 2 weafesii -'
■■ ■ ' XhrOe/77 .'7 ■ 1 ■ • ■■,/ 7- '' 7 ;'■//
49«,
.. ■" 1 / t*
.'■.. / 'Three/weeW/after''pharyngitis’k,©;/became’ .aware- of—-.'''.., ■. /'-
• ,.' '• .wealmes'smof-.both'legsy/•,:had to lecture / ■//..
' ■, <£rQia<% oh&!x»e \ .fere.-was'/ at- the /same/ timey-. considerable'/- 
'/ .. .ting3,ihg''/p^^i*(a<3£3tli(^i^la /feety. finger - ■■,
,.;. "tips anti, occasionally' -the-.lips* spread#/-
/••;.' Th© .legs’-ached with '-us©- hut /not, at-'rest/afcd - there; was. . 
v/// no calf ‘tenderness:;Hi© - ri ght: arm- began -to "fatigue.;'/.•.- '' , 
'.■ - '-When' writing _on‘"a'• blackboard , and then .shboternal pain '•’'- 
/ -/mW/ .effort -ma ■■wfcp^.- / ' ' ,-,. / o; ; ,.-//. . . •/.; ' ' - ■ •..
/•-'/,.• ///. '.-TM >pnpils''wore/ tpiequat, but /-reactive.*' - • • Pinipri.ck . - 
‘ ;. •/sensation'w®' diminished/at ■ the/finger/ tips*. ' Tendon- - ■ '
. ; -jerk© ■■’were ■ decreased. /but..-nob.'. absent* •- '.'All ■ muscles/--of ■'
'thbljpper /txmba,-^hov^ed tpat-holiogical. fatigu©9 and/a •' ■.- ;
. ^.i-IIci^Mroy-Mas^Lsuid^tost;, w; typia' a! '. of jay as thonia//( Fige 4*1) *
' ; // /^vortheXes's ,.th$‘referring- physician ’s',■■diagnosis'--of '/. ,; ’ 
. peripheral neuritis'. was'."accopted in view,-of. •.©.ensoi’y.'"-
. ?■ "■''changes . and .' the ’ finding .of.' decreased /conduction velocity _■
- 'of the. right/uinaf;'hefvev - FBo/CQndnctxon-time from/' • ■
■■;■ /--dwfi$t: i:o.. gabc|v,ctc^x’';;<^igi1;J..-nKliij.bi<.'tby^<^he method ,o'f\- '" ;
'-••■. ;. Sirnpsopy 19S&b} "Was ■■■asec ♦/'. It- shohid/not 'be /more ..
-'•/...,' than. 4-5ws.ec*-'' ••,..•■'// './/:/u- ;■;,./"/'/ /a" ;
'/;j;y/": 195^/tingling"of'the. finger tips'‘ami .weakness •/ /-
• '■■../ xr©curre.d /for./&"short /period-'and again/in'; 196X4•.• ;W had
•■•'•"/ always.refused to/take/pyri dos-Mgmihe/until then* It• - ■
/- - probably ■Improved' .his. eondd/tien- but" he./alw&ys; attributed =
■ -,.. •• improvement/'to - some. ether ' factor.'/. ' In •1961/nerve" •'..'.- .- ' -
■ ';■'bonduetien' Velocity -was normal*.' . ? . / ■■ / .-.-.' ' /•?..
;:/ - /. ■ The popsib?lXity of a' myasthenia 'reaction associated ■'
' •• with -polyneuritis•• wili/'be dlscuSeM, in 'Chapter.9■-"*/"■'in 
’ ■' re irospeet ii/iiw .seems .-more likely,.' ‘that; this mi©/-a case,
.;'- /of' true - ‘myasthenia.■ gravis t$/th prominent .".sensory/-symptoms
■ v'-Case/-'; ■ '.i'""' ? ? ,• \ • . "\ • ;
  
?-.?./ had. a 'transient Brotei-S^quarti'/C^ynds^dracj® " ',?' .
-" 'Baser.HHC0458 had a ,oaWa equina ^ayndrome ■ -at one stage*--■ ■ <
■, i//.?/ a, ; •ft-is 'l^iik^el^^gr.gthzat the tw 'latter oases\ . ?
■ ' ?;examplea' o f;o oinqidoatal disease' * . ■ Nevertheless ' it is- //
■• • apparent'/that . aensory/.disfe'uyhaiawea ■ .''de.ooew/ ■inn -patienteY?' -■ ' ' 
'• . :\v&'tK/m&a©he»i& 'gravia, ■ and we •f.raqtueiiXy reported;-before cf _ 
/;-,'.' ©he. : ".diseas© . waa' ; ' explained■? - = aa■ - a disordesr. of neunomwbuiw. -'
••;??•’ ts^^iwmise:l^on* *?.?'£>eme-of ihe oan .W/?.. .•.••/'\y'.,
■ ■aoboimted - for on ■-sMehaBieaX. grounds but -it,ia difficult. to „
' explain. tta-u all .-.la■ this. way-and it' is.’neeeeeary to. eoi$ider\ 
"'/•.the ' poaMhility. of. weaaiomX. involvement- 'of ‘sensory?' ?•' /; - ■■ •
‘■ neurones or,,of ••‘qeas&ry ' end-ergane* da./''•"'..- . ' - .' ' dd^? •..• ■ ••
•; • ; dgdopnd • and ‘•Psychiatric.-.disorders5. % ' , ...-, . . .-, ■ .•
■ --' ''."■ ddMee’ MWfeS- had -a -miscarriage in. 1993 whoa aged *• • ?' - -
' ’' . ad;' ifexf; months it?ater;8he’deve;^o|aect-. thnrotoaieoais ’tSbh ' ’■- ' ■- 
"; ' ',d .• -Subsided /after, "iwntw , treatment -thiempaciX»•,.;• It; ’ -.'
' ,haa 'aot recurred -but-;site still • Ms • anti thyroid- 'antibodies '
;; ‘ '<dia\;hw . blood .(Table 15,1)and 'thaw are, supraorbital pada.’ \'
; .• / ^Lijd:tc?ai;‘iag?nnevious. e'xO>hi^hal^isbsa^Cl?l;g«'-5sS)® ,.Xa<19^^ ••’
: a. a •• •••/•.colics-■•began' -to - hay'o' piqsi$,.and gepbrhXisod ■ fatigue;^due>to ' •'
’ " ‘‘'- ■ myasthenia.; gravis # ; ii‘Y wee- wll. eon trolled ; ,by aewtigmlae
- •', ? and’ /she - ;had a: ' yoaisSion ■ '■ for more '•• than ' a- .year -■ in ;X9Wr$8 '@ '
; - • _''' ,'.-X» -‘'1959, ’ there' t/as'• h?-slighC Teourrewo; which subsided;; . • ., '
■ '. _. ?i<th6ufc --treatment^' 'In ' itareh -I960 .; she -had “the -. fix^st 'Sfa
• a" •series of., aiifeisb/ia which - she/suddenly; lost; ^onseibusnese ’ 
;•••:‘'.‘^ithpUy -warning^ •''hunt^^ng liey?head''i& the .fall*; ,She a’w&s , .'.'/
, -• uwoBseious' fox'- '‘minuteB and’was nots;±nepatia©at® .'-'Oh‘ '
• •-- - .••.'.’ • ad®iasien '. to Kaityfiold -Beep ita! §; ' Bunded^ ‘lumbar ptae,fetti*o •' • -'
.' yielded /xanthochromic ■'o©rubrospinal ’ .fluid ‘but further'"
•„''' ' In we ti^a-tloa in? the Department 'of Wdf ©mirgery * . .fedi nhiwgh §
-'• ?' • -showed‘'no'/oauw -for--a«d; ifcfws attributed^to;tho ' • ? 
' ', ■ , head/ '■•. : ’’ , •-'i- ./ , . / a/; -a - ; "
• /head;’ injury * . ?0n;/trahsfer ’-M :, sij.-care, ;©he; showed .•• ' . "' .
.'. ' ... of .'gen.eo&li-SetL -r/iya.3$hen±a/ in’ the/ later.’ •.pasr’t; of• the’ ’-day * ’.•.. ;/ ■••
• was. fully.'dpntfplled’by •%Qmg»'of py;r.i^c^^c>£^'t^g5miae:;’ ’ ,.,'; ■
•/. twice daily.*; ' i;',, U; , '• - •/-. ? /. •< . \ '•'?■■’■■' ,
■ <•••<'••.,•?-in-’r<^i^brua^^y^yaO^^,ih<^c^^'n^mioa.;g^^^e^m^^^^'«&xipa>xt;u/ ■ /■ - ■ •. 
/;/- -•■wa#. followed .by: ’inerOuSAng '■ealsneeB' -but ’ 'she •ioontinuocl ••- •’ • 
;'■■■/ /ah^'inad'o^at'e ’ -dos'd as; ©hej.would’ never-accept.’/ t'-, ■
•-. . .a.',the’■li&gnosiw/‘'In'\QcrC^<o'b^^3p.'l<^^(^2^/%i^iij^■?;ott;'’holiduy,-.We;’ - ■' ; ■,
//./, WoWing;...lier Weey ,hahd@ and’ feet;. -- - !
' /tingled; she -’ gavo ’ Rory, ',and:fell to'/tho;ground ’ ;// //,'-;■.■•,/ -/-/'.
■cu^3lc^l^Ohclt^^li^,:vWi3h■'<3^r.fgi^^i; muscles*/ /L&ter/th.e same'/-///,;'■' '' .
; - '; "-evdnfhg: a- ©imilar' '&ttack/ dut^lUrr©d/'’lW^iikB ’ ‘ she ’ ’.wasAh \ . ‘ ’ ’ '•
/ • -bed* = '/■There ’Can ’ '.be 'W-qbe©ti©h‘;;pf ‘ -audden /ioao. of ’power*.
. ,/,.,©$“ her Xegst) ..poWera!. syncopey, or.*.ovordpaage’’with /// . .;.-'/•-’.;
’ antlWolia^WeraeW^xyge*. ...Radiology of.edciX!,’.and :,“..■ '•; , .b-
W.oKefii 5 ’ ' Wd-; BE® reo'prds' taken4- Wring -waling;' and’ Weeping' . ' -•
■- ' Doeriods’ wore; normal* ,- $®j? blood ■ .did’ '.’hot:Coi^t^,ain• /L*B* / •-• -/' • .- 
cella,..The *fit©*/iRwW tunexplained* .- .. . .' '
■' '■ •-': '^OW'Q34Q1 .devolOped/Myaeth©nia‘ gravis when aged W*'■ ’ / ‘A ' '" 
The’ iiUtialysyrn;ptom Was ’'inability;, toghold .up -her’ 'head*■ .
;l‘.followed in’ R5 weeks by dlfficultt,- ;in;chewing* .-'wallowing’ I-''
;' '-.and ’ •blurring'' of ’ speech, ’ which /wore -rapidly relieved ’ ' ’ ; ■
•;•; i.;; •.' by ’:ndb's tigraine.'. ?. - During „ -the. first .-. 'two mouths ’ of the,; ■ ■. ,
--.■"/...minses ’ she' ‘.bad; ’.two •? blackouts'* * ’ The ’ second of ’these-A'-. A'-/-' 
'.; ;.\.o©cu3»ire'&'.i& hospitai -and '’;was .fallowed’ ‘ by-..'figh ting’‘and’ •
' shoivtlng.' :•fo^<Rrailnt08' ’, The‘•gy.eatest .dose'.of
' , ./pyridostigmine ’.proscribe'd .at; thaiytime ’’ iw^js 360i]g» - . ’.' -. •.
;.\;.: (6 • tablet#) /in . , one ’’ day ’• and; ShB/w#:•hiBeY'havi^m^<:.b.e^addbi^^^iai» ! / :
-nysasihlo .symptom# llat'er, , developed,’ on -a ’ -dose o'f k ’ ’ . . •" -
60p*?2dmg4 /per ■ ’ day* Y BEG'’ roooxyiing’ ’Ywaa'- norma;^, ■/
-,. and:’ the /’fits' 'never :recurread ;. She .died- .two’ years later ■ . .
'' /•■.■■'.and ’ ,no ’ /autopsy wd# -obtained* ’ ’ ■,■’_. /-• ■' ; ’’
v/ -5?*/
' ’ > . 5hii^©/29;, year-old" e3^^^o’tr?:1^€>:Leni--:-h'a<d always ' ..
.', ■ :YbeehwVy?<&ctiYe%</<HtSyh0bby •w&svibXg , 'dls^apua©-';.'.:■ '•'•• •• . ■ ' ' • 
•''^/cycling*.,* -TehdyeapS' earl3e.s*\ lie \wa©/iai0cfeed\ ont/in '-a-' ■ -■ 
r '. road •' .accident* ..' :/5enr aged 3,6 he had, exophthalmic;-•goitre* ■■ 
■. . '’Whin, .first . ;seen;/iuP• iWO.’ -..his ■■©yes'- were, very .-prominent^. • •' - -
hut • •.there;'were ^ao’ algae: of "•
• "< 3^KtyMia?i5h’;196o;:%e:\j^<^^13^’ -from/a •■•s.t^a^g:ln^^9/Gtr^:^i;ing -his ' - -,. ' .,.-
.;:/-\chin-it .0onld /n©t/be • :aqcattained/Wiether. ‘was• - ./..'.:
■' /. due' • to ■ a ; ^blackout */lbi t;< ’ from ' -: that •• time ' ' ' bh • die ; . had ;;; ;'-•■'; - ■' - -" - •;
: ■.-ifroquent: mbrnmanary • t'ap’aea /-.of • c.WmcieubnbsB * /• /He, had ' . .•■, ;
\/i.t'0'‘.g'iy^^<5/,ixo3, ©yoUng , as* he ;,##©• /faiXihg •:$©■- often .and; ;■? .;.
d/.'/foit>is3^e3c^o^yf^'', • •.///He ,-mspoo.etaihiy.'U^r^ceaG^i.<^iua in/oome/'
1: -of''••these* ■-had • io .be • ■ -•’ . 
'■/, iremyVoMo\& position 0 f- less,’ rbspbhsibiiity-' ’at-- hiy-/ ,. < .•'
’. ; .wfe-'-and’ hie, father^ beoanie ‘©oncqrned ''.at .an apparent/- ' •'. * - 
d /•<• 'intplXe© pual •• det ex’ooxnatio** ;,.• A ;.'i^M5gtgi^^e^<^.d'/,<^:^^^aagnoi£^/;b/f •. ’ 
■/■•.•iOos1:*is^;Pl^u^^hl©aXiVe©p©e^£^iion^0^e^c^mop. reasonable*• ’/ : • . /..•,/-/ . 
/. ■ /■— ' / pm- admis sion. •'to/ .thep.Nop’hern, General ,'Hospital-'- in'. ■■ ’
• ••._?• -/ June ' X9'6Xl h©/.was .unable to remember .much "about • -the -'•' " </
■/ /d^0Yi©us-''yo&r*' xi^^iefispei^/Is/p^/^-a^ittomai^iLm • .^rpo-.■.• % •
•.(-/•/.witnessed* • /-.'. ■here/*Was• -slight' ' weakne©#' .of the/right' ■ -"' •'- 
. •'''*thigh mmdeai-left*internal' etrabimma • ..and-ny©’^^^•’ , '■
,: :/ to- both'.-sides:.. •bu;t'''.'th•e-•a:i^^sl:p^3^^<^^iab.<^.. of ’these / findings •/-- -.. .’ 
(- •'/.-was, not" appreciated* ■,;■ - Some*'- illG* recordings- were• • normal®
■ .'. others /showed '©co&sionnX .bursts of',?©'/©''tllota• waves- ' . •”•
< . —Xfbbhtally 'or--'!©,*.t^b<e/X^jP■t temperai/region* .- . Sphenoidal ..
xWording'' -and'•■-sa-tivatlbn-'--wth barbiturates' did •.-not' .^^^ve/ •
• ''-.further:, evid/h’c©v/w• a rbbbrinng.:.w<a3’ made•-Awih.'Le ..b'emfe^gg^rLde • 
./ /-T30mg« 3*05 'slowly•'injoe^e^d; •,:.' This "/eyoked
’. bilaterally• synoh:i/noui ■ ehapp/and - Glow• waye complexes ' • ■, *
” ■ 'and • ' • puns ' of '4~5©/s:' haves •'• wi th —ront©^©©^©! • phase.-— ' - •.' ,'












reyerb&l’//T^ft© -’ /reoofdkw## . n omp&.tlbi ©/with ' /epilepsy ’ -./,, 
but •< .did '' nat//#i!ggestea ©• ’discharges*
Xaba'-Iaier • '('U'haetivated) . -^recording- ^p'm:e;,;aixai/p- ; waves', ■ '-,. 
app<^/^^3^«^<d'jiia''‘X©ad£s.? from'lhe/lcft/^Pemporai. ' • ’." '
ejSp<a<^;ia\llly^../dur:Lng'"*dvihT^^3^f l^a1th:tng|/’UUd ’tafcing;ffcj^^<^^-;Wj^^3L0
scries-of, -recordings YuPo yoo2^^^:ldbjpa‘t5o^u;.i:t/;'apjp<^^i^3^< ’^d /- -" 
•thUt-iMere . wap ./a . discharging. - focus • - ini -“that - .rogimn' o f, -- 
Pho'Jbrnih*/'/' -;;//yeY/-/' ’ '''■ Kr'. /•'. '/
•’ -'YFY# Wfencseed -’ in;the ;ward -•.(and- -'recorded ©by. - .Y; - - 
cinema tographyl/wbre- /oom jUtble'-• Wth - - a - /temporal . lob©/ ' 
origin', ' '.. - Be©-iacdi^nXy.’atopped"-speekihy'./- -kbar©d- ;and "
•?e^<^jnm©;:i.m©e emadb/irf©guX<r - ''Switching; movomentg-; of -’.both ; 
hlndso ■/.. ’Thick’ glairy, j^iicci)3’.0tr^i^'aned frim - Yho-paonth, 
•Ho--did -’notefail' andYwis'-prob&biy-- never- Yhcootininby; - • 
.Tie'/att^eifek - lasted 'for' - J/rainUte© -; and- ' recovery- - was - ’,-/ ' ’-. 
sudden,Y'’-';Y ; ; ',■■ e;/- Ye,Y © , "ye-/;. / y/--,e :-Y: Y ''■■
•- . - -Air.’enoeplh^tlog^^r^aphyedld- •hb^t-roygd^i-nUy-gro^^© -/•;’-/,
-oep.ebrifi abnormality - and - tho - nlrebrl#fin&i ' fluid .ws- _. 
normal - #0 - - -tho . fils - yw ©ro - treated - jdfeb- 'antioOuvnlsant - - • 1
ISih'ce/19'6i eh©/has/ had; hdhntoinapesYYe •/-’/,; /./ "'
ijhc^3^^Joba3?b>iP^^iio\lmd primidone, in different' oo&MnatjohS
- but', continues-' to -'have '2Y Y attaeka-”every-• Week* -'ey Y■'..■', • •. 
/'- - in/Bay/1962 /ihe;sttaoks-ybllsal '.aBsociatg&lWlth.?;, - ■ - 
,bMef,;.1 oholkmgl,/ ’ '' ;A,... fW; days- lat W he - c omplain.edf - of 
-pain -inlii ©'{back ^/difficulty., in /oontroiXing''-his- -.hoad #
" and ’-is©?e©eY0akn©#&;- of'- his - '• ospop:^-!^!^’ In-ythe . - e - ■
sxoxinr# ' ;Thia -was followed Yneahoth©^^©^ by- /upper, 
limb - weakness© y'pppfeia /of - .the ■ right oyelid * .-’d>ouiil€>'.? //. i, 
vision--and - . loss' -'of -''yolo'e©when - speaking,',..’' /’Ibasahntlon- '
■at - that- - time 'ahowid - typical *;.y.epy, ac^v^c^re/s-. - /gen^^Ori3Lij^'0<^; 
.'myasthenia - gravis, confirmed. - • by' --eXcetoiayography .and-
 .':-S42
by .an/edrophoinhum test)'- • In - retrospect'-it -.seems- ;• •;. 
.-possible ’that -hi# inability to'-cycle was- an - early' ' ■ / (., 
symptom-of myasthenia*./ '■ •'••;/• • ' ' \ . '
‘A■ / .'Despite- - increasing dosage of- neostigmine lie/ ; ' - .
'became - extremely, weal* -so ' - thymectomy was/pcaried' out-'- V 
by Andrew Logan on - - 3/7/62* '/.-The thymims,- wao' ' . ’/
unusually vascular but was /.otherwise /'typical of .-•;'. 
myasthenia- gravis * - . - The ' post-operative'. course was ' - - -'
- unusually, -difficult.»/•■.--' He ' had a‘ myasthenic'/,crisis ■ - 
three 'days ' after operation/but by the. tenth day- he ‘
/was ‘in .b&lmico and- on - following days- began - to show - /' /
'signs of overdosage/-- -'/• H^£3;bOhd:lt^;^^osl;Cnmai^t^ed; grave ' ' 
for; many - •months* swlnging-'from --one/oxiremo (myasthenic 
ci’isis) - to the - other - • (cholinergic - crisis) because a -.• 
severe- neos^’tigmnneresistant weakness■. made - 1 f -' di’fficult 
to assess/'the ; required dosage. 'Tracheostomy - was - ' / .. 
carried -.out 'on‘.■SX/D/fe -amT ho? was .' ventilated 'by a - / •
.-positive-prosauro - respirator - for most - of --the- following? - 
thirteen -.month's, .Towards- -the - end'- of- ' this period- he - . 
'became‘ emaciated - './and/ food and- mu ou© ‘were entering the' 
lungs despite' 'constant'-vigilance- in. the ■ management ;of -■ ■ 
the-ciuffed"tracheostomy tube. .- A-jo jnnostomy was made ■ 
and he .was fed./with-caaein hydrolysate/ 'milk and eggs 
by- this., route* (Fig. /S/if) -i ■// / . ■
■ . Moemnhile minor attacks had. p^x’sisi^e^dg/.aipparen'tly 
unrelated - to -’the /therapeutic state* In September -1962
ho had a - grand 'mal seizure. - He was disorientated - for .' 
many..weeks« ..The-mnscl e s - barely ; respond od-to '. ; —
an ticholi'nes t erase -' drugs -. ( suppl emented .-wx th ' ephedriao s - ■ 
potassium pprednisolone, anabolic -steroids - and - ■
-spironolactone at -different ..tismo)* ).'.1t- seemed certain 
./that/ / ' - -, -.;' /■ ' ■' .''•"- '. ' ' '
'■ Y - >Y<YY c . Y -53* .: y y- ??Y. ’• ' : ,. yy-y / . •:
:,Y ?fch&VhG\Waszgaing; y /•'•■ ,Y" - •■■■"/-; - - :"YY ' . ■ '•
\ . •; du" ";2/10/ 63 /(fiftewi' ; months "'.after - < thymectomy) "ho - ? ,? ;•■.•;_.
.?; ■ho<3aim\T^vey^j/^^^^-ta^‘feei5f/\p)v.l^JLWO'.io^ut .-the tra&eho0pOcmy---.&nO Y, ■ ' 
Y/YYjejundstomy " ’tube,#"and- 'seemeO/ocY'be >la:#Vi paranoid state#,-‘ .■
... . (A"''froiY that •dayYhe:,begah".• to .\improy#'p&pidXy# "YY,A response 'Y-.
:. "y • tojneostigmihe- ^rOappoarod.',: the .muscle© ^OeaaoYone" ' - ■ . ■
Y /-bulky* , mubcutoieou© Yfat-" reappeared; and:"hi# -mofttaX; •state Y-;\ ■ 
y ■ -; - Yrapiily " . returned'' to - -a'OrMsdl# Y Y .lu' one '-month. W - w©', - abley - to . .. .. 
Y. 'YYspch'd " weekend.# - . ai/home - and/ in.- two-'months. wasY discharged•',' ■; /
; ;;;;>home Y. HoowY s:hx:month£r later Y he-" is; overweight"* -poworfUl" : "' ''
■ . a "but -.with - "myasthenic -. "fatigue' ’. whioh - is; well O oft trolled?,' •;
/'YYooy3X5Mg#■?. (2l'-tablets)-Of.neOstigmlne/daily*.? - H@Y#tili.- - Y • 
?Y.. 'haft.-minor. fit©'2*3. times.' each- week#.-'. . ■'•' ■ •■ ;Y Y ' yY';;’■ ''■■ ?
. y -. Vr This ;ease"; .has ; been" - described in; 'detail ' toYxin©traie / ' ■ • 
#0!®.. .points which - wLlX?.?be . -made ini'’ other chapoors- ?suck'?aY; -!1) ' Y. 
.theYl act: that '".my&sthenio./ weakneSamayYbeYqhcmgbi --to? : tehoXinergie. 
WeaimOss '-without- intervening" 'SOfmaXystre^ngth.'‘(Chapter 19)2-/"". .'? ’ 
ix ) "ihe - •postoperative; remission - may / be '.delayed; for j.lwMyeoirs. .. ■.
then,/..bo '• jd^/aLBY-satisfaooory'&s ; the .l,mmnei&te - ones Y> . ■ ■
('Chapter, xdl/iii)' the . Joftset of Yymptoms;;.mid fits .'YYy
appedredyto .coincide” with the -first" ''myasthenic. symptoms#* •'•• - y
Thisy and . the frequent-:.oppO3rt^^^3^:l^•1f^or'■;o^b^^^'av,a•<^3^^^^t>. undery; • •':' ■ 
oOntroll'ed^cOnnOiioftQg maOe " it .quite certain?-that -the'- fits '•’... • 
wore'’,not/dum to .asphyxia-.- or - -to oyerOoo&ge .*wth drugs# ■’ y ‘ Y ■
. ;•-.. YGaso: W/PS/AO had 4-attack#- of -•.unconssiousaess- Ye-twoOn - 
Y.;;?'X917" jand.X9’24<,, - 'He .‘Ooy.e.lope'd. .myasthenia 'gravi#""in "1936. ..
;Y'G~^gis".JMI/B>Oj/GT'' had 'bimils .spells! on ; several -.occasions# '•
." '■ C^^nM/MYAW'' had'-myasthenia. ..frbmYi'938/to, 1933.'.'.(when.’ Y"' ?
■ Y , iast-seea-).*: • .'From -"194-3 ©ho." -had '-ooeasioftaX bxnL©£Yy,YY''Y a •'.
■ ■ ■ '';?ens&tion.©-.0f.'b-eing/'.Y'far away.'YOuring..which" ■she was"?? ' .•.. v­
' - ." ' ^unabimoo-spimcY?/'•.- •‘Y-■ 'Y ' YYY/ :■; >;Y-
: Y /0&O#/ /.' Y - - ?;:'Y; - . • Y- - -"Y ?\Y . \ YY: Y v,:? ,
: ' \ '■ : •' . , 56Y < ■ ■ V •' , G. ' , ;■
. 'Case' NHi2'3?4- Kafl fitaffrom ago' o ' -/.Myasthenic. . .
' ■■-gravis otarted-'when-'he- was' 35 .and.persisted - until .' ' . •/.
death -at-3% years-• •.;,- Y ' . . - "'/• : '
■ . , ■ Y Overdosage - u f - anticholinesterase -d'rugs-'or ■aevero ' - '
hypoxia - -adc Quitted - -for '.the fits which .•occur rod- in -' 'the -''first •" 
few..days • after-.operation and which caused the 'death-of-, 
three.patienta (100.8338/ -MXN6O3 .and WB?88) «.■, In ;the ' - ' ' '
other 'oases the nature .of - the , seisiiroa.'rem&ins unexplained* ■'
-None'-.o'f - them -'had,•lupus 'erythematosus'-Veils ibY-the ■ blood■ : ' 
and there. 1ss at-'-rP’eeent* --no- evidence -.of gross '"cerebral' '
pathology. ,' Yin ' two' - cases there were - unexpected.--findi/ngs. . 
in - .the ' ■■brain '.-at-- pos t mortem#-/. '■ ••Y'Y'Y: ' - •• Y-.Y/Y - Y." 'Y -
• • iax-griw from.1.10 ■... - .
■■ until her death. in 103?- at the age -;of - 31 * - In -1031 . ' Y •
. after-a spell of hard; work - she-became .- acutely .dyspnoeic-:/- •
■Y- ' and.bvery thing wont' black*;#. ''Gw.-ffilYfosward "in her - - ■.
Y‘ -’■-.-"car- and ■w^tspprobal^3^;-;-'txnobG^^cous.-/\.<6rf,9'~0Q' MnVnte*u - ■' yY 
. - She, had -two similar .attacks in -.1932.and -1033' but • - ; ,
. although she hadbeen- oxtre'rncly.'tired' since-1030 it .
■ . - - was - not ' until - -1033 • that - myais theni-a. -gravis '■ was. 'diagnosed * . - 
Y ' 'Byon-unger ..treatment ''she.; some times' /ijfeil- .’for ''"'no' apparent "
. -reason but it is not - certain ; that - she lost - consciousness#
. - . 'She often comlainod-of burning -pain oubsteernally. and 
' ..in - hex' -.throatt-g unrelated- to -exertion* - " ■ TwrG .w&eV’a .
--. fOjdi-ily history of - diabetes*' •■••• . /-."- " - V . ■ '■ •’.-'
. ■ ,.-.-. She -died 'in 1037 # ./•'•'On" reviewing "the '-case-nO'tes it - '
nov/7 seems probable that- death -wa's due to overdosage with 
' '• . -"; neostigmine f -"" . Autopay ' revealed. V. thymoma' X which ' " was not - 
'. -' visible dnY Yadio'gi'aphs) /.and- abnorihaaity-of; thV- thyroid- ',■■-
.•, ' gland resembling -lympti&denoid goitre -(further, described -'
. .in?Chapter. 5)* . The ’spleen was slightly ’but definitely'-
















.■■■ a»iargc&-Yv22Ogmi and?,contained tVm.Mltisb.no&uXeG':/.. '•#•.-, . 
■ Yv : v 'Showing \ -lymphoid , -and r otic ular -' hyperplasia,, ■ _ Y. - Thor©" Y' '
■,. -•wa’#'/no -eyi done e' :;of . mmoncrdiai • disease#. ■ • .The- wiilte-e- . •
, /hiat'toiYYo^'one .■conyGXutlo.n:'. of the . a.eerhbaXXoorOetm.,.-'.'. ■■ . - 
' * ^Y/wMieh.-.:wna-.’-eo&ninne •..miC.rCsaopiCau.iyirshowed-Ysblghi• y-.y # •■• ■ -•
-:(Dr#-'A»F»d* -^Maloney) ».Y-, YyY < .'
; .... Yla®®’:M#3£3X.: dioclYab; - tW ages- oilAS#after having?had'Y -. -
y-Ym^^mB’thoni.n/.Yg^s^a^’srn^/'f^^^'r: 15 -yearn# ' yyTY thymu#-: wae- removed y 
' Y ;:'th'nl;i?teenYy0.ar’#^;';prG'vJLou£^;ly» : - peath-wasYduo'#t© ■'•'•.•:-.•..'■-'' Y -■- _
-'•■ Y'Y bhaiinorglp' '•••cri's'i© .:C.U^a^:ht^<^3^-‘ doseribod#dn' Chapter' 19.) ' • . ' ■ 
v y Y«Sh# last aanseldudueaa. ••■just .'before . rdea'th''but had-, mot : -■'.. - • -
: '-,-■ Ydone ; -aoYpn' ''any: otheiYoteo«aaiesi' ' Yso-f af ' ’##;.■!#• ..known'* ;' Y-; '■ " •'-••
Y.-YTherewa# Y, -#.■.,'
\YY •: ,Y•::A’b:,autapsy:■Yth^,: myocardium' sh.bwod..-brow- atrophy ' •'•• Y ,•;
• ■ - : •; Yund- there -Y©e-minim&X• a^he^x^^c^maYoir the - coronary' •artforiaBY'. , 
. yY-YY feWY -argyrophilicr /piacim#/ :which Were- m0apPologlCal•ly ; ' - 
-/•:■ --identical ' Yo.Ythsee©, : found ' ‘in ' -,.43%heimdr 18 -'.‘'Disease ' wary:'- -
■•'f^o^^nd'.©^ai^tn^3red:ipa:l^^^;Ly and'ir.regularly.in' the: cortos •,-. - 
of/ the' frontal^‘.and: temporal' lobeaAof: Jhe,.brain# Y.-There '.
;'-Y;w^j3.- novneuroglial,-. Y,^i^fe.t^;ion:‘"io.;..i^hc^.iY:-Y^pr^^^en^.e^- and'; •' • .
Y . _'.apparently' nY-los©? of'neurohCSj and ' ho : . nouro fibrillary': Y .' . 
■Y.'thngleSYC.r.e' -Identified (Dr*' lUF<d*•'Maloney)'* - • ■ Y- ‘ •
.■■■•-.<-;, - .The signlfoauee, of the?, latter- -fihdihg' iSr'ukhioxmu'•• y 
In- Ythe : former - Cis#, i-t ' is, possible' .that' 'the MirogliilYY -
hyperplasia, was. ’dueY-to' '-:g-crob??nl .<-nlt^cd.a» •-'T'fc doe# 'not : s'oem ' , - 
likeiy:^^^^l^^atYt^]hlsY;caiUl'd Y^<^3r '.bases- iuehYas -OT5652 '-' -
wheree.--. epiXept^:tc^t':fi^;ts<co:^s^fcsieec^r. wx th- :pr- preceded# .the :: onset-, ? ■. 
-b£;my&sthenil-'gr&isY?' /?#• - - YY ;<-.Y?Y. . • t.. ■ • Y 'Y.. ■
yY-■ Y/yhsthehli 'patiento' '’'tend : ;to ''• be , -nervous -and : excitable^ -
;th<^^YYj-.exm5ohh^-.-Yky':-pesem^^l^:i^hg^' that ;associated: ' Wdth thy-rotoxioOsis 
11; - is : - hot '■• supppr sihg Ythat fear tof c hoking# should . .cause' pahis 
or/ '' •
  
/- - ' .>’■ A 38 l/A "Y;/-'. , - y/5
os* hysterical reWMjans\\^'W6.3p45^?^^25i^^^d/;d0pr’^S'simnA/Y . •'■ ' 
with Yf ear-• ofYdyingd dupin'-/-s/^:©e-)/Bl03j^7^OVYYNH^^6^5^95)< 1 #! ,:.• -."'.A- •;, •'-•• 
fnilyAunderstandahle) ': ...'In -'addition /to this# true -.psychotic - . Y 
di s odder a Ke re.. reed dd e d. in / e igh tY c ase s ;'{ BH/Kp/d’ $ * \' $Hl833 8,Y:.- 
o4<WY'.:OTSaottfY ■ yyaaAaa w$) ;,. x t . • • •; -. a
X3 possible/ that;'those? OhWbpsychh atrip. .abnormalities ; •'•/ Y
are? coincidental? but -it'.' mttat'Abe-? recorded/that; they?' 'feature , ■ • ' •• 
in' three • large’ series/ PpdeediLaan$ t 1958;i',Simpsmi Y/X9S0&5 Y; • .." ■ , ' 
StOrm^NaihisenA ^l^teifcY .Xhese^series ada,: compared /in / ..
Table; ;-? v 1. 'of -..Chapter A » AAAThe;-.coincidence Jof - myasthenia'- ;.<'• \ , -■ 
gravisy - and epilepsy/ ?, -has! .been, hated. ..befo£e • ; ?/-f earnsid os .(1915) 
ahd-Tage# -■an/YPBSo’uanb-; (195?) ' £aoh?' re.por.ti.ed; single Yoaoc’s. Y ■• 
but ioe.fe^ ot'--&l p 195S,)- Wc or deci': ..eight,patients•■ in? a'/soriasA./-, 
of dlS0/0a©es?--.o£: myasthenia ’gravis. .-who ■■bad . /convulsive - ; ' . ' • ' . , • /: Y, • - ; 
aoissurea .-'-and . one -•-additional- ..patient- .who Y.had-Yyhcopal: - --attache " , 
without /convulsive; 'movements?'# ..■ In. ; cases/: -. A;//Y ' ■- Y
epi^^iep;syi--luiti/bec5si...in^e0©ntYfexdseveral ywr$; before/tho. /■ — • '.’ Y; 
onset■- 'afYm&athenic- symptoms» .'-"""L3i -raoh- .of the/grand' mal- -• Y.. "•'./'' 
type; 'associated in -ohd W.th - psychomotor -•dtAachs-ahd^ioY •• -A ... t' •, 
■another. Y-Wth-, psychomotor . ""ah---^^^^iciY;mo<to'3r-Adeihur.<^©»,/ ' -..Only - A/,- yA:
•.<^3aeYYio-':1^h^<^^l.e:^^g^h^’t^Ad’aa^e^^^'-had^‘A^^^J^i^C^-: pattdiuiApermittiOgAa /,/..■/,, Y ? 
diagnosis' •. of, epilepsy#' • W- was '.repordod ;- -from' a. child- 'aged' -; 
Who /was-Ye aitVito ■ have.. had ’ myasthenia; ‘gravi'e/Ylnc-e /birihYwth Y A 
slow - motor •’deirel.cpmaat «-iYrandYml - YdpilWsy - first / ap-eared?:- A ' 
,-at the' .aga>, o'fA'4- yearsa ’• Y'Thle casd/appears. YtoYhe-9 of /the -'" - .- ’• 
■'aongeniiai - 1^jTX>C' describe# Yin', Chapter,'S/--ydilch may 'd:L:ffexv-- from; • a 
tru'e- -.myasthenia: gravis, - : Hoe fey -and - -.hie 'colleagues - ,.ay'e >.,? . ’ 
probably1 ..just^.;fieAVi^n ■their ;cbnolus3^<ihAthat’Athe;yljio’idehco,. . A- ,■ 
Cf '>pile.psy . inAthis/small '’-number,. of -myas tho.ni’c'Ypa.ti^ehts: is '■_• :
greater Ath.an /would, ba.' e±pebted/in - a; ymdGm<.sampIe '?of; Y the- ■'.- '.- ’
pop'u’Lat^^on -/of 'Ww /Tpx’h -but Yit • must' be., statedAbhat- one - pa'tieht - 
' had ' ifii' family history * of /seiamres,. a • second • ;Wi- a ..head ‘injury • ■-. ': 
at/;;/ ' - •.
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at '..the 'age .-.of ;3 years -'with ; loss 'of conseionsneas of ' .
third had' 'recovered fCm • ■;-.'■ ' ' ;- •
apparently ; uncomplicated ' ■ measles ; W^en- the ■ seizures started 
Autopsies'.Were'• ••performed -in three -of 'the pat lent slwhofdied- 
The ' brain wao'noh ' .examined- ' in one.-' and;;no'-grrss abnormality 
was': fund in the. other -two»;= -.YRoge and; "Parcouri ; '(1958 ) /' ' 
report a ease,' of myasthenia.'With thymic tumour . -;who had -' ' 
oepe'afced'opiiep'tio' ' attacks and ''0Ohnusifcnsn.a3tate&es
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mNNDQCRXHOWGGy*#,, '' . ■ " Y . '• .?"; . ‘ '
. . . iiiT'mjrwnftfr'■, / 4 ‘ \ . 1 , 1
Thyroid:-'•••-’ ...•. - % -t... _ /'*■/ <J'. ;'. . /-' •••-’/. ■ /, . .. ' • , _•
relationship.'betWeenimyastfaenla gravis and ,
disorders. of the.thyroid gland- is beyond doubt. The .
.association- with thyrotoxicosis was first. reported by 
Rennie? (1908) who. considered that' it vao- coincidental#
'The literature, is suhnarised - by. Millikan and- Haines - (195?) 
and by Osseraan (1958).* Most of this literaturethas ■
concentrated- on the' . possibility 'that thyrotoxicosis - hay 
be causally related - to “ myasthenia''gravis*, '-.Cohen,and- % '' ; ;•'• •
King; . .(1932) drew attention to'.-some similarities existing \ 
bettoeeenihe two diseases, -notably hypertrophy of lymphatic 
tissue) occasional'iyappooytoosb') ‘occasional glycosuria,' 
and- -thfe- presence 'of. lymphorrhages in. muscle..-tissue',' -•' • .
Thyro toxicosis' 1 •.< ■ . . \
-Ovi;he "basi^^;/^^f .a .numaer-?'o.f- patient® - ..(Thorher, ' 1939? ■
.MbEabhorti.’ and .Parnell, --19485- Mad can and Wilson', 19?4) - it ; ; 
has .beon-.suggested - that the/e - is-.-a '-* 8©e«sew'relationship- * - . 
between the'- two diseases’, - increasing as. M
'’thyrotoxicosi's - conies control -and vice - versa) ?Ho - -
such relationship - 'was .found by- - Bartels? and Kingsley.^( 1949 ) -. 
-orJpy?; levy. ■ at a!- (1<9 51')Y and ? indeed - •s'cmO/- physicians. have - ' -' ■
^^akenYthb.f<^^^3^<^g^^tL•i^0{^^^c^:^.nt of-viewy; -ordering- thyroidectomy. ; . . 
for - their -patients- in the hope -of - favoYiably influencing 
the- myasthenia - - gravis'. - •The/firs'.t- report- -on " thym©^^^'- - - .
performed- by .Sderbrneh for - myasthenia--gravis :? ■.
dhd- Roth', 1913) - describes marked ' improvement of- Aiyafethenia- 
af ter thymectomy - but an associated - exophthalmic- goitre?- was 5 - 
not affected. They 'made the - .ih.tore'Bting observation?- that
lymphboyyosis- present - before - operation returned to- normal ?
 .after it (see' Chapter'■< ??'’
it'?.?-.’’ MlLikanmidlLaineaC 1955) described S? . cases' of ■.? 
hyperthyroidism ; and-: myasthenia " gravis seen - at tie-Hayo- • ■.
Clinic # ,’■ ; They, found --that - t^he" temporal - relationship was 1 ; 
■'qui'£e - irregular. "• . In-48 - -'per ’cent -Of cases the - fyper-- ?'■? .
•thyroidtsm 'Came - before.- or - ssmuUtaheously ..xith the .1 .. . ..
myassh&niiijgravis ?(12% more, than, five? years- -previously). - - . 
Trey occurred virtually - simultaneously - in -,20%- and?? '.;-?<';' ;
'myasthenia:.- gravis - 'preceded- thyrotoxic ohi a in - 32%. ' ' -They - '■ * 
werO’urtable 'to?" confirm". .a .relationship', of? •'
'physiologic ahiagOhiuu*- - 'between " th? two diseases - and- \ ' 
concluded - that they?were"- -separate .diseases,- which, were- ■ ■. 
associated - in some - ’unknown manner,'' -.-yMy'•• experience .'.has ' ?’
been-’'similar,. ;. - ?\The '■j^O)^.OwvJii^g^lT^J^^^’es.olnbat^:^'^^(.., cases - ■ ..-
Illustrate-.-thyixooxibMis? preceding ?uy6ih'eniat- .(MN662v" ' - 
?I#4630), .preceding - myyathenia- then’-recurring" as myasthenia 
subside?? (.04)34 ), - occurring - pari passu - with - •uya©then’ia 
iMN743) - .-.and, - following resolution - of ?uyasth-p'nia " (.MN??!}.
■ ■.•■'•.,Cage,- W5>632.;• iHud • exophthalmic goitre; ?af the - age of, •
•• ; " vl6/ from" which he - made" ,’a full - Irpoovci’y., ", -His " eyes - •. ■'
.... ? . remained ‘prominent and lid^lag could often, be . .... ,
'?'"-' -.'.deeu;os:rrated# 117061110X110 gravis 'started at --.t^h^e>-- -age " ■'
•-.'■'Of ' 29*- AdesOripyiion of - this; will be;- 'found " in - ‘ ,
Chapter’ 4 '" (Fig?^ ■ At -that time his - serum??'?
; contained?6»O/ugU, ";of - 'proteinf bound iodine.- (normal),
;•?.-- 0-01^1®^hi- . fixing antibody - aga'inst/- thyroid was present 
in-his blood -.io; a - title of ?l%.l6,» ,, , . ■
'<??aaso'-- MH4636 is also - described - iiv-fhapier 4, ' She- ■' •
? ■ ;had transient thyroto^ioo'oss >at - -the age - of - 45 , and ;did. "; -
nbt" develop"1^061110X116 'gravi©- until" 9 years " latex', ?
■/.At - that - ..time theyonly." clinical evidence .of. "the - .former -
; ' disease " was - slight palpable 'ei^;Large^^^nt';''of - the?thyroid "
■ ?? -gland/. • ?•?/-'' ' ■ - ■ (. '<•?/.-
••Y/627 'v- ' . ,YY ' "■ ■ .
; v" YgluEd and.'■ • prominent (Yiig*.' 5,2,)'* '" f\.-'v■Y
Von■'.'YaEtef-e 'e sign -was 9ocG.^a^s>oni^^y^.,rr^{^jent^# .At ■ the
- /jY-tirae.’of ■/the.jpho^Qg^&ph-herA/p^UuffiiVivee-.oO-protein’- — '■ '
/ /• i;b0uhdY,xodin^Ywas ■ Y5>X}.£?/XOOmi:*‘--< , Corn m!eien infixing. .. , /•'.
•5gi:iMtibO&'ies■.-agaipYt■;thyroid .-.were^present ■.inher. blood ■. •
' •' •.'■.?to.,?a''ti$rO f Y/f. f - ,Y:YYY' ' ,.-Y- ' " - . .
. , ' YY yTheseatwo'YcasesY.are representative■ of*. many■ in ■ .? ' 
which, ' thyrotoxicosis■ preceded myasthenia 'gravis by ■ a;, 
number of years., -f ■. Y . yY YY • -4-
Y YY/dase"MlM9234*?'. .In ■1956$ When vaged'■.■ 26, she -wasf • '■ ' ■' , -
YY,n.n®S tigaied sfor-? thyrotoxicosis ..on, acopouii. ’ of gloss' ■ •-• -•■-.,'
. , , ■ pf weight and tremor but ' .there . was"*nb -goitre. >Y ' " ' Y - - 
"!.• .•/exophthalmos or Yperspiratioh* '' There " was no :"family Y ,■ '■’•
• Y' history■ of thyroid ' -disease'#' -V.-YRer mother' tad' Y ' •-" "'.y-Y-Y '
I- Y. i;ly^cpshri^^-^^^^'so^^:^^al^^^diwit^hYub^dy^:^.ty.aaI^<i,aa,.P^;berl'ial YgYY ' ■.. - 
!■’• YYpncle died of .diabetes^' meiiifcus'* " Y; Y'-Y '■•'’••. Y ' ■ -.
■.,■'YyYYY-■ Myasthenia -gravis' began in the ■ early months! ofyy'Y;Y',■
* ’ ? , 1959< without bbvibuG■ .0 ana e-.’'and- - beo ame ? qui to/a' e vere'■—■ Y '", ; 
/yjY‘-though'fully responsive ■ to pyri^d^6s^1:i'gmj^n^^.,(4^().?6'P^mg. ‘
, ■■ Yd.aily )# .'"She tedded; to retract Rer ..eyelids '-whOn Y '■ '-■'..' 
Y. ' xYexcitedyarid , her-- .-'heck Was full, ■but ■ -ther'eYwas' hofi ;■•• , ■
Y Ypvidehco’-o.f-gemnine —hyfotpxiOpsssYCFig* 5,3,)'* ■ Y
" ■•••• ■ ‘ • •'fhymectomy wasY; •ppy'formed inY-Juiy-'- 1961 ■ '-Wth immediate-
.benefit* TheY'doYe '.o.f■ -pyridostigmine'- was;progressively
Y<-: reduced ■ to Y12Qmg;, daily in the first year ' ■and 60mg/dhy' ' 
..Y'fin the second-.year* # Y •' - /• ; ■ ' ' . \ Y#Y-'
Y'/Y-i.,.' ‘ 1n October 19.62 her .'-eyes became very prominent# ■ ■ • Y
Y ’ : ’"•/'■In; danuaryY1963' after ■ disappointing' news ■ she .,;,^«£^gan ■ to ,
/.fo'se ' Yweighi and ■ 'developed- a :£inhYiremol*■ and moost ■ ■ skin -
' the,.goitre vinci’eased"in sise (Mg*.;■ 5»$<J--.Y^5ad tachycardia 
/Y ■ ■" 'with frequent" .extrasystoles ■ was ■ found * TheYWruin'tYOeyel 
:- Y'of/Yy.■" Y- ' ■ ■ ; <V.Y "’YY- Y(.Y-.. , '/Y;'
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of.'protein-bound iodine;-at ‘-''that /time was greater •-. •:
than/ltyug/ioOml* and antibodies/against ■ thyroid---
' and. gas trio.-, mucosa .were/, pros exit in Her -blood' (see,..: ■ 
'.Table 15, )« Jfhyfcotoxicosis;fwa'a controlled by ./
oarblm&£ole which-she/still• requires'i /She feels/'-.: • ■. •. 
very<.’tired/- at times' but thoro is ho '/myasthenic • / / ... t.
/. weakness - and 'she -is/not helped- by. taking pyridostigmine. 
/•'This ;was”discontinued, in February 196^* ’,/•''
■ ■ .Case. W75A5-■' no tic ed Occasional palpitations -from/the ‘. 
y'age;. of •'•••3?/ /When shewas7 36 she/ had double.-' vision in '
bright .sunlight.' and <notie;e'd/tiring ,of her-arm's when’ : 
/-dressing, her hair. ' There was'then" progressive spread-’ './ 
.: of,myasthenia gravis ..though; ‘this•, was. not- diagnosed,' until
,;2/years/Iater* When/ she was: 38 she also'developed a 
' -Raynaud syndrome •■ She' had'/never; had a goitre but'a' 1: ■ -■
maternal aunt had had myxoedema'for 10 years.,
' Xn.--.the ;Worthorn General',Hospital ‘in the fourth
year -:df myasthenia', she.was thin , 'deeply 'suntanned-' 'and' 
•'•exci table.- • • There "was ho ■ goitre or-, specific ‘ evidence. .
. of -thyrotoxicosis, A high titre of, antinuclear factor.
/ AiW.F.) .was present/in her blood hut ho antithyroid/
substances• A radioiodine test of thyroid;fundtion 
■ -gave a 'rT’!; index of •/££«$'and;Kt thyroid.' clearahoe*)
of 16*G, figures well-within the hyperthyroid range/
‘'Case.-107781- (G.W.T.^’M733/52i-’-•-in? December./195i ’' 
t-his ;3G year old woman started:-.toVhnve’-'myasthenia 
gravis . of ;the.; extraocular, mush 1 os. and - face (Fig;.:-.5»£) •'■ ’
■ There"was' no personal;or'family history of thyrotoxicosis 
Her'-mother -had rheumatoid arthritis1. ; .'/'”-'• /
. ■ - -X. treated‘.her with AOTII and. cortisone /which seemed 
to Improve the 'myasthenic-' weakness f or a '.few months but 
thon/ - /,.-■;.. / ' ’ • ; - - ''
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■ Y-• them . her, ■legs ..te'e£&me weak* : ■'' Ab'the/aame/.tlmo..,•• she ■
Y?. {beoesie./de/df' iuhi- the'''left ..ear ' .(pQndue'tive "type) -' and ./she’
iiad ■ nightiswwa ts'i'.. V“ She Wab.-exc 1 and rath e r
. akgreeaive#' ..^MyaafeheniarrQSppnded' well.' to ^neostigmine.
■ and . ;.I'. did .'not -/ see .' .her • again las., I.. yje ft './Giangowb ■ ■ ' / ../?““/< 
■.'.- v‘- /inzi'959- the my&st henia neiApsed and' ' she ' .‘wasp Y.' 
:• •'readmitted. .%0iGiasgbWjWstern‘.7ri£inraai,,y under' the Y?'. •/
// ..care/of, .Pfp fessor'-Ei J* Wayne,# . .‘At that ' time 'she'. # .,' '#■,
■:'i. .•///'had 'slight' 'exophthalmos sand/moderate . iron .-.doflci'enoy,
«Y fah'aaeia# '■•/ A .radioiodineltes#«3ioWed/a/g3an'id; uptake.' ■
. of .'72% ill 4' hours, ’74% in 48 hours .Whh- a ' TpI ' of/i)i75.»
■•■' - results - , .suggesting - ‘ early • thyrotoxicosis#' ■ ;Wo'. thyroid Y
' , antibodies..Were .'found • in - her’/ 'blood ''(Dr#. J'#. .'Andorson)-•
. -../??fn? 'thelnext-•••few ' /months -symptoms. '' and ' si^gns.?of / . /<;.-‘ h 
; " thyrotoxicosis. 'increased' and a/goitre became-.apparent
. ": .' . X-F'iLg*#^’. 5*4-) , ■'The; .basal .metabolic./fato- .was..mow '<'t3Q%Y' /
• and .. the ' a erum/pro'teinYbound iodine, ( • PB1 /■). /WasZ^Tb#/ 
. ■-XOQml # ' • A thyroid ''suppresaiboi./test'/with thyroxine .<;,./'.'
in. March' 1'960'ws® negative* .■. Those fihdingsYihdic&fc'a
/ < /.h;^;^p^3^,thyi^o;^dimn. ■/,■ '/."• . Y-. Y ■■ " - . k? /,i ••:• '"v .;' . .
.d: '• /■ Wo i essor /.Wayne', ' kindly . asked. . jui / to .'see -her again .'. 
■ . . .‘"in ./January. .I960'*,' '"-■..■■She . a.ti'li.'- had //’ fatlguable* Weakness 
, pf the. proximal'xmmelds . of.-the'.'upp'er limbs/'but .4 '“ - '
'<•'.'Harvey'Kasi&nd test “showed./’a . recruiting -response from#
Y Y&bductorldiggti minimi# ' .. ' - YY. -YY/yY';/:
. ; .• /' , - -In'.-my '.experience. •a/disordeiy. of.-thyroid,' f unc tioh ' Y. 
.h&sYbeen present '.a.t'.fo^he . -time.'or 'Another,. . in'' .21 % . of . women ’ , . 
•:{ii<di. 9%.of' men, suflYxY'gg'.from myaaiiiehiA.'gmvirn# v Thps’b. . ' 
-.figures are much higher thanrthe/.i^ii^i^i^e^nce of 5%. suggested 
by 'Mllikaa ' and :■ Haines ( 1953 ) but their . figure.''refers .only 
'■to ' thyrotoxicosis# ' fyYmy.'aeries /other/types /.of/: thyroid .; 
disorder;. VOre.'-no t©d; clinic ally ex’.' at . '.post '/mortem?'-, ' ■ • 
‘.exai^mK^^s^tiLoi^^/ Y.:Y.Y. . • -'./ . ;Y /,/.' . ■ , YY' ' ■
.YxsuinGiationyX Y.-
' \'y-Y i) Y :ThyrdtoxiWGi3"
-■ , il)Y- yv Transient '’goitre-, jytoxic"-'symptoms#’ " y..' ,, "Y:Y-
Y' ,-’Y iii) ' /'Persistent nor-’toxic goitre#'.,' •;Y.' s. y. ./' y,
" , Y : Yvi) ,Y"' ;%xwodsmm* y . Y #’7..-* '-•■-/ "v Y '' .•■• Y • -Y-. • Y'Y; /•'YY'-Y-
. y v)Y'Y .Lyrapiia.clenoid-.goitre# , Y' Y ' "' Yy'-Y; y y.--
/ ' •'•/,-• y Not inc ludod " in Y.this?"table. /but" .probably' ^example©' ... 
of ’"’' type -2. WLthoutirecognised . .thyrotoxicosis' arGymany " ■ ;'Y • 
patients Who' had '" a' mocLoiralYe.. •■'degree ‘of/ exophthalmos#. 
Thia'bas • been"•.«no'ted"by ’' pye.VipuY'Yauthors .(Walsh,' .-1959')# - ; ■
/Other cases' ’had' aY thick supraorbital. pa^cV' of YfaiyWiich’ Y, ' y , 
’closelyY-xesernbi'os tha/h seen/, in '.recovered' thyrotoxicosis , ' "
, ('Siraip^bxiV '/196Qa')(iin#3^L%yyi2)"k ior (1930)' '.. has '-previously 
described' 'oedema of the , lid's in . a . '’'similar -'O'ase /pf1 '\-y'. " Y/ / '■.. 
.mystheiula. ' '''-Y-. , / ■ - '- ' .’ -.'• ■■•y Y Y’ YY//- ;
Y/'’ ' /figSe.’ftffl39,l2o /One ' of ' these ' patients hssya.'high -//'/ -Y
■ ••'■■■’ titre ' of c omplement' fixing/ /antlho dy cgain'st thyroid' . - 
- ' YY ■( 1/128 •)*/ ’Which//WuU<lYsupport they concept ' of'' previous •
. - /y Y''Y{yYbidydibeape,.' - ;'She, '•also;,has',a' raised-' titre ' (l/LY) '=- 
-■ Y O'fY antibodyYagaihs11 -gastrie1 j^ubbsa #■.;• yY he has-• had/. /.
’ ' ’ Y/, iron def j^oiOney Yan-a'emiii ’ but '■ Bill haas 'ggatric acid in' . c
,y '''i^^l^i^onSeYtb'/.}:^i^is't^a^mi^I^c^Y’^^h^//Y^',norma)l' '-Level- of .vitamin B12/
Y-Yin; ' 'the' B^^,un/4^"5.O^'ydg) 1./ Y Y -y ■■ -• Yy...Y-.
.. Y.Yhntih^x^^n?roui^/iu:/:w^^^c^m .the ..diagnosis of^/non*-/ .YYy
'goitrous.' .thyxo'toxicosisTuiisY; be'YchU1^cVe’rbd/is exempl-'fi'ed. - 
,by. oa^bs, HH52j52< NH11102, KH2J450,. 'W5315?,. HH3571Q# '' .
Wi-plS, WHSa—J#' iOiolYZ, KHe5Q2YyAil.Y£//the# 
comp3.sine<l of / prof ub’C ' sweating' ahd/Wight.- -loss and'/ many -
■ .Were unusually •norvousYor' irritable / ' / ..Yi'ese .symptom's;-;; 
\Y^‘t.(^il" •'Yppbedo&YYfche /use/ of. • Yuitiehooinestex'ase' drugs './so "
■ ■cannot be...' 'attributed yY^^.'Ythe muscarinic '’ side-of feots' of ' 
:Y^.r.ea1^me.nt# '’ " They . were' elicited reix’ospeGtively ' when.' -I ,
,,examined '/-'/ Y.y-/■/..',■/-'Y? \Y , ■ / -Yi/ Y'-: y-‘';' / ' ; '■' - ■ ■'
66#'
examined /.the '. patientsa-. f oxonr-UP!clinic # ;. , ;None'/of/'- / .yv 
themshowed ' clinic ali/igns ' of goitre /at'-/that '/-time and • //", ' ''' 
none wore Xio ted iin"/ 'the 1 earlie.r ' -caee records * . - Both 'Of ' ' : / 
thee'd/gionpB ' mint ;.-be '•'suopec/ted. of " having • had - > '
-thyrotoxicosis''/at'/Oome • time' • in - the .pastybufc- - they •are• ■' - / .■'' -
excluded'from the'calculated 'incidence/ .
'•‘Non-tdxio goitre and • lymphadonoid .goitre.' i'/' //•;.• •,
•,- '|/'|" 'Attention-must now ...be/directed':;to/the;.remaining/ -■ ■'■
c/tpas i ■ ‘the; non-?toxici goitre/yand myxoCd©^. -wh±ch'> ''have' ' ' '•/ • ... / 
'■booh''ignored. in iy-':if . •' • '
’unjustified is shown ' ...by a brief review of''the; literature,;' • ; 
from' pathologists ..whoidescr-iheyin' bhejmain non^toxie,'/' ./■ / ;... 
goitreByoo'flonllymphadenbid/' "(ilorpi-s i 1936 - /Miller,/T940/5 ';< ' ; 
/Gl^2d/^^^^3fj^O; ' and HaymmS;-i9i4/'') *.y /I -"These' /a.Uihe'rs /Usually' //- /' ''"/ • /! 
.coj^^^3^<^^^^3?<3ci/.^.t^ha',l^lie' changes. .'■ w.ere Inyo lutip nary infa //-■”, /;/;.// 
''proyious/oxophthaimic /ggitre•/ , .7 /Rowland '' et'-al' (1956 ) i/ti ••'',/ ■ '"" 
.however fyfou’nd' ■ .four - non# toxic /nodular./ goi tres/in' a poet - ' ‘; 
mortpm. series.i>:f' '26 imystlhji^a:c^^^/-a^^d/l^^ii^g^^i^i;s' (1951)'/-../’’■ ••
/found ' 5 abnormal'/thyroids in ' l8 autopsies » Ope/. of; ;
these -was1. 'a ' "•^^n«^,t"^:^:io 0;nodular.-'-go.tr e /(Without lymphoid'/.- "/ / / 
infiltration),. one/glanl (fo/m a" girl of' -lOl/was/-■ , i /i.y 
.considered'' to ' be ’' o f/toxic '/type, dud/ three ' " showed/patchy' / ' / 
parenchymal atrophy '/With ' cellular' disintegration associated ' 
with, dense lymphoid. ' infiltratl on, / Two/pf' these had/ , ■/
lymphoid follicles 'in .the/ thyroid ' ’givingpto the/picture' - .
/a certain resemblance.'to' /that/o£, lymphhidhoid/ggltre;’ * ’// '/r / 
Both '.of/ /these ' patients'hacd’a thymic//tumour * - / ' / ./ ' •'-; •• ' • //• ■•
t ip. ;/The; following case 'seems ' - to ' .be .'c 1 osely;•.S:imiiax*., ' ./ '- '"/i
They thyroid section/ '-was' showntih" my '/^H^^nmmi»^^^-Llll^e^le.e ;' • .'i /•
••lecture/and the/ pdoUibiilty of ' ’i^’fcc/b^^o;^xxg .HasMimeto’s' dise’esb' 
,w&s .discussed ♦• /. 'The illustration' was; /bnitted/from /the '■ y .. 
/published/ ; '-
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published 'veaXsi0B' on ' the. advice of a specialist i-m 'the 
BUiy®©t but passing . reference' was- made.' to the' possibility 
:of- an . aasQe±si±Qn.■wibh lymphadenoid ..go&fcr^e- (Simpsson, J1960a)# 
- ..Case' 'MH257. in 1950$ ' at the age of 44 'years, she ' ■ -
' T ill' Utf Blrwi.' - nw - . " • ■ ' , ■ ' ' - \ '
had' a' series of.'choking attacks followed by ' 'severe
.tiredness'and dyspnoea# in one of.these attacks 
in 1955 she had substernal discomfort and. pain in th© 
left ' flank ' followe&.by tingling;. in the .-ulnar border 
of the left hand * .Wwekness' ’increased and she had
.•further ' aubsterna! discomfort# ; .She was admitted to
:■ ■ ''S^ihurrgh Royal If fimarry/(Dr.#- 'Halidday CooQm } in ' •
■ May, 1956*. The diagnosis of my&dthenia gravis. was
" then established but she remained very weak despite' ;
' . increasing. dosage of neostigmine. Wien she was ,
. # admitted,;to-. the.'Northern' General. nospital-in -April,* ••
1957 ! she? wad '•taking 105mg# ofneostigminih and 2gr, .
“ ephedrine daily. She felt /mpr© comfortable when ,
, - ,. the? dose .was increased but never recovered sufficient 
, strength to' 'be put of bed. '• She 'Was.? troubled, with 
. . colic, diarrhoea. and. 'headache but','these.‘smxptoms were
■ controlledwith ^^tooplne. At tha ' date ths© was the
/ acchrthd management, I would no longer ittcredsh the •
dose as I . did then to .42505* ne'os't^i^f^hine and 170Omg# 
py-ridostigmine. daily (equivalent to .70 tablets. of
. neostigmine). In retrospect it is certain that death 
. . was due to overdosage as ' facial -twitching was noted in
addition to muscarinic signs (Chapter ."L*9)*
. ■ Post ’mortem ’/hXdmQhati'on revealed a thymoma which had
not been detected -radiologically# -■ The 'naked-eye.. 
dpp^hardnch of." the • thyroid gland was’-'normal but . ■ .
microscopy showed .'severe parenchymatous atrophy, some .
• slight interstitial.fibrosis and . a very pronounced ' .
.' ■ focal/ _ ■• > .... .. . >
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’ -foc al’ and--.dif fuse-lymphocytic /'ihflltratlon* <There... ’
,wbre*’ numerous-,large:.lyndipoxtd/Aflli clea /with./ac’ tiye' //.:? .■? .> • / 
gpxmiB&l--/ce’htrns •$•.. eliartae-fceristoY.pf- *lymph-adenoid y- :. . '
goitre’/- (-Fig*- ••5">8i«/—-The --spTeen'ootft&ine’d -white-' ' -
, nodules?- which’ "showed/"!ymphoid -. and. ’ reticular ’" ; .•..!..."■ ' 
hyperplasia- -.-(Dr,-- A. - F.'dW” Maloney)?# -• . / T ’ . ’ - ,•■’:?/,y; : /-'•
Cage? ,Mi2327. '-I saw’ /-this-•,19’year - old - girl-’in -'•• . ■.
Glasgow' ’ Western .Infirmary - in May 1956 -with-a 'three ■ • ? • 
month history- of . /myasthenia- grayi© A'//Thymectomy. -- " /
•Wea?'performed,/In 'September; 195,6.'*'' The -'initial. ,■: ‘
< response ’was good: hut, ahe - ■.•subsequently, relapsed, ’"- ' , ■
i-hen' admitted. - /to'. the /Northern /Genera! ’'Ho'aailtTY • Y -. ■ .. ■ 
/Bdinbur’gg/'ihhApril 195?. she 'Was./W'eXfcohtx'biieU bn " :' . 
JiObmg - neostigmine ' daily * Her* tongue? -shcw-OdY -three
...lonnitud in al furrows.. -.-There was mi sustained '"ankle '• y 
' clonus ».-• /.Towards/- the'' ehd-of 1957, -she#relapsed’ ,ahd in •-•• , 
/February 1958: died ’suddenly of ' respiratory failure, '" " ■ 
/Thyroid#disease had not, been suspectedyduring-life* y,- 
’■ • /- At- autopsy . in Law-'Hospitaal /Dr. ' R.T •' "Shaw Dunn-//■.,• ' 
found - /24gm*y/of ytbymio'"'tissue.- The aorta was of-.Small. 
calibre* •• The thyroid ’gland - was normal? in -eXternai-• .•’ Y 
appearance - '•■'button- - microscopical examination. - showed - a , / . 
diffuse - ..lymphooyti o - - infi llration - .-'deeorib ’ed as? ’ alosely 
■resembling a’iypie.&X, ■Hash±moiQls,?slxuima* '*• ’.There.-was- a 
.-.cystic* teratoma .of the ’ 'o.yary'. '-The-spleen'- was- distinctly 
/enlarged- -■• (229grn ) /and -’ int,rapulmon&ry •' lymph nodes - '- were "-...­
©lightly more -/prominent -.than-usual '■ • / /’ Y/;Y--/’'
, G eqgje 'MN5503-.. ‘ ‘This' ’ female patient. who .--had mmy!.Gi/}ie.n;ia /- 
-gravis and. pernicious .'.anaemia- wlth slight'- hypothyroidism 
is/./deaeribed in - -Chapter-■■?,* \ At -’post.mortem-’it - was . /" - ,
. -found ' that"; -her. thyroid..gland/ showed changes ty'pical . ’of •
1 Ha'Shimotofs/y/ - . -- - Y'" " !•'- ' -A? ■:' ' ' '• •'••''..• '
■ -nashimGto ’s;-disease. ■'- . ■ ■ / ’ •'‘/I3-X -. v ' ' .'•' /.'■
''-'-yin-. 196$'-&rW#' ' Lanbaster kindly' <re£o,rred-.- a
caed- 6f-'myaathenna-.gravis".with clinical; signs' ofy-v’;.'/
Hashimoto’s disease*. .-.A point - .of - special- 'interest- is'; - .."' •
.that-.. - tliS"1 at ter -'-develops &-';'5-7 yoaps, after'* ;/i; . . . *
'; i--/Cass-KiN7S?0 « otfxMMD, '(pale-) was -foimidt'--to/ have: active •-••• '■ '.
'1 Ax pulmonary tuberculosis - and. at ithe;sim.e -•.‘time'- he . ---'•■ ■/-' . , -■
5' - - ■deveidped' ptosiai' 'diplopia j dysphagia' '.and - weakness -/- ■•
'• - /...of' the - arms, in , 19.43/when, aged- 19*.- "'Myasthehia- gravis' - , ■
,■' -. was diagnosed '-and treated with’ neostigmine, until,’ ' •• .•
r - 1955 -.when. thymec t-omy was carried - put - by - Mr-,' .l-at'drsoh ; ’
.. . - Browni ip'-- Edinburgh -Eoydi - -Infirmary, ;•■ .-Neostigmine- . ' ■ '
'tpequiscnents uMre reduced from . - 23-'to ' 10-13 - tablets '•' .' ' •
.‘•dally* ■ , " .5'- ,/ " ■' ‘ ',-5' '• ■. . '
;»../.-’'■""-.from- 196.0 he complained at intervals of.abdominal - ; 
vit tpainy- sweating' -- and - : ti•re'ehpss -Which'-were- alleviated by .
I. -5 ' - regulation-Cf -'the 'dosage of deisiigmine;,' and pyridps/iimnin!
". - 3}bri■ng one .such- 'episode- he was admitted'-' to:. Inverness.' •
- ' ..-’ '$oyaX:: -infirmary'' (Dr* W Lancaster /.where it - .was' noted - •-
tlmt. hot.had - a -•diffuse- /goitre, and;- -pigmentation -of the '•
■ / .'face ('fig«i§9#)/, ' -.-.He was commiainingiPf - tiredness and - - '' •
i .-dyspnoea which were not Improved -by■RefglIation'of ‘. y.3
, ■ . 'dosage’ and were not ..apparently - due - to. - reactivation - *:of ' .
•.tubQr'cui^siS' ,’lffo- was--'.overweight 'and showed no clinical - : 
.'evidence of- thyiiotoxic,oa.is♦ .- -• d ' ' - . ..' ' ' ' -■ ' . -
./■ '- .A ■rUdioiodinp: up take-. test - gave'.- a './.I’PI of -1.6 - and- -the ,
, -Rictein^bound' idd-inA was;'!'#4mm/lQ0ml,- i -■ Serum ' ■/ - ' .
.;. - 'ph6iesterol concentration --was 200mg/l00mi,-• Antibody
■ - 'titres-. against .thyroi^ci'- tissue - were 1,C'H.' 1/.2»300,000; .
■ tOK.Tii- 1/23G;; zpp'ecolipxtin<.test positive within---24-'hours.
" - ihe sine' suiphat.o' 'turbidity.> was l4, Aunits/and ;-thymol •'
. ;^^ux’b:i'di^.ty. -. 8,2 - units'A /^^:iagno'si^£3.. .of ' Haiahi^mo to - ? s.. disease, '
was/. i- ' 3 ■ - . - , ' ; ■ . - O'
:f?0. •
\?v‘waa<Wa&e',au&' tnda.tine^r^'^^stax’.ted ..with', •l^thyhoxine (oo.ime-
daily) in v February; 1965«
He waied to o, 
1965# The /$.$.>,/wan., 
C VWs 0 orgr eii) - N-ooii. $y'
... and;.ahtinu«3,.ear,- / l a'Cto'r 
:' ■; . • ■ tl irea.7' -agairiBt sthyroid
the Neurelbgicai 'Unit in July '•//,,' 
VQsBjmm.'*' W'-'the first hour 
cei 1 s ' w'ere .■ found >,.in 'hia;. blood .' • 
'Was not'7detected. \ Antibody .
Were estimated by. -Dr."'- W#J.* Irvine
aO To0*k,;nX/25:>600, * COF.T.■ ■ Ho antibodies'active
■"* :againsb"'gastric- ’ Oh'■''liver tisaueaNwer'evfound,’•',-- Spchum; . '
'7 .'eloctr?9o;>hQoee3ir /phewed ihoreaee,dgcRiiffimaloibUih »/ 
"•’ * turbidity' ’'war ; 3 'imita* and the - dephalin- -' - . . ■;
■•' /eholCaberdl, flocculation; was .positive,:- Ihe pulmonary;- .„ 
si..tube'rdtiioaisvW&s' - considored' due, bo ' ;in&o/feiy.e» . No' 7 ■:•. ,
' ’7 mediastinal- tumour" .'7c'ooi.icb-be , det7?oted-ibsr'/■radiology« ' /
..■, NMyaarhenia • war - well - controlled.'by - pyridos '<"'
'• 'i6‘Qmg»-'tsd.r. - and/nocstigmine. IBg*-' 'tVd.s,. (alternating) 
■. //- 'and- -ephedrine %r>4kt*d.;?s* ''blBbsrbtihg;.tiredness 'Was .
■ .cons±dered;/to: be caused -■ foy''Haeh±mo7to*e disease*- _ '•/•• 
e . - ,;_.■' ' The - occurrence of 1Hh,chimb toXa.dis.ease - in -a, patient • 
wLthout a - thymus'/Ls ./believed - to : be "'uniqu(i .■Wile it was .
'aw^lt'ing'p'ui^Zllication (Simpson.) t.l$6Aa) , Daty'.bnd Jackson ' 
( 19.6 A) - - reported;; aho ther- patient - /who- ‘had - • Hashiob>oo* s .disease- 
associated-'with myasthenia grayis*.- /It- /is. possible:/that•- - 
•th*‘ comminatioio iS/mor e; - - fro quept ' than - - hither 16- /real 1sed,k- o'.. 
The finding- of - Cihgertz (1931 ). - 'already' qUQted'lhatr .' - .; 
lymphadenold -change'was’ .common - 'in - '.the - /thyroid. .at' 'pd's-;;- -/- ..- - . ' - 
•mortem - -in - myasthenics - is, . substantiated by- cases in this '■
serlesi -, Fosterhuis-. ('1963) lists one case,- 'of - .’'s^bruWn.;' - ' 
lymphomatpsar ,in'a myy-a^ithenic - woman who had ;&:'• thymoma, .'• 




Myxoedei&sv: ■ ’.'•/■>■' • ■ ' 1 ■ -d/.-’;
"/. ';' d’'Myasthenia.- -'gravis-, - was’/•associated with- primary . ■ -
>myo&demea - -Lin three cussed reported-'£rom>.-h.©'■ Mayo,. Clinic’-, '
'(deirbeyg p. ' kl- ' 'i'7571 -d if ik?nnc£aasiggly;recognise# '■ ’. 
thah:-sorcailed .'primahy-/ttyx©edeMa.is .Usually . 'attributable . ' 
to . ,ila.ahinid to *a - disease ‘,but-, this -‘diagnosis, -was not made •'••' . 
in these cases. ’ ' Oily one ease: QfhMyxoe&em&i0ceu5?red - kin ■' '• 
;ihe present-SetOsc -‘and .this, da's.'-attributed 'to the..effects '. 
,0 f rad di therapy applied/to >ihe - larynx c.;, -.-The-: patio ht' »s . :. \ '
‘blood containdd.IdE . eeXld(-Gns© .GK/ES- ..deseribod‘in , <■ “ 
Chapter - 7), ' Case 36 ' of Storm-dtethidfen- (1961) described 
‘inkihapto?,.'?; had - .arthropathy and :a - his tory "off: ./-
haemolytick.Jaundice. .. and’ may -well " 'hay©,, had - an laU-tomhin'U.ne. ., ■ 
disease. • ■ ' ' - k k .y.-.
. ' ..-.It -. ip’. - important - "‘not to . mistake thyrotoxic -pr-,.--.. ‘ •, 
my^X^l^<^^^^in^ilo^Bl■mtyl'pa.tyy' - for -'myasthe.nia‘'gravs’s'- Both may '., 
pausd--fahigughief w/eadnes^■ but; .doynoh■-r'e-slind f-y-t/, • ■
;a^tichol±he&t©rls©' meddo.abi,li (Chapter ' -17) » - k . - • . ' --i d' 
■',.... ; ,-! .lhe relatibnshpps.'just described invite
■ speculations, It /is - submitted that - -chance - ©linoiLdUnc'©.'y. ' 
must --he - dismuiseue^d^k. -• Nevertheless thyx’pid-»func toon- studios" 
do^not-sh-jow any .teMdency- for , th© maaorrty of rnmyashehnes •• 
to - have increased thyroid function (Chapter -6)-,- -' -The -? - k ' 
inp oihsis t en t- - • t ©mfcdallr.©latimskips hetwe en thyrotoxic o sie 
and-my asthenia make - - it - inalhc©ivlble- that one - ' disease, - can.,.'
pause8 -the* other-/' This - possibility is -finally demolished 
■kby the report /of an a-thyrOid- -patient- who - developed - -' \ ,
myasthenia?-gravism/Ora©!^^!!- 19 6.2),*/-.'Tie - •special .case ---of,- . 
nashimpto ifet disease • wi 11 - be discussed 'in Chapin-' 13,- but' - -
at..hh±k'/-pbint' if "is neeessary.; Oo conclud'e ' that - all - -types 9 ' 
oO hon■i•-aXsgnh^i' tltyroOd dissess are in som©-.Way linked - 
with/ ■ “ r d ’ '• ' i , - m .
 72, ;/. . P/P./
W-.th, -P/, '•'?••- P'• / ’ p-. • ' ’.PP;P''. '
P Th’©''due. ;to /.this /i’fiatianeK 1 p' /may...be providf-d' P...'/ '■
by/ /the .'■ fol.Llc3xing/"eb£3e'Rpv^a^tion which pis• be 11 eved to • he > ; ' :
,l9-6pm)v .Xn ’ 20 cases, there.• 'Was a.-y.' .-' : . •
/faMXy hiatqiyr cf .goitre:,:;\to^ic.--Gr• simple’- . /or - of " •', , ... • 
ymyxied'ema, Tho hlffeet'ed.relative . Pis' •''.UeuaXly a .sistbr-p P; .
or a • -/female and/'could be on either side of • Pthep-famiXy / 'pPp_- 
.('Table/9 ?/p,, k ' Tlie-ekaot..inoidenQo" ia' uncertain, since •'"' P.;P
patients ''have . only been ' questioned" ^s'yqiem&tie’aXly. -since.:-,/ 
'1.' became. avmro:’ .of it /atP the bad • of 1953’" - Soon '..after P • p '•, • 
thi© Hac/ra© (195-) ' reported <a •/my&etheni© 'ohiid• .•'W^xoap /■ • , ' 
•mother/had .hyperthyroid! amP •- '‘P<o0terhui8'• (3,965.) /hae. • •••. ■.■
recently .'ropox't'od; that ,39 . ;:o f ' XX6P.pati • ent</; • wi th • • myasthenia ,' P 
gravis1•■'■had • a'family-/-his tory • of . thyroid; '.disfa'se'.' (and/ 5 bf p 
these-'.had• •■.-personal• "eyiAenQS'of thyroid disease), ./Its .
importance '/liosPin ' the ,fapiPihat . a P onsti tut^on.al ;of /'J P • -P ‘ 
genetic ' do fed t-Pimay predispose /■■to;’ t^hbPdo.vei^op^mGj^^nb- of '• ' / ' 
Graveey/' diseaee/ (.Bax* tela »Pl94l ). ;:XiPxs, therefore %%,/•/. - P/ 
suggested- that ' a:gqn@. .may •' have variable ,oxpresslon..,' . P. • '■ P 
:producIng , eitherthyroid ,'• disorder, myyothehia. 'gravis os?.' , , • 
.both •( Simp'soh/.'l9S0&-)P/p; Quite''Reo ehtly ' Itha’asf been' ; 'shown • • " 
that '■■there- (is.' also ' a ' /gahetio ' fad tor '/in the autoimmune • .• '. •.
diseases ' inc eluding ', thyroiditis,,,.- '.Thus ' the varioiwPdis'orders' 
descixi^bed/^^.n-this ■■■ s’ec.tifh/ 'may;,, be . '/'part/of' '.a spectrum ;of -,'•- /' ■ 
diseases,.-;, genetically.' determined- but- perhaps- 'requiring - P 
ah'-acquired •precipitating'' fao' toro ' ;,/PfKis' /genotiu . /.defect/.’ / 
may/-.:alter-.' immuoiogicsi■ / re spouses -- (^^s,.m]pj3dn'' 19,6049, X964a) *; - : 
. '-P. *■-?.Further' discussi^on ''.is delay ed’'-uhtil ' the ' restppf,'';'/
■'the; evidehiePhas' been / reviewed''' but '-at/ 'this'•‘point it - ' is/ ' • ■-' 
-.appropriate '.• to % suggest - ' that '-' a/genetic ' .con troi. of - the /‘ -
.thyroid . Pf uld /be' XilpelyP .16;' ao t'' through'' a/hypothalamo^ ' : '■■ - ' •/. 
pituii^^£^s,y';?m^^'ch£^n^'if3m^ ' (chapters.'-13»lA) - .'..- ■' / ‘ /p/P' /p ■■ . '
■ Pituitary/ pP. / •// p'-P-' h-P........... • ".-,/. • _ •'; • ; ' _ Pp • '
< , - ' - /yi ■ - ..// - i ; . • <;. < ’ .
Fxtuitary j ; . . . ;. I ../. ... ',... =/ . • \■ V - ■
..-There .isscanty • /evidence !:of a •pitirttary: factor . •-y
s. in -myasthenia 'graais'/though it has<J^n3e;^^"c3^£^:^m,ad' •' that, ■• • • 
pituitary • extracts -modify, neuromuscular /transmission:' in , '
' ■ -.that • -disease (To.r&af aud\W0^^f 1951 ; • &aa$,/1955)« k yk ■
' ■ personal '/■eKPrr..e'-n<3es .'with •the •administration of- ' /
adrenocortioo.trophin (Chapter: l8) indicate - that the 
effect could .bp: .dUe to - the • thymol.tic action of. • that 
hormone, '/This/oouid not account fpr• the • reported/ 
improvement of myasthenia. and • of malignant thyrotoxic ,/ 
exophthalmos• after irradiation of the'' 'pituitary by , -■■
, and Ticbo'. • (1951) • • but• this result,. . has never been
.. verified, 5' ,./ /.,- . < v„J. f / ///-k t
./--./ • ■ ■ k /.'Gases 'of myasthenia, gravis associated/with ff, ■ • 
adenoma'• oJk'-•the • pituitary are■-repbrt^c^dhby TiXney (1915),
/Ditiler-• (195#) and Grab (1958) • ■/ Torda hnti Wolff / (1951)
,'dcscribed? ed.Mh'ophilic •-accututaiiohs • in /the pituitary r
On the \ other hand • Rowland, et '-al (1956) • found •no - ; -
- abnormality in • 22 •' pituitary • glanda -..of' patients -dying'-: of ‘ ■
••• -myasthenia gravis-' • •'■ ■/-, : f ••••
. In the present 'series the pathologist 'reported;
''• -/■-that • the • pitui tary .• gia'n'd • was ..'unusually large - at autopsy-, :'
■ ink-three Cases, ’'/'■/. i' '• -by ' '/ yk/'-k kk- •
' - • k • 'Oaee^ISlH/HH/GB• also had. a large thyroid!•gland (hietology • 
./■' nob described),/ 'Tv k k-kf '•>-• ' if.-. •.
‘■ / • •' / Case- • ( - described ' above.); .had pernicious anaemia
■ •'/ . - and Hashimo to ’ai'disease, ki.-k-.-'k,' - y . .•- -
/ , k - Cas? IMH7o/k' had a thymoma.i. '• ' .. /,,-. ■
’ •■'. . :. / ■ Bmfo-r'tuhateiy the. pituitary -glands.:, were• not . .
- //"examined'microscopically but there kisv• little ViQ.ubt- that'. •
■ abndrrnmii'ties• of the pituitary are. not •'present ink the' .
majority/ '•'-;''• '/• •-■/• ' / - - - - .
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Qsimoolty-s9f - cases.-.and,-jink’ ray' 'ppilon/,- are .unlikely k/to-w 
b<\ oa &eO±0,logdc&la Righ'ifiban/e• .■ ' -Nevvetheless -' it- ''mu/t ' - 
be borne'. , i.h; .mind. 'that 'the "widely- 'accepted' kpituitury/k■? -■■ • 
f&ct'dr ' in" okkophtfraimio. /gOftm 'is: 'not./aRsociiated'/with.,, - •
r.eccOn'n's^a^bl^^-lii’sSt^O^^i^^^^i^iBai -•oKhiges// s a-v . •/ . ;•/\/ y.,; •, ..
k ' Thp/contrary;' view- _that-o^.Ujiaar-adr^emia^l'; ■ ././/'•.- ' . ■?" 
insufficiency-hmay/be - responsible -for/myas 'thenia'i'gr'av^^^a', - 
is an':old ' .idea -/roqeht!y? 'revived ' -by Kimurai'/and Yaraoinoto ' - 
(195.n)<••-• ■/■These- workers - foupd,.-. uirOphio -degeneration/of •. • 
.tho-••-anterior- pit.uitary $. sn&r/ed atrophy "'of -. the adrenal • 
cortexf a'h.d:’i^3^j^pz’r^3^€^j^:ia of the" - thymus , at .. . autopsy of a / - , . 
severe/ pSae - '.'.of/gravis/:;./-They - suggest that - ' ah; - 
an tagoMmitU -exist®-'■betwe en- th e ''thymus./and adrenal ' / /..
ncptex! Possible- feedr.baek -■ relationships. -between - /the ; ..
thyraua andktUe. pituitary ' 'have?be.eh .describee! >y- . . ' .,
ex,peri mental/ hiplogis'ts/ ( GhSptpr/lg)-*///-The - following . ■ 
case - is of - 'interest ;in- /this respect. \.ib/./- ;/. .. ;
Laotntipns" ■/-■■. •■ 1 , k.'/. ■ ■ : ' ' '' ' .1 k /. k ' -
/ - .••'•' / ’ Cj® e I#§1509 - 'had' - ' a'/ thymectomy- - bo-./ -Mr / - ■ - Geoffrey'- -Keynes -'-- •
' - yin - kX949 /fpr. - severe -•vyafe^-tlee3ii/i;/'/-;ie5'he" - .had • diplopia; - -and ' •
•"* : / ptosis -.eight - - years - '■previously hut;'. generalised' - spread.
../• - had .occurred . iir 19/$/ ;' - - There- ' was - - a- good-. - response-' to / '
- ; operation-'wit!/ improved response, /to;... neostigmine - so -
/ /. ■■•hhht.-two..weeks after - the; ;r^]^e^x^^^tionk■®evex^^■/mUiG^'o3S^.^^^0^^^.' k 
•/ /?' siL^ns^^'o'c.curr^ed ♦./:<•'At/ the same./ .'time. ;she;heg&n to- kseeyeie ’’ 
- -'/ •■'■mil/•.from/ both breasts /and k-.this --lasted/for 3 .months.• '
'- ■'/ /• / k Lactation -associated' - with-’ exophthalmic' -goitre - . - • •
'( - and .‘possible - - Hashimsto *s ' - disease) /was-,’.described -by .
i'1999' )*./-- .3H^,..^oosiid^^^ed" .that- hie -’patients, -wore ,suf ferihg 
from, /uh; over#ppddue:tioP, -‘of. - m^jre - -than./Obe.k j^^pi^T^^tax^y- hormone.
'Post;® thymec tomy ' exoph th al m'osO 
k ‘f‘Another/;?
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■ -•-■■Another observation-.which might t - -be interpre ted 
‘ >as; withdrawal'of - thymic inhibition from the- pituitary, is - / 
• /.the /'transient , eye*lid/retraction which .often occurs - ;7-- .
. immediately after , thymec tomy/-(Chapter l8),■. but .probably- '
7 the -best -..evidence fop.- -a'-pi tui'tary/fac t or in, --myas t honia/
'graxdis rests /oh/ the effects./df - pregnancy, and- - pf-- •. '• .
-menntruatidhj : '■/. 7- ' .-/,-■ -.. '
>-Pyeg^^gifkx^^;y;- .'and - menstrUati.oh:• •' ••% . ". k■ "/'?///, ...- / •■-. '''' / 7'f''r'.';./ /. 
. - .%■- - /-; -7 -Many - women' with - mmyasttiejnta- gravis /are -weaker - -,&t - 
some- -- time'- in the'imdnstrnal 'cycle ’(KeynOs $. 195?). / -This 
is - ■ sometimes ; the: -first -/three - or - four days. - of. menstruation - 
• .b.tttllu others- it - is" '’the; premenstrual' -worse
.bleeding- starter ,?/■/'• />. : -, - 
' Psychological fac tors- - may - be more - important- - than ’5hormonal*
' "hhe,-psychologic-al 'state must-aisjo/be .-considered. .‘ ' •'
• in/assensing .changes -during; and; after*-pregnancy* /••Two. . • '
patients -described -a - sudden -change in‘their - myasthenic -- '
■■ • status.- at -a • time ' - when- they- had ' - just become .pregnant •-./. . - 
-/•.although- they ./were' -unaware - 'of/this- until- the - next' - menstrual -
.period' .was /missedi-V/fr/f- /" -/ ''■< </. - "f.f.- ■ ." /■■■/" - -// / : "
Case - - .NB4384 - .suddenly. - .improved before- she - missed ba 
period/ She was'- - convinced/, that-.this - coincided .with '
the- date?of conception- fhich she/ was able' to - dcfine-
accurately - as - it - occurred during her husband’sreturn"
' . ..on-short -’lO.ave- during- the--War-* ' - - recurred'-..-• •
-/just - before the - first;, pds,i’*pariuin'period - three -■ month!- 
-.■/■/after /the -baby - was .born*. / f . • "'•/ //••' ./''• _ ..<•••.•. ... -
k' - Ca^ekffiH/SH/iS- on the - other .hand , - ..relapsed - ' two - years 
/////after - thymec tomy - and oniy/realised '-later.’ - that -she -• was •/ ' 
’-''-■ -//pri'g'n ant. She had ' previously -'been -- without - symptoms •... •/ 
•;/- - Pregnimcy was -terminated- at the' - fifth/,month* . My asthenic 
7 ‘ symptoms/ ' ' '-7 / y "" . / . / " ■ , ’
-k symptoms disappeared■ on the .sa^te^y*/' ' ... .
■' ' .? '? Tilnoy (190?i slaw reported ! the-•appearance of • •-• 
myasthenia .gppx^iris-iranied'ljatel^r" after ' conception*..
■ 'X/f Tlw'' effec-t'.':..Of pregnancy’on.‘myasthenic , weakness -■
is. .’very variable,Viets'.;©t.ia! ,x A9^£ $ • 19.4-8 $;?i?ra©0.r- • •
and-Turner « .1953' S ' 'Kennedy and ’Mcers'ch ;*fT937)* ' •’ ' Some ■ * .:, •
patients have ; a- .re! apse others a • remission,Viets.et- ;
al, ■ ;( 1942■). concluded ' (from a study .o-f -.only ..'8 ^patients) ; •
that?• there-wa©’ commonly -a ?mt)tierc^i;e?re3^apse''in;?,tlie first' ,
trimester-.;-and often? a' •reniiesion> '.-sometimes ' completej ■'.i-
durrihg the ‘last'-six '•months* The. pattern. may be ?■/• -i i '. ,
diametrically; opposite?in. different^ pregnancies. fin, the • •
sarnetpatientIThe? largest series*. .by Fraser and Turner
(I953)i reported on 14. pregnant women.. .With.myasthenia ■' •
.gravis5■ ‘ one'.’patient .wag seen in.Iwo pregnancies, . They
: agreed "with :'h<x]^'O^;y?;;1^^^^))^S^34't^ltJafk'‘thi€sVC;;iiu3rse was; most •,
•: -,.?■■. '■■‘'ir; ,,???•■., .,. .- ? I' '- ?;?. '■ s ? ' i? -•■',? ' *■ ,• ■'• -. .
variable, but iwere\!'Ai?rt^b3^<5A?/t:o confirm'' 'the .Xate««pregnancy• . 
remission--deBdribedyb^■■'Viets’ ot a! C 19h2 .), They’ ■ reported 
' that ■ labour.'W0 relatively normal' but '.-advised- that . fc&ey . 
pa tie n t?s.ho ul d ;be /-.admit tod : to '•,..haspxiaX12~3 'Weeks/be fore .'■ 
the ■..expected date, io • anticip^aie ,<or '-avoid premature onset 
o:f labour v. They -?gave--.an'lncreased dose of neostigmine ■ ' 
as-’-labo.ur pr00ceded to.-combat .muscular fatigue, . ..AlX/ef /" ■ 
the. author® quo ted,. . above /are. agreed that".- a.' normal?, labour 
can bo. ;ekp pc ted*. .other /circ'ums tsincee being normal * but 
that t;h<^^s'e.?i©'q5X*eat .danger.? of a relapse .in the .'poSt-parium 
-period* especially; during ?th^ first '3 '/weeks. According / . 
to Fraser; and Turner ' (1993) -this, occurs- in. about .-half, the . 
patients,' -.'I " ■■ ■ . / •’ ■ -- . . 'i • •
- > ■ \ 'The series -described here. is/Uirger • than any .-.yet .
reported/but .it must ie ' emphasised . that mostdof..the* --data ' 
is .'based-, on x’et'^o?rpeot3.?re interviews with.patients coupled 
with/ '■ - /??".- ' ' 4. ..A -/'; ■ , . ”• ■ '?/.? : . ■ ? y ' i?
With a study .of contemporary case records* - •_> I have "only- • 
hooked/.after' .'fourkpreghanCies-and no relapse ,- occurred; - k k ■ 
during-’ or - after . pregnancy in ’.any ' of , these* These/patien ts - •'
■ f elt.; f i' tier. .than - usual ' ■ as in - - many’ . ’normal pregnancies );.-•• but t - 
could - not '’boe.said'■tok&h'owpgemiine remission-', from: myasthenia*
;>-'e;;k-4'k/.;^t.’'i^o “these differences reflect .• ’f :
'•’d^^n^diyl^diaai'kk^s^r-i'ati^^onB'.-.i^n' the hormonal' changes during;. ■, "■ -
pregnancy/"'asfgUggeste'd ' 'by- previous aufhorso ?but - it .‘"-'"9 - . -
migh' t, - .bo to' '•.consider ' in the future '-.whither - the patient -*s -
emotional state is- no.t - a ' 'more/important - 'fact or*.- „A .wanted: ,- 
pregnancy .. b oraetimes ...seems to ’be ’ assoCiated-with;.'rernitesion •‘ 
and ' so "is a.' desired .termination of ' pregnancy•ifOn -’the ' f- k - 
o therthahd th"illggi timat p .pregnancy-or'-.&a nccidental - , a'- ’ ’
niiBcarriage ' "may precipitato ■ -, a /rilapsett.''.The' ’curve'( .shown . ■ 
in Table 5,Jf parallels the '''omGotohal responses '.of tainy - - ■ 
normal- ' w^^raee^<;fco their'.pregnancy, labour' and '.‘the exhaustion' ; 
of kthe: 'puerpesSm • ‘Xlt is .'interesting, ' to- no te that' ‘I '' have . - •­
no, ''records ' -of 'pregnancy' -occurring la ' a'myasthenic '' patient . k 
who' is known to ? hhvokhad.va ' thymic '".tumour* ,-. k;k ' vk ' k k .
.' - ■ '•;;. 5<5"'*iki-.G5a ;^^.vrange<^^^;that' it can'khe''Hsed' in • ■ - ; -
the .same .way,as a 'k’balanc eld hart ''’used-idl^^^ochemistry -*• %It ' ‘k 
does hot' include patients whoywer'e unaffected by- pregnancy : 
but this does not;, affect' the ' concept' of a ' balance* it will 
be hsk.eoxii;; that ' there' lis, no;;cQ^n^^iLsteht’^^^ffecl:" of pregnancy;..' ■.,
.on ' myasthenia bht ;that?in ^general.'..' there ' '.’is'-- a ' tendency;’ to ’ ■
relapse'.in' the 'first • trimestert' to 'rernit.in the ' second' . . • 
and ' third » and. to .relapse' again af ter ' the ' chlld "is: - born.
The;' 'la ter rem Is alon" o ft en " oc cu rr ed during; or '-immediately' '■
■ after ' labour ' which'isoim times required' .^n^s^’truc^cjr^'^tk.i ' assisaance, 
-In iny' opinion--Eraser ' and Turner ■ k 1953) /.underestimate' the k
- dangers; of 'labour. ' ' ' . k • ;.-; ;.k- ' . - ' ■ ;
Case' GK/LB had a baby when she 'was, 23* -The child-/died .
: after ' four months' and two' months later -the patient' began
■ k to, '.have wyathehia." gravis which -became' "generalised' with ,
' k severe/ ’ ’ ,,kk ■■ ' - ■ ' k: "’■ "kr-" ••' - k- ' .
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' : ;•• severe'* bulbar'''involvement* She -required -18; •.tablets. ■
. :' ("270fflg% ) neostigmine - each ■ day*;••';' Thero • was a good '
■ '.response /to thymeo t ogy- ( Mr'* (Wo ffr.oy Keynes) ' in March’
’•■ 1931 * '4Soon- after" this ;she' became; 'pregnant* She ; .
■ 'improved, greatly' in'-the ©ecohd .trlmest'erk&nd'v’fhs'able' ,
; ‘ 4 to disc on tihue the .6 tablets- of ••heoatiggin© which' she
had' still required •4';.'labour was' : uneventful ' 'but the • .
i'child wads myaathenic -fo ?’ia -.'few. days' .-sq-ter' • birth. - On
' ■ '•;• . the /third 'day of the' puer-perinm . the • .patient".had,: . • •. .
- - sudden ■•-respiratory .‘failure and died doApPte attempted
..■.ykesuueitaiiox* - /. .,3.k ■ ' ' - ' . ' '; ' . : '
5 ' ' ...- —hs /.patient ' developed; • myasthepia'' gravie ■
' ," k:inkl942• When; -18 k-y#ars9old*/ 'Mri/'Keynes performed'. a/. .'
’. k thymectomy in 1946 with' great benefit* Xn': ' 1'947/she . k.
■ " . had -a . baby- which• was myysth'enldhfbr' .a few '-days' ' although
■ at ''-that time--'she neostigmine* ■-
' /W'/Sho reswOLhed'-Well '“''uantLX ; February41953 when:she had • a '
' •-imiscarri'age’ of /a • 2-'month-pregn&ney;. / there was" a '•’ ..
.niight/reourrencs • -of • ray asthenia* ■ ■ ■- ' •.-•• ;■ ".' .
■ - ; 'CasjlME91?.5>- -"'-kTbi{i .patient' .ftrstishowed ''sign! 'of '.. ..
■ ' " '‘-‘after a\ miscarriage ' in when• sh,©'' was' '. '■.
. •'244years-old* in ^a .second.- pregnanbyishe remitto!' ' '■
■ ...during, th'e' .sioohd--’t:r;^^mo£^4v<^:r. .labour ■ was' .normal:'but-- ' }
k' : there• 4waf5/&. a ever# '^i^^Lpps^* iWiaJediatsly afterwards, k , ' 
Dboppte''these .cases x-'would ''agro! mih; previous' ’
authors ((reviewed' by Osserman. 1938) • that • a • normal labour 
pan • .usually be’ expected' and that ' my sat hernia gravis.-.does ' 
not' 'normally, -•constitute' 'an 'indication for- termination • of - • 
pregnancy* •'-' : 'k. ’-i,. . ;.• ’44- . ' ' ' ' .'­
Gonadal • : • 4-*4'‘:: : -. ■ •-. </ - ' ‘ .- ' ’• . •'
- kk- The• effects • of .menstruation 'and ^.-pregnancy just' .
..described/ • '•
'■ \j79*■ ,;/y/yi’A •' .■--.' ^/••••;
descr3^b^ed/.:h^wre^\ been --related •■to oh&nges/.in -pi tui tarry y - ;; . 
fu'hc -tion - bu-t.ofh’er workers- have- considered '.the -..- -' - y, ' -.: ■
possibility-. that • gona&alyh.ormori.p.s, may-.iWluen'oe- the '■ . ■,
neuromuscular a tatus 4 ' i.Tho- aMaaolAo -"ffec t:\on protein, - , 
pf ' tlita..'-group .of steroid. iiormo.nea-..ia, weil-known but. • y.'-y , . 
seems,-insufflelent to .-.account fpr .the c orrelationa-4-'- y y 
<,-y-'ib<y>sch:riye. ( 1939) investigated/pregnandiol y -, ' ; .
metabolism ' in - .wemeywith. myasthenia--gi'a-yia-.* .- He; 'reported - % 
that - • -t.h ere - :- was an abnormally , low. .excretion, of pregnandiol 
in'ithe- -urine during - the - proliferative- and -the, luteal;,'. .,
phase's of - '•■the, menstrual . .cycle * - Schrir.e is -unable to ; . 
account-, for.-, a- cX6M,pe'c‘Qveryyof pregnandiol from; - -the. urine, ,\ 
-afierkipjeoti'en 'of-,- -progesterone- into;hisfpatient'aynor, • ' -. '
for -'the ...r 00 overy of ' very largo .amounts ' ;of pregnandiol - ' '
. 0? AOTH*, His' 'suggested:- -’explanations ,. • 
•^io.'-.-^c^itkc.arryk-'cpir^d^isti^^h/.a^^d -Dr* K*. -'Ftherby has been - unable 
fo'confirm •hia-" results in .my-.pjaiktienj^©/-;Simpson - l<i6Oa)-y--y .-' 
(eee.Gh^ntor.'3)■'. ■. -. ' ' - y; ' ' ,,y. y.k ' ;
-y -/ ' - The - involution- •.of/the 'thymus whiohkpomfflonlyy •; 
'pocuira - in ' pxeg$iah'cyyhas - beem '' at-triWted'' by _ some-- workers .' 
to-the - effect- of ovarian hormones .(.-Venning, -1953'):* ' ■ ....',/• 
nteteVer its meohsoiisjm-’.ihis- might play a part - -in- myasthenia 
gr&vi§4y- Ossermajh- (1938')'• iiecussesiihe- possibility -fhat,-- - 
aoe-tylchoiine- may-,be- - formed in the " gravid uterus - ' but;doos- 
•nep-Unske, a(c0nyin■Cing•-<£as'e*'- / -He.. quo tea.-'various '
unproduu tive-' trials'-of oestrogen®, gonadotrophins $ and" - •
.■testbseeoonoi all - ;• apparently - without offeet* ;l.hdye - - 
used -.-anabolic, steroids ,in -the .treatment - of severely - ' ', -
■emaciated ffly&8thenie. patients - . (Chapter .3,8') but havo - not . 
observed- any1 alteration in the my&sthehic status, y i •
Adrenal? ' - ' ''•'-. ' ' ’• ' - ' -- , • ' .. .. ■ - ' ; - ' -i
y y'i;y”.-The- •.recognition that 'muscular weakness - rosuitod '
■from/;- -;- .-.•i."" c-ikyy,-; ... '
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from. /failure" " of the: .adrenal q or tax" led' ko -bo©©"’, niwritieal 
' attempts -to a^ok^oui^, for %yast6ien'i&'.gravis in terme of " '
’ adreiaodrMcel " xto©ffXeX©©oy#. -Xt " '©'oqp 'became apparent', '""
. that;Wyaihenla ■ grayia' w .enfcLir^©^^’'di.fferent' fro© the' '. ■-■
.■ adynamia' of -AclMaon®©, disease.# •' ftewrth'el'eas there " are" .
• a few report©, of; the-cqA.ncideno© of adrenal-' in.eWfie.ienqy 
-with-.true "myisthenio, gravis- (Kane- and' toed/#1950$ Boulet '. * 
-,-©t aXj/-X93&' "IboXat .©t'.-al* -1959' Wbiodet ot'"ai,^''#^),^^^.-//-/ -
■ We .dan© occurred'-in; the present aeries* _
,'• • O&se MN-5'o9* "' He ••bb©&n to 3mvo 'double" vision 'and . ’ . '
.Bayn&nd'*0 syndrome ’at/'th©"' Age .of '16*'-.. -.Diplopia was -, ■ • .
: '-b:Variable’ iVdegree but never >baehfc*.; ’Apart from . -
'•=‘ ‘ tiring"" easily ' Tx©?'" had pO further• Xooaiiaed ■ •'©ymptoio .
•• ■ /'.until 1960 when he- "was 38» when he developed-" -ptosis
‘"’of; tWright eyel^dlaUi;l’;U,gk "gli^^iai%?ilar^:,f^fjvos^*''W?hW X ' ' .
. •-’'••Swk him foiir %ohtto/.aafer.tto "onset" there dMar-Ve^ness, ' •
../"//' ''Xheretoed by effort" , -
‘ aztd of 'the ■ proximal..©usel©*- of the '.limb©# -'/Tendon" <;• .
.-,,"'.,-:/ jketo "wore brisk,, and -plantar "refXe:&ea' flcxcoR# He" ' then .
' ,''.' .'remembered-'Wat""ho". " had,''been •imabxpktkO’p«w©e--hi©"Mp©- to ■
.•'.'-, /' - "5nflI»tve&\/X>aXlT€on&--’f ad the prwintW'‘4,,-years# . ilia■ blood -
■ ;' proosnre" wan"'•X30/X'<55b&* *%#" He fel.t stronger on . - /'
/' ■ '• '<pyHd©stl'gfflXne"but""©CH3©X&ih©d" .p£/ao to ;iu -aiX" tWselep. .... .
’? '©■/aiW £or«3qaai<m;im&er bi© /©ki'h# ' " 'When .the dose- was *
•;'• " "'. /increased •t©>-2S0fiii/d&y"he"-felt ©ore otorgetio than'ho ,
"■ ?//'''had'' done for yetoof - D^e^xplte this "’he was emoilonaXly " . '
,' /unstable/and,' frequently' complained of" visual - deberooaatl'on
’ / - . " ••■-. Xn" -March 1961 n©<r3m€kX- " touum sodium ;/—•.
/-. -. .X3A®Be/l» > serum- '’po^gi^a^Ci^t^© wrui.ehXooXdes . . ■■
'" /-' ■.'(--^aa'.-M^^^Oi} •XOomj/X M 't6W.L. plasma-pre teins ?«55diO0ml»-' .....
■ / .Tests for 'A/W-F, » rheumatoid " factor -.and; h,S*/cells -< . • ’/■ • ■'-- > * ■ . ' / ' : ' „/•.'», * -
' . ' ws©-’*©/ .• ■ , - • ■ ' - , ? ? ■ ;•' \ - ,
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' were negative, , ...
In .the'next' two years', his condition varied from 
time to time but even at his strongest it was still
■ possible to produce.ptosis of one eyelid by fixing, 
his ga&e.above head.level for one minute. He had 
some bizarre id eas, At one time.he- tried complete
'< elimination, of sugar■ from,his diet, This had no 
adverse effect. In December 1982 he prepared a 
strong infusion of liquorice,. . After taking- this he. 
had oedema of the face and ankles' for 2 days but 
otherwise felt well; (The cortisone«like action of 
liquorice may have been beneficial but its withdrawal
.’.might account for the'next part of his story) • . ■'
Fourteen weeks later he drew attention to dark
pigmentation of. his buttocks, and elbows, His face : 
was now bronaed but there wab no buccal pigmentation,
. His blood pressure was now 110/?0mmHg, He was 
readmitted to the ward with.a diagnosis of Addison’s 
disease. All tests.were confirmatory but as he had 
. an unusual ability to excrete ‘water' in the Kepler test 
the endocrinological consultant requested that it be 
.repeated after giving cortisone, . The delay was 
unfortunate because he had a typical Addisonian crisis 
which did not respond to large doses of hydrocortisone* 
DOGA, salt and. measures to sustain his blood pressure.
Autopsy (Dr, A, Gordon) showed that adrenal failure
/was due to bilateral adrenal.tuberculosis. He 
considered that the.thymus was normal.
It was considered that the adrenal failure was 
coincidental, since diplopia had been present for
; 20 years and undoubtedly responded to pyridostigmine. 
Goni/
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, .. . Gosri. (1946.) ■ has ro.por.ted .cases of myasthenia
gravis ' with' adrenal lesions at autopsy and reviewed .
reports of similar cases* The lesions' consisted of*.’ ■ 
Xyrappooytic .infiltrations ' and. similar • ' lesions were found 
in other or^sin^* These have been, reported for msanyy years 
( Bi^sss^jw^d, 19035 IBoi,, 1917 » Rowland et al. 1956) « AH 
authors 'have, considered .' that they are coincidental* In 
the present series • .'.-they• were found in cases MR77?2' and 
07783. ’ . ' i,. . 7- • . . . ;• ’
■ , . Simpson (1960a) pointed .out. that lymphocytic 
infiltration, of various .'organs-might be due to ' a defect 
of immunological'-, tolerance. and it ' is interesting to ' .bear 
in ' mind. the .recent. evidence. that • ’:id:Lopo.OiC.e'-t.• Addison's'- 
disease ' may result: from an -autoimmune process (Anderson et 
al, • >1957)* ' . : . 7 • ' ■■ m / -
.In some• ;of the .patients • reviewed'itere small • ‘ ;
adenomas have been., found in the adrenal ' cortex (MN3231, ’< -
•MN7783) and Rowland et al (1956). found an adenoma in the :
• adrenal glands in .two'of '26 autopsies* The possibility 
that these might be . provoked by a .pituitary ' hoz^mone may '.'.be 
considered but I. have 'not been'abXo. to investigate, this ' 
aspect further, ' .
^^jrathyroids ■ . ■ ! '
. ' Blis'eard et al (3.9.2) have supported the lutQimaune
concept of Addison's disease by the finding of adrenal 
antibodies in the patients' serum* . .They "discuss 'clinical 
and .serological relationships with'thyroiditis and with ■ - 
idiopathic. hypoparathyroidism, Two of'three 'patients with 
.the-, latter condition (w15^c0. -was -associated with moniiiasis) ' 
had serum antibodies against .adrenal tissue* : ’ . ; . .
. ParaThyroid hyperplasia' iias-, been ' reported at. autopsy
in/ . ' • • :.i - .. ; . ' ; ' .' •
in-. three case's;;of; mycisthenia. gravis- (Alter, jnid Oshato, 
l’93O5•’ G&fetleinan 'and Morris, 19^9)-but -Adams et al (193&) . 
found; no-disturbance of the blood levels--.of calcium .and 
phosphorus and?my own findings ar.e .in agreement • (Chapter - 6)-
Pancreatic islets! . < - •..
■ ? .Many authors writing before'” the', introduction of
anti cholines t erase >. drugs reported ■ gly c osuri a and ;. abnormal 
sugar-'.tolerance in a’high'.proportion. ;of cases of myasthenia 
gravis ■. (Williams and. Dyke,■ 1922-$ Hale~White and Payne* 
19^6-371 Cohen, and King, 1932). Brain (I9A0) stated 
that-there .wasidiminished. sugar tolerance, with or-.: -. 
without: glycosuria, 'in-many '.myasthehics*; • This statement- 
is omitted from' the latest edition of hie textbook.. 
Nevertheless’- glycosuria has-.'been present; in- 3/&.'of patients; 
in the present--.series/ -.Diabetes- meijitus :v/as confirmed- in 
cases ,GK/»Q'»; ^H/PM/WB,' tfHlUofey- NH59839V , ‘
NH61493 and:MN$279» Glycosuria was also present;in pK/LB,
' NH39&2 * N1j44x96 - nnd ' MNb301. Pur ther c uses wi th diraini shed 
glucose tolerance are listed' in Chapter ,6• f -
.The. incidence of diabetes niellitus in the general 
population has been estimated as 1-»0~1*3% (Joslin, 1999) 
■but the incidence of latent 'diabetes might be much-higher 
and so there may be no.significance in these figures but 
, the'* following;-cases are interesting*
Case;NH6i493* A 33; year old B.A.F. officer developed- 
, ■■ ptosis at the end of : I9M1. ‘/.Myasthenia was diagnosed.
. ..when,he saw double and had difficulty in chewing in 
September 19^5* Sir Geoffrey Keynes removed his thymus 
in January 19^6j, The operation wasvery successful 
though he had a temporary relapse in 1951« Two weeks ’ 
after the operation he suddenly developed severe- ■
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’'Case. Gj&.P,Q, This’ ■ young .Woman •began - to have ' occasional 
9 ■'double vision' in 1933’ (age . >27-) when she\hsd heir,first .
■ . symptoms' df • '-diabetes* Her .mother 'ami-' brother. had .
>• diabetes^ellitus" * ” In-'1942; .her-' grip ' became• wevdk"‘
and .in 1945 'She • was .unable • to apeak or swallow'" 'unless.
,. sh© . took ..neostigmine# • She’ died ’ Wo’ days .after' /• ■' :
., thymectomy bn".'September 194?» /’Poorly controlled ■
3 ,• ••'/diabetes was a. contributory?.factor# • ? - • ’ 9 - .
Qssifman•(1958) found•diabetoa in 3% of '325‘cases
of myasthenia,• ’.gravis* ; Thuusp-'though’ Bo!ten ( 1931 ) ? 
considered^ "that ' th© "’j-m'ost -common abnormality. in/myasthenia
".was ' increased ’ sugar toibr'Sntc; e". there .appears • -'to be •ar -prims,, 
faci! case " for' conaidoping’ a . possible relationship of
9 .myasthenia gravis and ’/diabetes " mellitua <- -I - have also ■ " • ■
. noted ', that " maniy" pati'ents.-Wiof do not /have.’ diabetes "mellitua'-' 
’havo, aa’l'araily" "-history of that - disease - (Si.mpisbri, ••1960s) '■ ’ • ■ 
-■(Gases. - UBO0149’ ’ (#0929),>W19Q0," W22'57i MN3Q54, ‘W4201t '
?m#46O3.» .'MH-Gil, MH4649, MB4934, .3#k497?, KH6503, #88092-;. .
This " possible comlatodn- was /not/considered at the. •
/.interviews of the National .Hospital '.cssis ’and so this’ 
.statement depends ' only on the recorded c.apls• The '
' /Edinburgh /'o^erienco’ suggests'.Jthatv the.tfue incidence ' >1
-may be higher# ■ .’/> , - ■/ ■ .'. ; '
■ . ■ •.•• Diabetes' "'is-t" of ’ coursea common . ' ’■ '■
Hi^sea^ei’^ 'In ■■ view of- "’the ?fmiilial thyroid disorders /'- -
described above and" the possibility " of " im^unnoc^o^^i^iSt 
.abnormality in / the ?causation -of, 'diabetes* it " is ‘'necessary?./,
• to" reserve judgement'*:, /Since ■ this'’ chapter was. written .
Frenkel (1963) has " reported oh ' ?thl"effect of ' insulin" and^
'potasbimm. in myasthenia gravis’, fThe subject matter 'of- ’
-• his ’ .paper / is ’.not- feliysnt'.in - the present ’context.’but it. ■
is/-/... ? •';-,• ‘ ' 9 / :'/ ’-p’’ >’ • • ?■ - ,?
is’’.'interessting ■■ •••to- 'that. nine- -of, eleven ' myasthenic ' .; -
patients inves-ti&iiteti.'by -that -author.showed ' '' ' . “ ... ..
abhormalitiGs ■ in glucose tolerance . either - oh 'simple. ■> 
carfeohydxuate. loading,/or' "after -steroid•;therapy#, •' ■ b 
- ' Spontaneous, 'hypoglyoaemi a "in myas thgn'ieVpatients
is ' - brie fly- - re f e.rr ed, to" by Walsh ( 1.957 ) ' and . - Os German"'. '■
( 1958-) * i Ko details ..are .given.
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Xi Xx'iA - ■ ■'X-'X^' chappe#... 67 ?' -.K .X, • ; XXX* X'. • . 
X -■ ,XX\ X - /' -/X.,X RX' '' •• '
k /.•'■•.•There , h aVg 'been , few reports 'dir' possible biochemical . ; ,, 
abnormalities' An the ''mnscles dr 'in 'the .blood .of myasthenic',
.patients' since •interest ' became focussed 'on " the' nenromusc ii1ar 
function* > - ’ •/'?"•/’• ' ■ ?.. • ■
?X '.-..Kevin (1934) /mialysed. muscle fx^oni a single. Case to '
see, whether' there'was' any abnormality ■ 'df the bound phosphorus, 
compound such, as. . creatine ' phosphoric' apid ' and . adenosine , 
triphosphoric acid, .which: are 'know'n to ' /play a'■• role in 'the' < ■
contraction ■ of muscle.'' 'lie' 'did not'/find■ kany, 'abnormality* ,
, / Ownings (1939). .'found a high ^dtaesumm' content'.in/a
biopsy -"'specimen ' of ' muucie# ..' Ho ' subsequently conducted, 
potassium/balances', which'-appeare'd' Rotdemoontrate that -•'•-• ‘ .
hedaiigmAne ' caused' 'liberation -of'-potassium''into ■' the ' bloods'' ' :' 
stream .-which • returned to the muscle., a© . weakness' .reappeared» : 
though' urinary/? exerdtion ' .-of .potassium;was ?not -increased • 
'(Cumings.,1940-'. 1941)# ; .. 'The.'work/wa&'&dhe'at'.'.ex time? when ' }
.it :was?\>do<reaXisedg that'iVis important to refer 'ail ' ' = ' 
estimations,.'to the level .of 'non-collagen ..nitrogen to -- '■•-'•'■ *
- e liminat ei :d 1 s crep a he ids .’due to. the .large . amount of ’'connective 
ti^*ss^e?'--l/h'pahbOl^r^g’<^^^^i'' muscle-- •' " '// / -. ' ' '/
'"'■ ' ./ \'Adam's??'get ?ai. '(1936)'' 'r^e^:^<5w^<^^;?/prev.i^^i^J3jsi^x^<^jies;.on, 'the 
metabolism’ o f: carbohydrate » hi trogen,; crpatine • ». ' creatinine',
.calcium' and. magnesium ' and showed ' /-that, ,they ' were' co'ntradie tory 
They'made persona?! studies of these; items ' and ' 'also,/o'f' 
'potassium, '• phosphorusy? sugar?,' -urea e'/ami'no\ ad ids ' and' uric, acid
' 'X-'X t/i’; ' • /XXXi ■' '
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•Their'. rml'tOiW within?normal- limits;?'’? §in.c.@ind-. Xtvtor ? 
authors ':■ havpishowu,-significant evidence - "to < the. -contrary.?
•I ‘'.do' ; not -.'propose • to-'.revisit _ -the : •literature -further*!.; ; c .. ■■' .,' -- 
’Crejatinuriacmay ' be? found/ . especially- isi women/. -hut the. y i ?.. 
Incidence - is W •--greater than in other ©die,'eases. .associated .? < 
with? dif fierity in •- tailing'--food -or withimsGulap. wasting*. . \ 
Hilh dr at land - -Wilf f ■ -• (193$ nho wM/tlwt ' crdatihurxa -in. • --?.;-?■/>■• , " 
myasthonids was increased-: when the . diee&se. was-.rapidly ."... ■ - .-
progressive''.ani-thisihas .-been rnyidwh<experience* 1 ? ■"?-.? ' "'k,
Serum and muscle . engymeS-i ' : k" lii'-fi.-;? •?•'' ■..' l?.i ■■ • -
■ Akkiormer'theory/.that- the? defect1 of nenromnsmilar •■ ■ "••'
transmissioniin ..tlyasthenia gravis k • might;be ■ due to ■ .a"i", ,
pathologieaXly • highlievel, of ;cholinesterase, ('’true 7 of i •. ''■<­
♦pseudo' * ) in * the’.blood was ' abandoned when- i't;,was ‘.shown that 
the iserttmiloyel'.'wadildw’ '•(Stedman • andyftusse 11 1 1937) .'or;I?- ?•'.' 
.normal (Wilson k andiStOher,? X9^M-*' ■. *. .' Goodman et al/.• ,,(195.9) ’•' -k
found normal; .valuta-;:i^il<mus,ble.6>' I-have. not.;carried 'out,,■ '
personal studies -since:•hi^et.c^ol^emjxJal/'rietlio'ds 'supjcort- this ■ -
conclusion*. ’ .' I ll?H k X' ' ' '• ?-•" " ;.-, ;.•?•• . -1 i - -'
.,' i/V' :.! have ?studied;' the serum' levels!of gliitamic pyruvic-' . 
tranB^inasoikC 0PT) 1 .glutamic' ' oxalace tic ' " iraftsWinaso (GOT)./;-', 
aldolase. .and • creatine "phosphokinase •'- ■ ■ ", The blood ' X evelrs of-,, 
:’t^^ies'ek?1^I1KymeS:-?ax’e - often raised in diseases, .involving^damage- 
to the'.membraiie of’muscle .cells; .,Th;e^ re suits ( Table 6»X ) 
have been ?^ubstantial^kL^i:noi*mal*'• •■? ?1 ■■... -■ ■ i-i?; •. '■ ..' ' "
■; . 1’. do not believe;.' that, current •'••bio.choxical techniques
■have anything to.- contribute.1 with • 'regard ; to k! the -fundamental s ■ 
nature-qf<myajstheh:ia”p;3?ayis 5. but'.1,have made-some., , ' ". .
inv'es ' tiRations• to? .do termine -.whc th el 'there ' 1 s ... any dis turb suae e
pf? protein •.ip. the pluamakand '.cerebrospinal - fluid eueh'ias' = . 
mlght?be - expected ?;^n i&ssociatioh with/abnormal formation of 
antibodtes/i lit- /:• ’•‘•y.'vi ’ .. . .■
ma'i-bodi e8,/( GHapter ' 13 ) and-to determine, who th or ' tha/Y, <
enBoerijie: :di^s^c3i^dlc^:s^^'s W'h.^<^ii; "W^3^<5/'de,tect:e^d  - clinically- /■ “ . - • • .
(Yhapter,/5). /were-- proBen't'- in:' sndclin,dai: form/ .i^n--other.. '.
cases;of - •mm^etE^tin^t^:lU.g:ravis/<’;'/' //",/. '■'/'-. "- '" /,/?■' -' •'-, '
/■ ., /■ -.•'.' AH 'biochemical CBtiiHatinns.' .'other - - than radioiddine 
-studios /were.. C'azriGd . .put, - in', the - ■ 230chejra.s'try/ Department of' ' .
'thh.eiTorilfeiar ' G ©nenal Hospipiilt|uh(^^(^r^\.r;/^'h .ddreeti©!! ,6f 1 /./ .. s - 
Dr>OS*-!*..•.Toffipsett,'-/-' ' . ■ • ' , , O''- ' '.
^Plasma- Proteins ■ <--' ,' ’ . .■■'/■.p,; ' O/y //,■ Y *
'‘'•,,/y 'in 4l - cases'/'/ /•,; .
/ahd'.-ole«tl?ophoiieti.e."sep£ai:atl.on was '.parried out in /
(,T&ble/;6,2); There /was'/ho "significant .abnormality ' in
’moat /cases / but•.:hybl®a'm^it‘'ObQUuli»a©mi&/was •-,found-. -.-. 
,in, ’li/cases// (ineluding. '-the four previously,.reported- hy " .
. Simpson, ' .196pa)' .- and'/in .5/ ' others the 'Pled 'trop'horetic profile 
"showed-.-'a' pp/omino'nr," peak/in / the - ©4":O ■ or- -J glibulin ' band©,/ ; •
For- the p’l^b^£^^^nt''yxu^^3^l^c^b^^c^^^../\ih.e. --upper - 'limits..; of-ndxm/al levels " ' 
for; plasma /globulins'- /taken'/as-™, ;b</-6*5,>'u2' -.Q.S,. 1,15»
y'/1 *6/ g/lOOml* /plasma* . (These.figuras exceed the.upper y,"; 
ii%i'ts/,usually/--/adopted Rop the electrophoretic method '■of• 
estimation/ so that it - assume'. that ./higher . levels ' -
'are . . pathQ.XQgilbll)//'-//Three. cases / (MN2327/, MK759O? /MK735O.) '•/., 
h/li'■-'2^^Os^m/3Opitl, -/'or■y}iobe■ of g6^mmag,lo1^i^liaj^# ..The . first two­
of /these cases. (dad/. Hashimo/to *a disease, ' - Tddrenard. and Monde 
,(•1955) - fohnd debrease,d .lam,mmgilbuXin! in- ,fi.Ve' oases - and .'■ , ■■/.
raised in ' one - but lb'wehthal /and' van - - Band'. ( 1956 ) -./criticised/ //. 
their, woxi/-on' technical. • groundis". pointing-- out . the' p0be's^;Lt"y ,- ■ 
to' .use. tbsblnee yOulues '.father- ■than,,percenta'gbs« ■ "-They" / , /
: found - raised/.•gammaglobulin 'and-. '-lowered-.albumen- /in the , serum Yy 
, of myao thenic/ -/patients. -//the ..albumen - <51x0^30^^^11 /■ms./XessYc ono'taut -/ 
-and /should" - Ue .'ignored ' '.-as it - * alters secondarily ./to - cdanges - in - 
■'•dh.e/Y,., //■.;, /< ' - .’/.././y "YY- . ./ /'-/'. >./■// //"’"/ ' / •’ /'.
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,/the /•globulins)'* (1958).'and''Bopyidori:;'(i960,) . . ; a -
-,i Qttnd’>;n0 ■foha.ng'ek in- ’ihe. elec trophoretic; ’’pattern*, y - •Single - 
•'.'cakes. -'oAA'-myashhehi©'gravis ■ with. hyjpeiyglQbulioieeffiieL.are ' ' ••
, included in ••kihe'-..report's' of ’..Castaigne •ktkai - a(1961)* "Sbeidl: . .
- e.iyai': •.'(1962) ...s^nd• '; Oosterhuis (i9&5)'*l >Sh9®9" results •.•are’ hot"-,
,• n 0(5 ess arily - /Con tr adic to yy ’ .©inc .©both • • hyp erglobuliriaemi a • and
. ag©nmalohwliha@nn.a may’ 'W associated. withvthymic- tumours a 
'(GlhateeK^)*"''*/'"'-; ’ ■•. /©-/'■■© --A a.' . *1•'•■©<•' iIAa'- '■ ""' "A""''k
' •. k.v'yA.,:, Abnormal .pqphaXin-ohol-esierol flocculation and * . •• '■
/thymolotY • tests ’ '. .were.- found?"in.©ome. yeR; the,- .-prresent ". ;"/ ' 
/cases"','.-"' Borne.-of’ these. had ■..electrophoretlc. ’ pat ter?ns '. within '.- 
.’'normal’ . limits; but' these-’ •tests'liay' 'indicate . Athe .presence of ' 
speci fib but -mn;3^'d<^l^i^;I"f^-ed"s^xr^/ber^ms' ■ - (Table}*'./y<.The. •• a ■ ,
;' ’• ery thrgGyte ' ; sedimentatlon'. ©at© was’’/Usually’ -.normal but- shows ;
/tghd.enicy .’to ybe/ xka'ised ■’ in aa-sodiatien ' .with Mshimotoos; .
. diaeaaea(WN2'H7»' M.h55®3» k W?3.90) p prmulieO0u&kamaemia' Aand. r ’■ .
- haomply tic "dnadmia-‘.'(Mh’5O95», MN$3P3» /MM7780) - but not ; with..A 0. ■
-.unbommiida'ted' thymoma*;' / ylhe sek c 0ryelatOmhs.©ugges ty that -/A
. may;, have*unrecognised' thyroiditis though her. protein-­
bound 'y iodine©©©till .i'n the normal .range/(Table'' 6*4),
' .They are ' 'consistent’ wlthA/ihe. hypothesis’ that/A^ammhb;l.og^^e.^l k y 
-meehihismsk. are ’ active’ .■■in .■ ..my&££hdni’a\gra’vi.Bk " , \ yy . a'."aa' '">
Ak A" ' ' yStgrtobecker ( 1955) found. ’raised 11 tres of ... .. " ■
- an’t:Ls3.i^^«^x^h^yX33^j^is,in.’in .72%,of ’ 25 ' casesAbf-myasthenia/. gravis A 
.. and k.yaised’ titre of ©•tr.optolysi'hyi©3W' of cases* •""..''..The ’ coll’
agglutination.’' ■ titre’ was ’/raised- "in n 64%- of ’ cases „ • 'kurther ' . -. ■"
A'personalA ’ studio© ’Uh/immune •globulin©©?©©^^^©#■’1©-’ . • •
• \Chapter.ki5 ' y ■*/ . A-- k': :'-•■/.-■ y.... -;-y ■ a/. ■ - ■ .
’ Cerebrospinal kfliiid- ’pro.Wins’i:k"’ " = ••©©•.. •. ..
' / /k; ;'k-',k As’ lumbar --.pumc.cureA’' ’i"s ’ xUirelyA carried put on’ maitemta 
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(.»wd-th' myasthenia ,gravisi?XI; is; -‘itVpoiSsibXt-.-tobGomnemt/jon 'the. . .' 
.■.V"fi*<qUenGyWtth’ Which ;.&bhorma3, . findings .'Wo mnd'e'#. ' A'high '• •
■ •'•■ /level-; of’,.pro thin' -in ;£hp /'bere brogpiiuxi 'fluid.'. w^iS/.pPr'as^i^ifeAiIa ' ,,
.-onb- .of’^S'Gwe.B .of myasthenia- • reported -by•‘Kennedy-;atnPMoWsch .
; ;.‘(193? ') » .' -/- bo/BauAQ' -.&nd''lRousa©X (1955) dteoribed a -CaseWith, •
. l^lWhoiao^cH^^plogibal^thG^^ooXa^^iOoi:^*#.- - y - • y
■' 'y '/■'; Xb'ihe proseht.ooiriba ' •few 'hadyo lumbar ■/ ■ - -
■ . ypuw-ture but./Lh Jtorithose/- the'--protein; 'content 'of /they. .' , '
. bf8'yp\ Wap '.•5Gragj/lWmU you ■ .grootor/C Tab-t- 6j3i«.. - • In-ail/df. ' -
■ ■ . tW'so;-hases -'a. -iodith^,.. .di'agao^^o
• of jhyaethenia .gr&visyy.■ 'The '£abXh;ahowa. -the;-reXhWd 'conditions.
; ■’ whiobf - might ,'hMVo ‘been’-G>2^r’<^3?ati€^o^' ?i^^W,th, the 'M'oehtMexX - I■ '
■ ahnoormmM'ty *•/••’- A pps sibili ty. ■ ■ which- - Wag.■ ""hoenyidcirod. ’Wien- - • ,. .
• ■ #0pyeariieA data -kjvrrWh't&ihed. - :is' /thabiiy’Raisgd '’level of / y •
protein, in -'the oorobr<0isp:l.na/l. fluid- ’tey bp ..assoeoutod'-With - . ' • -
; myxocdinw -: . .--hla, posslMXi ty - 0em q ortainly be -• e%o Xudod- '■ im..- -
" -\'^he.Xasb thro© caaisyy '’'•. '‘‘..V. •-- .' -I : • '' y yy—•. !■•. ,'
'ifejpcrine - i’"Q8tjHy.y-,t ■.’ ' y-. y j y/, y .;yd v y
■ ."' ••'/. . -As .-show 'in./Chapter.,5. there is a high inoidonoe of, "
y-pIiaicaX■Xykroeogmxs/&hXo disorders of;>ondooxntne. function'-.in . • - 
ynyywthenlc .pa’tlent#*'- . Vif -;£h'ese- ;to-bp,.consideredl.-#a- / ■■ / ■
, ..ye^t^p^a^ia^^^; though- reldtM /entities.;!/., iy.neco'seary,- tpy.7.yy.;,. •' ■ - '
;..'• yiemoms-trAio : that /there -is -‘not'- a jsnboXinical disorder - of- . •. ' ,,
' yendoParirne-;k?1^nno"i^:0c^a/k.’;nH^■.-; all- cases<y • % -.a biochemicalyXeoion '
/'.'Wore .causative-■'i^^^yio^^uld'-be ■present - in -every oaoe; Wwro&u ; . .
• ’••Withy the rfeXafc-idnshi-p postulated ink' -thisyihesin" the'.' '•' .
"•. y■knmdcrihOxgdaXk/ ;/abriprm&ll ties' -would - only -be .dotte* ted ‘ ■• ■■'■
. ■-'oocaoiomiX/V# /. -'Xn-i this - ooctioi - arc -'llsto-iy tho .•rpMtlW of '
. burvoy - ..c.terlod- '.Cut yin- the Northern, GQ.nce’aX Hop!tai. • k .
•sdinfjurgb-. capes .of w^y^thonin/gravioy _ -, , ■
•'. '-A".! y'f '%■•■ ^i]^]r(O^d/0-;y; .;■?■ ■ ’' "• yk.;- y/8 %••• /-- . ‘ o ' .' y ■■•
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/'Thyroid,' function tests .we re 'carried put on - 4l t 
cases ( Table6,4)* Host of the .'rad'ibibdin© and proteid-
bound iodine tests-were. made by the Department of 
Endocrinology of the ' .Western:' General Hospital, Edinburgh . , , 
and -•.•the plasma bllblbseebll- and basal . 'metabolic rate .
, estimation® by the - Department of Biochemistry of'-, the . ••,
• Northern General Hoopital,- but ..as so me of the - radioiodin'e . 
uptake and clearance ' tests were, made 'in ' Edinburgh Royal 
Infirmary"' or ' other'-hospitals' using-- different - techniques, <. . ■
the . results are charted according to the - interpretation 
of the laboratory* ,/ Normal figures were recorded in - 35 
cases and there . was - evidence of dypexlthyrbidism/ia 4 oases* . 
Some of the;iatiopts who had normal tests of thyroid function 
had a.- previous history - bf/goitre . pr of-,ppssiblb-hyper", 
thyroidism (Chapter,5)* •, Hypothyroidism-was found in,.
Case MN55O3,, shown . at-. later - autopsy. to . have Hashimoto ' s 
disease/' The - •other Case - imth. subnonmi l/^ct',^:lty (MN64-76).
had a ' thymoma/' , He died later in another hospital - •and‘:no 
.post.’'lmotte‘m". examination, .was ' made. - • .Case /MN739'0 is ' /the , - .
patient with Hashimoto's disease., described and illustrated 
in .Cheater 13* -."...' ■ ■ '• • • .<•-/' ' /••
: .These .result's show that -there is "-a high incidence
■of- disorders - of. . thyroid function - in patients with . myasthenia
. gravis but as*, the' ' maior-ity' of . cases - have normal function 
this-tannot- bo a causative .factor* . • •
- Tie same tbm'ffl^I^^ may be made on carbohydrate . - :
met abolism - as - measured by -. the’ standard ,glucose.- tolerance ./•..•;
test' .(.Table .6,3/.* ;• This. and- the following series , of tests ,
were - tarried -out -under the direction of Dr* 8*1* Tomps'ett.' ■
of the Northern General Hobpital* ' Tie .serum calcium --and
inorganic -'pdbsphate,cbncenirat±onS wore.'normal in 34-tases .
(Table 6,6)* Urinary excretion of 17-hyaroxyytbticostbrbids 
and// ‘ . s- ' ' ■' .. '
'■92f
' /and • 17 «ke tbs ter odds. /W&w/iorraaX. ( • Table -6y7- ) except • in .•• • •
• Casa•:M#t5.409 • 'during'• ; inv'os tig&tiom. for : ift©.* tuberculous : .
adi-enoccrtical failure .-.which terminated/mhis ’llfe.&fter ., - •
/.- y mahyiyear©• of • myaailienia, -gravis , (Chapter'.' 5)*' -y The* very•• > •'. .■■/■
. lovrvaiues reported for Case M1N6453/ were'• probably, due to '
. incomplete collection • of/ux\ine-and' the ..same explanation •
may.; •abp.bunt’ for- the unusually low '’value' in <ano;bher • 9 • of • // /
/. ■ the. 30? cases# . Tiere1 ha© certainly be eh no clinical • - . >•"''/
■ ' evi donee of ••tadenoooo'tieal insufficiehcy ; . .TwoyCase's,. ■ 7 • ©'77:
. -(MMHZW and MHH779) 'showed d normal eorsinopenic .'response 7
to• the ..injection•of , 0$3m.t bf • 1/1000• /adrenaline solution, : ..
, .. . ■/ '/.■;•/'iSchriro©(19£9:)1''haG,krepor,tpd7aniuimsUaliy ''lowd;'/; -
j’^^^cbvery' of • pr'egnanedibl from the urine' -.of/' patient's.• with' .
.myasthenia, gravis./ k Dr, K*. Fotherby of th±e' Medical./Research
, •/.CouuGii • ; Clinical • \F.ndQexdnology• Un it. •h.a©/. kindly carried• put" k
.. ' some • -in,^^f^d3i^:tgatie)nG • on • my cases, •; -He. ih'yes tigated • four 'd '
/. womenjduring; different phases of the menstrualk cycle ' • /.
\ .(MiNt275? /MMH95>6,'• MNH-86 and ;MM46il), • oine ■-•pregnant woman;.' .
h. (MN39121' and . one .man/- (MN-i-,301 /■. In every '.case , Fotherby ■
'oons±d@r‘dd' that the • kpregna.ne'dioi; ©xcretion wasknormal, •for the
- a.ppr^eprIate•'c ondition • / .He/also tes ted/the response to ■ ,
in jecHons'/of ACTH. • 'ani /of progesterone,•again •' with' normal
7 d kindOngs© y/'/ / . • kk'. ;.k-.vt-;,; ■’•-/;/•'. k '7';. :k//;k:/ ' - •-
’ .■ ‘ • X- .these• •results•it may • be •■■e onio luded;• • •• '••.’ 7' '
1> •’ There' • io'no evidence of •; gross /myopathic disease*
' 2» • •• via; a high/'ineddence of... disorders of plasma and ’ .■
. 7k ■ y^-p/sr©^©©^!^! fluid protein 'fractions, consistent • 'with
.■ v , ;an .7^iam^n:olc^g^g.oa3/kVi^3c^3^<der/ (Chapter.:,/!).,. •’ ■-., '7" , -. 
.-,..• .? 3# •, V .There /is no 'regular disorder .-of/.endocrine• ■ function /
7 . ,7 ./ • fflany/0&8ea ahow evidence of • clinical or subelihical
. / • • •■ &±e>burOane©• ..of thyroid •-, function, or• of carbohydrate
’ '7<7< y ' .'. " ' '"''./• k ‘ / l. .l/Vy ' .< ■ , -
■ V -i, .. /i? •• .
metabolism,.’ ’ “■ '-.'.-'1J . ■
4* Low ;Ra-fce©:df •' excretion'’ Of-Rteroiets, are ' reported _but
.••••,; ■ : .uncertain/’-:' • Tie • x^epultsy-were ,
obtained from • a,- 'routine'■ laboratory ’un&exc. the -.•■
■ / ; /RupervisictiL of- on .the’ ' 'estimation of';..'- T'/'/
. . i.' sbexoidd in tie, urine • bu t '-'-the •. ufinobep'ecimbhs •'.jwre. :
/■obtainOd'inna-busy' Unit’ 'with ' insufficient • 'nursing •
. '•'b!-- / ataff ior abcurate-• biochemical '-work* \ ?*?;-•' •' >
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mnxoM, wxmob -of.dismimaatot dioao.
When' radical opinion ie ..unanimous about the nature
of a disease'# any observation' which conflicts with the ' 
concept la rejected' am- .irrelevant or mistaken* Thlm has
■been the 'experience of myasthenia gravia. The possible
■association,of the nauromuscul&r syndrome with other
' disorders has been overlooked -for the twin reasons of 
aoeming irrelevancy* and the current thraldom to the 
•statistically significant1’ with the falsa corollary - •
that .any lesser degree of association must be coincidental*
- anaemia.J > . - .
' One .exception .to this rejection has been pure
'reduce!! -'aplasia which-ha# been associated with thymic 
tumours, with or without - myaathenia gravis* %e ■
association of selective erythroblastic aplasia, with ’ 
thymomi'was first reported by Kabras and Prime! (1928)* 
The aplasM. is - nobalwaya confined/ to-the ' erythroid ' ' ’ 
elements*, Of/the blood, but may - be/pancytoponic .(Green, 1958/
;•■aaneS-abd 0*Gorman* and'the first case associated
'witbrnyasthenla gravio and thymic tumour was of this' type , 
(Wintrohe* 1946)* -“The; neutropenia 'with thymic tumours
/may be -cyclical. and •nSeOolutedwJith•agmramagX0hulln&emla. 
(Matin et ait 1956; iambic et al# 195?? Barnes and 
0*Gorman, 1962) but the latter ham not yet been reported 
in' -myasthenia- gravis* - ' . " .
■ -The thymic 'tuacmr may be of any of the variety of 
histological types which are doscribed and there is no ' 
consistent pattern* Parry,et al- (1959) were unable to _ 
demmontr&te/ ■. ■ "
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: ,7 demonstrate’ a : humoral’ marrow-inhibitory factor in.. their’ - 
. ■f.patieht ..'.who .did hot ’have' . rmyasthenia* \ - ■ • • ’ -■’ ..
Since..'the. early. report of ■Wintrobe' (1946)$ the ' '• • . 
ohly.patients who. haye •■had . the syndrome .of . thymoma. with
. -erythroid/-aplasia. ’ associated 'with myasthenia. grayis have.’
' been those reported.by Chalmers and 'Boheimor (1954)* ■
' B%er '.(1954'),* ••Weihbaum ..and Bompsoh ('1955) . .’and -Grob . ;
■ ' The’-esase of Chalmers and .•Bo heimor .’(1954) , was from ’.the .;y.. .
. Watiohal... Hospital .series. included in this' :®uryey/ andyis-’'•
-..described /briefly below/-■-i ■'’ • .’/. ■ -•• •
' ‘ ’ Case.NT£22?Ji** : gravis was ..diagnosed .’-at '‘age -'•
i‘ 46 and there wan excellent . response to ^treatment’'With,
,■ ■■’neostigmine and ’ ephedrine iv:' Eighteen months . later he’ - - '
'■ - . ’. '-’complained/...of jnrogresaive .and . t- . • •■•
palpitation. although .‘my astheM—iTtfas. well? ccn trolled, ... '
. . .' He was found to have severe 'normochromic- anaemia With 
b^'o.ih’llpc^’Wai.e ,, ’ The bXo0<l< piaturei.vma ,■ '
■ Bb. 2?% (4g)j-,B>B*G>% i,34b;000/c.,mm^; TAK 1X.5%» ... .
'•a . M*C,.VV’85c^u-'yM»G*M*C.. 25%yfW-.BfC. •B2O0/c*®m$.’ .(polymorph 
;’’ - neutrophils 49%*’ lymphocytes 47#* monocytes 4$,
... ' 'eosinophils 'absent)* .platelets ’/323*OOO/c#mm.* •• Ko ' • .
,retic^llocyteo or ’ nucleated’ red-’cells could bo ' found’
■ ./.oh repeat^ed exanmlins-^^i^G^n#-■ , . . ’ - ‘ '. • - •
. Sternal marrow ' showed .-normal precursors of white.
cells and . platelets . but few if any fed-cell precursors- 
\ ‘ v ’-'4. slight 'increase ’ -in plasma ’and’ reticulum. cells -was ,. ■
. - . • ■ described -(Dr* Chalmers'),* .a.;' ■- , ■ •'■' . ti ■ ■. ■ ; '
; . \Tho’ direct •Coombs. test’wasf-negative and the total. '
’ serum protein level, was (albumin . 3+4g/1O0mi$.
globulin 3*5g/100ml')». Bed cell fragility* ., .•‘bleeding-time,
clotting time and cXob.pe tract ion .were normal*. The ' • -
_ ■ " blood/. ’ . i ' • '• ■ .. ■ - ‘ , ;.• .'■ • -
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blood Waaesermann-and,Kahn tests were negative# , , .
Tie serum bilirubin level was less than.0#5mg/100ml;
blood urea.21mg/100raX/ thymol turbidity 1,2 . units, 
/alkaline phosphatase 3*4 K-A units* - The first alcohol- -
histamine test meal showed no free hydrochloric acid 
in - - the stomach but free acid was - detected in a repeat
' ' test# ■' . /;'••• . • • '. . . •• " ■ ■ .
, , •/- /..,/Radiography (without tomography) -did not reveal 'a
•/t^h^ym-l.o, tumour but in view -of the .mown relationships 
and - the possibility of helping both the myastlleni■a 
grdvis and - the anaemia - (Humphreys and Southworth,- 1945) 
the chest was explored.- and a thymoma found. It was - .
successfully -'removed,
. ... - Chalmers and Boheimer had previously admmniste'red
adrehocorticotrophin -and. various henmatinics -.without . . 
success. An initial haeramaalajEgLcal remission.- followed
. the operation (Fig# - 7,1) but was not sustained* but
further .temporary - improvement shemed■/to.'follQW- a -later .
splenectomy. - '..-The. next relapse responded - well to AGTH 
and the - bone marrow -then showed- active - normobbaotic- ;
erythropoiesis. This was maintained for -a short time 
but then the -.patient required further, -blood transfusions* - 
IHaermsiidrosis resulted which caused his death on - 3/2/55*
It seems unlikely - - that- thymic tumour ?cauaes V the -,
.anaemia since thymectomy is not always beneficial - and indeed 
aplastic 'anaemia- has - developed - in a- patient two years after­
. resection of a thymoma (Clarkson and Prockop*’.1953)' The
Coombs tost for human globulin-has been negative in the 
reported cases but Eisemann and - Dameshek (1954), have - 
reported autoimmune - haemolytic disease associated-with pure 
red-cell hypoplastic anaemia and a possible association 
with/ /. ; ' .• , -
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wi th ' immune logic fl --ddiorders is- .provided -by -the ' red'ont ■ . 
finding by Kolborrov et al (1963) of - antinuclear factor 
in" the 'blood -Cf a: "patient -.with the ; syndrome of thymoma - .
• ■’;■ and.. red*cell■ aplasia' - • ('WLthotit--myasthenia'- .gravis),- ' . The ■'­
favourable response' .to- AOfBt -(Chalmers, .and.- ■ Bohoimor.., 1954) 
and - to prednisone - (Parry ek - al* '■.■1999) . - would -be in keeping 
,wi - th ■ a; ' possible -(aoch&niam. "• . ...
".'Pernicious .anaemia.;- ■ " ' • ’: . - ' /■ ■ • • . .: . .
*n ,WTn iftjiiwiii ifii>-ixi»uLnnii<i‘i it Av'■ xyi o rm-.r-ui tr.c "iVci—rri . - • * * ', . ' . • ,
■, ' :. • lio - other-..association - between -myasthenia /gravis
and -'disorders -.of -.the. "-'blood was, reported until - my -papers
• of l^Od^and? 1964"-'apart - from - passing -■reference's -.to- - single
■ -©ases'- of" -'’pernicious -'anaemia - in - the - ; series of/myasthenic
- .patients '" Sported by /Sohle&inger - .(1940), Bowland et -a3l,- ‘
. (1956),- .Malsh ( 1957- )" "’Aid-in- a- case- records from. - -the • -
. Ma^£^fO<^]^i^u^'etto -;;6pno£*F»X Hospital, New-Eng.*- J* Med# 5(1956) •-> 
-.When.- I' " saw.' the - first .four of -my series -of ton >casQf.o-£' •
-pernicious- anaemia - I assumed that this was a wrong - .initial -
■ - /..diagnosis.- made.- to ac.’coun-t ■ fof5 thk-pationtel. weakneses In- 
.'.these',.'earlier- cases,■3k-was hot-possible to - confirm -.the - ■
diagnosis 'by -''rigid - haematological -.criteria " so --they '-.‘were .. 
simply described - as# ..cases of -macrocytic anaemia- (Simpson,
•• 1960a)* / ''$h later. oa'seshthe.--diagnosis-is. completely.-.
■ authenticated*- .-Since - this" /association-, has been
- qon&t&ehed/'.coincidentai by other - authors -but is an ■ - , 
important factor - in-the argument -" developed - in this -.thesis - .
_ the -cases - .will bo - described - more - .. fully.ith&n- others /cited* ■
■ .-. QAse.""?EH.£7.9* '.•Wisei' aged 16, /she .rapidly " developed a "' ■■
■- -.‘goitre# . If "lasted/ - for; 2 ye.a’s-"then •'subsided# ■ Won
' 1 /"men at -the - age " of, 55 "she -.could- .not describe thyrotoxic
’ ■ symptoms ‘-but. the -B*M>R* / Was knoxm. - -to - have, been +55/>of
. - '■•normal/-- ' /•••/ /' - ■ ' - - .- .. ...
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normal# ...A"sister"had."/goitre --and /died 'at ..'operation* .
At / ■the -ago ..of• "-50" 'sha/developed. pei'nieioas anaemia " ///■' ••■ - ; 
WXC',responded,ib''-injeeiipo.. of-liver. ■ ex.t tac tf G.,At ./ ;• ■; // / 
.that • '-. she • was- e omplainlhg " of ino teasing.. -1‘aiaOi tude $ /■/ •/ .
.fatigue, •; .pallor j/ioss'. of .weight and /hr e&thXeesnessG.an'. / •.;/ 
/exertion.• '•. AXthioUghi• the " diagnosis• eQuld "not.-beG' reviewed" 
.Ah.' reirospec" tf the■ hls/t^oi’y • is entirely- .OQfflpotibXe ''/with 
A t */, ' : At;./ 55 \Years she noticed ptosis" and weakness'' of . -/'" 
-the■’• -proxi.mnX/'.muS61ps •of/all .Xi-mbsy.‘with' /aching,'.ofttho ■ G•' 
-nook/,"'"Arms""and lo'gaxhUt no /parae'dth’epia*,, "ih'er'O /Was .■
• severe• deafness in the left'-ear ♦ .//G'A/.diagnoSis• of,, ' / /■ 
myas th enia gi^avis• was .made • ;• oh'o' ’ mon th,--later • ' by• 'B?* George• 
.Riddooh*. •' There • was •fan • excellent -jeSspohSe to - \
neoefigwin<e/hUt/4o table ts /4aily • ';.(6QQmg* - -were/ " //,/" •’/-•
. required, for• •-'control. • of 'myasth ehic,gsymptWs # f. • /' <f .
•Thymectomy•six.• months later" •showed • that' iho-glann '//" 
Contained• ta • cysticgpavity ’but it "■ wasyother.iise• '-•/' ■' ’• 
.involuted, y ’ / The reasOoh'se •' tb/thymectomy" was /very/ ’good, . 
the’ 'nebbtigmihe "dosage bei^rg///rdU&^j^<;"\t^c^. • ‘l6'-tablpto •'•’ f- - .. 
faUOmg#)• bhigeighi 'months/af ter’.operation .she ' /" ' ‘ ‘ .
developed •-pneUmonia" and '"diedf "■/... • ••■ if i ■-.//./ G; /". . -.. ■ '
Case* MW4650f ’TiiS'..pati'■ont ooBpiained"-"'of ".tiredness, G • G •' 
breathlessness- and a sore tongue "'at " -the ago Of 29^.' /
A-diagnosis of • pernicious -anaemia "'.was made " .014 "'she .G'/- -G ■ ’ 
•received injections of /liter extract -for •’’ the/next"'16' • / -! / 
-years though the diagnosis was never confirmed in • a • ' ■ 
(hospital*-' , Wen oho, was- 45?.. ahe developed ".arthritis ' ■ 
‘.of hands " .and" •.fee't 'and" <a.t - that time "/liver ihjec tions• 
‘were discontinued, - '’-When" she vae 45 ’both • eyelids f 
/started" to" 'droop/and she • had occasional diplopia# .’./•/•'•.• . -G 
tX\/ G’: /-/-.; / /. G .. - /■// //, G. - .
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iri; d.lC* * Gaylory saw; 'infirmary/'-and .- •■/
<ade'7a diagnosis -,o:fLwyauthehiaL- grayis# u There'was./a- '- /V' ■ 
-Satisfae tory response'- teyn'eostigmniie#- / There; Was a • - ■ 
•■family'- his tofy/-.0f ' %yaa thenia-Iike. - illue sO/ 'and/-of '■ = * .' A-
isydescribed - iml'Chapter /S/BX. - i.//. - 
/;••.. '-. ^if^(^o^_tuna:iel^^y/?my''-'oaas£/ynoites - '(made - Before'- theW hr * - ■'* 
rosBl^bib - ■,aign'if/ij^5xn^c,e , Waa- realised) -do not r©c.ppdy **? ',’’• 
whether . - liver -''therapy, vwa_s r eaumed - . a O- the diagnosis - ■-/* * 
la.-ratherMhcertainp-W' 'for/tho; aaaie mson, the ./'*"-• /.
-.-potes. - .on tC|tt^,^^^'/f^q‘j.oxil^ngp.--:lu'eec oases* ;ai6O kindly ... . y,
.referred .-by-'WC'W.By Gaylox*''' -are not aa well ' ' ' ./ '
■documon ted •/as ?;o.pe'/would. wish ywi th-the exception /of - - . :. ■ 
'.r50QX8h/; /.■;■/' ; ■' /--.,y;
hassHH77?8 ,' ( GWiX-rOWS? )C■ i.-ShU' /petiont; /'C ; // 'By ., .. 
'-lex*elop.ed •myM-theni’a - 'gravis' at;- the? .age- .o:f,?6gc - y Ho y <! ..• •- c 
'wa^' deaf but "able tp -hde --a?- hearing ...ai/d #; ''.For; /twenty ;
years/prOviously pie had;'b'Qdnyro.qeivi.ng/illyer''ihjectiohia 
' forypernieioua ' ; liheii ■'admiit te'd -to /hXlaagtW; ;- /•-■' •■ -'
Western -yinfiroary'/under- my./care. - in 1955’his4 -blood ' .y . ■ 
/picture/ . .Aii/that time - the ; "' 
Eg hHiing/ test i’fo.r '^absorption- O'fjyyhn&eObalaMin -wwa; '/ * .; 
■.not available but - there- whs. -'he’-' = Me on/- 'to- ,'qu es tion- .the- ’ 
barllor.,diagnosis.'' He'-was'’ .treated-. by,-irwUd^I'ati^^on ' -of yh 
•/he-- - thymus' -in - 1951 and ' by /AC //'$/' i-LL . • The l&t ter. . ' % ./.
^i‘alU3ed'ct^e^ip<^3^'ary romies! oil ;buthhoylater ■ developed.-, /' / - *
: left; vonbric.ular failure with- qiiric'ular fibrillation ■ - '/ 
•'which/ -caused .his death/ - ./////’-MW" ' ■'■'-.-;■ . .-/-- /
-Oftse:yH77Sii(Q^w-g.i; 8/5yWU'/i /•"'/At '••the^o of 
■ £ j - - he ■ had; ppogr es s?iyc weakness''-f op-. 6'hion thsv; ■ ■ 
yd:S^e^ghoea^^«^9o^f/-;p%?n'Lcj^c^u^cj unaeilauW^.s/'iadp - ' (.no/dc tails ./ 
•available)/and -.he -was- ..eOMiGiderM. io be improved-'by.a -., •’ 
/liver/ \ / y ''-/-/'h/ ' / ‘ - / // y /- -
  
7/< t 7/100/ p.y ; •<: ■■ .. ', y7y "■
/' liver, -injec ticnUiy77vOne'yeah .later hu noticed-'7:71 7?''; /-_ . 77- 
"/difficulty"i'l. a»d. weakness.' of/- 7;'.,..;. / 77' 
' neck- ■ muscle i'l .-7 -XtVzaS/np't- ‘until'rnbthen eight months-- 7"-, . -1 
'- "/that he ' was. seen -..by- Dr#, .payidr Vhc' diagnosed-, -- • //-■' / 7 / '
•• m/aathchia gravis# -There’-Was■imaeMn-te-improvement ’ - - , ’
-"trnadiailiion; . of -7.the7ihymus#-" -. ■■• 77" - /-
-■• " . . y-./hriijs ,, was' m&SLnta.»-e'.O- forj;2'. years' .•but-7Kcs. then7'had ;• • - 7.. '" ,■
‘' •' -aV - relapse - 'after ./flit *7-./ . ; He' 7,/- •'.. „'/- -"7./ 
-.WOtc^z^r^^-iTnfiimiair’y-'.under m^'Vsupe;ry;Le^:^e^ix' in Aprlla X9-537t -7" /" 
•..\.severely myasthenicA/and - vi£h;'caadl&cifaiXur@'.i;,;l - - ' .7- /• - "
., /.assopiated- witfothypeiitpn'sion (75Pi ""210/1X5 lon/Hg)#'- .'.•• / .' ■■
/7-The diagnosis - of myasthenia--grayish was. confixmned-.Tby - . • 7’ - •■
'/- -■ el ec tr orny ogi'aphy - 'and ;by' An - 'sdrbphoninm" .tea t# -.<■': " '" ; ;/ 7
77/ v On ...admission he -had.’ -a ’high- ' ., y - ' '
7.,- f colour - .index- (.5 -, 800 *000- red cells/cu, nmi ; Ub * 13 * Ogm/lOOmX-; -■
" ' 'total ; l^e^uCocyte£^-’-OnOO/cu ’ im) 7-.-. '8 ev ere 7myas th eni n /•..- ■' '•-
"■ vreaaneearwasnoi; greatly •imprWed/by. - 'nOOmg'gMicostigmine --' 
y ■'■;.'■■■' y ’ y s : 4- ; 7 7 ■ -' - - - ->■'■ ■ _■< • - y 7 • ■" ■; . /■ .77 ■ ' - 7.
y7-daily «< ^OorHapne. ;25mgx -b# d - #, Vay-atarteO'.button - the .7 *' •- , ' 
/•becond' day respiration-'Trailed-and could pet be ‘ • •
- 77ren established'* /..Aty post martcm TEDr""1#M7Johha t one- ; ' ' ■
7--.- - found ^neph'pssleroSiB- -with.' signs ’ of .hypertensive ,.
: 7-cardiac - "failureA" • A-.f'eW‘ybihy- lymphohrhagsa -vv^Jpo /found .
i '/ih 'the. right atexni-mastoid muscle:- and- in - theya.dxU-Ua"-." _ ..
- yglanlBs 'Hb 'thymic . tisane was y5deirJtL:f3^ed-\ The thyroid ' .
/ ••. glyUKi w's’ -■''noxrtm^el*'- ' The1 's •tom&chAwas-•smooth ^and-'.atrophic'/ ■
, ."..Mot ah normality --.of Tbone marrow bi •'spleen .-hves-. present - / ' ■
--'•/but- thefindings, -were- ' consistent ’ ...with •-t^reated-pernioi^ous■
7"7.MaeMa>7 y/ypy-u ,.•./•'■/ - •• - "'-y"yy7' •'.-7 ,-777-. - ".'7/ -./.7.' .
■ Q&ia.’e7.M30lBT -hhita patient - /Was ’ ?O Tyeara -.old when he,’ 77 ’
., .' .developed' myasthenia gravist - - Dry /I'B/'OUyXoSy ■ '/ '•• '■ 7 7 - /:
.'-confirmed-7^lh3;''diagno;^;la by a"thbrapexilic' test' , . ' -/'7 7 7­












(noos•tigmihi- ) /and; 1; ob tained ’ an:-'elec tiqmydg^aphi q i -
.-.response consistent/with' this- diagnosis*!-- Tie- HarVey«-- - •
•. t.-Maland- topt"gave, - a'-recruiting '-reaponse*-'•'• 'There’' was ■ ho ": 
: -'personal - /orvTamdXy / hits to ry - of- diabetes’ /or-' of , thyroid-. ..
■ di same;* ' -7- ,v '- . s ‘"1./.,.- . - 7/ . >•
■ ..';.: -7 - Kcnuir-years; earlier. Jx6-became'?pal'e,* ;'• ' e. ' - :7?
7- -jaundiced, aPtl -'fit ■ as / 'if -he --.was - / going ’.to ’ faint »- ;- ■ He?. ’ '-.. .
■' was - ''admitted to 8 to hhiH.. Gen er'al - Hod pi tal, _ ; - :Gl'asgow * / .7 l
' (Hhit iio; 18064),.under/'the.- care /6£.<-Br*?fd*L#,-Mirksdn, ’- 
7 - .Tie. - haeniitc^lo\g.ic'ta'7f3^nd':i^ngs were’;•* 77'V? -■ ' •-' - -'.- . ' i ”• / -
s-- Haemoglobin, .g/lGOpiT :,T - ’ 7p»0;;V> - '. 99,35/b '
' ; Bed--t ells-2* 110 '*Q00/e u*ma#. /.; ' C.*. '3$% ..
'•:. ><- -The- blood /-'-film- ah0W!ed''maor'6eytosis/with; a'n'iso* .; ■? •.'/ {■ 
-''y •'pdioLiloeCytoisjP' '■ ' ,T\. -?;?’;.- r?' •’ '■/ ’
. -. s -The,- bone marrow - ’showed megaloblastic .erythropoiesis#.'
' T^^^e---was- a ilisfcaminefa&^t-&hllrhhydri&* - /;"'••?' by ? ' ■
. :%e bbood 'picture- . reverted tG;/iic^pnix3^i - /af texyin j 1c tion.--of -.
;- and; has rema innhli normal. with- regular ;
. ..injections of that drug*. Ho also requires 12 -.tablets'
.;l,<.{720ig'*) rqf pyridostigmine daily* - - /' ; . ", -'v':'■ ••-
Oaho -?.HH50ffi»- -i.-This womma/became/pali phd.. weak?''in7'193S - .'
../- att thi- age- -'of ‘43* "' Pernicious-anaemia ;waa ■dia.gndiod -- ' - -
"’ind-Leith Hospital -and from -that., -'data she was ...treated,-’. - 
with?liver and’ thin .with .,,cyana'cQbaiam±n by injection*
- In'February---l^li.-Wen-aigcd'. 69, ' she-received a bi-.,'-''-.’* •
-severe emotional'shock- . ':w"e'ni a''friend ..di<ii";WhiXi "'/?- / ••'
/accompiatying herbon. -a 'bus /tour;*7 7 A7fiw-weeks ’ later,/ i ■
-- -" ' she developed-/ptosTs .'nnd?''generali$bdt-fatigui - and, - pin /: - ' ..
, ...a further - /twO" weeks, ■ difficulty .'-in; speaking?*; , chawing ‘ '
' and swallowing-* X saw - her -- in consultation - and;made , a i -/ '
. . o linic al diagnosis-''of ' myasthenia gravis - which/ ?Was later •-• i 
tc oh firmed/•.,. 7- > '5 -- - ' ..'' '77' ■ ' . ’■ ’ /.;' .;'7''!. ’ .
t - .'102.
/, ■ ,r. ’ /confirmedby-;'elec'td<misyography - and '-:&n. edrophonlusm.--est*‘■ 
; She was ''found to have ..wild -hypothyroidism, later . shown
-• to'he duo' to. -HashimO'td-’s disease® ’/.'Thhs,-aspec,i .of the : ' 
ease' is- described ■■in Chapter;. 13# ./ '7%e response' to ■
' '. treatment'. with - neostigmine, ‘ andl'let er pyridastimaine.
. .. . and'.- apiToholaOtonay was- only', moderately. satisfactory
■ - . /‘as', she had. -frequent . relapses * — ( Spironolaotone Was,
■ oonsidored\ to‘be valuable ' by . -the - patient -but- no • •' • - '
’ • objective evidence .of -this could be dewnntr&ie.i).
'• When -admitted .to: -the - Nor.theiUh'General Hospital -
' • there ‘ was -.moderate , ahaemia.- (80-^/-‘haemoglobin) --but
/ it - Was always normocytio- and slightly ' hypochromic. .
‘-.Neverehebl’eab despite - previous - -treatment the 'stornal 
... marrow showed meggioblastic - ;-erythropoiesis ' and -.‘the, -. -
‘ - ''Vitamin - Bl_2‘ -Content - of 1® (lower
• .‘limit of normal range l^CJujig/inl. ) * There was .
1 bi'slaimine"-^^ uelhlorhyddla* . . - .
■ , ‘ 7Ahsopptioh,. - of . lyqnacQl‘aibmiX‘ was. .estimated. - by - ■ •
■’ giving‘“-an oral, '•dose'/of. _Q»5/Ag. -‘of - radioactive '^^Go-B12
/without.intrinsic •fiCtor'(and - with - oirbichol}♦ Only •
? O«A/\Qf /this ' amoOnt'/wus recovered -from, the urinei .
. , . with; - thu method. Used a ‘‘recovery- of;-less than la
: definieelyi£bllommaX*- Aitibo'die.s against -gastric. .' ■
mucosa .were- detected in the serum oh two ‘occasions
’ /- (Table -l^V Chaater; Iju " -' ‘
Xh^ft^3*tu'nat^e^l^^^^7t^1^<^'.a3om«ta^ch. was grossly autolytic -•/
-// '■.at post 'mortem•examihabionbui Drw.A® -Gordon" reported
■ - ' that ’from the".presence - of some..islet's of interstitial 
-. ' . - ‘metaplasia. the- •gastric, .mucote does not appear to' have
■. been normal and 'may well ' have- been atrophic*®/ The -’
■ liver and spleen contained considerable deposits -.of.
hiemosilex*in/ . ■< . —• '••. '■ ■
103.
haemosiderin. ■ Bone 'marrow was grossly normal.'•'• The 
thyroid showed the changes of Hashimoto’a disease.
Only a few atrophic strands of thymic tissue were 
identified. . There ■ was 'cholelithiasis. Death was
due to aspiration of vom.t,
The clinical, biochemical and autopsy . 'results 
completely'substantiate the diagnosis of'pernicious 
anaemia. Tie association of that' disease with
Hashimoto^ disease is. discussed in Chapter 13.
Case . MW7780 (E.1R1. . A diagnosis 'of
pernicious .anaemia. was made in this patient at . the . 
age of 69. She felt well on being treated with 
cyanecobalamin but in the following year she began 
to have bilateral ptosis, ' especially in ' strong light. 
Three ' ^ears ' later (two' years before admission) she had 
an emotional shock and ■ after this ' noticed weaknessof , 
her jaw and tongue _ when talking or chewing. I' examined 
her at the request of Professor K.W*Donald and found' ,
bilateral ptosis., ifatiguable1 weakness of orbicularis 
ociD^^, pterygoid muscles, neck flexion and the deltoid, 
triceps^ and adductor muscles of the arras. A diagnosis
of myastheniagravis was confirmed by an edrophonium 
test and a'Harvey-Maeland test in the Northern General 
Hospital, . ■
Professor Donald confirmed the earlier diagnosis 
of pernicious anaemia.' Haemoglobin 87%, P,C.V. 4l%,
M.C.H.C. 32%, B.C.R, 21oo» per hour, W,B.C. 8,100/cu.m., 
No' L.E, cells were' seen in ' the peripheral blood.
A first test ' .meal was thought to 'show the presence 
of free HC1 after histamine but this was not confirmed 
by a.repeat test. A Schilling test for absorption of 
cyanocobblamin/
 ■ above! qhowod ,no urinary excretion
••'Of ■radioactive ■ cyanacobaleain* /• /This was oorroated by 
.giving intrinsic*. factor.';/ Folie acid absorption. ■ w©
/normal. ■ . Jejounal/biopoy.. appearances wore, normal. •■/
;• .was ao• radiologic?al evidence of a -thymoma.'• ;' .
. •Q^eMM■ 8279 tb«QUu 557/M).*:/,/'A ■?? year old woman'-
<. ■ was admitted ■ forth©; Basf©^/-General Hospital, ■ 'Edinburgh
■ for InvOiBfcig&tAih/'o'f- difficultly in .swallowing;: og• gne • '
,■/year*o , diiratinn/,! -It 'wan mo fed -that aha had. .recent;-. '
, dyspnoea 'on "Exertion and both eyelida hae been, drooping '
'/ for, the provid.u©; five ■ weeks . , He?'-voice e© nasal, in ;
■ quality. Eho ■ -proved' to havo■ rapidly,.do terlo rating
mry^asib]^^3^:ta.gravis. .- 'Dr* ‘MiB* 'Mathews asked mo- ' to .
'/ see./her* Th©' reaposaae. to; edrophonium , and ••nsootigmipe '
- - was .mlffl©trf t;W..©stabiihh* the di-agnosia hut/ash©-was 
■', considered to he too lliffor ' thymectomy, / Ehe died- ' .
one ■ month after ■admimsion. Ihla warn contributed 'to ■ by
■■ ,. megaboXle" .aoi&oSie ’.’aa ahe; had been' diabetic .for - ' •
■ / aCv©raX' -yyarrs,.cni./this' • became.;uucootroilod when '’0110
'was ■ unable ■ to take a regular diot* ' ,-8ho had also , ' '
complained of acrSeya^oal©» ' •
■/ Mine■ .years previously pernicious, anaemia was -
■ ..diagnosed*. - .'She bad been given weekly injections„ - ■'
of-;.XOQpg* cyanooobfala^min ®o it is not surprising.
•that-her .blood .picture was normal -on■ 'to ■ '
• hospital. ‘ " Unfortunately no autopsy was 'obtained*. •
G^Q.e■ I ara indebted to -lord 
Wain-for.'permission to quote,this case* . Bhe was 
aged 54-in X$W when she-was seen at the London i' 
BoepitaX* ''''.'SSib- ■haA-had a thyroidectomy for ’ ' ' ■ ' 
exophthalmos/ /-- ■.... ... . • .
eXophthalmos. and ' heart trouble ■'when she was 42, but - , 
./-;/'was/caid to -.have /mo goitre. //.Six .months' before - .being ’ 
:•- -ae'enby/p.r* -George - . .Riddo'ch .she '-was. /found to/have - •/•./ 
■//v-pernicious./anaemia'and/was -put; on injections of liver 
, / -'extract.- /Her - oWn'/.dqc.tor had obtained a blood .co.unt.
When . she. reported, at the ' iondon Hoopphal' her blood 
count --was normal/.and - the/colour index 1.05, . : Two■
/ : months. before - reporting- -she ■ complained-, of blurrbd/
, / vision and this was ■ - followed-- by . double vision in all 
; //- directions. / - Dr. - Riddoch. diagnosed - myasthenia’ - gravis
hnd- prescribed neostigmine. . There was - a - previous ■ 
history- bf - asthma - and bronchitis-/ .-
;; -/-: // , .bate.r- - in 'the; ' seme - year - she ■'whs issen-' by Lord- Brain 
v wibli, - muscarinic symptoms, - fasciculation of muscles . .
/ - and mental - deterioration’* Bhe- became increasingly
■//.. - disorientated,- /demented -'and -/st^uporbse'i -.-/She died -' in - ■' ‘
■ • • //January, l9^b.//// ///’// .//////.''/ />- / • ‘.- ’./ '•■ .; '-■/ -• : '
At - necropsy- she 'was*- found - to- have a cystic ?
; 'lymphoendotheiooma of the th^i^e.- The. spleen was- . /.
/• ^Lisii^tlt/.hll^t^^^rdnand•nditre. w&s-/c0nside^&bie'n//a (1, - ’/- '
- .:' - 'parenchymatous- '.disease - of, the'liVeo»/'•": ’'%e- 'gall ,
i-.bladder/contained- four cholesterol - stones* - The
/ -brain - showed focal areas of congestion in .the-lef t- 
external'- /capsule and around - the - lateral - ventricle.
//. , it will- be seen/ that - the - hitherto - ‘unrecognised! 
relationship - between- pernicious J anaemia- -'and" -
gravis is./more .■common than the acknowledged - association -. 
.with - .-re&~c<eil aplasia described - in./the - previous, section, -/­
At -the time •/.of.my- first - paper the relationship was - /'/■ 
•'merely-’' used - to - establish-, the - hypothesis - of - a - difiuso -, - 
systemic disorder - though this - was -/elaborated' along, ':' - 
immuiioilgioci// . /• '/../ /*/ b ../ _ ' ••'—i'/p //-•
\ /' >■ '•■>•■//-< ' '1o6*/-/\-' /'/ . - / /'; f7/',
' ' . CS3.mps.ot^i,.1960a)> ■.-. At . that time/, '•> '
■"' //however/. evidence 'begap'-,to accumulate suggesting - that -. ■. f
■ / ; -pernicious.‘..anaemia'.is/ aspsociai^d/with' an immunological ' '' •
di^aorder with 'production of. anorgan-specific antibody ;
./■'''.I'-fc© thaintrinsic factor and' to the parietal cells of the
stomhoh; (Schwartz, i960; Irvine ' et • al, 1962; Taylor' et al*
’ ’1962)7. <A ‘search- for . antibodies /in the .bipod :'-of'•■■35. //.'' • ., • - '
myasthenic patients gave positive •’results' in 3.of whom ,
' .-/; .'one. •(MMggOj)' 'had, clinic al/pernic'ipus; anaemia" (Simpson, • ■' ' ' ’'
1964a)> With• the method. used (for which• 1 ' aim ..indebted.
■' ifo'..Dr* -are obtained /in-’8%../. • . .
of • middle-aged . female blood donors so the significance ' of 
/ '"the ■ other two /posi tiye' ' results''cannot ' be -'-.assessed ' at ■' ''
; •/present'#Unfortunately -'the -other patieh ts'-wi th ^.clinical ..'/..
pernicious anaemia are ho' longer available for immunological '
'Studiee, This' aspect ' is further discussed in Chapter 13*
;:/■.Haemolyticanaemia 1 /‘-/ ,/ .7./; '?////:/
■' ' The exact .nature of' the following case ''is ' '/-'■' ' ■/-■ . ..
difficult to assess** There Jwap./a 'megaloblastic anaemia 
with low'- serum /vitamin'/B12 and' with a reticulocyte response / '
■ .. ip/cyanacpbaiamin<but/-haemolysis. was *'/ "The', .
anaemia was a ' terminal event in .a patient with, a thymoma 
who' had hepatic and perhaps renal insufficiency* . •>. "
•■'-. Paso‘.iMg>Q9.5*' /-/In; 1950/(&ge/43. )' ' this -man -was ; found ':' to - '
have<myas'tUohia? c-At'-thoraCOtomy;. a thymic/./ > v j// 7
tumour wap found ' but it could not'. be removed completely*
In addition to' severe' generalised myasthenic weakness 
he/$hter-'complained of -bizarre' penso'ry: symptoms .which'. ./
■ * -■ . . - are described in GlhUptor "4* These' included• -.. , /'-••'
parapOthesia' and sensory loss of the hands and feet.
? ■ and/ ' . ■" . - ./'.'/ - / ./ ■ ! '
\107,;;/ .• • • ■ Y- ■ . ■ • • ;
and loss of the -sense of • taste. The latter may ■ have 
been related 'to the atrophy • of. - .the/mnc.ous membrane of 
the tongue which - was noted' On his adiiLssion to • the 
; Northern• General-Hospital in' November, 1960 • ( Fig* • $ ,2) , 
There was - also • angular stomatitis * He was known to- be 
allergic to- penicillin and streptomycin.
/•. In NoveMber,; I960 ;hia Wast^-lSfjraia. -.in ' '
:the first • :hou.r (Wlntrd'he• method')'* Totalt ' plasma' - ,
proteins "'were 6'*75&r/lQOmlv- ■■'There', wope/signs .of • • 
.•hepatlC .'insufficiency - • serum bilirubin l.-35mg/10Omle 
• On' first-estimation '.and,-X#75mg/100ml/..on ropCaiy ‘ ,
thymol turbidity 4 units'} c.epP&iih-cPlePesierpX', 
/fipocuX&tip'n '•posiiive. (4}) alkaline phosphatase 6 K-A. 
'Units*,. ■’ .'■■ ;■ • ' • t : ‘ ;
On admission' his" bloodpicture• \wa&($r MM *8 #6gm/OOOml. 
p»Q,lK -28#, ■■mG/N*G-.*.' 4^4pp • (5^ • eosinophils}/'' '
f &•film • .showedimarked anisocytosis • 'and •'poikxlp’cy•tpiis •. - ■' ‘ 
.with.Occasional /m&cppcyies.-- ; 'Platelets were present.. /•:•;- 
.The haemm 1,010^X001 abnopmaiity • -was)'' confirmed in six. 
l^e^poe^^^^’/^t^£^nmi^e^t^;^.pns;':t^nd • there • was 'no'. response to- iron • , -
"or/ •to •' repeated'. thloO ,d transfusions /(six 'pints )* mt-7 “/. - '
'/Thesevwere• ■'ppeouiaably --haiemQlysed ;as<h'is Obnju'nptiv'ae. ■■ . 
-became icteric • and there was • ho ’ • change , in liver.
".function tests/-/m
Tie • '.sternal •■ marrow 'was • normally • cellular but . 
contained /ttUmeoUB, 'meggiObbasts and- • showed evidence of • 
arrested maturation • of erythropoiesis* Meegikaayoeyt.es • 
were, •'promittent and •.■.white'.--,c ell • precursors normal'
(Dr. J* The further course • Of tihe blood
changes' ' 0*000 cpmp1T•Cited • by • the deterioration in 
his clinical state* •/ He had • a severe myasthenic crisis • 
on, ^/i^/p0 • • re4uirittg'• respiratory supper t • by • positive- • 




pressure respiration* - 'Ho was never again reasonably 
powerful becoming-weak on reduced done of pyridostigmine
but readily became overdosed and the letter happened
several "time® in- the - next two month# (see further ' .
description’ in Chapter'- 19)*
. On the 9th, l?th and 22nd days he was given blood 
.■; transfusions to a total of 6 pinto* At that time “
his blood urea rose to a -maximum -of 84joo//100oX* but 
dropped - to normal levels in a. few days- Two days
later he required an oxime (PAW) for treatment -of a
. oho.llnergla irioI£* Four day# later his conjunctiva# 
were Icteric* but.da-he had the aoeond blood' transfusion 
between -these times it is uncertain whether haemolysis- 
was due' 'to the drug or to the There wore
no signs 'of-'haemolysis after the third -tromsfualon 
but hie tao;Olla01n level failed to rise*
AA/that " a tag©' the result -of •• serum vitamin .#12 
aosaye were received? they were 145 and X52 /yt;g/m&- 
(normal - .I^Oh-XOOO/iyMg/lQOml ) -• 'Free. HGl ww.-repor ted
to .be- present .in the gas trio 'juice - after a maximum 
histamine teat* He waas./given oyaniCib&Xamln ’iOC/ag*
intramuscularly each cay for 3 days and there was a 
reticulocyte naponee after the -third day but it was 
considered - to be auboptjms^ml^* Further investigation
wan prevented by the development of anuria with a 
continuous cholinergic state which led to hla death 
on H/2/61 (see Chapter 19), ' -
• Post mortem'exa^Onati0n•(Br* A* Gordon) confirmed 
the presence of a/large fibrc-cystlc thymio - tumour 
consisting of poorly staining fusiform -sells showing - 
mo/ . ' ■
■ -• ' - . /.109/,- • •' , ■ ' 7-.- ~.// •, ' -
-y'y y ’''mo •arcMfceofcwr&X ’pat ter#, y-B- . -•
' // ' -was/ - OemifiaM©'. am# : there -was no ■■ evidence. of /- z/7y/ ■ .
, ' • '/ -.malignant /infiltration-...- , I^mph©orhaf£ee,and- ~ Russell/ y. . 
y/ o/typo I-lesions - wore- /prominent /in many-of-•.'the •'mi’soXeea • ■ '■
• • - The/livor • Was-largo (2300gm) but of 'normal . appearance# . -
- • // ;-. the' pp^loon. -was large-(00g&&')- ’#^d -the - cut '-surface - / —; y % '
■• '• -slightly f-fhrptid#- - Gastric' mucosa ‘was .too • 'autolysed - . - .- ..
-f yyexamin&tion*. ‘'Sternal - marrow showed s^me---fatty / ••
/ / .’ /'change -and fibrosis /which was- - attributed ;to previous ' - ' .
- -— yUdi'e therapy,’. '-’.Rod reactive -.marroW•waspresent; la - the ‘ /
■' shaft of the - -long / bones * rlBie - 'kidneys appeared --io.. - hey- /•/? '
• ■ / - .' / /mormdi#- / There - wme.xioi obvious cause-for -anuria,- ';' - y- '
■ •' vyyUnioriunateiy -'the-spinal-cord ’‘was--Mot '-sectioned //“-■. . “ . , ■'
- •• --../?• ..Stprm^MaihXsm ( 196l) 'described X patient-'--'’ . . - -
- . < (Oaso-56) - who had been /-treated - -for - .haemolytic - jaundice - •-. y-
7 ■ • before . /myasthenia -‘gr&vis -began -at the; Mge-df 32* -fight/ -% . ' 
.-..•-'-//ye/^aa/'X.Mare.. after --remission-of -/the myasthenia, .'she -.Mad 7’- •./ ■/ ;
’ myxoMomh and- arthritis ---with - -a ‘raised blood aedi^^^i^l^.b'tipn »-■.
■ "/ rate* - There-/waXno, -'rec"^^^^/©;? myasthenic-we^n£n<es,© - -. -y-. .
■ • eight-yyaaX later. ‘‘/ Tie author- .dobs--no;t Xommcat--oh - /the; -/
- . : Xaee - and does ../not -’appear .to - have ‘ considered - .a diagnosis-- of . •
. system!©- lupus - erythematosus. -Case -4? --of the seme-author- .
•■'7/ had/thremboey-topehia-y'yy y -' •/ 7;%- -7y/“- -7 • .
. ’•’• ... '/- ' ■ It ,is“- - interesting- to -note that - pernicious “anaemia
■ and 'haemolytic 'anaemia' ' have //occurr^ed - in' pa-t'icnts ‘without'-/a- -
.thymoma 'but that ;.ali- ” cases -of- aplastic-anaemia- -‘reported - to ; ■ - ’ 
/date-have -been associated - with -a thymic-tumour- . ’ •
.Reticuloendothelial disorders' a , .-' : ■'/■• . . ' '.. ■ -
.. 7. y.;--y --/ .. .I“ have-'-never-'been-abl'b--.-to palpate. -;th'e spleen of- 
7'&'myasthenic - patient as - reported - 'bye -Montesano (X898) -but - - '
,, - ■' the - spleen; was '- - found - to be enlarged - • at - /pos t. mbr tem 'ex&rnmhation 
: y of -.Ggs*s- . - ■' “
, -/../-/Oases/ . “ /.','■'• - ■ “ ..-■ ' •- . ■■'/ -• •/ - - /- -
:yiy ■■■. -'7- ' ■ 7'7y-
Caees' ' Krt-?86£Hsnd . MM-6Q3 JiSd ■' a .geneyaii'sea J.yiuphadesiopafchy
■ .■ Wutheut;7'aaMust©7?©3^Biam^i6B#■ . y- y/-'/’ '/- y'/ • - '■■ y,7 '
- % - "'OaeerMgS.'Sg^' developed ■ - typical. ®y&sUh'ni& .-'gravis/when'? ,7y' y 
' -•• SOyyears/oXdy/ Wiiiia/a month -/ _/
'« ■ .•h'O&’i’vy/ 'Thyfflecto.my. carried but' at: thmV time :oau©e&/.; 7/y' "
■ ■' Immdiate- :^mpx*oVem^^sin^'?'WhiqhL/' _ cTOntinuwd''■ im' the ‘7following7 - '•
■ / year • -/'' Major ■ irapin<^5?Bsaesit^ti^aa"^n».t^;; obtained 'until/fourf.-.”'.' '
•. .■ years* •'after/; thymociomy »■ , /Bight'year© Softer7.'the operation-. .. 
•,. ■' -7 ehe/hoiice.d a' lump-' on'/her' leg* ' • She-.’was/-found. tp-hiavo ■■ ■ / ;
7 ■< geriefaii.sCV/l•ymphhadenp&tfch*'''D^a^h' oOGhrrod'aojen.toeh' ' '
'' ■ - 'month#■ MMe.r- and-'.was. .att^r?;^?oiit/^d‘ 7 to 'reticulum.'oelX/. ■•" ■-- /''- 
■ y sarcomatbsis» y '/ -’.-///y-< /■', /'/'yyy. - .
. . i/./' ///'Dry'.Jyterny 7'e''$--the;;Charib> Clinicy Prague/-/'' /•/ - - 
■University and ‘Dr* Chaialr's'e^Mi-' thlity of -the , .Radcliffe... /; ' 
XUfirmary* , Oxford,/haVo/roq'enily. /.inform edirne/of 'two .similar ./. 
,c&a©©/u»deir ti$i./;yaax‘©• y'S©^/^©^/ young /children; who /.Had/' • 7 •' 
neOstggmihey^esp0LM.V,e.. ‘ m^sthonia/gravisy as©pelO.ted .' with■ -.'/: .
Ismiphoeareoma' )#y;/'Mter and ‘ Osnato • 19SQ-)', / ■ /
de©crlbeayyaas.e70f /mmaaebenia/graaVs'-blth',generalised . .... .. • ••
and: 7-, . ...
eoha^^^^der^e^dl- ‘ by-, the.. authors' to7 -resemble 7Hodgkin*s■ disease*‘ 7 .- ' 
Coppell ‘ and . -Bramwell 7'(X9O,0) .record -a': case ‘ described;-by 7.7-7- .
Senator , (1892)''- of' .•* multipl'i;' sarcomata’>•' anaemia*'-aXbnrao©uria'‘ A 
and /*chronic■ ps^r'ea^oatf®atot^^b;.i^/hhnm^^^s^^^'h',,the kidney**7 -•- ■',. ./y / 
Senator’© j diagnosis•'appears 'to .have ‘been -muXtiple
'■ I't‘via/d'cnU.tful. '• however*'7 ‘whether ;the'..' muscular fwaaknosa ■/was /
t'riMy/of -myasthenic type# ■ •'■/,<.. ' •••'. - . . • -7 ''/- .*-/ . • -
. -y/y ‘ -These‘ disorders ;of the‘ -blood -and 'rltieutloonddthelial
S,ays ten;ar@ excdption&X’‘ and may -.net...be ■ gelElted■ .to- 
-gravis but ■ ii' should/ be ..rememme.reS .-that. lymphad©heo>'aihy. ' ■ - - ' 
"^(^js«^<^jlated with■ rheumatoid‘ ' arthritis'■ is ■ ' virtually■ ■ confined ■ ■

















\ -to yowg^oMii'dnen-.The^3^-^m;a:yto/some/ofathe ■ 7 7 •
. \ ■ following, condition© '-which ' were", alsof mrnd in ’‘the: present-; - - 
.’• ! neriesJof 7jmi&sfchenifc-patients*1 7 Thtoppseible nature .of - the -
77 .relationship-is-discussed .in ■ Chaptera- 9 and. ,14*. . •- 7.777' 7.
jEa^ooidoo!i3 8\’-.^/.</■' ./7V7: '.7 , * ;
• .. / 7it;iEt. .difficult;- to ifioelde 'whether' 'this' 'o'onditiqn - .
e'houlil - be : .oias.elfied /as<a reticulosis' ,or ‘as "a disorder;o'f ...• ■
■ ' .iwuso'GoGitf&X' - mechanisms :( ToiluaV -X94B.X, ' Oh© 'patient' 7,- .' ,
9 '-’;(Case'--'W/EC/iG.-and - I188?) had' /Sareoi&o'sis* ; ,Xt -has "hot '■•• • '
produced-any -further •<mani£&st&to©sw' ©ine'e; the -.thymus s. was-- •.- 
•■ remoy ed/in?'1946'0'77$h©.?how''has miniMX ym^asthGni’o---' symptOrns- .’
: • -and 'Wlirs^^s'a l1B^pitaXl"s.^^c^2^<^^a^r^3^^:';:" "She.,, has /prominent' eyes '
■ • ', with; - von ’Gra©fe*a sign ' but - 'ha#' ho other 'sign®. . tp; MUfg&^ist the
‘ ‘‘ Ores©n<^<^'.of,•"'t.hyrotox:lo©si^^^l^^/.'•" -.'•.,;.;';■ ,7/7--• -. 7'., -
Systemic lupus erythem&oaiUUsT-- '■• f "’"' '-.'7 J ""•■' - •.;--/■
7 • . ■- -" • ■.■’ .'Harrey? et al •'‘(i954)/'described iyya^^^e/,. symptoms
in three - oaaea 'in .■their- 'olaeaioal/paper- on- ayaiGmic - "lupua - ■
' erythematosue - (S+X.TB)*". Rowland (1955) ’ found •■'lupus.7 7 •’.. '
, ery-ther*at;«5Uu;(\C*;E?S*,) sells- in- the7p©ripherui -hlcod/Of.-a • .■'
• -. patient - who - presented -.as - 'myasthenia. - .gravis,- -. ■ .. ' 7,,. / ■
= ' ■:---'Cade - ,,,,C./ES fi'rsfrnotieed,weakness of the lege -in -.•. .. * . . •• • ; u^iwft-Kjwiwj. hi x»7 - s . > 7 ; , - ; ", .. , . ’ . - . ' 7 „ •• . ' .
- > ■ - 7"-September -1946 - .slI0 '-fws aa7<sil-''49*, " This WiToiXwea'"
' ' '. by - ptosis, and - ■diplopia-, and them bulbar and* : later*. ' upper
' " limb 'we’dabwis» - iyamthwia - gravia ' .-.was diagnosed- - at’" .v 
, ../■'' /’•St, /^arboiomewisL hospital*Loadof-.-in 'October-1948,- . .'
7 7- 7. • ■Thor©.was."©, g©o'd7r'espena©-’'tp 'neostigmine. In 1950' she
•' ■ .' 7 '•fiad'-pbxrleaMii'tis and ahg±‘ohQ^ur3i±e- oedema - and in.. 1952
' • -iw^o -treated by - radiotherapy .for suspected carcinoma ,of
’ . 7 "d fthe 3^a^2^2^$^3^c« '‘m 1954 ahe 'attcndlbd .Haanmismlth lioopit&X' ' 
_ 7, fdth -.myxedema, -’A-diagaoais - of chronic /lupua- '’■.. -• 7'
. ,■ /■ erythematosus was made ^because ■L.E.-':;:"^'ee'l.s wore .found 








. /Il'S. ■■'.■'/ ' ' '■/, , ■
"'7hor'/blood* "' ?At • ' .that ’ -tlmo • /the" 1 possible/association.
. / • ': ■ 7' .with' /thyroidl'tis..' amd ' /myas thomia • gravis • • was ■ ‘ no"1 ''knosw/.
; . attributed to" 'radiation damage
■■ -to tiithyroid 1 .gland'#
7- ■ '', 1 examined • -her • .ih '/X9^5 sh<WWas able ’to led d a
.. normal'"life .If' s.he'toolt 10. tablets/ (XOQmg) pf ' '
1 Neostigmine/each '-da^* -. - •: " -/ '' • ,. • 7 '
•- Till©'is • '.'the' • only• qaae 'Lai the'present serie©''in.which''7 . , . •-
■ eXasscoal/i.E*- cfella have been ;foittid«./ * Antinuclear factor 
■' -has • • ?be'en ' deteotpd - In /the/blood . .of " eight • further; cases-' • 7 /'■'
■ ( Table /3J). • .' This •relationship , is • fully discussed in/ 7 .
■ Chapter 7X3#f7 / 7 iy 77 7->'< 'a/, ■ ••// 7;-/.' 77: ■ .*
Acx'oey&hoMs s ?/
' •,:./' . L*#^yud?sm-iyh<ag©me was jnenblone dby/in''patients'in '".
. • ■ -the /oMgihsO,. , - siriea'fSinpxse^ ,.19.60a)an&/,by .a' further' 5/' = • • .',
.- .■ patients*' 7/ - '/’;. i .7 7 ,••'/•/• v.j fz-j .7 '.-7- 7-7- , •■
; ' ; 7/7 'Gases / '■<'' . -
f ” $105*46 *mw4?x*/®3x5?a$ , 7.
■. - ' i®4977M; * M^h^8^ii^97?#?53^7/'' • ■. ■■;..' ,■ •
•, 7This‘ ?symptom".bas' hot-been reporte’d by. ".©thes/authors#/. -The •• . ■
true "Ihe'ide'ho©';" might" .be greater; 'einbe "":the '■symptom " .was• 'pot >7'. 
•/' /specifically -asked • for. in 'the • first 400 eases*" ’.Many., of" ' •
■ ■■■these eases showed.' ; a/poor ".response. . -to 'neostigMine'/or /t©’-- 1 ,
■. , 'thymectomy*/, 1 have' jjaaW./^hre/that, .the evidence for ' a •,’.. / ' . 
/ ./ myasthenic• <reactl'ch" la" .. sufficiently"' WiX' documented7'to " v?' ■ ' ' 
_• 'imhe'-each' base• acceptable 'for ■ihtxX&&io& "la/the." .series" as’./ / 
■; ./.-this finding may be' . of ;.a'e®©. proghQS'tic;■ Importance'' as'-/- •• - 
' -indicaticm /of irreversible_ 'muscular dam<agi•/This Is.,.o'f-7 ' .
some 'importance '-as 'aGro©"^.^!© ••ts a' -'bomrmSn' :-a©co'mpabffm'etf4i . . 
/ of .-polymyositis'.(Walton .-and 1958)# , 1t may/bo;,' • /' "
• caused .by auto^agglutinins' 'in - -the1' blood - (/Forbes* '-.194? )* ~ ; '
/ •*Wiettmmt©id’/ ' ," '• '■•/• '"/' - - • ■ - - ; . /•: //■ •' -
113/'
arthritis g . ' '■' :.’ - • : •- ' • -• .' ■ '
■ ■ •?' ' "." The■ author. was.,also the. first. to draw '.attention /
to an unusual incidence of arthritis in patients with ■.'. ,.•
' •• gravis (.Simpson*"' 1960a,5 'X964ib) ■ # Xif some ' ■_..'. "■.
•':-.."patients .the painful .‘swelling 'involve# -peripheral■ Joints'
, an#' was -transient , ? (Gases ■ WGH/AP\ • XM7783» -#62028 }, . Two .
■ - ’.patients;were considered ’.to'/have ’ankylosing spondylitis
J/(Gas@8'.feM4lX7o»' HH6i507).; ■''/Xn.'a■:fUrthe:5?', l1 ■ cases/the 7 7/
/joint .changes 'haio •■been permanent' (Gases- GE/BA* Gk/BB*■;:- '• ? 
/. .inr/B-B/JH* ■ 'RH980', ■ ■ .-#3X9X9-• W^a »..Mx6iA96* Mn2>4 9 MH675, • '
77 7/ ,.../-■-7-7/7.7-. / 7­
. . ", .■ 7u; ,-Bn.e' arthritis . io/in&isHnguishable■ eXihicalXy■ ..
and/ radiolpgioally -from true . .rheumatoid- arthritis (Figs ? *2
- and^^2A?^);bu‘tt thti'modifying/quotation-marks were used‘by ■
Sigipsoh' il^Oai/ta -innddate 'that\'d#H»tdly-• could noii.be■ ; ■
. assumed#' : .ne'eiriheless,/ 3Bnniet,.'.(1962a*'b) has used my ■••• • , •
• evidenco (acknowledged in/the'aoaohd paper)'to.support>the '
- hypothesis I was • then, suggesting'. (Chipters ■' 1,3 'and 34/)■ .-p ''■
• -. 11 / will '■ ■ he .shown ■• in- Chapter 13 ■ that ■ the ' arthritis' .may-.--be; ,
difforentfrom ■ t hat of true ■ ■ rheumatoid arthritis as - judge#
: .'by-the /Rose'-Waaler test# ■ • ; " -;. .’'••• ' ' 7- •
. . Nephhrtis s • "•/..' i . •• ■ . ■ < • , , '
'•■'CaseL^5357L had acute nephritis just before thymectomy 
' in the third ■ year of his myasthenic illness*
. "Case OCb# ■ /LLatV•-ac'ut© nephritis following thymectomy ■■in ' 
/■ the second year of ■ illness * He ■ also had a .small non* ■
■ .. toxic goitre* ■ ••.•'• ‘ ■ ' •' 7- .7 , ■ ■
' ■-Asthma■ was-.no ted\ in seven patient.©. (Casea NK/HH/HC*
M/Gs/ou /i#3636^' M336/*^W6 and, IWWh In
each cPs© .the asthmatic symptoms ■ had preceded ■true ■ -myasthenic
' 7 ■ .. •: ■',= .• • ....<• .' ' . ■ .
lib.
symptoms so it 3.s Unlikely that the attacks were due to 
ventilatory failure or to overdosage x^ith anticholinesterase 
drugs*. . Nevertheless the circumstances of the death of 
-.case’ 14^6^7.6. in. another hospital froni.9severe -asthma8' vzero ' •’ \ 
very suggestive, of a cholinergic crisis (Chapter 19)#
, Other cases such os NH6755 who died of. ;4 asthma t several -
. years,after thymectomy without’ having a previous history 
of, as,thaa, have- been excluded from thio, .list*
... : Four patients had their.initial attacks of
• -myasthenia; or relapses'precipitated'by. .allergic, reactions-/' 
to foreign protein*, These cases and others in the 
literature are described in Chapter 2#
, Qtheyss ' .
Ulcerative colitis and',-hepatic ■cirrhosis werek
associated with systemic lupus erythematosus which,, followed 
thymectomy for myasthenia gravis in a patient: recently' 
reported by. Alarcon-Segovia- et al (1963)* I have seen 
•'.two-, myasthenic patients with acute hepatitis; and two with 
acute haemolytic anaemia# . Tlieso'cases will not be
. described here as the complications were considered to be
. due to drugs - chXorp.rdaaaine- or oximes '(Simpson, 1961a 
and’Chapter'‘19) “<but cases' recorded in -.other‘..aeries are
’. listed in Table/3*••••'.• : 1
Summary .1 • ......
.it is:clear that none of these associated,disorders
occurred with sufficient frequency?to be considered'
4significantly9 related to myasthenia gravis in the' 
statistical souse# Nonetheless It is a remarkable - 
coincidence ’.to note -1ho occurrence'of the same .conditions 
(and some endocrine disorders which have been discussed in 
the -.■ last chapter) in th© other major series in. the 
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/// ■" ■ <•. '■' •■gimpsom- <X9'60aX/drew .attention'/W the fact /that?7/' 
•many .•of-' 'these ' eon! It io ms?-* 'which -have - -in- ■ common . • a ■ . dipordor/- 
of - the . •.reticuiQdm^daKeM'oi-. • ays tan or .- of - ..the - imKunologloa! ' . •■ 
mechanisms •*»•. also ■•featured ' 'ih- '/the-. list-' of •mmnifeot&tiongr of 
/systemic . •X.mpuo ..erythematosus by- - W^jp-voy-ot - .al / <1954).. /and- ■'- • > 
-that/the- precipitating - .-factors,the . /ago ■ Wnd-. sex /./ /--/?,' ?? _?,• / 
die-tributioW,' , and .the-•remittent' .qowraea■ of .these ' two -;•'/■••- - t 
•..diseases ..weqe-//stri&ingly, elmi-laya,-.The - ou&gge.t'idn '-was/ , '.
.made .that .myasthenia.-ggdvis,might .be.;'a ?local neuromuscular' - 
'■maaifotation -of -•*a ’’dis ord or in -/Which - other - ..tissue'a/may;”./- ’ /.'
-sometimes/-hq invo Xved'f - /•’• A- disease - process - resembling'' but-”• "
•w.t IdentiP al 'With -systemic, lupus/erythematosus/was/ •'' - ■ 
■suggested# >'.via'•'the ' rest' of /this tTiesis• the evidence' -and • .­
-discussion- mil be - /prcsented '/in' - such /a.’way- as to -.throw-/ 
‘light /op - ' this - .hypothesis - ■ Wd .to- 1 ehoW hoW ■ it-•.•Was ■ /further'
■ 'investigated*,I- •■-/.-.•'" 1. '/' -; - '/ ./. • .- ••'-,• ■'/• t 1/ •’• • • . - ■/’-//.
/ 1 '»,'/?.. : '' • •' =• •• yt ■ - . *» 1 - ’ • :• ’ 1 . 4 v ’ . * •, - • y ’ ’ *
; 7 /'///i/. ijcHAgm; jf 7.//-77 7 r/;.;7/7, 7 '■-■
•’ ■'■■ '. <•'• 7 ■mm,:iAA AND'#JO0OE^^1^!lAALM^^,STIT^lE^A^<^'7'" / . l''//
. ' • k y Mt'MTi^<iT »-i-iniriy-fnn'-ji-i“:Titifiiivf rih7.).Biiwf-n.iwTr.rr.Ti-iiHL-Tii' ffrwrfriri«- ■.TTi’^'iTir—‘y rrrTrr- t -I—”r i'i ii'if h'ii iii .........J , • '
'■ %% ; ■./•■Myahenia'gravi© rarely. occurs/in /‘more than • one
member "of- a family but there yin a well-documented ■
literature: Indicating that thia rare event . happens" 'more 7
accounted for by cbinoidehce. The
cases;"described ■fail•'into' ".three./clear•groups* - ■" '•
.•;'./•■■ //i)'-' , .Neonatal'myasthenia graviB* •'•-'•/' '.’
, yy ii.):V .'-^F^:iii^'il;;m^^^f^'then3^a^\'grav;ts*'-''j. / '' . :/y -..•’/a*
< v7; iii) A Co.ong«^n^^tiul;e^j^txsth:^oh^i^^^;- ., ' -.V .. . - , - .../yyy/' / :•."'
Neonatal • myasthenia: " ■/,, "•■" .7' 7' ■••'••• .7 . - ; ' • ■
■„ ". /The . firot.recognition'of myasthenia gravis in- .the
newborn-/child" p'J^.'jamyasthehics. mother ■ • by " Stric&root " e t al,
■ (194.2) wa confirmed • by/ilson "and^ Stoner (1944) whp: '7 7' ••.■; 
■reported '/two/.c&ses.'■ ■ ■ iFirther •''reports • -soph ' - followed. " ; in '/./'■' 
'I960 WNer and .• Schptland were"a^bie/'tto’-'s^t^mim^x^i^^o: : ■
in /the7 literatriro to ; that 'date and.'iiilihhap ahd Dodge . 
(1 $66);. added -.16 fu rth'pr .examples;. y r // 7? yr / ■' - ■ .7.7..?; 7 /•.-... y .
•77./.iy: ; ..Wereythe'•'•fnc't-' is ' mentioned /there ' 'app£ars/t.o- be' " ' 
■56110?©1/a agrejemiit /tlaa7 fo o e al.mov0’®.^t '/a 77e Sore '
'birthf ; •\®^07)^^^1^^^*'•,.^r7i^c^wevex^7■•y^<5l^y' we/d.'-ar.ybirth .or 'within■ 
n7few..hours,/pf'iii- 'atCU^'•*7.Wtreated^ Is• - likel^te? . die rof "/ y - / . . 
.respire tory/ . f rilU;©g$ >• 7y There is-/ severe/ ■ weakness. • of"; bulbar.. y 
'Spima'i:,/ thoracic 7 and'' limb muscles' nnd ■ptosis, is,/common■ but7"/ 
I,eyin." (1949) /'comments "/on the rarity of" external ■ ophthalmo- 
pllgigya # /The'/exact .duration of • 'the" illness is-a little / /'' •••.. 
■uncertain "" as/ the7.b&by/has -usually .died • -W thin ;.a'/ few / hours:... " 
pr'bha'sybe>‘n .maintained; on: neostggmine/'for. several '.weeks-'" : ? //■ 
but • • from" the/vrgu<e'i;rccounts in the " reported cases' it appears 
io,bp'more than'one; W^e^<^k/bu^i p^:^,?b£U:^;^y ebss than two ".months. 
/Recnrrphce/ •-
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.^/Recurrence has ' never- been reported except for the possible 
case described byOsAerman (1958)# His patient* ■the child
: of- ;a: -myast hehic - mother* " had - dif ficulty- mMtil sucking/ and ■
" -swallowing .-after' ''bipthi;" ■..This, 'persisted^ for ■ ’several- weeks’ - 
?;.:&rid.’ ' then - - disappeared;- 'Without specific - medication* - Symptoms 
■' ..of-:muuduUar weakness- ^reappeared -at- \2: years of- age# 1"
: ■ ‘' -Tie ' ope'urreh'opodf "neonatal" myasthenia--is' ..unrelated ' ..■
,' to- --the - severity - of "myasthenia,-in- the mother and doe'sno t -
;./'.i;QeouWM..th ev'ety. ippeghaneyteven. -with subsequent ones- ■ ■
■' -;(OTl£172* - . MN53^^12»,’M#4i86)#,;- - ■ ‘""HeovsM/of- .-the -- motherls-" thymus
, ghofore or - during - pregnancy does - not- prevent - the baby from 
having neonatal myasthenia" (levin;' "1949"; Kilsby, 1949;-; .
Geddes and , -Kidd*1951 )'#'•""-This-"'is- confirmed by the- history 
o f-; cases? G/PB( 'deacri^i^e^d" i^n - -Ohapter 5 ) ■ and of-TG/MM: ... 
who;had - armyasthenic-/ohi'ld-■ three - years; after thymectomy."- , ;
. ;Thg:;Htter.''-cape'; was' no t " taking ' neostigmine or aimilar drugs, -.
, throughout. - the-ppregnancy *- , Bix/year.s".later-.the" mother’s - -
1 ; myathonia;- relapsed- after- a- miscarriage. . ' - .? ;.
*" /""/:•- In 'the'- .patients-'observed- by we-,- 59 -women- had 81 -- . . '
"-g known., -.pregnancies - with- 'go "live/births *- "Of -these 64”-Were - •' •-•
■ "" normal. There - - were" "three - defini^•^e5l;5"wyaathel^ht^^."babiLes - Mnd-' 
another three . in" which - the- baby was weak ” at birth-, but "
recovered without - specific- treatment# ••.The three- confirmed
; -/eas.as-were --.born- before'-"I saw" their'- mothers- and -'IWavo/not- •" ";; 
bad--- the; - opportunity - to observe neonatal-"myasthenia" although
./. ... /’I have -'attended -."the - Ihbpu'rs - of.-'spite " myas .thehie." women*""- '•"-" '" . "' ' - 
'"y ■' • •“ ■ ■ The -"transient'" nature - /o f neonatal - -myasthenia .is - best' - ;.■■
. ncc punted - for - "by .-. the- t empo rary - pres once- -in- the- infant Wf a - 
'< • ’""-toxic' -■: substance. -Which . has " .passed - ; through'" ihe" .fr.x^c^^m- ' ?
.•'•?• -.Ith^m'olher# """The "rarity - "of - this - event-makes it hUlikely - .. “ ■ .
; that --"neostigmine - passing - from" mother -tp" ;child- -prevents 
normal : endgplato-"maturation - ahd"- case - GK/MM was not - having 
drugs/",.,
;iil8* /
/-. drug's " throughout ■■pregn&hGy* persistence/of/ the. effect 
'/•/..• fori3*6 weeks i.oh the -/other hand, an? unueuaXly 'long 
1/-time/’for a toxic- mibstahce to persist.. 'Itis about, the
//duration' of persistence ...of•-•.maternal- antibodies /in the -•/•'•.
/ infant*e • bloodsireerni (Chapter' l4) and X have suggested
■ that. this'kmight be' the- ' mechanism--o f neonatal- myas thonia.
: ;.-<(Si^nips'bn^vX9u0h*';-lippehdix C) * .-/ The/rarity of ' such /an;' -"•?
event (about 1 in 23 births.) would-be accounted for if 
/the postulated antibody1 was ' 'inactive unless. the infant’s /.
.. -/--muscle’; was- anfigehib&iXy-. similar -to './the mother’s*' .A - . ;•
/possible. ’argument against this is the/occurrence of . : —
, ;./;neonatal myUbthenia/in babies born after ..• -thymectomy had 
been /carried out ' in. the- mother.* This is a less serious
ob jecti^on than'■ it/may/seem since there is no •/doubt /-that /'• •
; /;. Hashimoto *s disease"' and other dLrnmunc>lo£^;tCal disorders may 
-occur -.'after the/'th;^mus ‘ has bo'eh .removed’; (Chapter 13.), nor
' -/need/it he' supposed that thecontinuing presence of the 
-/'thyims/'is..necessary • for the production of antibody*
?rny as.thenia gravis g - - ■' /; .i._ ‘ / • ,,, - - .- - •- - / ;-■ /.
'■. • ;/,/•/’ ■' /There/ are .also/ a /number-,-of /reports 'of /families./ '• '
.; .With mono than one case of -myasthenia -’gravis* Those., have 
. usually occurred in pairs of siblings of either sex' 7 -.;...
■ (Oppenheim,/l8985; Marineseop 190$5 ’Hart, ’71927-5'7 Riley;and; 
Frocht, 19fe ?; MancusiT^Ungai^o.^ : 1927 I*./? Rothbart /(1937)- ’"' " 
tiescr.ibed -4 brothers with!myasthenia beginning in infancy 
and 'Moyes (1939) /a- ..father, and 2 daughters In a-personal 
communi<cat/.onto I,bvih ( 1945 ) ,1 Pr * Eaton described ,2
’“’".infant /brothers and,. 12-' year old /twin sisters with -symptoms; 
■ a of - myas the hia-gravis* ••-.'-lii-- non e of these; cases was'. the/ - .
uiother- known "to; be myasthenic * 7- Teng , and •Osserrnan (1936)
, -reported two families of. myasthenia- in adult siblings but 
/ sibling/ < ; /• 7, '//, 7- /■ ? / ' ' - J'*
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sibling l.np3^ditenoe%'-/'aiG. -/much" greater iirlthe juVerii'1'es ..- With " -.
//thei^o'Vaei' sIbo, involv<raent - 6£-i-'-3fL3rai?’ % %
-cousins*." This ". review' "of "l the .-iili^eratiw.e': suggest s""th-at’./ there" 
is " /a "high;- ’familial" incidence" -whenTiyasthe-nia. first" ‘.appears " 
in" childhood . -or adolescence*"% //''""' .let 1’ /.""I"’" '""// " "/'"
//,-t"/ .""-"Tho?dpsQPipti^^^^ms".3^^^ve.l:^46p.nbjfpr. .doubt. isr'sorop'• ", -." ' ; 
Cases /re’gardnng:- -h"di©ti-hction/. fr^t^m" ’the" group texmed/ "••••■ . , ■ •■' /.." ' .■ 
- Congenital"Myasthenia.: ( vidp;-infra). " ' KevePth'oXess, 1;"feel ,,.•■.•.••' 
"there" i©;"&ipXace' ’fose --a sepai* at©/, group"" in /view -of /the..'" ■ .'•,•% - .•' 
faramiiesvl;. have 'j^n*"y/;. /•/. '—/'"//y"";/ .-p. "
’ ./ ■. O .ao'e;" HII$£Q33’-' was.: .adraiit e d" ..to - the"" National- Bos pi tai eg,
(Sir. - Gordon-- Holme's); in - 1932" with "/myasthenia- gravis""//w-//, ." 
•' starting "on'egyear "previously. when "she- was" 22‘#."/"'"There " ;
' wex^i/'^emssiQhsffrom/193A/ to 1937. "and then after"a , . .
short: "relapso from" ,1937" to - T933 whph - I "saw her" . in /' .
/ Dr, A. CaUffiiehaeiih ward.i■ Her grandfather was
•...- • - also ’the great ’ iddfa ther" - of iheinpK-t. " caeer .('Fig#/-'- 8,1).
■ Case Nn29355"was-, admitted- to the "ilaWonal Hospital.'!n. -.
.. "February,; 1951V/"Sir .Francis .■Wshpediianose&i "- y ’ ,,
■ :- -l’myasthenia- gr’&wis-.'/ His».ago wa"2% "years,/ " -He"had a
"v.. thymee torny/ in"1951 i"(Sir, .'Geoffrey/ Keynejs) - and - was .% /
. ■"/.■-having only rare." "myasthenic" - symptoms - .’when I- saw him.- - in '
y 19,53* ": -/There" ‘wero- no - ...other-Shown caseo of myasthenia’ . 
y , "in - " - family - hut? at" /that time - I w^i3";not - aware" "of the­
- .,.-/ ""possiblo .link'" "with -other/ diseases""/Ftg-i , -8",1 )," ' _
. ■ /-■.Caa-o- MM^-275* •'■' ’"Eiia-??- year"- old "virologist undoubtedly /
llad"mi'ysP;}He.l^a gravis"" (Figi" 8,2)#/ "There.- was a typical . 
hi story/of- " rerflissidns.," .and/of intermittent, ptosis, " " ,"■
diplopia," - dysphagia"- and / wesanioss' 'f f limb 'muscles increase d 
by effort -and relieved by"rest# - - For three week's soon 
after" the -onset - she - had persistent" .para’osthleid of the
■ w -hands/. ’ ■/// '."■., ;/■ ’ •
  
y • • „• •••• .. •; -120.-. .■ :;, ,y /.y,y / ;•. / ' ;? , ■ . • . y ■ '
hands ..’and' feet •* % ■ The- ''response ’ to ' neostigmine was-. ' . -
excellent* ;■ ; ; Thymectomy ’ in-eDscWber■$ ?• 1939 .(Mr*, .Andrew 
logan) . reybalpd. - a ; large • fleshy .thymus; - described as. ' .
bo^.-ng/;*uhjLnv(^-lut e'd?» /-/She. had. -A .temporary relapse ' ■
afteria. road accidenthon’P '•yOur-lator* '4 4
;'4 ;-She -; vms ' adopted/ as -;a-’ .child' but .her doctor was"/.,. ... . 
^W^jre /that; her,.real mother-/had-heem taking- ’neostigmine .­
for - some t^^me/.bi^ifoir@"$ei' death at ' the age of ' 30.- ; - It- 
10 believed 'that-- she - had- -ptosis . and that 'her death was' • 
du oho Yniyasthehla •■gravi.s•#';'/-■-4. /. - 44 -; y/'/,/ - .. ....
Case- ‘KHlgj37|* •"''BheVcomplaihed -• of . Weakness after ; a-.•/•..- ; .:■ 
febirtie Allhess/With -.dieturbanee ibf/'Consciouehess - in .- ’ 
1933* ’••■•’Sii Gord'Ori/Holmes' .diagnosed . - .mY&athoiiia--grayish - ■ ’ 
She - L.be^c^^^iae’'-' steadily -‘worse -..'while' ■' taking /ephedrine - but .ih • 
■1948 -'had - an - excellent - - /response to - - neostigmine by./ 4 4' .. 
4n3ptctio,»*- .. .Thymoo.tbmy iinythat’ year wasbfdi‘1 owed by :- - • 
■imffie&d'&ie- isipqovament '- but 4eh©-' died - in-41951-. (aged' 51)- / 
After 'gastroenteritis* ■ y4' ■ - • •• " " ■- ' - •-•'.. /’ - •
Her father; -was,...still, alive , aged 70, surviving-/y , ... 
removal - of a rectal- ■'parcihoma* *.'4'MeyhAd4no :®ymhtomm4of 4 
myasthenia -but -4his -••mo.thor - had 'died - at,4-thq '.ag'd - of -..63 -
.af ter '.thirty years - of-- progresaive weakness' 4of all Uimbe* 
.eyelids' -.and 'bulbar'- muscles* ’ ..Mho. had ' a, goitre*.//-The' --./.• ' 
patient ’a aunt- ’(aged-76) had - been unable ’toy-use her arms 
op - to - walk - abou t - for ' 10 years * She ' had thyroidectomy 
for -goitre* /Other 'members of the family had -•■' ;'/..',J4' '• 
exop}ithalmi.c--'goitre i-,(Fig. 8,J.)*- •' y / -4," '‘. .
G^.so - 104650.*- This patient is described in Chapter/.? 
as-s^he - had ' pernicious'- anaemia'^ for 16 years -before;- the' 
oniset of ' ocular myasthenia - -at/the age of 42 years.*/ She 
had- also developed arthritis ' of - the - feet;and ' hands' ' ;at
■ - ?. 121. - '• . •' '
.gome ' previous' date.=--,•• ; Her: mother, '-..aunts - 'and’ uncles 
' had familial -ptosis' (and possibly -.blindness ) and- her
, .-."sister’had*’ ocular- . 'myasthenia -gravis.- ■■ Ihifo'otunaiely
. the sister 'had '-died-a few-months earlier .but both .
sisters' were examined '' Un' 'Glasgow. Bye* Infirmary by .
■ Dr#' d.'B. .Gciylor, and ■ shown 'to have: •.-partial response, ■ to:
■ noostimmine* Both ' sUoters are illustrated in 'Fug. o,3-
- and-'' the family ' -tree .us shown.:in -Fig. 8 Tim. ' pattern
Us toox-'e .suggestive of familial ptosis (or ocular
•• , ' myopathy) but ' the, .px*op0OOtUo wsis ..convinced that : .
neostigmine improved. ' her ptosis. Blect.orayography of .
-- peripheral muscles -was -normal and -I -was unable 'to- , ...
■ ' convince' myself that the ptosis was truly myasthenic.,,
In'' some ways she ' resembled the *benign congenital '. . - ’
. .‘-myopathy with -mydGthenic;' features* described 'in , .- 
. s -Appendix-© or-the, ^congenital myasthenia* - described in - 
■' . thO'-next 'Oecti^on. ' • .----'V '- -'---' ' - ' <-. - ' ■
-The ' "same 'problem of 'diagnosis 'is' present in ' the, ■ 
following cases ' s«- ■ ■ ■ . ' -■ -
■ - .Case,'- HHA9Q87 ' ■ began ': to '- have ' ' ptosim ' and ' diplopia when ' .
she 'was.'59* . She. 'was hypertensive' ' (B.-P, 170/120) and
- ■.- suffered from migraine.-headaches,' She' ' •complained of ;
, attacks of profound' fatigue' but not of muscular
.. .weo.khe^^o*''-Heostigmine .caused fasciculation of' the.
eyelids and diplopia' was ' increased, -Her father, who 
also -suffered from -migraine, had ptosis ' and cataract
- and her: 'apn-was said ' to,'have ' (sleepy eye's!.
: .. It wdll be ' seen ' that, the evidence for ''familial
occurrence of true ' myaaihenia ' gravis is not convincingly' 
supported by the ' -pres ©.nt series with-' the 'possible' exception
' off- . .. ■ •• :■ < - •■•'•
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■ . .of the first, two, cases '.cited ; Nevertheless in ■ ■ view/of the 
•’..reports quoted above /it ’ must he considered ■ whether there ,
■ may.’ not-bo a hereditary factor.’in myasthenia 'gravis./ If .. 
.'.' /.there is,; it must be'.of’.’ very '.Low. -penetrance since - I have ’
seen one ..patient. (Cnoi^.^') who ■ has an ’ identical .twin - without 
. ■ tho/diseas'e./Fig.# .§».() •.(Sippson, 196*c)*. ‘ Similar./.cases .
have •been'’ 'recorded-ipreviously : (Alter /.and-Talbert, .19GO)* . •
: , i Ano then 'approach might be to consider- -the ' ■ ■ '
- /possibility 'that nah ’.abnormal gene’ may have different 
. / expressions. In' Chapter 3 it is/shown that./thore is an •
unusually high incidence of disease./of’ the thyroid ( ’and
.possibly of; diabetes me3.l±tus) in . the siblings and. m../•■ ,
progenitors’ of myasthenic patients. ! Unfortunately/miich . 
of ’the’ data, was obtained .before'/the.-possible significance, 
.•was appreciated .and’ so ■ the true ’ incidence is unknown.’ In
, 'addition it is. ’regrettable:’that . no enquiry vzas. made -
■ ..regarding ’ rheumatoid arthritis., dr; .pernicious anaemia'since
a’ hereditary factor'is highly probable /in these 'diseases 'too. 
I have ’ suggested that,a genetic’ factor ’ might actthrough a ’ 
h;y"J^oills^3^^ai^^iopittA:i.tary .meehanism, ’ sometimes? /thyroid .
disease, at other .•times’.a disorder ’ of /'the. thymic regulation
: of i.mmnooc^g^i<^j^;i tolerance , (Simpsoh, 1960a, Appendix D). ,
. This will be 'discussed’ in Chapter l4. ' •
Congenital. ’ my as the nia.: . / •, ‘ ; ' ■ .. - •'; ... .
. .,,/ . . Wile ...I have ’ no,doubt that tneonntai* hnn.a ’ ■
is ’ a ’.true, ’type ■ ’of myna the nia gravis I have indicated ’ .some,
. doubts abou’t the nosological status of the familial ■■cahe,. 
The status of the next group ’is even’ less’ assured. ,
Levin (1949 )/■ ’appli ed the term ♦ congeni t al ’ my my the h i a /.to oa '
/syndrome ’-occurring in ’ siblings and cousins. The mother's , ;
. . ■ never/ ’., ‘ . •/'' - ' : : ' ’ . ' . , / ’ - . ••. ' ■
 '\-he'W showed";rayae’th‘enie 'symptoms. fahd"ohe; mother '■.had - a ■ ■'. - . '
" ‘//normal .;reap tion .to . quinine ). - . Unlike neonatal myasthenia 
.."/• 1 $-was/’often- ' noted " that'; 'the ■ t foetal, movement's were . sxeak." . ■ ■_
/ There "wae. oon8ider.ab'Te<’my&sthenio .weakness ’ increasing with ..
■• •"/•effort;and.- wors’e•'tQWSs&'S.evening/ involving’ ’mainly;the - •
eyelids' -■ and. extra-ocular. -/muscles', but .usually.with - , 
''■/';ge;h^i^^^^S-s©o^-<hyoc^tnj^:^./^.;:-?X^^eyV.n;,di^^^^, attention to"th©.-v//;,:..;._ . . •_
•' ••':•. striking. .symmetry. of .involvement-*;'differing. in .'this - respect . ■ •
: from poSt - cases of true-.•/myasthenia grayis * In . all of the :
cases . described' by ’ him ’ thero . was an’excellent therapeutic
: , response to oral administration of ..nedotigmine . (but . the.. " ".
/"marked ..colic .reported-'in/ one '’-case ."may ’ .indicate , some’ ■■ . ■
,"dl^:ffe^3''e’hce. from ’ true .myasthenia...gsa'is) * The. natural
history: of tho . . disorder/in / the .- cases ' described by .Levin .
(1949); was .also 'diff.ernht-'from. .rimy©thenna 'gravis* /.There .
../wfrano ;,rem'ls'oions- and .'the 'disorder was not '.progressive.- 'i.
In fact there, was a tendency for slow .improvement tot occur 
after/ the/'age "of/ h«l6:/years'♦. ".'/'j^e^eVLn/tfOt^clt^U^^e^.l^h^Eit'. ' •' . ( ....'/' '.■>' ■
i ‘./COOBenntai myasthenia differa from neonatal ’.myasthenia as
it ’ probably ’ begins.-prenataly.and ’ that. it- is probably;,, gene tic '
'• /iu/origin.,--.- .... “/-' -g;"'/ 4 4-' "' ;,-!AX; , y
. . '. ;■. ■• Wa'sh. and ■ Hoyt (1939). '' accept' Levin’s '■classification ,-•
-of, .myasthenia.in chiidren"ihto‘''neonatal, familial,. (normal*,- "
• .myasthenia’ of ’ early . beset;,- . ’and congenital. ; They . describe 
-a- /a: "family,. ..of "six- children. /in. . which the, . four boys "had- ; ■' / ... '- '
isymmti^^cal^^, ’ neostigminerresponslv©. "weakness of . •eyelids.■ .
// ■ .’and" dw'teI^hal.•0;o]^llUuamlopl^€^gt^E^'C^c^n:^o^^^^ming exactly.tojihe, •
■ bypegof" Levin. . - The, oldest brother '(aged’ 18)
- . also •■had severe "generalised"weakness.•’and. f align ability of - ' ..
"his" limb musculature -which.?w«as"symmetrical ' and ' which showed
•/•.neither .remicsiohs -nor ’• improvement. with’ time but' which ' ;
/ b3?css>ondbd/". ' " " " ■'-■ ■ . , . • ■/' "i
A I'M
ronpohded- Abciia tie ally;'to■■neobtig^ncA;- i X^Fteoltreoom^vPg^'dphy . . -
oarrrfoA. AhA'inFtwo -pf- AlAsObbhy.'pA’ ' 'David- Grob); fshowed . ' 
classic:' fatiguing , ©f'.'-toidsOp- With.. *f&l\t«6tU\'pf -action .“•.. ■, ■'• ■ 
potential^4i&teXy,- rwbored " „ to e normal"' ; by 1 - .in3 Oo tixrn - - - . ‘ 
of /acUuphQnrlhm W-.;.Hfr.rmha't oX$- it' - xs: • -not- •stated' 'i-fbethox^ ‘ , ' 
hhid .to' .-of d - ■ - t ..
ve^iLinafa'ary'drbnt^i^i^cs'tDaii',- dr-'tm XhAXAdoXA response :tOA ,; ' ..-■ -• ., 
firadlsaMonf of/tbd "Motor,'norveg'' \ y AoA .<-• ,
. , F jio^oampa'.bl^^^f- roported'iwl slater^; With,. ptosia ! F-' 
f if&txnoticed -..at 'th'ei&ge.o .- 
%ho .'Symptom8o&fc - described t&QA’-my&sthonie* but wfe\ "' •/• . 
hggriavASd "bybnpodfcXgw^be*" .'" 'From' tb.e "description 'in. ■ thiet '/- '• ' 
pppor $©W«s possible ybh&t ;hho .-•tost may/Aawthewn acrrriM .
fut--' Mil©, cash .girl. ■waaSi:bsij;oayic;0.^hqiMi^;' symptomAof FAf'' F • 
.dhvWdwaso ■ of - neostigmine-; t&bahFby.'mouth <F;- ‘SUstf - 'A-atggec.’ ' 
isAowetiw0s -. of by.'patients." With:■ -'opnog>riifc.&l A- ••' " ■
'ptosis'%n<Vi"PW&0pt0®18 A-Chaptp'r• 9) -th of ocular' ; ',..
UypqyofAM0onX&% it .-may'- ,-
WCtlWtt those 00808 -axA not; tWud oampios' of Congenital <
iHy&fhcni&s" ..^ fAfAAA^A A/A AnA-AA^'AF* A.; '"' -
AF- ' A^rott^lrAhd .BiAshlsonFof '
.'thO - Royal'XfospltbX" ‘ fop ,8i;cj^k..';0|hl3^d^ioe^»'-'GiL:#8gow$ X have.' boon , 
able ApAxtAine Awo . a'isiobSWvhbm-,! --believe ■ to have 'congenital 
yS'&sihoniM" of.''theAyye/deaoribed4, '- AAAAAAf" ' F'■'• 4 F" "'^ " ' a\'
4' b GaaO rtHlAbF-Wasi a "•full >- timed baby # •' 1 Fo'etaX. toovWen'is had • • • - 
- ' " •.. bpen:. normal' buA a! :hdr " birth. eho '.yeddirod'. ^n'AxygeA''thnt1F 
A;A. owi-nAto" foehlo •'raovomontG'dA'' -Sho-newer;'CuoMed wlld'A 'A - 
AF' " At','tho' "' -third"6 id'f .mirth ^onbA'her- enother 'no tieodGilat'oro! 
:8>;-?-8 "ptosis;AhAhldSdeeiotbvary*;: A Weh•'•she ••‘wis waned'" ShA- hqd 
Aid froA^nAoholAAA atttaoks.A’wi^th-ifj^cii;! pdocoo 'ofbfoocU. " At - '

























-hospital In London at that time she was considered ; 
to have myasthenia gravis* Neostigmine 37*5mg*. by
mouth every four hours kept her well but she -was
nearly 18 months old before she walked though she was • 
alert - and talking well* -
When 'she wms 3 her thyrsus was removed without
obvious benefit but there was ' no' further deterioration.
She was able to discontinue neostigmine at the age of 9
and , was able to - attend school,., Though unable to skip
or to walk quickly up stairs,, she. was fit for ' most 
activltiesj but ptosis persisted'and when 1 saw her at 
the age of 10 she could not close her eyes completely*
She had never had - diplopia-and .ptosi-S; was always•
■ bilateral* 5 - , . • ■ . .. ’ . '
Both parents, who were unrelated, were alive and 
well and had - never had ptosis or muscular weakness.
A younger sister had ' a similar disorder*
When 1 examined her' in January, 1962, there was 
bilateral ptosis (Fig* 8,§). It was little if at all 
increased by fixing the gaze .Xove head level* Eye •
movements were restricted 1n - all directions, ' orbicularis 
oculi and the retractor muscles of - the mouth were - -weak 
bilaterally. There was also - weakness of the neck - flexors
and of the proximal muoi.es of the limbs* The upper limb
jerks could not be elicited, but lower limb reflexes 
were normal* There was a suggestion of early ’triple
grooving’ of the tongue*
Case- M6139* The younger sister of MNlW was aged h 
when 1 saw her in'1962* Foetal movernants had been
normal and the - birth uneventful. She 'was an active 
b&by/
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•' ■- <, bahZ/Mib'. '•.&£•• el©V.ehl.YaonfchM' ■ was- •• / :,f "
Wien/ ‘rhq/visited- tim &©y.$X'S-' ?' / ,
;.?' ■•.: HositaX : for -,‘Biok-OhildrenV , MiwgqwV'Xvd'iH 'ier/ sie/tor#.'- .
<•- -a She;iadi nbWon! ?/x'*O Wwlng ./oWwa&Xlowing.' .but?--tondod/ 
’••<.' / tpWveb/pamifppeoch/ wfenn'tiMedW'''- ' . ;- ;; / - ‘ ' , , * • ■
'••■ -oM/jjn;XH-i theretwb ymwbtrba&X/pOoeSewhhich.,'',, '.
/<;• //receded - only/©Xightly/ WL;th Aaobtfamine . (Fi^*<3 $/,’»/_ ■
' ./.fit’; was; Migitly -' iner<We#d by. - ai^eWPWfi:to fr ,.-
/'■ •• • iblffa/'minutb if' iHp&rr \aed\ of - r
o' , ; 'bib .,/eybm.- wore ^greati^S^/red.^e^c^dl'/./; y There - war' wry?/little'- 
. i'•;..-ybi’&tMlTovomorttbher’ Meter's •• / 
MoMfOro•" wan* slight tWoafwJ/of - ‘noafe- flexion /mud "‘the ■ -
■' - ■•‘'■dOXoMSs ;and/,Mpy*/llbxer 'mwles .-ini it; won nob marked/■;.
' •'.; • Upper " l^^:mb*/jerik^eJ;Wex'■qf'Xep.rb^OPoX '- bub .©biers - were./noffol* 
.</'-'.- /// /./Tin- "eiitdi"was muck-’lea©- ./seyerel;?' ;®ffaebod; «//tl«an' •''“..; ■ •
\'-io j/©ss't.oxo 'hntxtier^yas-' Mp^.doubt- thaixsho/’wao.•suffopihg 
?./0' f ;frmW;t{iir'§a#e." condition*/,'" Tie" responsey to' aebMXgmiie. • • 
'■;■/;• wa/evei.lean''impresaivb//-'; ? / '“" ? ';x ■"’ ■'/■//";/ ?•••
o,;f:'.■;■' // WiX«3hfa.nd. ioyti CX9J55) 'aOnwl^^X^e^xv•f/^hiat';mh-•nntt^^^i^]L■ case, 
which Xfiavo deoonibM jO'r^’^Vixusi^^ (oa'lton cf ai> X93X}o©'ay.
%/-'an /example" of -/.<?6^^n^^»3ital\'h^^ast?b<^3^.ia«"; T^<^’'‘/le,^^^ii^^i' M,' o 
diili'^oBo’/^fm-—in Appending ■ B> ' '.■(Note "Ubecfia-o
Of ;tho/ - doubt .'about WieWlaaMflco tioh/oi piilo ' caae/inthSiS.
"it ias - not -"been/ MiMhe Mi tlotip M• '.anaXyMw; in - -%
Mhor PUapteo&i^ - Tiih,.. patient-differocl. from bhooo-'o;-.\ - ,.,
'desQl’’tboX^'/.^?'if^^^eV;inl/ (X^MO,. io iaving" twbfUU&ifotbd aiMcreM
FreiatoX (and' inf on tcio/shabuXur"'' activity ' was normal *
SymmPtOW-t-Ga'ar.pd; W-ibi - 'aiq -,wm& 'i&ged’ 9M0: month© ’/Wion.- boyero' 
gonorMls'M - wwRnoao, dbVeXope& - <^010X10$/ biluirmaX'--ptooi^o* 
.ProMmaX/
Proxlmal muscles’/Of .. tie.;- limbs. ,■ were .'more -affeoted .-than 
dia tai- ones4- '44 A, Ka" r vey ■ZHsland- tost' ffo, myas then! a , -gravis " 
.vw\8':ncOg&t.tuLe4'/xnd;- njoedia'-^electromyography ahqwed- evidence •-. 
pfmyQjj&thy/-' '-4'. /Biopsy' showed -‘minimal; myopathic - chah^^^sV; - 
ho,'- abnoirffiality 46f .carbohydrate 'mefc•aboliim• of imuseie;:-.- •
Oou'Xd ■■ ‘be - detected - ''.to -'.gceohhtif or. ’ the ' wh&kneGs and, there. ' 
dfaa no .change.'. Mpeh' ' '-the’■ b3^oOd4.po^l^f^^3f/^ffi^y^i^J^velL; was 41 ower o d*/ -'y 
Unlike..levin.ip.-. cases.; -thb response to: neostigmine - -was- only 
moderate '«4.y. A. slightly;. better. ' and-.niofe- -sustained- response 
■ foil owed ■ adiinlstration sofsephedfih0 »-4 -Inythese' respec ts. 
iho/syrdrome; bp^re yeriyy'the. ’ . 4 y .. '•- -•
-resemblancees .fp --yaathbhia. - gravis* r ■. - Never thel ess- there - 4
.w&S4;ia veryisbirtking-toi eranc'e-to decimetioniura ’ such/as. : 1 ' 
has4only - been/, '-described - : in. myasthenia grayis - (Churchill—,' 
Davicdsoniand.- Wchax'dson/'; 1952.) - (see, ..Chhpte.^^ -17)*' .-As- will4 
b.ey'aeeA.y'from •,Fif4.-§..$4the .injection "Of ^ecaraethoh'iumyA /,’..- •• 
o awed' -a.; temporary - ., in or eas.ey- ih- /the" -'number of- muse 1 e . 4 fi bres ••
- responding to. - supramaximal stimulation tof - the - ■nerve* .
<■■ : y4y.y--; -The patient - sonni'l'ered.- to'- -have ' a .benigni.- 4...
'econgeitaX’ -' myopathy - ;Wi,hi}:,myasthe.nic4*f'9a’t^ires 4 4 tiam4 ■. 4- 
pertainythat - she .didyhotyiake --my^yati^c^^li^L^.,'g;^.Pv;Lm4Pnc^■,y/\
;,thef eiarei obvious - d:i f f erenc e.s. from 4sevijn,'s (1949 ') - c ases-.
•of-- congenital - -ira"Uienla .but tt^es-siggej^^i^on o- f f/aash-, andl . 
HogtyC 1956)- ^t^ha•<^•.,our4'‘0^^^<-iwPS- related yto Devin*s /.syndrome
. ip/intares ting and. -m^yi-be^^- jiistifie'd* -4y, -y-4 -••••’"- hi*/‘- '
- NcuroMfc-cular -trans mi-ssi on- -- in - .the - infant j • - 4 . ' /
. 4." /■."' .•In/view.'of-the obvious'-clinical- differeno.es between 
'•.dongenitai - Myasth# nia- and aii - types, in .particular- 
.itsssymrne.try. andy tendency -''to .improve,it•wouldbe y 4, 4
inter e'e ting’. to-. consider y whether /there are - any- differences :' 
between' ne^W^;Ssborn - children- and - adults- with - regard to . 
neurdalucuiar/ ,.‘4 4 /- " 4i44y y4’4.yi4-1 4’ '■' 4-,-;4 . y •
neurb'^Bcuiar'-transmission..-- ■ - .,••-;• ■ . 4 ••
r ki sometimes noticed’ . thaV4/4; 4.1.- -, -
hewhdrn infanta tolerate ..’'relatively large dp sea of . \ ,
depc^lat^'iM:gL{.^-r'ro lax&hM ; andi:^y^^\ar^^--yery aenpitiye:' 4,_ ,"(/<. ' ■
; to/4th©4 nonldepolapi Zing ''ficormptitLiLvei ) ‘ • • type 4 (8 tpad $ 1955 - ’ 
jReea.,'. 1959, )’•'‘■"//-In/'thia ‘ Pps^pec1t.'Lt1^.0;',iU£^^^^te4bf/.thu . newborn ■ 
;:Lnfan't; ^^r^^^.pj^l^li^jS;’;that \0f.• iy&abhGihLajgray is i'h4adulte;.-. •/• .'■ 
.(Ghupher .15)4• '•Ch^^3^(^l^hL3^'3^-^p^^^;idi©bn'end -T-iLse(1963)."-have „ .
/studipd//the effect'' of deoamethoninm‘ .iodide bn: newborn 
Infants, ‘many of which' were../premature »; .; They' 'used' the . 
ILhrr^f^U^"*M5ldn<^,d■fc<Lohni<^l^^^, to/study/ the', • ‘ability. of /the'- '' .4 .•
;n'eU'roil^(;lU^^^/■jx^3^<LL:iovLb^bLJ^;^^s^Slft^.^^i.F^" series-pf/impulsGa ,' 4 
at .pates- from‘ 2*3 to. 5®/oecondy4 with ‘.theusual .' precautions 
C&pScT.ibed /'in 'Chapter . -154 4 ' 'Tie ' /-infants - were ‘.lightly ;4 . .
an ae's thetisd'd/ . end •. re.ep’pratioif ‘was as sis ted. » ■ 44 At - twi tc h - , ' 
rates of . .stimulation. .(2>3Z»spo ) the height ‘ of the - action 
potentials'; was.' well /«u stained.,'. .4 ..Tetanic stimulation was ;' ... ■, 
not/well,t^^c)^lJ^T,at^u^^* After. a'period--.of20 seconde the' action 
po ‘teniiais'. had -of-ten;. decrease,d ’ . - to ‘ less than-, halfwtheix’ . ; 4 
‘ original size. 4'/4lh45 /infants.. there .-was;. postytefah'io‘ .. '
.facilitation ' for.- a ‘ f. evi''Secon.de../aUd;/iLt4A. out ;of: 7 .studies’’ 
a -period‘,of4po s t-te tUnic exhaustion. was‘ observed- ’ which 
lasted -up‘-i6*15 m±nutes* . " ;4.4”‘ . . . < ■
•/- 44*4 -■■'■ - .40hrc^^hi3LlD)la.L:^{^£^o'h and/. Wisetconfxp'med- .that''The 44'-// ' . 
.infants;‘..wix*e^‘•relatively ‘tolerant' 'of de0,ariiethonlimi4 . 'since/ the 
‘dose: ‘required -tp. paralyse . 4the . limK'ymuieles-was '4**3.. times 
4the adult dose . when calculated. oh :,a ‘'’whighi. basis. When
the nerve .. was/.tetaniBe<d 4a dec remen tingires'ponse. was * 4 ,4- ' . 
- Obtained-: .with 4 pbs'tltp/fcahic /facilitation, /—■; The ' decneaent .; ; - ■ 
/wae/noted‘/even/at/ sio.w,4ra'tea. of stimulation ‘ (2♦5/seo),- ;' -
resembling/ 1 "•’■ . -: ■/ .4,.. ' . 4/4 .-//'/’ - ‘ -
rosornblinM^fi^h^P- effpct -of,‘ a. i/compeiitiw*• ■btockihy’f ,5'"•<' 
substance iny-the':adult.:' yb. further*' resemblance' ws that*. ■' 
Hie nnuromiScular^bloclpt Caused .ini iho infant'' by,. ...... /.. ■' ■.:-
docamethorium- was'always' /re,vepsed'\to sorie extent by.the ' 
ih’ipctpxRxi of/heoMi'gn&heVhh-ii-ryi' t t'n-'f f-t . •' -
i;i h-■ /,t Tbcp'<ppj3©;^.hl^‘e^rne.cli£i3i:l£3n3£^-' iuyolvod in the v-' • / ./, ... ■
1 myaslhcnib■.responspp.will' iHb'diCciiisood in Chapter >16' '-,
bu tr- at --'this stage! it need; Ohly : be said-' that ': the? abo ve;L . 
.find in gay are. cpBipatiblG;:vn,th $'/..(i).-p ■ .
•exhaustion-:' of-acetylcholine; production:at motoi*. nerve , 
terminals r:e(ii) a difference1’ 'between the; 'infant .and -the \ 
adult- endf-plate.;receptors,y. fiii^ .a ' circulating* .substance.,. 
whicii can,- compete /with' acetylcholine; receptors?,-.-.The ' r
third ^hypothesis ' h&sfm&ny/point^ ■ in/tin favour in true •< 
my as.thehia..‘gravis • '-'and dparticu larly.. inf Heonaial • Myas the'nia.• 
Ib mloes . not /seem ’ ilfcp'ly 'that' this mechanism could '''account. \ 
£prf the'-loti isafe ty» fac ip r-i'fcx^s^usnii^aiCio'n;in ‘ th o- -;n,;;;•' \ :J 
newborn.!' ;;-,zA,j3ui?gas^'^.on' by Keynes. (199A)':' that the thymus' - : 
might-, produce - such .ra<--Sub$tance; to inhibit,' foetal movement 
cannot ‘be•/ talc on seriously/'' li"i£f much', raore/iikely' that ■ ' \ 
the. safeiy^faetor is lower in -..the neonatal -period',-because. 
o;f ,:l/nmiaturi.ty\of\'tiie'- lov/ex’' motor neurone or' relative' :
.inadequacy Of vtlie-i^^titio/,'of ..pre* synaptic: .to'post^syuapiie... 
membrane- as ti/jmonstsi^'atedfin '•-foetal'* rats 5 by;J)i^i?ioiid. -and < i..: 
Miledi '(l'9&2)v'Weso- auilidi’’s.'' showed . tlialb1 the'' receptor' " \. . 
surface, V7os adequately..sensitive to acetylcholine but 
was""spread over, a, '^^ar g^'.lix^jca'uf-'’the-• muscle .fibre." .v\Me. ' , 
chemO-sensitivity bf* fh 'ey embryonic - rat muscle fibres/was ,, 
similar to -that: of ': re-innerVated .muscle' (Miledi^ I9601# 
/•-yl'. post~sy»aptic factors may' be ■ ■ ' - f 4 '
prqsentf since there is ’ eyid'ence / to show that the maturation
of Lie mi bcle '''.fibre '-ari#},par ticuiarly-- Of; . t be ' eid^-pate ■ ' ' 
regdpa depends, bn -a :.fabto>r;/reXeabed by ,-the mwe !"' --r / / ' 
endingsy/y ■' /WhoLien phis- fa-torpid<acetylcholine (which f 
is,' ^liberated 'spontaneously' in small ,-an^ountje ), or an ■■ ' . , < . 
uniden tiffed ■- subs tanc e /.'i b -/unknown; ■ -a,b ■■■the ' ' tiac .- o f, wri ting - , 
'(Miibiip1-962 )'♦• •„ 4: '.fbac.eiy ' . the same ' ’kiiLf f-iculty? arises ' - - ■' ■ 
wi th/ r egar d t o'. ' th e - •tr,ansmi's si on f allure , in myasthenia- " ' 
.ggayis and,ibt -is'' 'quite' 'pose ible - there is botlfa ' ; t /
pre-synaptic" and - "a/posi-synaptic. t defect, in 'that/dis ease . / 
(Chapter;'.!6)i /'. • .y , ' \'r-- L? ?•:• •py-’lLy"
■ The physiological work just reviewed refers' to 
the normal /infant »'•••'<"- 11 .requires' little -' straining of the, - 
facts to. 'postulate' fhai' <f allure; of -• normal maturation; y- •' 
could '"occur as, a :here d-itary -^ahhbrumli ty *;'- "‘The- symmetry, /
.0 f-di'atrihu tion, ybbs'eic e ; -o' f - -remiss!ons- andy tendency/ to - 
•improve- in - .later, -/life ' .suggest /that Congenital; Myaathenia - 
tay.-W dhe . to-a ' matura-bion' failure .'of"- thisitype,.:.- ''.This -" 
conccptewouldrplacb:, - Congenital Myasthenia closer - to -the - 
condition knoWn as -'' Benign - of. --in fancy.
(as suggested -by Walsh aid' Hoyt - ,yi9'$.6) -: thanftbimyasthexiia 
gg.&yls* 4 ' i - believe that this is ‘ its - /true"' nosological 
positlon'i /.J; "ft '■ . •' ,■ /■ . • 1 '' ■
;MW¥HmC' SYNDMOS.;.
// :i//44, For .'the pnrpoqes of - thin/'thesis'.,' in Which- ' it - 
was required to, show that disorders other - than 
neuromns.huiar , could 'oo~'<&Kisfc with , myaathenia gravis,-' ■ 
it - was' -necessary- - to 'use' 0trict- diagnostic criteria' ' : 
which ' wduidbe'- acc eptabi'e - to - all - workers, in the , field *
These - were*'
■ i.) .'There must’ be - demonstrable weakness of nmucl.es 
• ; . which -increased ’ with maintained or- repeated
■4' . contraction-"and/decreased-‘with rest* •• .-Here’-\-
. h\ tiredness , or ; a_ complaint of •fatigiiablXity* •••was
ahot considered adequate . *
.-- ii) 'There-must'be a olear*cut..seoponse to
’-<••/'•' drugs such as - edrophonium?
'/ f 'Y /' 'bif'neostlgmine., ..rn' '• ' ■
N^ntl&rainhereslstant , muscle. •disgajse,.n--" ,
/;■•••" It -.is not’ intended ’ .here to enter - the debate on
the ''.validity- of - the/secend c ri.e'erooh';-whic h/has - recently 
been discussed -by’ Rowland ’ et- al (195$.) -but it is now’ 
necessary to examine some cases which have proved 
difficult to - classify- because of inadequacy of thC- Y/ 
response to /a --therapeutic /tess#< / ' , 4/ / - 44..' . - /Y f . • \
•*; y - /In .Chapter 8 ■ - Shed , Appendix /ig I -have described - a
patient - as a case of •Beni.gn
Congenital -• Myopathy’ Features * which was
conSidcred - , "to •• be in - s -. bord eiland -of - myopathy - and 
Myas thehiaYCWal ton ’ et al, ?'195(5). : In-the following^- Y, 
cases there werc features strongly - suggestive bf 
myasthenia--gravis ’but the dia'ghosis was - not - considered 







444 ' Y ;yy4. ■■ r .. */ "4/
BuffielehtXy v«sXX ,egMa>i£sh«ex: • for ie.c.Wur.ion .in the maim, - ■- .’ ; 
soeioie- • '/ ’• : ;///"/4;/. «' •. •/ ■ /■ .4• « •.. . _• • '4
'A • '••QaAq38$,.• aged 35, this" woman who • •’.•; ; .
?yy-hadrhmd.a yypamlaatlksee ... •/ ' ;’.5;«. • '•'••
'•4 \by X.'ief aided pptoiie /Ci .. •• -4 '•
•«. ;4-:ftho'h©xt?'>;^yeatW4 aho; doyeXoped eomppe.be « - •• ' • '
■; 44;ii®toraX.%xtraOotfXar«0p8ha&XmDpXegi&*; «In 1954 *• ,. ' ’
/ .Iher'YMn -We. imoint, fn'geraitromtXpUo ;OW pula'© ' ■-. ■'
' Yrate4Xp3“XW«minu$e, She Jmdv oo'caeionaX ♦rheumatic• •'
:. 4 'ppinsJ -in',her'«kneee?r ■'Wd4 ShWU^eWa* / . Anadteiodine • ' ,_„v 
: 44 tastiabiMisbdrgh RoylVafirmary ahowM •-.'••' , '" /;-
; - ; "thyroib.oooia,' -•• /•his• ■'subsided; after treatment'-.-nt 1 year . 
; • '.;3 •v^Wt^liY.t^i^c^s^u^ra^A.X#.' ’AxA.A , . ,. . ,,/; ■-/',/■ / ' -
\ ./4/:'/Xn 195/; abC developed frthhitia of ;eMSUmtt»i& ' .' ' .4
• /44 typy.'thanhs'/Wigi 9i3.)i- wX©'-©'.^', elbow*' ■
4- '■ ,Xm-^SOohhxexw^he^ga •o aebh-'and,eC^hv^li^/.becs4aie. .
/-..< ;-wwO£?’-'g<^5sr«.t^-^su^<or'ti. her• .’aw-aind head with; ■••..-: ;
• , (Mgp 9td)* /Her-Voice.,• became weak mid• all/ ■' • . 
■"/x-iimba became o&ieoGivvXy tired, '.©aepeiaXXy proMm&XXy'' , . .
4. ♦ •■ ■. ■ 'a(WrtW«$©;.•$&©. 8S'<^kelm•••-•• '•/« «■ ■'« .-■'
>; ;,4; penOraX" H^S^^^^tt^all4^^>s^^8lay^>-••,^^f^O«^Pinc^<^3r^^he’..care-a""’ /. ' ' ' -
4« j»«B)f^-?.,St£^?^^on'd?<?m^niiso Of fiiffi^onXtsy in awslJ.owiin%* ‘ ' '
.4 ■ At 'thha^tma©;• ©tse.’.aiao ,of ■rreroatera&X ' •,_
: 4 ♦bightmea© *«r4 .• She _wa4^h'eathhpae On 'plight; «©©toMon ' . ■ 4 
-._• YOhd '•fad'•podema hoi/ajn&eo in' the'-evenings*• « 4«-' 44/ 4 / ■
•//4/ ; \©h:o 'hadippaPia©^, . of' •the e3©3C^wa"■pe:^^;Q£^y^^1^^o^ma -'and '•■' . ' 
/"... 4j^©c^jli^i|'g;-p^f-Y/'i^cr.;|pMmar,«awrfae- e 40f ' -'the •'hand PMg/'PiX) • .
’••••■; Her ..tongue' '..phdvod;4tripX©' gre■oV:^a^|«4any4S^Il^.^'had 4 .r, .-; .; 4, , ,4 
.4 / ’04phenomenon « /!y;|".- '•' ' 4. 4'4 >•• / ' ' i ■ ; 4 4; -' • ■.
/.• ,|•4;4'4,4; in • #11 "reepeets the ' pietoro- wo ome of ' ? 4 444•• ',.• 4•;
-4 . •"imyi^^lthemLfii; gravis commPieabed• by • • pro^:^s,oua thyrotoxicosia /1 






♦rimamatoid♦ .arthritis, end- psoriasis* ”I. examined,
■■' her bj ©l©©tonmlog^aphy and found a myoitio •
.pattern in the muscles of' 'the right 'arm# There
was no evidence of pathological fatlguabiiity with.
-We , Harvey-**Mal and teat but an incrementing response 
was obtained .(Chaptor 33)» She- showed resistance to 
‘ paralysis by decamethnnium in the relatively • ■ -
•unaffected muscles of her hands but when weakness .
appeared -the response to a slow tetanus became ‘
, j-decramentaX- • although -it- wap- -still - incremental with 
. .'stimulation faster, than16/sec* , . 'The , results -of ' .
these tests were ih'koe,piig with, a- diagnosis'-, of ■ . ■ 
.ffiylathenia .gravis but there .was no rpsapiap to -
repeated. injeetoons-’of' edrophonium or to neostigmine ' 
by, injection or.-by mouth# -■ /.?-• \ '- ' .
p glucose tolerance.teat was normal; serum • 
proteins were 7#25g/X00ml# with - an electrophoretic '
' pattern showing -a--.-.slight increase-of the- gammaglobulin 
fraction# The ceahaXin?*ohpXe©te^ol .flocculation -
test was positive- (4), thymol■turbidity 5 ’units*./.
• •’'Serum cholesterol was 350mg/X<OmX# There ’ was .gross
vcreatinuria# Serum electrolytes -were normal-and-- •
the urinary. output of X?*hyhldryclpPic0^stee©ids' was '
• '8#5mg# in ah hours# ' Tie peripheral blood- picture ’
was normal and no'.antinuclear factor -or L#E# cells
were found*. .There -wa© a positive sensitised sheop*
.• coll ’toot (l/iX^S>* The ' Wassermann reaction was -
••niggtive in - blood and 0#B.PM the latter being . . 
•normal in other rnapects# . / - . . .
A diagnosis of.,'tpol;myo©itis* was made and .she •• •• 
was treated with prednisolone# This made no obvious
•difference/ ' ' ' • • ..
:4 ; •• ' : / 44.;4 13W’; ■ g > ' *' "
■. On 7:7 s6q she choked and did not 
respond; -'to. hronchoseopy and resuscitative measures#
'4?/ - 4 Autopsy ;by Dr* ""AiF. J.- Ma3^_oney;.-£^l^h^vwe^\;,ss^i^v^3re .-' .. •;.••;•/ 
•myyoitis "* with . foeal - necrosis" and . infiltration by 
lymphocytes $ plasma /cello - and histiocytes. - Some ■
small nerves in ''severely-'damageed'muee3.es showed 
partial demyelination and endoneural, fibrosis* / /
Some peripheral nerve trunks also showed cellular 
infiltration. The central nervous, system was
normal, ^pVTibre ".Was '.no •. vasculitis. .'/The /thyroid,’'*; *
gland , was hypertrophied (BOgnr), and- slightly - nodular. 
Other endocrine' -glands were /normal*? ' Tie thymus' was 
not . identified. The "spleen. ‘Was" congested and ,
slightly large ('20'0gm) . but ".Was not histologically 
"abporm&l*" ; , 4;, /■ . ' •.• • ,. 4 . '4 ,, '■ _ . 4 ; •'• •- ■■ " 4
The ' final diagnosis"in ., this: case was (polymyositis 
Offunknown " origin •* ? " dermatomyooitis* but if she ' had 
responded-to anticholinesterase- drug© she would, 
undoubtedly have " been accepted as a case - of myasthenia, 
/gravis. ' ' ' ' .'4r"v " 4-;4; '4- ' '-4: 4 '= 4 ,
Case -/HHll?*)* -Wile' in hospital for treatment of. ,
peptic ulcer in. l95l a doctor ' noticed' that this ' man, 
-•■th©!.'^'*^ 22,4had•'■ilateral ptosis' *.i - This " was ? 4/ 4. , 
/progressive*/ ' • ' XtyneVe?-. '.•remitted . but /seemed , worse. ;at.4 
•night* His "' father- and/ brother; Were- said to have . ptosis 
4 Examination ' revealed unsuspected weakness of
biceps and triceps muscles - of ■" both 'arms and of the 4 
hamstring musclesief •, both" legs.- AH" reflexes . .Were
brisk - and - sensation":was./nopmal*' He acdiitted ' that
' his" voice tended - to tire when - talking for long- periods.
. - My ' original ' diagnosis of'm5x1stheu.ia., gravis seemed 
untenable/ ; 4*4 : 4 4 444 A ' ,.7?,v ' 4 • 44 ' ' '4 ‘4:
- '<44, s4; 4-135* 4444*4. •> 4 / . ; 4 ' .
% .• <ntenable-when .--to wosM^Xne .
. 44 and- -the 4pp@©lbXe; faily hie lory : suggested- the t /he = 4 - ' 
),;>4 "had.: oouXf^r' imtecuUei^.4/4 Oh Omiesicm .$© the ' - 
■ / 4.;^o^thera,-■■General- - Hospital"he 'wa' •TouMt 'to --, ■' - ”• ’ ’ 
4 44hay@.hypertension/tho4 .- 
\4- 4hioo&' pressure;•'s*©ee>j?<d<^c^. • In '19i53 ws X^/Sbrnratlg*. '.. 4 \
4''; 4 <"Bp®itjine'. oatweiiavsharp ?.te>p' Irn the "MasWile.- pfoshurp - ; 
'- -4-4b6t •-the .'$yet<^jl1<s4.prp0G^irq  -rose hy4X0aa* ..'Ao -ho had _
-; ' '-rPhehtly '; complained ..of - paln-'1% - the, ‘- loft - 4flenM he -wae ' . 
4',:,';?','tr^f^n3f^frr5?o&’- tjo4ea'''urciXogieiaiumil't^'-' for'further '.; 4, , • •
" 4'; ' c Xh vea ligation« 4. - WXXm<hg': relrogrMe - ;ohth© tor .lo atlpn " 
444' 'f thio'ureters ’he- ^Xot /xnur’,!©.,.- . - This'- wae'4 ' ‘
- ' 44 suocee#fully -relieved hut; lie .-.'died- suddenly on ..the -4- '
4f$iipM'W4d%y< 4-4...... ’4'-‘ -4'":;'4:; ■ •; ' ■''4,- • - %• '4 *4.-4. ..
4- • 4.4/4'&ut6>oy-' 'C$ri?lit4Me3e&»)'■ revealed ' he’.eons©- for '
>•4'. .-.the- hypertehsioh444Bw attsdl'es - we -praXo @&imo»**pin!£ ■ ..
■ /ihvdpienr •4?ahd4oh'\hibtoXogloaX-exa^ljiat:toh-;"BBic^1^w"d ' 4' 4,- \ ■; ' 
, 4;;:i5"<iil<leph^:llje\;eWjlj^:^^i^^.'Of--the' 'saartsoplaea ' vilh wnom&oXoar -
-4'- < Xancopyhlh"" foaoMPn'..-./ -'There4W proll f eralien' .e£4tfce- .4 
'4 *'4- shroeXmaa&X'-huelei• 4- v &' YliPghpeisi W ,3 auoeulor- ;dyatrophy 
.- - " ‘ 4 was ■• 11 Pfe@rved4 lhta'1 ‘the - thwhah <iO*2gm) .
.4 4. ohpWed Vr.otarrcled involution’’-# ■ .• ■■ ;.- • - •' .. 4..'"' • '. 
4'-44 ,.■ •• The’ eXinipaX and pathologicaX;findInga ..are ' . 4.. '
• 44 pf -/a'dia/pxooio -<Or mzaelhPnlav^&vls
; 44-in every ; respwotc"ehe opt 4fc.&0 • £a41ur0-“ to respond - W—-'’ •• <. . 
444^pa£Xg«ineir4 4 ■••■ '. -4 '•-.; ' " • ' ' . •' ’. 4\‘-?-' 4
• 44; '■ - - ./The., -Wo' oaoeaf 'cited are row eaentatiy© ' of' five - or ',.
e&K'Peeh;'a1;x"^lao" Northern'-GerepE^ BoapitaX- in* the'Xaot 4- ,
eight' ‘yeara-and• prPyXMpn&XXy4 dXhgheaed '’p©; *peXymaool" '4'’• 
hp&aiipe -of the;. MolPXeglcaX ehangees. In pho wooXop • and- 
tjfce.-ahoenpo of- rc^rmse- 4to- -odrophpnitw or nooatXgftiXnw* '
•$0pe/' 444444 4 4 . -4.4' _ • . 4.; 4-..
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©o.rne have had a slight decrementing • response to ’ the Harvey- 
Maslan&.test but .‘.'more• often they ’.have shown . a. -’reverse 
myaethenicti . incrementing response • of. muscle ae is 
described in Case MN?S* This reaction • will be discussed
\frQU the electopmyographic point of -.view. in . Chapter 15*
It indicates that some uusoTe fibres • are,not recruited in 
tvdtch contractions but only .when the . acetylcholine. ‘ 
released ''"by. the .nerve- '.terminals ia increased by .tetanic 
stimulation... I . have found if to be a-. regular' feature of
many -cases -of polymyositis, (arnddm --the.Y burned -out* ’ stage ■ 
of '.myasthenia. gravis. , f .similarpheenomerion may also be . 
found in clinically unaffected muscles in. myasthenia’ gravis 
XSimpson. and henman*.. 1959f ©impspn, lOfiOa). It differs.
only iu degree from. the phenomena considered<by ’ bthor 
authors to .be. ,diugntotlc,ofeCrccnnomateus-• myasthenia.
-OasSLSSSyth is an . interesting case of polymyoostis ,
• under’ the observation of . ir« i*B* Stanton-at the
'VI/orihern' bal*ai.nc o-1956* ■ Meekness
started -it . the. pelvic girdle and spread to the 
diaphragm ’ap'd . upper., limbs* Apart from ' slight
weakness of ’ the . right side of the face the . cranial 
muscles are unaffected* -PoMer . ha's; improved in each
of two pregnancies' but otherwise there has . been . no
. b remission and no variability throughout ’ the. day*
There’ has .been to response to edrophonium or. r
- neostigmine at -.any .stage* Muscle contraction•
sometimes develops ’ in a remarkable. slow . fashion ’ 
described by Simpson and. Lemmat (1959)#. The Harvey*
. Masland ’ tost shows ’a ’ slight ' twmoathente♦ reaction with
slow . .’stimulation.; and progressive increase ’ in .the 
evoked action . -potential with fast rates . (M.g* 9»D*
. . 'The/; ' t < . / ' ’ . ■ .'-J'-" , • ■
, ;:The' - slow recruitment of .voluntary 'muscle contraction -
seemed .to be of 'the s^me nature*;. , '. - ’
' - The 'Cause of the' muscular disease is -unknown*,. ■
©ie 'has a slight.non-toxic goitre but certainly'does
" ' ' not have - myasthenia' gravis*, ' 4 ' . •' ' ' ' ' ■
.-.'The;' nosological - position of poiymyooitis is
. debatable but,; following -the usage - of Walton and Adams '
(1958) - the - term is limited to. an acquired, myopathy ,
'without- recognisable lesion of the skin which-may - appear 
in acute, aubacutej-, and chronic - forms dnd is related to - 
the - connective tissue ' dis,eases - such as - dormatomyooitis, 
arteritis -and to -malignant 'disease*, '• Infective and 
ondocrina'i forms of - acquired myopathy - are- • excluded*, - 
' Polymyositis, with or - without 'dermali'tis1,.--is
Sometimes - associated - with a -myasthenic - type of weakness -
which may - be responsive, to edrophonium or - neostigmine
, (Benodek,- 1944; Christenson and Levison,- 1950;;'- Hagan,. 1950; 
Reese and -Harman,. 1954.; Walton and Adams, '1958 )♦. in
most of-the reported eaits'the decrementing type of 
weakness -has -been transient or the response to’neostigmine 
has not - been maintained after the first few dosqa (Fig* - 9*5) 
(van Bogacrt and - XRadermecker, 1954; - Eaton, 1954; Bonduelle, 
Bouygues ' and-Goulon, -1955; Coera, 195.6)* In some of
these cases the diagnosis has been changed on many' 
occasions from aeryatoIny.oo±tis to myaathenia gravis and 
back again* The' ' true classification still pei’plexes-
the- experts' (Rowland'et al, - 1958)*- '
Systemic IjUpps Sryi^iiematosus: . ■ .
A similar.-muscular weakness responding to
neostigmine . has been reported in systemic.lupus■ 
erythematosus (Harvey et al, 1954; Rowland 1955)» In
58,
one of the' cases' 'reported. by -Simpson ' • (1960a) (OK/ES 
Chapter ?)' L*E. cells --were found " in'the blood" 'of' 5a 
.case of ('typical4 ' myasthenia* ' ' .. ' .
...• ' These observations have " previously been • :
considered to ' indicate that ’symptomatic myasthenia’ 
may exist itfiich1 simulates•. ’true’ gravis.
Rowland (1955) • and- Rowland,ot al " (1958) discuss the 
quandary-which'may  • exist when typical' myasthenia gravis 
is ' shown to have • the., histological' lesions of 
inturstitial' myosstis• which are '.described' in Chapti' 11* 
They: label • those cases as 'myasthenia gravis with -
poiymyooitis * but confess .that . there ' are. no clinical' .
criteria which' difforentiaee./these patients. from ordinary 
myasthenia* ' When it is further considered that
poIy}ily0oitii may be -associated’ with ' a thymoma (BonduuHe, 
Bordet et al, 1955» ' .Maier et al, 1957-), that Hashimoto.’s 
disease, may be; associated ' withdo^mato^m0o'itis and with 
rheumatoid " arthritis' (Sharvill 1958), and that the
■ Raynaud phenomenon and other .disorders which I'have', 
associated, vith myasthenia' gravis -(Simpson, 1960a) arc' 
also 'common in the' whole group of connective tissue 
diseases ' including' •polyfliyo0'iii‘i,- it can only be concluded 
that there is ' ' a vide' spectrum " of closely related tissue 
reactions. The predominance of one or other clinical
pattern ' may_ permit a ’disease’ to be recognised, bait the 
frequent overlap'is no longer surprising. ■
Experimental'' ..myaa.jthenic syhdrqffle:
’• Mankowski (19&5) has recently reported on the
effects of injection; of"the yeast Candida albicans into 
the spleen of rate. In most cases 'no disseminated 
infection occurred "but "many' of the animals, developed ' 
neoplastic/ .
•>'- . a . y-; ; •' < ■
' neoplastic/ .conditions• or - a • variety of connective .'tissue 
disorders' /thought • to^ resemble -'human dermatornyosltis,
, scleroderma and poiPil^^j^^'teipS./bis nodosa, . Three rats '
showed muscular ' weakness ■which ' improved with,injection
, of•neostigminee/ . / ' The' author- /describes.them as having
'♦myasthenia 1grav3;s.lr./,. ,-lt qeom8.,io’e:,.probable- that the
, condition gof- these. rats Is more. '.like?.the myasthenia of •
"■ . human dermatomyositis*; • W5,yerthe3^'ess/;the;-;.^3r<^^^l^€^c^t</j6f '
having an .experimental ,135^0^10:0^ preparation to 
investigate is-.moat. exciting . particularly ,sine.e<it.t's ■■.
. '- causation ■'appears '' ' toehe.' due • .to;-a, disorder ,of .the, ■ • .,
■ ‘ reticuloendothelial.'system* ' '-a .- ' .• - -
CarcinoiatOuS-iy^SthenLa / ' '• ' •' '' ' ' ■•• ‘ ,
, ■ -'-;• / - in'/view■..Of: the' definite though'-Unexplaihedp •■■- ■
.. ‘"•rel'ati'6nshij) boiwo'en• ■sd'e’rmo^l^<^myos:^^tt^jBiand:»o.p3^i^^i^ii^///.
-./: " (Walton -and Adams, • 1958)' it is' not„ surprising- to find■ •' '
- - .occaalonar cases of a ‘:m^^g^g^1:h'e'nic syndrome associated • with
...-p- neoplasm in s^me-,.c>2?^gan* This wa's first---reported ’by /
•-'</ •- Anderson, ot al/(l9$5').«.; •.■/'These • authors described -a-.. 'man• , .
.. aged WW with•progressive • ’muscular • weakness and transient • 
-id diplopia*-••.". Wealuiess' did not • increase with maintained,
' contraction, of -the/muscles; and '•myasthenia, was apparently•
ho ti-considered• in the ' first ‘instance. After radiography •
of -the• • chest and • broi'chda'cOpy he'/was found to have a 
bronchial neoplasm.'When'anaesthetised for bronchoscopy
. he • • was given /emccinylehoXIne, • & relaxant drug 'of • ■■ •
depolai’isiri©• type* fhexre • was prolonged apnoea following
/ this', and olectx’odi^aghos^/tic • tests revealed considerable 
neuromuscular•block* , Blood' chollnestera0e levels wore 
normal, '/Oh;’, testing' 'the effect of another depolarising
■-••drug, .'decamethonium• by; the.' technique introduced ' by-two of 
/the/'/'-; - , ;• / - 5. ’• 5.4 " :
34 oy
the authors (Chapter 17) the - changes 'typical of - .
myasthenia' gi’avis were-noted. .. . 'Addmn'ietration of 
'neostigmine then improved 'skeletal muscle power. This
paper" immediately produced 'a- /number of 'letters to the" 
Lancet describing similar cases in• some - of; -which the.. 
weakness" increased with, continuous use of * the- affected 
muscles.- ' '■ '■ .4 .•••?..• .4- ■ .
1n • the -same/year Henson (195/3), reporting on 
mo tor •• neuropathy and myopathy associated . with eareixioma 
of the -'bronchus, noted - that some ' of the patients had, a , 
histox?y of muscular - fatiguability- suggestive of myasthenia 
and these v^iro further reported by; Henson- et al (1954) and 
Brain and - Henson (1953). - In the latter paper, three of 
the - fifteen - women - with carcinomatous"aieurcmyopathy (not 
all myysthe'riic-) had‘unexplained myxoedema. - Charnmbrlain' 
and Whitaker (1965) x*eporting an association between 
Hashimoto’s disease, dermatomyositis and ovarian carcinoma- 
suggest that their- experience might .offer an explanation 
for the myxoed'ema- noted by Bxa/in and Henson (3.958)*' This
interesting suggestion should- be - confirmed as - it wou.3.d ■ 
support " the proposition - that - carcinomatous myyethonia is 
related to the 'non-rnaaignant - autoimmune -diseases. Walton
and Adams (195o) already accept carcinomatous .myopathy as 
a variant of polyrnmositis. Tumour antigens have boon
ieiineti*attd in the serum of - patients With various 
neoplastic diseases and have - been shown to bo - capable of 
provoking "" the formation " of antibodies of cix-culating type
1958;- Curtis et al, 1961)* References to the 
, rapidly expanding literature" are provided by Row3.and et 
al (1958).
. Fui-ther experience has shown" differences between
carcinomatous/
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carciuoffiatoue' ayaathenia and, classical niyaa thenia- gravis*
The h"oBfcigaine response is less satisfactory and tends 
to- disappear ae the- .disease, progresses*. , The- extraocular 
and - bulbar - auscles are less frequently - and loss • , 
severely affected in - carcinoraatous ayaathenia and the 
tendon-jorks, - especially of the lower. - lirabs, are . 
depressed or absent '(Croft, 1958)* The-latter - ‘
phenornonon - is . strikingly- different - frora/the state of 
the reflexes in true ayaathenia gravis# In - that
condition they are usually present and cornraonly- very
brisk - .CSLa^JE^.o.n., 196,0a). This - clinical point led -to the 
.diagnosis- of bronchial cai’cinorna in the following case.
. , Case MN531* /This 48 year old woosh was - referred
- CiJ ftJ*. MU WTM1 w LWj . . - - * • , •
to ae at the Northern General Hospital as a case of
. ••irnyaathenia- gravis, clue to - a - thynooa (Fig, 9^6). - She
. had- been well until six rnontha '-previously when -she 
was - of-.difficulty - With swallo wingo . Soon after
this her left leg and then-her right leg becaae weak.
At about the ssae tiae she found - that she was unable 
to apply - any pressure- with her - right hand. Tiere
. was -little variation in -her strength-during.the-day .
but -she thought -it - possible that it was worse,, in -the 
evening. Shortly before adaission she had - increased
difficulty in swallowing, slurring of. speech and- 
weakness of the nock Gaud shoulder auscles. She had
. never noticed ptosis, diplopia or - weakness of the 
, face. - Although she- -had responded -to neostigolne in
the ref erring ..hospital this ha&.becooe less satisfactory. 
On ex'anination,- she had rather drooping - eyelids
but no -fatiguability♦ was deaenstrated. There -was 
wetness of the neck and prox-iinal - aucles of the 
■ Habs but,- unlike ayasthenia gravis,- this was greatest -
' .in/ , . . . .
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in the -lower - - limbs -which wore w^«^-Ked, ■ AH tendon - ■ . 
jerks "were severely depressed, Electromyography
showed the response described below,- Since these
clinical and electrical features pointed to a . 
carcinomatous iya'aihenil the ■ •'thyioia‘was re-examined 
■ by,tomography and found to consist of- -a -mass of glands .
. which:were compressing' and.invading the right main ' '
bronchus* Bronc zioseopxc biopsy - showed - . that the
. lesion was a bronchial carcinoma,.. No L,E, cells or 
A.N.F, -were found in the serum, ' Protein-bound- iodine
: level was ,$.£^g%$'!the " protein" level was ?*-5g/100ml*
and. electrophoresis showed slight excess of beta- •
. globulin, Cephualn-choocaterol flocculation -was
negative but the thymol turbidity test, gave " 6.-units,
• Serum- G,P, and -G*O, -transaminases/were' -each' 11 units 
.’•'/and- serum aldolase 9 *units/rmL, which "are normal
findings* 'The. E.G.H*- was no.rmd (13mm, in the -first
hour,..Westergren)* ,
Case , HNNQQpt* This 4? year old woman .was ldmitted to 
the of,Thoracio Surgery, Edinburgh Royal
Infirmary in January, 1963 with " an .anaplastic 
carcinoma of the mediastinum. Mx. - JD* Wade,
considered that it could not be removed when he 
examined it at thoracotomy* Uve months previously
rshe had noticed that her legs felt - ‘heavy* and a 
little; later she - had" difficulty washing h'eiv face*
She had double vision on a few occasions but had not 
observed ptosis or difficulty in swallowing. In January, 
1963 slight - bilateral ptosis developod - after looking 
upwards for 1-J minutes* Jaw - -muse!os _ wore .fatigiable,-
AH/ : .
1^0*
AH ‘upper limb and • trunk 'muscles showed progressive 
loss of power bn attempted contraction, and there was 
practically•no -voluntary power in the • lower limbs* The 
knee and ankle jorks were absent and the upper limb 
jbrks • depressed. There wh's no response to edrophonium;
or neostigmine*
Plasma protein content’was 7»0g/10Gml. The
electrophoretic curve was within normal limits 
(? • slight elevation of alpph 2 glootilin). Thymol 
turbidity was 3 units. The E.S.R. was.’27 ’mils* In
the first hour (Weeteirgren)* ' The protein-bound 
iodine contexit of the serum was B.l.g/lOOml* but a 
radioiodine''test.of -thyroid function was normal.
The•blood-picture was normal aaart from.6% of ■ '
eosinophils* No ' IaE. cells were seen and', no
antibodies against .thyroid, stomach ox* liver were 
detected (Dr. MJ. ' Irvine)*' ■ .
' She ’ died ■one-'month 'later*' No autopsy was obtained.
Electromyography in this patient showed ‘myopathic’ 
units in all the muscles tested. •--When the ulnar 
nerve was stimulated at a slow rate • (^•i'/see), a.
Imyasfchenic fade' was seen, ' Easter stimulation (.//sec)
caused an initial decrement followed by progressive 
increment until the evoked muscular action potential 
was IfOO above its original level. On returning' to .
slow rates of stimulation the decrementing 'myasthenic* 
response reappeared• (Fig*,9,7). .
Case~I.8280. This•34 year old woman provided a
difficult diagnostic problem. IVen admitted to
Edinburgh 'Royal ' infirmary in October 1963 under the 
care/
iw.;
' care of' Dr$ Hamilton 'she ' -gave1 a history' of .- : '
steadily progressive', wc.ak.ness ' of the ‘3.ower' limbs.
' beginning five-months earlier. • ' Soon afterwards'.-the "
‘ .upper• limbs ' 'became weak • and clumsy-' ahd two' months ‘ •
. . after the' onset..she had .• attack's of vertigo. blnrred • -
vision' -and intermittent'’ dipl^opi^a^. Relatives noted '•
, . that. her 'left eyelid was• droopin'^ Two years •• ' ■ ■
. -..earlier- her' mother 'had died;bf a' similar' illness ,
. after 20 ..years of ' disability. . Both were- considered 
- .’tovlhave' disseminated 'Sderooisrn .Tie' diagnosis .was .
supported 'by ' evidence of a't&xia "arid equivocal .'bn-t; 
•'probably: extensor ' plantar reflexes. • '/Ptosis was.' .
attributed, to a'recovering'Horncrfe syndrome, A slight 
- -.’."/opacity ah tthe 'apex of the left lung, wase&llifled and
. considered to' 'be ' tuberculous■ and ^a ..right 'hilar shadow 
. -/was interpreted in -'the ' seme way. ‘ -
1 :'■ In’-May l^^.she' 'was,:x’eadiit■ted with profound .
generalised weakness and wasifng?•'biiater&l,ptos±s , t 
and absent ^e'ndonhref loses. ' fl'antar8 responses-wore '"
' ' - still ' extensor' from .the lateraXbboxdex’h of ' the ' feet
. and- she had ' scanning dysarthria and .nystagmus in all 
.dil’ec"tioni• Injection of '.edrophoniuin.inchpased'the .
.'--.'time'for which 'she couldhold out her left arm -from ''
... '23 seconds, to five 'minutes and 50 seconds! The' chest
, radiograph. now showed an obvious .bronchial- earcinoiTia,
< 1' saw 'her in consultation at .that ‘time and agreed' with '
Dr. Hamilton,'that she' had cpirc inomatous neuropathy of - 
• . .central' and '■neuio.muBcular types. - -. : ■ ■
' At ‘the-. Northern General ■. Hospital ,1 measured' the .
co'nduotian' velocity of the ' left ulnar nerve by the 
method.described previously'(Simpson, 1956.. It was 
■ waiaa/ ■ . 'r '
U5,'
normal - but.on- -totalising the nervi --1 •afgtiaaxable.* 
response was/ evoked ’from- tho ahductor .'digit! -rnn'niii 
muscle-. 'This wsas.aboXiehhd by -injection of , ,
edrophonium (lOmg* ' i'nirvvenQusiy)* /No . incrementing
response"- was obtained at - any time in this case*
Th'e, .injection-of- edrophonium also reversed • . •
teipomily the -bilateral*' ptosis.,; This case was . . 
seen' while th0 thes-e iss being written- and is. ©till 
•.alive, - ' ■ - .
Case-- MHjolhO- eoipXaine&- of difficulty in" /Chewing- early 
in 1950 and soon" developed generalised i’yaithenii 
with- ’incomplete" response "to neostigmine. In the
same - year - she " had hl lately al mastectomy for c'lrc’inoiia 
of- ?the breast.': /She '-died -’in-duly 1950 -and post -mortem 
revealed " ‘anaplastic/ 'idhnocarci'nb’Hii - of the - - trachoo*- 
•bronchial lymph gland. It is unfortunate that the 
thymus, /was not. examined as- . this' -case is said - to" have 
had brisk - reflexes. - She ‘was- seen - before - the < syndrome 
of olrcinBrnatousmyoithenia-was., /recognised.,
Oast - 1K/AB was also;©eon in 1950 by Dr. S-A* Carmichael 
and -M?i Geoffrey jKeynos- prior to recognition .of- tho - 
syndrome*- She had carcinoma of'the; breast treated .
four years - previously, - The presenting 'symptom was" 
diplopia and- liter, there was ptosis " and hulbir weakness. 
There "la no recox’d of "limb weakness or "of the - stats of 
thv reflexes but this-patient is said to have - responded 
well to .neostigmine. She was treated by im&i&tion
of -the - thymus -but died in Appli- 1951#- . . ' '
(Two other -cases who died of carcinoma, • HH/PS/LB 
and NB/S/JM probably had this as - .a' late cornmpi’c&tion 
off myasthenia gravis).
The/ ‘ .... ' • ' ’ ' ' ■ :
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The unusual electromyographic phenomenon in - 
careinQyatou® myasthenia was first -d'eocribed by Eaton 
and ’ L&mbbrt (1957)* Using the stimulation and recording
technique of • Harvey and Hasland (1941) described in 
Chapter ' 19* they found ’ that the first muscle potential 
evoked by a • supramaximal electrical stimulus applied to 
its motor nerve was subnormal but on repeating the 
stimulus' at short intervals • there was marked• facilitation. 
The same phenomena could be induced by voluntary 
contraction of the muscle. ;Post<«£etanic exhaustion
lasting for’'2*4 minutes was also noted. A characteristic
i^ncx^e^^^oi^^^ing response • was recorded' from the • case just 
described ’when • the nerve was tetanised at a fast rate, 
but a decrementing response with• alow rates of stimulation.
’The incremental response described by Baton and 
lambbrt (1957) has' been considered by ' them ’and by later 
authors to be diagnostic of’ careln0mytQlS/yyoJsth■enia.
Wise and MaeDermott(1962) showed that the incremental 
response to fast rates of stimulation may be'changed to . 
a kfade’ of; myasthenic • type with ’ stimulation at 5/accq'nd • 
or • slower. it is my opinion • • (Simpson. '1964b) that these
electoomyographic changes are not ' specific for 
carcinomatous myasthenia since i have ’previously • reported 
similar findings in different types Of acquired myopathy 
(•polymyositis’) and even in myaa-thenia gravis (Simpson , 
.i.960a*b)« The matter is discussed further in Ohapter 16,
it is not questioned that the incrementing response is 
highly characteristic of* and perhaps beet developed in* 
ear.cinou&tols yyasthenia but it is important to make the 
point that ’ the disturbance of physiology is not ' unique ' to
14?.
that condition and does not clearly differentiate it© 
mechanism• from' that ’ of true’ myasthenia gravis.
it • is .unfortunate that yauy papers discuss 
cn’rcin0u&tous neuropathy, nyopva'tHy'and • uyyathonia' 
without 'iaklng'it clear whether these ' are discrete 
syndromes or whether the author's investigations are 
confined • to ode or other group. Baton and Lamibrt (1957)
doted extreme • sensitivity to curare in,their cases ’ of 
carcinomatous myasthenia* Croft (1958) described
"similar• excessive respohs.e ’ to curare • in three patients 
v/ith carcinou&tous neuropathy' but without overt uyaathenia, 
Two ••'other,patients 'wLth carcinoma but iVthout obvious 
neurological disorder showed similar ’ abnormal sensitivity* 
His conclusions .wore cri^tlc^d tyddiscuGsed in an ensuing' 
oorresp'ondehce by *010^00115©eists•• aho.; considered, that there „ 
were alternative explanations 'for his observations.
Croft claimed that prolonged response to • suxeuothoniuu 
occurred in one of his • bases, • like the,'first case reported 
by Alderson ' et ’ el (1953')* , ;Mse and ’ •.jjacBeruot/ (1962) 
found that their cases• of carcinomatous myasthenia with 
the Baton^aubert electromyographic sigh were paralysed 
by an unusually’small dose of .docayethoniuu* Though
the paralysis so • produced was partially ’'eversed • by 
nerstig.mino 'this sensitivity is the • converse of the response 
in true uyaathenxa• gravis ('GhurehiXl-Bavidaon and 
Richiardson, 1955)* They examined the motor ©Md*plates 
by • the’apodal techniques • described’ in Chapter 11 and 
found 'a non-specific• degenerative ' process affecting' the 
distal nerves’ and motor end-plates’ but • without the 
particular featuresclaimed to be specific for'myasthenia 
•gravis.' • ■■ . ' ’ ' . -
' it/ ' - • ■ ; : .
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‘ ' It must bo concluded ' that carcinomatous - yasthenia 
dif-fors in clinical* electromyographic* 'pharnoao logical , 
and 'histological details’ -from true -myasthenia.'- - 
NevoethGleas there 'are obvious ' res'semblancea and it .may - 
be ' that ' the differences are ' quantitative, X‘is not
possible at present to. reach/.any 'definite. conclusion*
Ocular myopathy and exophthalmic ophthalmoplegia: •
' ,. . Ocular myopathy is normally of Importance in
the present '.context only as -a problem' of differential
diagnosis*; There'1h no -difficulty' If 'the weakness is 
lessoned by Injection '.of neostigmine as most authorities
;would consider the appropriate -diagnosis was ocular 
.- myasthenia» -The ' difficulty arises' in cas'es which' do - 
■ not respond to' '.MnHoh01ineisfsnuw© ' .drugs ''but ' -in whioh ‘
weakneas isrincr eased by an abnormally small ''’dose of 1 
curate* . • Case©' Jiave,.been' reported by-Howland (1955)? 
Wlsh/Ob^^X/and' 1965) and'in.-assoclation 'with ■ /
thyrotoxic ophthalmoplegia by Millikan' /and Haines (1955)* 
Bowlnnd and . Bsmenami (1956) consider that curare- .
aensltivlty indicates'ocular myasthenia, but there la .■ 
little doubt from' the; careful, study.'of 'Hoo® (1965) that
' is 'common in ocular and limb muscle® 
in ' the ocular type of horedltaxy mwcni&r dystrophy,
■ . Howland et al -.(195$) review the literature 'to ' .
that date and ' oonsidor that'' Mf variability Is not, a 
,feature of an ophthalmoplegic syndrome' and ' tests with' '
neostigmine and cxurare are negative*' the diagnosis.of ■ 
ocular myopathy seens justifiepd* . if .variability ls\ a 
•feature* myasthenlai' may-'still be considered* so matter' 
what the ’'histological;. and '.'electromyographic' findings * even 













diagnosis • • e’.anno t ' be -made' with ■ cer/tain ty 'unless'-l theae ,'; ; 
dr^(^fe^/ev<^l^e'^.'ree^X^bnse^, 'i y This • aptlytuimmarises■ th e.i ■ ' ' ' •,
position from' ihe/pracficai ■ point.-pi'view- but'''leaves'/ ■ ■ ' ,
•room ’for ’ argument ■ 'where *. ■ as .in ''some tases"''o'i ■ ’exophthalmic '
ophthaLmoplegla, .'■there ' "is ■ apparent ■ iAhrovempht . -in ■' eye '• 
movements/,•after' Injection of neostigmine'. . I agreeivith , ■
•RoWLanid et XL (1958), that such ■ a_- pase/should■ be ' • /'-' ' ' '
•considered ' to''/havd myasthenia' .gravis/' inihseociarion with. ,. ■
hyperihyrod&lmffls; ' y ' -'/'/' / >' A/y’p t ,, '
/ 'Case" M5809 wa'S' '-referred from the /Endocrine Clinic
': ‘ - »g.mamUMiii» *—ir«, • /, . ? • ■ • ' 1 . . , ' > ' • • • f .
/ of/the' .Westeiniir*Onr&l:, H)ss^ii^'a.l/^^/;‘13ddi^^iix^f^^tt■/ by V ; ' / '■', /.: ■'
•yiy'Dr.: J"#' Strong. '■' '/"She whs /a ■ 'RS,year/old' woman eornplaining ■’ 
,• w-/e^;^,(hlt -lorai'5 -/oonittigg 'aiid '(ocxltxd. ► Previous " /y ,....
- symptoms ■ had suggested,'.thyrotoxicosis but specific ■
' testing had produced equivocal results. /$he was" /
. '. : nhted. Io. have /bilateral and. . ' / '..
intermittent -paresis of both lateral ■ recti althoughy
. sheyhad rarely ■ noticed double vision* ' The 'lateral ‘
,■ : jrbetus ' weakness was „ apparently- reversed „ by edrophonium ■■>• 
but pto&ii'was, 'unaffected or' worse*:/•'.’The/cur'are'' '.' /
y, '•. sensltivity, test/showed no abnormality but a' t-' /..•-■ ','> ;• -:■ -
/' / docarnethonimm test using the left ulnar nerviand ai ,■ •
/y/hand-muselo-' '(Qhapte£yl7-)? gave .results intermediate'i’i \ . 
V .'between those' of /a normal,' and a. myasthenic person. , y ' "• -■
’ '' 'Ho d:^^^^{^3^€^i3’s^’£^?^^€i'6^^;7-y€^;fcb.ee^^^^ma^d€^«' >"'■''. * 1.
Oohgeltal pbosie/and/fpseudoptosisS’-. ■>. -... ■ •-/ '..
, - . • •/./ The nmne eoyisideraioona /to .'congenital; ;ptosie:.
This iS'.-often hereditary.'. /When.. it '.appears in childhood . ,
’ i t. ..'may; ■ be ext rem e 1 y '• .‘d'i f f i c u 11 . t o' ' di f f or e n t ia t e from ■ ■ t h e -, ■ .
congenital/, . L , ,: - ' .'.-.//I ‘ •. •,'■■■'■■. ' ■ ■■ • ’ ■ ''y ' ' .
c.ongegLtal' ,typcy^Wmniaj(0h&ptoi(' C).,/ p 'limy"- ' ' ■ '■ y-. 
opinion neither' o'f ‘ those//ssydromes--is- .to true-'/’ ' ■ ‘
myasthenia -gravis! The ptosis4,./ sometimes-/-fuailiaX,. ■ ■/ ;'
which appears-.- iiK/elderlyWdhen; is •'temeOMpseudoptosis * ' -.
by - ; Walsh -/.(195? )- whoyatti.ibutes; it to - Xo'O.al-- ehanges; in; . i . 
-Soft/-tissue S- ,whioh . -permit sagging, .of;'- /the/lids* - .■Some../1/ -- '
■authors .consider'-that it . is-a for— .of ocular' myopathy - • ’ -
/(Fuchs', - •'189.0 l-l/Kloh. and '/tevi-n,- 1951 ) -•'-.•-.Like/ the/. latter - ' ' 
'disorder-it- may; cause difficulty - in/.diagio'siBy . asybh'e - . •• .
ptosis/ is - more.prominent When/ the. .patient is tired, .;- In ' ' ' 
my\-experience. of - four - cases .-the" .ptosis ' Was - not significantly -•. 
’incieased./Bykf££inig/ihe-gaSe.CupwrdS'’/oi-'’by repeated . j/'/' - -/,. - / 
'opening and,closure " o.fythe /eye's/.• nddyh'e//, '.tirednessS/-/■ • //-..--’ • ' '/ - 
'oompiuined'/o'T,. - was/ - fatigue or - drowsiness7'■•rather • than, true ’ -/ -t
/myasthenic weakness,., .-In . mytopiniory this is - not -a- 'form 
of. myusthoBia''-Mx-4vv.S/ • / .?•.:•• 'y-. •/. p . '
'/ •"■.' -" •pasB-- i®5?6g, ' a - -r etiij^€^d//sc hoolnistress naged’t$4,- c omplained 
.- . that .her ey^ei.'^./had-'/Been'- 'hea^v^y^* when- driving- .Her- car-, ■/ ■
;/- f 6rhthh/‘previous-y-yr,..-‘ Tiler’s- was- nd - other weakness -. :-
- '- ,and- neostimmine''%iv/h-by. Brt - H•^^^l:lx*y-,Hiil^er^9/.,Ne^^^^^^^^.t^i^^^'/-- ' ■
y f who .'kindly- referred-her- to me, ;had' Been.unhelpful- ■
•/;- Her'mother-'tad- ’(x^c- diabetes •and ’.thyrotoxicosis- -. thrCretL-. 
J, '..whs/no, familial history- of ptosi/*-/. • ' ■ , I;/ V‘f- '•
■ ' /- - There was. apparent, 'fatigue^. of the eyeldcSs when , '•
y '.-she concenirateod- oh/visual work -and ,n .it/nd/hey.',0o-'- = /.-- /,-■•• 
•.' ./spasmodic contraption -of .orbicularis oculi/was -... .
-s noticed on both --siO.esv - - ‘ /-Ho'/-paretic ptosis ‘ could - -b’e.i' •• • •• •
.■ demonstrated (Fig* 9 $'/#-')• •' Curare sensitivity wwas( , .
■ •■'// -normal- -and."'. 'decamethoniufo. test- within - normal limits­
' / - / - / - /.- The/ ppssibblity. - /of, a - - tic.-..(Biophai'osp'asm)/. was ., .- ' '
. \c/ons.iOored.- - There - .was certainly/no. evidence - of - .;/- '
/myasthenia- gravis-/ In --April -1963 - the difficulty- in
■‘•x ..-.kaepipg//,/ //•... / -- .- /By -• \ ' -
i /ke.e'ping•• her eye© open ' was so • much' worse that ' she Had ' 
to' ' otdp' regularly in ■ ' t he ' street to ' ’look 'and ' 11 steh'*
■ .Case ' M.MlL-6,. a. woman', aged •;5i» .OOmpIained', of/difficulty 
, '>;;-::':Ln.fik^<^3^:^;^lg.her eyes; 'open \for';3..-'ye&rsV' Tils ' was .worse '.
•,';lf. 'ahe was./anxiouA 'or '.trying' to ..concentrate ’hnid^w&s. '
. .more/marked 'ih '■ the '.right /.than on '/the/left'*;.'. Hor// './/-*• 
•.// '/mother' .had similar/ptosis' in ' /.later/life -which' ... ./
/ ' ■: 'progressed' until ..she- Was .hardly.’able to open them.’*'./ '
(The '.mother .didd■ of carcinoma of the ./breast' - ' years ';
' ~U‘?later so .it /is/possible '.that ' she/ had .oarcitl^CTato^G' ./ .
//.. .•/..myasthenia).'; '; /A/brother 'who died' ■■ in /dnly' 1965'.had' - . 
•//.severe' weakness of his limbs* .No. details- can be >
. -obtained,? ■-/I •••-y/./’i . < .. •.
-' ...>>// < f 'The/'patient '/s eyelids' . tended-to' cl,bse- suddenly '• '
? .---mid' not' .'gradually /as-.in ' myasthenia '.gravis /nor .c.o'uld' /•.''
■ •■;‘th'0y.'be/fatigued/by maintaining 'a ' 'posturebn by '
•. /--.repeated. olOsUrn.df'''ihn.' dyes ••(Fig*, 9,381%.-/ No-/.-/ 'y • ■
-' evidenOe-/of --myasthenia' cOuld/be '.found' in ' bther-fmusbl.e's. 
. - ./by/blinical /bdsting./6r;by ' -.elec' tromyographyi Radio*- ; .- 
dLo-dino' /studios• gave ' a/ H/1 -index: ' /of 1*9,' Kt ' '(.’thyroid. '/
.. /'.''clearance '' ') ' 'of. '—*2<■ / :/ These/ figures- are-- 'in .‘the-/- hy^d»-».' " 
/..//■/ thyroid .range'• but ' the. protein-bound iodine _ level.,in ' .. 
''-/'-the serum' .-Waa/5«0oiU/lQ0oi« '//plasma' cholesterol was .
.'///'X83mg/lO.OmXyy?'. and' glucose'/tolerance ' and ' plasma-/pro.fein 
; . .'-studies' Were' normaX*.' . ■'//- '' •' - '
• .;..t1^3^i^^^./rr^^^.ex«a^;lnnd 'a year .later',' she,, stated that ptos
. had 'increased* ' .Tb0';mea8ure''d palpebral fissure 'had. " ' ' 
deoireased .by /2mm'/ on ' 'each ' side' 'but;, this ' was'' difficult '
, to '-assess -because.,/ like.'the '; pre.vio,us/patient■ - she ...
/ /blinked frequently-;'; ■ •- , ///' "' '■ - .'..'. •••• —
/'./.• / r . Tbe' similarity' of’ /these .cases-and ■the..''case..' ' /'/. '' ■ 
illustrated, ' .by RoWand.et/al' (1960.) maae/it ’certa±n' ' that- '
they --'have' a- 'definite?lesion. - 1 ■'. None - of - them -"showed;-.any- '■ 
improvement with ' the ’-use . of -sedative' or stimulant drugs'; 
-and- the-ptosis appears. to -be progressive#--' .- the'
nature of --the :abnormality..it"- is, -not- Nhyasthexiie's•••-;•..'- y.. .■■'■
other myasthenic syndromesi -
. ’ ' The; muscular -Weakness - previously da schased' - in ' this
.chapter has so m&hy relationships /with .true myasthenia- 
gravie ' ; that It is - justifiable - to1 ibok- for a' common' 
mechanism if ' not a - related' ao 'tiology*.- .: - Bom o' other 
syndrome! have now. to - - be 'described-'Which"sipp.e&r: to' differ’- 
.in-both, respects* --/•■' r , .- . -r.,y- - :f ' ■■ -'■■
TMophaliiis;-vith - myasthenic symptoms was .reported-from' 
time - to ' time., before -the - modern - era .of, .electromyographic 
"and- ph&rma'cologgLcal : teats - -for' my&.sthenla. gravis- i Reviews 
of thebe fafieB/by'McKenire ©•: arid, Wolf- ,(1'935-') ..and MoAlpine
■(1929)- make--i•t:/cl'ear :"tha.t '- the, ■ dinpihioiw-' was -unaceeptable- •­
or - that - myatheni'a'' and' .eaceph&iiiie. wore . -coincidental* :. •
-Case HU/EG/LT-waa. thought;' --to have'-'sleepy sicknea’si;- 
in - 1930-when'. she complained - ‘of -.weakheOs and '-.ti.rednesa-
• - of the '- ' - She was’- then -aged-'jS?*- Definite - ■.; v - -'
- ; eya6theni'c- .'.symptoms ''developed- in 1933 -and- -continued '■ ' 
-.. - until - her .death in-1944- .'-IRes^c^i^feT)- to neostigmine was
- .always poor -but-there ■ can .be ho - doubt.-about the " %
- -diagnosis'’ sinqd-■ autopsy at New.. -Bnd •Hoopptal, ■ 'hond.oix, ' , 
'■' - --revealed ' an infiltrating - ' thymoma*- In - view..- of - this.
-- -findingit iis).' probable' that -ho original diagnosis''-was'
:iho&rrect/; ; - ..7: , ■; ’ •
Disorders of-. - th e ; lower--mo to r ' neurones' ■ s' -
'; <"7-/7' Thoro ±3- no- doubt- that- increasing- /weakme.ss- of 
•sustained/ '- - . . - 1' - 7 '• •.’-
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sustained on/'X*eps&tdd with a; I' f _ .. '.■, ’:
decrementing .oleoirOmydgrapbic ' response' -to: indireot " .•■ - \ ;
• faradisation Jiiuaar- be,-found -.In scwi sases-of 'disease o. \ ' ■
the, antoxecord - horn - colls, or' /peripheral ' ’nerves . -(l-impSon •' :, - ;■ 
.And .Lehman, ' 1959% Simpson, l'96<g.-’ 19$$'p#.% ;,Theso cases’ ,-. *-' •
have-&smyeappwn±<s- 'phenomenon which - is/usually;,detected .- , ■ 
by-, ©1 eo/txom^c^fg^^phy\aftdL,. ’rarely by ..clinical examination-'*'' .'- / 
;(94l^l^hough. the^my'astKehiO’: oymp-t<^K®- .(with .reputed; .
- n'e03t;lgm^.ne’ree,slo^t^sivoness) ./sometimes' described in- • '­
porphyria, may /he' ••of'.,.this nature ■ C'G'ilihespy/mi Smith',- ->19$4.):,
* - For,-this \roaeoh ■-the - '<d^.^^^^^^si-o’n is; ' deihu-reed/initil the ' ■ ■ / ■ •'■ / ■
;Cha'p,^e^''>c^xl diagnostic' method©:.heieande 'of 'their importance . 
in ■’&.dx^x'ti^erx^at;i>oxl.,/^;i■• -/bheypathoppysiQiojyp.Qf’ brad - -and - /' . - 
.©ymptooiatio mtyssthenls‘ . , iy conclusion baa been - that '
damage,, of-ihc-, loww -’msO^cr■-■ -neurone - bay oauae failure \of- -/ - /'
/aynthe si.e /of,- 'ace iylob'oXino »- /.- -The .effeo t - ' on. n owominae hiar-■ , ' 
transmission 'resemble® that. ;of... myasthenia-' - gravis--’but. 'the - ■ 
mechaniarm!may.ho/differont ’ (Chapter .16)-- - ■ There' is -no '■ ■ - 
.Clinical ar/- aetioXc'gipal reiaiiOnship. • except ..in/ so.-far .-as ' , 
' aom’e - - - cases of -polyneuropathy ofjthh. sMilain-Bhrre ' type - ' -
meay/ba. paused, by an C.s)sWtOogtcaX.- meehaaism .(Simpson; ,X^62P*- 
Thia 'haa .••nGo'- so far-' been- associated.- vi-th-abnormal' thymio 
■fxn^o-fco'n'S^^^-- V •- ‘Z. -/■/.' ;■■ /? /' ' .._,' '
■ / ..iSteidl-Ot--al-.(1962) ■de;3c.xihe/■iuscuCt^'^ -change© •?. ,
-.whiih. they i^nt^e>3^p^^3^et:. as evidohce of .peripheral .neuropathy -
in- -■ an - - .otherwise - \ - typical Cw ..of -smaathenia/ gravis -/hut - ’'the . ■ ,
evldeGoe/'is lean than 'coj^^v.incing-«*,.';Wio-case a in -.the . 
prosort aeries were/first •diagnosed- aa cases of - polyneuritis 
but - the/subsequent - . course -was’, typical - of myasthenia-gravi©»
/dese il0i36.- is - described in- Chapter -4 -.with 'an ' -- ••'.-:- '
/ . .illustrative - eikethmXoogFsM•/(,Cg|--4, l). . • „/ ' . / i ' .
-' .-■.'•/Case NB/PS/dF«.- fHad- humbnea© and..ppane©ttie©ia of-all ' 
.'•:// limb©/ / "-/'■" f ■/,/ - • • /,. - ’ . ; . /-' ' ;/ ./f f;
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.-limbs-' at ■ the ‘ onset' and.- hi®" ;C ♦ SyFl-® ontained 125rii»- - 
'pre te in ’> p.e,r' •lOQmL * The Tater/course -was 7 myasthenic *
"-,■ '' -‘"but the final "outcome -.1 s.-inknown* ' ' ' ■ ' .
-'Case.■ KH75?06 ■ .developed- -myasthenia gravis at the ■ -age-.
. - -.of' B3*’ She ,wa's-hot greatly ' .improved by thymectomy* . .' • 
■ <, Ten year® - later.. '(I960.) -".she was .'admitted to the ; . ' : .
-•-.,'-": -"'Ntional' Hospital .with.. evidence" of •motor and sensory "•-. .
■" polyneuritis.-'- -- ■ -The,-0 .S.F*- protein’/level w'as-;.22 Omm/lOOmm
’ -'"Therevv-aG ' hyperg"a^^^^tte^ia;libblinhCiMa -'•■bit-no ' L*E# cells - ■ .■
.• ;- were - -foihd in-'hor" '.blood*’. • - ' 5 >’•• ’®
T^^jjC" gridyhij^^3^^:^,ti^Qnai-,Cais.®si" ■- • ' s r"
; ^nscular-'weakness-ofvlmyasthenic?- typo-has-been ’-. ■--
'doO^i^^^b.ed.from Franco ih-chewers of tobacco which had- 
fexmentedgas. the -result "'of-’oohtamiihationiby.-d3of iridium.-; - ' -,, 
perfringens (OQUlGnjou- 'and --Salain'- 195£; - •-L^^x,j^l1jte-- 195S ). 
>^^iLsnO:riani£^^m--n^l^^i^£^a^^ly- caisessevere- myOs±f^Q (gas - gangrene) 
tand'it -is - possible;, that- ' minimal', mdscl© damage -may -be ' -.-. " -' 
r<®ponsiblo for - the' ^symptoms"-described* It is interesting
to consider-theippbsihility - of-'an exotoxin sich - as that - 
. produc od;- by - ■ the related - organism'.-- Clbsiriilura botulinum.- as-- 
the mechanism - ...of - .paralysis in. botulism -has resemblance® -to ■" 
•that, jist 'described for- the - neurdhopathies*; '' . ' -; ; ’• ‘ ■ -..
•. A disCasO-name'd- KubisaguxU in ' Japan - was ' described-- ’
by -M&ra; (1897 ) * Thia was an - outbreak of p analyst a'.with- - ' 
.ptosis' and -'bulbar .symptoms* . Similar tpi.deries./6ce•ir•ri.d• 
in'ipri<sbher7pf«war - camps.' - in 'the■■■'r'-I';^^j3’b-.-(i^Ms£^.€^3.rm^3n^''';1945;' • 
Kat% 1946.1 De.anyrBrown- - 19.47-),*-- Weakness flictuated:-. in ". 
severity - and -- wms sometimes - worse - in - the evening» -' -The- -' ".. - 
..reports differ-regardingf" the-'effect -of neostigmine.’ bit;- "it .' 
seems, probable; - that-- - these outbreaks •were'- essentially -' the - :. 
•saro©. a® Kubbsagarl - and - probably die, - to nutritional - .
dofiGi'eh'oy/' - i;"., '" — ' "
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. ‘dsfici- qpcy -’though fa-'heurot oxin Xsuchkas- -Tick paralysis) ';<’" 
;'•;can - '.not -bebdxcluded' (Monaghan-,' 1960) * „.• Benny-Brown -<{194?)
. rop.or t'e d-'that' ' paron t or alb administrat i on -of - ■ thi amino.■ .cans ed-•
• .-thet.aymptPm® '. to'- disappear - .in - suggests - the .
: .possibility- that- defective -acetylcholine- synthesis may'.. -
• aiocthh 'the -mechanism - -here-..';. ■< -,. b'. .. . -■ ■ '
*bAdd{^^rmitn;fcigg ,rosj)ons<e to repeated -
' yoluht’ary->;.or.ieleetrical ’ stimulation 'm’ay-.be due- to '<bb.:;' 
hmyiathehisa''gravis* - a variety of - muscular diseases, --and ••'•.'■
' aifew 'disorders'-of .the, flower -motor neurone* /The/b.v' ‘ 
■mechanism - ;o:F' the-'- transmission .■failure., is probably,- . ■ ; . . /' '
/ -.different - in- th.e.,heurohpp'athies; bui'-tho close clinical. . a 
' •electromyographic,-, and - pharmacological', rhs'emblances .in ■ ' .
' - the-myogenic group -is in ■'favourbof a./similarity of . ■/■'. . • ■
'■• . A.dou,hle - Tpsio.n-^ of - nerve-- endings and - /
' - motorbend-plates f '.Wth.fi --balance )between degeneration.- ■ ... ..
and regeneration. ;-*• will - be ' discussed - as , a - possible. Pause’'

























• THE IKLPEHOB/OF - BBM(^Vt:N0 THE THYMtUS. GLA^NI^,, . '•
The operation of •. thymectomy for the treatment
of myasthenia gravis • was first performed by Sauerbruch.
It was said to Have improved but not cured the . patient 
(Schumacher and Both, 1912)# Sauerbruch • 'operated on
two further patients . with thymic • but both died
a few days• later* Von Haberer (1918) was no more
successful and the operation fell into disuse rnh?.!
Blaloek successfully' removed a thymoma in 1936 with .
resulting'cure of the associated myasthenia gravis*
Blalock• was also the first ' -to report removal of an 
apparently 'normal , gland from a myasthenic patient In ' 
1941 - and he ' was soon ' able to report six•cases (Blalock 
et al, 1941). The •later reports from Baltimore became
steadily less ••favourable• (Blalock, 1944; -.Harvey, 1948' ; 
Grob, 1953) and their conclusions • were supported by 
workers at the Mayo Clinic (Eaton and • OX&gett, 1949; 1950; 
19531 ’ 1953) and in Boston • (Schwab and Passou&nt, 1952; - 
Schwab and Leland, 1953)* ‘
'The • experience of Geoffrey Keynes, in London - 
appeared to be entirely different (Keynes, 1946; 1949; 
1954; 1955). Despite a high operrafcive mootuaity in his 
first series, he was sufficiently impressed with the 
beneficial results in some cases to persist with the
operation and Insisted that the unfavourable American
results wore due to their failure to•distinguish cases 
with and without a• tumour of the thymus* Ho emphhmised- .























problem■ qf/treatment-anid^that-false1 asiessment io . •. ' ' ,
&mp0aqibxer\uw£©as patients -Mth thymic '-tUmoura ’ar’e.\ '
-.treated; in a separate category fsro.a- those-/W thawt# -In. .
•'•'-.addition-he, drew attention to '-the- .fact that aome .patients .
'■develop .a- ♦myopathy ♦ .■$». shown,;by mwcnlar biopsy, • which -,
":couXd; scarcely he. expected to-respond 't©-treatment • ■
. (Keynes^ .-1953) .♦• ■-? ■././■-•;-. • ' • ■■</.'•■ . ;' - ’ '
•’ / ' An ■■'independent -"anayyis 'f'100:-consecutive •.
•patients 'operated- on by Keynes ■ was ■ made .-by Rons (1952).*
The--result© wore described- by-K©ya®e--'(1954) as, ' , ,•
' ■ 'considerably, •better •-ihan anything ■ ■ ■ had - ever .claimed . 
myself'#/ /;■’••;.•'.• •••• ;•,/•■ ' - , -. ' . / .', -
. , it .is/het .surprising that the apparent Xachmof ’
• agreement,/between’-the 'few'centra©'-withv-rice* e^^x^ee^rLenee of •■'• 
-'thymectomy•has /caused/111080-Xcknin^ • for/ guidance to• /assume ’ ■ . 
that, -the •'evidehc e-was'-teo'. equivocal ■ 'to Kwry ^conviction :
■ (Lancet- 1954)* .-.Win wna the position in-1953 when 'I, was .. 
invi ted-by I>rvE* 'Arnold-Wrrlehsal t° ■ review/the case# '..
i/pee;ipd,?&t-- thib National.’ Roep’itai/ for .NerVcm# Blseaeos,
Lpndo^# Most of" ■ the opera tines 'had? been-performed. by ,
Mr•’■-.Geoffrey • -Keynes -and by Mr* ' HoXime.,/GeXore» Sir '"Geoffrey .. 
■Keynes kindly Invited me to 'extendt the ".-survey..to-Include , ' '
.. casaa-operated/onby .Mm at St* ,‘BarthoXomew’s and' HeW/Kid • ''•-
, /Ro©pitaX&, • -London*• - Whose • oases wore• compared• vd-Lth -a 1 - - •' .
- . series •<j^y^ea.1^e^d without • operation,- being -all; patients/’. ..
.diagnosed. as my&athenia gravis • at • bhe .Rational Hohpi.t&X • '
-niWWe’ ‘1934* ' 'Special predations •were -taken •to male© -the •- ■
-survey ''complete 'and these ire debMed 'in Appendix o*. '- .
'■.It-Is 'unfortunate that’.-no randomisation of treatment w&a ' - --
■ • ...p sod'and to this •.extent the • c.oippai©0s,-•ly -lens than ’Ideal.
' /Rw'eethhliess, •comparison of' the opera$©d-and non-operated











' serio®-- "in- respect "of .age > - Sex* - duration ••of illness/,- ; •■ ' , 
Severity/ incidence, of t* myopathy’ and of thyroid , .
disease ..showed that - they ' were acceptable samples from 
a single■ population for statistical purposes (Appendix g)*'
A ■ preli minary'account' ■ of ' : the’ ‘Survey Wa ‘ presented• ..in 1956 
mid■ .'the'‘definitive evaluation.of ‘■thy^eoto^my in ■ 1958 " ' ' ' '
‘ (Simpson/ 1956; 1958)*'.' . ' h ' . • •- •
thesis-as ’•.- 'i- , '. ■••.
'.Appendix Gk'which'.' should now be consulted/ • A summary' '
■ of -its oo-htentsk follows?* . ..< , .’• ... . •
■' ' ' P * Ii5li3-f ; GPi t eri a-for inclusion in.,-the survey*’ '
. .Extent• of•.availability* -'Glassification "of. eases*
,-.... It -should' be .noted - that this is' _ based on, a ’change '
■ .. . of status■ - with.- respect- to presence -of signs and •
- - of myasthenia'/, exercise/' tolerance, and- ’ .
‘ : * ■ drug iequiremenW-y■ -% o statistical, techniques to
be adopted were .based on the - ’nuH. hypothesis’ (that • . 
.-the two treatments did - not differ) and. so ■ in case of
'/i-idubt'i patient, was -''assigned‘-to'the »loWer: categoryy'
' !inF./3jl«*11,?i ” ' Comparison ^of.-c.ohstAtutioh of ’operated* . '
; and . *no^operated*• series - (non-*tumour)* , ,
."P»1iy^120 * .■'GempPrison;.o f change of . status .of ’operated*
'• , .-..and.• *n6n~'opeiated- *" series* - The " - conclusion® • -are .// : 
embodied' An,-a table . and diagram which .are reproduced
■ * Tiey, show that the operated series contains
- . /•'.&’ higher-' proportion of- .females in ..Category, A-ami B*, .
. . . "(cured ir.'greatly. .'Improved) than- ' would bo likely to
.-' 'fibecur by-chanoe -.'.-(nt the ' 5- phr -cent -level) -and the - ;.-'. ■
death' rate from /myasthenia - is very/'significantly
. ' - r^educed,. - 'Even when 'the operative ha&ar'd is added/.-. ■




















■'in the hot-operated 'aeries#- Males " "'Show-a-'similar.' • 
trend-though''the-differenee- la .not-statistically .
■ significant 'except. if Category'C* (moderate. " -
’improvement') #<lhaped ticn gf -the 'defa'-( P*ll8 ) -. •... -
• ••suggested' .-that apae'&ibie '-explanation''.-might he - that- -' . , 
/Without - operation - the /prognosis- is - poorer .for women - - '
.'. W't - "this .■diffeienipe . is - - reversed- by " operation.*' / .
P*j120*2i25''examine -some .factors Which may affect • ,'■ . ' '
' the 'response- to'.operation# \it- '■■had ;been suggested-" •• •-.' ' 
,;by - - 8 chwab - .-mid ••'Leland- • -(1953)..-. and '-by; Baton et "'at -(1953) . .
: that ' onaph "at gn ''early'-age. '"give®-?a "better chahcb- of . 
.good .operative;, -results .in'contrast" with ;a poor ^prognosis .
withouh operation* , My. data '.go,; gome'/way-.to auppor t,--■. •'•• '
■'this -but"ehGw;,'thai..&'Ohori pre-operative history. of'"' .
-factor."., , / ' .
e^^i<^i^siy';youngf^U:^i^:lcal;v babes 'arefiikOly to - have -."' - -•• 
short - history "so that it is not surprising to find that ? 
?he" prognosis;' is betterC if the/patient is young " at ".the '.
""time-of operation " . (P*123'J# "- ''" /". . ■ = 'i,- - , ' ■’"•'■
' -■ There was -no clear '"'evidence 'that ihe'VsvVrrty. of -" 
myaathenia mateMai-Xy-’ affected the- final ’state of the 
survivors.- The foXXovw*up-period of - survivors 'Was the
Sam® 'in " each -group*- • •- ■ . .- ' '
/ - An interesting point which- had " not'- "been previously' .■ 
yr.eporied.-iw’as that. - those patients - who - eventually " died- •".
of- myasthenia 'gravis did eo on- average 'four to seven ■ ' - 
years -after - the onset - of the " disease" 'whether -thymectomy, 
was - carried out - or not* Deaths from myyathenia - -gravis
''per/Se ' ..rarely occurred -more than - ten years after the • ■ 
onset of - symptoms* Tirus the most - dangerous - period- was "
also/ ...' • I,"'/. ’ . • •'
? /../' " ..
ai©o, "the. period .in/ which. symptoms -?wpre m<?Bk likely ■ - _ * ,y,
; y- to he' reversible 'by thymectomy* Tlis '.observation , ' . ”
'/- led to the concept of ..tn .'’active _‘stage*- referred o . '
; to in .'Chapter .2 -(Simpson,- 1958; 196^)*- " . .. ' . >’ ' .
* The-. cases.' with, thymoma are treated ■ . ' ••’ >
aepavat^e^^^s^^* . ./.Apart -from - a-.higher age of onset /there. . , "
.... .was no -obvious clinical difference between., tumour‘ •? . ,
■ annd- nonytumur-chsesi/.in respect ‘of - incidence but--it?.' ■'
. . . was - confirmed that medical control.' was. more • difficult e.,'
Moot deaths occurred . at the- same interval of time from ' /
/• .•' • the- onaet -:as - 'in.-'noh^tumour-' o ases*/; - OKyhes .has ‘.stressed
/ the :.<poor prognosis for myasthenia in the- presence of -a - 
. 'thymoma*? ;The'‘present survey 'confirmed- that myasthenic
death is mope likely to occur‘ than in- non-tumour cases 
,. ‘ ' ‘and; - that ‘ ‘ the . very. high. . - mortali ty. rat © ■( 5O«8g?0) ‘ is - no t- ' - ..
■ ./strikingly /Ibwe’rkd- 'py-'thymectomy (50*40% /after Comparable
. survival)*?' Nevertheless in. some’’eases ‘ of -..thymoma?' /the‘■ .. 
s? immediate effects 6f.-■ operation/ on the myasthenic status s 
; •'./'were /.cs6mparallbtr with/the-- - nou-tufeour ,pa‘fc.i'enta- "and ‘indeed
..three; ofhth'em had-long - periods/-'(.2^'; 6- and ,- 7 - ypars) of - 
complete remission from -myasthenia before the - relapse 
which led to- - death ‘in a short 'period*
.. •< "’ •.Those 'findings substantially support the claimfe of
. Keynes - ..as 'against, the American Cnee* WUe the survey
' - was. - being made; Baton et al (1,953) reviewed' their -' ' .
matcrial'an'd; - now treated tumour‘ eases as a separate’’' ' ‘
• igroup and found $ to- their, acknowledged -.surprise,- that' ‘ / 
... /there. Was strong ^statistical-support for ..the value /of ; 
;//thymectomy in the non-tumour series'*
• -.’/./In pp*ia8~138 of Appendix. ,0,‘ the. major series- --in- / % 
the - 'JAterature 'are '- critically, compared*’’• It -is/ shown ' ■ : 
that/
.■g; gg/.;.g 'h :g.l6lg ;-'ggg, ,ggg - /g ' ■ -/g g
that,, .apparent-diifere'nc’es.&re. 'due- ,t'o<V ><•
'/gi), '/‘''Selection •gbf. oWseagfor:' operation.*. ' gg -y -.
■iij ■‘■«>id-w3inO*-t^n.K^o«3?---; f '- - .g
■ ■ .•■•'; :'-’<ja8e0r,‘, ' b %; '/ .-•'•■ : •...-; gg gg/ -g/ gg ’.. .g,"'' g/g-g 
j/ililg /'Differences-of.’ 'crd^t^^3iaa«^'’ni0i^€^b3^y-’ tbe -'usog; - g.‘ ;• ■'-- 
g/g • ;- .of 'end-statue instead-of. ..'change of-ota/tus*;'--,. 
ghg-for OiaesifiCatlon# T.- •/••.. g gg-
? ’.•'.‘.’iv)„ Selection-of.- unoperated f'cohttnlG^v?'--' g’ :••%•.' g • ''
When - the reported -.aerie’s are .coPppred ■±n?'ihegggg/.'
light ' of . these -differences 'it -is - .fou’ndhthat'' ' there’ is; ’' - 
general, 'agre spent-on 'the -rnor tali ty - rate .and - extent '-of 
'rGpi&sion - in-operated . add .not^Gperaied series * g:gllg' /'■■" - 
i PU^neeptres\'*(Jpildon? Mayo-- Clinic %. )
agree' "that tfcype0opy;-reetiit0-±tt<a-,WQr.th£wMX6/> •
■i^mps^^v^e^peht.. . in - prognosis-. for 'gomen‘» ;. particularly- -in - --.'* - g; 
ghe.'reduced .portaiity.'rate y/but,--.the-'.'three American'''■-g 
eph.tr0$ < do noth hQh^E^’ider- th at/ .pales ’ . -are si’gn-i f iOahtiy- -• •■■ 
benefi ted by- 'OperatiPh *This c pnclu©lpn- pay'' hot - ■ be -.: '- - 
valid .'as .the- ’ ppotality in - '.operated ’ wales - reported by ' . ,’. 
.Ee*;on-a»d . - Olaget't- (3-955)- giyg entirely--ah 'operative - g .-• -
/pdot&lity 'and'- - in - -the . series, of 'Schwab 'and - /.Leland ’ ( 1953)- -' 
.it is predopinanily... so* (The. - incidence’ of" -thypdpa' whs - -"' 
/also - .TOuh'ggcater in 'pales'; and-'this ' ■ iBginpiude$/i«'.-I -,,. • ■'" • 
hh'eir '.figures)g -'.-//.■ g-yhi i ' gg . • gggg-g/gi/.-. : .
-.-', It-is concluded' ( P*X38g141,) - that .apparent- - ggg' " . ' 
differences- of . opinion - are - due - to sappling’ 'errors'- /or / - 
i"pHdwdoo,o'gy •-...'•Ho. c'yi’eeri&gwere- found fop; 'sel;ecjt'i{^3^o;o"^g- • 
patients likely'-to -.benefit ..from', . operation<g '-young /-.; ;•' g 
ywoien - gvith' a history -of -less than'five years- -/vereg. ; ;- •’ - •' ' 
:rnoot, likely " to-do -Well ’but'- ''equally-good - result dgwero-// -g 
/found in 'sorne, . pen, and in older .cases ’ of ’long-.‘duration*''. .. 
/The/.— ; - ‘-gg; -/-' g:gg"'g? 1g'i 'g'-g'-' g-gg'g/'/-g-g
 The' severity .of’: -myhethehia - (4s" judged/by the' ' 'dose /of -. - 
'required to toontrql 4yiM>tbm3)- 'did 'not .-. •
-;';.appear to ’..■influehie e ' '..the --'quality; 4 f' ; survival though".: : ''- 
. ,death- 'was'.;morel likely.' -if-4;large -dpo'e .of. 'neostlmhOo;',-
-- /. - .\vas9r squired, ■.,'-'' ''■ ' •."-'• --" ’"-v.":,//-9'<,•■•,'’'•>:•. 9 4 i /d' ''‘-S­
./’ ■': ,.'.' - /: - - Vi'o'.W 'ahd-Schwab - ,t(i 960-)4borrQb.drate umyireoiilt® -1 1: /■ 
and . attribute - 'previous.-Uontraiyfepiutono/ to/fail.urdb'o..' '•. • 
oOraideU male • and - , female- ■ oasos,---,separately*:‘-Eha-ii.o>'t'.;”;-■ 
aerie's not, quoted in /Appendix ;G- aredtod -.©mliifor; '; ; ;- '- / ', ' 
adequate-atatistip a!- treatment' but/;hieB4'’^:'dft^^n^Pllui^0<^J:^^^^/v'. ■. 
are- in- Substantial-, agreement /tVietoffi^P’i- Brea- -et./al',- -
i952f -.'Selipasr, 1952; 'Serghi' 1953; Dunlop ;and/iD^w,--?- -X953')*' 
■No /furthor.; /reports; - of, major -.■ series .-'hp’y'e'tbeeniptt^bb^/is^h^ed-••’ - ■ 
oineo Simpson - ( 1938) ■ and the.- - conclusions - 'made -• •.therein have' 
be on -.generally - 4op op ted, - ' ,lh.. view, ,of -' thia-,;,-1 . ..have < ' -a,, 
recommended, thymoo/tqmy; to aalJl7pati@nts ■•-opining ' npd^r/'my' ■' 
care - /.sinee- 1956 - '- -('(Northern -' General, Hospital, ' fedlSlbUx‘£i^') - ■-- -' ,- 
if-the .•hi^t^y^.jO'faiy^eist^^^i^iLa ’is;' ieE^e/;^h^^n^, ,firr<•--'' years,-; / '
the ."diseaso 'generalised *■ -and. the age - not 'greater, - than 50 - / 
years./-’irroopec. tiro - .of- - sex, * ■ Xf - /the. --Weakness is' - .oonfinod 
to - the extraoeular' muscles- 1/ treat the; patient /'.mediCally ." - 
but/ao'/soon./as ' spread;-to- pther mmoles is ..detected X feel- 
it. is -',wiser. to, remove -the - •.thymus. -.without -.further; delay/.
■ :< ag. .;. .'if- the his.tpfyiio if .
.the' patient - is - - older; than' .5'0*'X;i';S-<Sk'fc ' 'the.,.patien t ' .medic ally 
for -'six.-raontha *■ if' it.does nbt ;detsrio'f.4tpy this -'treatment 
is/.eontihuecf feu'Cif-'Weiaineos. .continues, to •-apr.cad to/ \ j;-.. 
.previously’' unaff^oqt^ed./muscles^ op'-if. -'the - dose - of - ' 5
‘antichoilneSt eraso/:4rug4'-con^int^e^£3;;,-:^7:';ii^<^^, -- recommend --' 
'ppex*a1lOon't-" ---Tis 'is 'done -, 1%; -the--knowledge- /that - the - <t'•-• -
operative/ • ' ... ■ ' ’ .- ;••/;. ' •?• a.., ’.’’f
operative ' -"moot aX-i,ty,is ' ■ exo eedingly XdW-1—' . the;, hand® of... ' 
iTrW, .Ah&roW/'Xogan o f ' "the #. xiWrgh; and.;/--,
that.; " operation ,has- Ueveh _;.uh!yoOr.a,aiy\ihf iueac®&-?ihe7/'-.. 
'cpur’eOof the/ '•ki^ea©®-- .""A®" .would;- be ‘ cXpecto'd "'• froM ’ \.’ ' - ?•; 
Simpson Xi958) ’ 'th'o' "resuitn-ia -'these. 'late'''qaoc^£^;/^^^3r<re.^^^W'3-X','-t.. 7 
eatis’fuoiory- tMh-ih-.the" -earlier ones'- but ' ®Omo ■ 'cases®/'/''-"-.-. ''-,, 
•appear' to ; 1^fnv^'--la:ha'd^r^o^I^*^j^ts:ion arrestd-t,-,' "if ' the" patient 
'has/a" thymoma;..!" • advise," its'. r?siWoal;;;)U,ge3^^^ax^P^-'.-^3^:i-—ilP!i^^*";• ;,
' Keyae®"'"( 1949 ;-,1955 ') ' oe:i^€^:i'der®;;t'ha/t:--the;.prognosis- •-', - 
-for/-iffe'-is■'.improved- by;' the . -ipppieabion 'of - high'-voltage;■ ' ■
twats be^i^<^3Xe/-;tl^e^j;x•■xrm,Oypl^V 7-,-■.. , . -.' 
'He''P©oomraends the /t^a^.ent7de£^^i33^;^.d/^',r'03y,; -Mi-iimms'•'•.('1952)..' '
but-- acknoWiei&g’es? that-.it ' may. •"/abmetimeS' provoke;/ "--- - 'h.O-''. • ."/
,.t,emporaj?y exacerbation .'pf -the ' symptoms, ’ ■ -iy -
'have' ' seen. ' thia " --happen' in oases"'‘-hot Under-.. my "'" ooh parbyii’.''?>•->•• 
.Mo"Whir ter (personai Commnico^t^;ibn)/'^^o^i^^£^‘id^;^'s' " that the''-.'- -" -> 
■value'" 0f; preObpereti'v®" -radio , therapy ti®' '/very '-doubtful ' and, ' •'' ''/' 
oU 'his'' advice I/have, no.-t'' prescribed "it... ,dn" a recent-case /••’," . 
of- "'thymic' tumour- (MK476) »- '■ -thymectomy was 'harried '-put-- "7-/-' - 
on t4/5Z62 , and' he- remained' wei&,-uixn:LX 'A0ril--ll64. '- iio- ' .'' " 
was ' admitted ' to another-' , hospital '^ith? hmyasfhenie 'crisis,; ■. ",-. 
-de'siatant’ to' neostigmine' * v- "’-1 t was ""'.'noted" . that.. 'he' . had-;; - - '. 
-.-fasoi/oulation'. and brone.hoap asm-.he!Ore•^ denth •&6 ,thefh-is .--. • 
lit/tle doubt" that' death .Was due/ to"'.overdosage, of ••-'
neostigmine "' ■.(’Chapter' 19 )/; - - - -•<'.•- ---- ' " .'. ' - . /' ,
.••.,./ — I..do not •recora^8ind '-thymectomy 'fox- -the' -.emergency '"' - .
treatment of ,,fflyastheirLc'-cx*i®i®# -■'-,6x^^fi?i;^'?i^;b"a3.-.'( 1956/)' '" "' '--. ■ '.■ 
report' .iecovery of respiratory' ' j^!^xWif/-a'fter'-t^^^^^^^^dmy; ■ - '-. 
in " a-"case .of-"atypical-myasthenia, gravis in which' x’espirUtery.' 
failure 'had "'o'c'c hired,/and"breathing; ' Could not be " restored / ", 
by" the Use of' •antim/asthenic;' drugs,# In that. case'-"the'.'--■' , 
authors/- o - •. ./- ../'-: —7, ■'-, ' -- -->0 :' /-•-.•'
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autbwWev.recegnse- Ihe•’"possibility that: reapirafcory 
par a!ysis./- imSf" due, ib/;©verdosag©' ' o£. ncosti Amine * X £ 
the' -.nature', ,oy'.&/■! crisis l. is eorredly diagnosed mid 
the-'appropriate-fma'a$e(%en•adppted'/X.Chptw-19) there 
can - •• rarely <be - - indication /Aery thyme© t ©my/in-' these 




. Hwcies .. \' ‘ - . •-? .' • - " • " .' '' ..
■ ".. It ia' well -known that there i© .a' striking. lack/of 
. eoxrreXat>lon- between '/the.' .apparent patholo'S'cal changes 'in 
'muscle - and"'the severity of veaRixess ..which the aarae /^usole 
exhibited during ilfe» -• It .seemed reasjeaable that 'thie 
should' be so when-the advance 'of physiological knowledge 
provided an explanation .for the myyathenie syndrome in 
tom® ' of/ a ;-" functional ;j dierhsrbano® - of. neuromuscular 
trdnsGiioufiem*; ■ Tris 'concept received ©doh?, generaly ;.' , -
c^ccepi&nee that moat of /the-/earlier work on the ' histology 
.; of.myaaihenio muscle was ignored. or described so •• 
'/’non^speeiflo’y ;>/ f;J -\ ; / ? ■ ;"y ?.'/ ' .' < ..■
' ’. • '• . / To WMgef-'(19G1) 1© at'b3iibu't<^d/"1hKs . first / " 
description of focal colleacjfcion© of email mononuclear '
_ pell® .and ' 'lymphocyte's within- the mmssjlG. •- His’ ©tgggjshtion 
that - they wore metastatic tumours was disproved 'by. .
BuKss&rd (1905) . who . believed that ihc-'cells--originated.. from
■ small blood vesseli ( . * i'y®phorrhsges. .’) * ' QUrido ' X 1929 ) ' ' 
noted that ' they wore, often perlvascular./iB-'position ..and
. .associated with a vasculitis* - •• Tie impori'ittoe ’.of the • '■ •
■ XyffipporPhage has been ; questioned by many twokers on - .
account -.of the variability Of it© .occurrence* y There 'is
' ■cerifainly,; but a poor .'correlation with ..the -'severity., of 
•'muscular weakness .but 'Mendolow (195&) 'states that ' - ■ . /• ' • 
• lymphorrhagos can /be' found la ait--least -5XM of myas©lwlics3• ‘ 
;X have •an unshhsitasrtiatehl impression-.that. the ease . with -•
' which -this '""lypyaf ••lesion can be found correlates with/ the 
.dusmtionyof illies® rather ’than .with -the extent of loss ''of . 
. poiwe'r/" . . ,■ ■ .- - , - •;• ' - ' "
■ ■ ‘ ‘ X66-* .-'/ ' , ' ■ ' •' ' ''
power;,-.being’ mo oak'-readily -found in'the. 'active©’ --stage of . 
/ the /disease (Chapter .2)* /If' this 'impression can be
. c onfirmed ' th e lymphoprhage' takes ;. on -a new ' Irapo r t anc © * ’.. ;
■ /.' • ;/■ it has been further-pointed, put bj many authors 
/that "-the ’ Xymphori’hage 'is npt- exclusive to"--myasthenia gravis -
, but is also present in '.the, muscles in -eases of. exophthalmic '
■ goitre :. ( Dudgeon and'. Vrqhhar t; • 1926 X; ...rheumatoid ar thritis
and .' other rheumatic dise&ses.t. connectiye •■■ tissue disease, . 
chronic • infections; myositis and' endocrine myopathies ' -
'(Ogryaco.# 194$). ,-The 'writer was the first to suggest that -
. instead-o f dismissing,-the i^yfmph<^i\c hag,p.■ -as ? nonspecific* on 
these grounds it ' .might' be more .prof!table/to .consider, what 
. factor -mght be 'common', to. each of these diseasesi.'.-It was
■ -suggested ..that the common factor ' might be an. immunological 
■■■ -. /reaction sine&-lymphocytic . infiltrations /hr© common' in the
■ target. 'organs/of -allergic-disorders (Simpson, i960).* . •'.
/ /- ./■///■ Other -neglected, findings' -.reported by Buj&sdrd'’ (1905).-'
'..were. degenerative changes ..of/muscle fibre* . -These'were -.
' re-investigated and classified by ’Russell /(I953.K' ■ ■'■
Professor' ins sell described three ' types ; of 'muscle -'change * 
-These /are'confirmed. in my. limited experience and 'personal . 
case® are/used to illustrate them*/.' ' v
- • . • ,-,-ipe I (Tig»I0T) is'-an .acute -coagulative necrosis
of the '-.muscle . fibre with eosinophilic /change#. loss of cross'’* 
-striatlon#.'./and inflammatory cellular /reaction leading: to '
. phagocytic .-'removal of the fragmented ' s'muscle ' fibre. ' This
process ':may be limited to one/fibre' ' or so widespread ,-as.-td.'
■. cause .naked-eye changes in the muscle# b '/ ' ' - . ' ■
' . . ,■ Type II ' (Sig.ni'^O.'is the ' lyrnphorrhage# .Professor
Husell considers .that it ia: secondary -to ‘atrophy of-a .
. soli^1^^ra:r3^''muscle fibre in which the. ' cytoplasm ' undergoes 
‘ ’basophilic/ - •■ . ' ’ ' ; * ■ ,
 h'asophiiic change ;an&'-cress«stri&fc±6n.‘- is lost*.' ’ - 
. .... - Type -I H ( Fi g *2,3 - ) is a. simple '..focal, muscle fibre,
chmi'ge. with...: eosinophilla - and. BWelJ.irig.Jbufc. without loss - of ' 
striatic, or • Inflammatory reaction*/. • . ••
Russell ' ' (1953) does -not consider - that any of - these 
.lesions, are' ’specific ’ for myasthenia gravis* •• Nevertheless 
It - --V;^'s' obvious' that the - ■ Weakness ' of my as th'enial'gp&vi©. Is - not 
without.-' some., related - .anatomical changes* ';Re<c©n-t
advances In histochemical - technique/have - show .further 
changes .Which-are - claimed hy the - authors - to he diagnostic
'of ''myasthenia- .gravis*’- . ... . ' .
-mtftr -ehd^plaWsi//■ '/-/•
.-/. Mott - .’and- Barraa-w - (1923') . ••81,01^^©^ - the'motor nerve
terminals - In- .t.he/musele of a case of myasthenia gravis hy
In j ec -tiOn o f me thyleno- hlnn o' he fore -/biopsy •, EL ther -' they - 
were-.uhlncky- ofy-ad .suggested ::hyi-dhhtemP'Orary critics, the 
diagnosis -was erroneous • (though*the-patient had- a possihl'e
thymoma and lyymkorrhh'ges-were' found In the - mwles) - .hut It 
was’.by ’a similar .-.method "supplemented - hy staining for •. '
chooinesierhse./In/-the Isnbsynaptic- - apparatus hy ■ the -'method of 
Goutoanx- that ’doers/and. Woolf ( 1954f X9959) ..showeddfio'rid 
moophoXoglcal - changes of the/intrmuscuiar nerve endings In
myasthenia gravis* -These changee- are ...of two .types-' (Fig* Ill4) • 
In: one,-’•the- ’dystrophic’ type -'there. ‘Io - Lnwreased/b^anchIag o'f
the -terminal arhorisation - and the - terminal knohs are. '
distributed -oyer a wider -area of ."the -muscle fibre - than,-usual’i..- 
Thls .typo Io. probahly- reactive as the - related muscle fibre .. 
ia "usually 'ahnorma3L-.and - the seme - 'type ‘of ,Ghd«*pX&te’'h&s’ heen • 
found In - other - nouromwscular-- disorders; In the other type, 
the ’dysplasxc ’■ .there are - f exv terminal knohs- and these are 
arranged serially ' -'along-a’ Scanty- number- of terminal hranches 
ending/ ' '•-'•' - " .■ / . ‘ . - - ■ - '
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•/dudiiig hn'' a ' long■ end-plat e• region. : Woolf e t • al ' (1.956)
. ,"aad;Bick©rsta£f 'and Woolf (i960) cansider''that/. •these '
''bhangea -doT not ’•.roprooeht: /the primary•■pathogenesis • of • •'• . -
M/yrathenla graVLs but .-more - likely •Indicate degeneration 
and •/x'eppA.Lr « Bicker staff. ' and Woolf ' (196 0 ) and " MacDermo t 
(1960) ' .described 'a /remarkable . ./degree of " sprouting of • the ■' 
terminal axons after ' .their -emergence -.from the nerve bundle
- as• /in • co/H^a^-fceril./'r^eL^xin^er^y^s^-^iL^^t^hWh'i/^^i^haccC'^mpannLes primary '
degenexration ' of • the 'lower, • mo tor neurone ' 'but also seen in . 
defraato'mmbbitls,' ‘AconO, sprouting . was' most prominent in . 
• the '•V^'o:LnL,tj^^•-o'•f/■a\.,lymm.lsn’O^^^i^^^^;^^^/#‘\■Mclk^:rs^:^a:ff• and. . Woolf. (1960) 
interpret //the ' elongated /ehddpp.&tes . . as the. primary
abnormal ty 'though they ;ar e ' absen t in cases. vl th,' a ' short 
.history#/' The ’dystrophic ' changes' are/ interpreted .as ' .
■ secondary - to ’inflam&tot*;® ■ exudates -.(ly-mphorrhagee) and .
. degeneration of/muscle•fibres and hence ' .not 'fulfilling a
primary role in the "pathogenesis -of •myasthenia/' ; ' / • '/" - • ;
" . ' - ’• Mabermoi • (i960) _ confirmed these/oobexmviions,'' • ,
even .In muscles which' were normal *or nearly 00' onboth 
clihlca!'■ and elec tromyographic • examination : and ' with■ . sl’lght 
or • absent histological• abnormality with routine' .stains#
. She •further noted that .regenerative' sprouting frequently '. ■ 
/arose' .from end-plate knobs (telodeadria). These. /; . • ' •
prolongations may .terminate- Is • an end-plate on the same or 
another '/muscle •.fibre',' 'and at-.'this • site a • similar process - '
■ may/agaln• ,be•■/'•seen, • giving .arise to• .'a ''.chain • of end-plate's-
connected by a ’singlefine 'nerve • fibre#', /-Tie final' ■ / ■/
elongated'.end-plates may• give off large, numbers of very fine 
ultra-terminal ' sprouts,• ' Ultra-terminal• fibres • have • been 
described in .various 'types of neurogeMcidisorder in • animals, 
■and/ '" ■ . ' ' ■ ■ ■ . . ■ ' " ' ; •
 ,A. , ; >,'5169#'. : jin ' •
ahd•' man '.when/reinnervation' of.. ®u&Xe is •• taking pi-ace .. ■ •
• ( Gitmahn. .arid . ..Youngs • ' Opera ‘and- MoXf* ■ 1959) '* For . •
, this ; -r eaoscm • M&cIDrmp t 'agrees with • ■Biekerataf fand . Moo If .( X 960 ) ■_
that ■ th©'--ippeEaraiwea of ••■* the nerve terminal's indicate 'a •
.goihmiilatlon of • degeneration ' and. regeneration'*. . This' .may " ,. ■. 
account for'.-the observation of -'do^e /and, Demmdt ' (19.59)' .
•that.;%0t all -of . the end-plates ahowed.“ch^ngea' or .were . ,1
/equally affected.in ...biopsies Btained<with; methylene' blue* •
■■■•■/. ■ The neuromuscular' junction '.has been fuxther 
studied by-' mie^s of • eleotroimiLcrosoopy'* ' •-’Bekerstaff et ■ '
al. (1960) . were tmabXe.ho detect .any ' feature. which'-differed ‘ 
from . animalo.nd~plat es ■ (theychad ;io normal..-Inman .control©) .
and; in-particular they remarked ..on ■ the presence of ..numerous ■ 
round 'or. oval profiles■ 300-500 A in diammycGr in the axoplasm 
of the . terminal. 'expansion of..the; axon#;- (ft ' has ' been. suggested . 
•that* these are. ■ vacuoles ■ containing' packets' of ' acetylcholine • ,
••which.are released by .the nerve^s .‘action'potential;*'). Circular' 
structures' were' described in the . terminal expansions of' some 
.cases* possibly. replacing mitochondria* Their significance 
•;is' unknown* ; ./:'■ .• - /,-/?-'■ .
; ' SaGka .et< a! ' (1962) studied muscle biopsies ' from' five
cases .b f' my as thenia .ggavis by •ileo trohmicroacopy * . They' no ted 
two types . of abnormities of the ultrasstrUctur.ebof the ' , .
•n'eurom'ttscui&r' junction* The first' type' wAsr-focal . decrease. '
. of electron density. in .the muscle '.surface .membrane . ;vlth:in; /
■ the secondary synaptic clefts * ®iis- was; present in two '
biopsy . .specimens .described' as, being from l*chrpni'c -moderately 
severe myaathenia ‘gravis* . though ope -was a .child aged 2t '
with ' a..somewhat 1 uncertain ' .diagnosis..of' Congenital M.asth enla. 
The sepon-d... type ■ of ' abnormaaity, ' ' no ted ji.n /•thio 0 cases of ■
■ ’.rapidly,/ ' . * -i- • '■ * - '••' ' '
5 X?0,"
, ’rapidly progressive myasthenia or.. acute exaeerhatioho of . ; '
chronic/myasthenia gravis’9,were major ’ degenerative changes . 
in .axon• '• branches end,, subsynaptic apparatus,Th eae _ authors • 
support’ the • concept of the ’ ‘.workers; previously 'quoted using
; the . Coors ' technique.', that ;degeneration, of. end-plate-., and • . -
subsequent, repair may occur during .the ’ course of exacerbations 
and '•remissions of ,th'e.,myalthenie• syndrome, . . Howwverf,-'unlike’ ' 
the • work of; the light microseopists• Which suggests. that ’ .
the • lesion is mainly pre-junctionaly’Sacha • et al (1962) ‘ .
consider that their ’ work points• also to consistent post­
-junctional abnormalities (reversible in ’ • Type’ 1 and ; , ■
.irreversible. in • Type/ IT). .. . • . .. .... ... ...... . ., , . „,
■ ../..Further, advances ;in this f^^^elddmay,.bei . expected • , 
though interpretation tdLXll*• -be’’-impossible until’ more •., , : .
- normal human ’material has been studied. Nevertheless two ' 
important conclusions./carn already ,he rnide ;© -i) There’ is 
clear evidence --of- structural ’pathology-of the • -motor nerve
..'terminals. and .of ’ the -muscle ’'fibres/in 'gravis’ ' ...
and ’a • ’pure1 ’ defect of • function .’need no’ longer • be -
considered; 11) it is not’ yet possible’ on, histological ’ . ,
grounds to’ •‘•'say• whether the disturbance of ’ ‘neuromuscular ,
tx^g^nsmliss^on is due to’ a pre-junctional or a • post--’ ,
junctional abnormality .(Chapter 16,)# . ■„
. Central: Nervous System's’ ■ - : ' .■■• •
, Tie •. evidence’-of ’.pathological change' in/'peripheral .,
nerve endings,’'whether primaryor relc.tiye,• and • the • ■ hypothesis’
, of the present work that myasthenia gravis • • may ’be’ -part/of a •' 
.multi-system disease, including such• occasional’ symptoms as
, psychosis and epilepsy ’ (Chapter 4) make it mandatory’ to . .
x^C^«^e3^£^mine previous claims/that/'the’’ 'centrai .nervous system ■ : 
may. show;pathological changes in ’myasthenia gravis, ' .
' Neuronal/- ’. ■ ■ ' ■ '•-’/' - / '
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Neuronal ' abnormmlit'ies and lymphocytic infiltration of the 
brain or spinal cord occasionally reported in some of the 
early cues • were critically, ana-lysed by Me Alpine (1929) .
end' McKendree and • /Wolf (1935)® . v.Many of the papers reviewed 1 
preceded the modern era of diagnostic methods, others dated - 
from tho period of the *lnfluenll pandemics of the third 
decade of the present century, The dearth of reports '
since then could be due to more precision,in the diagnosis 
of ' myasthenia gravis or • to the,psychological factor, to 
which I have already , drawn attention, that• once a .particular 
concept of•a disease ' becomes universal any apparent 
discrepancies are rejected as' irrelevant or coincidental,
Th© ..nosological• position of . some of the cases recently 
described by Howland et al (1958) is very doubtful, .
In my series" the' following oases were encountered -
Case Nl/EO/LT, -This young woman was agod'22 in 1930
when, she complained of tiredness • (•■?• sleepinose) and 
xwoakness of the logs, • A . diagnosis' of em^f^y^iihU^'tis
. llthlrgicl• was made at the National Hospital',' In
1933 generalised myasthenia gravis developed after i
-road accident and;, during a time of business-worries, ‘ - 
There was initial response to' neostigmine' given by . 
injection but in• subsequent years the response became'
. poor* Helapses were precipitated by infection or by
emotional disturbances, .
In 1944 it • was decided to remove her thymus but she 
was considered to be too ill 'for operation, She died
at New Bad Hioppi^ta^t, London and a' post mortem examination 
revealed that she had an infiltrating thymoma,
There seems no doubt that she had myasthenia '-gravis 
but the original diagnosis of enc.ephaHtis wms probably
• mistaken, • - ' • . ' , .
Q&se' ffK32l7Q had a transient Br'own-Wquard syndrome.
Case/
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Case. -NH2Q468 had a -eauda' . equina syndrome at one . stage*
No further details are available but there.ia no.
. definite evidence that the spinal disease twas related
to the myasthenia..
It is most .probable that these oases and the others . 
in the literature represent the accidental coincidence of . 
'myasthenia gx’avis.. vith'-another disease. The earlier 
attempts to .explain muucular weea^ne,ss .on' the - . .basis of a 
central. lesion must certainly be rejected. - It, may, however, 
be worth. pointing out that the current trend of thought is 
to regard the fundamental mechanism of multiple sclerosis 
and d.emyylinating encephoaitis as ’autoimmune’ in type*
Thus it may be necessary to consider the possibility.that 
they may have a common' pathogenesis with myasthenia gravis' 
.though they do not ' cause 'it. The evidence is too scanty
to support such a proposition if only the neuropathology . ie 
considered but it needs to be taken in the whole context 
discussed in Chapter '7, , .' ^ , -
Heart ? r . ' - \ •• .• : ’ ?; / '■•*.' ' ’ ,, /•'* . ; .
In Ghaptit, 4-I haae referred'to a few cases in ■ the
present series and . in the- liitwho complained of 
precordial -'pain.or‘ paapiteHons. -'Apart from.'these I hvve 
not aeeh clinical.evidence of'heart disease, since dyspnoea 
was Usually accounted for by myasthenic weakness of the 
muscles.of respir&tQ0n* .
Most workers have reported no evidence of'pathological . 
changes in -heart or smooth muscle but lyaihorrh£goes and muscle 
fibre changes resembling those of'skeletal muscle have 'been 
reported in the myocardium by Weigert. (19Q1),. 'Bussisar.d. (1905), 
and other authors including Russell (1953) and. Rowland et al 
(195S)* A striking feature of ’many of these reports io ' that
myasthenia -gravis was associated with a thymoma (Brem and 
WeehoSer, 1934$ Rottlno et al, 1942; Giordano and . Haymond,
1944/
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1944$ Mendelow and Genkins, 1954; Waller et al, 1957)»
The myocardial necrosis.and myocarditis described by these 
authors was usually accompanied by changes in the skeletal 
muscles of sufficient degree to be classified as myositis*
The best reviews of this aspect of myasthenia gravis are by 
Rottino et al (1942) and Mendelow (1958)♦ The lattox’ 
author closes his review with the following statement 
♦Many investigators feel that myocardial necrosis and 
reactive myocarditis are basic aspects of the pathology of 
myasthenia gravis and require explanation in any valid 
theory of the etiology and pathogenesis of this condition.
The apparent Close relationship between myocarditis and the 
presence of a thymoma may serve to further distinguish this 
type of myasthenia gravis from those cases without thymic 
tumor and may prove to be worthy of consideration in clinical 
management** ‘ \
Infiltration of lymphocyte© has been reported in the 
adrenal glands, pancreas and liver, (Buaaard, 1905$ Bell, 191?$ 
Mi, 1946$, Bingertz,, 1951$ Rowland et al, 195$)I 1 cannot 
say how regularly-they were searched for,in the pathological 
material available to me but the following pathological report 
was present in the records:*
Case, MR7782 (W.X.O.-G.J. 8/33/48). This case is 
described in Chapter 7 as myasthenia gravis preceded 
by pernicious anaemia* He also had essential 
hypertension with nephrosclerosis. Death was due to 
respiratory failure. :
Post mortem examination (Dr* J.M. Johnstone)- showed 
that in addition to the expected changes there were 
small collections of plasma cells and lymphocytes of 





' All. the ‘authors ••quoted' above 'dascrih©/th$so -lymphocytic .
. Infiltrations. . as !hon*spheifi'e * If .is• Impossible to 
State -'unequivocEOLly . -that 'this "is not so, but' it pay. be - 
pore profitable to, consider that like the lymphocytic
changes. :in puoele ahd "-thyroid" they are part of a diffuse 
process' which pay be ipraunological*' ’ ' ..
.Thyroid - and " Thypiis ; " ' ...
The" pathological changes found in the thyroid
/gland. are 'more conveniently discussed in the' chapter- on 
clinical -disorders. of that organ (Chapter . 5) and the -role 
of the . thymus is . so/central-’to the thesis being developed 
' as;; to - justify:' -d separate' chapter ' ( Chapter 12') »/ : " „: • '. 
Reticnloehddtholial. ‘System;-'>/•/< ' . ' • ',• ‘ •.
The' -authdr’a phper- of i960, was the first to. ’.draw ■ / 
attention' to' .' the- o^^i^nal/occurrence; ' of generalised- ' . ' 
lymphadenepathy, /splenomegaly" or ' reticulosis in cases of .
■ myasthenia -gravis# . it - mu a t immediately'  ' b’e!. at at ed' that,, most ' 
cases /show 'ho evidence of disturbance of, ’this 'type. though- 
they have also been reported without . comment by -G&stleman 
and -Norris'-119491 ahd by.Ringerta "(1951)-» Indeed " /'some - ..
authors/have'drawn ..particular - attention to the ’absence of 
lymphoid hyperplasia"'of vlymph" ’nodes‘and- spleen* On the-other
. hand - these changes are . seen- in hyperthyroidism, acromegaly -.and 
Addison's, .disease which have 'Similar- thymic • changes' to. those 
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jgajthaegg?' ■ . -1//,'•' • <; ; 'V' /
to' aWoci&fcion' -of -thymic pathology with ' myasthenia■ .’
grrivis'has been -recognised 'forr/more. -thqn sixty years and an ■■ 
explanation;of ■ the fold of thegihymtts'is essential; for any - ., ,'. 
satis f ac tory •• theory ■•'of- the.'nature \ Ofmyaethenia ;gravisf•/,'' _' •
-(Simpson^- 195&)-* d-.feefeidenee-ds^fetwo'types ft 1). the ’ •. . ■ /'g 
close, association between- myasthenia gravis and pathological 
changes in the .thymfe, and, (ii) ’ the ;beneficial- effects of 
ihymeetomye;''''' 'Evidence jbf'.the/first;hind-will• be reviewed; . "//■ .• 
here* lh - Chapter; 10 it ' has, been shown that there-
statistical -confirmation that thymectomy favourably ,
.influence© the - .course 'of tife;'disease 'but only- if - ife-is. ." . '
.removed ' ; during ' the' .'- active ♦•/'striW-'df ' ■■'the - disease - ( Chapter . - .’2). -r 
• It ;ijs 'also' clear’ .that - the course '-of - myasthenia . is'more,,,', •. •' ■'
''severe dfthe'patient - - has a- . thymoma — Chapter-' ) ' -omd/. fe-f ' .•• ■;' 
'coopfeeetiione.'in-ther, orf^^j^23' are ..fioreol3-fe<^jly,rif^;:,^h3^moma ; ' - - - 
is . present/C ChapPerB-’7. and,'. I3)fe i'/'-M-y I/-; /' ,
Attention- to this -''correlation /was -first '-drawn-by - 
the report of Weigert (19011 describing q case of myasthenia 
.gravfe,fe 'which /there-fes '.a.'.; thymic fernour f Bel 1 .( 191? ) --/and ' ■' . 
ferria -(1937) 'reviewed-the - .'literature-ft different femes -/arid .' 
established - that feigert *s .. case was dot - unique*- They found 
that of the reported -cases had,obvious thymus
abhrifealifeegr and-.abdut,3G$ of -these; t .(15*20$"'of /all /cases); ' . 
were '-thymic- tumour's.* The<-x'eim^Jjn3^ii|- -^abno3?m5il:ifees -Mere'• ■ , '-■/ 
,dt«^i»or^^itbe«^^fas -'hyperplasia* -and Norris/ '(1937) ''considered that'- ' 
a '-thymoma . was '.not a true . neoplasm but 'rather- an extreme form 
of-- hyperplasia*Idevre* 1936- (Cited ' by ' SeyboXd et fe* 1950) •. 
carried/'- •' ; ■' ' ' ' .••.•-■ fe ;' . ; :
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: carried out complete autopsies' oh 6? mzasfchenic patients 
and found thymomao in 3&% and 'parols tehee* or 'hypertrophy1 
in a further 4S%# •’ • ./•;. ’
At that time .the moire ' persistence of the thymus 
pin -Mult life was considered to bo abnormal since the 
'■ gland -was gonerally assumed to -.atrophy ’during' childhood#
The other'-.assumption* which -remains 'in vogue? is that the 
thymus is & ductless gland of endocrine ' type# If this is
. 'true it .is very.-strange that no -normal, function has. .been ■
,, ..correlated .with its -'ppeaenoe*. that it can -.be' dispensed -With ’
.after . puberty* and .that it© surgical removal causes no ■ ■
deprivation symptoms*■ or if there are any they are ec subtle
./■'as to .-escape-detection-.' : '; , J'-.,, ’ ■
■ ■' ; •• .The.'/ffrst -of/these misconceptions .'was, soon -dispelled
by the interest of' investigators of. myasthenia -gravis.
Harnmr (1906) found that the thymus of non-myasthenic 
children and.adulte had . a wide variation- in . elsc and 
cellular!ty and Boyd (1936) and Sloan (1943) found that the 
thymus never underwent'' complete involution# Sloan pointed
. 'out 'that .'the ithymus from myasthenic, patients wasp not ' '
distinguished . from the normal by ''hiise (thymomas excluded) but 
by.histological change# He noted lymphoid ' hyperplasia . in 
both cortex and medulla of the gland and in particular the
. .frequent ..presence'-of 'germinal .centres*in themedulla ry - '
portion of the gland* These ' are identical .-.to the structures 
of that name in hyperplastic lymph nodes?#
The germinal centre (FigildXO consists .of reticular 
cells* large lymphocytes and '-macrophages#'. Frequent mitotic 
figures indicate active cell division and . the centre is 
considered to/be forming lymphocytes (or thymocytes)* The
' .-germinal'centre is surrounded /by .darker staining*-' more/- '
? mature/ . .'.’ ' • • ■'. .. '
./• 177* ' , . . - ; . ,
■..mature small lymphocytes* " '' : ■ ' ■ ' ;
' ' /.,-'' Sloan (1943germinal centre© in seven .out • ■ ;
- /of-ten.' 'operative:specimens -■/of ' ihymus...removed from ' eases ’ of • v 
myasthenia gravis . but• could ••rarely find..them in normal - . ■
.. thymuses afrorn cases'' of .•sudden-death* ''His findings -.-'were • ■. •
C.dnfimindd';' by ■•■'Bratton (1948),- - Gastleraart- ’and Norris- •.(194$); ': ' ’
..and MngerW/^ 1951 ^'...sand ' '- it ••!©' now.. -certain that, the • thymus -/' ■ •
of myasthenia/gravis-/is characterised-/by-,-the '••ps’eeence-.of " ■ ■
-■germinhl centres rather than hy-, ''Ihyperplasiah*.•’•Failure of .
involution '.might/hie ' - a/'mdre ' hoc eptable -//term*,', Unfortunately. ' - ■ 
"/this 'is • a/t;iiil;:tihf?«ffi^iOtihir:’ tO’.mq^t/ /pathologists* including-/.-’" ’ /
;■’beut^opjsttliolc^g'^'si^ji^-yahd'-^tt“is/impossible^ from the -material ; . ’ - 
.javaai^able to me , to- form "an '-estimate of the. .frequency-of • the' ; 
charge :de,scri'he&^^ / /'X know 'that .some. .reports.... have-Veen '. • '
',-changed , from • Jpormaif/to 'pathological/i whe^lr,'^/b^^Vv■^■''aske^'d'' . '
to - see the sections and pointed . out these ' features to the 
pathologist*Gastlera'an- (1955) ...stated that 68% of- patients 
with,,myasthenia. have;. this -■.-type of change* Wien/thO,.'-number•
.. Cf /the-,-remainder. .witiv tumours' is considered-' it -may .'weir be'’ '
... wondered if; the changes', described "are -not present - to -some? • - - .
degree-'/in -/all-/cases.-,' /it-'hasi- seemed. to me that, -.as ^tyith/the* •’
■ .lympi^«53rrhage«3'.-/(OOi3?t^«53e-//l^'i)-- germinal'•centres'"haiv©.been/most..- ~,. 
readily, found in',the -'/glands ■ removed-•-e&ply in the history of "- /'"'” 
■ 'the /d&seaee't- what -1;have -/Called:the /'motive/ stage '-"(Chapter -■ 2) 
X do not have /the material - to - confirm -this /impression but it 
would - fit - with -a - report, b>y PdeiXetoan - :(■ -1955) - that - although 
/.there,/. Wad'no' /correlationsbetween 'the /numbers''of ' lymphoid/ ' '■ I? ■
. follieles--ln/ the- ^thy^s/'and ■ the -■ciinicrnl 'course ' - of / the / ’/"• / ' '
myasthenia gravis, those patients - with fewest, follicles in 
■• the?. ojSeiaai^i^Ve/'.Spt^iCimen:: seemed/: to- /.have/a, poorer prognosis •/''.■■ ■••'•' 




,‘‘.b0; borrelatl^on' --be tween/ the •"number ofA-germinal -.c entree - .. '
A and-' the. /effect /bf /thymectomyf a-It has ybpea slwwn /in- /-"/.''
. _ .yGhhptex/ 10: that' the'■results' • of 'thymectomy. depend' more/yy a- ;.., /A 
•; •'//•.•oh'’the. durationAof‘-illness than on any ‘.other factory ■:../’'/ :
. i"ThymA . TundUrsi/AAA 'Ay A A A-iy ' , / . "v: . -..
"'/'• •■‘...■The subj ect .of/thymic tumours is A a' controversial "'A • ■■
y, - one which need'not '■ba /considered.-herby./. Thoreyare ■ a . . /
' •" .excellent reviews-', and uuggested -o lass 1 fie .ationsAbyy■/
: Oastlernah and Norris (1949), /'Murray and MeBohuXd'/('1945) . A ■'.//■
' . ''&ad/lyer©bn'Xi^5)).*/'-coommon ■ to "all .-'types '.'and /differentinting''• •
/■ ' '/'it '.frori the, ' non- tumour /typo of -pathology .b.osoMhedA above;
A, ’ A is/ hyperplasia- of ''epithelial piemen th though - the ; '.••/■//.'•
. i lymphocytes (thymocytea) may be . iho. main’ proliferating ...' / A ■ 
y\ - bell -•jtyjm //Tie ;mnAoriiy -of A these tumours /are encapsulated ■' • / y
' (•/F;g#I'2i‘2.) -.Tiere^is -of tea'-breakdown of ' central /parts tip . form' ■ ./
, cystic areas containing ' milky fluid and calcification/is'. <
■:-Common. - ''In'; somb Ac as e b■ -1 h e, ©pit h'elial. c ells ; form cords ' o r. ' A' A ' A­
. tubes, 'giving: the . appearance of a' secretory tissue ( the
. only /time Athymus /looks like -a normai '/endocrine /gland)> //;A'A..-
\ i2/3:)> ■' A//'aAA.- y '; - A • .A- , y..A- / y: ■ pyy y , AyA /
•/ \y •*'/,A/A'A- The typos A of //thymic.'- tumour; associated iwi'tb myasthenia /
■ • ■'•/gravis■ .usually ^benign*/. .If/mal^^'nnn^nl^-tlhsy are.’ obhisiderddAy
' -• to;Ab'eA/'di-ly:-yL‘C)c’6^3t3^2fA;j^ai^:i|fn^sniti./wlthin'A-tha thoracic A caviiy#y yA A'­
, -'Spread-. may occur - by ■'lymphatics At©/ the 'neck' or /diaphragm,' or A// /
to the '-.axillary'-..and/coeliac glands and; to the .omentum AA 
(Keynes , A1955 ) * AO. do not' metas tasis.e by ' the , blood' str em .
A\ . (Seyboid etyal»;Al9595l;M3:rgahi''-andyE^ud:t'ey;iA/1955) #- ;- ..// •;///■////?' '■
-A, - ■' ' Tie - ..type A of tumour *- /benign ,op-- raaltgh&ht $ Asebms to' ' A - hy 
-a beAof' no - ■consequence ' BO/Afaiv; as the. Occurrence Abf-myastheniaA: -.A'.''
■- ./gravis’' 'i— co'nberntedly'A’I.t /may be mbr'e'; signif Icant /that many/ "
©bspr-vere.' have noted /lymphoid' follicles .' within . the - tumour -A.
’ ’ '.'or//-- - .'/--- . A.A/’. / a . . ' / //..A.-;’ y . ///■;"//"■''■'
ri'.fAA. A . Aa 3£Z\M^U' •<
or in 'the - surrounding ■ "'normal' -thymic tissue beyond -the .
' .'/ “■■ capsule- 'of - - the -• tuim<0iUr.’ (Oastleman and .Woof Is, .' X9**?? ;;7;.,,.a7 -•■L'
; " Mngerio, 719515 .'Mendelow-.-'sand,- GjhclhS>• \i?54)•♦•'.; My ;own A'Aa,. A . • a
' A' .'material A-Conflrms this,.in '■those inst&ncesAwhere 'a '.«-• -■■■> • ‘/ A
ii.searc h • for-germinal .c entres -has been '- made (Rig*'*, A ’ y 
_ A., - • - ■ a. /a ' - Reviewing1' - - th os e <ch£mge&,'' A, haver sugge's t ed - .that 7:. 7a ■ ■ i
there ' was - -'mtU--evidence ' that ’-'the- thymus acted; as - an 
endocriUe organ inAthe ordinary sense hut that’the - A A 
features moat regularly associated with myasthenia7gravis - *
A-A';..germinal -centres -■?*-were, mofe"--in. keepin^-vAth an -‘active organ 
7 7' 7 if - the' '('gimpsoh,-, 196Q ’ $, _ 'Wile' A-... 7. <
thia; i^ooturo - was in.preparation, Smither© (1959) 'writing - 
.• ■ ' /OttAtTuidupa.;.•ox -theAthiyfoidAid. relation -to -/Bome general ” A ' ’ •;
7. cOnoeptS-'-of neoplasia.and ;t^iB'-'-;'Ole'’Of..the. ' ,
■ thymus and .iS^y^mphOoyt ea, .'remarked <that7-thB' . thymus-' - changes .7 
•A - in - myygihonlaA'gravis ’ resembled ilo .changes to be .expected '
; < In ‘‘’autolsmunity 'At ’the' ‘^^ae.-'. these-.two .papers’ were, written •
■\ Tbhe --thymus-.'was- .still .considered to be - ,/an --endoc rime- gland • -
. ' .'.-.The- evidenc'eA-for -Ais;- ' IrdmunolOgic al ..role...foUowed.. rapidly - , 7-.
' ' 7'■■^:nd^AthT^^.AW^Jt^;'nlwAl^^^'■^^^p3Cri^l^€^cl* aa. A.'..;. ... . . A.A7- aAa;
• . The - '- physiology- ;of - the;/thymus I .AA’ . - AA ’ : ' 1 A ."T' - ■ - '-7- - 
'A .AA A-a-AA'A^a Ac:pAiPAeeiV absMoeAof-- .function in normal -people ■■ A. :' '
•• A7 has .hausedim&ny.- workers- .to-'fail- - into .the - -trap,, familiar.-to•■'*7 •'
■ neurologists, iof postulating’ 7*‘functions'' - To - account for- -
' AA•.•preSumed7mechah±Bms7©oeP\ih7disease•. A-.Txus.-all clinical 7 " 7;
, . thinking. ,-has ;been-concentrated-on -.the- lines 'that ;(i) -AihO A .7 AA
' .thymuAAmxist; -boa& -■dubtiess -gland .which is ''not - necessary757. ' -A,-
7'A after.- puber.tyy.and.-that it has.-., some -Influence on growth,': 7 a-
/either-.pro?'or ’ .ilStaunta!,.;- and (ii)- that -'it secreiesAaAp-A ... 'A'
.'A ■.. c ufax’e *^3LiLke-.Abubsf anc'eAthat - bloges.;;neux"lm^isS.uU■ar’ transmission/ •' A 
- ' ■ O^;'■'^^xl,t{3i*;Xex^l^£3. - with- the synthPBis7lf-acetyleh0lnpet A ' '
Mj3Ssxc^t^i^3^'n/i'
■l8o.< *
- . McNaehernAC 1943) and Ksynes '..(1954).- 'Wonidfed 'if _ii/might "A" < ( 
,.; --serve. -to -• restrain - •t^he --•.muscular' ’. activity -of' the foethe - in'. : •
. '/utero*/• . ' /•' A''*• '.■/ .■.//.; f -p,. • .' / • '.-
*,.foxin t A. ' -'./’AAA- ! •"//';• . .
•. ';/-'AA/AA--. d'-Mler-( 193$) claimed to produce weakness in dogS 
by- repeated implantation - of thymic tissue and that the
. weakness 'was '.relieved--'by '''neostigmine,* / His - findings •/could /' -■
not ' he/confirmed by Bomskov and- Milaner (1941) and /
He -Each em (1943)* Constant et al (1949)' described ;a 'curare*
••. -...like' *A action;‘.df "saline-extracts- of i human, - thymus ;ih ’the ■ eat 
•' /which >m^^iSt^‘</^:^iJii;err.Jau^^i^<>3Sl3:;'failed-/to- 'confirm-(reviewed ; by -’"/ ' - 
' Eitont'j^it//s^a^1Yi9B)''^e;y/. ■ f /a”’’ ?' ./■/'.' ;
'■■ Inhibition:- of -acetylcholine - . synthesis* ./ -A - -./.-'/A//'--;--
‘ : , / / MilspaMt 'Xii (1953)' criticise/ the fpf evious-/work/on -' - - '
technical - .grounds' ''"such aS'<?ihrori^^eci:£^oX^<^r^t’/di"t't^;^mic /- ' ' • 
tissue or/ inadequate; dosUge* They - obtained - thymus gld^nds'
. removed. et.. operation -'by Mr*. Geoffrey; Aeynes froni’Wg. cf/the.' "/•
--. -patlentS'/incU-uebdiin/the/ - present' - report/ &hd--eotrac tod - -them- ■
;' . with/ac Stone, -/ /The- acet^one*insol^ub3^f^/fx’e^c/f;:^oh■ .Was hom0geni&eU 
. with - saline/solution, centrifuged. and - the supernatant fluid.
- suitably-' adjustediferr.ph. /das;- applied-' to ' the'-phrenic - -nerve,/
/ diaphragm -preparation of /the 'rat, /-'They- found evidence '.of -■ •' •
'. ; h^1ur,^rmse^^^iax*'^"^b^ock' .and ' c-omp£<ed'it With, standard " doses; "Of A:/"
■ -. d-tubocurarine - AchiorideiA; /They c.Xaimeu;•/tc" -'show; that; - the/-/, '■';
glands- which - on - removal - produced - . thee- -gost ' beneficial.' -■'/./■///'/ 
A -./therapeutic-/ -effect/ also ---produced /the -'greatest - depression'A'd'
/; -; in - the -the- : herve-musc le ' - preparation, . d/dsl'n^n^^^.- ''/'
'/ from' - '.'normal - .infants'(autopsy- /specimens )' - 'also' showed-high,. ' '- - ' • /
'/-activity AWher ease- adult- glands' -.did not* - -The-'neuromuscular- ;;- '.
, 'A blooding'.‘effects /Were/, trqnsieht'’ and'- WerWnof reversed-.byAA-> A . 
A .■;.ne'osiigmihe. '-.(itoson/and/ WilsOny/ 1955)1*''/ In a .comment - /on- - the ■ 
A latter// / // / "'A A' .///;.■/-A. ' ' '•/,//. /" d . ‘ v'/.-A ;./-///
<///';> /;/-///<. i8lh">/ /v /-//■/, Vy-hh •• ' h;7/V •■ F-//■•<-/"'
: la tier 'paper -'JS5aoi6B.'.('195$itstht^jd -that he / had /obtained '•the;//-/ •’•'•• 7 ‘/'• 
.Game, "ef-fect -from-,both/acetQne~spIUVie.\\fm& ao.etbnerins'eXublp .' ■' / / ■
: extracts - 6f ' .’myasthe'ni^'-Tt^b^ymUaes' /but . found■ that’ the .muscle' // • •< .:^Z 
■jeeame--':Li^©xc'iita,bXa -to direct •'’•stimulation/. as weXl/ashto... 
'indirect/stimulation/through/the 'nerve.*/.; W was''ahie/to/ ’• ' '! ' - '
account’•fd3*h:the block by' finding high. conoehtrationte  //of.
potassium irt .the^extracts»\ -/l///<‘ •• ••••> .._?..' • /;
///hvyhhespite this criticism *;-and the ffilure of other ' ' ;
Vo rhers' to .con firm. their reports ,’/Mlsbn■ and'- ,his/co^orkers..., "' ■■■ /■ 
have continued be '•s.tudyy'th'h ■ pharmacological actions of extracts ■ of 
human /''and ' foetai \ whale / thymus \giaUda?.wh^ch ■were,' ©tated/to' ■/'; ':•• -■■'■/ ’//. 
produce/effects of' the seme' order ' (Newell' et &!,/1959)»-■. ''.//•/ 
.phe"’Liverpool’' workers -have‘-recently .reported" two ' Quaternary / -.'// 
nlhOogeh/baO ea'inh/ex traeis',from7 - - t ",:
.patients with myasthenia/gravis///.These .'wera-also-identified '%
(by;-a<'ep-lorim,e1bria•■ method)'- in post mortem .specimens- from;.-/'•.. 
Peonatal^lnfantp. • but'• .tipi.''in •■ normal;/adult'-thymus. ’gl* ■ • Th«r/ h ■ ..-.. 
•compounds-? have /not • -yet ib’o.en ■ :com});^<steii^^/-<^haraCtc^:!oised ; but"■' -' ■ / - 
-Wilson/emd hih co* workers' consider them to be quaternary .. • '
Citrogeh-compounds*" ' Restricted thnrmrboiogicaX''///■- ;'/: •- ' /."
' investigation' ’did' not /.show' .any ■ neuOo&uscuiar blocking. •-"'■•
/effect;/ /Oh/ the '.• contrary,. '.the OeSponse/of/ frog ' Oeotus t/■/ •<■. . ? -.•
^^S^^^^<^3Le;■’•t^^c''h^<5€^i;ylchol^,i!ne/;w^^^j^•-'").ot.t^n^ttLa1^e^C^>''5^n^^dL. the ■ effect/of/’/ ■: ■ - •
iuboeur&oine;- wah revercM*/ -/Tiey. suggeO'h'; (Howell./and -Wilson,. - '-;
’1.9 $ 2)- '••;thha tone/of/ihe ■' sub stand ea' - r-heemb 1 esh die<^hyXc.holi^^^e "'■ /'.. / - 
.and :speculate' ’hoc.'its -having /properties- ■ similar - ho■ ./t-" • -/.• , • h"
-tr^;^'et^l^yl/hh0.l^^^€^;-V^lloh’"in'terfeo^.es - with'/the synthesis/hf h •’";''/'' hh '/ 
ucetyXchoiine■ in' ••the hic>to.h 'nerve ■ •terminals-’ .(.Chapter' ih)t /- // / 
:-Tiey '.haYe-hot .;Css0hS t rated ■ .hyny/effect- of this .hatUFh at /h/ '//•.-■
’/^lac^'tiblla/Q^^writing> /■•/./ '// ;/' h ,//;;/•'/'"'" I"’ t v//7 /';777l-'?/h?/. '
■ .■ •/hfO.d'ih;''and.WoXff/ (19^b) '.'hnd- Toe thewi-e■ /and '•hWi^l^^ •. ■' - ■■.
l1$hh)/have ■ -'previously /claimed"/to ■ dernoostrate that .h
extract// '' '•
ms?,*.;
/extraCt'/int erferoe wlfhAfhe 'synthesis /of acetylcholineA 
Htoerk antAKorpefh(194A) and Nelgh/and'. Hyde (19b5l •Wer©‘; 
unable' tq reprpduOe' ;.fhhir .results#// A^his hypothesis seems 
basically improbable. in the: first place the type . of 
neuromuseulor block caused .'by' inhibi tors of acetylcholine.,
' ■'.syht^i^i^e^'iPssucl^^^^asAtjti^'et^hyl^c^Jiolin.^is^s''not •reyers&b'i’e- by.,.? ,.'• ■■■;. ■ 
; a»1?$chMinesterase comppundis#• /An -<'the - ’ second.'..place '•• it - .-.would'
' he .difficult' to account /for ./persist'ende. -of myUsthenia /after ,.
.^thymectomy' and . impos sible to account for those cases which 
f^ir^J8',^^AS^c^UW?;>^ma^t5h'■<^3a•lLQ‘•'iejlgnB/^^a^l^^|.15^:l''^\<’^b^^y^mlc tissue /hhs''. //'
- been-rcmovedf '’gatoniAt AglA'X955) * AaaAa " ’ V AA-'A ", A AAaA 
Gontro^iof.jgrowth ; A ' ::A' • A' -A" - /; •' a a aa/A'' ' ‘
•' "A- A AA.Ai$ce.,th'.e Ahymws/As/peXAtiveiA' 'larger' in - ’ArowinnA'AA A 
/ -Children . Ahab '3% . 'a&dlts/it . Aa -not, burp-rising ; that/it .'/has a. / "A// 
been ' lA^nsideAe#? to'/produce/a' ' growthA'hormone A'A/TiO w^3PkA^is’t Aa-
reviewed;' 'by' .Oamer/'nA(l945) • and need /not beArecounts^d/h^^Je'e' ' - ■
. as .-all" Claims' ' made/ 'An '/t?heA/ra? 19£0~40 ■ wef.©■ subsequently ■ ■' ' A 
: denied Aby/other 'workers*' AhH^<^l^e^lt/l^^i^siO^ns^AasJ5P^cit;<^jf///i^e A t/A 
■ woikA ' Thom, this /era'' ' may/ justify • fe&ppfaisal*"' .Rowair©©' et' A - a. 
'■• ai, (1955) '' 'gave ; daily- iAt^3^pe^itoAehl^''//.^jeC hions''of' -.acid " / 'A 
, watery ^extracts/of young c'aifAncckAihmmUsAto 's^u^^<^€^£^‘^iv^A ' - A A 
. generations' of rais^A/The first' '.generation' of/ratA;beeameA A" 
y-heaaier A ' brea'-'rnor'e't-fr equ eh tlyvand '.;gayA,Aise -to''• larger lifters'
of above ' average -weight# , The.. Overage/ weight - of ,.the seventh
//generation ,/ab- -6.0 'days -was 'l80 -g#.' against ;10p-gA ' in normal aaa 
,yat's«#Ai1'bu£ -the '.excessive /growth /was / However, "
-• aA'claimt. which/eonld'-be, 'significant that „ the A&aXier ' ■'
;. .-if not/, du/Ao, / A A.'
precocious ' 'differentiation' of/iisoe© A- /This -’.work -seems' -to' A­
,'. -have -been' •abandonedsince JSegaioff, qnd ''Neilson (Igbo)' '-And. A, /"• ■­
others were uiiableAfoAonfirm- itA/.;, / ,•- a/ .. / /,.' A A - • / / '
- AA'A /Morel/. A AA- /-■■' AA' A.;/' a- // AA- . A/a/a?
 /-. / „ A?s/ / ' /iB^As • <s/ / ■ /■ \ r / • . ' / _ -
•"• gs>•: 'Morel/and ^aiaeete. (1939). f^ound-that ihj ections of A/,/ •;.. •• '
/ ^growth ''-3hbr^K^i6rt©/ of- the -an t brior )pltuiiaryA -in to .-rabbi t s // '/.'
; .; scausetl' enlargement s'f. 'the: ’thymus but /i^mplantiati^ons/ of - " - .A", - / /
; , thymus inhibited the ’thyroid'/gland’/ of the rabbit #
Bhffldt/ and Huliquist (19.53)# using . crystalline . /'gx^owth .
/ ; .hormone -\ih^..:jrr^€n^3^ftn\^;r%t^t0i/;co hfirmed'Ath afrit caused' - /•/■>'. ' ;/. A/A
/’AA hyperplasia of’ the’ thymusi/-Cornea' /i’$5fei ’reported.-' / , ■'■/•’•-••' .
/ experiments /from ■..which- he '.’''con eluded-.that; the '.‘thymus' was . ..' '
' a ' significant factor mediating k);lhe‘; growth' effect-'-of --•'.;/ ' " . / ‘
•’anterior ’ pituitary /.'growth .'hormone and, that ) iss.i.ntf// / '•. ' ’. •
, .•■• ithyroidt ;ggb£re®®s9£A'pf the activity ,"-^ , . • ■ ■/
- ' • Of -thyroxine "oft targe f, tissue's -such;, as/ muscle ' (Ooms a -1958 b)'. . ‘ /'•
/ Biawsoh: et. - al; (1942) - .considered that the thymus inactivated . - / A
,.'.’ the 'hyrri^d^sfiLm^Ui^^^^^^ng -"hormone. of. the - •.j^d^.tn^.iia'ry./l^iii that" A"
' - .-. Afhjg- effect; wasBaleo.-/preseni/Lnn';. lymphfglandsA ' "The.;, • ■'/•' •. /•
- - '-extensive literature 'on /the ’/'action /ofthe thyroidA^apdn/' •. ,’....
/ adrenal - .glands bn the thymus is reviewed. by Gyllensten // '
.. . '(39?3) # It,is -quit ©/clear'from';his ’review’-and' his. .meticulous /
'’ research - .work /that 'in'/ all those. - relationships -.(of --/endocrines '/'/A' 
/ ' A;oj& thym.uoAand' of /it^y^^fli^^^',.f-i^£3i3txe-'a^n,'^^^ndicr5nc'- 'glands)'/ ' the A-’.- • / * -'W/A 
■ ■ /thymus-/is.'&±mii&r.:.to the /spleen- /.and -lymph . glands -'apart' from.. -w:- 
/' quantitative' diff erpnoe'S#.. Gyllenstei .ii highly - '-’critical of . ' -:.
- /' .demsa'i..Work.'.Whioh’- ;hev<"ois^ders..i.o /be '•unsound.- on statistical . '■'■ /s
/grounds# He confirmed- .that 'thyroid - ‘ ejimul'atioh ' followed ■■■■ • , •••’•• 
thymectomy’ in ;th egguine a pi g but"-"l''"^<'as,"?,;Abrns^it^ry- -. ^.(it- is.) ,w
' ’-. .possible ’that' Athib/ac. 1102!^' brief f ihdu'ub’it ’ isj-coulid;'account-
for ’.’the transient /retraction-'-of the/-uppar '"eyelid whichaXas -■.." •//..
' ' haye - noted; after t^y^5^mect^^^my;,foI"A/ey^as1^l^/eI^3.a -gravis .*W.?-/■/■, • ..' ■/.■'
AW Chap ter.10 )’’• i-The thyroid ntimulatibn -was- accompanied /by. '/ ' ,
■ a sliiJght"-'hyperplosi4 . ofY-lymphatic. tisuipeb ■.. 'Be- also .confirmed
' the.-..finding of -Rawson'/et:’al (1942) ’the- thymus'-is,ai W'- ■ "
• target/• ’ ••;/•'/•///••.//•*. ' . V ■ -. ,'A -<• ' ' s ’- '. /.;•: /• ;
;'' bwiget''Opgwv ,V fw< the". th^xotregMo Iwrmwoaan# ;-tas . \ .- ••'< - ■ •. 
power he Vnaooiivatrit*. ./’ ..;
7VhHV’■MiVox^rihemfe.-a£( indie ating? u; feniam-a©,-' " - 
- &yiWe<m ' growth of ' thymma Viqmio- aW' lymphaMcr tissue with - ' 
■, .axis-- Wilmg -nEs^a' Pogulaiw*- ?'\" g V ’•■
•The.■ hym.s;.cjaa.;-(a;;i^:ymp,hoii-d-; organ%%v / ’fg-vi ■;■/ % - - •'?•<• /••'/'-?'" ' , 
\’A,/'- '/ /The rweahXne6©V' 'WtWeen.. ^he'th^mh^-onlja* . .' ••. .
.• lymph 'ar^os:-'0bVi0^U^^*^i'^^OE^®4l-^4Ai^^^3;o^gf3t^j^; nw agree V-/ .•••
/ Abhi .’fehep'e aueOn£^--©/L^nni^:lcant' differeMoea /between ■ihymye. T.. - 
' /. Imphooyees.wd.MOwVt/lympheeytee hut .-therV.' are/ qerf&In ' (•' •
' • ;Mff©rcncoe< ie f hettO regyonto Vo/^n^dlff&O&ore • (Xqil’^y- ' • -' 
•: anl'-feennhice#/. 19 S6) A.' ./Vhe, .thyMw' fiVen A reefer-mere''' • •' '. '
.• - Intend<li -and $O>r0: to .'the-'-.
' in^q>'lutiioai/l h;riJoot^/^;-?^:^v a$ren9e9>llbqt:tWMhT gonodo trophic'' ;.
hormomw .v uoxtyd hnouoneo ((Mnny et al, 3991; Dougherty* , 
’VlV??)/ , TW'Wnhept -of’ a 'thywetympb&tie "^yaom*.. acting ./ h.- 
•/ 'together -in: inf ebtion'a« tlyi th - •- sim, ?"' ' •
; ■" Vme Per $■■ • mu ■ 'MdejlF'.'di deiwe ed'. -. taere Vh vv Vth 1 P ty y wsV- ago - '• ..;,. 
; ■(Kaimnnev X93lV,w-V\Oh/dfffieuXi^'-.in 'the •'W'0pfcM'o'y’ of .-’ / •/ ■
:VV'HoUAoendotheXia!" Vole.. for . 1W; thymus---wai its/apparent ?''//'
, ' fMXwe/ W-';R’tb>cit^0^c;;;M^h:ihod3eHi*".'-''#Vda /.objection •-became,. less ',...
. V vaiid/when ,11/fha#;/ •ahewm ithafelympHeni tan-/entering -thn ’.blood’ '
( 'vtt^'nam 'fx^om the- ; diiot/dpintfVc obtain 'anfeiboVioei.■;-••'•■
/; butt'; are .''«Ca^^a^15?^;^^ibf.//PX^>dtu^:ln^ -them''fye/yitjo/. (iVeeXehy X9^5>2-)#J ■
■ IRoio of' ifi^untpogWl. weeeesym'<VV'?///(' :;-'«'•-•'- ...W- . i a
,/V V ;//'/ /VJlWegweo thu position’ '.X953/-59 Wah l/ ■/-■
, V/wwon iwyahiagVihg ;-
'ooh VhUt./.ih tho.l?w^low-;'.o3i^''fconni'h"hul entalftiahing ti'in/V>; .V' '
YthymOc Wmy Jhad V^Vlnnto; valua .In 1'WtXoVatment .(Ohepter -IQ)* 
liwnXecilob • ^i^L?tbotle^Ih^unV;;^;ia^1tou:• of’ •thu-'dlooama • '/Vnl ’ of-j / \ • 
;•;'Abnormli fci ’
185;.
/„,. -abnormalities•of 'other /organs •• which' were..sometimes. present, ■ 
•’;•; led :m©A"■ to.. formulates as/a-•hypothesis.? that the ' disease. was .,
_ qf ; thetA'pe^of /abnormal.. immunological ?'•/■' /A
/ .. ■ reaotian<**; - .The ••rele- of.-/■=•.''•• 
?''. •• •' the/thymus had• rnever?been- • •• satisfactorily ,fitted-' into -epny "A ■' 
A 'theeMee:;of: the miechanismr.of'.; the• disea'seY sX.OOnM4eW&?AA-•
' ‘ ' '-'.‘that ?tl^f^"‘;rc^^^«i.€<Lid3aships'-<wqi^Itd ?be -lOgicalAif ^<he-"thymus? was.:- " 
,.”.: • funetioning? as?? .• 0/Xyymhhid?brgan?• r«Lthe3T?St^’ha^n<iia;-?a.-d^uetless . .
A A? glmid; -jin '-the rime/sense*/ "Wile ‘this -'.hypo then is -.was .b eimg - 
• .^A//elaborated - sm.itln-jrs?/((Lj^^!^_9) V-wh o. bad been,studying-the .-jraie/--, ' 
,/’•?nfSthe-thymuo'a^j^d/'lLyrmphpC^tes. inycLLs.eahie .with-.special?;?/ •• >
. • -"reference Xhat "'the?:'. "sere- -implicated, -in '
??■’autoimmunity A-hd remarked :"-that, the thymus ". changes/of ./< ? ■-■ 
•./••myasthenia, gravis resembled/the Aymphhdenoid . •’changes -oofs .
, .; <^he<^t^;ro>dd . -in? Haahimotq 's-'?ddseasK;'a.hd/!mghhrhe --dne/.to/a?'.,
. ?/?? similar ..autoimmune. proeess*s-.b/interpret. .the "paper ■•../.•••/-/
■ -• ••. correctly.v/Smithers was'suggesting that " autoimmune?- reactions.
. may'-predisPose ?to lymphoid; tumour - formation,’ " Ma . - own ,/?? - /-//A 
interpretation -Ls./the. exact con’/^^i'se).. - /Auulng" -thia\same ' 
?periOd»"'ALetcaAf" C1'95$) •'■found, . what• may"-be -/the true . 'hormonal.' 
function, of• ’the."epitheXtal/cells-bf'' the " thymus*?? prom .a"" /?•' 
. culture •of.-these?--cells be .. isolated ■•- - o©13Afree? factor .which 
could- .also• be ■.detected ?in - -the •.•blood plasma - • and "...which . acted ' 
"as/a? 'lymphocyte -^.tlLinm.i^^tj.ng/'faoi^iar^,
■/-. . .??;?•, '" -/On 28 th Aprils/196>0' iO ,$0^^^0111(5^10 'Lecture ,? 
/ in.- the.? phiyersity. Of./EdinhUrgh • 1 • .summarised.‘my - work . and. ? •. ■' ■
. hypo thesd^fs?"^.s\?4*t then stood, //.To: the best-of .my.-,knoIWJtd.go ■ ■
' ’ -this ■was -the .first, clear’■ statement of an . ■ active, role .for- i". ' 
.5 /ihe/thymus?- in- an to immune - di $ eas es and the . first; .fully ? . •
. elaborated/becount pfy myasthenia' gravis...aa' an aitioimm.ine ■?
-•“ disease* AA'-'' A. A-'' ?■?. :/? i - '- • A" / - v':'1 ?' '•■ .A"//A i'
"'"- . -.; ■■ A ? sy n thesis -of the previous - -.work- ' reviewed- above " was
..made/-/-, .’A'/ /A/ ??.?; e/-/-? . - A-. ' -{ / ??-- , A?-., - AA. ?
‘ / •: /; .i86*.-../;:/'. - - ■ , • . .
made In the■ interpretation illustrated In Fig# 12,5*lt 
was suggested that:,. .a .gene tic 'ally-determined .pituitary-'■,
• hormone./.somatotrophin'’ or - a related/euhst&nce * might •
• controi-'the.' ■sir/e'- and ’ aetiwiiy of .the/thymus * The 
thymus - In ■ turn alight■ he responsible'■ ( with another
■ ‘fraction ■ of ’growth ■ hormone) ' for differentiation.’ of ■,' - '
tissues in the embryo ■ and ’ infant ■ (cf* Rowwtree et ■ !aX| 
1955)* ■ -The, new speculation was ■ that the only part of 
this '’action ■ ©till...required. after 'Childhood Is ''thep •••-<••. > 
differentiation -of; the' ‘blood- ceii©**;. 'If the re^'^lciil^o-*’. •/ /■, 
endothelial -.cell©,.-be- Considered as'/^3roi^<Ji*^forming .
organs, this ■ idea .may.be expanded to ■ '.cover a 'control .
•; of .certain -plasma ■. proteins# /'. The ■ concept described '.in 
the lecture ’.is. shown in/.Fig* 12.5*' It'■ was condensed for 
reasons ■of ’space in: ■the ’ published ■ version (Simpson, 1960a) 
One Of, the -functions of the -globulins formed ■ by 
lymphocytes is , undoubtedly ■ to act as ■ an antibody ■ against 
foreign proteins* - '1-t/ was suggested that the thymms■ 
might produce ’ antibodies against ■ the receptor protein 
of muscle cells* In 196p the prevailing view of the 
autommune mechanism ■ was■ that a normal antibody*producing 
mechanism reacted aga:^nst ■ protein ■ escaping"fromnormal 
cells ■ i^ni-.which -it■ normally’' be isolated■ from■ the ’
.anti body-foaming cells* It■ was accordingly suggested 
that the muscle cells ■ may be primarily damaged by an 
abnormal pituitary secretion or by ’ a ■ delayed~type■ 
allergy caused' by infection, deductions based on the 
known ■ precipitants ’ of myasthenic ■ .-relapses*/; -As /a■ result■
'of ■■■further /studies ’ reported ’'in ■ /15 ■ and the
chahging .view■ on. autoimmunity, .’■ ■ I' ■'now'' think it ■ is ’ ' 
•necessary// ' . . - ,,/.■• ‘ . '■ . •-
• Bete£©ary; .to ■ goheldPr'that .'the thymus ; is .producing-■ • 
ahnOiTMl • antibodies.. .without ■-provotetlon /from' a ■' *XcmW’*. •'
' in'-lhb .'target' organic; .taaml '■’ '
mechanism - .described 'herb etmnot;dho. Ignored mid will. be 
tether ,'adwrtte teip'Chapter 14* •;V - -- .
• - ■'. •. _TM '-Hypothesis- gMnte ..rapid -support -in tte next'.. '-. 
two •.years frte - tho-work of .Miller C19&X').., on the 'effect
■ of ' thymectomy on one*day old >±00*- Such mice appear .
'normal; for; about • three months and ■ them ratter p&pidXy . :
..develop a wast&g; byndrorni''‘which is usually, fatal* '.. .' -' ’•.
. Miler: confirmed. earlier observations that there la.no ' ' 
algal!leant’diminution In the immanoXogtcaX capabilities
,-of tsHe. animal .bhjiwoi.offiXed -Isa adult life hut ■ fouM.<th&fe 
....the fatal wasting xllsoate which > follor/te ihyteotcmy, soon ' 
after .birth Cwithin-'/one .weak) wa© due1- 'to a failure to - 
. form antibodies CMUler# 1963.).# He likened the wasting 
diseaseto; .the'so-called hrunt 'disease'1 '.aeon in graft*-' •
■ vex;au^?M^>H’j£7lb .animals deprived of' . immio logical •
^©activity and'upnaluded that -the .thymus ' h&& a key; role ■
. In controlling ''immunologic al'. -rcac tlyi ty i ’ Mi Her - ;Ci9'&X ) 
■suggested .that during emhryogehosis' the -"thymus would. ..;• • 
produce - the 'originators ' of • irajmanlogically competent;-cells
.■many- if White would; .have migrated. to . other si tea . at /about- 
the time'of--birth »'■ This would suggest-! that?lymphocytes'
■ ■ leaving- tbb ihymteate specially noXectte Thcyr '.•
. .might populate/the '.lymph- gland's' or -'the' latter, could.be
stimulated- to .produce .their own. cells by Meteeatf ,*$■ ' _ ■
ting factor already . referred'--^*. .- •■•:
Oabba .--aud'-MlXXer (196?) /brnve. recently shown - itef lymphoid
•■'.cel'ls, ;ar© . enabled ’ to; become’ iwmtthdl’ogic&lly .competent 'by a
Amoral/factor../prosout in thymic ' tissue*' ' /- ■ • '..
'!<"■. .'SurhetZ i;;\ .- ' • . .- ‘/ ’ ' ; '' -."■■■
3,88*
. ■'' . Burnet (i962h) » for '/long the, .pr'otagonist’-.of 'a ,
’selection’ -theory 'Of-iimfoun3.iy- (as distinct- from -any - 
’.AnstaOtOox*'theory) ti&a1'incorporated-these • ideas \ .
■ .into 'hie .theories#' 'He - regards the /-thymus -as the chief ;- 
, ’first - .level- * immunologic al' orgahiia which*the lymphoid ' 
•••' ceils, arise which- proliferate.- to 'produce -functdon&Xly -
;.'activ'e-,&'es0ehdant-- or collateral'-'cells' In .the ’second 
. 'level* ''immuuological organs# spleen# lymph nodes, hone
■marrow, arid local Xymphho&de®ii aggregation#, , , - In,hip,;,
' ■ concept #"mnut'ahit cells la the-thymus:-give rise ' 'to- •
, ’forbidden clone#’ of descendant' cells’in the ’second 
. .’level’ .-lymphoid, organs - which are capable , .of-.producing 
. '• ."'antibodies ' against pro tein--natiw to. the.*- body - and - 'hence ■
ofprovohing' .’autoirnaiiae*; -diseased;/ In deriving this
- - . concept Bjrnet -■/■(■ 1962 h) made full'.-use., - of the material .
' and ideas‘of - Simpson (1960a)* -The -further development" 
of those concepts will he - "discussed .-in - the - next- -.chapter*
. , " Z XS9* . ■ . , .
. ■ / '■ '' ' . ■ . <• CHARTER ■ 15. , ’ , ./•••• . .
/ ; -i^mrv^ii^ooToAivD^OBDERs. - Tff.-. : ....:, .
...,•> ? ? ' • -
The -..concept '.of -an .-’‘autoimmune ..-mechanism ’for-' . • - .
myasthenia :-gravie suggsest-itself '.because \--tho,.age.-and ' - •­
sex distributions and; the''.relapsing-natural'-history-:are ‘,. 
strikingly sim.ilar-to those'of ;x^3^io.umtc^i^<d1arthriiti£^^ -.
ayatomie ,-3^upus-<'eryt^^t^ema^.Of^^u3. and, diss aminated sc^toroei®. $ .. 
in-all.-of which disordered ''-immunological 'mechmnisms,' 
have .•’been--demooBarated/or' suggested*;.VThe" factors / ;
associated -WL-th - tho .'irat-.'■ait&oka and:-with th'o - .
precipitation of . relapsesare also -. 
associated- with: rQl&pspa ' of -tosseRMoeases-... .A/circulating 
■antibody, transmits-feidl;through'the/placonta would -account, 
'■'ey - neo3^^^'fca^.’'•.»mj^a^^t^t^*^J^0la\.•tif^i-le.. being compatible-with'the . . 
co^lstent-.-failWo- to -' tyansmi t --the./discas o-'by cro's$».. •
transfusion1 between'- .adults ' (Simpson, 1960a), - " This aspect 
is -- further' discussed in Chapter -16 # i " ' .■ •/ ' -
Simpson- was "’the first to- report the '•
association - of myasthenia gravis- with disorders of joints 
and reticuloendothelial system and to - collect scattered 
yeferenc ’es 4o..;hee^0legie&l''''•aBa disorders ’••'
associated with - the. diseaae^., it was- -also pointed out ’• 
that -'-'there -was-'a’consistent ‘histopathology of nerve ‘and 
-muscle of - a type suggesting immttunoofgLeai reaction and ' 
that the - -'.same type of - reaction could account for the- 
similar’-, histological - ehangoss occurring-in, Mother diseasea 
which had previously been con,si^der^^^d- to indicate - that the - 
changes were ’non-specific - !- * Tin , ImmnuologicaX - factors - 
in. the- related- thyroid, diabetic - and- Ho€smiologieal- 
disorders/ . . ' '. ‘ ' ' ''- ' ; ; ' ' ' '• • •
disorders described below ,’Have only " been described• since " 
i960* /It" was- further, suggested that the.'typical . ' ■ ■
pathological;. ■ changes‘in• the;thyiaus,-the.■appoea’ance' of" ■ •
germinal centros*' strongly -suggested/.that; the-organ ,was.. -
immmnoiobgcaliy active: rather than acting as an ’endocrine 
'..gland in the\usnal;ennse» . Wile this work was in -•/y "-. / , 
preparation* Smithers • (1959) -.made the same suggestion "y '"
■’regarding, the histological appearance of the thymus:,, in: / 
..myasthenia, gravis but did not suggest how . the . '
disease could "be caused*'// ■ ■ . .•• ,’i ' ••
. Antibody againstmuselei ' ' /"- ' *■• . . /. •
.In 1995s' with, the 'assistance of Dr," J>R, Anderson,
I •'■made-, .an, ai tempt. to .produce -• myasthenia• 'in. mice .by ; - 
inoculation-'of homolo^me. .muscle' - with;. " Freund 1 a, adjuvant 
in the. hope- of .provoking the formation of antifeodies- 
aciive against the ;ho©t-mttscle»,. Ho positive results were 
obtained and, . the experiments.-vere not reported in :the . .
.original publication:,beeau'se of 'a- restriction against '
diseusaoon of animal/©xporiments’-in a: Hohymmn*Gillespie, . 
lecture. Oosterhuis" (1963) reports negative results
. in-/similar experiments on rats and guinea pigs. ... . .
Dr.* Anderson,and, from -1956$ . •Dr* R#W- Alexander collaborated 
with, me in a seareh'Vformiusele,. .antibodies in ‘the serum of 
patients' with gravis* W were • encouraged to
continue despite, essentially'.‘negative results (vide. infra) 
when .Nastufe.et al (1959) " reported that* during an... • 
unsuccessful search. - for a -• neuromuscular blocking substance 
in myasthenic' serum, the serum/Caused..lysis of ••-frog--.-muscle 
colls.' , Tie -cytolytic effect --.not present in each • ■
sample " and • -was;. only found- - in• two casee out ' b f twenty*two ♦
It/ ’ --.V . . '■ ' •' /<- ■' ' ■’ - ' '
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It was .present in, -lesser. .degree ,in. smae -Sera from normal - 
controlo 5. nevertheless.-ihe, authors., thought it •-•worth 
further - Investigation/ - Soon after the - publication• . of * . 
my lecture the 'American workers independently concluded 
that myasthenia gravis is -a, disease /involving a destructive 
anioiramune ■ mechanism, . -.Weir■ conclusions,were based • on ' 
the finding,, of, changes; in- serum, complement activity •...
(Nasiuk • et ai» 1966) .and the demonstration by an , 
imimuio fluoresc one e technique- of a musclerbinding-, 
compXCmnt~ffirf.hg globulin, .fraction in the serum 'of '. , ' " ■. 
patients wi th myasthenia gravis (Htraues- et al, 1960). . ,
Nastuk et al? ,(I960) reported that the cytolytic 
■activity previously• reported-occurred. in of patients
afflicted With myasthenia '-gravis ' ’and in • 23% of ' normal 
• controls'* ' The relative .'strengths of -the active sera 
found in each , group' were unknot#* They found that the 
level -.of serum'^complement fluctuated over an abnormally.' 
Wide-range./.' There,,was;- some suggestion that a low level ' '
was' 'correlated with- - disease exacerbation (though three 
cases with exacerbation had an - abnormally high* level).. 
Conversely, remission of - the myastheMa• gravis v?as’ often 
related -to a - supernormal - complement , level though - ' ■ '
' sometime®'' ''to- apsubnormal- 'one'. / "-.They/suggested that.-"- •;;- 
. complenmnt^fixation./w&s occurring in active .'myasthenia 
but offer - - no- explanation - for-, 'the supernormal levels in - 
. quiescent, .cases* ’’.Their 'Hypothesis of an autoimmune" \
alteration - of the - Bmscie. - cell membrane - as the result -of ' 
conjunction. of - a foreign, antigen- and -. an entity "found - in 
-the plasma - .beffibb£ani.'Gr,-intracellular elements of muscle 
is' virtually - identical with ray omm - proposal {Simps on, - - 1960a) 
including the - suggestion - that there might be two- grades of 
.damage/ ;. • . ■ J. . ' . . ■•-■'' .
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-one. - altering the c on figufsti on - ,of • the post* p ' . ;•.'. 
j.^^^^lCt;i<^'n^aiOinmd^jtailevv■all'o■thex^\ -more /Aeyerpv -oaUf-sing- . ■ 
'reylr‘sible - -or /Irreversible damage - to - the ' •'Bmsc-le-- fibres*//
' The/ - terminal arborisation of; -the ' motor - nerve; - might" -be/- -./ 
indirectly or- eIrectlyf■±nvlXved*. ' \ "i \ ■.. \- /- ■ ' ,.•
". ///■;''' In - apeoffipanionpaper'. Sfrauss/et/'kl’' Ci^O^i-v-?/ ■• 
applied - /aniimunQUuores! ehc e technique' to study - th o/.' ' - 
proslnce -.of- globulin fixed- /to the skeletal ' muscle'-of. --/i. 
patients 'iih;•)lBys'theftia gravis'*- - They/pooled sera/ '
from - ten -myasthenic /patients of whom',vix had thymic .<<:•-'.- 
‘ tumouro* The globtuli^n- /fructobn; precipitated by- 20%/ . - •
- sodium /sulphate.■ was ^conjugated with '/fluorescein;/ -•"/'.////;, - 
.'isothiocyanate and ..sources of non-specific - fluorescence /;
removed - by'absorption w th rht- and mouse. - liver powders# 
They .wore - ..able -to dei^^oostx^'ate that -the globulin - was -' /
'bound^to/.a- ^amp^iPf/'mya®then H- /mussle/to xwiieh -it- was ,' 
introduced and .no/similar/reactl>ori-/•cbul&'' be demonstrated - 
"in- 'a- similarly prepared - normal - -serum globulin pool^^#///-/// 
The - myasthenia gra'vi 0 - globulin - fraction -was shown to- . 
/fix/guin'ea-pig c'ompleme&t/.to -.human- skeletal ■muscle and p.• 
this;- waslconsidered'- tb/be in favour, of an immune . ' ,
- phenomenon. Not all ,.mya sthenic -sera- gave - rise' to ;>"-- ■ - 
fluoresq mt- skeletal- muscle sections - by this - technique^. 
Sixteen /Individual - /sera -• tested ■ subsequently gave - / //// ' - - v 
negative .or 'equivocal results*- .-One\ serum from - a patient 
with 'exacerbating paroxysmal myoglobinuria’ - - caused/ ' ■ 
.cOmplernont-fixing fluor000ence of /myasthenic - muscle but 
no normal sera--or .sera from patients -with- other ” ./ . • 
muscular - diseases- produced - fXnlleascenC-e, “ 'The,, appearance 
described by Strauss-/et al .{i960), was of fluorescence -/of
- .al ternate s tx’iations of - ‘ human - • ekeletal muscle * / One
serum/.- - /?' ■.. :•'/- ■ . - '• •- '
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scrum/' fi’om‘a / cas g ■ . of/.dermat omyositis caused; sarcolemhial 
• fluorescence' buizdid' noizbind-fe"''the eross’-isbrietlionc/ / .
. of/the-/ jftusoie "fibres. ■•''../• . • / /- '/• ...,.,:.///< 4 /'/".' ;
/•'../ ■ , ••: //‘lb/1960-61' ALexauders/'A^nde3^j^i^n.';/^x^(^//X investigated.
/ fifteenm'nyusfhenie ;,sera’. for autlim^u^sclej/ antibodies #' / .'.
’ -Seven■ -.ofyWuse proved--to be aafci«abmpiemen'fciFy, and/ '• * •
,•'useies©-for/further-.' study„-. 'Only.' one/'-of ■ .these .is" ' / - < .
. represented in■ Table-13 '*!#-■ ■' Of "the •rema.'ni'ng'eight 
'•• . • c as©s • /one ■ ( ' MN294 ) ' showed - a low ' titre of . anti-muse ie •.:
'■ activity by”''t^h©''tanned .cell haeieaaggvUlha'fcion technique#. - 
'. . HWe showed/ specific. ' changes ■ tw.th-
/ / zfechhrOgue..'(OiMpaQ/-, . 1964a)' % 'The '^sericun, r ©smlt s'a&rel*' / - 
/,, .however # con£imee.dyt(y*;iButoner. /e t' a!., '( 1962 ) , / 'and. * PoXbhmp'
. -at ,al. (1963a)' # /'•These1'.authors' describe four different '
.. ,.• of reaction /of globulih-'to . muscle/based, on '•'. .
. / imffluunffuorescenoe/bechpiquea*/; * /' /"T •* '/■// ' •. ;■/.'■ . '
'/ /.. ?;/•/ ■■' i) "/fluoresc en'ce ".of "the ■ Wii.ch-a I '
k’ //v/'l/:/-./•;_; alec/occurs/with control- ->orai. 4 '■ ' " '-'4 /
- - - / ' ; • '"-'f ii)-4 fluor©scenee of , the" '• / • bands iof muscle ■ fibres,
■'/../';; -/.: iii)/'. similar" involvement of ■ only ' about.- /half...of ■ 
•••"•// ' " diVf//.ithe'musclQ^fibrbs/X/behra'/ type)://.; ' •///• a 
' 4/•</■.// ' /iv)/" Nuclear ' fluorescnnc.©* - /';/ '•//-JA, '4/ / , 4"; ,
■ /Only?types. i-i ) ' and lii)., s©W; 'to. be specjific.■ /or*.- myasthenia 
_//’gUayis*,; ■ .The nuclear fluorescence is due" to the /presence '
■ : in 's'omU/'eer&' of' antinuclear ";fac tor /.which - also/acts /against
■' 4- other/.ceiliU. .ai». .1963b 1* '//*'// ' ■. /* /’//: '
•. - specific if yr ' ’ ‘ /■/ - ••••.' ‘: ' ., • . ; ,.. ..
Z , , ' ■ //• ■ " Ticveytolyfie, effect ef /myas the nic. :"in: frog;.
/ ..muscle 0 ells ■'described :by ' Has tfe-/et■'aX/,{ 1959) sugges ts ' ' 
/'•../that jho/.auti’-mu.sclo /substunico,. /'if 'suchii/'' /W). is -‘nni «- ■ - 
■ ' ‘ specees/. '/ ' ■.''•'/.■/J.:/ 1 ■. '.'’"•'' / ' 'i-// '
* - ? lUe-globulln Wiich ts capable 'of ' _ -■
-’• skeXe’ial muscle .also/attaches itself
Ito, -.skeletal- .muscle - of -.the rat'(Strauss'© - et ai*"1960; •• .
.Fel^M&mp - et ,alt' 1965a an#yb). With- regard to \Orgahr/-‘ ;- ..
- the available 'eyldeno'e -.is inc onsis tent-/
' 'StrauSs nt-. ■&Xt-.(I96Q}'\fotmd-that- the'" globulin which • . . ‘ ••>-/. 
■■■'binds . to - skeletal - muscle- -•..'does, ■ not ' do ;so . with cardiac, - 
■'.'or;.uterine, muscle 'and they -'aleo --had •negative. resniSa...., .-' •
against -thymus - tissue obtained -from. two,myasthenia;' -' '-./
■j patiehte* ■. Beutner \et :‘ai- .(1962).'..confirmed - their results'. .
on skeletal muscle with sera from S of 10 myasthenic - 
patients*. Both'of the- active sera '.also showed - 
fluorescence -w.th the.- heart muscle -by '/th/’direct and 
indirect - ' an1iiOoy.r^^^^contCUeu«^^^-, "the -/ -/ •> - '
complement-fixing - and ,staihipg; technique using heart 
■ tissue;was-.negative*'. , Theyg'euggeet -that..; their .
indicate the presence of - at least .iW0nantibodies, one 
specific to- - ^skeXetaimtouseid' and the other - reacting with
. 'skeletal 'and-.cardiac--'muscle/:' ■••••1 //' \ ‘ .' '....  • • .
; . V<an. der Geld and Octerhuijs -(i96>) using- an
antiglobuXin - ;'b onsumption - test : with - or - without, 'the aid 
'of.iuuttuoeICctrophoreBisV''' found -that 40^ : of .sera ii 
. containngg/antibodies - reacinng^WLth skeletal muscle -also - ■
'.■.reacted- -''W.th; ..'thymus*- •. - did not, encounter -'sera- - .with - • ’
' -antibodies :-aofcinig ;:•iXcXusiv.ely- .'against-thymus* •/•' Gross* /; '
abaorption experiments -suggested/that?there 'were' two., •
distinct circulating /antibodies* one - of-, .which. reacted with 
/ekeietai /rnuusie.'-'or thymus/the .'ether with skeXetaX;nmsele' .■ 
alone* '.■ ,Ho - reaction /was - - ■found - ..w,-th - heart muscle* - liver- , ■'
■' pancreas/or/kidney UssUeeK', •.'•/:/ •• • -■' ? "• ,
-. \ '''//Xn/ ' ./t.'- "’ . , ■' /■ • ' \ •
/•/ y195,/'-
• in., searching/,for /a-/possible. V^xi^htiion- of , '■•• ' ■'
■ the - /failure /to - globulin, in my. ’ Small
series -'and the/. apparent- , dissgf^meht;. pf- these . authors// . 
reegadXh{gorg&n~spedi'£ic±ty» /X have - drawn -.'attention ...toy .; 
one /important - ■ aspect .which - "'is--hot '.'.Gom^m^^^^od’ ,on. -by ‘any- ..;. - 
of’ the papers cited,(Simpson, l96^a), y§traiGsa - et - ai
(196O) obtained; --their- /ppeitx-ve’reault© on-'- skeletal - - v 
muscle- from samples of pooled - sera- from IQ myasthenic-/ 
-p'ataontn*/' Six’ of theSe-had:. a ' ',
•-•peXerlend'e -of--'X6- individuals sePa-- .was , apparon tly negative 
The ’.only - Wo positive-eera of the - . ten - examined- by , //? f • -...
- et - al (1962) - were - from the only ’ patients -with - 
a - ‘/thymoma# - y -Peltkomp;- et • al ’ (•,X9’65&)-; found- muse Xe.binding..' 
globulin 'by .-the. -Goon/s- fi^ndi,j*e^btf/ea<^iindlque-^:ii^; W# . •■of XXX 
/myasthehic?.sera but /auGiiidedhsareoXemmaX ’’ fluorescence*-'-' - ’ 
•Their-fata •■'are'- a-.little/difficult' to. interpret- but- -a'- ' . . 
1 study of- their/fabler;If suggests/'that,. in /fact /UnequiyoeaX 
fluorescence of present in-- only' 25; of;- .
-the - .XXX - bases; (20$) * / In --a. further - comment /on- the - same/-. - 
/material- (—suv' der''eXd’et-al*; 1965)-.they- state that' ' ’/ v ’ 
.-patients .in'’whom. -myasthenia’ ..graviss- was - associated - with-., 
a thymoma -appear, to- fall - into - ’ a: apecX&l- 'group/- wi th’ a - / 
consistently .-'higher incidence/of' anti'M&eietaX~ffiusil'e-./■ 
antibodies#- //Of 'their’ 8••’oase'a--withy thymoma* all showed.'r’
. anii/muscle antibodies.- os - against 50' - of / 90 - cases- without 
a thymama* Unfortunately - 'this comparison was - made ’- Wth- , 
/a^yx# ‘ahtigiobulin- consumption'' -testy which ’ their Sabie/XII / 
#sugge0ta/&Ql^3/-.not ^correlate/exactly with/the / /' /" •„•
' immuhOfXuore scene C technique#/y ‘'/ - . • /•//•■'/ /- • '
//' ■ .,.// Thio-review strongly uugg^estu that :the /sera-.,/. '
■ containing • muiible~bindiBg.- antibodies /as ■ 'judged/by -.an- . •.
-imffimnoff^ooeecennw technique are ’ derived ’ from myasthenic 
patients// -/ . /' ./.-• - '• ..' / ■ . /;/
.pptients Who, . have a /thymic : -’tumour;'’: ..Hone;-of -the’patient's ' ,
tested in .the. present series ' had- a . thymoma and. '•.-..,
unfortunately no . case of- thymic ' tumour- has been- available 
.for -'study since this-correlation• was noticed, ..It might
.: ."also ’bg-rclevant .to note that. muscular wasting, was: not a ■ ”
■ .feature . of/the cases I/have, examined for anti«museie '
antibodies,. - ' Xs- pointed' out in Chapter. 5 and in-Simpson .■
(1998) ’myaathOnic . .myopathy* , is more . c^mm^n in -association 
: with, a-, thymoma though not, confined . to'/such- cases* It . '
., -'would - be interesting, to ••examine.. the .-correlation between ;
muscle, antibodies1 of . the ..Strauss type and the. , sq'*c ailed 
' 'myasthenic myopathy.. • , ’ ’ ■/., ■••■.-.. - '
' '. '/'/.// The considerations'‘just "discussed are of ■' ,
‘ ‘considerable importance. In my original ''hypothesis- 
, -'(Simpson, 1960a> X-. ' suggested that'-' the 'disorder of- \ .•
'' neuromuscular/-'$^01^10Mon of, ' -myasthenia gravis ’ could be
'• . .. / • /■' / -Xt : -r, / X'- V- , / , , ■ '
accounted for by'- -the- blocking of -chem’ooeceptors/ of the , 
muscle receptor ^one 'by-an .'incompletely ' -fixed' type of ' . .'
antibody*. .This . specification - seems necessary ■ to .account 
for - the ‘rapid. >changes '.-i -n -. the ' clinlcal - state ;which have
, ' .been^deseribed' -in■ -Chapter- 2, -' -.The' Strauss-' type -of' '- > ' .•• ■ , * * . , / • 'X • ; x r v , ■_ . " • . ' - '
antibody -.acting against the contractile part of, muscle
’ 'fibres does .not seem .to meet .the- operational req’uir?<5^^3aib<?/"
If it - is-'a--patho genic- factor it .would be expected- to " .
.. cUnse -partial'-'or.'- complete.. - coli . necrosis, \ In. Chapter 11 ' ■
it has ' been ' shown that .museXc ’-cells - may indeed, - be affected 
by -a , *mos±s;ic’... reaction? but -that-this -is 'scattered, /, \ - 
■ inconsistent,’'and 'apparently unrelated to the ifftiguable* 
typo .of - weakness,* .Tie .elec.iromyographic- evidence •• • :• \
(Chapter. 15) leads -to the - .seme conclusions* -If 
addition, the -.-Strauss, typo of -/antibody- is virtually - -
_ confined/- •- X. . • • ' - \ '' - , , ; •' .-. ' . '*
■ ; 197. •. . h \
■ oouffned. to. oases .--with a thymic . tumour- it seems possible • : - ■■
'/that "there .‘may still be •-•an. antibody against - end-plate .
/protein which /remains - to. be identified*. in this -respect ■ ;
' my. - hypothesis remains - unproved, Nevertheless it - must now
■ be - accepted/that in- some - cases ' / of myasthenia- gravis - an •
. iUbu'«ol'ogi.caX ' disord'er ,±u relax tod ■■■to ..mmsole damage and
this-fact immediately increase's .-the.- possibility' that - the / ■
. original/hypothesis •,is valid,p ;/ - ' - ■ ■ -■ .'
.•- A n.i inns leap - •• and - / rh oumatoid .factors, t - ' - .
' - Since- the autoimmune - -‘hypothesis was -in. part -.- .
• / derived from a consideration - -of the ' possibility of • "
iamltiple organ pathology in ^^^^s^a^thdhia; gravis ('Simpson '
'I-1960 a- jv"3O'hptdr -7) !'it /follows ' that one ■wonid /expect ■o ' ..
. ■ find/ serological .evidence - of; antibodies ’against other ' • .
organs* -. ’ ■ ."- -. . •
.possible relationship with/irhoumatoid- *■■■.,■.,. . ■ ■ •. 
arthritis;..was 'suggested, -by-. Simpson l( 19&0.U). ( - The; •' . • '
.quotation marks' wore used- to.indicate that -/the arthropathy -
•••might- differ from , true rheumatoid arthritis though it ’ ■.
” resembled -it - • - closely ' -/in af f ec . ting -.mainly -.the - small - joints ' :
■ ■ "o f ' the; - limbs * -... - It wwa,.. -however-, sometimes - . .transitory. ,
, gWn'--dor -.Geld zet al(i963K haye/recently reported--that , '..
the!'.nbettpmioid-factor was, pxresent -in 'the serum. - of -.3 of 111 ‘ .■ 
'- (b*5%j>?c&se'.S''df. myasthenia ’gravis (Table -13 4‘ 2 and.-.-^),. . '
-8ix-jpaiehts, in their .’series .had rheumatoid arthritis (sic)' 
-but. if'-seems, from a' letter by Feitkafiip et-; al (1963b)- .that- '„•'
only - one'..of these-uatients had -, the rheumatoid; factor,-in' 
-the/blood so-it - -would/.appear 'that the other positive-...
" findings were made- on’-.myasthenic .-patients without/clinical-' •
, evldenCo of 'arthritis;,-' - Arthritis • was’ ^present. in - 3 -'of 19 - ■
..' - -' - cases of myas the hi a gravis ' .reported ‘/by.iWhite’ ..and Maarh’aai,. ' . 



























(1962)* (I omit omo of the 16 oaeos reported who appears 
to have had -oardlnom&bou® rnyanOhonia rather than • '
myaatMhia ..gr&via.)* Tww-of the three arthritic omen
■ gave a positive latex reaction _ for rheumtold factor
and, each had • hyperglebtilinaemi'a at the -'-time of ’ •
examination•or previously# One of these eases was later
di&gnoadd as Systemic -Xjupw' Erythematosus* ' ^it^jLnn<^^Lenr 
factor OUB'UY) was aesooBtrated in 6 of the 15 oases ’ ' 
and^Miother 2 gave positive nuclear fluorescence with 
.undiluted serum# Anfcinuol0ar factor in the serum was-"• 
doteatod by Its action On thyroid '-tissue* The 'positive -
reactors iaolddod -all • but .one of the arthritic oases*/’- ?
one case of outaneous lupus crythmMtOsms$ and 5 oases •
without wid'dhoe of joint Involvement* . -
“ ■ . Simas (19G2)• found -no oyidonoe of against ■
-akelataX 'aMsqlexeall -nuclei ,• but Biilmear ■ ot .’ mi ' 'CXS&g) and
Feltkmtp et el (X#>65^ and, • b)'reported Its predonoo# - Th 
'isioidenee of positive results against msda nuclei is
not recorded but • with;human ;leucocytes ss antigen Faltkamp
6t al (1965b) found /Oflri lg of • 111 ;casoa (13#5$)# 
’Antlnuclenr factor .was not do too tod in'any- . of ?0 normal ' - 
controls (type ’unspecified)# ■ • . •- . ■
,. ' Ahtinueloar factor•was •estimated in the'cera. of
4g• patients in the • present series and rheumatoid factor 
in 'toe# The A.N*P* testa were performed on human - 
leuooeytes aooording to the teohnlquo of Alexander et al
(i960) • '-who found • 4$-positives in '580 oontrolO (healthy ■ '
young blood donors Of•both Boxes), -The oases • relevant to' 
this aeotlon are summarised In Table 15#1* Antlauelear
■ fan tor was ' present In sigulfleant titre as defined, . by . s _ .•
Alexander et a! (I960) in S of'the 40 oamem (Bimpeou# 1964&), 
No &#E* oello wore detected in any of•theeo 45 oases but 
one/’ . , .
-\X99i , 7- .- ■ .. 7 . , .. . . -
one other cane- reported earlier, Cfimpaon 1960a) and
deecribed in Chapter 7 had; - cells ' .in . her; blood* ; 7’;.\
■ < / Hone -o'f 'jthe,-n3^ai€;t cases ■examined -for the
rheumatoid factor by the ' sensitised sheep-cell test- had 
a significantly raised titre* The series is very small 
but includes Case MN 294 which has been described and - ■ 
illustrated in Chapter 7 and 'Figs* ■ The negative/..-
result does* - however? justify.continuing to differentiate 
the ■ arthritis of myasthenia. gravis from »true* rheumatoid 
disease* Oosterhuis (1965) found a negative Sose-Waaler 7 , 
reaction in four cases' of * rheumatoid* arthritis 
associated with myasthenia gravis* Two . of these and 7 
another 6 of ;bi^s7li<> cases- had a family- history .
of rheumatoid- arthritis.' The high . incidence of' A.N7F* :
(20$) though less than that reported - i'n the .smaller■ series 
of White and Marshall (1962) gives . strong support to' the 
hypothesis; that immunologic a! mechanisms are ■ disordered 
in myasthenia gravis 'and links this 'disease with the 'so- 
called ■ /symptomatic myasthenias* described in Chapter 9* 
Autoimmune aspec ts of . associated blood disorders *
/<••/- . /'Pure .''red-cell; aplasia, --.which was 'present ' in 'one ' • _
case (Chapter 7) waq not* at the time it occurred, ■ considered 
to be of ' immunological importance* Oosterhuis (1963);
reports- a case in '-which the; direct Coomb*s test was -positive 
(an interesting ■ series of radiographs shows . temporary ■ 
shrinkage of the thymoma - during treatment with prednisone)» 
Another of his cases and' one reported by Castaigne et a! 
(1961) had' hyperglobulinaemia. A- recent report describing - 
the finding of a positive A*N*F* test in a case of this 
disorder; associated;with a /thymoma, but without . myasthenia 
gravis* adds to the probability thatimmunological 
mechanisms/ ' ' ' ' .. " ■
mechanisms may be involved in the /blood dyscrasia 
(Holborrow et/;al>;-1963')*--'-‘
In the same way, when X recorded .the association 
'between myasthenia gravis and pernicious anaemia (Simpson,.
1960a) it was not known that that blood disease was of 
immunological interest* It has been suggested;recently 
that ah organ~specific antibody to gastric intrinsic
•■factor,'and’' to the parietal e.ells/:'o£ ’'-the' stomach may■ be / 
-responsible-for"the’ production 'ofthe''cyanacobalamin'/
deficiency which causes the anaemia (Schwarta, i960?
Irvine et al, 1962? Taylor et al, 1962)# In the present 
series of myasthenic patients, antibody active against
■ human- stomach 'was detected in 3 or.fe/.cases<.using ./•././;.<///-■•'■ 
complement fixation and immunofiuorescence (Io)
techniques with gastric tissue (Table 13,1)* One of these; 
patients, (CaseM 5305» Chapter ?), had pernicious 
.'anaemia.*';■ Mith/the-me.thbd'-used.'positlve'.results ‘are'. 
obtained in 8% of middle*-aged female, blcod donors (Irvine,
-196^}.’The other patients with pernicious anaemia 
described in Chapter ? are no longer available for. 
'immunological'studies*.//,//'■'■ ■
Pernicious anaemia has recently been reported to 
be associated with a number of other diseases e*g. 
rheumatoid arthritis (Partridge and Puthie, 1963), 
myxoedema (Tudhope and Wilson, I960), thyrotoxicosis . 
(Kelticol| 196i; Doniach et al, 1963), autoimmune thyroiditis 
(Irvine et al, 1962?Karkson and Moore,1962? Taylor et al, 
1962? Doniach et ,al,J 1963)1 systemic lupus erythematosus . 
(boniachetal, 1963), and with,diabetes mellitus 
(Arapakis 'et. al, '1963;:‘Beckett-and Matthews, 1963)*./,, There •
i is.thus an overlap between pernicious anaemia and several 
' -diseases// ■ .
diseases . associated -' with abnormalHroaunoXogical;-reactions 
and to these - myasthenia - gravis should now. -be , added 
(Simpsony. ;/'’?;/• ■'' ‘ , v ' • ' ..'■■■,■ .
* Autoimmune' thyroiditisr- ■ . ’i7'?- ‘
? / vThe relationship7 between* thyroid- disease- and 
myasthenia gravis' has. been discussed in Chapter 3* from 
'the.''clinical; point,- of -view and . -a- 'case . -;o'f ' H&shimoto® .. . • - '
disease'. dcd'cribed^ ftktthhtl  ^* was drawn to - the earlier 
reports'' of lymphadepbid goitre as6ociated - with myasthenia 
gravis - and further ' examples were described* Through
the -'kindness-of Dr. W*J*- Irvine - an investigation has .
.been'; made for ;the presence of - anti*thyroid substances 
in the blood of - 44 patients with-myaathernia -gratis* 
using the - methods ' -described - by 'Trvine<{Xi64)* ' The results - 
of-the tanned -cell haemaagluti^i^j^’bion - ■(t.C.H#) and complement 
fixation test's (CiFf*.) are Shown in Table 13,1*
Specificity was ensured - by- absorbing - out - antibodies - which 
,<WWre - 'not' organ~speciMc the - <44 - patients -examined* % . ■
12 had -significant titre of antithyroid antibodies by one 
or both tests* Six of -the - '.positive- reactors have - had 
confirmed or suspected - thyrotoxicosis, at some time in the 
past,;; Another 4 cases with a similar history (tt4336, 
WH3623V- MH7343# - MN7781) did - not - have a significant t5.tre«
One - caee- of non~toxic- goitre (MN?833) and one case of 
thyn’ornh- with biochemica!- evidence of hypo thyroidism ( MW'647'6, - 
Chapter 5) - hod - no - detectable antibodies against thyroid - 
tissue* The - other cases of thyroid-disease - shown in
Table - X3,2 wear© not - examined for thyroid - antibodies*
,/-/.7X' The only other report in the - literature is that 
of van der - Geld (Xi63b) - who - found antithyroid - antibodies 
in 36 of-111 cases of myasthenia -gravis*''/- , -7 ’//.'.
,'y W:sKB,T;ibLOGt-/O1F... iMBX; ■.GBAVlSy <C.’/?’-. ". .
it’ -■' It is..convenient at this point -to review- 'the ', ,' ;?' 
ppcylpus ‘cBapt.Srs-.yfrom the point- of-.'ylew>of - the - aetiology-' - '■
i-p• '--’’.i,/.• ■ /' " - ' ; ' .'--hiy -. .y-’v-:--y
' ' iO''-Age• and .Sex- - ■ (? hap ter 2)V .- y.'Myas tho-hia.. gratis •;- • ■
. ■. ' occurs, in both sexes: but-. more/ .commonly in- 'women*.. - ■
■'••'"h.py ■' Theymdd'a:yawP ■ a A ’the aubet Is -20-23, 'years - ?>/v ' '
y • -. - -- irrespective.; of ’.sex’,., ’ iy : • ' < ■ •,.' > J . .•••'■' - ' - ,
v; li) Precipitating ' faC'tgys' - (Chapter-2).*- ; ^asthenia/'/ - 
.•■ •;•'• '•. - -may arlaey spontaneously - -but. the - first- . attack- . and - ' -
y-,.;•■ subsequent.- relapse's- Aare"c om/molyypx’eeipl ta'tpd- by- - - .
■ tloh©y'o.r /by -.emd.tiohql .diSturbaucb -amd.. " . ■,.
. ?-o-gc&sionaily -in - association -with/allergic disorders* 
Relapaos/are- .also brought oh- by pi-egnancy:. - ' . . .. - '.' ?
. /•/ •t':rmnst3?n^^'tion- /ahd.-'extrom'e.s o f -cold-or -.warmth;..- ' •. !’
/Colrse- . ( Chapter- .S' )-* - This is variable - but. is y-- •-; ’ -
H \ , characterised--by relapses -'••andlr emissions' -during’' 1 ,.
y .'the first .3^7 “years* Later- remissions-.are, rare*
, ..There.. Is ©me evidence,foxr-a.stage, of ^-active * ’ • ’. 
■•■■■'. ■ v '■/- disease.’ during-'this period In - -which - --the'--natural •••■•■ 
" ■, ' --’hiqt.ory ..Rmy^y^e:- 'Influenced by --.removal '-/of • the /thymusy
, - > ■''•’ ■ ■ y gland - , (Chapter, >10) * '. The lateri-course ..-is-, .on‘ 'they--. ■ • 
y ., • .: 'whole,./dotei'mined/ -by 'pffci^pLlc^gi^cal-change© 'occurrilng '
/ - during/the Aide ti-ve »■ .stage* A. j---" -\. A- . ?'..
.’ iv) BeL^bedhd;JSoxdeXS .('^Captor©, A,3'. and-7)* The • ■
' ■ y -A- ■ neuromusculary- ©yndoome may-'be'-aewooiated with a ' 
,-.1.-'. - w d e - 'spec t rumo f - di s turbane es'. - b f -.the -e e nt'ral- - and •.-'•
' peripheral - nervous ■ syat em , ., arthritis of * rheumatoid *
/////a/- •; '.:r; - ,//'//■..-■
;y.7., . type» '■ „noroeyunasis»‘■ splenomagaly.;/Xm'ph adenopathy # 4.•/ • .
.,'. .7 /7/i:, perniciousa anaemia#. haemolytic ' ,
■ 777.';' a»&emiay-nephritis.#' " hepatitis# -hicoratiye "•..ao.p'itis# ■ 7/ -7 
;" 7 ■ • _ ythyr^’toi^X^^^fC^^^gL's/att'i'-^'thea? thyroid •disseaaes1 including 77
- 7..7‘y'and' di&h'.ete© .meXlitw.' --Th©-, -.
77.7 je 'theae; dlacrdera • • .With• '■ attiommmmne ’'.’. . • '.
•-,7' 7;/-/ .diasGsgeMH^ahoW "in Oh&jjter? X3f •'•?/. .77^.77 '_ y7 . • .•
„../v) ■/BiohKmmistry. Chteptep-)>};,^"‘7ili<^:r0r-ei."\n'o ' •’•
77• -7 ’ • of endocrine/disease -.ether'' "then7thyroid :&nh' ddabetee - ' 
•77//J' •■., and th©7Abxroxd may- he' affected/in; many/Ways/. .non*,■ ' ‘ 
;/"' ;/''' ..toxic; gdiitWmyxobdem-a; and '-Eiabftimofco's-■.disease• as well 
.... '77'. 7a© * "• HypergXobiulinaemia "may 'he found- • ■'■
7,7.,/ -..■anol.#. • oeeasionnUy# • raised,protein content" of/the;/- '. '"­
7, /"'Cerebrospinal' fluid* '/,;y,a?7-7//?//'■■,/■//•.,-.'/ 7.’/. ■ 7’
7 vi)7'o Q^ibc^diess.chantsri$j«/ 'increase : ...
' 7;/ 7,;7'of. org&n*apeeifie' antibodies against muscle# thyroid 7// 
"'/yi an &nd mtomach of.-antlnuciefr fWtOr/and-rheumatoid"' •
•-,7777 • f.faotor is' found in -.th© .neoa 7G^m.7^iy5^j^1^hoiii?3^^-73^?itientSil' / ■
■ '"Neona^ait^myasXOhhnton ;8)"/' Myasthenia -- '7-7%
“-7/7occur^3din^/i^;^.7 <^^mo children^horn/to..myasthenic ' 7 7 •/• '•■
///- . ‘ - mothers iepslstsyfor/4-*6 weeks.7;.This suggest©.,. '....
.' '-.7 'passage:-.0f a- toxic • factor across the .■placentala. 7; •••• -
7--'I'; /.barrier/ yet yh'©.; such, factor "can '-7o • identified". 7y-' /'. .'•; / 
7;. / .." cress*transfusion experiments "in--"'a^dni.ssTC'G^ea^'^tep ,1'6)« •" 
M; /"7' These;.results’-would. bie/e^lained/if••.h©e.' ♦myasthenic/'"' /: 
;-•/•"•/- toxin!/Were mr-.antiboaynA y''"/-7 7 / •- ,-,. - -, . -- A'" .’ .7" . 
viii)-r / gymptomaticT.APmSihe^iU^'- (ChUp tep/Xft»7 ;-" .Myaaihenic ?
• • -- /, y'weakness -"may /he"-.found /in systemic lupus erythematosus# '
./y.- "■ demmaiomyosihis";aar©ii©oeis/£m&■- cariiommatosis-*7 - ■ _■<
. '%)") 7pist^>^c>lO77■:(Cbiatea^.,3^:lt>»•7 .' There.are/eo3Qs^^^^3tent;: <7 ' '/-' -■•
- ' ■ pathologitx^X changes 7iii the -.t^hym^f^'i./m^otor^.^nes^y^^e'/ /'// /.
- 7..77-.! ■■terminals" aW'iWucX©y and' 3ane--'0immmnly yin-- other 7 -7 7










-./ : organs/'OX/Of. type !suggestive/of itafflunoXcigixsai/• ■. /' ■
■ . ‘ dds©6d’er-..'y". •• ;y . 7- /./'.y’ : •' ’'7'-...'? '
■ •'■ ' x)'•,' Tbymh^^uncrti'On-(Obapter 12)# A-A’royiww/ Of/theA’.-'
. y-77 physiology' ef/the '"thymus' shows'- that itrr main'.. ■ .7-'
x ■ .v A function.'is. .the/ production. .of;immmdlG'gio aliy/AV ' 
5 -. '■ / .; Opmpetent ll^mpWoytee*.;..-XVis’ impori&ht, in • , ■- • •. .<
' ■ ‘A - eOnfroXXing.ihA'deveX0pkent''Of - "thAbody/eydefOnbA:' 
;, ' ,' '■ .• •mechanism ^&gi±2nrs^iy:fo^exgn' protein in foetai-/and.y, ' 
:7.A ■- yinfaniAife'' and 'may' play ' ah 'intermediary /roXe/im. • '1 
"/'V' ';--,A growth' .and; '-maturation/.at that ..time A ." Disorders' Of-' 
- ; . . Ifce.'fchymtthf-&fe!•nOWJchoWnyfcd -bo' associated with;
••••' ' / failure - Of'.ife^d^ui^O^o'gic£^’"^/"/fcdl^e"x^aho e •"in later ' life A
Am autoimmune . .. hypo thesis ; ' . . ' (■'' ' •• .A.-A
■' ^ThuuU'ihe-.recent'■:evi^<i(Bi^oe,.c^ni.t^h^3rmic5.;frnne tion , yy- . •
was not "'availablei //-i/ haye-■nterpnete& .thG data jaumnaaised 
here ’as indicating ' the 'possibility .that myasthenia? gravis'' 
is the result of"'pyfailure of TLmaunoiog’i<^^^^l' tolerance, ' y 
with • the:-predUcti©m\p< antibody 'against ''-'the receptor'. . . -• - 
protein of-y’musale-ef - -some '.similar structure, -at the Ay / ’■. 
neuromuscular., junc tion ' (Simp^3€^ii^i-'y^'^<^C*)#;.' ■ The further.'' •" ,
.i.m«m:i^^<^:^?>gic^c^’L;;S^Udi^<^f;y reported in .the -.last chapter/-- . . • -' ■'
■ eupportthis concept * /■ A discussion of the mode 'of. • y,\
production. of the . failure' .of . neiwo®uuCuXar; transmission,. ••• 
will. W ’.postponed yhnfilytho •'•physiopathelOgy.' has Been • •.(.-. . 
dxamiae'dln Chapter .16#/ .' '■■. .; ;'•" •- ’ -''''A ..
A.. iy.yy//Tio .'respoasd-'to /the 'autoimmune - hypothesis.-wae \. /■ , -
immediate* •' -M&x^rh.al! .-and/Wito’ \( 1951 ) showed that-direc,t ■ 
injection -'of .bacterial .antigen.intoythe 'guiuea^pig thymus • 
produced ’.a .histological -'•reactieh’‘Which--was••oasentiaiiy’' '
the /same-.as- ythai'.seenyin • mya^stly^nia- • gravis# ?' Aheir- studies-, 
suggested '.that"-a BXoo.d"thyrim<;: Barrier-/exists,which would’ 
preclude/', - / ’ . ' .y-..y- •''•/••-(/.• .y - A? -A- A .?" <••..;
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preclude any cellular reaction - of the normal thymus to 
circulating antigen and so facilitate the development of 
i^mmunol<LgicE^3^:^.y competent cells active against an 
individual*g own tissues, By this time, .experimental 
biologists were - coming to the conclusion that the thymus 
played a very important role in the development of 
i^mmnolc^^^iceat response - (Miller 1961. 196$ $ Burnet, 1962 a & b) 
and Strauss et aL (i960) and later -workers had shown that 
anti-musclo- substances- could sometimes -be dem0notrated in 
the aerum- .of myasthenic patients, Harvey and .Johns (.1962) 
reviewing the evidence in 1962 concluded that the data 
for an -automamune disease of muscle due to disordered 
function of, the - thymus now- *provide- a anbstsaitial - direction 
for future research ♦ *. .. ' • ' . i-.l-l' ■
1o view of the evidence - reviewed by Simpson (1960), 
Burnet (1962a) has included myasthenia gravis among the 
autoimmune 'diseases. " (Xn this and all - subsequent papers
from the. '.same author/the arthritis described i.n - "my paper 
is described as rheumatoid - arthritis without the 
cautionary quotation - marks. Burnet.'does not seem to have 
any independent evidence) Burnet (1962b)" classified 
myasthenia gravis in his Group 1 (organ-specific) type of 
autommune disease " while - acknowledging that a possible 
relationship with - rheumatoid - arthritis - might necessitate 
revision of this - provisional classificatoon. The evidence 
now presented supports the hypothesis -that maathenia 
gravis - is associated with disturbed aotig©n^aotibody 
reactions but demunotxv^■fees that there may be several organ- 
specific antibodies present and that there is- a clinical 






' ' ’Mtibodies against 'muscle 'fibres -are -rare-''except•• • /
in the •pp^egnee of a thymic- tumour ■ and -may not account ' '
for -the -.dofe'et -.of .neuromuscular transmission*- The ' ..■ ,
.possibility/" of "a more 'localised: ' reaction .remains- "
unconfirmed but is.perhaps more plausible •sinee the . *. ' ■ •./
. pxodiK^t^:ton'‘oil/mii^:ip3.e antibodies "/is now 'established :arid/. '
■ this-may justify -^c^me" further discussion of the" possible - ' ‘ '
■.mechanisms .'-involved -sine e 'further facts are pres'en'te'd' in' • -
' this thesis,, which .'are.' not generally Imown and yei.. may be -
relevant ih‘. the" Wider context of ..au^oimmttne; 'disease* /. "
. ' xi)?"ihymectems: (Chapter 10)* -’Removal of -the /thymus-, ,
may cause arrest or " resolution'-of' m3raathhui«iaL-^feaarr€^^?,.‘ . ■ 
.out during' theppropos'ebu ’ac^vve'.stagS'K-Of'.the -.dxsO&ss- ■ ' '
(except ' -in no - far :a$." 'permanent muscle/ damage has1 -already
occurred) but does hot "always, do' eo, ' ’'Furthermore,- -- /' ■ '
"myasthenia gravis has first manifested itself - after - .the? 1 
thymus - 'has ' 'already\b4e& removed? to, eradicate; a- tumour' .-/, - ■
•^Creon ahd -'Booth,-1958 )# - - .... \ / - //?'.../- ' / - ’•■
.'" "/ - . These clues that " the thymus'is -not the exclusive 
' source-‘.of -antibody responsible .for autoimmune' reactions - 'is 
•supported by. the -occurrence. of " H8u$himot0,s - disease -547 .//years 
after thymectomy (Chapter 13)* 'M&rco.am#Bgovia et -/al, (1963.) . 
reported-' the development of ulcerative' colitis ' and ..systemic ’ 
lupus erythematosus after the thymus had been removed, for 
myasthenia- gravis* Hepatitis and aoule haemooytic anaemia
■ developed - ' several ".years ‘.after removal -.of h .-thymoma in
Case M 3095 (Chapter' 10). were .probably due to drug - ••• 
toxicity*- These ' observations suggest that the thymus is- 
not - . ' for the' continuation of - .the disease or for
the .subsequent development of autoimmune disorders* It •




















.••• , ■ 20?* \
may bo that the thymus" is" of prime importance during the
first five years-or so' hut that other /parts of the : - 
reticuloendothelial "system may then continue to " produce ■ 
auboantihodies without its presence" (Simpson, 1958$ . I960)*
•' 'Several' theoirbical'.poosabilities have, been
•;disouBe&d"-and a fuil/review is not /required here*' One . ■ -
theory of autoantibody production-.which was fo^Voured in ' -
.recent years was •" that-protein ’leaked’.-from damaged- "cells
Wthin/which itfwas normally;■confined and that thia" acted - 
as- an " antigen Which .’insirueta1" the" reticuloendothelial . ' 
system to" form " apprbpx'iate" • antibody* . fie multiplicity : %•
Of-.antibodies in myasthenia gravis and other diseases makes ' 
a -^leaV '’theory most improbable though -it -.was allowed' for ■
■.in -/the. diagram/illnpti^Mn'g. my/hyppthheisFig* 12,3, . ;
(Simpson, XOGC^}* It is - more probable- that " the antibody*
. producing.mechanism • forms' a' wide " range ..of proteins •but/// /
normsllyt these do not reac t. " wi th - - the - * individuals own tissues.
Burnet /has developed a .theory# which hae/been -.modified ' 
froml time■ ‘to -,time, based; -on the supposition that clones of
lymphoid cells develop-which produce antibodies which ' 
cover? -bll the antigens, likely to be . encountered in a ■■ 
normal ■ 'environment'* ■ ■■ in the early stage ■ of his theory he 
■pdstulated. that/each clone'"Was : .preadapted■ -to react ■ with" ■ v
only; ".one 'type ,'of • antigenic iehermiixsmh.•- He "-now considers
fthat-it is necessary to • envisage a progressive development
to specifically committed clones., " .based' •oh"the •.
. differentiation during embryonic •life" of receptors ...' .
concerned essentially :with the "recognition of patterns-‘ ■ 
that are or m&y-be present" "in-body 'components* The theory 
requires that cells " parrying receptors which could - react
. with -normal body components’-must be, destroyed during .










embryonic- -or sequestered, in 'some organ, with .an-' , /' <, .,
Gff ccA:ivebllonW~organ. /barrier* In view' of the wot of..
Miller, (X9'6l) he'suggests this role for the thymus - ,
'(Burnet, 1962oi)«- ’The -lymphocytes producedAthere -are, in 
this view?'- /uxicommibted ♦ until they edm'e. into contact . •
wt th-,’'the '.appropriate.;antigen and• then• the ■cell .proliferates 
in .other lymphoid tissues such,, os ■ the spleen and lymph 
'.nodes* During• this proliferation he • suggests• that ;
progressive .specialisation • occurs .of the antibody • formed •
'by. the-clone- which is now /committed 1 .'by-a process-'.of . -
mutation with- selection. • clones, of-cells which would •-, 
produce antibody against •♦self-components* are descr'-ibed . , 
by-- Burnet • /as • /forbidden' clones *a^id ho cotusiders.- -that .they ' 
are ' normally .immured/Within . the-tthmus’.hy , some form of ■ ■ ' 
homeostatic'.control. If a • to • a-form ■ . ;
resistant to • homeostatic control arises >--it• will proliferate. ' 
in '-the ? thymus, .instead .of being, inhibitedior1 destroyed, •/ ■ ■ 
thus. giving '-flse/iq active '.‘germinal,no'pbres* - The escape . 
of a • forbidden• done’Into the blood stream- would then ‘ ..
■ initiate tisxue-destraction# ' ' - , -'-'. • ‘
, Burnet (1962a) ' •states - - that the - ' favourable.„response.: ■
to -early. thymectomy suggests-' that - "in myasthenia gravis ' ■ 
most - of- the development, -of- the forbidden clones occurs in the 
thymus or that this - type of cell is rapidly eliminated' ,
• when -It escapes into the circulation* '-..-Mite '.and - Marshall ■ 
'(196BX- suggests that/a breakdomn. of a - blood-thymus birrier 
.may- occur --in myalth'ahil gpavis* The failure of Tate -' • '
thymectomy might suggest. that later -population of- mature ' - 
.lymphoid tissue (spleen, -./lymph nodes) may occur /(Harris'- -
ane.--lFx,r^e .,1965)» 'The occasional occurence of.■splenomegaly 






















w 'ia asthenia 'gravis now mrnmqa. sow
dtmifiomwo '' (GhaptW 7)* • '’ , : ; ' . ■ ' '•.' .
' "'v.' Mill or {X9&35'' Offers aXiermtiw theories for tshe
role-of' the thyme? amd' favmws t the.viw that It'may emdow
mom^thyroio .iym^ioeytwWvdhh • .tW propwiy of irnmnoXogioal
eompehoheo ' (Osoba and' ;1963)v .&e e<mddwWtli&t ••"
Ah4'$mot e^uito clear tW "Wymuai play® any ■
direct'part'in the induction OfapealMe-tolerance Wt that.
Hi irn more Mholy Wist it plcw 'a -part in the bywttw of ■
'■' '\Xt.i© unprofitable to-dleews ' forthor* ' hhW'Wry/ ■ . •
{poeUOfewS eW rapidly' - advancing- field' but It wlXX.be/ - 
apparent v,that--&t ' leoi mao plawibXo Weary of immuoXogiQaX •'. 
io^i^r^^^^hsho'roeiuirod a of the ’thyinde .In ,
early. Iff*#?, ,i "-^ ■■■:b•’ ' "■ ' '■ < • '. •
sii) -Geno tic. factor.# (Chapter 8)« 'Fai-lKt 'my&@th<mi& •
ooeur# . && a rare wwtf 'yoW- only oace.of a pair.of 'identical 
'twima'■io afootedTwer lo .
thyroid 'diGe&e^ '-and pornolhiy'of Mabotes mllx&s*' a&nsg 
the' and Siblings of /mwth<olil paW^Lld’e*'
-■' xiii) .|Wocrine rQiajij^ont^ih'^s' (chajpaw .» the • .. ;. •'
. S.esoel^«^1^^i^d•'endllor^l^iU!' disorder® 4$ mot 4%fem to bo oahMhXy 
related "ti the . ntinmisOonar ' aymdrWo*' They oamnot alX ' ' ’• ■' 
•he alGomMed . for in ‘terms of - • -
■'tolerance#; Jlria ongge^^'tld that they or# IMlrutly related " 
•by h&lVl»g\&!llmma hypothaXmo^pPtbh-tary mechanism (Mg#i2.9 )»
. . .s'/'These' 'Wo 'proj^iXtiojayidy- •"l»M<atl that' thore is o -'- • 
herodt’ary factor - Whloh determines ••th! ronctivity "of.-th©. 
•lhypltha^^l®^uG and/br- the pituitary* In most i&stnolK this 
• reeWere the enlhjooi' lLiabXl to d'lwXlp thyroid diaeaab-of ■ '
various/ . \ '' ". .- ' • /
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Various types' unde* suitable provocation* ' (In others’ 
■i&betes meilitus may’result,.bwt the' -evideaee in this ' _ :.
■ 'respeet’is insufficient)'* %n ’a -.few 'iases myasthenia, •'-. ’
. •• gravis results, the 'appropriate stimulus - being an ’ •/ '
■ emotional /br’ infective one or k '•pregnanoy (Simpson, I960),. 
'This pituitary -mechanism ’.could provide.. the intrinsic (non-’
■ irmflunnlogipai) ’ stimulus ’ to. - the'thymus or the ’ horm.psttat;ic
mechanism - re quxred by :' Btrnet * s theory ' ( Simpson , 1964) '
in the original ’ presentation (Simpson'i ’ 196it was ■ '
' suggested’ that ’ the thymus might play’, a rHe ’ in ■ tissue , '
differentiation .during em1?3?3^<^^^<^e^€^e^iiis of ’ which ’ 'the control ■ 
.of blood colls .and plasma pi^oteins may be a fraction which 
'survives ’ after’ birth, ’hhus harmonising the’ iuMnuu0l0iic&X , 
-•rbXO-Mthf earlier work, on’ .growth iond ''differentiation ’:which ■
'' has ’ been ‘reviewed.’in ChaptereX2».'iA ’.similar’ idea is implicit 
in the suggestion by Burnet (1962a).that the thymus ’is 
primarily concerned, with■ -the, ’maintenance ’ of ,tbe .chemical 
.•integrity ‘oflhhe/hody4 ’ including the ’ fbl?<^«^cL:fic ••
protein ’ synthesis, mW ' that thevdevilipmnf "lf the'.- ’ .
iuuuilQlQgiaaX. competence of the body is ’'part of ’ the ’process 
of ffi^lphnlogiC.al•a»d -functional differentiation •• of the .’ 
‘embryo’-and' young animal*’ Weiss ’ (1950) and Burwell (1965) .. 
.have developed■ alternative theories' of ■ cllnfc^ll by. the >• . 
reticuloendothelial system of ’ cellular - goowth and’ ' ■ ’
d^fierentiatlen* ’' My -further suggestion that this. mechanism 
is ’ e bntrolled by the ’: pituitary ’.gland .may ’ be as ’ rewarding as 
.the first part-of 'the' hypothesis -''on'' the.-role f the thymus 
gland in .myasthenia gravis'-and in kuibiflUuni 'disease*
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rfefeiuofe' if ■' fee'miotor'feint'-of - a •feaeihenfe-auoP loifee' • ■ - ; 
atfenlnted by'a,burat..^of •'far^<^cli<s'.efepfele feyrfefeCfefew-'b' 
•a. ■ rapid train'' of/. - whereaa' the''' fe' '
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'feibuXithvWa feiUi' fee. oxMWafefe'%yfe&fc: the farapie■ - ;-■ -/■ 
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■ 'though'. there', was pxx>grosslyc. lops' of fc’GGponse. if• it','was, - 
stimulated ’• 'indirectly 'through- its.motor. nerve.. Sliloo' ?■
" both 'the motor; nerve and' '..the’ -muscle -../fibre ■ havei ■boon-;. •' .;' - 
considered</until recently^' to., ho _iwi;mdl;.it'^eompcV-likely
\ •’’that'/there; was a- defect of trahsmixwioh/of; excitatidri-'/';-'-
.’ .from nerve 'to musolo. . -• • ' '- •._ '?• ’ . ., ..,\,,y.:
• /.;. ■■'.; . • ‘ Pritchard-;(193J) 'identified,'.the cause of ■ the '■
■' myasthenic reaction , as.VZedenbky..'inhibition*..; In; tiie :
■ Wede.nsky phonomenon :.&■• pai?tiai/-.bio.Gk/bf .a- nerve ■ ho. ■’ 
:■ prolongs .’its refractory :■ period that .only-, the- first' of. a.
rapid ' train of -impulses .will pass,-through',.the ...blocked' ■••■ 
.'area ’though &'•; slot/ -train may' pas's without /difficulty* ■<:
- The.-result ;6f,-’a .'series'of tmpulsos- at/-.& 'Critical.-/■'-•'
- . frequency of stimulation will'= then.•-.ba-a •single ransc.le' ’
..twitch f not the decrementing aeries .of twi to has 'found in-. 
m'yaetheni& .gravis*. - The concept of Wedensky inhibition.-, in
-myasthenia gravis’. still •'h’hs/ .Sqrae.' currency- in/ the Soviet ■ 
states'''•but ■ can no .longer’, he acc opted, ... ;/ ';, -,.-
■ In view of/the.'.4*es‘eiah5.ance. to curaro. poisonings 
dolly .'.(1895) suggested' that..-physostigmine might,bp. an 
./effective; fantidote* .to- !myasthenia .gravis;' ps.eudo.’par'alytica.’ 
(he was the first to use that term), but . apparently ho - 
never tried -it* , .-That hondur gdos/to' Mupri. ;(l895)/ '
but was not followed up as the patient showed .11 tile, 
.response* ."In 193^. Hapy Walker'/gave .physostigmine to n/' ■ 
myasthenic-..patient .with; dramatic benefit .(Wlkof t<195*f&).■ . 
and later an analogue; of the’ alkaloid^ neostigmine
(Walker,- 19 Mb)' At: that; .time/ the possibiliby- of 
chemical transmission at the neuromuscular function,'was
a ctirront topic among physiologists'and in the same year





























DOLe and ' Feldberg (1934) confirmed the role of
acetylcholne in neuromuscular transmission* Viets and
Schwab (1935) ehowed that a therapeutic response to.
neoe*'-’? gm*ne was sufficiently characteristic of
myaathenic grevxs to be used as a diagnostic test*
From this time there has been . no serious doubt that the
myasthenic phenomenon was due to a disorder of
transmission at the neuromuucuiar junction though the
exact mechanism has been debated. Indeed 
gravis became a favourite subject for the teacher -of
medicine as the ideal meeting ground for clinicOni
physsologist and pharmacologist* It seemed only a
matter of time and of refinement of physiological and
pharmactlogical techniques before the true lesion would
be dsmoostrated* *Ia that same period’ (I wrote in 1958) 
’knowledge of the physiology of the neurosusculsr junction
has made its greatest advances yet the solution of the
problem of myaathenia evades ue’*
.TMeMMeUrOmUS.CUlarM■■jUnttigln ' '
Farther consideration of the problem requires a
brief review of the mechanism of neuromuucular
transmission as it is at present uaderel88d (FLg*l5j). 
Tie motor nerve axis cylinder ensheathed ih meein and
Schwann cell syncytium, has a terminal arborisation
(telodendria) embedded in the sarcoplasm of the terminal
Schwann cell (teloglia) which continues over the fine
branches though myylin ceases at the arborisation. In
mammaSs the terming branches are normaiy grouped
closely together in a ’plaque* applied to a discrete
region of a muesle fibre* Each terminal fibre, often
ending in a knob* is embsdded in one of a series of
grooves/
■ . • .214. . . -./■- '• '
groove's" oailcd'. " Syttaptj^ct- gutters plasma,-? •••;•
membrane of the muscle# '.The neurilemma' 'Which lies."''.///-,.’.-. ■
. outside " of the terminal' Schwann sheath merges Into " the.
•,■ ■' :sarcolemmsL at the margin', of ,the ,end*piate/ sone and 'takes -
■' ' no ' actual; " part in " the junction >:// - The'-envoloping ...' • ■. ' . ■
• connective tissue , sheath." of .the- nerve fibre, .the "-//:' •’ '
endoneurium, " .becomes continuous with the - endomysium*
■ •.■ '.'Thue " 'the . cytoplasm. of. .-the ..axomsl terminal '■knob isi . ) ■. ' .. .
^covered-- by-'a very .thin/- layer:, ofiteloglial - .. -
cytoplasm "••which is separated by a gap" of "•'200*250. A from 
the .plasma- membrane " of the" -muscle cell . in the corrugated.
" ■ ’eubneurai,apparatus’/•ofiGhuteaux, /;• ' •
■ pj^^jsi^p^ogy./^f.^neuiromuculhar^'Kr^ensmg^ision'; 'V.--'- i-i'X
The cytoplasm of the? axon terminal c ontains" many "
mitochondria" and a number of "ovoid particles can be" ■/.
.• ■identified by "the - electron 'microscope -.(Lehrer and
Orns'tein# 1959)# " ' These 'are'-believed/ to' bo vesicular'/. 
structures containing acetylcholine or its precursor*
Some " of -these are ’’considered to discharge spontaneously "
; ihtO'.the'nynaptio cleft, .but the majority: are . released ,/• .■:
-.-•.'•.-only by -gome’’unknown./'change accompanying' the ' depolarization"
- '" of "..the " " terminal knob by . the " occurrence /of"'.an . action ", .;-. ,
potential . at its surface benibranee •{pre-synaptic meimraao)* ; . •
■ ■'...' /./'The ..acetylcholine liberated /'in. . /this way crosses ■ the i ■/-■ ■■
'■ '^.narrow/ gap ".to "the/ -pos t*»Oynaptie -membrane-of 'the,
'■ end-plate. .’At "this ./sit!/-it "-la considered that there -10 a ■./■'
protein " which " has a " m>o<^<^ular . structure " complementary to "
•/..’ .the -.shape of "the -acetylcholine '’molecule,"This 'acts ./as ':a .
- .’receptor-* " surface 'to.", which -acetylcholine' or' similarly/ ;; --
.- / .. - formed'"moleoulesr-readily .1^3L!^<3/■/b.hem^^<^2lsze^s♦l-''3Ln ' recent" 'years ". "' 
there has " been an" increasing . tendency to restrict "the









•• ' " ’? v///; ■ ■ '</ '■,'/.... '?;/,?'.v .
■■ term ',*’ehd~pihtef ’ (previously need mere- c.omprehonsively) - ? 
to the sub-synaptic region - of the muscle membrane* The 
•union.? of/-acetylcholine" to--receptor protein\ln'some.-way?. - .
Increases the permeability .'of the end-plate none to ions
■ in- a relatively unspecific way ♦ .? As" a./consequence of this;. .
■'- permeability • change, ’ an ionic, current' flows across"’-the'.:
pootsynaptic. membrane with a di^ection and intensity which
■" depends' -',solely . upon;'- the - ionic’■.gradients? and /pb ten tial ■ ? 
difference across the membrane* The inward flow of sodium 
ions .causes. a;"depoXarihation-'of';the. previously' polarised '., 
muscle cell- The ’end-plate potential’ which results
.. 'Causesra ■current flow-in the -adjacent.resting .muscle?-. •• -.-
■ membrane.' Xf this. reaches, a -critical level of “’.current ,'■/■;■ 
flow a muscle' action 'potential is. generated.- ■ This ;;in .'
. ■■'turn-.activates- the.;contract^.ie '©iibstane'e- of,: the. muscle.' ?.'?'?■/ 
$ote that a-'consequeno'e'/of;-this-io.,that?if;- all'muscle,-- ■
. fibres .'are.'-depolarised:simultaneously4the -compound ..action/ ; 
potential is more or less directly related to the 
'accompanying .'twitch • tension* - '-'It \is''.bbbause?.cf-..this./ . • /• ? .-.? 
relationship that measurement of/ the synchronised action ; 
potential of the muscle is noty used, as a measure of
."muscular; response" in place of the tension as’..-in ''the-'"'.
-.original test of dolly (189^)*
‘-•The' muscle/cell, becomes repoiariaed' by■ the./’■;.?"
outward passage of/potassium ions and almost immediately
/.-by the? expulsion by d?metabolical'ly boh t roll ed /?* pump*-- of ■ 
the excess of sodium ions- Thio docs not normally lead
to regenerative activity even though the receptors may
■ still-have acetylcholine molecules attsched* There .appears ■' 
to be some moohanism causing temporary refractoriness hut
,/ its nature ;±s not understood' (Axelsson?.and-..Thoole'ff.■ (1958)-, 





























If the acetylcholine/is. hot displaced this is ' followed / 
by ' prolonged'block'of transmission in 'the sense that .
further. discharge /of acetylcholine. across' the synaptic ■
cleft will not evoke /an' end*ppate/ potential. After. the 
'••Work, of Wr us £&&'Baton ••(1951 )/ this" was"considered to 'be .•/ 
due to " persistent depolarization*. T^<^,ugh" it is now /.-'• 
known that.the posteynaptic membrane actually repolarises
the block is still' described as' a’depolarization block’ ’ »
• ' It - is-. the ’ mechanism 'of ''block ' when /,cer tain .’quaternary .' '■/'/ '/ 
ammonium compounds related to acetylcholine (decarnethonium,
;• suc'cinylchoiine) are - injected into the normal human subject*
/That this does . not happen ' With' acetylcholine is - due to the '
, fac t' • that it is" - rapidly, hydrolysed; .by .'aispecific’'.. • - i
acetylcholinesterase which is ' concentrated 'in the subneural . 
(or ' terminal) apparatus lying deep to the . postsynaatic folds'
of the ' muucie' ;membrane* . / Chooinesterase destroys , ‘
/•'; acetylcholine '-at a' very '-high 'rate* • .'-As .there is, ’■i^n ‘
addition* free diffusion of . acetylcholine' out of the 
synaptic ' cleft into the extracellular space, with which 
it . . is in Continuity, the concentration of acetylcholine . .:
■ at the./. receptor :siVe"faiXe'Vfcry.yrapiddy*- permitting the, ' 
muscle. to respond to/ 'a rapid . series/. of nerve ’ impulse's '
and their ’ mediatory packets of "acetylcholine* It is , 
the failure of . the hydrolysis which" leads to the . 
prolonged . *^^3^^.e%arr^%t:ic^«^^';b;loik^* when the closely '"reXa'ted 
deiamethonium is given . to not^^lL' human beinge but. y 
acetylcholine .will have an entirely. similar’.-, effect "if 
it's hydrpoysis is. prevented . by ’-a. •comppe’te/inhibition . 
of cholinesterase,by neostigmine and'similar substances'.
'■ (Chapter .18 .and 19)*. '' ' . ' ■■• / ./'.' ?
' Electromyography/.-'. • ■ . . '/ / ■. ? \ ,•
21?.
'Bieg trOmyOgr aphy -of s-yoiu^
• X??< .•/ :■ /iindstpy. ,(1?35,) $$O'<.myographi©/ and ■ ' ■ X • • ■ .. **
•sIpg trOmyographiO' • studies,. using, coa^cliai ' .needle / elp^pt^;^c^d^^'- 
-tp.'X’egdi,&. the•• activity? iof^-\;Lndiy4^^dltia^;-'^^Bci.e;Xfi^t>3?^s^‘ or wX X 
pf/moiorVanits. . ■HeXfoundlthat?the 'rhythm of .discharge . 
of .; .the ' motor- uni Wyom /voluntary.' con trac tion was /normal * ■ ■■, 
TW-piso. • uf • the/p<^^^^t^iin;tiai^ir^c©S03?ded. from" ©'ach' • unlit "was■ ■• 
snOjee t -to.,- wide variation. -which- -was. .-greater: with? fatigue' •• 
of. "''the. • muscle hut wt0X■•abc^;^„io3t^.pc^-'jxfte3^’r?'1^je^^^ct^^]n^':?Pf ?; /; - ' ■ 
a©pstigM»e'#:/."' Mb/,considered that '/ the .'/function/of, the X/•.' ;■ ■ 
motoneurone ••was- /normai-but?■ that /there, .was /intermitton t -XX. 
-block/ • neuromiscuiau' ' transmission '•'t.c^'.d omp, of, tho-mtise 3Le
fihres/whicli itX/ihnearVated •.- .Mth UQhtihupd,..'’ef fort /there? ■ 
10,. a • pro gr 0085^^0 . fall-out / o f-mo tor •-uni ta X'?I f " a' spec i.a!.?.• 
•offort•ip/requested '..'./ja how and • poorly sustained. burst of 
discharge occurs*" . "■ Denny•*.■B:rOWi ' (1953).//states ..that ..•.tfteX< ; 
unitsiforming ; this . ■reheWd'Xdi.eeharge; /arpXnotX units’ /'which . 
have recovered -•from/the '.pr eyi^c^us^.?*afstitg^e . ♦, but; -aUd-heW •’ '/ 
.UnitshresspoMihg, . only, to 'thp'. 'Special ef fprt.'•'... This/ • has- • X;. .•■ 
not; - been my- own. 'Impressoon.Xthdugh"' ityis /impossible Xto / be"' 
dpgnatic . about' it. /". It would, fpr . instance,’ bp . 'quite 
impossible :tp 'state/ that ’ the "•firsst/units to. dr bp• ,'ont;"had,. 
•not? recovered .since/ their X•
during, full• contraction . by normal. methods • of recording# , 
■J4.have 'described •cycle's ' ;,o f'. sudden• . failure 'o £,,.© ohtracti on' • • 
with . r©hewed-'/P£ forti•iwhiph’' resembles• a, hysterical-// ?/-" 
rm?niifstation, .and’ .t^hei^^:c,??^iCor^^^?my^c^^r^^p)ht^<5•;C^<>hcoBtt^^^b • •., 
(Simpson, IpoO^'-• but- the. latter is published here for 
the; . first . "hirne•• (Fi?| d'H2).'♦/ '-It will be. seen . that the . 
eon£use&//,ihi®r£ere»c.o‘ pattern♦/ of-’ the ••.p'ibc.tromyGgr,m7iX\ ■ 
'decreases 'in ••amplitude.. andpbccdmpO;.sinmlifieO ' by • : the /' 
.sudOn/x '■ .,-■ -,/ ' i' /;?- \ ‘ ./?//■'-., . X' .?.-,X •*■ 'X/-':. ■?/■ /
■? / ??' ' 2X8. ■?-'' ,/?'/ ' / ' /?'■"'1-.
sudden; cessation; of. ■ activity-eg some -.units (Benny-Brown,
1953; Lmdervold* 1954, •.SimpSon-, :'X956)'iy- '/ At this stageX?.?’ •/ 
the contrac.; 'ahdy'tif.e' .motor- -xnits- :?- • •
.tend 'to.-sy.nchr0'ni'ee,/ jAha/isfouhd'In. normal. 'fatighe/X- •;. ■ ' ; .....
-of ' muscle- weakened by 'a- ?X": '’' " "X ' 
y&riety?6'f'Pawaes.v. ?j'have suggested •'•that'yl-t 'might;- be./X ,',. ••
due to. .-a, 0 ha' ge'/from' -a contraction • regulated? by spindle -: -... -
reCeptore to -.one •regulated bytendon - organs? (SimpOeUn ',?X ■
1962^*' <,hhe?to entrap tion'. then', stops abruptly-'but 'is''X'?X'- /• •'•' .’*' 
-reon.m'od- --n. about .ohe/'second' with.■ greater; intensify*? ' / " . .'?’ . ■
Bather ./than' DannymBrown,’®- ■eeppanation' /Of ' reoruitmeht'of • • - ?' .■..? / ■ 
h hidden-reserve’?pf/high-thrdehhodbuhit-;. X ‘have;.? !.?' . • •..• '. ?■
’-suggested.that - the /iMief/'pause' allows geyelopment.- of'.' - X ;! 
•'shdrf.-iasting \poist>rtet^anl.e /facilitation. . It,is? the'''/. ' , 
same' mechanism•.1^hich/■€^^l^Sl::^f3he^a'.i^id^u?ed■:?^i?--^:l£^Otfe'tll'^■n''• y * /
patient ?is ,aiXpWd.?to‘.bbin'k/.'dwiiig/teating* ■Xt'iaX /X- . /'
■probably, ■ aWoXthe mechanism 'of. ' the ’coarse'/mohbeuiar ->X. XX-X--?' 
nystagmus .'which. . is.- sometimes? present’ (Simpson/ X19S0) ' * .;. : . - ' '-. /X 
. -X I//Many/.of. the/mb. tor. ..unit'd XinXtbey af fec t ed wsci'es'..,.--'’; l
have /the polyphaeie . .action- potentials'of . a/.’myypabbi.e *,' 'X.--X " 
mootor unit* , -This 'may- only be .seehXinXthe last unite’ = '??':??-:? 
.remaininglefore.' final ..oeseation'of the weakening? X? ;':" <X X X . 
opntrottionyuuinin^;9^d^s^5^Xcase,3 similar unite.’ can be. -s-':y. XX- ' . - .' ■ 
found' at' the/ beginning .of contraction ''even after a. ■ . '
■period''of rest* ..., This, is most -x_ • •
the deltoid .and., .triceps;muscles .of /the/upper ’limbs*'' . - . -
jn-’a, minority of'cases ' mussies ’affected'inX/this'■ way ..■ ‘X- ’ •
Show scanty -spontaneous’ fibriiaatoon,' positive sharp, . '
waves t, and /increased mechanical. sex it ability* x All.of --' . X, / . 
thees 'feature's.- are/indistinguishable - .from the/electro-' -' ' ?'
mybgr&phio pattern o£//polymyoitxs' . (-Simpson,/ . 196WX'( Fig. 15 ,3) 
Unfortunately/ XXZ ??-■> X-. X X' X ; .-/ ? ? .■
■ - '•'/'/ fix .//2I9.; . ••. / ./ ,/-/
"•/ :Hnfortunat.eiy‘ the' -existing techniques do '.net' permit ■ "
’ ' satisfactory‘ Isolation‘*o£'.a single motor unit to study . 
the changes'/in Its action' potential' throughout strong ■ ; ,
- voluntary effort/-.'..;.'C^<nsi^«^iraa^Xte<d^xioorV^1ti^<^n of ■a, '-■
■•- ' s't^at^.l^tic0^inn<tti^3^^^\e^a^h'i^^ih'oweVe3?i; be-obtained .'from the ' '
study of;a /population. of motor ■ units', integrated' by, •
•x recording from the'Wiu surface’ .if'each 'is stimulated ’ %.
■ x more’ '-.or -less ' '’Synchronously/ by ' means ■ ^of/its ' mb tor hper ve*'", ■,
Possible•abnormalities’ causing’ the' myasthenic reaction:
' " In the 1950“30-.. period. it wwaa’considered’ 'that ‘7,.
/.the myasthenic .response Wust, indicate, o'ne.’ .of three -/< " : 7
. .possible’ - ’chemical; .lesions ’•'at t^^/n'eurb’^iis^icU^i^ir;..iunc ■tion: 
i) insufficiency/of /acetylcholineA/ii)/ excess,/pf ;V , ’ • ■’/'"-
<• cholinesterase.,' ‘dr lii) ' az-block' of ’ transmission- resembling 
x /curare^pdisoning, .-'and ’: presumably ’due • tp. 'the' presence' of/ ’ •.
\ a;'<nn?.al^.lioal loa'£^s^tI:^.t^P-i(^. .toxin’'’present -in ’.the ' blood; / / "’
■ //(Wilson'"and;Stoner*’ /X9Mi-)* ’' - •hbj^5Lb<ai3y'iit;,hh<?uld' be •' '•
. ^/considered -that the, ' reqepter .■'js/lIo of the end-plate ’"' ;x-. ( x
.-■', might. be abnormaa .'but- ' this /has only' ■'.rebentXy' - been . !•/. ’ ’ ;/■ ’ '’ ' '■•
'■' ■' postulated (gaimis7 et ,aX.,/X9;9£)f: /.%e •..ihvestig&titmss-/-.//•/’ 
,'x' - carried /'out - to determine ’ ''between ’: these ’ possibilities^ '.-are' •
■ ■ cleet.rophysSological ’ and , pharmaCological or a ' combination'
'•-'•of /these two*/ -’ /‘-/i A. '/■/-'//'■, x 7/./-xxz. •./• ■"■' / .. . -"• /’x/xx.
./';ighe'-iarvey^MaiSi2n3d‘t^S!tg ■■' -//'//<■ ••'•' ■ . -/■'■'/-'
/•: , ••- - ’ ’ Barly- reports,, of-the/changes in/the ’.action/’ ;•■////'7 /- ,
7 ''pol^<^n^i^^l■7c^:/;/a7*^yysSi'h^ihta. /^^i^m^3.'i&..totjan5^^s3ed- by repetitive; •. 
etimulation.oo a/motor/nerve -"■moy; be/criticised’on .-’ '•-/ 
technical grounds/-(Herhiog/ ' X9X?$ ’ Fichler at/aly 19^5>i'
■Harvey; and’ M€^^■^l'^aO^.'.(3^9^^4^l^;/d3^^^v^•’' attention/-tc^ the .•.'////, i/'’ 
./importance of preventi,ng’'di£?p)7^e^<^^^meint; of' the' stimulating
' ' electrodes' placed' over the nerve and of using/ /■" '•"*''" ,/
supr dmj'ucimal/'.x •' 7';-/ ‘ \x//-/ '• -■/'/ /' ••'//• -
l -. •
230.
supramaximal stimulation to ensure. that .every motor fibre 
in the mixed nerve io adequately stimulated. This can be
a painful experience for the patient, emd it may’ be 
preferable to block the nerve proximally by injected• 
local anaesthetic (Deamedt,’ 19/58a). Special precautions
must • be taken to prevent the .electromyographic record of 
the evoked muscle potential from being obscured • by cm 
artefact.caused.by stimulus?escape (Pinelli, 195?)# ; \
Most .of the present work was done with an 
electronic square-wave stimulator similar to that 
of Ritchie andSneath (Witter and Mtehie, 19ty)), The 
output of the simulator• was connected to the 
primary of a Muirhead transformer (Type, D?139*B) 
and the secondary. wimdinga.of the transformer were
v-',; applied ’ to saline pad. electrodes. fixed over ;the ■ - 
appropriate nerve, The electrod© were placed 2 cm,
apart ’with a cathode. distal to the anode. In this
way• tho stimulus was isolated from the ground. The
wave form oh the stimulus delivered at the electrodes 
was virtually square but the. wave ' form is not 
important as the •. stimulating current reaching the 
nerve is . distorted by the resistance and capacitance 
of the skin and other tissues (Stephens, 195&)* In 
later experiments a baitery-*0perated transistorised 
..stimulator was Used giving a stimulus isolated from • 
the . ground without the need for transformer coupling.
Using the shortest available pulse (1Op.eec) at a 
frequency of 0,5/see*, the stimulator output was• 
increased until It was’ 30? greater than the current 
required to produce maximal response in a muscle 
supplied by the nerve which was being stimulated.
If/
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' if th±e was -not obtained within these ' parameter©! 
the stimulus .piniafe was gradually lengthened, The
. actual stimulus. applied varied.from ease to camo'a '
• but ’-was always at least 30% anpr ©maximal, -.:'''•
the notion potential evoked by . the atirnuXu© was 
•' .recorded from an appropriate mu sole by surface ■-
' .••’.‘.electred'©© (O«.3cm* silver-silver fofelori&e discs) / 
•leading to a conventional push-pull reaistaaee-. .. •
capacity coupled' amplifier and a two-beam
• .'Oscilloscope*. ' One electrode was placed! over the
belly of the muscle and'the other over a tendinous 
•part of the 'related finger, they were fixed .firmly
in position with adhesive tape* Time calibration
■ was .applied to the second booom of the.' oscilloscope
';d&. 'EdLgw&n' l'eW~£res.c©no'y’ o&ciXIator ’-or crystal­
, •■•,' controlled timo •'oar^khr (Mig-itizer ) ••producing a ruler-­
- type time scale, Becordn were made on 70imu 'moving
; film to.demonstrate sequential changes in the action 
potential amXlindc, In a’ few instances the -action 
potential of the nerve ’’was simultaneously -recorded
. ' by similar electrodes placed over its course proximal 
’ . to the point of' stimulation. ' ■ .
■ ' Harvey and Masland-' (1941) found'that the action- '
potential of the muscle after the second of .a' pair of 
supramaximal stimuli .was depressed 'for--0»!~2*0 seconda 
'after .the first (conditioning) stimulus. ( With -a train 
of .stimuli (’tetanus*) the effect varied with the interval 
between, stimuli but .even with-'stimulation rates as ’ low as
, 13 per second there was an immoddate and progressive 
decline in voltage for the ' first. few responses^/ . the' •- ' 
voltage of the evoked • . potential then continued with little 
change^/ . . •
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change ':.at(.thiS;, ioweaU level " :of. •••"
was ;,moj^'ei'pironOuiWid WhW the . muscle..-w&o-■ partially--' ' 'f 
Jf&tiguedl-. - (sic.) Say"a5re8U.lt *of-''p&eyiou;* periods of (;■'ff
’’dec^ePfcnk-/ wa^igeakdr.Witff’fs&er ' ('"1 ■ 
rates' •■of - .stimulation* ' ‘'Then time pours©" -of ' peppvery- ■.' - •■•- ■ 
.following - 8 tlffittlatioii S^vsits '•'(tested - withi single-- (test ' (• f < - . -. 
shoc&S/^pXied .-st/varioUs''intervaiS/afte/a-f Standard'." •;(;' 
tetanus.- ■ "" - The ' ad tion ■': potential' - ' did- -no t7' rSghdn, -i/tsf (-.(•'■• "‘ •' ,( 
initial \vo It age until 1, 5 'doppnds' (after?;, -the termi na tion ' > f 
bf'. -.th'a-tetanuS'?- (■ '.<x'-' ( ■ a o' -- f ;;'(lf ■ "//f .-.■ .• • ••, / ( ••.-•/ •: . '
• ,-(-(";y,(*.inf a- 'inter- 'paper; .XBapypy, ;e(^:-al- y' -19^4$ '-'the ( -• ' ■"((;(-■■ 
Baltimore ^^^w72-Iks:rs''/i-'e?'p(^3r.t•••fchp(-fiTe't; eVookdpS/",; ( ;’.( 
potential- was' sometimes .' suhndmai; i#’'-myasthenic "patients; 
This."' wafe ;sd^^jbimdS(-^c^l3^dw.edf by- 'transient - facilitation (dr " - 
WedUiMme V of.. ndi^ir'pim ’^d'dul^^r'j^.^it^r^^s^xje^mtsai^^’^i^ hand 'Into ther-s U' 
■ profound; deg3^<^^^..pf^:d^epr^^ siony; /‘^^^e;e?;;li^t?ej?3^i^jS,tW,%(.(-(
. as - an -indication. ‘that somefmnucl'e-'f ife©s.((. ' 
.w^;*0^:i^ndapab;Le;(-o;i(:S.t?:i^mn2td;ti^on-Uhl5:ii7:neuromXfij^i^3li^:r( ' "" ’.,( '":' 
^3^l^^^m^lS^^^^o(n‘(,Imxs■;f-iPi^;i:^.*:al^^'•i«^^.b^y^;k>re^^^^siQja -'of /stimulation
short '■ period-, of - (The*increased - yolt'dge... ■
.could ;not; be ''due(to'(bcttei* synPhronissafionof"musels ?(- .
'response.. ’'since. it. .was"(accompanied .by - an(incr'eaS©--In; -the7; • 
duration of -' thd- ppj^<e2^ib:iL'c^3U.,•• (There ' •w&S" .no evidence .o’fl- ■.'' ■ 
-repetitive"-:' response - (of .’the - .musel© "yfibhep)>y./!» ' one ' (i ■" - (; ■ 
patient both ."''depression- -and faci3^■it^lfi^d^(i^©if • . seeny :.- . ;.
/:.( ■•(• ©a - Tics© ' ■"•results- -were; •confined and- • extended' by. (- • a 
(dohns-'et "'al , "■■'(193$)* ..They" •no^ed ' that "- patients (With ' a. .. 
generalised -•'•gravis showed-nn - abnormal ■(responSe'
to"- repetitive"" nerve " _st^:^mu^^at^^S^n- nt - rates - as; '■ (low* aEJ••.5((J/i'i^'• ( 
a e.cend yd’, Initially - * 'the - ■ ampii tpde;- - o f -the . musle-’ ae tionf-'- " . 
'poiJej^^L;t'al^''ied3iined\3rapiil^y'and'' then,'^turned" toWard-fthe.. 
initial? ■(.■.-' -,. •1(('^ ■' '' (■ ■'('/.iff' • < '-"ff (( : " (
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initial . value.- This was ’in 'turn followed by a slow
exponential fall in amplitude* ; -As the stimulus frequency 
was increased the initial trough deepened and the rate 
of the late exponential fall was 'increased* , Similar 
results were reported by 8trappier (1954) and Pinelli 
(1957).
Johns ot al (1956) noted a facilitated response to. 
a test -stimulus sometimes occurred 1*0 sec* after a 
tetanus* Such an -increase was never seen in normal . subjects
and they concluded that there roust’ be muscle fibres 
av^lable for recruitment in. the . myasthenic,- or in 
other -words, that there is sometimes. a partial ‘
neuromuscular block to transmission/of a single impulse*
The degree of poet-tetsrnic facilitation may be increased 
by stimulating . tha nOrve at frequencies above --bh.ats&t which 
the ./muscle fibres can..respond, or- - by-continued. stimulation 
after the muscle fibres have ceased to respond* These
facts suggested to d°hns ot al (1956) that the . facilitation 
is a - prejunctional rathori than a -post*junctional 
phenomenon, probably due to - increased output of 
acetylcholine by the nerve endings when - stimulated 
rapidly (Butter, 1952? Liley andfBorth, 1953)#
Personal electromyographic . studies? ' ' ' -
• My own studios from 1950 to date arc in full 
agreement with the at Johns Hopkins University.
The . illustrations show examples of the pure decrementing 
response (Fig. 15,4), the decrement tempooarily restored 
by facilitation (Fig* 15,5), initial decrement foUowed by *
facilitation and maintained response at the original 
level ), and facilitation without .decrement (Fig* 15,*) •
Post~ietanlc facilitation - is illustrated in Fig* 1-5,**
In/
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lu ©ome • 'oases ’ a: deoWh^ntingprespOnfio. Occurred;. ai/lsiow '■ '. , 
ratesof .stimulation ■ (loss than ?.10/a3p.O'/)■ rhu.t. :faCiX&a&tOon. 
at..- faster/ rates . (Fig*i5,8 and-'Pa£^me.6^i^'i?'(195?^^;--. ,4,...-- ■ - -('•’' i 
!':• .V'-• •• ‘ ■ '•.• -It. ls.-. therefo re ’/••he.rtain-' 'that ...M'lh -.depirSssion/ .and..• : 
•'facilitation;. • occur =in.(.true may.'-, /
,be/-trnU,/ that- 'iho'\facilttablo'h.. response’'da,, eeen/;. iH/its. ■/ 
5^^m^d^st'''(^^wnxie5e^s3if\e,d^<^rni'":^ni c£^d*aiiK?atat(^^’^^f3.myaa0i;henia -., ' 'l-. < •'/. 
/('Chapter -.9 ■ ^and/Vif*<9«:7 4 hut■ .1 ■■ Have .no doubt,that• the. . ; 
difference: 1©■•'only ..one of ■ 'degree'*. . .I. Have■ the..■ impression . 
-that/ -the. .rnmueles which:■ show -.the;■'facilitation response •' / •. 
With 'IXttlH if 'anv?decx^€jm^s3ji;-.^^^'n ■ .1^s^*ueim5ry^as^th^!^^^^a gravis)-./ 
are ■■.-those’’' WlhLc.lv, exhibit ■itho ' ’dual response i to -the/'. ■', ■ '•
test. (vide .infra)■ and that ‘this response, ■ ■ _, 
be'c'om'esh greater -in. /the ' ^burned out* /phase of -.the.-disease. 
11 /Will■ be---rocaiXed'''ihat ;;’n^m9?^:s.i^'ipi*/o^hiain’ge.s Imay then he y- 
prominent in the ■/HLstthpaiholof?# ?/TisV phenomenon-' -.0Quid■ /, 
adcoimfefor -the ■ (fm! c ’that .. some patients/eventually . found ■ / 
an itox^rkyeweit'" ini their /muscular,- /power.. after;. ■ exercise, ■ ? (/ 
.'(Chapter' ■ S;'d:ihd./^^jse;4.M^‘-,1?i4?:// ■ . ((simpson? ' 196(g) #/ . In,''/' .'
those 'patients/thepJ 6 lly. ' t’est-whi Qh/'-/?eQords-/i^he.. ■ .power /" of ’ 
contraciion‘• of the . rmiucle; whenn/gtanised■ (rather.-,-than/’ifts / 
.action■potential* /i© misleading# ///,;..
•Poett-activation .exhaustion!.' . - ■ //-■//'-'' '
< j 'WV i h<i ilr:* Jir1htiti“t-i1i"j.f r.i'CTi|-'niTia~rtrr»Jf niiliiTrii!.,.i WBIT'1. ■Wiri^'murJ-Oli s . ' >. ■ ■,*-.. - " '•- k • ’t-' • / ■, " -. •-
■ '■ /'.- ■•/'■ /besmcdt / (195?k’.and /b? -1958b) /'has ■ made .a Special’’ 1' 
-study' <^'f.^^li^^//enxi'ta^bii.:Lt^y changes-foil owing an hndireotH - 
-tetanus.Of. a myas. thonie ■ ' muscle *'. :./'-iHe,reports 'that/ ,thrO/./.post 
activationlfaciXitatooH-is shef.triiyed* (■•X-t■ 'disappears ' 
20-30 seconds ■ after ■ far'adi sation .and /is ■ h^doceded ■ .by ^a' /■..
■ stage.’of /*posh-fttapic--oxhanstion*.,..'(.his''’/tex’minolpgy)./<■ ’ 
.during.;-which the- ■ eleotj^^:^:cal■ and ■ ;meechihiC&;V respon£?(^Q5s;"(l€^le 
greatly/
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.greatly?, reduced/aml a short ■‘train; of •stimuli.at, .rates ?■’ -’•■ . 
aer-slow ..a©/3/per secord" dause.;m^i^i^c^d\d^ec3^<^fflent-'.or-’;'j:.,'; • -;■ : '
^uecessitVe. ..ree^’bppeo * - /?.TThis ? i-p.oety tetanic exhaistiohiy/;'-'. - " 
slowly - dxq appears/‘wi/i;h /a? half^fime . ’of; ;10?*15, -‘minute's *4 - ••'/?/. /' 7/ 
:fiemedt ' cOnsidorsithat "' ;this< .■rather- than. '.the -;prompt ■ -'.. ‘
decrement . jaiUrihg.;A tet ahu©,'•■ is- the/reai/ reason/for-"the '. ? / . 
iphg*X&sting .component /of .the■^athpiogxeal/. fatigue; ////■/?'■ '/ . 
/seen "cXinicaXXy . (Beamedt,. 1957b).* '" •;! (have/hot/studicd',"••/ 
th±e."'a8peci/W detail/but.there/is- no-doubt^^.-tiiia^t' ,&■'■'" /?■ ••/’-. '• /■ 
/’myasthenic .•’ reaction i"'i&ich/pshnc#ybe,demonetra1^d/vlth ' - ' , '•/' 
a . . bpX©fia tadiitaixGji 'Of/a. 'motor ' • nerve/miay. torntiraes'-be •- :■; ’ \ 
■'demono.tr able. • ' after? a'pidj^^u^ng’c^d-voltmt.t^’^'yojontx^ac^ttion, .' "of " .//''?■' 
th,e, muscle" 'even? though there' ""has . been' "'.no , obvious .'failing . g ■ 
of. /.the voluntary /ConiractioU,//A "/.related phenomenon- is/ /y; ; 
illustrated in" Fig, 15',$)><• ’’This"'©ixow/thatthe " myasthenic..' 
readbionmuyf■. .Only^b.eycTe tee table . "after ■ repeated ; applic&ti©ns 
of', a tetanus . with brief intermissions$; animpo pipit/ . i/i.. /
point "-/When using the .Pea© tioh" -as-a. .aidghbstic/"tea t'.?''//• ; -' ;/;
- > A,-; •: -, . g-,-/-. '
1 ■;----;f ■ - 7;-:'- : id mawtaajia gWoxba’-." ■ • - ••-g„• - • '4­
, - -The' mechanism of .the - . -.- '
neuromuscular junc^jti^pn- • has//been.: . deac^ib^ed id -chapter' ' f!5• ■ ' •• 
Transmission',may/b,e/bloefeed.by■ yfioubAtypea of -A- <'/,-•- ’ 
abnormal!ties.•'-- Before•• thesb-Urc-outlined/ it is '• desirable,.. 
to- point out that ■ /present concepts. are ' based- 'to /a- large ■ * 
extent' -on' a ..study-of '-tranamifc.sion/ .in thb-norm&l.frog -•';.'/.’ a. 
or, -jubetiOn''and; -on- -the;- -••-;•-'•-. ."—- ' ’
rmoifioatiinq. ' deteotabie- by- --jP?<o^enV " technique's .when-- -•-' V, 
drugs, are applied* 'from - the ■ ' nwabor ' of - papers 'appearing/■•. :. 
every year ••it. is certain . that- p3?c^s^«^n'^lhnoi^W^<^'dge- .of . -'■the-; --./-'. 
site -of--‘drug - '/action? --^..s^/lnoc^nap;iti-e*--'/Qr;- 'instance-it . has-•./- 
b een -Wdely' '■ assumed- - tha t ' the -actfLoih'■.of, -'quaternary - 
compounds -is-.entirely/pOst^sjyiaaP^i-whereas there-ia-now--- 
increasing - evidence. -of/'^laddxtio’nal ■prb-synaptic - .action*'- ■ 
Nor-is <i-t-'•'permissible-to-/-extrapolate' results -'obtained' ■ ' - • -. 
from.- norm^al- neuromuscular -• junctions- -in.- other - • mamMliah -'
species -to - human muscle altered by-dipo&se</'A - •• ■ : ■-■•
-• '' - With • these - reservations - the -possible- mbehaniems--'. ,.
of"' transmission, -failure '- appear ' to - be.-as’-follows' -a -"
1)a'- Beficien.t '-formation'-or--^e^/L/^a^j^<'5\/-^o/;-£^^a^^2ty^biQoj.heV;--"" •
. ■• - . from-tha- mo tor' -nerve endings*-/---" - - A? "• • . - ’./a. - • ' 
E)-// ''Excessively - rapid -removal ' - of-acetylcholine- following 
ja ••-■-itS release* '"•• . ’’ - -' /■;••' ?,/■.-' ' A -.a '
3) -/A- Competition - for -receptors- - between'-ac^^^bylcho/li^ne'; and -• ’ 
-•'-'-;-- & • sterieally. related' 'molecule. A-,- • "?/' AAA',- '■ -
4) - . .Abnormal- prolongation of -the action.' of acetylcholine
5) ■ '--'-fbhoorml'.strubture of -the transmission substance#. .-
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6) . •• • Abnormality of structure or function of the:'.. ■. .- .
receptor- protein of the muscle end-plate.-
7) Failure of..ac.t'ivafcibn-con.tractidh coupling in, - /■
. .the muscle fibre.: . <"•- ■.
Unlikely possibilities t ' ' ;
. Of these possibilities numbers 2, A and7 ?h
may be dismissed from further, consideration* '
Excessively rapid". / removal of acetylcholine from the ■ 
synaptic cleft is very unlikely, since' it can.be"shown?'-.? .• 
by histochemical, techniques that the concentration of ; 
cholinesterase, in<the sntaneural apparatus, is normal 
(Cohen et al* 19%) ..and it is certainly hot raised in 
venous blood (Stedman and Bussell>193?$ Wilson et al,
19%) • Abnormal prolongation, of the action of acetylcholine 
would lead to the condition described as depolarization1 
block. In this state the motor end-plate becomes 
inexcitable to further addition of acetylcholine (by 
nerve stimulation op by arterial injection)*. This type 
of block is often, preceded by;,‘an increase in motor 
activity.but further nerve stimuli evoke a subnormal 
response which does not. decline further* This statement 
is tx'ue if cholinesterase ac tivity is . normal but, as 
pointed out by Grab et al, (19%a) there may be
progressive Intensification of the block if cholinestefase 
is absent, or inhibited* . This exceptional state can be 
excluded from consideration in view of .the previous facts 
but it follows that the degree of block will be .
exaggerated by administration of acetylcholine oi' 
anticholinesterase compounds*
On the.other hand block ’would be relieved by 
injection of a competitive blocking agent such as 
d-tubocurarine/ ■
&*Uufoo<uu:p&rnnc/»;! Th^fais--' no pqstteban&nie1 faeilit&tnpn-- • 
in •'dopQlariaatian - block*; < In ;all; of, these, reaped©?- • '.. . 
■•-that 'condition'. ■differs from• hhe■•'phenomena'if myasthenia’. •.;. 
■gravis-;'de'cept 'in'Zha event; of •ncCe&sxiig; weakhess'' ."•;, ;• i 
,&e ao c 1 a ted ■ - - w± t h - ■ overd osag e- of '■. antic ho i'i'n e s t epos e -. drugs -- 
.the? so«cal3a?&d-»*choljiergic •nrisi.sl /XGKaplieir.:-19)> -. 'it"- -.
i© - now .'know ih&t ihe Zmso X©-;m'eB)bPum© '.‘do e©> .,■ in f fact;-- - • "' 
X'epolariite 'despite, eohtnun di ■'occupation -;of receptor- ■/-- -; . 
sites '.by aoehylchoXine bnt the. hhemdiwepoox's are in ' . 
some;'way. dOehsftimod -. (Thosleff# 19.5S>,? -.Cats - and V ( y',. ' '. 
Tke&XHff't'i1957-)i\';>"She: -aevohth' possibility t ..failure' -qf , - 
activation^0ftfcx.oBionf-'Ottplih&'iny je '• 
view; of - the. '.fact that .myasthonio - - musole -..respond© i f: - ..
pomip|Xy11 0 --oh© •- nataa-aterJ^i^i3.‘';.i:i4'Co?^^h'hc•<^'^^•fadt>t’i^l'hhi^3^il^^^©
- COja0h'.;p,t- alj .• 195^'b)'.'-^Md. jp- .direc4-eiec.tiioal'' stimulation, 
.'(doily,',"!895) A-;i L;Thifite3^<^^{^^5^6^j!3--for.'0s«^:iQiu©'jS(On£^^is^j^)^iaaiidi^; ' 
mechanisms' 1 and-6» -' -■ •' '?,.. •
formation-'or.release" of.acetylcholines .'.Of?-';", ■
j* ii iw Wi 1 i*«wwiw>iiimiti»BXiii Mi rLiriL'i^*.i■.>iw—w<wwM'<»■ > »"i.i»p i mi1 i nw i l■ll■■«^^^■B■*—***** ‘ t ‘ ' ’■ • ■- ~
" - <>,■;' /’' ^h@. off @0tbjof f^hl^e?- Si<hi-failure
■■■•have , been studied "in eacperimehfiai.';
'.appears -to-'"exert- "a; specific facilitatory ' action; oh. .'the-- '••';• 
,;release of ao etylcholino - by a ■■ nerve. impiils-o and - magnesium 
i©';;ant.agGiisfcOc'fC0thia, reactoonv- ;,Xf the .calciumin -the; 
envioommeht; of' them motor. .nerve sufficiently.
.'w vertCd-.iorjhhe m^^^^ie^:n^^^^r^^aisod)^;';,i^^:-lnniiils©^:^<^n "failure '; '.. 
o>ccur©-which has 'to- failure,'of releasst' ' ?
Of.. aoetyl0lwXine^fliIU- the 4 ■
Kats, 'i95Z)>p ■.'; ••'' f ''4y,i , , ■ ^i;V; . ’/ •<?'•
-'■>;,"? ...•- Synthesis 'of- •al©tyXlh0lihi'■ by ''nervous - titeue- . ■ ■ 
.is strongly - 'inhibited by .lu^p^ichhli^5^^3.um,iM^c^3^^^'fcOsh' et'-'-aly;1
1958)• : Desmedt (1958b) ha© -studied.it© action in • the
cat with the Harvey^Masland technique. (vide . supra )• and 
compared it • with that, of curare# Both drugs caused ,
de.cremental depression of the evoked muscle action 
potential response to ;a' train of supramaximal shocks 
to the • nerve and when these were'stopped there was a . 
brief period of post^tetanic facilitation followed ' by 
fpost~tetanic exhaustion* such a© he has described in 
myasthenia gravis (Desmedt# 1957b)# On the, other hand;' ,
he did not demonstrate any pOst*tetanic exhaustion in ' 
partially curariised muscle# In his opinion this evidence 
strongly ' supports the ' possibility that the rnya'sthehie 
condition results from a , presynaptic biochemical defect 
chronically impairing synthesis of, acetylcholine> ;
Desmedt has repeated , his views in . many later publications 
but X am 'unable to find that the evidence has been , -
extended# The only details ' provided' are in the letter 
to Mature (Desmedt, 1958b). Xt is true that the timing ' 
of • the . post*tetanic events in the hemicholinium-treated 
oat are • the same as in, the . single, case of myasthenia ; , ,
gravis quoted# / On the other hand the decrement in the 
evoked action potential did not exceed 7% as. against 
35% '!» the myasthenic and 30% in the example from-'the ,
' partially -eurai?:ts^<3l;<<^fiiij;''^us<^:t«^.<v' There''is no evidence'''’ ' '■ ■■■
that the influence of, different dosage • of dftubocurarine 
on poet**teianic events was investigated and the statement 
that ' in "curarlssed ’muscle *the synthesis of transmitter 
would roughly keep ' pace with ejection -provided ' physiological 
rates of stimulation (less' than $0/sec-) ' are used*' would 
certainly not be accepted', by other ' authors#
: ' ■ -■'•,-.'The action of /.curare is ' described below but it
• may/ /■'..' : /’ ' - . - ' " •’ ' - '
-/?;'■ - ' •■■■ ../ . . ■ z ., ..
mayshe ' said/ at'/this/point that/;'ther©/in - a general:/// '■
.acceptance.' ''aom.e/nfZbhe---/edd-pX&to'/'- ■''/■/ " ,
receptors,.1 thereby Reducing-.the, .*safet^y ,factort; for; _•- ; .• 
•'tramaraissionZ? IfcviatCpnaidOfpd '.that'/the.normal- nerve; -­
/ending Whenf-teisuitsed ■produqe.sz'a'. - qiuaitity' .of ' . ■'•/; ■.• zs/
• acptylbholine. with' each ' first;-• ' z. 5V' -•:
increaseitqWing/.to/thef apilitatwy- effeet;,0f/ •£&$£;.' - ■ 
stimulation'-.on ' acetyich<^latn<^/''^e^L^<^^a^ifWhich/b^a^s. been': ',
described' above*-. ,;This'’:a£;/ ft^,rjat^ccc^nnt^ej5^ai'cta; 'a-'' /-Viz ' 
progrettire' deple t±oa • of - & tores ■ of; preformed '.. : z ; ?./' •/ ,- 
aeetylcholine. In the-normai otate/'.the /.‘safety'' '' 
/f^fa1;^^3r*-d^;;-sS^cht,f^ih^^1}^(,the . amount, -of j/tri&hSsitter -required 
to. ''do tivateiaXi - receptors ' is - considerably lees 'than; -/ '
. the .'/am^’u^lt released. during '- the -ftrstopar'i" . Of = a 'tetanus •' 
/For/this ' reason .-the /ffcotitatoon,/effect.-Paa not - he . ' ■ 
Observed . either /during" cr/nftepzihewtetanus . .i^«.-the••',;•' • '■-// 
■normal' 'and. /thezresponsd, r.eimihs-;ffiaX£maX'/until the ->/■■' ;Z"'. 
/eXhaus tion of - reserves'-•lower b . the /ou tput ' of - transmitt'er. 
below ' the. level '.-.'required ? to, ac tivat e . all ' -- rec eptor s-. / -■ /'' - 
- (Farmer' 'et/al# /196o)/vZ'-bgy -■3^,^i;^:vi^3ag.-^^€^,-?’^Jee^^c^1^y .factor? - 
■.curare ' discloses; the- /'fLcilltaiOnnee:lhlLluetien/cycle //of/' /' 
acetylcholine; release, /bys-the' nerveZtemiinals,*'.;■.; The;/;//- /■; 
progP.e'spi^Vre^:/dec*^<^m^j^1&--.of/action potentials ' of/ a '/'.--, // ■■ - 
Gurarised muscle when ' it.---nerve/is '‘St^:^mu:iated‘-m^I3^^-'•-/:/ •’ - 
-d^ie3?.e<Or^e-•ri^_el^<^i^"/'iS'■/ao:rmii;eVent/ at-the, motors nerve.,,- /. z 
.terminals -which .Pesmedt '.(1958b) asserts/is- only./present
■ /zz //;'/././. //■/'
•“ ;,. .It, is ' Unfortunate -hat pesmedt ’p./publications's"
do not/-illustrate.-the :•eyentt: during pet/&nisaiion/;0f . s'7/;. 
.the;hemichaliniWs-treatpd/heree-; '.The'' post*tetanic'.-/-.' • ' 
faC/3Lii^tttion/t^p^pe'sI^fi^'; to//le-small './(.though' ■ '''-this 'could' ' .be'' 
■ due"' to - the. .sm^t^^il;-'- magnitude --'of ' ''the;' depression ■ during' ? .. :- 
/tetanus//;/;■ ;/ ■.. s;s; . V ' . /-';' , - s' : '/•:..'
tetanus) and there is no evidence regarding its effect 
on - facilitation dtxring" tetanus In Botulism! - which - is 
considered- to - be a paralysis caused ' by poisoning - of- the 
motor nerve terminals with failure of release' of 
acetylcholine (Brooks* 1954) the action potentials of 
a muscle evoked by repetitive, stimulation-of its motor 
nerve decrement progressively- and usually ''Without the, 
transient recovery of facilitated release (Burgen et 
al, 1949)* - 1 have occasionally ' noted the same type 
of decrement in disease of peripheral nerves and 
interpreted. , the. absence of facilitation as evidence 
of - ahnormality of the. - nerve terminals -; (.tig*9,12)
(Simpson 196t^ 196^j< The mechanismi -suggested by 
Deemedt would account very well for the myasthenic ( . 
Syndromes associated with peripheral - :neuritis and 
perhaps - for carcinomatous myasthenia but does not 
fully account for the pharmacological-observations ■ 
which WLH be described below*' Hc "can only -account 
for the changed .reaction of the miyasthenic muscle /to ■ . 
drugs by postulating secondary changes - induced at the - 
motor - end-plate* This suggestion overlooks two facts*
In the first place the altered f©actionsto drugs are' 
present in mm.se les earlier than - clinical - ox* :
■ '■ electromyographic evidence of ; transmission block*,' • J : ■
Secondly, suppression of- release, of acetylcholine by 
botulinus- poisoning causes an' effect on the muscle 
membrane resembling denervation. The' region' sensitive 
to acetylcholine spreads " from - the endf plate' to the 
entire musd e membrane in - a similar manner and with ' 
the same time course as in chronically denervated - 
muscle (TheslefJ^,'- I960). Changes of this type should
, '■ /lead/ <' , ■ ", ; • . . . / . : >’
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lead to-/*supereessitXvibyVi&id. hie 'eXectromyegrCphlO-y//.-,. y ■■ - 
sigh." : of fibrillation*- yet ■ thi/arY©' " rare 'msytsihexnia ,'; ’ /•
graviaYanjt if 'it ' does occur Is'.'-o'f/'the •?type;vfound-:-in --//■ . . - •• 
acquired' myopathlaa; (Chapter '9)*'/ Furthermore /thepCffect /'/ 
of,- heoatigmihe-'in muscle 'tension' during- a - .•//,■/' -
.tetanus ' is ■ negligible, in botulism-(Burgem -et,.'a!, X949 ) *;; - -/■' 
y'/y'. . It; mUst be '-concluded that - the , /evidence for ' - , ;/,■'// 
presynaptio failure in myasthenia- . gravis'is/ ineonclusiyey',; „ 
Competitive block of -' transmissioni- .//-•;>; - ‘ - -yy-/ y.
mjUnni wSiiUlmmiilllH U||Jill ■    Iirjiim^iiiniiwn!«'ii'niw«»i»<—im^l^lPT'^'^WilWIiiiaiimMl ' - ‘ ■ ■' . ' ' ■ •
••’-- "'/' -/ ' -It' ..waS-the 'resemblanceof - 'the •coinicaX .state'of . y.-. 
■rayastbeMia/gratis. .. tov.cuira?e - poifjori^ige; W7h.ij^.h .suui;get<^(^. / ' / -‘ 
- the -. tria$y of -' physoWtligiiae -'and i ts analogues - <f£v its / ’;.. ; / 
treatment. , The -principal /active- component of curare'is / 
d^tubocur.arine*-' -,Xt'Is a'quaternary ammonium compound •'••■• y 
with structural' r^^seml)i^iftm^<estto'uoe^tytcho*tine.j if/is- ■’ ''.' •. 
.reaMly :&iichhedztq:'the ' same - /receptor v'-s<tes 'in- - ;... - yy '/// :/ .' 
cholinergic synapses including - the ^heuromdseuiar-.--'-' / /
'junction -hut /the -npion - 1C "relatively-.loose - 'andhdoes - .-hot '■ ■ 
lOad' '--to ■ 'the • permC&biiityYohinges • -of\th‘0-;.muhaynapiicY'; - '- ’y • ,;/ 
'.membrane/WhlGh stimulate 'muscular .contraction * y. {#heroocre# 
unlike' other '• quaternrry'''mmmohuum; v, -- •' ;
■iecarnethonlum- .which- 'resemble z'ac etyloholire.. mor’©vcXos.eiyi - ■' ", 
there ■i&Yno - initlal - stimulation :of - When■ - ■-; iy ..
■d*tuboour&yine - is applied;: to/the/ end*pIatC# • -On.the'.-/'- •’ /■/' 
.conirrry-'-ib competes -With -•aeebyleboii'ne- '-.for ,r ecepto.r.. ■ '. -
■ sites . and "so ^inhibits-.the - ;a'cti^v>2i;-of" --the -..n^^tiural- transmitter 
••' .iyikyMCoitriCai- 'recording --from..the' normal muscle/ ■;./-, •. - 
'end^plato''--shows -, the'•-presence' - C.f ^spontaneous/-'miniature- // . - .- - 
..CttC~piatC' .'pCtthtials- "■ whieh' ar©z - eoheidbred-toybe -'they - - "/■'/ 
result/Of - of/ jCuantai/Qf- ' / ' ,. /
'acetylcholinC;/'/'-y'/' /'//'/ay-/ - -•'/’/■■-, - T- /•/'/;, •/' ,-y
'■ / ' • ••••, , .....- : /-,,//■ ’ . ' '/ ■.b/<y'bW,
the/iotrr-.-fterve ^terminal©./ .fhe/., *'.-•* /; ' 
tb;>eddeeOthe .sis© of .-/• •// •.„ < 
tho.mOOiatur©'<p*s) ♦•.,/ _ . •,:/.. , ' 
pio/ouch' larger eBddrp.&ie;.;pfcentiai' resulting,' from /* * . 
nerve/ -stimulation. Is a sumOiion./'of'' similar? /iniature ./.*••■ 
potentials ''^^e^^tr.'^he/.disChai'^gez.c^rf. many z^pata*/ .of ■/*/■./.■/ 
acetylcholine'by the nerve •iapnlUa^^^^roi^^aFifwiO;o'fa *'// 
the ': end-»piate ‘'.potentials by • means.,rf/a" mic'?c*eXaetfrde,,// 
del .; OastiXXr and Katr.,( 1957 ') >found . ihat/durarb- abblish®®, 
the/reactivity. rf" the. 'pest**©ynapble/ mbirane; to '• ?< ./.</• 
meetylcholi ne without: affec ting membrane resting •_ •',•>?"
■pr.tentialy' resistanCeY’ rr ".oapjwity*';/ These . : ac tiops-• -ere ■■•- '• 
'crnsidered tr .be due tr. crmpptlticm ;frr receptor©*.,. -The• • 
result rf this is " that ' the end-plate 'potential,;resulting 
•from-nerve.' atimuXatirn /Pith , / •”'
■sufficient .curarezihe ■ e$d*^;p3^late/pit©n't;tal • may nrt .riso//...
to .th©. critical 'level- 'required 'to initiate fa '/prdpagated • 
''action . Pr tenti at -' and ' /honee • Je;.. muscular. .• co$/rac/ir$ *./.- pith 
smaller drses. 'the . .effect;!©/, .o .'lower'.the'; ’-.safety; faciei*
'(vide ■.supra’)*?./ Pie natural facilitation* 
depression'.. events. .of;nerve stimulation/thus/cause/a?.; •/ •; 
.sioilarydycie; rf 'changes . 'ln/the/uc tion; potential and. .' 7-'. 
tension. curves" rf s-the stimulated; .muscle-#.,, Pith '/slight*/ 
/dr'sege-.th'e'- inhibition :ef7S©c.eptpfa*is: completely . / /?P" ' 
'c.c^iuii:ers^c^^^s^^d-,;by. the /fdci3^^i^f^ia.ed.<.i;-Yipetyichp^l3^ne'’ •'release - ' .- 
'during/ • a tetanus; 'so .that •' the. onerl©. . response/shaws ' /cmiy. .­
activation.*"' ThlS•.phenimenin seen , in/amphibian '
'"1mlscie'‘i■firsm©r ' and HrmOu y • -1932/''bui/.ie:' present • in/Xbsser 
degree.. i</,mamm&Xiaa. • ffiU©Ole/:('Brow$*?i9338/l"McX©s' .ri/aX*'. 
1941)*' ,.• ipie-mammalian r.esprnsO/resemhles that;/of .the*" .■
• clrsely • in. • .a/loW-/calcium environment• - ('Lundberg
and/
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and -.'..Quilisoh* . 1953). and •;.this.--.may - support- those -who -. : / 
•favour- -'a 'preaynapfie -'.oxplahatibh,’ for--' mya'sthe nic -'.y; 
veukri.eS'a*:, - Wvyrtheles©'9it is>'as‘-.yfXiil^d^9'Ero«^x>oi<^c^^^.'- \ ■■ 
that---.nothing' is known of ' the; 'action of . dtfeuho'cur.arinie- '’
■ on pathological.muoclo ' and '• it-- is - -possible .$MatJ-Uueh'\-
.Mtadlo.''may' - require - a snpranorWeai -' oonQent';irai$oa;of ; ’<- 3
.i.eott^^^^h^o^-ino for - 'its - .fullereeponOo.' to '-he' seen* .- ' - 9 ’ • ■
.9.-. . • Though - Harvey and-Mwlmid 9(1941$-.and. John© 9,'_-' -
et ;. al* (X936-).-'.considered - -that both - the >■ .decrementing - •-'
' and''th"e'- facilitatory 'types-''of ' response”' inf myasthenia,
- ’phoh^o^meha;' of - partial- 'cUrnrisa-topn'' - the#- ' 
do'Vnet' - be dm'’-t oghave'0 oh'sidafed - - the - difference' -;.hei^We©n- ' 
.amjihii^^is^^'-i^d-^^^ca^G^al^at •. '.Harvey-•'©•$’-'ait( 1941 ) later-g' ,••;
,6t&ted'’ihat'-the ©©coillt&tfon--hbenp^i©non...:in. oneiof '
their ' myasihenfcipatients ’'more'..closely, resembled - that- z 
op cur ring - •'in- c uXctmmtdefio i eht "Qn ima%8'.#z ?I#.eyerth el e© s ’ -' - ,. ;. 9 
' 0 rob_et ,al (X936 d ) -show - fan • ''©yoked -• elec toomyagrem ’ ‘ '" ■' '; 
'illustrating'' -i'^''s©qUhhc'P9.,of depression, followed' -by z /.>- 79'
■ -fcilifation. ■ and.'po©t*zt eta'lc c facilitation . in ’ a normal'- '- f 
-human, 'being who - h'd --..been injected, -■Hithi; d*tubbcuuar.iie& *9 ' ’- - 
it - is.. strikingly .similar. io;9'tho9u®ual - 'type; ^''facilitation
—g&vi’e,' f"ig<';9..’.&nd'- 10 - of, their 'paper) »' : 
-9heir-studies, onzthe jipstttt^’ltah-icl^^eyi^od were .not99--'-• . ' 
extended-. long'enough' to oxplore'-the-iposi"tetanic' - .-■ ■'
; exhaustion*'-desoribod'--by --Desmodt ; Ci95?b)*- .... - ■'-',.'' -9-9,99/ g>
'•939" '''-,9- Qu'uatit&tive ’-differences -'between --the - .response's - ' -. 
of -io—Pfheniez- and'- our€^p^a^J3ed'.mu^^c3^^©'-deS,cr,il^©d;by;-0rob- : .i'-'- - 9 
,et.,s&X '(l95.6d) '-may- be important*;-' tlf.’it-i© - :&ceeptod-''fhat '--' • 
.x^^-‘t^lbocus^^^t‘i^i.e, ; lowers thog* safety',factor*- -for..tr&&©miesi0n 
and/.thpreby.-- discloses ' thegchanges - - - of output -of: - g-z •;-•■.'•
■ a'ct;—.choline- 'frdm9 the'’ hefye''" terminals *•;. it follow©' ' -that -
the/--- a'./'-'-' '-"9. t'. . ‘9',••.../ ' ag-g..-
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the . curves should.have .’the. .asme time-course in both '. ,
conditions* GrOb . et aX (1956d) ' found proportionally ,
greater. inhibition of t.he later '■••potentials of a ' train... 
in. myasthenia than in curarisatioh* They also noted . . 
that . 'intra-arterial injection of■acetylcholine' was
. s tad kingly / effective • -in .restoring' ■ transmission in the. ; . ,'
myasthenic' but not .'in the curarised 'patient* This ..
suggested to them that the presumed coi'npeeitive block 
•'pi*esent "in ; the myasthenic patient (1) may.be ■ exerted.. 
at "different sites on the cn’ddpp&te . than the" curare " j ' 
block .and .that the ‘-forhei* may .be more easily " displaced 
from the ..end-plate by ..acetylcholine than ;i’s d-tubocurarin© ,
and (ii) ' may increase during voluntary contraction or. 
^electrical stimulation, due to . the . formation of a ..' /. . •
competitive -blocking . substance by the liberation of . ■ 
acetylcholine.,..• ■ ' . Z . "'■''■'J' ? -./Z- ,
. Their point./of view inevitably ' requires' ..thoy-.t ; . ■.
proposition of a ’myasthenic toxin * .'produo ed pari . . passu 
with. the . voluntary or . stimulated release of acetylcholine.
.They, suggest that . this . ■ is choline formedby. the . hydrolysis. 
of. acetylcholine (see . Chapter’ 19)* Nevertheless their 
data up. to . this point could be adequately accounted ' for /.■■.
.. ;by. : assuming' that the. progressive decrease . of acetylcholine 
of release’ during. the. tetanus --had a shorter 'half-time .-/than< 
normal because of presynaptic/failure and' the better J -
..'.response. of the myasthenic end-plate .to . directly . applied 
acetylcholine would . bo . -understandable* . ,
■ -Dillon and . Babaw&Xa (1959) .showed that . the .
hypersensitivity to curare of myasthenic muscle could 
still be deionstx’ated .'in excised samples and that this 
effect. persisted after . repented .washing* They, conclude ■ ■ 
that/ a'- •• . . .. ' ':./ .-.//. . /' • .• '' ' Z /''/ ' ■■
,//T// .'"/—/A . / <,236i> /' ./ /.//'.J/.- ■ /Z/.
that/- this /"makes'it- unlikely--that --/aaubstanee . *•</. 
is"* -the 'c aup e' 'of the 'hiock »/""'certainly ' it - Would//.fcequire'• to 
he .'firmly '/bound ' to ■■h^b///jgiu^nCt^<^3^f^/t/'fegLLen»’:. c'• -"/"/ / - , ..
-Abnormal •structure" of ,the./iyanraisPion gutetWeet^ •', • .-.
Wll|IHIili>l. l l illl'i»|l|ll jHllWH llil»lll«»HH'!IT'».lililWW,'!II^Wiywll *Wl>'»i*l*H»>«i|!WWl JliliMKlll|«IIUim'.|il,|ll»l "mimn I LHL*im»*li||i |IIRil»Ji|lliili.l)'l!l|llHiWlHI>!.IHH|l|mWj>»MWlW - .
The / arguments -• aumwrised-"sd: -fay/depond bn the' •••. " , --
• aysauppipa' t^ha^t//,^lic^'-/t^3^£A^Bmi^'t‘t<^.A:©ub.staaeh in ■.myssthoniaZ.' . /'■.
grbvis: iW aceiyXohoii/ne'-’aa' in,/theznormaX * uriaecormpanied ■/- ■ 
'by my 'abnormal- .substance's* - •Grrb'/pt -/.aX-*"/.'(X<_ / 
x nfesligated the/, o ffeot - o f '"'ae e tyXcholine/and' choline-' . :, / -'•. 
injected directly ..into/. the -Jaf teflal. '-blood . suppiyAibhlhe'/a ' 
limb ;'‘puodiep/in / normal / sub /and/if/patients /-Wth •. •.-, • •
myasthenia/^rr^vV^»:; ' -’ z Z:'. "'h-'/:.. "Z '---i7’"’-'-";-''7 ."/Z"'/ z- - - 
■'-'Z//'W</ ■/. in /normal ’-/subjects".acetylcholine - 'intrpdnc'ed.Z/isi • / ... 
.-this' way.; produced/trAnsient /stimulation -/of .motor/ activity^ ..s 
follWod - /by --ai/ric-f .period"-6f^deproshiQn/ of - . nenromussuXar. Z. 
.izfnxaihsion* • "Af-tox^ .recovery.'from ;l^K^ig^^/LPr^x^mpl't'//,- depressant
: effect-'"there / was / a --•"■late/* and "/moro - pre3^^oh^g^bd": raduo tien - in - • 
'funotioa-r.; "'Tie. ;*p€^mBi^P:/dd^3^3?t^i^^i3si^s^'/W^^^/ ^/a^ncre^^^sgd/-dn■xd'a '*/' -, - • , 
proXohgodZby' the prior - 'admiuidtratioX"of -.noOj^^^i^g^minb- /and; -/:? " 
this/appeared/ to 'be 'due - • to.' porsisibace'.- of/thO/ initial'"/""" _ 
.depolarization’ 'caused /by-- the -injected//'ScptyXehdiihe# /' XX""' • /
• contrast/ ‘the 'Hate? / depression//was not -"increased#-..• its' ...time ' 
/^'<^lufig^c/. / ■and- the - "/degr'Oo. /'bf •. bL^0^^^-.^0sbmbLbd;"-ti^£^■t produced-hf 
ihtrava’,teriai -/inj .eo/tlon- of c ho line and - -. this .•suggested-- to" 
.these Workers' .that/ -the '•i'*Lat7C^*. /depression/ -■might.he•due. to -/ ,- 
Choline released' '-.as'/a" result" pf /hydrolysis; of,'acetylcholine 
'-(Prob- -pt/al,. 195Gb)- * ’ ./Noi-ther- /aoeiyXchoUno- /po/r -/neostigMne 
/re?yeivsed /the’' Z late.*/ depression ->0000000$ - by. Acetylcholine*/
- -/-' . • .The- type oHneuromnOcu/Xar block pfodue/ed'by/ -' Z-\ ./ ./ . 
•_choline varied- With-;th'e degree -of -block in/nOrmaXZSubjects* 
Wheei'rnodee&te - it had /thoZp'ropex* ties - - of- -the' depolariwii'oa ‘ , 
■type/. ~ ’ •,//-.Z^-'/'/-Z/-.' ' Z//:"--'":-
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/type# resembling'zth e '*iat e, -/..'depr #sSbO/-Z.o f &etylcho 1.1ae .'' : - - 
bu.t wham., it. wa ’.-/taakedyit'-\had^/ mamy ' of ' tW '"proper ties • f . , _- •. 
•the /berameiltiYo'' •, 'type^efyblqek"''as' -judged/ % 'the■•. offe'ct/hZ •'<>. 
of •added ‘ acetylcholin e /' or• and the, presence/ ' • ■ ,
of; post^ tetanic-/facilitation© -.; ■ > •/ ' -Z ' : >• /. • ;Z-/‘7' : '•/ ■
//ZZ;: '• ' .' d/n' •Myasthenicrpatient8/jGrSb'.et.ZalA (1956© •''’found/' ? - 
:i©SS'- Tprompti depression ,&ftoriintra*ar 1 eriad-, .7 • ‘ //./ / .. , 
ace'tyioholino • and ' a in • / • • ■ ' ,; - 4. ' .•
neuromuscular • fun© fcioh. was; .interposed. between /the' '.•’prompt h 
and; Hate*; phases,, ©■fyitepreasidii* ' '' .'Myaathenie'' 'patients'. Z- ' // 
alsoZdiffared 'fromithe/.-hcermal xn ■/hhat/zfhe ' 'i’Xdte V phase-fi-"- 
of/depression-was / reversed, ''by’Seoshigmin© '.'o©."by further ,' 
injection /.of-/acetylcholine# /■■ 4-:-'/-4' ^Z ''i/'Z , .••</’
/ /•/."'' z ••. The', time ''courseZdj • ••^h'e/<JoB^^s©3c^i^^^‘-i(3ef<^^_t . of <•-./•? ■ 
cholii-tte. 'in th-e/myasihenic' patients- • $1 ff©red, signif ieantly-; 
from ..that ''obaerye'd. ‘.in/normal' /subject's*' , ./The 'latency/' 'of ' ' •/, •. 
•.ihe'Z&epreesani effect/ was ' .greatly ''increased .dnd/the///h / ' '/ 
block/ was '/smwysZf •*<-oo^#p.e:i/}i^V^e^^:,i' typ#uZ/-The' depress ah t/ • / r/ 
effect/of choline/on clinically ■ unaffee t©d.- muscles /'was". ■ • : • 
leas-‘.then/ normal'■■ Mt? .in, some/-of/ • these/patients - 'the' type . /' ..' 
'of ' '..block'. was- inf ©mediate■■ between' ' • that/ observed/fn,'normal / .’ 
■subject© ''and clinically 'affected -mseles/ito. myasthenic' . •/'
patients©./ - ', /. /-/ , ’• - //.. /' '/'// f ' ••••' - Z/-z/#/ 7 x/i .// / s /,; ' / //'/ . / "/. _ 
,4. ....... / ' 'Grofc at ' a!--/' (1956c') /consider ' /that; their* resuita /
iSdicSte/'ih’.e ': o.f'/tlhex/ .•/• //. '
.myae-theni©.' neuromnupulSr ’ junotion. /'' They;- suggest.. tliat//■ -".'/• ' 
/'’tlie- —irmecoiursc- and other /propertiesiof/the 'J’ttate■7'//..// '/ ' 
.depressant; e ff Sc.tvi of &Sc.pylc ho line Zin /%©©. theihi©;.-pi^i^:t€^i^ltS -/ / 
indicate ; that. it. may /be, 'px^oduc^^d'.-l^b^^tsi^k^b^^'inei. released'h /•' /. ■ 
/ ‘following ' the/'hydrolysis' of - a©etyl^^c;hOliiileJhy' cho3/ln ent erase 
.An {ia'cmaiou's.‘feature which/they point/o'Ut/is'. ''that/ /’/./Z/y ' 
•&Oe.iyX©h©lifte/■:' / //// '/'■■- - ■ :, ■. / ;; 'Z / '' / // /I •/- Zz-'Z//% ’
acetylcholine produced three times a© much depression as 
choline per sig* of injected drug whereas calculation of 
the amount of choline yielded by hydrolysis would indicate 
that acetylcholine should be less active* This could be 
accounted for by postulating that the choline released by 
acetylcholine hydrolysis is in closer proximity to the 
end-plate receptors than would result from the injection 
of choline but the abnormal response to both substances 
could also be due to alteration of the receptor protein* 
Abnormality of structure or function of the roceptor 
protein of the end-plate of muscles
An increased sensitivity of the myasthenic patient 
to curare and quinine was demonstrated by Harvey and 
Whitehill (193?) and Bennett and Cash (19^3)* In contrast, 
Paton and. Caimis (1930) suggested from a consideration of 
the, different inodes of action that a depolarising blocking 
drug such as decamethonium might prove less effective in 
myasthenic patients and this was soon confirmed by 
Sellick (1930) though Dundee and Gray (1951) thought that 
the response was within the limits of normality*
Systematic studies on neuromuscular transmission by 
Churchill-Davidson and Richardson (1952a) indicated a 
generalised tolerance of the muscle fibres of myasthenic 
patients to deeamethonium iodide, particularly marked in 
those patients in whom the only clinical evidence of 
myasthenia was ptosis and diplopia* Indeed decamethonium 
sometimes increased the strength of myasthenic muscle©*
Grab et al (I956d) could not confirm with intra-arterially 
injected decamethonium that the non-affected muscles were 









Davidson;; and; Mohar dsesV-mgs' mcuM-dl ffibuX 7- to;' demode trite
vTw&;'tHd/W^ole •;* fatigue! di,fl^2S^p^^^adyai£l/'.;it'WR^p7lbo<. -
Au./these ‘-tesples. '- a,f fediod ';^y:-i:iteZdi£?c^a^p i\y<Whia ..implies ., , .' 
;that':tfo dti^cr^e£\s^(5zi;w^©ik^si(?J3©-..due. -toythe 'dx^u^; ia-'£iys.i.y 7 ‘ -
'eoehyin- 7ha;.'0i^iJ^i<^^^13,y. hf^^eb'fc^jd''msttw "■ On further'^ yy 
investigation; they -/found "ilrntz • ^e;:0eait»eo©‘ no AMuc.e.d,/-•/•'•'' .
wa® • '-rapidly - -&hd7o Wple taiy. ;r evoxaod7 ""y antichpl la'e© 't'erasey' 
mhs'tshces and 'ythafc. '•'betaulebraids<of/stimulationr qffthe •'’••. • 
muscle bwpre ' • netfeo’ /well '/sustained' 'as ’'-h - twitch: ;. (Churchill*-''; 
Da,^^;i^c^39h','.anid> ;MphjfrdSuh- .Xgggb, 1995$') '*/'•-' Tula wab';Xater . -••'' ; 
,-nqpXiinad."by:the, finding; of "Grof/jt /i7Cl9^^d) "that—■ .the; / ' 
firet 'response to ?s tiffin lotion _ (Wtwitoil* 1 wnis' more/ v ; .••’• • 
renidmknt-'- thaw' later . ends f ( #teh&nue.0.<‘ . %^’d;dxmg#\.■'normally 
OP - * dep'biei^:i^Eiinb^><b;to<ffe:i^ng§'7atafiit-y. appealed ytoy .aq-i./An ', thev -..•"
■ clini daily ^afS^^^cgabd^^nkspl^e^izX'aU. A - Aqompa titiye *. .hiodkinZ'"'' ■ .-•
■ substance’'? after a; fiebiing depolarization »*z■- This• .-'they//,- ./ •-..; 
AeseribeyAa-&"- t-duai/blabki*» . a "term coined;-.by SaiM's;'(1952). 
to denerlbe ©imiAarXaejiicuw•.■ b'7seiW.-h.f yf thy'nmsaXw-'of;/ . /
'someyani&aiy species<,y Their"result's'ih&yo 'beenAonf iraed;- ...:•
■ by ir'rsh "; e t -" " (CL"' (1956 d) ": -and;' by - - . say ‘ 'own tudi o o 7, : •' •';; < _'
"v-: • ■ y7/ /'^uirc^^li^L.XilDJf^Arzljaaonyyand/^B'iohiardpbh , (1952b); AAhhcl'/7 
:hb"''^ff^^2po«^<s<^-'fj^€^jt: normX'ia.' th^c^5Uriin^r^s/^'7'a;£<^a^iet;"on -raio . ,.'. 
AfdbcCMthoMtm. ahdi.iviwaraf-'.. axerei'ed/unednaigedK /'-Tiey ’ ; . .--/, 
eoaoludad : - that; -the ’..differont -- ;o0tibh- -oaWbtha. accounted - . . . 
•'for- ’by.--ah’ &1teyaAio%bf - ;tho ’ •coffiphsOiQhyof■ "the' drug- -and ,- -' ’ ' 
s©. pbitiiliadec^^'^x’hchangg^'''' AnyAhe/A harncteris tics © f -the:'/. •;, :-;- 
-mpitbar-'and~piatos' WdLcli-epnlMbW•rCKpowiblo'-.'for y. ,
.srnyia3i;hohio.. raaertibn • byya.l‘G^^iin;g>%^i^'.?raxi)d.pse: Ao■ ?? 7-;:.;% •
■ m e tyXoboline '•er.tene ';o f A in- bxe'akdowypppdhc tb*, - •.- VZ ■■ fz"' 
":;y 7 ,.; dt'^illyW'apparent thafc/thereXated oubsafcaneon .'•■ 
vWe tyichalinb #/ bhalino ' #' and'' ;4'ecaiet hbn'iun.iM-^i /ac t ;&U< '• ?•• ’
jsimilar/.. ■ ':z 4 % .'7-7 ;:A ■ 7 -,;\7;.■ y; -:; 77Z- 7 -7'7>7 <7 <. ,■
similar-'' way© in MW rnyasthonic patient- .Xt'is ■’■ •y -z ■,.-,'/■ 
...therefor©/.undesirable'’ to /explain '.'the ■'".abnormal' findings' yi.- ; 
ofArob’ -eit'■ al -(1956c XyOO.:being,-due to choiine .<?*-- oo-the; ■ 'J- v 
.produetier -of 'a'toxic:; product during nervous 'activity; . • •
since ■ 'the • same . change ' of function <at , the motor. end-plate • 
could, '-.explain both sois'of --findings* ./■■.-:;-.;.yy.. y.zy *•;'? . .. ••
'' y '; The - position would, ho -.clarified by a ..'study' of ■'■■ -.' -;- 
-the.-'seasitivity--ef. -the , end-plate■ .-to /acetylcholine * ,''y 
:The , XieeraturOzis aonfliGt±ng..lh' .tMO/;respac'fc* ' ■ Banari.y . y 
(1937) ..was -the--, first, to? inject’ 'aceiyXcho3;ine^;:3jntp hhey z'' \ ■ 
-brachial arbory ' /of / a/ myasthenic patient. His opinion. ' ■ ’•'••; 
'.that■ '"the. myastheuic,/munle ms'. aabn'ox^ma3^ :^iyr--.’aen©s^jtl^yre-■ to.-' ""■■ 
acetylcholine- %as: -confirmed ’by ■flarTby ahd---3lii^^~i^ir^ha^’-...':C^^Ji^^4L ) 
'These/ authors .-.i.hj eetedz 2Qog0-mg<ylnto'- ;/fehe -brachial-artery' ■.' 
distal, to, 'a - Cf f :.,pb&bpttcfigg/ ■ the/ .venow /return; ' y'-The ; y' ; - ; 
violent mbtor response -'which they'obtainbd/; was/zmeh y,/yc- y 
greater, -than' they-had -found .in''.normal//subjects'' and' . the.; ••••'’ 
gripystrength'■ '..-seemed.' nmehangedyWhen-' .the .spasm '• subsided* -;
They/ concluded'-'.that ''the _ myasthenic/muscl'e -flbies, retain ’■
the capacity' .for vigorous cohtrnctoon/wtfhen adequately' -. ./ , 
.stimulated ' -and- .th&ty.they y^i'e-'Z)iy;p<337f^'dns^i^;tiy.e '.to' ' ' ; "'•'/- g •• • ■ 
acetylcholine =,applied • in' this -way-. q-' They - Were drawn ' to '/' " . ■ 
.- this/ 0 on Xixsibn •- although'' . ; it- • c On flic ted ■ ■ wi th their ' belief ;, 
.tha"'-^©^©'-^© a ' ,q 10s.e.’ah'a;l^<^|^r^y/^^etvweell' the {myasthen^io I, . / ‘;
;/yy.;_y-' ,. ... y. -\,./' fy,... y
a '/..'y';yAcheson 'et,.al '( l9t4)'.-AKeysiteii’&3?' studies' z /.yly,/' 
using!] Afeg*,'of acetylcholine '’i.ntxa?arteriil3^y -and/-,-- /,.■ . 
"concluded ' :,that7'the's On sitlvi ty ' of ' -ayas the'hiO //mus cle.' ' to y 
bhi^s!. -©uhs-tapee,- 'Vas .normai 'or .'Slightly .depressed*- '/ ' ' - ''' - 
WUson' and' B toner'' (194?)' andy-Enngaehy^ 1951)’■ opooiudedy-'.
0 ' '
that the myasthenic end-plate showed diminished 
sensitivity to acetylcholine# #ngbadk (1951) reconciled' 
the conflicting opinions' by showing '-that the result - 
depended- on the dose of . acetylcholine* The-.norraal 
threshold ' doae was. 1GG-350pg# 8he found that;;0,2*0, 3mg* 
caused . a motor response' in most'- normal' subjects but' / 
was insufficient to dp so in myasthenic patients who 
required far greater doses, indicating a ' raised 
threshold# The apparent'hypersensitivity reported , 
previously, was /due to stimulation by ah ' overdose which ' .
. would' have 'caused depolarisation block' in normal .. ‘ 
muscles# ' 'The Johns"Hopkins teems later'-changed their - 
views in"agreement' vj th lAgbuek;'(Grob e t a! - 1956c) *1
. .This ''mOster' r.e'qui re s .'..fur ther study# ' .'.If., for instance,
'it <ws found that the end-plate.' couldi.be.' first . .. .
. hypersensitive' and■ later hypos exinitive' to' .ace , tylcholine ' .. 
this would suggest the 'possibility' .of regeneration' after 
partial denervation (Miledi, '196O)# In support of ' ; . 
Engbaek,. Grob' et al, (1956b,c'l showed' that a .suitable'
• .-dosage of ■.intra-arterial ' -..acetylcholine .will cause--'; ' 
rapid ' depolarisation:, block of normal '/muscle' while; . ;- 
facilitating the'activity of - the myasthenic junction* ‘
Those studies ' suggest ' that ; the changes in' the
• response - of - my£ts the nlc ' muscle ' it6; depolarising substanc.es. - 
including the ' natural/transmitter, are associated ' with ''.'an' 
elevai±tni ' of threshold* - .Thiscould also /account ' in pari' '
. for ;th© ■ xweiX-known ' tolerance of' myasthenic patients'.', ' to . ;
■. doses ' of anticholinesterase.drugs ' which' would be/toxic in
/normal individualism.. . •«. r . . '■ ....■■
■ ' I 'have proposed a theory of drug action which -
account's fox* ' the reported' observations (Appendix D',- ' / 
Sampson/,'.''-./ /■' 4 '// . A" /V " ’ \ ■ 4' '',
/gimpio#. • 196%'. /7it Who ''proposed’ th&t y^he''''%LffeeA:Ly©:?.;.<..;/ 
condition for depolorisution of the end~plato membrane 
'.may "'be ./the ' density''of 'ionic• •■Marges /attached'' to the 'z7 ■. :
■ receptor/ substance ' •'(•iglCill.7/’ ' 6n/applied SiUWt&nc© >,
' will ; be 'offec t.ive ' . .in ■ '.depolarising 7 the . ’ >na~plaCo /mdffibran.e; 
/only ■'If/ (1) //the '-'ionic •Charge.?, of. 'the • ; substance rih/adequate// 
•(H.k'er»\ 1953) ' and; (2)/.ih&re;' io7 an 'adeouCeC/ caai’f^<e^/-per^/?;/7 '/­
."Unit; of '.recoptdr:area# .. If /this- ■limiting .charge’ 
•is pot; x^eache.d•i=i^oe'.i^^j>oil^ri ’^«atL^O>n^. occurs. '-jand .. thevat.taehed’ : 
chargexmereiy/hlocfes'.•the. receptors in /&-«competitive ’■ Wayi• 
'ThLs;;id- 'the ' situation W th'■ quhternary';ammoniiwL ; Compounds' - 
•''such/as .’d-tubocurarin© "• ('7 ? ..< "/.'/-II'••">• /../J 7. .•'/;/'/ 
7' .•'; 7 ■7;/,'7'-/ if ah ;-/&doqu7t'a-charge, density' appears/the/ / 7/ f 7- ' '•/' 
/mmembaheL.- porm’eabilc.ty /iC. ' altered, 'and/ '.a-/ local' response' - /77 •.. 
./caUses'/d epQlaridatiQn*/.//i' suggest ed'/that.'-'c/eriain7time/'\7 / 7 
.'factors-may be .neoe’h’sai^y' and' Paton -/(!960 ) ..has. 'eiabor'ated 
/#h' alternative/ jrate. theory7'/of/drug /•.aotion#'/ 'If'.thC-/ . 
"charge ! d bn si ty / r e ac he s7/a/d r i • t ic hl ' v;Xo v el ' -. (lower- bori son tai ■
line ' 'in $Igl6 ,1) . .it-'becomes •^Oel':f*«conrp3^^ting»;'i aniCotiCh ■.-. t... 
potential • /ia. propagated ‘along/the/-muSClo •’fibre -'and ./it''",/-/ •’ .. 
/twitches- isee-Chapter 1$)#777/, ' ■ 777 " 7; 7,777./ //;
;- ■ • '■ ’ .•' 7’if:, the- ‘Oluaa^‘ge.7de^r^s*l^;h5'/- his es too/high/ 'Cthe/ "upper "9/ •• 
‘'horisOn&ai.'/ line-' ' in -tig# ' 16 j)/Or/i£ ihe '-■ea^;tmu3alt^f^fy/clc^m^:Lo'a3. 
/'substance is'■•/rOsisiaht .io'' h;ydroiysiO7by./-choliue0ierase/•,/7/ 
,' dep^hlLapL'sat^:^Pn■ pori^;l0 ts-causlhg/&' depolarisatoon/' type/Cf'L/ 
.bioOR' 7'(p*-227 ) *'7lTh4fac;t;/ihat dQcam^;thonL^t^m<in//ip^^aOtt^ex^;l<^; 
muscle/’does.. not inhibit' the' ’prompt’ •dcpolarising action 
;of ac etylcholine thov.gh Its later block is of coupetitivo 
/type. ■■ is -, readily .L^l<^ll^x^st^ndat^i</^'/-tt^G^u^gt]^;G^3L.ob'.-et/;'a! (-iC^dl/t/;- 
dO;^^c^iLde»eL^;?//ii^ij3,-t0/•.'he;.:L/iic^COiC^^xBi,:' '7 ’ ' ■/ >7.//-;/ ;/ / ’,/-..-' 7 ’ 7//:/^
7 ’ /'/i ; As' ' the' iohoeh-tratipi'"of ' substance '// '
Mie/ ‘ . j7< 77/•
 falls, 'charge.is lost ■•from the end-plate and it is . 
allowed to repolarise. by the normal sodium-pump •
mechanism* Jlwther "stimulation is prevented by
’desensatisation’ of the membrane (Meissen and 
Thesleff, I95S) but 'if the destruction'or other means 
of loss of the drug is delayed and the.. ionic charge .
remains within the ’critical zone* sufficiently long, 
it may ' facilitate neuromuscular transmission for a , 
brief spell (Grob et al, 195£b,c)* .
When the charge-density falls below the critical 
level it enters the sone of ’competitive block*• (shaded 
in'Ae where it .will tend to inhibit muscular
response to neur&l stimulation or to the application of 
further depolarising substances until the ’sticky mo!eeules’ 
(Eaimis, - 195S) become • slowly detached* , Tie - two latter
phames would 'be.more -prominent with large'VdosCs and with 
compounds' resistant to hydrolysis' (ace diagrams)* This
sequence ' of events would- account for ' the .'dual block’ of 
Salmis" -and can be •made to accommodate all' the phenomena 
associated- with the ' action of drugs on the end-plate of 
muscle*
•' This model which is suggested by the differing
actions of,a'range of dosage levels of neostigmine in 
the normal subject and in myaathenia of various degrees 
of severity (Grob et al, 195&d) -removes the necessity to 
postulate ' abnormal breakdown products of -acetylcholine 
or decamethonium in myathenia gravis* It may now be
used to study some of the possible ' mechanisms involved 
in the transmission. failure in .-gravis*
, If the charge-density (hot necessarily the total 
charge/ '
.7. V2W , / - j;,/ ,, 7 9- •■■■..;. , r
chas^ilMs^ dGcrouSedy"th& 7/critical 'level Vis'- rdlsed..-.//' ! •
(FIg.« 163 * /Acetylcholine^pj^oduced'/by, faofciyity .-9. % /' '•'
or dz^TagaOeted'-in^O-t^Se- artery, - supplying, /the - 'mnsdle-/.'.-/ ■'' - 
Mil <acQuffihi&tq\;':charge' on- ;fhe -receptor /site,. too - •r’apidyy/. '■ ■ 
to/perRit/:d0tOetioa 'ofthe9pafiy9 ,cooiiPittyre.,%one -bufM '9 - ; 
th", 'pj*esenoo\ .of-a ■■rMsed-^threshold/would .ba,-d'eteoted ; ',’ 9'/'.
.Sngbaek,-v 1951 ) #//'.i/higher-/dose •whi^'Oh’tt^oui^d..Btiiutxi&t'e y.,:--- ■. 
the '- aQmm3-A52ni*-9l£^1te 9and■ caupe, 7; transient , deppl^lSatlon' 9, - ■ 
Medic ( ’prompt ■' -'dopreesipja 'of{rob --and;■his .colleagues )! ;’• - ' ' 
would. oaase ,’pMly 9ttmnlation laOhe, myasthenic (Gro'b 'M ,■ ■ . ' 
.ax/'.19560IkAMrooA' a-■ m&ssiyp do sp/.would still- oauaeM'.'t 7.':' ; 
Strmgd contrao tfoataJhimf may/' pa-"js- .•iptPj, a brief ' i//. 7' ? - '■ 7,' 7 
depolarisation 'block ' ( riaryoy. ■ aad “Ldliaiith&lj, ., 'X9'4X--> # M 9 - .7. •. 
This ■'xwmld be '.followed by a' 'brief -period-of ' facilitation 7' - 
rad ■ thea -by a' 'p^liiaBe/A>.'^;:7'*eo'ffipeyi,ti.yo hio.c"9 - ( -0rob ■ .‘et.'al*,'' ' 
1956c ) - WtiK -a;,:^^^^d.^C,#^_^,.79epen;dingi•;op /the/‘dpoay.lonslanis ., : 
p f the -particular/-pUbat^a^pp'^♦'.'•'/Wher©- ■ the. 'latter-. phase / is' -7'7' - - 
■mapkecXif may' :b© Vreep.ghis ed , '.ae 7theMd9dU7'.respdhse' ’■ of ' f .9: . 
kaimis <195£)» Brnller doses which merely the '
slimuiatiioMSohe. .and.-■'^^ICm7''<^r^c^l5vx^^:p^.dly -7through\hhe 9;’. h . ■ ■ ■.-. 
oempptiiiye - W>he■ ,giye/"7r9se''to such/phahimehh. .as .77;-.\;-.■; // ;
-1 deoa^^^^’thon^um" -/resistance' ’ ( phuroMli'rpayldaoh - and - - /, .... . ,
Mdhardson^7l95S)'«/'I- , - 7' j ‘7 7 77II/ :9; 99-9 '•/;-.•_ ' -" .■/
a/.-"79 './ Allowing, fori-di.ffirOht97i'irne■ factors,and--ionic-. ?9, /..■'■ 
/char gees 7Wth- diff eZ^e^^xi^/.dZ^igs/'/and •- animal/. /thio \ '9 . -
schema/ cam;’be- -used to-: -study " thb, alternative , hypo theses > /'--'" >-•' 
/for , /the, . abnormality, lm;•■>yaa^S^,hehi'a^'--^3Zay;iS .which' eap/'be /'••■■ ■ .7 
rosoived' 'investigat^^^;oh9)p/J^r'/'he,/fap.torG;7d©^:o^m,^^^t^^:.' •- 9.
the- positiph9 of 9 the /' cri Mo al/ley 9l f of or Idepolariaabi o V/ - ■./,'. 
7In9yoUgh•:.to:m^s -th.b -shaded .Op.eas&Qf #ihe ‘.diag'rfcras / represent -. ';, 
/blie/amou^^ ..of-' neGshigMlimc' ■ deppl&riEsation





•• 7 • '.’--7 ■ ■ -7—
Of - the'-endplate' (©f *-thP ; findings; of-WW ,;0' ,®£ P -. 19L-M957.d)
7‘ V- --—. /inoreaWd, We—-.>7
'subnQUPal ' ‘appaWWWTwouLd ’ke0rease7W6-pato:. ■ of :':ri$e7Pf ^$^77 
oPry©’-,’ lower. t W ofest -ahd- Pt eepen . th©-.falling '.. phase.;- ,-7; -7
-WoWesuftWWich .cam ' -W '’deduced.^C-not. -fit ■ the-'©bsWyed-''—
• fWW* y'. The ' rale ed'' thr©sho'l&W©pl&We-dp©. to ' ' an --' / /-•' '- 7
PlWra tier -of., i^he:7px'o pertles-'of'-thk-W&r'plate' roceptors ■
ppqulring' a . ■ greater/' .density' ' of 'yh&rgeiy; ' - Or- 1 t • 'could?' he'' 7-- • y 
due': '.to-WP.''xre^d©pi:ox‘'7 PrOO'' beingiaWormaily^iarge'. 7' --7- -
part^iL^l7die^ne3^y;^s^.tO^B':? Mledl',. -l^oO) - o.r -W' hocupa^^omil --of ■■. -/-’ ■' 
.aomeiaoopp'.tor'.'sites by- with -P 'yic^{g3^Ai^^iibL.a7’dhax^’ge«7’'
Each’,. .of ' ' theoe' -oonfcepte. would .-fit '.-’ We ''obsCryaiidns* . T’n .- -
• first*' two./are ‘ We..' * Wn0p$&iLlty'' : theory .'- the’-7-''7.;.'
-third' the /oiirare«iil£e- ypbshanc©;'theory W ’The' geq.nWce"-/ 
af-©y.epi'b '?-JP' -Wao.7-liheiy. to -pcpnwfpnddlmnnmshod ' 7- '7'■ ' .7 77.
at,./ the;' nervo'• ''endings' -C though . 7- 7'•.- •-■ 
-L^o^weirlng..of. spontaneous;production'.''of - aeetyiohollne' ...7/ ■ - /'/." 
plight -have ': this- ef f eo't ) but' ' a -spatial ' 'dispersion. ’o.f - th e- '; ' ••-' 
iohlo-Charge,''©‘puld' -do- ;sy»'oj/rn--/flj^tW./>^^'/We ,-hihtGXpgioal*. —-' ■. 
/Changes ’ ■ ’ at ‘'"ihe-Pcnve;-’ondingy' 'by' '-^c^^ers'yV^r^^ddWoXLf' ■; .
- ,(X959) -this-..'posaalblXlty /requix4ea .serious ..consideration.'-' - --'■ 
.'■A •'■;'. '•' The'"conoittsion-I . hwe -drawn..-C‘$imPS°n,' ;l9S0%-is,— ■ ■- (
- that./.the . -. result e ' p i - W J’Se h’iomy'Ogiapphi© '7 .
-t©st-©.0upl‘©d. with' .the, pha^r^^tj^^eolj^ggc^^aTL-'atndles 'are- — '-''' '7... --./- 
—©mm&tibl.e .Wi-thPeach' of 7•hh©.,-t^h3?6^^-n^_h;.t-l©err,©s ""and -/that ■■';' 7
' 'studies - of this-type-’ are -3^^3t-/lJ^te^L^y^;‘-W'/'^^^tt^L^e-, ■a 7. 
7th'e. matter'/lf. my. 7Wterprstation of-7t^h©/-j>hyslcs of/-''W'e7y .. ;.•• . 
, sit that!on ' is- o orreo t*' -; .Sbleotipih• -W fween^WWult'ePhhtTVeP' >' 
-must- therefore -depend • /on-dWhr’-factareiU’17-"'’-,'-- 7--777 -7".'-V.--7 
-MorPdplW i,rQd■esi;^dles 70f-.We. nGur,omus<^ulL^^.r • ,juhc 't/lon: - - - ■ •
: - -- - '/ a' We. most-ddre'ct••7&pap0dchL..to'the- study -of-the -living 
.•pathology/-' -'. ' '' -7"' - V-•------/■ •. - •-7-7 - - / i. - -
of 'the. miirmmuculf-ir junofcipb:?in ■" jfly&pthehWvI-r- 
•gfivis 'has, ■ been- mdfe,XwyP&lb»cte p’t '&X •(X96i')kX. ■ ■ Wese '"'iy , 
workers ' ;u'se&Xisbl ated. "int eroostpl muusles' ohtil pod by 
biopsy- under regional, anaesthesia, ■ ■ Weammdie-' -samples 
Were ■ -studied.- immediately'' ' by ■■£!)©... normal '■‘technique fox5 
imfcxyGcXluXar ■• ■ s7ecoi7d±ygywlth 7£gLa»s’s" ' ^capillary:- /mid ro- 
eXeeyrMde&v7 the/-sample-/being-, h4thed7-kit-h7XlXey W fluid 
and -the'' ■ temperature. p pat rolled* , ..7 .' fi-_y .-'/-'■/ 7- I .' 77
. -77/,, ,7 XTKeer'fonnd/ ■ that ■ th'e...reettnn7membmbne7kVtauti&XX .7 
offpipgle'd'nuspXe, .'-.fibres ''was-.•7-0496mV iAiiphyts 'similar ■■'■■to - ■ 
that of■ ho'rmai-.. mussle, 77.Spontaneous
potentials' ;'(m*-e,*p«-P.*'s')yiWi?e ' - Usually pecrpaspdyin . ■ ". ' 7 7 -'- - 
.froquopoy pP - coMpPotely,, absent $-.' Their.'. -amplLitu'd e - and"- ' 
time, ■courdo 7vqrc; .similar '■fo//thpse ..of . •'normal'-. ausol'ey . ■-'•-An.-'":- -; 
Wor-oasa Mnythe7potjpsslum concentration 'f>rOH^7f^*^;^oaiMy^^i.dy-... 
hot produce an " - increasexih'"requeney''of " ih^e;a^7e^7p^^,T^*k^■v• £ ' 
such; as7 occurred.■•inxcpntrol" mucle^js;.7normal subA ec to» 
The ' authors. c'^J^^^:iiez^^d^/;''^;^^.t7-J-ily;/^*^^ra^l; 'hmpXXfude and ti me 
p©UpS.e-zof/the;. m* e mp-p*p; indicates'-- that'.7th@7,’ohPmioal 
sensitivity'’ of -- ■ the, .ppstk jnhclienal . rnealbrane ' in wu^(^:Les 
■ W0m/^■y&iihenm.c paii.emts7is ' - similar- -toyth&t- in ;mp^P,aL-,-; 7'' • 
■.h0'^7^t^h^y^^'-8ub’jt^c^7Ss-i-.':7^^^^^7X9w■ f^equmnhy f7Up0nSkyoouo 
p.»,#*p,'p-*k'• •end the''..lack.-.a' ■fx^(^rp^'ehcy■'/;^^1^<■r't^'ase in 
'r.ysp0haP7to' -potassium-suggsted' a..
d©fie ie/acy-a f fec tihg-''the relea-y' o— .:ac efyleholine * The
■transmit ■ ter .' "rel'ease 'produoed hy ;'mO^Ve■ . Piimiiiation was 
stukied -by-. .doterrains Won/ofXthe' ampXitUdp;7o'f - (straw ted) 
1exxd*"plat© ,po.t en tis-ls7 (p7p_ p ? s ) " - during. .Sm A following 
'perioda '.' ofl-repeWtii-V-haWrye/stimu'lat'lonX th







•by blocking the .re'o.eptork' with dliibocvrarinew y'.in •■:', ?
A a short/ period.'..' of .--high-frequency ’
.(about lOOyfSec.^^.'y^'ei^ye-'P^ij^^^muits^^^kq^ produced- a, las ting ,
block p f. t r^ttomiejsionr/to. ^ith' e-majprity:?Of 'the'' 'musele>'-. '
Sfibros .;xndA'xcs■u“■ceW.n;ie .faoc^^Wlt^eJ;Oon;ef th^Ci O■♦TO*p*'. --•••./, 
)Ws slight,'pr..Shprt-iaStJi^h^^g^-." 0n/the/.0hhOPha&b&. they. ,.•
.-seme proeedhr0<oxnyofprised.o^d3?mal^XRl^l^lAcl^^c^^.I^x^c^C^uc^0^C^d" ,■ / •. 
after a short -.delpyk 'o kodeMlincrease-'in the/-. - , / ? - ■ .
amppitudeyOf. ;the.' e# pvp-whioh -persiated .•.' fr-about a 
-mlnptt-s.fier ' th.e‘yst':i^^'ule^ltl^o^m/had s'h<05pojtxc^>' :-?'
//.;•;:■. /• ' ;-• -Those;js tat wants »&ppceea3r-?io ' coffiet ' with ththr 
;ELgv9 -which s,hcwG?^mrked? 'inhibiticn" of ..the •. endplate'- . ' 
/po.tpntioia. .dux-lng-stimnlaiioh''.of the . curariked• ••norm^^-- '.• • 
'anisole whereas. -in ./the?my:y'.a^st'tj^<e,nic.ri/'^y?y-,0 the 'fall'was •'' '■ 
slight L They ,©t^^-V . that . ?thep a.- xMs.* no . osaiVa % dec line
and ..that /’-the attpiltudeyof suc c e© siye-’Sub threshold 'kpi-p'e 
'flue tuated. at random*** it- is;.not stated whether the •’.;...- - 
stimulus was ' supramaximap' ’'tpT'the - nerve . fibresix 'Ih-’atiy'" - 
event' .'the -lack. p fy dec r omen tf.of. 0i.p#pi" 'response:'- 'sugges te..' 
that ■' th o .-musc lea . test ed, we.- hot/- ' ' typie ©1 ' -of . - myas th-ohi-a ; '
. It. WLiL'3^'*. be reeOlXeeted; Jttat>tfcheinfcercd®iai;. museieS/nre' 
'Gm?n'gi'thei- 3.apt to ;liA'-'%ffe'^:fee^d^r •.b;^^t.'ip^^'ti^^^f's. 'gp&aV-p ttw ;.-.... 
\(ChApperi'2).\and'.; in -fact they were '//not ' -evidently. involved 
cpihcaally/?'' --Wverthel.es> '.it must .•'beiconee’d.ed'• that; the . . 
'diminished- ''of .spo.nt&eeoua ?m*,e#p,Vpf and' ■ the -’■
/po'or.-yespdnse’- to increased,':pcta.Bsium.''in the? bathing' -fluid 
•.point-stroigl-y-. to? W C,^ptes one eyof. a? •^c^Vr'^< quant ai . content'- - 
of: ■ ac etylc.holi he. rel eased/©pen. tanopusiS' at? the..-.nerve?; ' .. y 
terminals ■ '- ,y?.;i ■?<'■/■ ?-'''?'.y''7/;.-<--"- 7' - . .xi/■'-
•<•••;.-/'-The interpretation .of' .'these ' finding©. depends'' on, 
the. •Puppp-itocm'-? that, the'.' y ehdiyPate'is-.-cyp&yi'e' ■ of . normal '' 









.the?normal-? tiansmittei*. .//A© -WjX?b5?dpp&rettt'‘;-y yj- ? 
from aprevious - secMon' this'yihv byyhp.,means -' ah '- ,' -' y hr';-.•■■ 'y •-- ■?.
UppUaetionabley - assumption'.- -iilof txahhnand- - Sterner' (-196-)- ..X ■ -. 
"3uppor’:bed‘' the -Swedish conclusions\WhihOLi' -’, evidence-' .-y.. ' ' y . .
iequlies - poniimatiohy beOauo'e; -of - the - unsatisfac tp% •; ■■? - y' ?."
'nature.; 'oi’--.the- nesting Aotentials^eOythe .ymusCle?;;£it>Ws'.'.. . y\? 
'■inypetigatod by thorn* They claimed to mbowythat. thieP?'?? , - ? - 
was.yppoi ieleaseyof - 'acfii^^;sli^lh^.li^k^e^^'^in^‘hyL adequate.; y. - r /'•. ,
.production --at ythe xiei.ve, -•teimto-als-'.as--the fiG-pierey 'o'f' •'• '? .;'■•.
e* p* p rsa inn c i aSoddwlth y'ao 0 lea t i ony e f guanidine?; y or ?, - -,y'" ’,
' veratrinev y 'Xn viewy of' the - 'evidence' ■that .guftaidin©' ■ -.A? - ' ■■■ - • '-’‘p . 
ihcPiaGds ■ receptor • 'sensitivity' '-■' (ohaptpi- <18) -?ph;d; 've'iati'ine „ ’
is- known- .to ;.ac-t- on muscle,-? 'these -' findings' could - be ' ■‘•used ' y.. ay 
• 1^py'U)p0oy•^b'/>a'ppsi^^^^3^yniOp^o/t^hGp%.».Vj,y..y?y,\- ,-; ‘".f .'- ;
. A latee oo«mnumcation from the Swedish workers ■
■ (Blmquidt et -'ai,> (1964) - iepoited%©.• ddimhnttPh'in* /'.''yy??'' \ y:' ?': 
ArPUUpttc’y--.of ,the- mo-p»p*a<- ■( nota-pri'n-t'edJih-Xheii'.•ab^^tiao>t,)i' ?? 
'-Txey. yppotfiimed Abbei'i u previous / - iPpoi 1t that'•*> ep #p ;! a . weie -' ,?s u y 
yiyyieui y- to- -f a.nd:yb^?t.''■’t.he5y.-y.^s^o^r^tt.--lt.h( Ue.suily.y af ten ,''^ttimtila?y.'yn'? 
-they were ,of HoW.- •mnyil tud.©- and;'Xh,^yypcu^l,d;-be.''iiydieas3-^d;'?b?/.-/' - ? 
y^c^c^d3^^5,neGs5•^;i■miih?y?C^Oyythe-i^^^sb]^:ing'; fiuddy ?■ -The . estimated,-. .
.quantum,y con ten .t'syo'f- ' ;t^l^^5•?'e?!■p;?p,?s?Wece^ystmL/^a^^^^? to- those; •??'•’?' '■
found' in -pur&.iis e &dppimSiO - human - - musoie -'fo i- 'a vjideli&nge’ j? • . - ! 
of? stimmlatIon.*■ - -TKougghthey. again. found •'' . y •/ y‘-- ? '■
; normal pct;i-B?/n5.ap')ic activity - - this-/timo?iG?.'p&sbach0X), -.• ?.;•...
■;thep.yhady to '.'concede '-'.that, .the: chs©iv&tionb - ’.oxi- o'uSintS^m?? -,. '- - 
C0niontyAO'mneOpip^oadi'd? h,op; allow -.theMytoyrule out; the '
.possibility? of t-peet~syhapiic' defect in' hd’ditioji to n ' ?•- 
wrymoyaaptic ’failurey ' ;y
? ,- y' It ' Is -to ybe*that - y^uij^^hei- ..experiments Will - •;















;"/;/■ •/' >< "■/.'■/■ .<249 ; • • Zvv”-' /.
r©solve 0thqy dopbt• Thorp.'is //vgrowl'njg ' body'/of /evidence ... <
/for; a pre^SykapMo failure,' biitylty- .i©... impo© fAto-P/to / f'/'■■ r 
.overlook 'the .pathologic&l. •'-chshge©-Inymuscio/‘fibre iy o- ///. • 
described Chapter H and there is no reason to
expect a ra'iSed';t]i3?esh.o.X<i/Oo'o: ^sihta««rteeii^^3rl^^;-apt.3^:td"^.' - A-.- ' 
ac e tyloholipe- - '.''indeed. the-’'converse•/Wqu^^pbe; .moreprobable . 
•'• ' .■/; ■'••. y;y/ If./the. ;.transmission>.Is ..b^O0k^d^ob^^or-:33x^Oenp4.nk;'; - 7- 
• transmitter" release., by'; poisoning - with’ Clostridium / " -,•■ *'' 
/botulinum -.toxin, the' m^jsol^e^.o . fibres'.undergo .atrophy ";/•//-, ; 
'..and - shoi'o^^Mnn^anoous fi.br:iil^a^13;tc>n/p^i^1e^m^^ia-te * /At the , 
/■same time .■bbe./'eAtir e. nust3o^«j'o'<oiRi?ibb'k'e..;bec6m^s--• Sensitive 
io • applied ’ a'70iy Ichoiini. (Ho_manyn i t/h-1, /1-9'6^4)■ The.. 
extreme .rarity-' of. .these’'- features ' in., -myosShenia/grayis • 
7irxst/mi^It  ^te '&gg.inat; the...acceptance ■ of ''decreasedi'beleaee 
•ofat! the 'pre~synaptic rnembfahpVfeo the. . 
'osole-'caUe©, .of ..tt&h©tesi^o$/^ /Yy/. "Y.Y. i.
yT3ranSfflj^^Sai^o^_H:at .iregen era ting.:neuromnpc alar .. junclions s '
;•■• ' O ) -' .„-A.. ,po©nihility- which- has.nPtybeany discussed-. byf/y. .a 
. preyipuB .. writers. ^'// that’.gravis’ cpnildybs/.due' ' 
Oto*. a ’ minimal lesion. ;' of . bo’th.. the npf ve.ytermiueis -and /the')
' -ejndpXik’fceo’ o f. 'raudel ow in /which there.-oiS '*a ba!.ano. e ) be tween . '
- degenerative ihd'/.regenerative ohangea . ,-o.f ./tho /nerve 'endings 
: yTiis./coneapt- O'*’-which .arises . out of.c% considdration of. the *.
remarkable /histologle al/pippeaaance* of. the- ■ phd>plateaY*. y,. '■
- (Chapter- 11) usn.Oscarcely .be. 'disdussed/ by 'comparison. 0;. ■’
" with ’ the '/findings in; ’ normal ’’• Juno^lim^^,o;•idiihh/-h^aV^^/;'’been1 ''■ 
treated’-with curare or .lowered /caXciumv - .The 'properties . -.. 
/of--. ’ regenerating ■neuromuscular synaPOes . in ’the . frog/have / 
ypeo'entiy'/bebn AnVps.biiaited- .by miled-i ' •/•.The-.; •• '••' / ’:''
spontaneous / mi:nx s turc . ,'en d«pl. at e ’•’ - po t Ontiul s . .we. r e .■dec Peas ed 
;in■•frequency-7; When ' e*p*p.*s appcp^cd.Yat-.ihe 'regenerated ,-■- 
/end/../ .)-y.y’■.-'/.' ' :.-/-/ Yy. Y--'). yyy,. ■" ' /-, . Y-'O; ■).'.'Y.4y.y.
b,--- S77bb .'<77/7-777 ibWX-b' b. ybbb •> . 7b ’ ,77:
ehd^plates' .as'-the’: result/.of';'mer.yeyBtimulatioh. or \<of ../ y - • .•. 
iohtophiE^xreltS^o/^^^^pj^lj^oatd^ijn., pf acetylcholine''. they/ware/y - ■■■•.- ’ 
always; adequate-. -to*-. generate .’spike ' potential*’./.:-' '*-On 7 7. '-b; / _ by 
repetitive-. stimUlatioK 'the.-progr eosiyebdedrease.- in /,b y '•••. 
emplitude; .e.i,■ • t*hio e<p*pt.s ' was" greater' than • norma;!' -and . * b •-. 
this. Was' increased:. by bpest*te tanie-vpo tentiation.<-.- ; 777 7 ';
Some ■ fibres-/shewedd abrupt • \f ailnrey bThese' '-ieatures 77b' 7' 
hear‘?a\ ©iriM'ng resemblupee- ■, to the ' •phenomena’' othe.;,' ?:' < b 
myas thenic •-' junc tioh.. .007 reported/ 7by/- the / • /Swedish . ’''worker® * b / 
.0a'•: the7Other/ hand■ Thomson• et• alY C199O)- found'':thatj. the ■' b■" 
deoremehtihg; -twitch •/ response' , of* / -muscle./ .-stimulatedbbb\ 
repetitively ' b>y//a7'jp^<&.efPh.er£^^ibj^3ig/"'ne3^'r(e/’ was- made • .worse.by'7b 
acetylcholine-.-.. ' -They -suggest’ thatadepolariimnti0x1 b-. •
block might he / caused bybabsence•■pf/'choii;nest^^erSs/-7^^n 7 • •.­
■■the /regeheruted\mhisPXe O-jp•.persisting •end~plate b bbb 7 
hypers ensitiyity • '-after .-recent, denervation^. ."'..There '7±*;tb:-: b ■ 
however #7 yji physiological work.. op .thebnature '‘"OF" 7 7 ?■ -./. bb - - 
transmission-' ■when /.degenepatlpa< and regeneration /of< *b •' '•■ '.7. 
motor nerve ‘terminals is associated with, and perhaps - •7 
'fK^^<?j^<ifn^y7to'^ 7. a'':di,sO.rd<^x’7of^7;tlae;7i^^<^c3^e:^;f^i^l>re# ••' Harvey ..-77“ ' 
• and 7 iilienthal.. ( 1941 ) - remarked, that - the 'myasthenic--? • ■ _ -
neur0musCuXeF7.wehanism.-!po;sseshee'-/chiars^cte^^l^jB'tic©.- ?■? . •■ 
.simii^'tP' those?* £ 'abnormal' ^isC!<?7-velic^i^1■bl^a^.:i^<^le:n-both • ; ■ 
AeaerV'ai1^<»^l'^Mid:?phi.t^'iai!^3*yeew^r^ieieeidi77••>b7" 7 ..'? '?<b--.,b;
'■ b ' '•'" 7y, -- b't’f-, this"'; hypothesis,- is .7 acceptable , it - would' bring ; • 
'aXlbthe.-- ayiC*mmt^e7: ^asthenias * -including -/^lhe'/.'-disorders - 
Of,-- the ' .-loWef ; .'me tor neurone $ / "under 7a single mechanismyi.. -7 b" 
but-'heed-hot indicate' abcommoh-- ae7iioXogye'/'':Xt'7has .■ by. 77. 
'/atre^d^y heeh shewnthat • t^here7a:re'.7,c:linidai7 and/"b bbbY /; 
pathological' ' correlations /-between.' the' - acquired myopathies 
(or -<ahou2.d' -they .-now . . be , considered'asjneuromyopathiee?)' 7b 
and/'bbb; 7b 7'
... -,g‘; •. -k-ky -­
and ■ true-myasthejn-a.;gravis- a^effabSent1 ' 'from tthc■' ';;,-■
’dia oases1'oik, the' -lower?: mot or hourohe' W-th 'the '•possible ?- 
exccption-of igiie^ial-polyhew^isbO? the ■ Qiliaih^ .' '’,"' 
Barre' type*'' 'lb is xi0w<nee'e8b&x*y-;-£o examine' the •;-•: ' - ■ / 
.remaining'hypothesis .which ' may ■clarify :thls ' -'.. -- ■ -..k -' -
relationshipi'. '-h *.,.'■■'■ - : ■ -;• -;>;■-<•-■' ;--' - /• > <• . .. . -;
M&ath'eftiex.toxin-: •-;-•' ■'’ k- ■ '; •'-i-yi- .. •-
, . . ' . : - X t' has ' been. show in' a • previous •eec tion .that ' ■,.'; 
the-results of kt^he. MasrveyWMss^jand^'. test'and J of. y- ; •,
pharmmcMcgie al s <^^^di’Ci5;;are\. compatible jsd bh.©&eh\p f;-; - - ■• 
the ' more, likely .:' theories accounting - for imy-asthenia* '■ ., .
the' possibility /if X’: 'eUr&r'e~li&c substance*'yk 
which suggested itself ipisiany- .observers', of. .the.-.last . ; 
Century#•->$• ©re•^e©fehx^.t^^-ee./sbS^e^<vtioni8;.which . have -been '•; 
considered ktW support -'jhis concept '•.the-; Walker _ y'. "'
effect,'■ (ii). neonaita!'my^^csthenia mh&^Ciii) a -therapeutic■ 
improvement ''after- :dialysis- - " y. ’• • ’ "- ;-- ■’ ■ ; •--''"
'•he■ Wg&kerJ effect ,t;'k—;■ yyy- ;:;;ky^kk-.-1 . ' •-.;.•■.- \ .—
;:/(11 '■ hao' been-sstaiedk by: -hEan-kSUbhors s sinca '■haquery 
(1898), ;. Bus-sard (1900) and Walker" (i938) ' that' ■ ..'eier'Giee.yk 
'ofks' major'• group -of mussies; 'in /$ my-athenic ' patient' """;; , ■ 
■Caused,'' thg releaseYintok the blood bi^3te^s^m.•if",,a'Jaub^Sts^nce-■•• 
which induced”; Weakness' kO'.unexbreised-, muscles,* "Mei-gy 
•procedure' adopted dby''-"Wai^er r ja^c^; subse<qxCntkwri ter®; <- ” 
’wan tC- occludf/the’' circhiaiionk iti-any Upi.er ..limb-while; k-;
’ Exercising' the''muscles■ '•of '-the.- •forearm*--' On ’releasing ;--/-i 
the constriction' an'increase-'!ih,-; ihe-cXtnicaXksighs, of . . ”• 
.mm-©thehla-. in- other* kpa&ts’•. < e-g-K• ptosis) is ”saiS kt0.'-be. -;- 
'present in ■ many case's*-' ■'••h-s • is-often. referred ■. tokeS'kthe 
' -effeei^*' i Wilson; 'and $toneri't 1944)' repox'ted. '-- .-k
similar '•’findings- substantiated'' ' c-^3oen^^aigr^3^iap;;^isn.dx•^<3^^';v ,
others/ ■'.■■ . .■.k-^f’.'a :- .ik-a-. k-k k- . ' i/h'a---'
- "YY \ .. ?' ."'• ;. '
o thero /'mocking -similar-''claims'.are -.GrbsserBrockho' ff; and - ■ '
Wolfe (1950.)$ .Btruppler- 7(1955)- uw! -Osterhuis- (1965 H '■ V
'<\xY;7'/Y7-A®OGkol&tos 'are’.;;f?€ra:‘:from . c.ony±hiin#.»Y/,%be ''- y - , -Y 
alteration.,. iir-'the;paXp'ebrai : fXeouresYpfthe cases' -,c.Y , ‘ - 
.illustrated; by ' Wilson /amd; Stoner. '( 1.944 )Yis: not ' '■■'.. .-' . '
iampesss ve. - ;.■Wlker '■ (1958l-recorded/thC onset. of .'' ,
ptosis.'’one . and a -half minutes ■ after • ■ .■ '
- the occluding .cuff*. Wilson and. Stoner•-. (1944). 'reported . , '
&-■ - range ' of. latencies'-from , ten 'secohdo '-.to; four:, minutes.' : •,. "
■' .and; ■£ trappier .■-■( 1955 )•' of ;g*6--mi nut es * It - .is di fficult " '• ;
• ••..•to- - accept- latencies of - ' this - ‘■o'rdef asr being ■■•'due to - - We-.' ? Y -
- . p.hafm&c©lagic&X 'action of. a- . subetahceYpO©sittg; from. 'theYY. .,
• am'veins - to the 'eyelid muscles.-Y. In '-view .of;the ;fact-Y ' :
■ t^hefbtpL^c^s^^tlr’may 'r&pidly- ocourfin^simatieho-of i./;Y YY; 1
■ ' - emotional as iressYorkin bright 'light ■.(suclv-as ■■’ an/ •; -'Y;Y<.. '
■ experimental- 'si tuatien ' wi th - cl^^s<^’rup)' '■photography)- it-; ■' " • .,
■ •■ •wedudY-beb oesirable'be/have--more convincing’ evidencce;-' • ■ < '■
' --It'might bei;;^oOL^tteS:.out^;;tUb1;k•^Ue'-.fact^Y■tho1:,;0^- blink will. ' .'
..:■ restore Ythe. dropping ;.eyeidd’;t©/normal* -j.due - presumably; to ' ■ 
—pst*tetanic; pOfentiatin*- bnd the-.similar .finding in ,.
; . 'Other .muscled t ;Orgues-fagainst the - notion ', that ' £.-toi'ic Y;YY<' '
' ' subs tune e - ...is -.produced' during' neuromuscular-ac tivLLty - 'and ' ' •, . 
in-. - proportion "to -the.' degree;.©? - . contraction* ”/ M.m'any - .-.' "'. Y - •
. .experiments' conducted- personally 'l;b&v<e never\be;en '■ •
"'convinced; of ./the reaiiyY;of -''the. Walker ■■effict f .•aSjit-'-hms ;Y . 
been/oamed* -and - thisYh&s .also -Wen. the- experience of • '• • ■
.; mastuk>et- al (X^R'^YiY;:y .V-'•. " ' •/ T- - ,Y-' \ < .-•; '
' ' 7 -.' - / ;->re .serious- consideration must, beYgivsnYto - the-- 
■'' '■experm•.en^^^,•r^.^TT^^U^^yam^7e't^:. al; - (1959 )■ These-.Ou thorsY'' .. ;
' tested.. the response - 'ofYbhe. - 'fai^t^lon potential - of , a muscle4'- •
... ;ro^;.o.nc hand;(stimulated - 'through- ;norve)- - beiore/;and;Y,'r/ ik.;
after/. ■ Y
 after -'stimulation of .a nerve -/of - /the' - other -arm - distal <;'to, 
exclusivecuff ♦.'About. one-. minute/after the - cuff'-.Was. ■'../'..
ren^c^assed:'t^he/pd/tential-of .the oontra^:^<aberaJ^.--SMAc’C^^e;..began ■ , ''■ 
to fall i -.''reaching?, -a - ^minimum - in .mine teO-.ap.d. ..then . /, • .
recovering in, -the -.next- io-rlSvMnu'teai The aepreseion' 1 •• -
'was .'less 'after admlniaeration of-an;anticholinesterase -a, i ' •
■ drug# ' ■ Tris-' 'report/is -‘:^©pe^^?^^$ii,S7^/Hi'7;•an '..apparent' anomaly/'- ,7 
4^^e/‘idleeu©sed. ia-: the: .’next- !-section'* ■•' 7:"-- '/"//■- • - a: :
/I,'’" ■.• '--£-•myXOthtnic/ fatigue4 '•Wre .’due '-to/tile, i.i. ••/ ',../ ■•■
'accnmh'&tion '.of /eomt /toxic'-- .BUbbtahoe: &i7'th-/'tnd*platcs':'S ' a,;- 
resulting from -'the.- activity - of./i to. -.motor/ nerVO • 6 x-- from - -/ ■ 
a''metabolite 'produced - -.by the muscle'- (Btrupplert 1955') 
one - 'would . expect. a - 'run away - effect vwith'' 'the, rate .- of '' 7; - ;.- 
' decrement 'Uncroasihg- -/progressively*' '-In/ fac i-the.-ZeKact,.' ."’
■ opposite Ahappeiist - inspection ' -of/ 'any ./Of/■ihesrecorr'd7in 7 - ■ \
Chapter id vWLlX/.'sfcow that- ' -the^gpoateat-/.■■ 
of'.'lho' - .action, potentials taRoo - piac.e"&t /the ■ beginning - of ' - -7 ' • 
the ydecremeht/.and {a latex'' plateau 7ievoi/ia- commonly-'! / '•• - ■'- - 
.established*'.-/ a**•• • • 7- '■'"- -.a/aYa ilAi'A-'/-Y ,.- ■ .-/A—77/7■--/-' 7'•“. 
'/ScOnatal«®yaaihSiniis7. a'f .7. . - .•'' '"‘"a; ■ •.' ’■• /• 7 • ;-Y77/7.•?• •.■ •
7’77"• .-• aTie, occurrence /of.. temporary,'myasthenia- in '-ihohphild 
.Of 'a-myad thenic' -mother- is "-host -.•ao'^’6ii^i^ttG^-'':/fO2r^^v;’by: the--., -a ' ■
■- trdnsmiosion. of - - a'./ toxic/’substance ■ from 'mother, to, /child <. -.,- 7
-presumably.-, through-/ the:-placenta-,',(Chapter /8), A We/-nature' '■. 7 
of '■ this /foxinphas --.never- been . de terminedt 7 but /it, is’ •' -Av - - ‘a 
•natura3.77ith^ait.7l•t•'^i^^?Ul^l; be considered - to ' /act 'ih' a-similar • ‘ 
'mariner '.to./Curare* ‘'A'infS..source-’'has /been/coriMdered' to. ' be - ■ - ." 
the -.neurGmuuC'ular - jump iion g presumably' -as ' a--byspr6tl.uc’i’ - of- ' '
: acetylcholine"b%-&''•'amt<^J^^c>i;l•^^is,b^f mtt'cXX)- ' of - '-We' thymus ■ 7 ••/. 
gland ./whose. - function -has .'been; ' obecur'e - until' recently* '' " - - ••
. mislyciX*-: -n --Y>\ai /''-'-■' ■'•, -’".'-/a'- 7//"'" ,.-7/. /< a
-■:a 7'Y/:'The/ '7- ' ' c j:"'?:. /-' a './/''a ' 7'' Y \. - - '7a 7 • <<•- -a"
-■; 7 254;./ ./•'•• ..... -d-:' / : , /,••/ •’ .. .
: ..< /;••! Hie:recenfcvreporV'hy Bsrlckor -et - a3L;,?(1960) ■•.'that'• ■ 
5 ■ -■of 78 ;patients ■ gravis7were ■ strikingly ■' /. ,; ••
Improved/by ■.dialybi'a:-of - -theix..'hlaOd/requires ■ / ....-•• ,.■ .■-/ ■
.confirmation* -"The: ' marked -influence, ;of-psycho' logical - . . -■ ', .• 
factors ■ and -rest ••with■ ^c.ontrolled ■ '.respiration!must- be■/ ' • '7 ,
considered-/before -thia Mmp0otani 'claim - 'ban ..he ' - accepted* .■■' •.• • 
The7<dme /resnit might ■ have 'been /expected/’.from ./in 'exchange. '. ■ - 
t^jp^anafusl^c^n • which.• Schwara. - (1952 l/sho wed ■ to• -he - Ineffective* ■ 
At tempted■ . i seladofn. ,of/ -■- toxin' .-from ...the thynms-s ■ ■ /•:■-.■,
7/. •.• ■' Y.-Asher■ -et/ai; (1929)7..and:/7Ut^yly^^iter•,lwO^k^30#i'kdve 77". , . .. 
searched■ for ';•neurpmuscular .blocking ■-substances in' ektricts .,- 
of -thyxma '-'glamda -.prepared In anny -waye.*-! '.The literature - ■- 
:is'/iW®arieed .by Ooaterhuia' (1963) • 7/'TpetheMe-■ and . ■•■•/■:...7.'•-..’'•■ 
.(fright■ ( 1944 )-■-■and --Torda7ihd - Wol ff - /( 1904)'-’reported' ■'that :; , ' ‘
/thymicf/exirac t' .inhibited/'-the ■ synthesis. ■ of/Zacetylcho 11 &©/■ ■ ••
in-- 'vitro »,••<•'• ■ • y 7 7 . '7-'.y .7' ' /7yvy yy 7
a■■•.7: 7 '111 a on : et al(1953) -/examined/thymus. gXahds.Y -/yy .7.7 
' removcd -by' KOchne/for/hhe 7 t3^^^ii'tme'n't//^^^7;mye^£3tth<^I^i^^/gravisi/- ..Y 
. fhos.. •gia^^^8^‘s7/wox^^^’?'3^mmUdd£^Jfcely^7.,i^h.,;7^i^<^^b6nc^■ and • ■ ••.' -' , . 
.extrasted. 'by. a ■ particular method. /ThC/extract. was '.'aeahyed e . 
'On a ' ■ variety of .. nervermnseie■ ^preparations-and -the-’•• ;■ ':'. . e•> • , 
•'authors atatcHl/that -a ■■neuromuscular .blockings ffcct -.,Was■ ■. ' ’, 
'detec ted * ■; This ' , was/aost. marked, - in the' ■ .glands . which - had7 /; 
.been ■ • obtained■ from/the patients ' /attaining most benefit Y a-.- 
.from -the'■•operation*'. .A lesser/degree/ of. activity• was. - 7.; Y-' 
■ -found' in ■ the ' thymus /of 'normal •■inf^t^n's^.bi^^t.^-not.A in ■.■the / 7... ' 
adult 'glatMdU • -later' "studies an the ' gland •of/y’p.ung'. cattle • „, 
and■•/•ihaloO/preduced •'siliilsa’/roOuit© (Wilson. .and Wilson?- 
■'1955 $7 Mowoll -.et■ al? ' Tiese/have 'been■ se.yer'oXy-'''■' 7
'criticised, and the /experimental resultas '.attributed /to'- ••■
.'the ‘ppes'ende of ■ potassium .In /the. exirae ta ---'(B^c^lk^;.;. 1958-) *7 !• ■ 
glose/'■ .••'. '.7'. 7.' -7'77. 'y : Y. :7_.'7‘7' '
Glceeearteriai' injection - o'f-small/dosee■ of/an ; extract.' ;■'..' .■. 
.of .foetal’-whale thymus' ' potentiated-the"twifoh '-'of. .cat'- ’ ' .- 
weole; indirectly .'s iimulatedv >JburgcrA do- s es first. ;v-<, ' ' - " - 
stimulated';. then- ■ depfesoed. tiie''-5t^iitch/';(iJ^W^;i^l'; et al #.-., ■'>■
1959)# This■'could hot be ' '-recounted 'for -by the-"- ''' !' 
•preaenoe. of''.el^e^c,^ool5^i^^<^s*;,.,;Ti«^'-j^ctJLye "substanei.es. bave ••••'.• ■• t 
recently', been -identified . by chromatography. .’ and are - ' •; ‘-;-. 
believed to be ; - quaternary Yiitrogeh bases' (Cal vey and.
'WX'soa.i 1965)♦ .. The -"extract has the •.properties ’;of. a-;- 
'depolarising. ’substance .-Mdvdoee' not’xin ’my' opinion^,.'..., ■’ " ■ - 
■.have the .’activity 'necessary to' ' produce'■ the known -effects; ; 
of myasthenia gravis*; . ' ' .;•'/’ ■'"" '. ' ■ ' ;
Search" for.; a . neuromiusc^ua^^ '' bfockfng ' agert in . "the-bloo'd s. ’.
. X..;‘. -■;’ - There.have'foeen many;attempts io' 'demonstrrie ,the a - 
preceded; of;,a- neuromuscular blocking;-substeh®®/"ih; the ’ • .
■ blood of myasthenic patients’’ by applying- the'-blcod-toi ' - 
an isolated';ne^^y^<^-^m^ec^^s.h■p5^^^l^s^r^S^’^•l<^J^;.,c^^f - the frog (%lson ". •- 
and-$tohep» /194h; dphehYet; &!'*- xM0Fov’ by. 'intravenous ;- ' -": 
injection . into’ dermal/human’.'nubjeeta;•('Bchwars* 195^ Vor • '
.live,, . mammls-. (lammers.. /-nn 'Moot - -Vah %pijk* Bfrupplers
,1955)*Y'Weee /experiment©-'!^* -not ’yielded results-"' ' -/. W •'
to critical -workers* . -■'•The ’grounds. --for. • • ■-"";.
’rejecting’earlier; positive, claims''are well' discussed by; '- -:- 
’Bastuk .’ et al> (’19.59)* '•-.-"'COoter huis (19.63) - gives-' Ol., good; ' 
’-eumramry-O'f '.the’ literature 1' -••: ' 9;••;•>• '; \
';; - ; ; . "Berglt" (1955.) ’’showed" th&h-.hegetive re suits . jnigghfc-; . 
be accounted for.by lack of sensitivity of the test/methods 
-used*/’ Tsukfyama.,eta! •/(1959.). • reported an interesting '\ ; •-. ; 
experiment* ' They drew - blood . from .'.the :-ipsiiaterai vein •' ’
of .a my&.stbenic patient: below. the"euf f/od an .•.arm-/ •/' .■/-. . - ••
;.exerci^!^’^<^--'by' electrical-, stimulation;.and- inj ec ted .' it ..into---
 ■h©7 brachial artery.. of. the / cont^tral.^tsera^:- _ amt'i.- ,. The .- •. '., ;, 
evoked • tauueX©: action potential' 'an ''.that Bi&G^showed; • ■.
the ‘ same • depression. as. It '..had ..done'. • ;a^ffi^^3r;r^e^leai^e. '.of '"/.■' • % 
the -oiaff as described -in O The -. - /'./-•■'
.resemblsnee-extended ..tPCtho • -‘/■aplitudo and the' timing ■ '
of 'the response'sltpdUgfc it. is'to,--be/p^rositmed ..that’ ' ,..
'the ..former teat?’ . twain' measure.• of the. effect- of '■&. •.•;,/ ■. 
randomly determined •'’’dope ...of • ’blocking/substance* ; . •' 
'administered, by;0ioseeartehiaX/injection whaneas ■■the /,? '7 ., 
Baiter -was. 'the -/effetet-.ofirelease', Lof a .rape h great or./ '■'■ ■ '
volume of- the' suhataneG.'into 'the '■venptts'-side ' of -the.:t x 
circulation# . This; aeeyas so unlikely-.that it, wouXd-.be 7 ; 
wise ' ,to .suspend • judgem©^-./^^!'. those • results.-have. been ’
■ confirmed* /''The • dapaheso-authors■■ also/r sported -that*;•';.;,.....7
blood • from ' the ' Jex'eroisbd of/a.' rnyapiheM&fpatee.ni .. X .
.caused neuromuscular. block ' whoa injected into• >&7voin 'Or x 
am 'artery in. rabbits# OspociaXly/Xfter. exerciseX-in/*./ x- • / 
■ischaemic .conditions (as •:emphasised .by''$■trappier * -lL-9$5)# .-
■ The' •noux^om^i^birl^^^:p.Xb3Ldck •Tpr^^d^ti'c^d^^.: in;. thia • ;i#ayx.wa© .'.promptly 
reversed by• injection of • neostigmine• y0f;Lacetyl^p'iu^^'ti^ne X . ■■
■\Tiey' suggest ' that 'their;•results- point to' the'-.existence ■ 
of ai ♦myasthenia• • subs.tanc'e ’ -obtained •/fr0m7myasth©•nio .XX,
, patients. -when .their muscles .are ’ixeroise.d#x' 'This'.has ' •
the •-prbpertiee '-.of • , a .'cojm®titive. blocking substance.' X<■ - X 
either alone "•<>£•'when, • .combined•'- with • • choline/formed''by.' ",; ‘ 
•the''.destruction '.'of acotyXeholine•7 .The .claims .’made'-ih •- 7' 
this . paper for/a'..pho£ilye-.Walker •offec’ty .an'.axatt*to':*ara.. .■ 
transmission. of /a? ^myasthenic •iubst ance * and ' for*, • a • ■/• •■'■'- ';. 
/blocking substance . /readily ;detec table ‘'in'■'ariimaXa'-refor.' 
to' matters of great- -difficulty for • .experienced ,<•’.../--.. ! '. X ... 
■experimenter s/
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experimenters .in-- the past* There does no't appear to bo 
any n6veV;ioohni<xi£;in the - experiments- described •and-' '■ .
Il - the. illustrations are in the form 'of, graphs* -Fxcept . 
for' one Waaher teat using a nerve-stimulation' techniquet 
no original records are - Bhom* For -. these reasons ' the 
claims cannot .be accepted until .’they have been - confirmed 
by other workers *.;- 7. . > ,; ' ‘ ' ' • '. • " ■ '
Xmamnolooical mechanisms. in - neuromuscular .block: ,
' . . . Wstvi et al. -(1959) ’ repeated some 'of the . ■ ' , , .
experiments just described* . With -regard -to the Walker
■ effect, they state that some inhibitor ..substances'may
■ ‘ be' ;roXoaaiBedr. -from' ' n.omX,attecles; exercised under hypoxic' ■ ’ 
conditions, (Schmidt and 'Chase. 19^7) ’and further 
criticise Struppler (1955) -.cn the grounds - that he used.
.tod,- huch, curare' -in his animal ^transmission* - -experiments* 
They -'werc unable to obtain -convincing - results'.. in the 
Wa-lker teat. •* They /proceeded ' to - .search- for a neuromuscular 
blocking - effect' on ;frog - muscle - of serum from myasthenic 
patients.,- pointing out -that previous negative -results 
might -be due . to - lack. of sensitivity '.of/the - assay 5 . ■'
procedure (Bergh* 1955) - or failure -to --allow for d. .. :
latency - of ' the response*’,. . With-..- the .appropriate-'px’ecatitiona 
suggested by these considerations they repeated the 
experiments of Wilson and- Stoner - (1944)* Serum - from 
some myasthenic -patients' was shown' to -cause ' reduction, 
of isometric tetanic tension. and action potential of 
the ' neurcally stimulated frog ' muscle* 'Isometric . twitch 
tension was usually 'not signifioahtXy depressed and 
indeed was -sometimes-.augmented#. Only one serum produced, 
an appreciable depression of teianu's and twitch - tension*
The ' depression . in- tetanus tension produced by
■ serum/ '. - ’ *. . . , ; ■ -■'..-•7 ' .'
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‘ /serum ■ from ■patients;w!th ■ myasthenia-' gravis had, "a '' ' .- ■' " 7 7
■ /'. relatively slow time '/Coarse' (l^,.hous?s /for'. $0%'’ re.du'ctidn) . '*
. ' and: the. change© 'were' .sometimes '- irreversible .. Similar ' ■ . ■ ■
• , chmigeG of- a .leaser/.degree ’-'.xere'Bound with .plasma' from' ; ’
■ 'Some■ normal control subj'ee.ha, . Hesting' poiehti&Xa, end* . '
plate potentials, knd action potentials,- 'recorded' by an -.
.-.•'. in tr koeilular oleo trade/from ' ■’ single musclo/' fibres* were’ 7/.
■ .all. subnormal- in' those muscles .• which/Showed a 'persistent . ■
. ' depression- of tetanus '-tension.''. These at ;;••
,7. the,- 'surface Of theymueqle'',&nd' ' were.-"noted/ to have beGorne;.
’ cioudy/in appearance*' •./They later began' to./disintegrate/' ''
• ..’at/;‘Various loci bearing -no/ disderaB^ifele. relation tO' /the 7.'• 
;/.B. neuromuscular j unctions. . tt-/was.’'" c o ncludo'd' that'..the/two ' '­
sera causing ri his oBfect /contained• a: cytolytic .- agent* 7, '
. A s*miar7<delayed)' cytolysis '.was' obtained'- With,"serum7/
, .’from' 'one of eight.- ' control /subjects.''/ Hastuk and 'his . 7/' , ' ’ 
.<7od.lXeagttes concluded that 'noneuromuscular: block ' had ' /
' '.boon demonstrated, - - The •-’/•. ' -
. . change -of. tehsioh/hadiddjne' -;ob/-becskise'/;<^;^-,,d^b^mageT;to •fimisciO
- cells of 'an.'irreversible nature, . •'-They' wore' unablo/fo 7 7’’
■ account; for. the .''augmentation of,- twitch or end‘*tetn'uuk7 . '
' ..sometimes' found 'With-plasma •’or serum samples-’from both " .
.7/•-. myasthenic mid ’normal persons* 7'-' - .' . . "7'-"7' "7’/ .' 7/
'/’- .. This paper '. appeared/wMlp I '-was'preparing '-my- ? . . 7
7. Tow/lecture, on' an -autoimmune '/hypo thesis .for/myasthenia 77 
gravis and:.it 'Was .considered'/possible ' /that'/the cytolytic••
: ■ effect ' might ' " have' -an’.'immunoOlgi<;al 'bkkUe-(Simpson."X96Q* . ,
: • Chapter 13 5* ".Mas'tUk and his ' colleagues' ''"made a similar /•
7 dedubtioh /from -their /experimental' O^is'^’r.V^itl^oh without/■''" '" -
being/aware of/wy .olini/ai' data ' '-and•''••their .subsequent- • - 
observations' supporting' / the concept have been described
• In Chapter :i3:< ' ’.- . ''•/./ •
' •' ' . At ' pointedt ---Out -on./pagolS-Ti physiologicalp'-
and pharmacological'-.data’ 'hithertd''' available on myasthenia 
■gwvis 'Can/be- accounted 'for. -'Oh-. any -of -blue previow- concept'
.tho/Msease... / ,A .permanent.-abnmormlity.' 'of; en’4*pXat'.- --. ■ ■’. 
structure' 'oentld ' however p - be " difficult . - - to.- -reconcile with -- .
, the taclliiatiph. of fee iks,. previously.■•described- during... and .
. after -a ..tetanus*-<•" Tier'Ore ,tHtf©e.'Mi»iwl>fabts 'which .
•must - be ■.Included'': in -any ' explanation'of the-pathological ' - 
.mechanism* . JTese'/.ar'-^iV-The ...'correlation -with- ■' ' •. /*'' • 
.abnormal!ties, .o f '.the ' - thymus-'.-(H )'.the- charaeteristic “%
-■long. Or. short*term remission' and -'equally''sudden .-.relapses5' '
. ■'(ii3.i'.iH.^':;^iroH'ai^i^-i^yy..-o'f - transplaoahtaX’- irlnefer/o^ a . ' • ;
■ _ fact pr/Cpuping. temporary 'm3^c^^g^thl.l^:i.^'.i0^a-i^o<tt,tt*♦• ■./To.-this 7 
-■'^'n^tflbl;idded';‘the ^'subjB'ta^^-ti^^^Lly./negz^’ti^^v^e/'resil^^^^ispof ’'.cross* - 
trans fusion' ' experiments. -to . . human ' beings and onimuls'*-. ' p I ■ '- ' 
have . ...suggested from - a' consideration of . the . clinical and 
•pat.hoipgic'.aL.'-41X1 '- that all ' •'of.these. .could -be accounted - for
• by. postuiatlhg./'that /the'..thymus -Is ;p .r e tlCuloondotheiipi7.'/-
' - organ .directly 'or. indireclXy .mediating, .-the. .production^ of.'' - -
• antibodies '..’(Simpson'/ l96%*i"-lhdb0hapter'''Xl5  '«• -•ffl^'•.■.•.;:•7 • '
anti^i^ody'‘Co^^JLd-"t^^^:f^C^3^med '.ngnin^-tbe'.receptor, protein': ?• •,
of - the muscle' - endrpini'its molecular. configuration ' might ? 
be presumed'. ' to. resembl'acetyl'choline/ since'- both would.-.--- , ■
be 'mirror;' images .'Of - the.,' receptor' 'ufape' -A molecule. .•
' .of - 'this - type would -be: -a- very- -effective' blocking' agent-. ■ / ■
- of '■ oomp) 1it! vo ' type */,'Furtho rmore - It ' would - be ' - -pra.c .tically .' 
/specific- for-the'-' individual*■/The. charico^' .of . -traps fusing ''
- blood'' 'containing; -the' ••’antibody- Into.-'anpther. 'person. 'or '..-, '
'- ,..'^.nColl^^^l;^^^^'^^h’'■immUlolL^(^3-calLy -identical'protein' structure .-
- would/ -"•''- /'■ .-./. ' '•./.;. . .////'■. '" ;■ _ . '
 ;26o.
.•.00511^1';^© very-©mall*’ The- proibalbiilty /would,-.. however$ . ’
be greater in the •case -of mother ' and. child# - The ' . ..= .,
•persistence ; of neonatal •./myasthenia ’• for six- ' weeks would' I '' • 
'require , a• myasthenic• 'toxin i . 'to haye q;-large- molocule’ . - . '
or to - be - bound -to tissues,. and only slowly degraded .or • 
•excreted*h. An 'antibody globulin • would ..fit.-this; -' i- .. ,
' specification ..very well-':'(Bimpso»,^' 196%* , ' It 'in ; known. ' .
. that; the Substance© r eapoi^siblo'/for; causing ._the I,#B# cell.
. phenomenon- and the . antinuclear--factorfare' capable of ; •. •
crooming the. placental barrier-aa'd' persisting* in ' the •«• /. . 
infant’©-- blood for '-a short period.. (Beck and .Howell/' -I96$)• ' 
.'The ahtlbodiee studied /by ' these authors • had a hatf-Iife 
. in the infant rs eixouuatibn of --17*5 -days* . This would '/ 
•correspond very -well, with,.'the 'duration .of ’-neonatali■ // ; '•’ ' 
myasthenia. since, the .destl^tic'ta^on/eL^'iu‘i'hatibh;'curve .■•is . • ' 
exponential* 1 •■ - • ' .-: '•- -Y . ,‘-- a/---" . . 1 . • ' -
• The idea just -described.is not, of •course»Ythe• .
only possible . Imunoolgical -mechanism,• .- As was pointed .. 
out in the original papor . antibodies' Could be ■ developed 
against, nor-ve' .’endings $ muscle ’ fibros'/hand. other• organs ' ■''. . 
including .occasionally 'the ceutral nervous ’system j- in'’’ ” 
close .analogy' with systemic lupus ex,yfbib^mrtbsus and ’ , :
dermatommyoitis# Indeed this ■ -must .‘follow' from .•the. / . ‘
fact that-it was the occasional 'involvement .of other? . 
organs which led to ■ the-'hypo thesis* , This-asp.eet has ''•/- •
been discussed • in Chapter 1l but. it .is ' now appropriate ' . 
to. point'' out, that ;.the -persistent failure to demonstrate ’ " 
an'timmacio .antibodies except "tin the ’.•^sresoncq 'of 'a. Y-'
•thymic,.turnom' '.(and■ then, only antibodies ’against muscle . 
fibrey not /the end’hplate©) and ''.the increasing/ •evidence /.-•-' 
for a ■pre-synaptio disturbance as . veil as .a -K^T^sct^^^f^i^^^/one
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tomWiWf&.ssi'mmito -Coee'■XChptnr X$% " ' " . <: •/••
V Y'YVv'. •' -A
; '■BiaGhoois*^ ; ‘ •
■ "••• ’ Bhe diagnosis' of myasthenia gravis may 'be - ' •><- •- , .•• 
confirmed -by . uaingTphyyiaXogi'aai and - pharmacologgcal 
tests based bn}the mechanisms described in the' last 
ichapter# A brief " aeobnnt of treatment is also desirable '
because certain aspects of the response to . treatment’: reflect 
on - these mechanisms# ' In addition,* some' understanding of
the nature of drug action in the' myasthenic- patient is 
necessary " ab ' ah introduction to the -final chapter ' on the 
cause -of - death ih: myasthenia gravis,.- ' %' ' . • // ' ' -
The ;m>ottimporrtaat test for:, the '-confirmation -.of a " - 
‘ provisional diagnosis of-myasthenia ' gx-pvls - is/ the .demons tra tion: 
. that a' • muscle’ 'or.-gronplof--muscles becomes' weak’- -at /an ■ . -
■ abnormally" oarly time: when contraction -against -. resistance •. , 
ih’/ppintained or repeated without • rest # /,- - The - importance - -• of • . . 
continuing- the:--ebatractlon-f  op- an .adeqpato -period’'-" of time - ;.
cannot-: be -overomppasised -COhapter .3) *.-*,• - ''Sustained - /contraction , 
for one - minute -is •usually..-' ;pu ffic lent {.’but- repeated intermittent 
contraction - (pig* crossing and re^ax'oseing .the •’Tegs-).- pay have 
pto/-be;eprtinued;'-£br-.3.*5’-'-minutes,; ' :,. \ -
. - -i If -the .physical- examination is'carried out, "in this • 
way, "- the - diagnosis -is rarely'- in- doubt* .’.-It should- always" be . 
suspected- when a .p&tient complains of a ■-symptom - which could , 
be accounted for by -muscular-,'-weakness, - ,e*g* double " vision,- .
dysphagiai/li-dyspnoea, or - .wesamees'of a" .limb. These 'symptoms’ ' '
'Pay. .be .greater*, - towards-/the end of .'the day but this .is not a /.-’. 
constant-feature* - ... Indeed surprisingly - -few patients remark 
on it until -specific ally-poked to- 'copment on it*.. / V ■
-’ ' ■ ■ . D ff e r anti al - -' Diagnosis * -■ . -./ ” - ;
 The '.differential diagnosis' of myasthenia includes
the following conditions (Simpson, 196^b),
1. The symptomatic myasthenias; Derraatomyositis,
polymyositis^ systemic lupus erythematosus, carcinomatous 
myasthenia and disorders of the lower motor neurone have 
been discussed:in Chapter 9. Here there is a,true 
myasthenia and the problem is to recognise its relationship 
to myopathy, neuropathy or cancer. :-Relative sparing of 
cranial muscles, diminution or abolition of tendon jerks $ 
(especially in the lower limbs), and poor or temporary 
response to neostigmine may. be important clues#
2. Non-myas thenic condltlons are rarely diagnosed,as
. myasthenia .gravis but this mistake may be. made when, muscular 
diseaseis associated with a complaint of abnormal tiredness. 
Polymyositisj thyreotoxic myopathy,-myxoedema axid .Addison’s.,- 
disease are the most common diseases in which this'mistake
, is made. , figure I?, 1 illustrates .si myxoedematous -patient 
wi th ptosis simulating. myas the nia gravis .•, Parkinsonism 
may be. a cause of progressive weakness oi repeated movement*. 
’Pseudoptosis* (Chapter 9) and the congenital syndromes with 
facial and extraocular palsies including congenital ptosis, 
ocular myopathy and.the von Graefe-Moebius syndrome are the 
most difficult disorders to differentiate from myasthenia 
gravis. It is in this group that the special diagnostic 
tests are often required. There should be little difficulty 
in recognising motor neurone disease or polyneuritis but 
intermittent paresis caused by ^vertebro-basilar insufficiency 
and hypokalaemic states, familial periodic paralysis, 
paroxysmal myoglobinuria and craft palsies may occasionally . 
cause difficulty to the inexperienced.. .
■3'# ■ ■ W°hg diagnosis; ■- It is much -more' common, for’ true • 
myasthenia gravis to be overlooked. It is commonly mistaken
■ ' • 26A. -
for hysteria because it is so often precipitated by
emotional disturbances, and physical signs may be .absent 
, if the patient 'has. rested before examination. The
intermittent nature of the symptoms and the frequent 
occurrence of diplopia and dysarthria or other bulbar 
symptoms may suggest multiple sclerosis or vertebro­
basilar insufficiency. The mistake in diagnosis, .which 
is unfortunately the experience of the majority of 
myasthenic patients, never persists once a doctor has 
considered myasthenia gravis as a possible diagnosis.
" ’. ^er°frffnho e Ton t s♦
:patigue tests appropriate to the various muscle 
groups will readily suggest themselves and it is important 
to test all. muscles in this way before classifying a case • 
of myasthenia as •localised’-..'Performance tests xare 
conveniently coupled,with pharmacological tests and it io 
then valuable to have an objective record of the test since 
subjective appreciation by: tho patient is often misleading.
ffrgographic • and r<adiological;
The. decrementing muscular response to maximum 
effort' may be demonstrated by means of ah ergo graph. This 
is, a useful adjunct . to. some of' the pharmacological tests’.
A simple ergo graph I’ecording on a kymograph drum. can. often 
be improvised. I have found this valuable ill the regulation 
of treatment (vide infra);* , .
• Eadidgraphib screening, of diaphragmatic, movement 
during respiration ox* of & ’barium swallow1 before and after 
anticholinesterase medication is valuable in the diagnosis 
of myasthenic dyspnoea or dysphagia (Viets, 19^7).
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ergographib ■.recording, have: the' 'disadvantag© that jit. bi '/■ • .• 
■musthe' pre.aumed; that’-the. patient 1© -continuing to maiie}-/' / ' 
maximum voluntary-effort/throughout.the-fcst* - •Many ’• ' 
.patient^ .with' Parkinsonism■ will show,■ -progressive 'fatigue* .-■ 
■yr-hii--. test*:.For•••• this■ •-reason.- th< Jolly - and - Harvey-Maalana- 
beeta/have the -advantage--of ■objectivity. - v-. ' f- ,. ' ;•
pff — /
f. .7 < '' Conventional . needle' .electromyography is rarely of f - 
■•diagnostic, value . because - Of - --the - difficulty ’of ensuring ' - 
,sustained, voluntary effort* -Myopathic motor .units may he - 
' found ;?in - 'oxcoaO* b' . The • -pattern is ■•’described - 'and..illustrated ' 
in Chapter -15* •.•'•■•bff’ • • "' • , •. ,
'Stimul-atiGn^reopenBe 'toata i'•. - • .- '' - -
; ;?'V " . *he •'teat “'originally described „hy .Jolly (1895) 'Is ' 
•still; &> valuable■ .'.ohef •/'-;'A;®otGr,-Mervc "hr BhP meobeif point b a - 
of a musclO ■Is stimulated■ "at -rates Ofh3*;s6/s©bohd with.an .
alternating ■'electric 'current..■(• 'farodism.’.).' oi" 0.01?1*0 msec*,
pulaes.'of shape' iaaunimportant )'* - ' /Tie ' f
'stimulus ‘-muat/be;' 'tO; ensure. motor- \a.
m'erve:. fibr.©to ..the observed .muscle .•ia.-.stimulated by. -each.. 
pulse of current.- ' .\The' rOsul’ting . contraction of .muscleY '
•rapidly 'leasena. ■but:; .reappears' aftorba/.abort. rest* •..•'.Tbis-'.iB - 
?thO.*■'-myasthenic ,-reacii^nt:i .When ’no,.-'further -.•contraction - . • 
is- visihle/.a • long' pulse. ofbhurrent ( ••galvanismt, a..pulse. ./■' ■' 
•exceedigg'XOOraso© .in .duration) -appli.eV■di^ectly■ to. .the " • 
Yu^mcl€^...3L3l^me^ledltt^:ly produces -a'full ''contraction. and .thia - /.
■can,ho /repeated -inddefnitoly,indicating that"-the .loss '.of ‘ 
con'traptiow witch the .' nerve . is' •stimulated.-is. not, due to . - - 
failLur^e?of 'the. ability..of th’e.muoc 1e ..fibre, to respond . to ban 
adequate/,a timnlu's aapplied' peripheral? - to the- mo tor. emd*--plat©• 
Simultaneous/ , •'• '• . -f. b:f . f;-f ■'' ' ' . '
;?\7266.
. Simultaneous " recording, ' of" the -nerve/action potential.' _
conducted - retrogradely ' to' ' the ' . olhdw " demen©o"ratos - that - all, 
herye flbyeo continue to /produce normal action potentials .
•In reoponae -to each - -.stimulus (AlajoUanine" et al* -1959)#
'■'* - ' "■ '-."The ,tost uaed- by .Harvey • and'-'MaslEnd ( 1941 )" "has - . ,•'
been /described, : in. - Chap ter 15 * It ' is -essentially " similar
but uses the - surface" action - potential of the muscle - as an 
index - of/,response. This - is an - integration--of the individual -
muscle - fibre potentials" which - are evoked - -/synchronously#
The? - area - "of " integrated action - potential -is directly " i"/' ,
proportional to - the twitch tension and - ite/amplitude'"-is." . " 
very - nearly so if "certain " precautions are - taken* Bo-telho
( 1955 )" has claimed "/that- '.-tension" may. decrease " without - : ?
corresponding' " change of action potential but" no " other* ' ...
""investigator - .agrees -id/th this - (Deamet,- 1961 ). . •A positive" , .■ 
"Jolly or " - B&rvey-M&siahd'tOst j ..if properly" carried] out, "is ' 
unequivocal evidence - of a' " myasthenic reaction " but " does" not- 
necessarily "indicate myasthenia gravis'- (see Chapter/9)t- -.1f».i 
hoWsver» the decrementing /response/is /abolished .-/by- -injection 
of edrophonium, -the" diagnosis" is - certain,/’ -/ ".-/'-'/'. / u "77
h "'•'/';p. ' -/'A more ..difficult problem is the -Interpretation " of a' " .
negative .response' when the. clinic al his toby " suggests --< ;/ ■-,/
bmyhsthcmia. " gravis*"?' A® pointed out - in -'Chapter 3»"’the " "ddstal 
'-parts/of the "'linibstare often;, spared - ' by "-the 'disease - "lyyeit" ls .
just" ' these. -•. muscles"/which - have - the- most .readily- 4ccees&bie;?:/ /
motor ’ her'yes./ "7 some times/an apparent-*'- negative 'response-'.- 
becomes.- positive " after - several- -repetitions "at ' short intervals/"
( Fig. - - 13 ) - or after, "strohg - maintained "voluntary - cohti%c tion 
.of - the .muscles"-being tested. - In ''‘somf/m©©'^'©.^" slowly
repeated ' stimulus ""causes. "a -my asthenic " "response- --but - "a; - 'fast . ■
tetanisa'tioh evoke© a progx*essively’incr.eaeongir'gfpons-et/n //"- 
This/ ' ' ///'•/" "7//’// ' ? // /bl/-^',/’ 7'""--//.;■ - ■ "
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This incrementing type of r©actio®'m&y-'be the onlyv..A,■ /
abnormality..-presont* 1 have the ' 'impression that ■ it is
'most ■ -often.. seen in'•which, 'showf■ '*eM:s’t&neeV to"' A 
•deaimeihonittm#-'''; 1t';is'''seen'ih..its.tiesl/-dramatic,form7,in , '■■ ,
•Carcinomatous myasthenia (Chapter ’ 9') hut . ,at so occurs in 
.polymyositis (Simpson, ' 1960b) *•/, , ' •• ' ?; ■ - ’• • '•• ..
_.//:A A: The; circumfl ex nerve . --may be used' /to ■ stimulate .the ■ . .' • ? 
•deltoid■ -muscle or . theyfaciai nerve' to■stimulate the. 
:orbiClUiaril.. ocull .(Bqtelho . at ■ al, 1952) but ■ 1t is difficult 
to obtain satisfactorily integrated ■ action•potentials from 
these- mhssies* Birectobservation- By the. Jolly ■ technique
•may’ be ’ more satisfactory'■ for ' - tho •proxifflai/miusc 1 Bi/which ' are ■ a >• 
so commonly ■affected, -.>••: /. ■■/..;■ /
./ •/ . i %/ The Jolly a'h&i;K&avey*JMsland teBtsymay conveniently ' 
be "supplemented /byj'■phafm^lc^l<^^^^g^<Ca•l' tests* , ,
. Pharmacological. ■ Tests* ; i ’ . A/y ' •• .• , •' ■'
• ■, .'/..-."The most ■,widely . used; ’bests are', those ■ involving .a ,
.therapeutic ■ response to anticholinesteras e■ ■ .drugs, cqhfirming■ 
that ' weoaknell is -of •myae'th©nic- type * Conversely,' - inc reused,
sensitivity' to',■ /curare .and similar/: . substances /may.;be iise'd/to •-// 
detect ■ latent myasthenia* - This group of teste . will be 
'describe'd■ first* / ‘ They' are- ’dangerous' and shouid- hot be used 
where ’ performance ettaa/ka-./.or' therapeutic'/.tests indicate ' the 
diagnosis* Their . use^■ should be..' confined to, cases. who give ■
a'Classical history ' suggestive, of myasih6nia/gravis ■ but . who ■ 
are', .-in remission ■ at the <^;^me of ' examination or ■ who do not 
•show convincing .'fatiguability.* (Simpson, 1964b) * ,1 ■ have
never*, required / a. curare ' . .dr ■ quinine test to. os. tabiish■ •/the' p
diagnosis, of ■ myasthenia■ gravis'/and■ . on /tho .rure .‘occasions . 1 ’’ 
’.have./used ■ them to investigate a ■/.’possible '.’ case. without' . ' 
satisfactory/' .,■ ',"/./■■ 7. - .'- '• ,-.. A ’ -.--.A- A' , .•, :
  
y'sati8fac/td.ry ^tberapeuti'c .•response the results have '• .. ..’.<• '. .
’ ,.invarimbly' been: hbrm&X*'■ '' '"-if•• -they " ■!©:. bopsiVered/needssary-, . '
y - ail/niedicatiQh\70.th' VVnliiobQlinBstereTierdrags^shbmXd; bo .. ■. - ' L '.
- r withdrawn f0r-:,;£4' /howrs IFwilxties l.or . artificial! ' -...
/■. •/ respiration' ': and: ■ syringe# . / loaded - with edrophonium.• "(XOmg* )"•'.' • ■/ ,
arid /neostigmine " (X#$rmg#)7 " should." be/prepared before' carrying. y‘ • 
‘ ;• out 'theytest*'• Since -a'-dangerous'"- te#.t ..'should " hot ji>e -yl ' ' • ‘
y,q repeaitd/withbut' good: reason -it/ is /desirable .’to .use' ari , y/
, obj eo tiLve. Method of rooordihga response » such' as; ■ .the' \
• . ' • H^3rV©y.-M^a^3Land-''tes\^;.br " an'ergographic "trace* - j"""y, ' ; 7" •' ' ■ ' ■ '.
- •' iroyocalive te#ts.r, b’/ ■ . .;y*;. y ,7 . '. ■ ' • ■ !y : by ;
Curare Test* The curarisihg./ddse' for normal .individuals ■
. is; -taken.a# 3mg*'yd^, tubocurarin© .'intravenously •• per 401b.: of .
■ ' -body/wight ly '^h® #uspec tod rny^^aS thenic patient is • given y', y 
■ ' . 2;-per’!'cent 'pf"yth.o'/•Pnjpmalqehraiisin g."dps.e and- obs©ryed". '-for '••'•”•' ■• •' 
.-. .jr^miiutes*... • ..lf..nofvWakW#s appears 'in /'that. time,;'’.5 ,per t .■ y
centbof.the' estimated normal cur arisingdose ia injected .
. ' (Bennett and qOush*. 1943)' • Bigger . doses .of 'curare. should' ' .
, . not . bo 'used, ;as" mudo le;Weaknes a.may.o c cun .in' s bme ■' normal" .
.'• ects . Witil", the- io /pop; cent ' dose '".'originally"■ recommended*;. 7 -
.7 Pelikan"" ot . ai (1953)" have " questioned the reliability . of the 
curare .'teat' by ".finding that;, some myasthenic .patients have.a .
y normal "‘s.ensi" tivity /toyfcho /.drug. while.'some " normal subjects.•' •' /.
. arc, .exsep.tionally 'sensitive*. .•-. .. ... ■
7 ’ -Quinine" ■■ffeat*/' './Quinine . bisulph&te-:0»65gi. (lOgy* ) .' 2-ho.urly .
' .by- .'mouth' to ' ..a" ••jmeaxd^^mum'; of three ' doses* 'maylbeeused-to' . -. ;; 
'/".'.precipitate.. Wedaies#''’in suspected myasthenic's (Eaton* 1943)*
In this , dose* '-■no / neuroikus c ulnr-lfef iec t> can""/be detected- in- '.d. ■ •
. .normal' individuals . 'but/, myastheinies may" •become;very' weak." " / . \
, This' may •-.•be. dangerous - .as-,the . paralysis cannot be reversed - "
■ by antic holine.s t erase, ""drugs* ■' '' ./' ' - . .1 . -• - - ••', .
Becamethonium/ '-7 -7 •-,7./-/. . - •-. •' ..y,y>-; ' , ' / . - 's !■! iijUiiw H.nu-aii. . . ’ . ' . , • - , f
DeemnetHonlniu -.-Test # '-The- hasi-e ' for this- .'tost' -is -..the'"'-;**-''-.' - ' '' • 
‘abnormal-/reoponso - of -myyOfche'nic--.muscle; - to this. "and- - other ' . v
de polarising; drugs which diao - b©en?;&'o'scribe& - in - bhaptor'' 16,f ' 
As reported. by ' 0hh.irchiXl«Davids6n - and Mehardaon (1952&1,. 
patients .with- ■. myasthenia - gravis" tolerate an 'nh’u^^ii' large ' 
dose . of -dreeamethohinm*' ., • ■ T^hLs. test-is -, also; perf orbed-after 
iwthdrawal-of gnfci'ohoiinOe’teraee'- drugs "for 2S - .hours#-* 
ieo&methonium - - iodide"is -injected - intravenously in ah - J 
initial, dobe-of-.,1 *9ls^s#:-i'?"Fou3^: minutes'later '0>9w»;.L-S ■ ■' -
in jpo ted- - and - this--dose ’is-repeated; at 2; minute - intervals "■ ' ' 
until m^ss^l.e -weakness - is - seen or - there-is -a- drop in - the - 
muscle action-potentlal'evoked 'thy - .suprfnti&xiffiipl - nerved' .. ■ -
stimulation-at- 10 per - second- when-tested -every' 'half minute" 
in normal, subj ec ts the -bi0elf.eauscd-by a - depolarising- drug - 
is non-decremenfal- and is-; potentiated- by -- neostigmine/i but • 1 
- ih - the - myna thenic - subject * th'e - depolarisation- -block sis'- brief: 
-and followed by - a - longer "co^noStLti^V^e-■-(‘Clrax^e^*^i^^e- )j type- - of 
block- ..(Idual 'rS;spl-seL-)♦- (Fig, '17,2)', . ■ ,
' <11".dd\'ho;t, use- this test, except- for probable, -cases -
of .-©0otigmiLieOr,esSsta'^b'-mya'sth’enia'- gravis# . - -On*m0s't'"-of ; • . 
these; occasions--thewf«"*§£• hast- bpOh .valuable j - a poefMve<oi". 
negmyh result being -.sub'se^^t^i^^^ly- confirmed by the - course , 
of - events* - . "Difficulty in - interpretaioon:- has occurred when 
/(partial- resistance^ ."has;- been epopuhterec# ; -i • haye" seen ■;- "
-■ three-;or--'four " cases- "in ••whom- .-the "<fall -in- ’-.the- action; potential-■•• 
was - 50“6O% - of. the " normal - - fail - with , the - appropriate " .-dose'* ' ; , 
Xp.each - ..of- theaO;^^^^<^ss. the true -diagnosis remains in doubt; 
(see' Chapter; 81 if. .■They- are .certainly."not" ’declared* ■ •’ ■ —
mya®thertiqs* ,-Gh urohillbpavidson and -ii-chardson- (3*9*61)- state 
that they have"- never - found - abnormal - tolexaunc e - in " any " o ther - 
neurbmuscular --condition than myasthenia; gravis* ' - m*. . - -
.. ^Therap^utio^teat^:;"^^_ ■' . — 1 /• -'I/cia;-' _ .■
, -Bdydplionfwa/ &ntimyasthenio'v /"'.--'' ■ ■' "g,
•. effect of ;edroph^inL’wak^i^3j^^:eid.e /(/ITehmilbn t) 'makes' it "• very ''' / g .■ -.
. . suitable/for .a' 'diagnoS 'tie ' ' testf/i/ A "syringe is' /loaded '-.With ' , . k' ■’
■ .. 1 'mi*' ) . for kj/3^it^:say<5l^^u^fS'’/llljacliO'n:^* Initially ' /Smg,. " i" ■'. /g ••-' ,
••••.•should' be' Inj acted-/to/ldeteot..;abno:rmai-/sensitivity'but if' <;•-' . . ■
'■ the3^^'-:ts'ni^^ir.eeponao;; 'ih&/ 'remaii&nV'Bag'*. is" injected ''after " 7, ' '- '
30.' Bec on ds' ' ( Oss orman' .and -Kaplan 1993)*-X'Within J, to ' 1' •:, • . '
,. minute/'the'Selis h^iprovei^^^^’c,-if /3eekn.ees■," is due ' to ^myasthenia ' ■' •••:
'•' gravis/- but. '-weakness- returns ' in " • 4~5' minutea* ./ /Somo-normai.i-' : , /
subjects '' experience ' no '' obvious' 'efleets, while' ..others' feet ' a ' ,/
/ tight/sensation' around '""the /eyes Sand"-/faso^Lct^'b^T^it'^n^/miy " be'' 1/ -' /'--.I' ;
, seen..-'fox’ /a-few /seconds $ particu^tariy'"in ' -.the '.orbicularis" '■■'/ -. .. 
ocuui*''•-•Adequately treated' -.myssihehic'.'patients' - show j.this ' ;• -
■ normai/ reaction* /'--If,' weakness /.•//./^s-_/3Ldx^/to' /<^l^€^3.d^'n<ex*g:Lc/'^:ri.Sii'. ' ■ -
it ;is / transiently"-i.ncf eSscd -and ' faeeidnlation “ may ' ■ occur # 
'UnforiUh4ieXy/‘respipa,tory •weakhesstmay-' .be'/incr eased' to an ' '
• . '' Tie' positive-responses .described-are ver’y valuable • '
"/ ,and '■ ret^:ti^I5'l'^'/i^naica^^^<>ns of. the'/myaathenic /•syndrome;' when/'"-, ■ • '
• jaS'sessmant, is''-'made »by objective means"-"" """in'-'my 'early-•-'"'/. I / . . 
. .experience of the '.•.test :1 was .disappointed; to find a '"number' ,
? •0f//pp.tieBtS ' ' who were apparently improved .but in '■whom' .•<./• < - -
subsequent " events ..discounted a diagnosis of/: myasthenia '"'gravis * ■
’ -With/ ' further ' experience'/it "'• became" apparent that •’thisywas/due'.' ' /. 
- to'• an "' error.' of ' 'procedure* /'I -In . every, cob'/- of ^a' ."''fa3^l^e;'s^^e^ie;l.ihlv^^^' . •. - 
/ resultthe assessment had been ' based on ' the;■ patient?' report '
of improved ' i^^^^cuU£^t.^-'perfolmrtance. p/gl'/have-’ 'never . had - a" ’faiso '' '
' ./positive®: r’eaction' since/ insisting/"that" the /response ' be" /./ ,/. • - '
.. .' considered negative/ " -uniesS ' there , '/ was' ob j eetive ' i■ipr0voient '' ■ ' '
0f " - some/' pe.rfai"Sance'- "teSt Such as ' the" .'ability to' lOOk" 'upwards :
^-for^Xy-i- X? C- X- f 'X.. / •• '.' v/’"• 1-1/7 - "'■ '<///
'- ;'\X ,'.27K? c ■V’-//-;/. ’ - 'V-A
for’- l/.mlnute ••,.W^'th0ut;?pt^^^^3^,S|,.'aV4^^:ii'’ty to "hold -the ' arms . ' /'<
'■'biftts'ki^tOtJhdcL-.o'foi^,':! ’^ ' mi-rift te g'incr-easedflepgth 'oFspecoh' ■' -- / -.'/;
''or; dysarthria.,' reversal' bf /abnormal. ••• , •, ■- •'' '• ' '//-/;■ 
X&rvey-MaM'and?•electOomiyOgraphio te‘s't’ 'and • 'so •/on,•'. It• • ' '"■ ,
-'iS?"-.essoni^;^.al -••,to ,mea'/riir'<£the' •time'■to-'eXhauistion-’•/.pf '.one •/ -..'./, /
.Pryotrier/group'bf./inuseXes'/be/oire 'the' ••Irij'ec'tioii and • to, -' - / '-/'/■
ro tesb./tk—''/rime''' movement ';.e*£ .Mnute'a-.. • /aftbr--theyiri j ec tion«
' •', It -is • -advisable/• io • ••test at least • - /wo - muscle g^oupp-: : ''•',' • / 
ihythia •' way/lii '.case', of the • -misfortune/ thatfthe: only muscle//'■./■ •- • ' <■ 
' tested is • -'myopathic * •and/ incapable- of /'response to • -an ./ .' •
^ahbiCholihesierasQ drug#' / • Tii's is particularly common /g •\'-"/ ' /' “ 
with - the • eXtraoc.ular .mUssles (Chapter. p) h '/ - ' . '. ,V ' -'./. J. ./,1
■'./ •■ ■ ■/.'/Failure/ .to • obtain'•-improvement•with" the. standard -/-i ' ." .
. dose/does/hot. necessarily' exclude '..the /diagnosis of X t ■•■*-' '■'•l 
/myasthenia-/gravis since the • neuromuscular • block .-may, be ••.) / ., .' -,%• 
.very severe,’ /rGquirigg t;wio'e//:t^h^e.- •.normal; dose, 'v; Conversely, .////
' • the/'norm&l .test :.dose op lOrng*. .may bp//e.xc©piBiy.e /for/"very „ .■'•//"-./..' 
mildly- •/m/yas the ni<x muscles; or during 'remissions, - so ' that • . /; ' . ■/
fapeicul&tiop/.may result*p-i/Bese .'false, negative* results ■ / '...’/-•
/are./more'common 'thaU/hhe/, '/false*-- positive.*• ' ones-'..-if- /due• .regard/ ■ - ■ 
/is • paid• to - the; ■prepahtlph• /about /.obj^^stive"_
- -.///g/./'-Adequately treated cases ef; iyya£h;b niia-gavvis /'wil 1- . /■ gy 
'.show • a-normal/-typ£/;p'O?.re©ponse-;and-Xf the.’.dooe of‘.•-'/' ‘ ••'•/.-. v //..'' / 
•a^rbic.ho;^-ines.terase,/m€^c^i:^^^Otion/-is• eXcO8Sx.ve• there' . may • be ’- 
faspiomatjo'jn • .and tejnp0ior.rily•"increased .weakness*,•: This • is 
due. "to •.•depbiarlsa-tioiv,block‘(Chapter 15)*. /-’Because fof • /this' •.• - //-.. . 
rpnge of• reactions '“if/ .is• /possible'..to ■/use• /the edrephohium• -test' :\.; .' 
to control •the level of dosage • and -in\emergenoy to ,
dlO^J^^^;^^^^3i'ii£^e*ebbeweakness • due . to. myas.theiiia./graviEr','
('myasthenic crisis* )' - and to• bVertreatm^t; with •.anticholinesterase 
"{^l^^^^(^^^^//{•®chQlln:^h?e^^^^<3Cc/^5JsS^.')• ;■■' '.’j^hi^.-s/ use • .of-'/thf .te®t /is/ . . 
further/
Xb/."' ... ,1 <2?-2, '■
fur ther/descxribed in ?19> b ■ f'/f ./--v ,.''•- b'/'b-
Nebgsfrxgmine - ..Test # "•' A'dishd vantage of . the . edrophonium. test •/•. 
is-, "that; the-short " duration. of.the response . ;pfovWeSM'i-ttle , • 
'time •••for' • assessment/’of . the "''changed 'staid,'' if .Ony’* '.J " f'bb / b 
Neostigmine,.' on" 'the . ;.o ^eh'-hahd.-:' has •• .a 'therapeutic ' action. >•. 
•for;';.i^3o'hours.-..or'...'more., 'enabling" /a ’truefb&s cessment! to be ■ • 
m'hdd'y. ''.Though" .the; latency. is . greater, -..'a favourable ' response' 
to - inj ec tion . of.. neostigmine . .remains" . . the most - . convincing . -■' . 
evidence . olbmyaSthe.nla.'.gravis . (Viets . .and " ..SchWaby''.1959')> /
The " duration of.-the' ian ticho linest eras e" activity, ao..., '. ''f' 
favourable ,i|;jn^.t;^£^X;'.^ie^g'jioo3^!g, " .fenders" it 'unsuitable ',.
when .cholinergic.,.crisis bis. suspected*.^bb- - ■/•./. • b' .
• • !>', -./.bTo / perforfb'tbe/ testy.. noobtM^inej "me thylsnlpha te- ox*/ / 
salicylate "bisbinj ec ted .. inf^:^j^muscular3^;^..;(3,5#g^» ) "/alone"/or■.. - .. 
combined.". With' -O6mg;; of'..atropine sulphate*. "/ ' -: Improvement • • / 
bdgins’. in' ib^ig " minutes'""bu t la " moe t/.obv-ioue af ter .30. -minutes 
The' same. . preparation.imay. be . 'used ' intravenously,■ . {-0*'.9mg*" ). 'when 
the/ re sp dhae "/ i s ' ''mo.r e " ' bfapi d' - bu t th e" d ahge r - " df ■ ' v C'ht fi c u lar ’••..' . ' 
fibrillation/or. ary.p^stt 'iu^i;g;i^G^atQS^b', . The .'drug" should .• never , 
be ' giyenuby. - this /route; .-unless; "'accompanied/.or. preceded. ■ ,bby. /•?%•. 
atropine,\b’./-bbb',: m./.i/b ■.•/./.!'< blab'/;';! -'■ a / b'; " " ■ '•
.• ,y./'/Tlr^' /response., to/15mg, - of neostigmine bromide orally
may be sufficient..to' 'make' /thi-/diagnosis; deaf* . - If any "’df.'
,the parenteral . feats; are. /equivocal band";the diagnosis, of b- ' 
.•■yas.fcMbnia.. gravi s-/seems .-highly " probable/ .oh 'ciihicai "/grounds 
/it"is ./Worth.-.carrying'/out" .a" • therapeutic 'trial ..for " a, " week.,-.; ".■■? '
GHAPTSR 18. .■
teamw;''-'
" >■'' v. /I;.-. The -dheeti-ahCbOf ' of ,'mbeWe&I ■treatment ' is ■/'/ ' •'/’ • ,
neon'tl-mine, i It 'restores ''.in'-whooe-or in’-part- 'the "-,"--! " 
.defect'., ' in heurtmmsc'ular; trah^raissioh.';s,o -long, a#-ah ■ . ..
. 'adequate. level of -- the ’drug? is'' meuintSined. in ' the - "f- - i. ’ 
circulation*---’It\ is-.hot' '/therefore a '’radical. fCrmi o£eo•?; 
'.treatment ■ .oid/so 5„to Q.in;^:ldox'ci^r*.oh -WilT be ■ .postponed*: ;■ ' - 
■ITwmbctomv V indications .an’d-mahjagemeju - ,,v"V .-
■ - - ' .Theinutommune hypothesis 'Mil' - ■ have .-served •'Its .--v' •
- purpose ;ap- ■lc^^g--’as&,.t-i^t^feml^^t^e^s hew at' '-'the ' • V,! .' - - -
' nature ,of/:myyhihehi&'grrai's* - Meanwhile -not - /thd;.• -least W 
of' its• ’'attractions .is that.,-'.'for the.;.first' time, it’• 'f .. 
, p'roVides-' a'-rational'- basis.' for . the'• treatment of • the; ■
■ .'disease; by -•thym'eoiqmyX -'ITe- operation•' in' ’ .
-Chapter. 10 '-and in -Appendix 'it* L ' hut it 'will he convenient 
to; summarise ' at ' this, point what I ' now ’consider' to, '.be '-the
, main’ ' in'diG'atieh;s--<fQr-'its Vselah&r' to '-discuss' ' the' post* :: -"- - ■'
•operative management-s- . / - W > ' iW-,i ’•'
■ . - - --.•••. Though' ’ the results may,be ' rather "better in ' women,- 
-than ' .men and. before '-rather, than ■'after--Xo ' yeai*s-. ofi-age,'•- • 
the ' '.most 'important factor' is"-the' duration' of \jmyath©ni'c • ’••'- 
;O$W toms ( Simps oh, ' 1958 ). " Oipratioh - should ’be - ■ of f ered ' -'- = - 
..-to/all patiejit-a with 'a ''history -of less-'than'.'5; years ' ' -
•'unless '-mya'sthen!g ’'i/daknOOO; id- c'on.fi3:e'd,..tQ ' the -extraohular; 
muscles* Apart- from ■ .ihisiXimi tation ' the .severity of ';' the - 
’..disease - is /hot a .signifie ant '-fac tor -in’”'debidlhg- againafc-'/ 
.operation, - Iho- -dmiger Is .-probably '. greatest "in 'paitieht© ' . 
who, ' have, marked' difficulty in swallowing, '' bit ' this gi'-^^p 


















tends to .have . the worst prognosis even without operation#'
. Patients . -who’ do hot come into these ."categories’ should .. be
, operated on if myasthenia is progressing '<&ospito .optimal." 
medical - treatment’ provided ' they are considered likely- to 
' survive the '.opefmtionXb! In' ’ competent .-hands ' / and. with a .. .
modern.skilled anaesthetist’ the operative . risk is very .. 
-low?. In the last eight ■ years in .Edinburgh only 1 ' oase' 
from a . series. of .28. included in .. the present ' work . has .
' died. ’ post*ope'ratively' and she ' was not directly under' 'my ■ ■ .
■ 'care*’/All of these 'patients ; have ' been ■ operated ■ oh! by - •
Mr ■*. Andrew Logan* ' . ■ :
. . ■ '.M’1 Logan. and-I are now convinced that' the- ;
major difficulty .is the .management-tof- drug treatment ' ’;/ 
at -that’time* . It is mm practice to - - maintain'ithe ’.pre* k 
.operative dose - of . anticholinesterase/drug\ until-/the . . 
patient .is in the anaesthetic room* - No further .dose ' is 
then- given ■ until--. the 'operation; is {completed*-' Before : '- 
the patient leaves the operating theatre the - anaesthetist
fully inflates the lungs, aspirates - any .secretion, in , 
the uppGXVX’Csplratopy;,passages.. and '-carries out
bronchoscojpLc suction of the main - bronchi if necessary*
Qhe patient does no t leave - the- ’'operating - room - until good . ■ 
spontaneous - respiration,- is relestabllshed, If inflation
is -'hot - adoquate j ;limmg» of- - neoatlgmine mothyl^ulphato is 
injected - intramuscularly* - • //• ->! ;
.-.On return to: -the 'wmrd an - intratracheal tube .is ’ ■
. maintained in - 'position until - the: putient/is .'com^.cious -and’ 
is obviously free from- ;respiratory distress* - Tie! previous
■ medication , is -. resumed ■ at -' two. hours - ' from -. return to ‘/the ■ /" . -.
ward. - . If possible the. ...tablet-is crushed and; given through
a gastric'- -tube'- but - in. - /sommioases an equivalent - dosage must 
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!> :xn'3&j/be$-xn©MW'iettl&rl^* ,.. X*m*& -of- aeosiigmin©'•• -l : 
orMi? •• ishould -be: repX6e.0%;?x'W-;ts1h: 'Xmg#- \6f • ■inoatigmlne ; by . -
. (-ia ©y-experience ' the- • equivalence, oFiV^mg^ '',..'
, (19?Olie -excessive);-. '■' ... ■
■ ■ f . ; "-Mere !©■ often-a-.reH.arhabXoreMnaion in -.the' 7, ■■.- - 
jfeoure/ime£H;ateiy • ’af t€^r^-:^he^;'opera^io]'i?'7-^i^e ■'maav •’ be -.ae - - s •
■ great-that - a patient- 'who, ba -previetteey,h'&d peraiatent'-' .
/ ■’tOsis-may ahow; tonic the-l'eyelidae. fhia '
-may ber-aeen a©\aeQn\W''the; pati^<^ji^b;'h^ae-3^'^*^<^v^'b:^'^^-f^;^^nii. ' .- - 
'. •the:a^naest^^het^'ia-^n5^d:.m^j^^!:’^Praii3t!f^<^r,/2^^'5-44^ t^%.' TUa .'- - 
. ' bay -be a; thyra trophic.: 'effect •due' - to .-removal' of an • .- -' ' ••.,
■ .-of •.the'-' thymus (Chapter .-12) ’hutvi© \ - -.■-’■/
•■ more’’probably-Mi. indication' of ;^r^cr^^e^@boil-'5?e'apc>rife-a';.-b o..' y;
-/antiohoXineateaaoo ,dung©"1 ■•This is ;a. point which 'Ig?.-2".'’ 
■..•Wah .fc©'-eaphh©ise -&av apart -from 'a - pe'raonal ; contribution 
7 (Simpeop|,--196*tM ib-.-haa’-nob''been/described-.in the;r
■ literature*,' :-.'!'--: . ■- . -" :- ■-'..- . --- -• ,­
1.’: "•' '’ tbrnMiati U’emiiaaiou1’ aftOr-opbratiom bay"- G° • •'••■ '
•. lower- the/.reqttireMenbs for -• /antie^^oliii^jte©ao.©@-m^t^ic^o^^^^^.:i^o^n 
. -that.’the do-ae-';requi>r^e^^:-ih^^:Co;r.e/'Opera^^t:lon,-'iS' no#.'--" "’■"■■"
.<^en^g^ercjoali^-'-eXoess^ye^^^';" -/&&:. obabrv or-uhfamiliari with • Mln-;.­
- h&hard' will • interpret the -'Ihere&eipg.• "eekheoB, -aa- ■>;'•-- -<--',.
. indicative. o:F,jl.;’inyas^1;hen'i^-‘'crlaia when—’ -
'.■-•-^<>.\;7;as^l^’**ia?i^e-d'^^choi^ni^^j^gi-^? . crisis* • -in-which• furtheir:‘
' '• medication m^iy.-b© fatal# iin my -• opinion', '•the -wry-lW; ■-;-,.- '
- m>otesi'ilty ••.post*ep©rati vol? - in my. Edinburgh series- --IgMUe-! - - 
-! to.rec ognition .pf,-this fact. * -Tie ’ ©ingle \‘po®trOpemtiyo -- - 
’ depthipccuurM-lir . a ''childJaged -8 '-{rt-MCB)-.'in 'the •dia? ---' ’p 
,. • following- Opera tion* . 'She • -.was not • • under.- my --carer and- • -. -. - - -
eigne- ‘O'f -impending -cholinprgc.p' /crimisWere*' not - -
, ' until - Ohe hacl, a ' OphWleiOn: -•a^nd died without recovering! ’ ■.-. • 
-•Cinnci€o^umOe©/:: , --.:■-, . •'.•'••■•••••'...- '-- . .-v-a-.'---
j27'6t
' . consciousness/:'-- - •’irTi'; ;
. . The Immediate favourable ■ response to . thymectomy
may persist ■ but. many.. cases ';relapse' a ,' little in the next.
’ few days, requiring.■ adjustment' of .'dosage* , These-' cases? ' ,
, then ■ improve slowly*. It is ■ often three years 'later :
' before ' they ■■■feel really well* : For- this reason . they ■ .
, may -he- ' disappointed ■ at .first bpt- -in-retrospect-/they ■ <i
realise after the passage ■ of .time/ that the 'tide ■turned' /
\ after-the'operation* -V . .•.- .?•..■'' ■■■■ .. ??.'••''••■■
... .... . The, less favourable; response;' to thymectomy/■ for . , ' ,
a ■thymic tumour ■ is described in" Chapter 10; .Even ■ after / , 
thymectomy two oxrk of'.three ■ cases ■die 'within five -years*
..//.Nevertheless'' the' survivors "may -benefit ■ 'io-the ■ same . ' ■? : •
. extent -.as., the non-*tumour■ cases .-Odiapter'iO and ■ AApondix'cOi 
This may happen ■ .even without pre-operative. ■ radio therapy - 
(Simpsont. 1958')* . ... : .• ?•'. . !
.. Radio therapy r'/- ' - . •' '?'■ T;'i ?'.;:/''••-/• \ ? f ,■ .•
' -'••• . The...'desirrbillty; of radiotherapy for thymic ' ?"■ .
tumour ■ was stressed by Keynes (1955) ;hut I feel that . 
this requires ■• substantia tlon*. , I.t has ■ . also been ■ used■ ,,
. sporadically for. thelnonrne'oplastlcithymus in the :' .. .
. treatment of. myasthenia gravis?? ■ : My experience /of i , ? - , .
this method is restricted■ to observation of five, patients .
.. ’ unds# -the ■ ..care•'•of .other, physicians-' so -i shall, .not■ comment ■'•■• . 
'.'extensively on it* Grob (1953) ■ reported ..definite-but
rather ■ disappointing,, improvement ,,ih. kO%■ of cases, and ■’ ■
•: Oaseman - (195B) noted ■improvement in /.almost ‘one- half *.’•'•'."•/••. , 
(his figures do ■ not', give the independent results for- the ,
34 non-tumour■ and 20..' thymoma cases) • ■ ."There is. a distinct 
danger■ of teiaporarily/.increased /weakness/Jones et./'.aX'; ' 1955). ■■
, and this contraindicates ■ its .-use in.the patient ■•who is 
. • 'unfit/ ' .. .. •.. ’• '-' ; '
'unfit?'..fof .-TM beheflt7doe£/ not •.appeal- .' to
be ■'eomp&r&bX# /'with: thio' results;'of ■thymoetpmy/ •>' • mere-- '- 7t 
coftnin...way '-of activity.■ ef 'thef ,77
thymus ’■/ ’•?.'• •• '. 7 7, ,--. 7 h/ ?. •'••- .'/
/en'ervation7of the■•.qarotid sinus'iv -7 '•' ."
Mffilwia I.r'il III J,1|I wniii.)ii>wi»wi<iFwyn’iiKuiHii'tim’iWww.^l'in • ’ . A . < . ' •' ►- ' • •• • " -.'
'•h ■■ '7In. view 'of. 'the early /-fav6upablXG' • .reports/.of-'an.-7.: - 
a»t;i*my<aS$henio' -action' .-of Oorticofrophin/and-' some.V - •r ■ 
evidence, from • .? -••; '
hypertrophy eecup.e<d?aafer,..Mlaieraiidenarrvahibn..-o.f ..' ;7\ 
atebrotlid;-' sinus, ■ narriefl -:oiUj;.tbia. •
operation7on. .1954).» > 77. ? .•
The' . favourable •. ’Of £oot7eldlmid■-is;;hQC tseen-.'fen .about 7a. •,7. 7 
yearf 7'Mortons'•(1955)7was /not- impressed; with" -bis .results*
,-hXrepO’ration hastnot■.’fbund,'jtsa^vuu7t^ince ' • improvement '' 7 •■'7, 
-( if.indeed -it-'isiai tribu table. to - thie-operation ) -. is' • -' '/.• 
•bpp^ehtiy. inferior .' to" that •following, .'thymeotomy# 7711 ' : 
'doest; ‘not-. Seem- -rational tpr-seek 7Si'pc>phy'/of ■ 'the 'thymus/hy'-.■■ 
aueirah'indirect-method when' thyfflec?Bom7ii3"--such’ a safe'N- 
operation,- ini experienced-hands (gimpeon;-:..11.64$; ; ;;/'7- ./';•,-.
. 7 Mdi e eabnenf*'' -''
. 7,"'. <4/ brief aocou^it . of this form'.'oi ..treatment. 'will 
be- . given'-at /this7point/because- any" benefit obtained. is 
likely to -'be 'dub " to "'-suppression ' of; " thymic? and-/ .. ' . •' '.--•' 
; reticuloeridO tMXitX ’fuactiohv''of to- some70ther . ahti-T. - -
imtouin>X0igical-.i.^mi54naism'*'' ' Torda ■'/and-Wolff . XX951-)'•frepp^ted 
.remissionsoff'myasshhnia7fdl,lowing''the use -of. ...'. t -. '• -s■
.?^^^’r«^^c^^<^.o^.i^:^<a'^.tp^c^J^lnin' { GTH) . - but .thet-drug is' now .rarely ,'■ 
'prescribed "because/ /initial' deterlorationis .- e0mm<oa'and.' 
may-: be".fatai (Gob’ b wf■ Harvey*; 1952) .-fad; .'the/ favourable •• 
'response'- ''may,.hot . oocur/;until;the-. drug > 3^si^;l!thi^/awnl;. .-. .7. •' 
•(Mesterherg/ ’ ••'-<y ;f Tf. /-i'•-y";■;, 'f :?f >777;-" 7 •7yyyf<. 7
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(Wes'fcerbex*g and Magee, 1955)* Cortisone and its 
derivatives are much less effective■and have no place 
in practical therapeutics*
Xn 195—w-53 1 gave ACTH ox* Cortisone to 4 cases . 
of myasthenia under the care ■ of Sir John McBee and ■
Dr# J#B* Gfqrlor 'in the Western Xhfi^iary^•Glacc0W• The
results were not impressive# No ©cvcrc deterioration 
was soon hut it was confirmed that the .patients felt 
better* after withdrawal of the drug* , .Tho hormones were 
given as.thie initial fora of treatment* Wien this was
•followed ■ by the orthodox treatment■ with ■ neostigmine there 
was no doubt that ■ the previous hcrmcttL treatment was 
inferior so I have abandoned ’its use* Neverriatilesm,■ the
Initial deterioratilon and ■subsequent improvement may bo 
considered to support the autoimmune ’ hypothesis ’ (Simpson, 
196000) ■ ' . ' .
improvement in their case* .Thxs
followed up*
Dialysis
Antiroticul&r cytotoxic serum: — ..
In viovf Cf the autoimmune’ aspects of Kiyadhc^h.a
gravis it is neceissary ■ to,'record the use. of BogomooQCs 
*ahti^otic^lltr cytotoxic serum’ in one case of myasthenia 
gravis by „ Btseaino and Re&i (1952)* Though used vithout
awareness ■ of the theoretical justification they claimed 
claimJias never been .
al (I960) that Improvement 
after dialysis■ -requires
The report by Stricker et 
in the myasthenic state may occur
ecnfiri&tlcn in view of the beneficial.effect of physical 
rest and ■ a hopeful■ therapeutic atmosphere* It is unlikely
that sufficient antibody would bo lost by dialysis to 
make a material difference*
Anttchooinestcrase/
■■V'V;,, .. / V 279» /7"; 7„////. 7:, •,.••• ■
.An^iajhOiineafeeraB^-.<drugs s' -7.'.7. , 77y77 7> A //7/7-' •' . ..■ -"7///
. 7 7Subshmnceswe. - .r-7
BtiXl-ihe7O>8i7usefuX^dru® ■ in, jreaafc«e»fc<<~ 'Even /after/ '•; (. 77/' 
<ihymeet0my"m$si' paf^:ieJ^'^eA^^%nire;'t^^o take--them/for- a77/,: ./7 7' 
/eriod. 'but ' ib/is' desrrable to -reduce'the dose' slowly 7 -
-but .' tsaeiaHly f ? ' 7 Many. patient!-.; 'are .unTWXling to '- give' ' up • ■ // -7.7 ? ?/ 
the' -drug 'they ■ .have' oome ' ; tP7depeh& on /but ’’■ 37have- ...the /./' /'•;• -. -
'iimreeMon .-that' -/it -•lojag^term /proggipsie .is -best . ibr.7m- . '■"/ .-
thaae.'’who/are' gradually. ableVto'.Wi-t^h^ct3^i^w7m<jc^d^<^^iati^c^x^.<.■•'..'.? 7/ -
(aimpsonv 1964X*/ - /T-have » 'On/’the/oh-hex7han<7 no -evidence/ /./- : 
to /a^pp^or?-^-Ha^^^e:y^,-(:9^iSI)^;/i^i^: til;^;iop^i^nio^;-t^£t.j the. use' /of..-.: 
n€^0JStxgi!nL3iej;?pi*c^^ee3a,tiSji*eis:ief3ieii^7"'^'/;.. 7,/^r 77'7-?/:77/ -7 •■ /•
-.7'7?7 /; ; M0^r^y^/'//P^3^tsnt£s'^^3*e';;^<^£^ik/^^eat^€^a.. by .■ m<jclic^c^l^?/)ma^jag3'j'"..77;-' 
andTthe 'reap'orise.in ;'.ttatt'Oi3^V-<V!^i^3^;i^3r€^l^;ifyihg'- ■ Mevvptheles'Si / • 
even 'the/response/is; rarelyccorapiet-Gend/ 7
the. '/exbraoettiarvttuaciea;in particular;.:of ten /cease /fo- ' respond * 
no - 'doubty&ue/to-the^deveXbpment/. cf.myopstiic.,.caagges/- ' '■' 7'7 '7 
;CKeyneSi’3^#^55')<7 "7'%;-!/. -''7/7- 77 .te;//77 7"’ 7 ./ 7 777!777-‘ 7 
77 Various 'drugs.-'-Mth. anticholinesterase-activit/--/ ' ’• :
.ape /available* Thia; /activity -"is attributed ;to tb'e/t/’ ■ ./•.;'■
/carbamate'- grouping;? .'"'Some'?of';these-^inPluding neostigmine7', ■;/'; 
and'pyridostigmine' are /cu'Utern&ry'J■•/mOhium ./compounds' 'and . / ' •. / 
may have an' additional/ depolarizing' action ; on ' the/'end-plate 
direcity.- or ' a .,-^s^(^^^:ii^^.atory effeet6n7thO/release -of-' /'--./'•? -, 
acetylcholine-foom motor-nerve •.endings' - (Biker ' • .et aXp/X$59 )/' 7 
.This., 'may ' account',fpp?some ' of-...the differences in./thc/// •,■■ 7 ’ .
-clinical /response ' to ■ diff erenf/drugs; ;but "there is; ..7777.' 7; ' ’
' insuf fie lent '' appr ec i&tion .-•of -the;-Wd,e- ■ Variation-in'' - the 7 " " ' • 
duration -of ac tion of ' any ?pne7-bf. 'these- 'drugs;.-from-’ one . 7' :■
1 patient -to another77-NeOtigmine-'may have /a/useful? action . ■-. .; 
for :8/hours/‘in. 'one'•ps^^^iat^^'•:7le^.?'^^^^3L•y'  ./l/^^7houre.. /ib'-another-..?:7 
'When/-' 7/ 7> ?7 7 777777-7 '77777 77 7- / ?/ ' • x'k', .7 z;-'/// 7-
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whentaken"".orally!//',/.For’ this / /.'
.est'ahlil«^h‘vth;e 'duration .of ' effective /action -/in each J "- ;, > ;. 
.•patient#’'-'/• ; A simple/ ejg.ograph;6.u'Ch ..ab- • the /on# ; described,'.,A/A' 
••in .Chapter- 17 '•••/is''/& useful ■ adjunct to> this \ (FiglSt'3K </ - .//• 
•■ AA /■/.. rapidly when. taken by .... '
mouth# /A I-t'a f st/powerful action lasts' for., only' H**i-| hours 
'and ' is folAowed/ ••by-a;,carry-over/fbr'-.a^further. 1*6 • hours* '• 
'•-I^fc^ie./ac1tiVity,i.,tiht’en''/tends, to ' .fall/off/rapidly, .> This Alet/ ■ ,/ 
down''-'dan ‘ be. Most 'discouraging/ tcAa/ . patient'#, ' Pyridostigmine 
bromide /does aothdyethe/./early. 'maaked-oefect of / v ' * ■ '.. ■ 
heoatigminev ' /'Tie; duration'/of- the ■'■plateau ' ' of useful '••’* ' ;. 
activity is ' longer, than that ' of neostigmine,
despite the ' fadt > that, it was introduced as a long-acting' 
preparation; but -the fell '/off '.is ' more gradual so-a.; •-■/,, /....;; /; 
smoother control/can be ' established ' '.if ' the ' tablets ' are' 
given at/ ' thb correct /time© --for the, particular . ' patient 
x^3^g;/:iB,,.) . ' :-/'i ' ' '/'/;.A '/A 'A'A '-; - Xa<; - - , ' . ' A’ /. '/- ' / ' ' •
/// In a doublc~blind: trihl (Appendix A*)most 'A A-
patiehte considered /t.het pyridostigmine was . the drug of / 
choice# Some/preferred ' neostigmine'because of the early 
' surge of -'power' but ’ mots, t eel ec ted pyridostigmine bee ause' 
'the? control was smoother without" the *let down' effect 
’which' necessitates very accurate timing of successive 
doses of ' neostigmine# /The use of each of . these drugs
is very '/©aj^iiLiar -to/ the use of ■ soluble ' and slow acting 
insulins in> the ’ treatment • of diabetes mellthus# It' is
usdal practice ' to take . sonie of' the tablets 30 minutes 
before /eadh,/mB^3?/i*h^^n there is /bulbar weakness and /other ' 
doses before /gpihg to sleep and immediately on waking in 
Ahe’'morning./ Xf other dosed are ' necessary they /&re//then/ 
/bm^d/between:/ these/scscording.io/Ahe’'results, of/a/tria! , ' .
such/ A/A A/A-A ' ’■ -A • A " / ••••.’ ' '• -
  
' • such--as5'is illustrated; , in .-Tig.-- 1$,;'!f ■ bulbar -.. . -, ; 
symptoms - ar-e ' troublesome ' . Or if - -the '' patient' ‘is - very weak--' - 
bnlwalklas in* the morning - it - 'is .-advisablc-to roouoe.him
■' /fopied'dase' at - the --appropria tor; time during > the;: night, ■ . < ■
.. Absorption is - erratic;';- in '- some.;' patient8\,ond it 'is then/ - ;
'•'/•-necessary to, rely on ’subcutaneous injection of - . /
y .neostigmine-'- motbyiyCulphatn .orAa&Xieyiate ;and - this ,7; ■’ '
may-be/-the-. rqute/of -..choice in severe cases* The dose - , 
may be - c ' alculat'ed - oh -a-basis of - Img. by injection-' -
haying- an - effect;.‘equivalent- to 'VJheh/:;; . -; -
-given by - this route, iieosti'Bmih'e - - should-be admihistex’-ed
./■-With atropine sulphate - - -Ofkmg*, to prevent - par^a^s^j^mpa'I^hi*^^' 7
, 'ojimsiio effects ' such-- as intestinal - colic,- sweating - and - ; 
bradycardia, / if - passible the-atropine - should- be- injected
. 15-30 - minut.es.' before - the dose of - neostigmine (Saylor- and - 
Simpson, 1964)*, 'The routine uge .of atropine- i© - not 
without ■tts■7^^^^3^i^^<ore-■(<ha;^'i^^^’r -19)! -i - ' ' ; ' - -■ - / -
’ ■ •’;/'The/v various’-&ntich{iiin'estefa'se drugs - -in- use ’will/
, now. be- --reviewed in the - light' of personal - experience' ,in'
the -order ,of - duration-of action* -. •.•//.•
■■' •>ff^WphnnAum^hiorldCoC,11 Tmsi Ion ‘) -* , ihxeuuae*. of' -the ---'' 
''■"response'- to this drug- as a diagnostic--test (Chapter -1?)
■•is, based on its - -rapid but -brief - •■action* fits maximum 
7 . -effect-.is-completed - -in - 5/minutes* * -By. the .-Harvey-Marland
elec tromyo graphic - ' .'testy i - have - found- - that 'some - .effect - ' ■
can still be found -‘•5,Qv'6i minutes later. - Osserman et -al, -; 
(195,3 )- have -also found /clinically that - •edrophonium ,
shows an - additive - , effect - .when readministered within 30 -
- minutes - but .thisyeffeet'' -was dissiputed-iniess- -than .bn - ' ; 
•, hour.*.. - ,-ThL 0 may -be " of:-som®;;i;^^>P^^l;.r^t^^^<>0'; in --.the--management ■' 
x of/ •• - •- 7 /•/;-/•.■; ' ' 7'7”-;7--' ' ’ ' .. ■. - ;-;
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of cholinergic crisis .(Chapter 19) Mt ' tho ' -main action 
i® too brief for therapeutic purposes.* - ' ' • ■
^^^^igmine,wbromide ('Prostigmin’)* This drug has stood
■ the'test of time* The 15rng* tablet has a cholinergic
activity' which varies' from 2*6 hours in different patients* 
The. total and the spacing of doses must be established by 
the ' individual trial described above* Xt may ' vary from 
■ tablet. t*d*a* (22»5mg*/day) ' to 3 tablets every' 2 hours 
• (340mg*/day)#■ '• ; Exceptional cases requiring even bigger 
dosage 'have been reported (Howland et ai* 1955) but an. ' 
average 'dose is 10 tablets daily (15Omgg) (Simpson, 1958,
. Appendix C)* ^Somo of the ' advantages and disadvantages of 
neostigmine have been described above but one of the main 
advantages not yet' described 'is the relatively small 
cumulative'' effect. , / ■. " ■ '• ; ' ■■■'. ■
Pyridostigmine bromide ( ’Metinon*) *' The advantages of 
this drug ha.ve also been described above* The slightly
slower ’fall off* of 'the therapeutic/effect 'makes it a"* 
useful ' drug for overnight''meddcatipn' even if it is not 
the 'drug used during the day but when pyridostigmine ' is 
used as the sole medication care must be'taken to avoid 
cumulative effect*
ThaaoetieaXly it ' seemo desirable to use a long- 
acting preparation to avoid the need for frequent dosage 
but all anticholinesterase drugs tend to be cumuX&tive 
and this is more marked the longer the duration of the 
plateau activity (X'Ug l8*l) (Simpson* 1964c)*' This. may '
not be obvious for weeks when using neostigmine or 
pyridostigmine so that the physician may be lulled into 
a false sense of security. Slow release tablets of 
neostigmine/ . . ‘ .
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neostigmine and pyridostigmine" have not been available *
In this country but pi^ei/lminar*' reports from the V,B-A, 
are encouraging and ifc7appears that cumulative effects 
have not” been' prominent ‘(Schwab et al, ' 1957)# With most
of the ' drugs which will now be described the cumuXative 
effect is so'prominent as to make their use 'dangerous 
unless the patient i® under close.. ' supervision#
Anbeeopjtum..' . chloride (Win 8077, "•’Mygsiran,, ),
This drug is not readily available 'in Britain and o' 
experience o£ its® use is Malted" to five oases, Xt is 
dispensed in lOmg and 2gmg, tablets, the latter being 
approximately equal in 'potency to X5ag, of neostigaine- 
The duration of action is ..•said to be only slightly longer 
than" that of -60mg".of pyridostigmine (gchwab ' et al,' 1955) 
but X have felt that unintentional overdosage' was ' common 
since'it occurred in three of'the five oases, Central
actions ©re certainly more common but.it.may bo ' that the 
onset "of cholinergic crisis is more.difficult to detect, 
Muscarinic side-effects are said to be less frequent than 
with" neostigmine or pyridostigmine but Desmedt (1957c) 
found that the optimal therapeutic dosage usually produced 
signs of ’cholinergic intoxicatim*..,' Wy very limited 
experience -eonfiras this. In addition" "I have felt ' that
cuffiuu&tive effects were noticeable' in as short a period 
•‘as one week, For these reasons ' X do not consider
ambenonium to be the drug of choice.
Bis-neostigmine' compounds- The cholinesterase inhibiting 
power of neostigmine may be increased and prolonged by 
combining in one molecule two neostigmine or pyridostigmine 
radicles'separated by a polyaothyleno chain of various 
lengths/
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lengths#' P&teisky et" al (1955) and' Hrsfeld et al (195?) 
have investigated the action© of BO-40 (Uexadistigimln)'', 
BO-4?, BO48, and BO51 (Htoxonarium) and report durations 
of activity of a single do$e exceeding" ono 'day* The . 
Vienna group have " found BO.*51 the most useful of the' .
series but noted wide variation in aassopti£^l^^ when the 
drug© /wex'e- given raally* ■ /Aw vvoaagcoall oseo f £ BO-51 “ 
is ?»5&g*" every. 4-days# More frequent.dosage is hindered 
by curnnX&tive - effects, yet the carry-over ia inadequate 
and heoetigmin© is - usually required in addition*
' . My - experience of these drug© is limited to a ■
•. restricted trial of'- ©uupll@d from . ViennA• , Five'
caeca treated with; BO-51 in a recommended dosage- schedule 
•'•ail. showed,signs. of overdosage within -a week, 7 - ■ '
; M-i-f eel that the - cuieulati,y^t1 action entailed by. 
the'. long - action of- this group of drug© 'makes thaa . ■ .
unsatisfactory fox* £^c^«m3c3^:iary use, ,. - ' "
Alkyl-Phosphate0 * This group of 'anticholinesterase j
preparations - which - inc Indes -di-isopropylfluox^opRosphaie- 
(D—P) -tetraethyppyrophiephate (THPF), " hexarnethyltotra- 
.phosphate (HOT) -and " octamtthyXpyrOphQS!phoraeide (OMPA, 
had a - vogue in the treatment- of myasthenia - gravis because 
their long duration - of activity was considered desirable * 
ThisAvery pi’operty leads to inflexibility.-of control 
(Simpson,- X964e)» Furthermore they have a greater effect
on central synapses than the quaternary" .ammonium compounds, 
giving rise, to headache, nightmares - and personality - .
disturbance* Borne " workers are still using JfEPP and indeed
’some,- of the present series- of patients treated by physicians 
at the;National Hospital-have continued to take. T8PP"of " DFP
■ for/ ' . .
w'for--many. years.' X - have-questioned twelve patients . who
< ,-''have.'heeir taking-;.TBPP/-/'/Ohp.^patient ’(HE61A57)''preferred 
it to neostigmine but the others considered that it was
. ' *useless * (GK/C^ KE8l62/.NH8327t NH955S,
/, 01X102, MU58>,.'KU125?4i;'OT6l50H, .061910) .-/Opinion'- .?'/
. was wore divided on the-value ,of DFP (Oase GK/ES, 'KH/EG/MG. /
• (MN887)., KH1190,, m49,84i WW-2)‘ Only one patient was. '
. ' . ..' treated-with QHPA' (Case. GK/B8),* -' She expressed herself ..
satisfied with it• . .
Thei's is a general tendency to abandon these
: drugs (VJesterberg and Magee, 1955)• -The relatively poor
therapeutic value compared to =the quaternary nitrogen group
. .is- of.'.some theoretical interest since the alkyl phosphates 
■ appear/to act only as inhibitors of,cholinesterase, /
whereas the -quaternary...nitrogen compounds may Have ah 
-/additional ’direct depolarising action on the "ohd-plate.
orpresyhaptic action as described above (Uiker et.'ai.,- 
1959)./ J V"" ;v .•-■ - '.:.,/ ' ■'
Colhnthamine hyArobromide (fill valine *■)'. / This/Is a
• phenanthrene .alkaloid isolated in liussia from' a .Bulgarian 
/ plant, Gaianthus nivalis. It, is related to. morphine which
.-'.-. has a...stimulating effect, on smooth muscle• and; a little - , .
■ cudori fie ''action. The-'; pure. ..crystal line*, shbstahce .(JniValine*) 
has been, shown to have■anticholinesterase;activity (Paskov,
','/ 1959) - A therapeutic- action, on myasthenia gravis, was , '
confirmed' by Bergamini:: and Baggiore (i960.) in Italy but 
they found it to be less active .than ‘pyridostigmine♦. ..
. . Oiihydro: derivatives of galanthamine^ named 
. lycoraminesytested in'America have been shown.to-be
effective in myasthenia gravis (Somers et al, 1969)* . I 
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haye/- rp experience of any of /.these--drug®- and- it is s till 
fpb.early- to' 'assess - ? their-'.’r'p^le-» 7- -. ' /7'7> 7-;77-7'
Dequailnium- chloride. ('Dequadini)..'. This , is a bis*
quaternary -ammonium- salt - need' clinic ally -as an oral 7
•an^^:^isep^^^:^<5>,:;:fii^A^f^?.F)b^her^’;t'€^_iw^^irj??o^mmi^o^unde it has 'a. •'?'?
neuromuscular- blocking ac tivi ty -.when -inj eo ted -. 7 ' ; .
Ihiravenously into-mice* Graham and - Grant - (1959) 
reported - a 'blind* trial -of -it© -use in - one case - of ■ 7
myasthenia' gravis and' claimed- ' that it was capable - Of ,
causingclinical - improvement. I ' have-not been able to. 
demonstrate any favourable- effect in two cases of ' :
myasthenia -.‘ (W525iy\TN50Q9) -' and - this 'has ' -been, .the ...7 --7-7 
experience - of other .•woarkers- (Schwab, I960). .
Adjuvant-..forms' of ■ treatment - ■, • • , 7. . • 7 , ,
•BormOnfflt The■ use . pf ■ adrenooorticotrophin (ACTH). and . . ■ 
.cortisone has . been ' described on ..pp"^??-??#" They are not. 
recommended* ' '•Gottlieb and .Laurent ' (1961) . suggested ' the 
use . 6f spironolactone'.(AdOrngg'). to '.-inhibit' -socre.tion . of 
•aldosterone? by the" ■ adrenal glands,'in order to . conserve ...
pOinsWiuriin ' the/body, It is '' too . early to . evaluate this 
form -of therapy*. -O*D*:iscOL-l ’(1962,).- .and ' .Gremieux and 
Mile■ (1962) have; reported single' cases. Who ' appeared. to 
."benefit. ' 'Riser 7eh--al '" ( 1962)preport--. three'. 'oases..Who•/%■' >7,-7 
received. cobalt . in addition . to. spironolactone. -Despite 
a. favourable ' reception. in the French' literature :my own 
-exp'ejiipnce. in ■ three . patients has not -shown any significant 
modification-in ' the■ .'■•response■ to . ..'treatment "with, . ' '7—. ;.7. .­
anticholinesterase ' ilrugs ■ though ' the ■ patient . may have■a. 
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Potassium chloride or citrate.• Though useless as a 
.primary therapy» potassium .has a 'role' as an adjuvant in . 
dosage of 3gr • b.d?« ' or' q.i.d* (Laurent ' and Walther\ 1935)*
The nausea and diarrhoea which it • may cause may bo . difficult 
to distinguish from cholinergic crisis (Chapter' 19)•
There is some'clinical evidence- that potassium increases
the response to neostigmine and it-is probably worth a
place as -an adjuvant -to that drug but - its. value -is
marginal. its action is probably on the muscle fibre
(Deeraedt, 1945'). , , :
Ephedrine - sulphate. This - drug* - introduced by Edgeworth
(1930) froni her personal experience is still used as an• 
adjuvant in a dose of - JSJmg. - by, - mouth.. Its - value
, is questioned but many experienced clinicians continue to
use •i-t. ./••'Ephedrine is believed - to function by- inhibiting
'amine- - oxidase and - so - to - potentiate the action of adrenaline.
Its mode of action is uncertain but is probably related
to /the Orbeei effect (BuXbring 'and Iktrn* 1940). An
increase in - motor power5 lasting 30 - minutes: or- longer after ' 
ihtra-arteriaX- injection of 0.4~*0.'6mg. of adrenaline /was
noted - in a‘.myasthenic patient by - Harvey and Lilienthal
(1941)* Luce, (1939) has- stated - that the - *defatiguing** ;
effect of adrenaline is closely related to its - lowering. 
of ’ the - threshold of - skeletal smle to stimulation by
acetylcholine. :
Gu^i^3LneL,hy(droch^iride* This drug has a limited - - anti­
myasthenic action also attributed to- sensitisation, of the
cnd-plate to acetylcholine - (Frank et ait 1923; Ddsmedt, 
1956). It is ' given orally in- a- daily - dose - of 20-50mg* per
kioorammme,- of'body - weight,? - divided into' ' three doses?*; ? i'








have\o'niy-uQed' i t " when'-, the -maximum. tolerable dose -of - - '/'
zieosiJigraii'ie or pyridoGti(minc diid not \fully.reRtore ‘ ■
.msc^iarUpQwrf?‘-pJOV<Whre.Q' .capes in/Wh:leK/it7wao 'uoedt- ih/7/./ 
"this/way thereWas - no /obvious" /benefit* - The . 'drug -tends .'/ - /' ; 
to ' - caW*-/'an'd':' '-fa - now '■•rafcely/used' /(Dodd//#t -;•■’•' .7/
al, X9tl), _ .. /:>/./'":'-'/'g/h ; ///-'■ •^,/
, Casein- hydrolysate,'/.( "'- Amijgen ' ) »" An./.enaymie •hydrolysate. ’ 
of aaseih was' given - Untravenousiy to' /five - aases of-/ -. 
myasthenia/ . gravis"'by. -foria ''mid/Wolff %3.9^4? )' ' in/thee "/'- •/%/%■ // 
belief; - that the - .‘Synthesis;-of aebtyiaholine would thereby . / 
bo/increased, ; -No"/. further 'Wo'bk ;hSs--been publiohed ' /" /■/■/ - ; 
supporting/ -these '.€^aLi^:i^^'"wb•iah:al«^^i^^;'"*^e^n^i^e^lit ‘y• discounted*"' 7
d-TubbouUarine'*, Chuuehili-Davi'ds'oh. and lichardfeoh(i957 ) /
.Mri&\0.1hxe'x*' w^d^^ke^s' -have.giveh paralysing doses '- .of . , •. 7, - ■; -
d-z-tuboCur urine-/-(while" /sustaining - respiration mechanically') 
to patients who - have ' become /resistant to- neostigmine' in 7 
the /belief/ that - the end*plates of- the muscles . may thus ' be - 
reSiedyand ■'■••recover' their/debsitiyity . .to, /'h'eo.stigmihoy - 1 /7 ■■ 
have’/hever - tised/the. /druy;.in. this. way - and ' find. the suggested 
rations^iisg/^iifficUlt to. aCc.ep't*' - 1 have, on the other - hand, ' 
made- a - tentative use of .the drug in the treatment of * 
Cholinergic - ci»i:ii/^(CQl^^«p^^tifr"^)*9\;-m ;-//- , 7/’- /7; - //,//y'7/
/ //■-.77'- " . ... 7 . .• Neostigmine'jgeeia tanc e* •- " "-7 7*,,;" . z •- - " / / "■ 
/■/._.' :- 7'- -The whole questioh of?neostigmine resistance;' is7 < , 
-a'-/formidable- one - which " keeps recurring - in the literature 
of";myyBshe»ia-'gravis’, -.._ it" .is /based - on - /th& "frequently 77 ■•, 
©bs.erVed'ifaak- t^hat-- optim^^l.-•/dpF%e- with.- neostigmine'- (or/7'. ; ■ 
any, - other antiahpilneatei^ase " drug) ; will - '/frequently fail
baym«sji*ihLa--
graves* As - the - short-fall-- becomes greater - i.n cases/,.-- © , ■
deteriorating/ - "./ ,-;,./ •/•/" •'"-/" 77 '' /■ ■'■;-. /'•'•' 7
dOtbri’dratihg' - in- 'Spite' of 'treatmentit pis’.•unclara tandalx!e _ -
■ should '..'■■have’- - ’.. ■
beeA’- ’'raised*pCAhiswidea-depends . ultimately'' tn.-a' belief;/■.;,;’•. ,- ; 
that • the ’’/myasthenicP'dOfect- is•pepitireiyZa'- ’’’'chemical! '’lesion. " 
of’neuromuocular ' • transmission *ip -The • •• idea’l's-’unnecessary • .■•' ■. 
in. . View .of; ’ the ./how - oSiablished •-fabtCthat’’ histological •;’; /.< > 
changes; may- occur.. -at ’''/the’ motor nerve' - endings • or ih• the ”/<■’■': 
muscle■ )■» 'c$ndedd,;’.the •:margin• 'between '-■• ' ; ' -
maximum • poWr■’■recovered • under treatment • and• the• pre-morbid •. 
power •may Pbe’/ considered ■/■as’ a/rneasure .ofC/the .permanent • .’••■' P
changes/whiLch X have tentatively; described (following Keynes 
1949»’ae ‘MyopathicV'-p’ ',/ ;./!'y:/ /.■ t; ’’’"i ’’P c' P''pp.PPP".
■/ ■./’ "’’ItPis/'w^e^rlikhown- that ’myasthenic.; patientscan • , ;.
tolerate’ unusually’' large -doses of anticholinesterase drugs 
without experiencing .unpbaSmht/ muoGerihi£l (parasympathetico 
mirnetid)• symptoms* 80 ’-far’ao’ ’the miiades are ’ concerned ’ 
there is 'a'C©^^;rklcihl^ta^^^^^^ilc^etof fasciculat.ion• (Harvey'’ and ’••.<'• 
tiliehthaX’* ’ 1941 )#• ■ Since ’ ..-there is a possibility that ’ ;
fasciculatibn • is • due ’ to ’ a • ’preeymapic effeci of neostigmine’ 
and similar• ’drugs (Piker et’ al, 1999 )<;’this• has ’ been ’ used 
to’ support• the concept’: that’ myatthehiM'gravis is due to a 
’ppeeynaptic • defect ’ of acetylcholine production or release 
.(xKr.voy. Uhd■-hiXlohthtli 1941H-/..’fromP’my ••/experience• ’Of’ , ’.■■ ■. - 
t^holi^^e^I^^^/L<^P’PO’iSohingc• Pwhch’wiXl be described’ dhpfhe • ,
next ’chapter, •< !• consider that- •; thiepis’ a relative.matter, 
indicative • of the raised• threshold • ‘of the’myasthenic muscle• 
cp .:/p I ’-have • •.nOePevi’dence’-’thatitrue ’drug/-'resistance• to ■
.anticholines aer aaepUgents • ,c an;, oo cur’’;knd. • .'the . ’evidenc e that • - ’. 








with'/curare; is not impressive. ;
g gA/gg. • ■ iberois, to my mind-g-no. doubt that- /some-gp^^uU^c^3le ,.• -
.responding-. ' . . ,'
Ao, 'acetyibhoiig e g . / Whey©,ike: numb eg - of- Aheoe'-fibres, ia* any - . ’ 
Appreciable Lggpjp£t&Ahg''0£ ((thgeggAbole /the; clinigCalgpicture. of- ',.
; ’mmAsWienie : ,Doubtless these - fibres
Are,- Affected- -by -the .necrotic;AehgnA&idefcegibe' d? in'- -.Chapter- XI. ;
.fiiXTeArfr^q&ennt JL:n.p«at±ent;f3i with-a " -. 
-thyAitgtuffloufgyB^s^^<^(^'*i_.t^^.gia/.-?-t^ee^a^-gLpti:enfs '-vhQAay.iiAv.e;.’' - ■ ' 
circulating-anAibodies'-'agai^na^tZmt^^<5.1^^3.-i^;^^1^:ee.;.yCas‘'.distinct - 
fApai')ena«^,p;i.'at;€^;ipr^^^inX'-:(L.ChApi^<^iZ?’1^^:)‘ it iagposibble- that-' ‘ y
they-are --damaged;.' by-an. autoimmune ■myAoitiny'--- • ■gigg. • - ' Ag
gyyi Ao long -as some fibr^ have a raised threshold to ,
ac'etyXch online but - are. still- capable ‘ of- responding - to a 
normal -; < i f ‘ .it - is- prevented - f rem. rapid - hydrooiAis, -
'neostigmine ' responsiveness romains- but -it- will be obvious - 
that there must be trarn^::^.fcJp^nal ^3tages''t^^^■t^^een\-’'c^;ll^^;;^^.C(^l'■" -
myasthenia gravis’ and ’poly-myes!tls 'with myasthenic‘ gA; 
symptoms’# - ■ ;-. •'; • ■. .■ ••• .-••••• ; . . .
Rowland (1955) lioo discussegthe ‘-problem -AC- - g g g 
diagnosis in c uses with symptomA-Wd a Ahtural history- 1 - ■
A'lobelyggesembling my&athen ia -'gravis- but - in/whom g there ' is -g.- ' 
li t tie - or - Ao - Improvement - after ad mi-MA t ration - - o f noos '.tigmiae. 
-A3-•hegpoints -out j/the-Casca- described -•in, his-/paper -Would ..? •' - 
hayAgb^-bn.LAsXi^a^i^^^lf^.iejd'-- as-myAstheiiaL- gravis - before’ ‘the;-‘•’I. .• 
Antrodueii'on-of Awstlgmine,.and' .yet.Mo;f Avourable ’ response L-
'oould beyde-tectpd.-.g-. ;Hi®g -case© included -pue case- of - apparent • ( 
neepatal myasthenia in- a - child born - - to a - - ’ffiyaathehic- mother*
His Case 4 (in- ‘ whichg’lupuA ©gybhematpsus ceils ’ '-were/ found'- ‘/ - 
in the - periphegal- bloodyon - two - Accasl^ons-hut,not on tWo--g— 
others)- showed an inp‘rpyenting- type of ri^isp<^'hi^"e -'to/ the ‘Harvey- 
Masland/g/ g-gg- g-g -■ //’ /, g-//-;••■’ 'gg,'; .- gyg; g -Ag -gA- /••• ' ' - '
'' '-/-'gZ^ZZ--. ' ‘ ' ■ .'., gZ' ; ;'V ’ ?
Mas ' tea t • \-My'/own 'cases, ( ' described ' in- Chap ter-’. 9 ) ' who ■'. ;
had.. .?a/-similar-' type. ' of electromyographic ' response . showed - ,.. ' -. ■ 
npZre.'ai-.improy.cmntpWhen' - these©'-with';heostigminei ''’.The • /. - 
hoeolbgical-- - position of these ' patients-gi!still - doubtful - 
butyl - Would - agree -with' - W>Wifmdb(19 59) ,-t'hat ' they - represent
' -ctie: - spec trum^of' .neuromuscular,' g •_.. 
'dia'ease©; EXiiblting;- 'the-;myastbphic ' reSC tion •*' ' f‘‘ '•<\Z „
'v!-''; describei'isi -on the whole, -g , ...
permanentt/aidZsidiffereni in nature; to the -acquired' •' ; •••.- 'Z '
■p eeisiance' 'pre sUmedf-by--Some -preiious' -authopsZand' • which',---Z - • ■'
- -'..Can ibe' r®d0'ieyed;-fxo>m . -.by.-' •resting'- the end- 
'platosigwith; curare-' and'w^thdr^^a^wing - neostigmine* - g;For- ' ; Z ' 
•reasono:'which.. w^l^'i<be^;-c,eec©^ibed' -in- the - • next - chapter' iZ- ,
consider - that - these /are unrecognised examples of '•- - .
nep'st^l^mihe. -■■.b^ort^ioaagi^^-1 with ' depolarisation- '.block-;' .and not - ''; ' . 
of - weakness ' due' to diminished -sensitivity to neostigmine*
On the ' other-- hand' - I - find - nothing- 'to support- - the opinion - of 
Haryey -' (1948 X that the . continued - use p f neostigmine' preien ts 
.remission- 'of- myetattHen&a- grayas ' = (see' ' also-- -Ferguson - - et' ''alt '-i- ' 
19555.5*—.‘.Although ea©e©^treated -with/—■'©ry iapge..doses,- of -. .- 
nbO'^t.tigffline - have--been 'described (lUd'er-et ' 'al,',1951 X'-u?- ■. -
.at;t'emp^^^'-t0^■i^1o;i/to "is fraught . with 'danger' :and it' may'-be w - '- -" 
'si^f^K^:tficai^tth^^l^j3;^;o^..c^'cc^£^^E^:e.-;o f this -high - dosage .has/ - been'- Zg\ 'g 
■reported since -’the-introduc tion'of- thA- .edr^oj^i^onit^m.- 'test - gZ ... 
for''discriminat ion between- 'myasthenic- and cholinergic.''Z' g; ■' ”'■ 
'Weaknes'o (Oss©.rraan-yand-Kaplan, <-1953 )* A I believe-.th a t ' 
mmot-cafee© ^QXghePetigmhegrosis'tanc©'' are in re&Xity'Zi .
.■i^3^(^nl.ioyir^^^i^^G^a^<^,'-.gfUt^i^3r-di^cut.£^^oh will be - < -. 
postponed' until 'the' 'next - chapter*' . -' •• - Z • g- 5 • ,■■ ?Xy ’'
- X ii-z^zv-wWiiw , ■ z. z? z ■
.’/-ZZZ The .; general management- of the '•patient’s. life is -' ‘ • 
important/-ZZ/ -' ZZ." . , . ■ . \Z ■ ■ . - gz <Z. ;
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important in' order/to,, reduce fatigue : and stress both•
X . phySicai and' emotional.• It • is• .discussed . by GaylOrrnand
■ 7. (1964)*"■. :/ a "'.X ■
X’.v Contraindications; XX' -/X X-x^X/XX;/.-/ '' >.' X X X 7
■ ‘.," . X~ It;'is.. ' obvious that ;'drugs'/with; .known"activity as . - .
/neuromuscular'iblockingXagdnts'.-must be '.used with care in 
myasthenic• patients ? Cnrr^:re, quinine' and ' quinidine, 'are ‘
example©''of these' which will • readily occur' but a similar
ac tion has some times ' beon • reported • with" an ti bio tic . drugs 
such/ as . neomycin; and/strep'tomyc in. I/FooIi©®, • 1958 5 Lodpr'. 
and" "Walker ; • X1959 ! • Msk, 1961' ; Ro.s’s •• et • al, 196.3)*
XX Polymyxin . B. has a similar/ action in animals.(Sabaw&la and 
: Dillon, 1959)* " The.block induced • by these drugs is
X 'r.esisiSnt/to" Xhiootiggmi©*bX-lC -X '-XX .X''/ / '/<■ ,' ' '" !' / ''
X" '/; 'X// • "//increased /twe^akneea' /in /myasthenia /gravis h&sXbee'n ’’
• attributed ' to . administration of . . c'hlorpr omazine (M Quillen '
.X : et al, " 1965 )> ; "These authors " have ' ' shQ'wnX that ' chlorpromaHine
antagonises ' the " action of " anti^cholihestei^^ee ' drugs in " non- "
"_./myasthenic1 '-patients"":(Mtu:ti'lonX^nd Johns *x"1963 ) •' A . neuro- ■
: muscular ■ hioekihg effect" has '‘■O'©^ ' /pr-evihisiy," recognised in '
/ ; animal©; ' in this- aid■XXt^ier/, tranquliiisihg ..agents : (KO'p.e'ra - and 
; ^Anmtage'X 1954; Jindal" and .Deshpande;* 1961 ) X but • apart from
the case -‘/just 'cited ' this" has -not" been ' a ' s.ignif leant factor,"
•"/ ■ 'in ' ' human -ceisiesxx' '.X' Z" 7;■X; ''/-/•• *."" ‘'-X’-/'Z-XX/ ; XX" '*X‘ 
X/’X X • The heurb&usGular" blocking actioh-bf - 'ether "..and . X/X' ’
other/anaesthetic 'agent©' is found bnly in ' anaesthetic ' 7
••• concentration and it /can fte'7^^000 by nebs.tifamine '
/ ( 'kmd ' Cullen, ■' 1943 )* ' It Xm^y" 'precipitate myasthenia
in/an unrecognised- case " (van " 7Nbphhuyk/'l952 )* MarphiheXpkidx
Xother" 'respiratory ' dep3^'estantt ' should be; used ".with' caution" ; 
X ^because of the " danger of"depressing respiration•Which ' may
be barely adequate but their use is not otherwise 
•contraindicated. An ■unlooseen hazard which should .be .
borne', in mind in ", the. treatment’ of cholinergic ■poisoning’ 
is that . the respiratory. stimulant ■ tetrahydroaminacrine \
(T.H.A.) has anticholinesterase activity.. .
. It is generally accepted .that an enema .may . 
cause' sudden' ’ collapse'5-WLth syncope in a /myasthenic -.patient' 
(Keynes, 1949; Simpson, 1964c). I have never seen this ’ 
happen because'^ knowing of the 'risk, I .have . never ; ,
permitted an enema to.,be given to a case . under my care, \ 
but cases NH6546', •’lUJ48570' and NH615O1., collapsed after an’
■/•enema..and case . GK/EW did '-likewise after/ using .a glycerine . 
suppository.’ I have' thought ' it too,. hazardous . to. .
investigate the mechanism or even to ' confirm the extent 
of/the.risk by a trial. : Distension of a bowel rendered .. 
hypertonic' by neostigmine is a possible ' cause ’ of. a vagal '
'.reflex." Enemata and ’'.purgation' are' known 'to, ' cause 'serious . 
potassium depletion .(.Dunning. and . Plum, . 1956; Coggill et ar, " 
1959) but the collapse' ;is probably ' too. sudden to be . explained 
in' .this ' .way - since, the"' ■ normal! kidney conserves ’ potassium; •. ,
when body.levels are.depleted* .
Ptosis .may ’be' prevented by a lid crutch" attached ' Z 
to an " eyeglass. frame './ If there; is.. diplopia, an eye ' patch. ' 
may .’be; worn but should ’ be changed from eye . to eye to prevent . 
suppression of vision/. Surgical . correction of . ptosis or . , , 
strabismus' should be' postponed’./until. it . is ..certain that no . 
further variation is .likely to. .occur (Fig. l8,3). Where '
: this . precaution is not taken ' .the final ' -result is not ' < . 
satisfacoory. . / . .
Case. HIK-75Q f /A "young 'Indian ; complained .of ddublo ' v 
vision. A-borrbc'tiVG ' operation /for. ophthalmoplegia .




vMo carried ' out in India. A fmz montlis "lator he-
developed severe generalised. myasthenia- gravis with 
. moire •isovo-ro diplopia -Meh has . ■ persisted despite
. fhymoobemy and optima! treatment with -anticholinesterase
drugs. (Fig.^7, S) o .
Orthopaedic -appliances have limited value in , 
myasthenia gravis rand 'rarely- justify the extra busrden ' 
imposed on the ''patient* A myasthenic patient should be ' .
wax^ned against eating grapes - and should take care at ©11
times to avoid‘food which might’lead to-accidental asphyxia* 
Persistent dysphagia my cause starvation 'with rapid loss 
of weight* A fluid. diet with . concentrated proteixi
suppxtemwttta should then be'given-by gastric’ tube. In very 
severe cases'showlng poor .responds - to troatment.-'it 'may be 
advisable to mike,a gastrostomy for this- purpjose/ . A ease ' 
whore this was noocsioary is described in Chapter 4
Respiratory embarrassment. must -bo detected early*
This may bo done by. measuring, the vcntilatorey capacity or 
the expiratory force, but an adequate method for clinical 
piurposes is to aok the patient to take a deep breath, ©h 
then to -start counting* A normal person should reach ®40-50®
before taking a new -breath* If ' the patient only reaokes ■
*20}* • it is apparent that the previous pulmonary ’ inflation 
hen been inadequate and ventilation must be assisted* If
the expiratory force required for coughing is ' inadequate or 
if there ia-severe dysphagia it ia also' desirableio assist
respiratoon. by a method which will prevent aspiration Of 
foreign matter into the lungs. , . - -- •.
- In mild ’cases of myasthenia gravis.respiratory '
distress is 'very rarely due to .. weakness off inspir&iooa;*' - 
Sudden/ ■ , . • -■' ' .
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Sudden respiratory dietress in such patients 'is . more ■ 
likely ' to . he due to' ^inhalatzLon of food* or a .-foreign" 
hody so' prompt -postural drainage with manually assisted - .
cough may-, be. lifesaving ' if." suction equipment is not at .' 
hand* " Veakhdss of inspiration usually follows progressive ’ 
weakness Of limb and ' bulbar muscles ' associated with, an 
increasing dosage' . of neostigmine, Since ' even the most 
severely ill patient-may have a good remission it .is 
extremely important to prevent asphyxia! death where this 
can be forseen. An episode of respiratory failure does 
not prejudice the '.eventual prognosis. The possibility 
that ' apparent neostigmine resristanee is due to hypoxia 
with."carbon dioxide retention should /beconsidered (Scurr, 
195^ )*. ' ‘AaeXffce.dU ventilation may" be; Iff ©-.saving and 
.frequently tides a . patient over' a "crisis. which would 
otherwj.se be fatal. For these reasons .'treatment of ’ - , 
ventilatory... failure should be started there i-a. 
appropriate -.indication.;. It must " not b© ' regarded fas .a 
desperate remedy to be kept as;a Xast rssort. It -is 
unwise to temporise if the patient has -shallow fast 
respiration . or- is ' restless.' Cyanosis is ...rare* Neostigmine 
(2mg.) . should be injected 'intramuscularly . at' oici and a 
respirator obtained. - .-This dose may be repeated hourly 
for two or three hours. If an edrophonium test shows. that 
troailneit is .still inadequate the dose should be increased . 
steadily. This is less? likely to give, rise to oiuiulativi
effects than shortening the' -intervals between injections 
although 'this may also be .necessary* Provided an unequivocal 
response is obtained to edrophonuurnir ..it" is safe to give . 
atropine in addition but ' its effect in thickening' /bronchial . = 
secretions is undesirable. and It should. be avoided if "it is
possible/
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possible to do so*
’.-Sine© ventilatory failure in myasthenia gravis
is frequently .associated•‘.with dysphagia and often with 
sialorrhoea, it is preferable to use a positive-pressure 
method of ventilation of the lungs through an endotracheal 
tube ort if assisted ventilation is required for more than
.24 hours? through a tracheostomy tube (Mg» 18,4)* Both 
types of tube.should have an inflatable cuff to prevent 
retrograde escape of air, and to prevent foreign matter 
which enters the trachea from passing into, the lungs •
As pressure necrosis of. the trachea may be caused by the 
inflated cuff it is necessary to deflate the cuff every 
two. hours* .•* ■ This must 'always- be:-preceded - by "aspiration of 
the mouth j pharynx--, or-upper trachea.through a whifeivle^tip 
catheter attached to, -a suction pump. . Despite these 
precautions food matter persistently passed the-cuff 
barrier and ente2?od;the lungs, in MW5652 fFig. 18,5).
This case is fully; described in Chapter 4 and is worth 
referring to.. again as an illustration of the importance 
of persisting with controlled respiration and gastrostomy 
for many months even though eventual recovery may seem 
-impossible* ■ •'
Another indication fox* artificial respiration is 
the development of ’cholinergic crisis*. When increasing 
neostigmine ’resistance’ or the.results of a series of 
edrophonium tests indicate the onset of this state.the 
safest procedure is to stop anticholinesterase drugs and
. to use an artificial ventilator to maintain regular 
breathing while muscle cholinesterase regenerates* .‘The 
recognition of this state and its further treatment will be 
described in Chapter 19*
’ —;-o ;■ CHAP^ER-19*. ;-,b- -- >
' ■ -u-yiMras 1jh©nd^cx-;gi»^vis-aome'tifliGS“'. belie.®-'its hamb? end' ■ ■' '
As-' a-...obrnp&rati-ybly r milch'disorder^g;: ■■' -Mpy '^aUbat®' /di . of. ■ 
ot^he^aid.c^xe^e^aises •' • such’.' as.- Cerebral •. haembbrhagh ; ■ ■ •• ■
acute ;mania..MX;Tl4^*954~5; 'br-by .. -Four' adqeo '"';
died-of :beCpXa®IL\Wh&'Gh -was• not•’., thought-.to• .be • •' 'the'-cause-Of ■<■'■ ■
VieW-of^Z/t^b^e^'p^rvi^ib©^; duration•uf■' myasthenia -it/'is . ' improbable’-' 
that;;t^heSe • -me:-base®. of • ' ca^3^<^^^n.onaiioii^m^y^a^©,^li«^ni£i^''t^lh^’ugh \ ■ 
this •/dihgnaB'tie/puGegory Was'• unkuiovu,‘at,• th©. _ time -of• -■their ' .
doathV-' yin -•the'' early•’days- .of1- th3m©ibfco&y-. mamy-patienta - ’• ’
' the •' oper&tibn• :Or • diod-ffLihiii/ aphuioot-/. • of; .••• - 
2 •'W.bsskvl.j-yF'^^th^^/isierehiBiihg-expe.ri^^cfiee' of• -the maaagernbiat’' of-- 
those ease®, operative death is upi; .uuhsual.• ( Chapter 18) *■-"'- 
;"• y .;•';'.;- f -Behth/ directly• at tribu table _to> ma0$k'®O£&;-graviise-'' '
oOntrs • .Ah ^threb/^^^zs'xybl -jy Aouto' 'asphyxia',- Ai); >y&ath©Uio > • f ’ •-. 
o^:t^dlay?ixiX '-■ -/ ■.- -••'*• .' -'*';• •'— •
--•f-.:- :; •'A' major•.hazard •'of . any'disease • :4»Vo lying -the : •/-, , •;. .. -/ 
respiratory -and ;phafyug'bal*• raWciba • -bl^mnt^,t^^ti?ic50uo3y-- As -the• -- • 
posaihibLlty' -.of <-i'hhaXatiba.' ,of-for,alga • -mat to??.. An . to the •iunga'y- 
.Tib responsible-disorder/ is /hot ' • fallure-• of; ventiiatIon-• bat..'•■ 
■deflbiency• .of;"*the'C^^3^3tP^3?atoi^3r'' force required• to- clear .'the 1; • •' 
bff ©aiding• -.subs tanc■© •from' the• tr&chba -or • ••brdhohzt#, ; .• -/The ' - • -. 
/foreign /ramtter els . usually:-'foo'd but• may.-be-Saliva—'-- ;iiTi©-'-\--/}- .• 
latter • may’ be •found • Ah:.untye&ted• and. treated • .caaes• Alike. .■' /. 
Myaathenie. patlen'tsi having-any .drugs ..imy;• ’pr©^^'.
largo /.affloupts • of't hib3-i ■:glbi ry- fluid/ -from.; the 'mub^ixe•;.meab:ia&ea 
of;• the >pharynx,-. • 3-aryhx•'and probably' from • /-the main ’ bronchi.
/aaa’ ' aaa-aa' ?-aAaaZ
Thio.. J o. .wve;. in bto ypaiiWt; rneM< . aatilchOit^^^s^wic^rasB'e'y' ', < 
'dr"n^K^<1bu^;;\hhog^</t'..ivav0'''M©ir:b4' ,- - 'a
Geer%fcfcm-, of y asonsia o A wa be^y■•saiiya' and- j>c>GGibXy'. ■ -1..-
aiWbrbfCmehW^hcH^'i >-Thia-.cany W ' MW^iW&'iWAthe . use: ,>e‘£ :-. ' •-, 
ataoo>inO•• babdihe Aen&GiwW. / sipus;^vim 'M. .A
woe ymew;4f ffiatt3AAy.evwmfeA AApoAnpal'/AmLnagn 93?■ -%/p 
sttdUosA:? ^atooticm. yb'
^-^ybOmmo''n&s^3^3i'dri^n:^<^^^c^O^<^;ty XXXn>nMqnb©<i -;A ;We^^-AW\'0MXX^V. 
BmwewirA •fA--Wd<$?a,• in"Ah'eAveXX ' qoMroiMA •p&bi&aW; A Wqay ‘; ■' ‘ • 
Xadfchd iafce AbnraM .bubVafca^b Af 'myCe’bh<^3ai^i3^\^iid''y0^imtdry 
^eseAM m^3rf;^^^-.;ilnkd'e€q^at^cj 'be cXeay Wo W'onohi wytraehoa ;; 
.e^:'wAxrdiaX^d-;;fm*Gigh\?bed^XCMmwba^X^OOV1?: -{ew^XyA ••:■•- 
yi'l^Xyy-.^a.ii'Hifcgi//^liMn;id?'nq.t' WA^XlowAAo-tfsb AMO-aad'&XX.;' a
othbi,a'..£$t©uXd'’ . t&kAg^eMv^awAWmo ,wMsgAlAAyAfeso' AAxA 
dos^Mbed' in - Chapiter ' 2 •: lllaetr&bwX t^biqy"^isk:'i^siV0^Ar<yd *\ ■ A' • ' ’' ?
;A a ■;%<sov^-t^. 'irvaoo/tirOA.Gd adds.'W* %h<A
j<Gh'.®a oWbruetlw aepliy^Afeub thW&Ma • - Mwatdt Xb •'ddafch ’’%;
failtoeddttG 'W wewJmeae'&f . 'W •dx^plwngcn a
.or AniejrenhtaX-mtaeXefcA AWhlG"-.mW 'eoMf- .'dh wsxAIXy ' XA. ■' 
r’@$ pone 0 bb A AnHMbhaXyw •.' p HyaXcaXb eW$W 3 Cine Xttdihg- in;j m?y ) ®
•.iaenbey'-iaf eetibno /w An ’ "pregnaney*:"’”' - A’ oni&is> ©A fchleA typ©.y yy'; 
>6qu&3?0s,Jifi^raeddi^^t’d^-j^Ji^rte’aGe5bA &ni<eliSXinee.twsBe' 'Medication 
and AdnbndXf'diA^Xiin\/ra^Pi^ni;ion ;by; AW saethoda, 4©Gai*ibeddi»r ;
■ Chaptte? ASAU. .■ X A lAaWiGAMG}'. (too. p^^angG- A^om; 'oral' - breateen t.' 
{W'au Wul&Wime--.6A iRtrwnwcnXa^ .tion .of -nooats^min^ -y .
Ahn A the ■ dra^lGh ■.being/ Ajoorbed yin '. kaoim- ;ammmtG « 
AefoW' modifying • ' $ra&Ua&nfc- ia;..Wi© '.way. "dleWw^l© AneA :W
Ao* make qn^fteV;A^^tain;;.'^liA t/Afe-Ay. •
•Crnwe W- dmo^e^‘a'^^^i'n&.;Vtmalcneg^f3’ io ,-nol ■ ov@’rdos©g«^'-<^f\ dr^go A-'..
b’/A/^A- aAA/aaA-A -Ay.yyJ ./'-'A'A Ay?- *_
•f ■299, .;'
• (-Rand t, : 1952; -- 3?e the'r - •
Duration - of action- --of ’ an.t^;b^l^<i3^in^GaGr&^o - . dbuge sf :’’ I ; ■ = /. ? ' .
•}.' -Severe. - W^0acceeS3.a^mt^hi, respiratory- -failure /may-. also-,• I;., ,,•■
.•be 'caused -by -prolonged - de^QlaM&atiQn- ..of --the- end-plttes "''­
(.Chapter ‘15)X . ,yTTli^-x^c^!p^n^d;t^o^^';^‘eocr^^^^''by.-clinician©;.'-•- ;-s --•.,' 
ae-I'cholinergic .crisis hmay-"bo C^<^T^j3<^ct\.by an-;aCuie.\\ <\.'; ■' '"-;,' .'; 
overdost'of- any -anticbolinesterase substance*- More • fi'. ' 
commonly - -th,e - - 'paralysis. r results . from. prolonged treatment-t/- {■. : -' 
.with /bme/of these drug®,"due '.to gradualr acbwamiatidn of 
drug within the - body# • 'mobf- likely to - - happen - ; with-: -•% - -
'thefbng^ae’tin'g - /.drugs-ledch -/as -the - alkyl-phosphates -/and the ? '.
bis*neb 8 tigmine'. ’derivatives - ''but. all- active - van tdoholinest erase-;- - 
■'substances - tend - /f o -,pe3!»®ij3t for' ,&'■ din - •tW - .
-bddyi":<'{As pointed. out in'Chapter -.18, ’-.the tendency - to-- • ' . ’ - 
cumulate - : is- - approximately- proportionalfo--the "duration - off .'. --- 
vf ecfiveftherppbttLic- -with" '- .
9 ' - less -'wi th - : neos'tigmi'ne t-'-andl hon~e/is'tent- wi th\-. -
OdrepboaiumV- , , ; ■ '\r- ''' . -/ . fff-f-f,':
'•-\In:Jmyv earlier-OeXorienoes-jD-cholinergic' 'poisoning - \ t 
the managernbutf of the'{c risis *. - s tatewas ; prolonged," by . .-- .... - "•’.•'• ;■
, failure - -•'•to - allrb,oi&tefh©w aloWiy mepst'igmih'e " and- pyrLdostigmi'h'e 
were-ex#r©$.ed-.(vide--infra)..*"f • - •.' if /"'- •. -'• ’■' • -'. - -"--
- gigasC - of f overdosage- o'f -" antic hol-fnes teras p-• drugs - 3 . \;f f-. /-. ; '-
. / • --' " ‘ transmitter J^l^l^s^a"^<^^€^:',li^;b‘e3rat©.d•‘:. .
tat -many - -nerve--'endings ;-fz-f luyad .ditionfto -the. / motor -"neyves- -to - . /> 
the. -skeletal /.muucle&fit/;is' also -/present//at-- -man'y.fsyhapaea- or:--% " _ 
neh?rb«'^-ffe"^ltor junctions-.o'"f .the ■ a;Ut^onoM.^^'-•«er^V^O.ue^-• bysi^e^m- 'and. - -'•­
-in- -■many --. synapses ; within; - the- eon tral ■ nervous -• system * ff.Wh on. •- -■ /> -• 
.inhibition .of cholinesterase allows -acou'muXaMoa- - aW ' " -. ■’’. . 
-prolongation  - ;of - -the . A-ac-tion - of -baeetyiohoiln© at -■ -these - -/synapses -''■• 
Ho/--'"" -i', /-■/-/•' - - " - ' - 'v-/ , ■’ • • . /-■ "'<• .■ • ••'/.• " " f '"--':-.
thb^reaultyib'’a mixture' 'of:'^stimulation '"and; &ep©li&;Wtion ", 
bluckyat, '.each; of --thieae’; ©it'os«’• It','is' /cd'nVeaienfc’ to. .Wlassffyy ’ 
thO" effects "under three.headings -ll
Hl). 'central* .t---1- ; .■
^mybsginreX^ffeatS^: '/- "'<-1-/ ' •-- / ••'’ ;y-yh 1 '. W.■•yy '? '■'
,.;/; ' ’■ •-• - The, earliest • sympt.Qms.lof- this • •'’typei_arb-,eo.llc',> ••’ ’ •’. - ■
®heartburn’! ; sweating*,. saXiWfcipn, • . lachpyahtion - •'and ’. •'. •.. 
'UOaefcricMoh of. ’the pirpils.■. -v.-With. Increasing 'dosage' -..these'•;•'< •
.are'.followed by;'di^£iW'l^<^c^«^".;'broncho3’,rh.oea-a^nd/;3^{ae'^ir..’ ; ;yy-v . ■, • 
.hrdnchdeonahrictick* ''.'l-Tie"/latter. •ai'Qf• W. •Ms.taMn for ?•'•".'/ .
•asthma. anl-might.fecaUTA:'for "some..of. ’the ..examples --o£.,’-that'. ••-• 
.disorder .;1i$' ted - .'Inf Chapter- ,y * .With severe overdosage^:'.-< •'. . 
there "may also ho.;i^^ayy^^^o^<^l^isaeuh';^: involuntary• def&eG.atiOn.-' . • ■ 
and' disordersof the 'heart ' ' beat*-' '' Theex*© tic ally ohe ? would ' ;;
-expec t. bradye<saediaviutyih '. faot; I .haV?elneveryseen ; this/'’ ; '•'' • On •. •’ 
thie: contrary"'{persistent'/taohyCardia" Ih.vbry' ’ auga’©©^^',©f , _ 
oV.e.rdoaago#' ' '"asGocnOtriaiiori $ywlth •'a bold"-pale; -skih--.©hd- ■ '• ••. 
s^«^3?di,-i^^i.se^Vm^ayr.. nevertheless-.-he . associated with aydropiih-.y 
.blib.d; presbupbi,'.;’ "'• A’ •^'re^h^^<^i^^el^^^;%nr-booiu!"ed sign which; X'.- 'have - " 
’•'noticed ";00" /several'' bo basione" ,1b . hy}3no3pabi - Which .0 ariyb.e";-‘so' f . 
’Sever©/ as.-'to" prevent" Infusion’- of/• fluid-lwib the , veins;#
• ■• ._.. ;.’• ’ No • one , Would'•- Mehyto • -’'continue {tbsith'-'a• /dosage y.levei• ’ 
producing - the. -more.'-severe ; muscarinic,y©f f ec t© , ,y. The "'©beend", ; • • 
-group.' ia ’always, .associated 'withiniboti-hi© ”- offoi th, andf.the-1 --■>• 
third •With';' • central /nervous '..system-''bffebMiy/ - Ihere .’ibyyy, ■ /■ ' 
.however* -a-measure.;'of' disagreement, regarding ;thb .significance 
of. slight' muae'aPih'ie /symptoms ; •"; b;
' salivation•’■ or -i&©hPymabi©nt' ” ' ,M&y-'’Workers •h.eXX^'ev.^/^fclhi^'fc by /'...- 
•these' -sh'ouid -.be ' tbler&e.dd--'W •suppressed- w!th -/atropine if 
- the ."dOsb - level" is -Otherwise yea tie fee topy '-'fo'P VthW;Sfeei'e. tal .. y. .- 
•fflUeeiOs/y
' rrausolW/ On the ' b ther' hand it ‘As wll iiiioim. ' -that■ ' •' , .
myasthenic -patients tolefateof. I .'. . .
/ ■ aniAbhollnesterase'' drugs; before suffering ■ miuseixr.xhic:' ' • /./r ■■. 
symptoms and-oif this account -'the..prebehoe ■ bf. these: offwia 
Should. .always' -suggest .-that-' too■ /large ■ ■ -■&: • dose. As 'being ;usbd*.r
agrsehWfthhSChv&b -• (.l§.$’4j . and.-QtheW:whb-: considerthat';, 
r the yearly■ /muscarinic.- ■symptoma ■ ; are'- 'a-..\^^v^:tna^hj^(;_;/Wiirring ■ -if - .
impending danger■ ■' and . ;ad ■-'^oonot. advocate the .■JrGutinehuae . .•.; 
of .t^^3^^:ladonn<a-deriVat^:iwe9A though' some/exceptions. must he-'- ■
".made#.,.; ' /The. -Maphoretie. . '.and ..purgative - actions "'of - potassium'. ;-..
, Salts'may'/confuse ther issue.,, .. - ; .' . '...... •.• ' ■ . .. /.s •// '
////A-f /X haye/fouud- that .the' sissz/of ■the.'-- pupil. As •-the. / /
best. -guitiew.-/ f A iW diameter is -wre/-An nOom&X</’ '
ward/lighting there is no. '.danger* .• .Atpupil diameter
.••the. paiieht ..is. -usually ^hewing ■nicotinic/ signs „■-and when -/•’••• 
it/Ai&s roods tricted Ab/'lsmv there- As/ a tweeiX . ..established '
r cholinergic . ■•oriai a. /( Simpson *<l$6lb9 * - Uy/ r ' - - ' . y • i/ ;
- Mcotinic/.effects s. '/• r ' . - ’.. • • •' " ' . ' ' • ■.
. ■/. lA, normalrgubjeeis- ahhiohoXinesterase. drugs’ ‘cause .-. 
'fa'OoieulahiQU . ‘ f ollowed. ' by . pa? A yala/-'^a . depolarisation -. , /■•• /
' block' Qnobr.srxwL.th increasing acouimiuatAon' of . ac©^!^©!'./!©',-" 
, It has often . been yr eni'arked. - that fas cic til a tion ■••rare3^y‘■-',0o‘curs 
. in.''patAbuts'-with t-masth©hna•" gravis. •treated with. neostigmine . 
ond/mimiler ‘drugs’. And /this /is. l;akcail.:.to . be ‘part of <the '-• ’ ■■ '
- ’tolerance ®of these ' .patients’*. Faacicuiatiob. eih'flned'• to •
theri^^c^we^. riim.bs. As/c©InpPtAbX@ with exeelient-oOniroi of//. ■
the /.weak'.mmoles. (ege .Case;. ' Persistent/- •// /
, fas©icuXatioi■• withA’-tenetsgiaine^reslsiant ’/myysthenln// . r
.•;•Wi^;an^d^s^e^St•^-W5tl^n^C:ed byr Oases’ 'HH980-'and/N.H8X62k . . //" '//// /'. • 
■//;-■.r^<a5e . ■ -had. rfa'geAcui&bioaAf 'hand-. and . l^c^g^-miuscles^^. '
-/• 1 hut. a hewed only ocular, wesdkness» " ; ' - ' //•-. c ..-'i
.• Case/ ' . ■ ... ’ ’ •' ,' ■■ ; '-?/_ ;./'■ .. , -• /’' . • "' / •/ :
. Caee-a girl of 19 years with .-generalised-- 
■. ^myasthenia? did not obtain satisfactory 'control <?£•••-.
1 'ocular and • facial' muscles until- three years after'
' ?./ .'thymec toiay * : At. that ■ time - there was. a-- sudden improved
■' response to neostigmine and.-her usual 'dose/caused-' - ■ ■' ■ .
'. -fascicnlation of'. the. lower limbs and; muscarinic .
■'symptoms* ; '•■ ... ‘ ' ■'.'■• ’
Case ^8279 «• who has been .described in.Chapter ?'*'was .
'. - severely’- myasthenic . ini addition to-having diabetes' .’ 
.mellitus. and: pernicious anaemia* We'akness was -brought
/'under satisfactory control- by pyridostigmine (420nig*)$
. ..neostigmine' (l25mg;--qx*ally and X^rng* intramuscularly)*
When the dose was-reduced -she relapsed* .- When the same. 
■ . ■•dose mas ■ re**establi»shedithe.re;. was definite: improvement
in the performance of-‘all muscles but marked 
■•/■was noted in the distal -parts *rof all' limbs*
fuse ic ula tion 
An
edrophonium • test-.increased furtherx the .power 
tongue and lessened ptosis but fasoiculation
of .'the'. ' .- 
of the logs
increased and the ..quadriceps muscles became weaker* .- 
This was interpreted to.mean that the•severely affected 
‘muscles :of/the head-were still underdosed but the less
. myasthenic muscles of the legs were already overdosed*
. ■ On this: account tracheostomy, was performed, and the dose
reduced*, Further tests with edrophonium ,:Ui the next 
.three days .confirmed that the danger of overdosage had 
receded but unfortunately the diabetes got out of, control 
■as,she could no longer swallow and death was mainly due to 
diabetic coma*, .’
/’;,'■ Faso ie illation may be present ..for years in an ,"--..;.
adequately controlled myasthenic patient but only in. the 
clinically unaffected muscles* Fasciculation may Jater
disappear/
■disappear am. cb.oli^neilgio-hrl.siis' develops;sd-ihe-.abBcheB : •- ' ■ 
bf.--/faBC'ioul&Xie» does not controvert' d. ■ diagnosis,. of .> j‘ ,' •’•■ ■'
Cheiinergie'/cxdOls- (Simpson,-1961b}£ >-. .-•- -•-.. • . , . .'. •
-i--h; .■{PV'i^jO^<rQ?^:i.ve^;w^<§a^^^m^©si3.. is- the. -moo t" timpor-U&b t ,--•• '
hico tinie -■. sign. of tha. - cholinergic ■stato •\.-Veca«i'.ae. in h ?
.nOrmal mu3ci'es -ie ' 'Usually-,-•preceded- by f cWpicuXation- but ‘ " ■ '
in •-•myasthenic muscles .this/may not . happen - ; so . - that the . ? '
ohiy-evldon©© of nicotinic effect iB'-increasing' weakness.. •
..(‘Ossewan' et" a!,- ;:i953 . ‘ MbW-and - ;et . ■ al-* ■ 1953) #•'•-The .; block..'-. . , ; 
may be - a -depolarisation'-type in ' the,-first . ' instance1 - but- ■ '
.this.- . is likely to change to ' a, d eson si t is at ion -.type--C see'/-, ' .-..• 
Map ter' X?)# - - • - ( The-dletinction between-;^^h^;-?;/{^€5Sensiti^^sat3o^n * 
stage-, and ieliolinergia'. Crisis hmafie "by" Crpb - . and -.Johnis..*Cl06l) 
may--he '.valid . in/theory as - an explanation-of %’refhacoQii'nGss’ ' 
but - it ihoanneo'essary in - practice .and has - the-disadvantage, 
of -co:ncs^ca^5^hig5tJ^rmr-;' the 'ihexpooienood--, that-bhis, - is-a.-oorm-":'' ■ 
of.-.block .-due - to. overdosago. - ‘.with .ahti^chol-Lne'a^e3i’£^«/.e drugs* .' < 
•Since;,the'term ^cholinergic ' crisis’ i$-'not -Beooss&rily ■■ •
equivalent to -’dspololriaation- blocks* X-see. no necessity, to ... 
.reject - the --teim'■"which-'.has become .'customary')* ' • --".-.-'■- •.. , ..
dentra!..nervous' -syatem- - offec ts. - g'-";;.-,--•-' — " ' -' .-.' =
. ■ "?- j;? With. eevex»a. degrees of inhibition.of - oho'Xinesterase ' 
there'is. a- similar 'Sequence; of stimulation and .dep6o.driaati.0n 
•block: .c>f- '’.central-synapses* -' - Shia may- often-., be- 'suggesfc‘«di by "'• 
observing, .tension ».. anxiety*. restlessness, .e©ooi^^iinij^',.lahili^^y 
'.or 'giddiness * - "-Some - patients -"complain of. insomnia -ah'& . ? ’' 
nightmares,- ' :-- 1 x- is. possible - that - ;a©me-o f - • the - epileptic - 
.-stat'Se; associated •-‘with my&sihohi? gravis; may bq''caused in 
■th-is. way,‘. Headache^ apathy* intellectual' '-•impairment,-tremor 
and-progressive. depression-of - the - ''level - of.••consciousness- ■ .'
-indicafceha •very severe. degree-.'of cholinergic ./poisoning*-- - -’. 
■ The/----"/ ' . ' . - . ’ - ' .1 .' --h'-'B _ '
. ' hef aillX..in bieoa i«BVure to'abQve^raay. .be. a'■'
■'.?central? off cat - - Cerebral' /death? may ensue* ■' but; -in. the? ,'■?', ''
. ' hn&pdsrityO'of' cahe3"hrath is, ,deo Oq. reppinaiory ‘‘paralysis: ? .
I of.••{eeLphhral-type «?•?<■’ - -?-?. - . . ' __ -.• . •/_; -•. =
- '.’t-y'Th:. recognition - of? weakness?&ue,'to; cholinergic'- . -
.. pc?C€^Leg is -extremely; important - .because- - itytheathhub ? j -
.-. .? ' is tdiah@ti?L?eaXXy oo.P9s£@©--;td.' that - of - 'hyasthheiO;-- weakhOErsi \ '' ' ' , 
-higlit.' b@' thOught/possible to-recognise;';a'?'stagh- -of -??- •
.• . --'eq^L^hal^^'Um^<^;^^,'p}^>whLs. -• transitional,.betWh'h.myas-thonioS-and-. ? ,•,‘ ‘•'?
... - ejihOineegec-.weakness*' ?kXe^ifas\t'--itiie ..qui'teeehhnOm .‘fox*:• 
y V'tsmettyph -o.f weakness to -'miooeed -■'thef-othor without ?reiy; . ■?
-"-ph&eyef.-eofhaX power y.Rowland et- ..aXX1-955)? .noticed- - ' -. •
■''"- /this 'when giving- of -•neosti'hffiine to '?’ • ’ ■'
•" ■ ■ ??pyhsthettXO -patients ahd -I - "have repeatedly aonfirmed...- their. .
-' -" " Observation! io t ■■ ,?■.- y? • -:?.-' ": :? ’.,.?• -7??'•' ?’? .' . " '•'
■ - >_ -. i? ■?'• ■/ -yThe;-paaa,.tidal- •i•i-^pox^>lare0. -!pf ' this. ' ob'sofiat-iOn twill.?. ' '
. ' -."-be obvierny vho?haye>trpaibd ,
' •.?';''- prtsis?mnst;'4iavy been?hhpL*£sse& by thh - •ihadequaoy -Of " ’?
„'•- .?.'succ.<essivo 11101.0111011®- - of- -dosage withi -neostigmine/. , ■Rowland - .
. . .' ' v'@t..al?-(IQ??) pepticm- a. case -'jL©qu3.rig^^2-2^<^<^hg>. daily -and, • ? ' - • , .
'.'.?. .■ Rowland-’©t?al? ?(.X9$W) describe, patients- who' failed - to respond ••
■ ? •?te:iX$*(rng«!O>f- neo-siih^W - given /intravenously■ during-‘ one, y' - ‘ ■
<,. ' - hour.*... This - phhn-ohenoii ?i0. tU^’U^i^lL y -a ttribu bed?. to - .re fLa c- torinOsa $' ' 
•?-'' - It -is-"true . that '- -sopefmwcXos pay. become' - atrophic or - '' hnybOpthic *?.?
■.- in - the '•.course - -6'f jnyasihhnia'' 'gravis and-'these -mWcXes. will ' ' ■ ■' ■■
' " •-;• f.a±X-;.t0 -heppQnd?'iQ 'aetiohdlia'hsthL.’&s© - rnedioatioieybut - there . • - .. 
?.' ■ i& no • reaX evidleiwe -.that ■. general -refract©rihess ,can cOicur -??••
•••' .space dry/r^,'- V:tet^s\-(1^^4^49:'ciOn’s'i^d€^3^<^d ; . ''
• that '-'refractoriness ;(is)-'m@Le.ly.ae- aeknbwledgernent ef-- •?' ' ' ’•' "
inadequate. dosage» y ' FL^^^hl"Il;J^•.-orii-;■:n^^}?e,L^•ie^K© t^he--usuai'?'? ' ' '-.,
.- - -'€Xpirmati0a of-.'felpp.aO‘©nt^\?^e'‘O^L•aGto:ai^e^eeifi^'•>.l^^- «Gosrli^h‘2^He is ?? f. ; • .
' - • 'ih©?"P:Le^3hneh Of-•'-chott^nergic- poisonings. To 'follow Viet® - :'??..'.
advice/. t -■'-
.• .advice . -in 'these clx’Cumat/ances could ' be disastrous,; ■ . , .
. •: 'I' / A-furthdr conclusion';made\'by Rowimxd wt' '• all( 1953s) . /
,•/" fOm/ their. experiments ;on/ ihtx’Uydnou's’" infusion: of neostigmine' ' 
... ''was' -'that musclea- /which '/had ' • no t ' been '’OliniOaXly'''wale , ■ • •' ,
.previously' wehe/usually . af fec t ed' 'bimtii tmioouely; -with. "the . . .
■ ■.'hnyaathehic i /muscled/ 'though' *paradQ:xlcul 1'- Obfsex;Vit^:linia. ; . a-
■ .Wre<ma&!h in.'one' ease* -' ' My eX^^^'C3^eiK^c^s''c^JLae^f^g^'ees with ■this/' .
■ .■•c'osiGiusion' 'too /(BimpBon*-: -i96lb )' #"■ '-The ' point ' ia of ' eome - .' ; .
. , importance {in■'tho: 'diaghoslsv of,.the cholinergic state .but'
...discus Sion will bo.'’postponed until' the,Use Uf the •edrophonium'
• . 'test 'has' /been evaluated, I.", :-/ • ;
/ .The' ••"edropheaiuffl- tosh for'' cholinergic' status.- t'' ■ ' • '/
■• '.'•■.; o tThe' 'ph^maoelogipuX basis of. the -use, of odroplipninm ■ ■
.. - for ;'the ^confirmation 'of myeaithejnlav-- gravis ' has ' been .■ddeeribed/
?; ' ,in' ..Chapter ' •< Q^^ox^man %t /al • (1933) .that'/it / ■'■,'■ -
■ m,g]^it'/?'£^^tso/ be Usecl- t'©'/ test 'the '■ ch'olin'ergie “status"'of ■ -.-■'/.
'. . '’treated '’myasthenic'’ patients * ■■ ' If temporary'' improvement '/'•'' '' ■ 
,/. Occurs after an'Injeeto'n* .the need for ' .a ‘bigger" ’dpae ' 'of / / I ' 
/antio’holineet'erae®.' ..drug, -iu . indicated»/.- // ' , - \ /"•/';;'/ •. ■
"../.. . //'/'■'•■ -The.-Usual /doee; dOr'' the 'test' is'-.XOmg*'' ■ of;.■ / "
ip' ■.•: 'The •fi^st'./Bsg, ; (0*2mi»). hhbuld ':be; /injected "
9 /'-intravenously ’and/ the, needle kept,-in place#/ '--/if/'the' .patient .
' ■" ip -hypf oiwi.tive 'to ". the'' -^3r.ug/:,o:r' in ' a' .e/holihergic' /state %.■' ■ .
' / //thim/dose.'may' ©ahae/,/fa.ae:li©tUa^t5/05^i^};. bl^j^lia2^c^f3E^pa«^fi;V^:^!Ssii^^^j3s'v/ ''
. • faintness/and/- sXihht---'mtsoaUinio symptoms# ;/■/Tn./.thia'-event- 
• -• the"-test, should /be/' 'a:ie":bc^xvvii.^t^^^:#' '■ - >If .ho' //11X»ef fed ts- •doci^ir .•■
;/■ ./iin/hal.f;aAwinut'o' /1s /inj ec ted/*//’'. ' If ' Ibbh- ■
'symptom's''descri^b@d';o"dQU^/3I^u ' ithe-. n'esct’" ^^'''ininuto# / it- Is'•.’'/-.■ " . /.. 
•that' no "rnyyathemi.c'■■ .weakness'"exists/, in ''• ihe'■' muscles'
Mien/ 'used.' •' to' tost' the ' . ohblinb'rgio ' statu/i -the /timing •






of the test is important 
patient in whom tho test 
best applied.at the oncl ' 
h as bee n adm ateredo
* . Ia the average myasthenic ’ ■
is used to ,adjust' dosage it -is
of the , second hour after neostigmine
A jwsitive response at that time
indicat that the dose of neostigmine is insufficient.
I n 1 a d equate* t r eat tm on t 
overdosage there will be
no response will ho .obtained5 in 
temporary deteriorat'an, A false
Impression may bo gained if the test is carried out at the 
end of tho first hour when the action of - neostigmine la 
raU&I as - a-patient may fail to show further improvement■ 
with edrophonium' at that time even though treatrnont is - 
inadequate. Conversely, three hours after neostigmine is '•
too .late, Eve© a ’null response ‘ at that time may indicate 
overdoaagc. The beet timing for the test in the control 
of pyridos,tign5ne therapy is less 'certain but’ the two-hour •
test is probably satisfactory provided that absence of
objective improvement is always., inter-preted as - indicating 
optimal or ovordo'sage- iosseman-' et.al, 1933)* At times of
crisis the t t may be.used at any time'but should not be
repeated more than hourly* The concept of ’titrating, 
the cholinergic statins is - sound? but I have found • 
difficulties in practice, C 8 • )•
Death due to muucarinic actions
The. following, case died very .soon after an-
edxiopho.niu?fl test! .
Caoo MN3231* When aged p4 she had' 'bilateral ptosis 
whioh was soon followed by difficulty xL© chewing, 
swallowing and speaking increased, by - continuing the 
activity* 8ho began to have double vision and weakness
of the arms i© the evening, Mya^xtheHia gravis was
diagnosed. 13 month© after the onset CSir Derrick Dunlop), 
Satisfactory/
Satisfactory- control -was-',achieved/ with.-’neostigmine&. '
•Six months ’’later.; her.-'thybus;;was;. remoyeiby .Mri'Paterson* •••' 
Brown*/ ; The ■'improvOffiOnt /experienced Was.••not1 .maint&i)xM--\.' 
and the ddse--'of; neosti^aia'©; required/increased '■ • •.-••
gradually ' from > ;,to - iSOmg# ■’ daily ♦ ; Her condition;;
then remained unchanged.' for : seven 'years-: until', she; ’■ . '// ■' 
'became, pregnant#. "/-. 'Suring' -the ’■ first - trimester-: she ■Had'';' 
it -myasthenic' .crisis--' of.dyepnddai ' -./-She improved after ';- ■ ; •, 
terinination.'oi'pregxicxhcy- but- hOver' regained her former .’ - : 
•state-.- of ‘welib'eing' and;, regUired ;'2S'9^3p0mg'a:'/of '; •' ■ •" '..•'•'• ?.•// ' 
'hepsfrigmiw'with, gr.ij'-ephedrine daii-yt’;./ ■ ' ’ " '
/During the"last-.'fhree .years<df;heV,life,it,.. -. '. 
there was -.coarse fascieillation/of/the-,legs. which had.-, / 
never?shown significant, myasthenic . weakness«• -Myopathic •.. 
changes had Occurred; in,; both’/. triceps auscles. of ‘-the•*" /./’ 
tippex/ limbs §/the- ;ieva.tQr''pi^ipe?braev;.;mas.seters9- -and -. 
tongue3 ?-hut/the Mother . muscle^fof/frhe; face$--ae&iy-and ’ 1 
'upper, limbs still.-improved, with, injection’s ‘/of -edrophonium 
or. neos frigmino/ after ’.temporary'; withdrawal' of/the/latter# ■ 
■/ i_ In'. June;2958y/the-;- fourteehth-'year -ofher illnessV;..
;>lhe-; was •'.-transferred': to" the .Korthora; ’General -’Hospital /.,_. ?.- 
under,.ray.c.are .fro bje'-iiear--facilities'' for artificial-;” 
/respiration' as it ,was’!/apparent that increased?'•-/ '. " ■.
iaaticholinesterase/.mpdicatiba; jvas ’necessary: for the \ •.-/;’ 
/bulbar .muscles/despite the t presence-, of signs of - ’/.?/ h;;' 
.'overdosage la .the; lower . limbs« ' The vital- c apaci fry of. t" 
tha lungs lyus/-'temporarily, increased- by’ injection, of - -. - '
X.dmg# edrophonium /from SOOmi# to .860ml* . ' This /’ indicated - 
•that, the‘respiratory;Medlawss:-was..-...fflyasthehic/and:'.not-: / ' 
Cholinergic«/ //0autious..increase of dosage.-.va©’- therefore 
peiviiitted and: the-patient. ';was iu.sfrVueted' hmv"to-".inject' - '
, neostigmine. - in case of.: emergency«-.- / /;A 'mechanical' support’ 
for/
/ g.'/// .■ ' \ k■ ■■//;./
■■ '--.".for • ,/Me /jbw" was," ’’provided,’ In- tHisi way she.,. was/able '•• ■, .
' M'./to’.continue •■ in {tolerable/comfort’• f6Mmd:HXWhaM/'y.e4ir '. / ■ .
■’/ /- /MeW-hor " doc tor'recpuested-• emergency admission*/ '/-Aopjrt';: /
' : Worn’• Me'/obvious/distress/her• -• //
• bhjt-" sher staked that "’.©he’"had- ’faXi'-unwell-and’ very :/ ■ ■ .< .•/
/■/■ ■breathless'’-fOr’■ several'• daysMikbough siioghad greatly” -
; ': Increased hex/ do'S'e-:' of 'n^^'oist^^isfi^:^^^i^;bh’'y:^;5 m^ou^i^l-)# / • ‘ ■ SH& / . - ’ .•
' -■ ' was extremely• -'nervous/’ and’.would'’ no t --allow• . herb tihgUe'’ and• ■"/• •
- jaw• to/be/held ■■ fIr^Wardbttho^^^hh'tb^3,^5' aided ’ / respiration,; // , •• ,: .
/ The/ amount ’ ,of- neostigmine • -/taken-;waS^trnknowh' • ' "The"’; / -•• ,/'-•- „ 
'.bpojssi hility of '-o hoinnergdepofiSis"- 'ra ther- than '.’• ."/•- • , - , ,/■■/
.//"'■' mf&oMoniqh crisis "was. considered - *{-' • hFas©icu-latieii/ was //, ' '.- 
' , marked -in - the” iegs - but 11 tile worse 'than .it • -had; bdeii’ •■ ' ,
.':' ''-for-/’Mye&.rsv■""-'-'The pupils’ we re ’.not’"con trad .tedl- ’ g.^
■'-/hi/ • .‘Oxygen 'was; given by/nanal catheter and • the..muscle • / "-. ■••;'
aendpplat as I .were hies ted -by''- hlnjoo tion.' ’oM edrophonium-- . •'-'■ •• '■ ./.- •
■ , ‘..ihtrawenoublf"./.f Atropine,• sulphate/gp-*l/1Q0, wa® mixed ; ; .
. ' ‘-w^-th’ '.'lOrng* kedrophonim# f An initial • /'dose ' .©’fgSmg.;h.had / • "• •/ 
' " - 'no-''effect :ke _ injection • was "bon tinned, • ■?• /'khen-3mg;’ -"{had -./ /<' •-•
•-. ■fobesr givbh''i'ehraSptratpry.7exeursiehhwaM'ooixeideyab'iy ; •■' , /, '
'. /-/ 1 improved’’but' she "complained•;Of'-'a '• burning . sensation7'±n ’// .• , /
.-/.."•••:her’-eyes ? salivation,- increased-.and' aho ’.wad /-unable""■to' / ., -•/ ,
■ h ■ *sW&llow■.sufficiently',xnapid'lyhtd ’ c|ear'-it.."». • " She ' panicked , ” , -
- • .and '’ -not ''keep’.-.hbr/liead :in • ©,’ position-tso-.pejrn4.*fc ' ' , h-•
" - ’•b’free respiration* .The/jn^o-kioii-was’ discontinued .'but- . '
• . hishe-’ suddenly lost; ponsciousneBS# t • -. - ’’ / ,
' /. /respiration’.was/started ,immadiakefy;" anj/the • rate '' h • ,
of /khcromygeh’ was ;increa^©dcU" ' / •.Mkethamide X4m3" ), *.••-’ /' - ' ■-. ■" '
•, *. injected 'latr'&venously 'had • /no -©iffept*; • //• Death appeared ; - -
.--to be iaiekaatnieousn, //Faeoiculatich• .•continued .after.-"h •'
// //death 'in ’ the legs -and was • • seen • in th'e ' ;' -.'
h''Upper ’-limbe ■ -for the fi rst.--tithe" / . h *./ •' '. ; • h '. '
/■/' ’ 'in/ • ' • :•'. V - ' ■’•-
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.<■- • /-/ .In ' this gcaGegther'e' was good-/reason-?to/ believe-•-*'•' /-
that -/the . requirement //for "' neostigmine .was • increasing - ... /. ■ - 
despite/ the presence • , ofgpepsistGxit - faBcioulatidn• of-/the ? -•. 
leg' musolea# ■ ■ Respiration-. was? in-.’ fact? •’improved ’’toy 'the 
.injection •of -/edrophonium- -but - 'the ■patient/was asphyxiated , 
gb''inhalation of aaliya ' and bronc^lii£^jL:'j^^(^t^<^-fct^:6r^g^' -€^ee5j^3L'te. ' • 
'the -prior '•'injoetion-o'f .-.'atropine. sulphate (CUlmg*) ' , ' : .
intravenously// .:/ ■/., - /' g _'gg. ..
- 7’ . ■' ■ •//The . '•.additional''muscarinic-. effect' "cpuld -also .cause 
death by .ventriCilar ..fibrillation-.or 'cardiac' -“arrest--as in 
'the?- following:;case--in- ■-which • -'this- eventghappened- .from ' .• ‘ , g, 
unrecognised?;0verdppegp f gnao’Pti m$n© - wxtheu tg the - add ticm 
of .edrophonium* g > ' - . g g-gg //•/'•: -/,..©••/'•:g?-
, ;. Case MWB.2237 ?--i’he' early • history of thia .patient gha© ' ' .
v been/.described ?xn /Chapter- 7 - and; the 'unexpected- autopsy 
- - finding of/Hashim©to -s- ' .-disease ; associated . with ■a' -thymic 
’ • 'tumouri. /The ''{delay 6f- -ff gy.earh' in waRinggthe .diagnosis
was. perhaps -''justified? as • she ••Wo? •• indeed?- - a - /nervous - /'•• ■' •
. excitable woman* • ' For the same 'rea^ssoy^^gth® ominous- ' ” ■
’■ significano e --of .he adac he . ? belching pa^d . 'heartburn*' was ■' .
■■• not appreciated- when"'she'- was admitted to" the -.Northern- g­
/- -/gG©nee',al-- Jloo.pltal in - the - seventh-'/ gear? • of , her - - illness in g ?
, 1937. # '" it -' that -'time .-.there" was " general-acceptance- of - .
../some ; muscarinic ggympfccsfts' as inevitable in the". treatment 
/’ of/sayyet.■'mmasihenia/•gravis*g/•'?-'.?/' ■ "' ■ "• . •' ''/•■- '.’" '. ' , •
■ ‘ " 'g- Dosage was progressively/increased '.because/0 f- ■ - ■ / g''
- *g of-the muscles but .when , >. ■ ‘ '/
' •/-diarrhoea?"/ ©Mea^hg and-OCeaaiGnal, .-facial'' twitching.* ' •■■ ..
‘ i- ' appeared-, ©h" a ' ..do.se-, -of" neosMgmine"'. 73#$*- "and /pyridostigmine
..30 Gag* - a every • three injure? -•" "the" dose- /wa - reduced and,;, .?;• ' .
;.? /atropine/increased .from -'P/*3mtg?Afo' ly2mg? every gthr©e ' / -"'' 
■ ■ ''■houusigg .gHer " condition .did- .not' improve - and, three /'days • ,• ''
'"•■ •Liatejr//’■'/•• • g /'//' '/../' ' '. i-." a g g ' ; ■
 
 
, V? I .. -/'- // A 07,. JX0- ' - </.?< " . ; '? . ' .
" ;; late-, She' '‘.'suddenly "' loat;"oonsoimisp.essl ’.• /She" was• "••7- „.
. A; routed; dn a' .few 'Mirate's . when" oxygen ' Wss&drMnnefcdred ,■ _
.. /Ibut {vasoGbnsiriptlph ?wa& ; no ted" ' and /puXaue " ;bigeminuo»"_. .• ■'/ ;
; "/-/Ahon-t/ twenty. minutes. ' later • her" ..‘heart lahd iwpif ation.. .a,' ..
stopped -and .,‘oduldAnot •• be'restored,byyaatifioiaX ■-■". . a ;"■ •’;' <
: ; . .respiration*- A• .A,";- ■.777; mil o/;,7A-7..'.. 7 ■. ' "•
A 7t■ ■ is 'neWohviotts,’that. the..qd'gns; of. overdosage. ;.;'\. ' ■ " .
•wwr.e,;.©r^^?^i^i5^iy' underestimated ".and; ' that • the;, larg©dWosage •," ■ . ••.'
oi^/'>a^''t^o^'h.^,l’dLne©tc^3^*aeo{«^:^ttgs-wauU'©od^^enBrd^^^u3le^x^'kVfL%lX^l£i^jtoo;-.’ '
or o&ddaeoWrest ' 'despite atropine' protection • of . autonomic.. 7 
'synape.^iBo-.;.' AK(&eoStLgMthe■.ia ‘knownio; •potentiate, vagal '-7A ... , .
ref1 eXea./affec ting" It be'"-heart and luhga" . (Fimaae • and • 'Geiger? . • 
‘X952){-.and ;it• mU©tAhe/assumed "that. edrophonium -.ooi^tXd• / /A‘ "7 '.‘.A
teaiponaaily 'potentiate• this ".action " to a degree which • could ,, 
bo t^€^np^roiis 0. /".. A / 7 A . ■ ' , /' A.. /; A -
7'7'. 7Bo.ife'';' of ;those- fatalities ■ occurredydospit/e''"'.the a.: ; 7
;±nirasW'iua7 in jOOtibn of " "atropine " ," ''sulphate / ( O# l'mg« )■• be fore 
injection ! ofWdropheniM* , a' Th la" whould I never,, he"' ©mi t ted ■ ■. •■ "•
'when the.' test. is ..used,foropep'ected " cholinergic^poisoning"* ' '
■yfffcyshtl&iu^hieoflfiieAa.etim A- 'a- "S , . /''.; .., . " •.
, I-V -A-; g The • edrophonium• ;tes t has one/inherent " fallacy "which ' •' 
-I.-"have'.--reported• . .-(• Simpson.? 1961 b) ■' but.’ which • has 'hot^./'been ,7, -. ;.
published •■■ previously*• ". •.; Xi -.assumes • that • -the/.muscle /tested .. 
•during'...its. brie?-.-period' : of‘ action... is’ repi’esen'tati^ve .-of',air ■ ’. ••. 
skeietal muscles* ; ; •• -Apart//from the "•possibility, of /.^ialtecti^ng .. • • 
-'for;" -test ".musOleb7xwi©hxhave •/'heeome "unresponsive" .from -?a,' - • '
■1 myopathic * -chango £ ; i t‘ ’"iw.ll; be, .appsarent’".f'nom, .the o ase.. his tory , 
.'■j^^^^.s^/,dds^c^rr^l^^ed ;;;that't;^^O‘mc.i'mx^;5clo^\" may ?impfbVe.'‘with'" the- 7 - '' .
."addi"fional. antioholihesterase -subsi&xlc'e•. /while' others • do; no't 
or/"get •". worse* •■"■'■ further ,example vo£; this■ phenomenon may. be ' 
,&dbe.riby<e4.; '7-,-;/'/' ■'-'• v'- AaA' ’ 'Ael A/A.. A':-- • ''";" '■ " " ‘ ,'■
p/A-.- Oaase took izoceaslngiy large'■ d0seie..;-Qf" pyridostigmine•
. •■';, 7td/fi^^m^:rov^/-€^3^^y^’'"-mbVemmp^te5 -'and to' ■relieve ptosis* '... ■ As-.thee© 
a..;' effects/ . . ,A • ' ■/■..,/ V "• ■ . ./I'A I. / 't- ' • - ' .. •. ■ " '
511
effects were achieved her limb muscle's • first 
fasciculated and then became weak* Mien the dose
was reduced the eyes deteriorated • but her general 
strength improved* .
These oases, which are representative of many, 
show that different muscles may respond • in different 
ways* Those which, without treatment, would have a
marked myasthenic reaction may improve, while the leas 
affected muscles are unchanged and the muscles not affected 
by ffiyasthenia become weaker* This is obviously wtocit;
might have been predicted and is apparent from the protocols 
of the experiments described by Rowland et al (1935) on the 
effect of intravenous infusion of neostigmine in myasthenic 
patients* A diagram from their paper is reproduced (Fig* 19*5-)*
These • authors' were unable to understand vhy overdosage might 
not be accompanied by fasciculation or previously existing 
.fasciculation might disappear, A consideration of my
hypothesis on the nature•of drug• action’ (Fig* 16,1) 
will show that this ■•effect is a predictable result of 
increasing accumulation of • acetylcholine at the end-plate.
The normal muscles suffer a ’cholinergic* block with’a 
dose of neostigmine which is still insufficient to maintain 
optimal transmission in the severely myasthenic ’muscles,'
It will be recollected that it only the *normal*
muscles which show fasciculation in a few well controlled 
^asthenic patients* The explanation for • this distribution
is patently’ the same* It accounts for the fact that
fasciculation may be tolerated for an•indefinite period but 
it is unwise in these circumstances to attempt to achieve*• 
full control of the myasthenic muscles. The quandary in
Case MN3S^1 (above) was that the affected muscles were 
requiring/
 pia*
requiring still dgreWcr,-'dosage .-of'’'neostigmine 4o .combat-‘- • ’ 
increasing’ myasthenic/. weakneiBai/ ■ The /-improvement/ in .,</. ■ •;• 
ventilatory capacity/after edrophonium •,'£©- 'clear ■vidence,'. ' 
that, the respiratory -muscles .' were © till-*. underdosed. ••//•/ ■■ ' -
This -'experience leads/one ’to . disagree -‘with’' --the ■conclusion© . - 
of •■Rowland' et. al (19S5)/-that an^'i^c?holie€^atere^©s>‘d'rugjS'/ - •
affect •all-muscles xii"* - theZeame" vmy - 'aidihe •ssmt©; time;. •-.'•■’They; '"•„ 
must ' he *tita&ted? individually. . /-' ■//•'■•/-'■'. '
y . Three^lpsyonic.mm hc' learned -from'-this oxpCrienCe -» . 
I). .incipient.- -cholinergic - erioi$-'-'xd,thd /'/. ‘ ,
edrophonium th e - f1 rs t muse Ids--,.to. be' ' ’tested'-should. . be- • ■those .
-Only Wen 'it , , is- apparent '■ ■ 
that • these.tare -'.not- .deteriorating•‘shpuidi atiehttan be paid - '-
to-- ' otheri'umsooeo* '.- -../'Thv- deltoid Muscles -' " o f - -the-- arms' ,and ' the.• - 
^lexM'muscles . of "' - the ' ‘heck -arotery /•commonly. -affee.ted . . by --■ - '
myasthenia ’•. gravis - but ' rarely- become-t ©sis tant, -;to neostigmine *- 
They.-'/shpUid ” .-be - tested '■/ next *. - #he^^/ocui£^a^;tinec^l^^^s, which " - •.
comnoniy - becomc ^myopathic4 / should-no the ,-usCd' - .to test for - ' ■ 
cholinergic: status. %/'.;/The 'short time-" available.- for ' testing •’ ;
,should -be . used - ,,£or,..mor© - . /vi.bal.,and/.consistently. ■ responsive- ...-■ ' 
muscles#. "- - zii')/•Some..-gpoppC'/of. muscles" -.may- -beoverdosed-/by - ,. -:.
'neOstigmine ' ..while .-others-'are-•.underdosedV-.'Hi), •.d--wgtlve • '••
response- aho-uld- 'always "be _ considered'/to .indicate 'incipient - - 
cholinsrgio, o.risi.s#/./ .. Fur£hermore>Ia statement'by/thq --patient 
that - he,, /feels -stronger* - should never ’ ’/be;. ".accepted .’a© "'evidence'/ 
of , improvement• if .-no. objective’ evidence/ 4©; Seen 4he‘/test
should - always, - .bo int/erpreta^d as " indicating:? potential’ .danger* '
■DifferenHaf' ,diagnosis/pf . -chj^^is/ ’///./'/ •'/’ -
•';? Mien 'a"patient 'does " hot /continue to .improve, or •/•-,' ’ .
actually- detepio.ra'tes'deepite /fnoreasing/.&qeag'p of-.'• ■/ ‘ '•
anticholines.e.ea&se. -drugs - it /must- always .-be - ecnsidered.*.' Whther 
the/'-'•,//-.■//.i /-/. /'. ■ ' H /. ■';. \ /’/
"the' patient ie,: bolhg ovOrdosed'w.;• -. Many apthbrs hay© stated 
that', the possibility ;;of -.giving. 'too; weh- neostigmine. to' ;a ' .-- ' 
patient- with.-respiratory . failure, is^rejao'teiand > that .- there ;. -• /?•' *
. is a ■ greater .livelihood ’ o f: giving .inadequate amount©, - when ■' 
..aypatient. is?critically.-, ill. but. aot^Ia/.-.a ■ respirator' (Harvey«..-;
: 1.9S&V;VietS| X9M)>\\ ; My? experience.-of': the?/last ;iO':years;.; 
"leads me to 'the.. * opposite, cono lusion* - ? In ’ray /.Opinion’, the-'. / . 
majority 'of "eases/of ©o*»cailed.-9neostigmine ’resistance’':'
■ and ?o.f •’crisis’, o<s burring- despite -/'previously- adequate' - 
treatment -have" been 'duo"'to -.,over dosage..a^lth; an tidhblinest erase.- 
drugs*"’,-. .7. .. ' -, ... ' ’ ?-?
:/.'Oh-reading-‘tire\brief?-.case\•histories-provided In’ 
illustration .it' might", be; cone Inded;'that.-the diagnosis of 
incipient cholinergic■ crisis '-was easy*, Unfortunately this 
was not the .ease* ;. Although", suggestive.-'signs'or symptoms..,- 
have been recorded chionologleally. In the... case reports'j • .they. - 
were -'some times-.; el io i ted-.. re troop ec ,fciyely,‘ 'by,. el os© qU e s.t loning ' ■ 
of-: junior'-'nursing..'staff'who had? hot; appreciated. -.'their.-.. .-• ••• 
significance0 - : garly symptoms wex*e ihere.&sed .Wealings colic» 
•heartburn, diarrhoear muscle twitching.-ox* increased ?:' '
restlessness" iFhe- nurses^’and .Indeed ;the • house •■•physicians,, 
usually-,- bo'll eyed'-that 'these symptom©;' resulted ‘ inevitably: from ' 
th© us©: of neostigmine* - ' 'Though they may be compatible .’with 
a’safe’.level? of - dosage‘they should.: always be considered, as 
evidence; of/possible danger *••/.?.I .have found/that- raeasuroiicht/ 
of the pupil diameter is.helpful?'. ?Xf it is 3r&olor larger .. 
-in?normal ward .lighting there is little -dangcx% 'Xf.lt Is -.'
'Ohly; gim* it., .is? possible /that ’• the safe."doh©-' has. ..been exceeded 
and at/Xttwu.. thero- is;,.littie doubt /about -. the presence of 
-'cholinergic'' crisis*?? "• poubfc ?may arise, however?, -if- there, io; ; 
respiratory- lnsufficiiency,.as;. the patient may then show. '•? 
■mehtai/'- -■'■?-■/,■?■. . '/. i'-;. .' ■..■- "/•? ■? y ?;- I ? '; -I
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■ '?ConfUuibos/ .'Apathy?' or . reatlessues© ?; wdaMn--and- , ■ •• ■ ■ ."
miosis -due 1 • to .anoxia-,'.With /darbon'-;dioxide • petention • (Table " ,
/19$1# -• $i mpson ?'/1954 )4? m .This ' diffiouity. is '-illu o/trato d' • . '
‘• by dase -Mj$5Q9$'■. (vide? Infra)* : ’• •':/"/. , //-.....A '-■■-A A'//-"/
■ '■ '■••' /Muscarinic' '• bymPtMa /may • Mot.be ■• prominent?' .•.'•*-. / '
^especially, 'if '• atropine'/has/been used TMCd>hy.TLaao^.eaa.il^/."- ••" / .
- in• these 'eases , abho; /diagaosi©'' -of ' the aeau©© '.of .inex^easing- • ' . •.•
muscular.Wea&ness 'Can '.bo'-very difficulty ? Valuable • -clinical. 
-"Clue© aW""" --A, " ."- ... '' ‘ • -/ ' "■■ ■• "•■ " . '
• faseienlatidh is '■present • in .any ' part of bhe?h©dy '•' • '/. ' 
A/; /'-the • •.condition ©bouid be .'.considered..■eholinergie .-until. ./ "
' .. •••’ thia i©/disprove*../-;' ■ , •. .--/,-// 1 .;■ ‘ ' . .i ".■ . •­
ii- ' /If "•'the '-'daily -dose? .eXceedS''$0Qm&m{ of//n©ediimmine. ©rally. •
/ /-.- •i(os,-;i^.t^^"l^<^t^:^vvi;ent)}?Qx^..i^:f weakness; 'develops Mthin an " •
-. hour ' ‘Of• taking -tablets' -it ' is 'highly • 'probable that it. is
• ■ ? • due. • to ■ overdosage A?eBPesi.aXXy if. there/is no' ' •obvious • '" •;
? //caued --for- •myasthenic- relapse! x -On ;^he ' Other /hand iT// ••
■"• • the’/deterioration /-follows- ah upset -or' occurs, ' ,
..' •,. in -hli©' course 'of. a •^pyrexial• illness: i© first /noticed?
/%. y -mGre'.-than two'/hours '-after/ the •■-last /dose 'of ’ . " " --. ? - ,
?■■• - ’ anticholinesterase' drug? -ft{my/be'r&ue' •/to-.a'myasthehitf/.
• .. •' .relapse? -/This• is moot/probable /if-the daily dose • is-: ■
• ' leas© • than ‘225w.g? -Of neostigmine.'-Or •its -equivalent;- • - ?
? / / ' It is in • ihe'-d'oubiful /ease, /that/the -use of • the ’. -' ' .
edrophonium 'test is .most ' jh.wtf fed*?.' ,/- if all '• the ' ‘Giroum/stances 
•■p©int ' to?/the' probability '’of' cholinergic/.Crisis it • • 'is not .■ ./
advisable to. incur 'the .further .risk ' .provided ..by injection /of . 
■edrophonium* It ' is • much safer to 'ensure' maintenance ' of/
-respiration by 'an artificial ventilator.? 'to inject• .-atropine, ' 
smlphaie 0*!mg*. intravenously? 'and' '. ta 'give no. 'moi*e ncosigminc
. So' ‘long '-as' .respiration !©•' 'secured '(and if necessary







< there/should •' b© -no'' ■hoai£&ti,0sr In - performing. .a^traoheotomy-,• •• - • 
-;.;.- /for.,,-this . . purpos©) . ±t - .la .. safe. to -wit# ,■ .'If - weakness is,.... .. ''
'.’, //increasing -in/tvp/'diours/ah . /edrophoalum■ - 'test may '.-be..'applied - ,. ■■'
//to- ebmfira- that /the\weaiii©es is myastMnib./lm ... type* ..•.If . -, '
■ .'; /the ' •condition'• is .''statlo ■ or■ 'improving the. test ■ 'should 'be ' ■ • '•
' / ./delayed/'for;-4t ■ ':’1 east : S'/hourbi--: . /-The. timing . of'the. test.-: ...' / / , 
/■ •;•vith-fegaMito. the . most.' recent-.mediqation should . otherwise-' •,.’
.'.■//foilow-' .the . rui-s . laid. down' .-above* • =;> i ’ '"‘'■/'•' .■//'/. '
..... /.'. \,,/5^hie'..j^ollsr.--or;/Marvoy-fe^£^iland test/may/bo useful ...
/-•••• in''- dlff er—ntiating/be;'Weeii''/?mre^a^1:hen.l0 ■ /and.phoXlnergie / ,
/ walkiesa* / in'/the/pres once of 'Cholinergic '/block/the .first '
/.' /twitch and /it— .ac tlon^po tential ' should . be . ' greater. than' : . /, •
aif sequent ' responses ' /but-/ the./ later' ;on-s?, 'should remain /at /a 
/-.'.-, subnormal -pi-team -level . without 'ehowing, .
t/esp-nee typical of the ' .myasthenic /.state* . /i .have found. / . '
' this '•prpc©dnr©<helpful, ip two oases .and now have '.a.suS^^L'..- ..
•-./ ' h—tieryldperabed tranei’atoyi sed ' ''-;^:Lmj.L^-bor;f'Wlhioh; ' 'enable.- a ■ /
/ ' • 'Jolly-test''/to be' carried 'Out. /in ' /'the ..patient? s home* // / '''■',r 
//-Unfortunately no .perm’ahent record of the response ' .has. been ,
. ..obtained*,... The ./min.,'—to 'the. ' method - is- one ' already
'made' With ' regard t.d' the./edrophonium/testy'namely-’ tU© /possible 
/-/ ' ..fallacyinvolved'''th ' e’Xtr'&poi'atlttg' flip-findings' 'from ;'one'' • ,/ - , ,.’
‘ nervemuseie ' 'c'ompex to; others * ■ This/problem will ' be ' studied ' 
further as .''occasion arises* •' ., / < /' .'/.-?, ..• /■ ./' - . / '■' .
' .• Treatment of cholinergic. cirxsia.. ■■ .• •.'., -
''" / // ,rX£ ' increasing '; weakness' . due to ■overdosage-of - . ... . ,
. .. /anticholinesterase drugs is/recognised/before ' respiratory.
. ■' /failure/ takes ' place—it. is .©^llfiCient/■-tt/;/give i ■
. - sulphate. 'Sing, .Sntrav—nonsly '-and to' ' o.mit / the. next ..dose'; of . •
-t .'.the ' drug. .. The ''.edro.phoniim' test should/be repeated .every"
t wo, ' -ho mcV..' no'/ mop e • an tic ho l i ne s ter as e. ' sub tanc e , gl v en /. ,
until/'-. //. -■' ’ • '.; •./ •• ' '■ '/■/■■ '' .. ' " • .'/’- '/ '/■
•W.'1
umtii>there/, is - 'an' WteqttiV'o’oaXi -improvement , :with "- edrophonium# /. -, 
:{ .. If .there is'.re^]^PL:rat^ory{.'^iat3^hre?;/the :patient .■Should: :,
he • respired'- .through -a -puffed endotracheal''-..tub©#’' ■ ' .Thia
'be replaced; ;by;a /tracheostomy.. tube in..24 hours-if■ further- ■•
. artificial,•yeapiration;ia '-aee©asary#• ';This ia.a.much moire ■ -> 
.-dangerous • state. . than the- ’•myasthenic '/crisis' because/ :0f• : the; ;{
haemodynamic' changes''present,anti -ithe. .possibility of /•■'- ■ ? ', ',• •■ 
so .intubation "should 'not be -delayed# -'There . ' .
.•;Mil ■be\up' worthhWihl©"• rdo pvdry,in" ’■ another;• hour;and ‘the ' / ' ■ _■
•patient may' i6se.--h'is ehanoe ■ oi'unvi'&UxXii. • .;Pasliy^^■'■1'-, . -•
'ventilationr of ; the'"/lungs {is. more . difficult in .cholinergic /
.than ih-;'na^^ia^s’iihi.eni^G. crisia .bOpaiiso ' broiiohwpam- may be,' -■'..- •-’
1 .presentV /■ ' Thia —WH cause difficulty- '^Wbh/''•iWe^eyale&-•or . . •
' .ares8ure»ayGXod. 'ventilators,"and aare.-mmutt' be taken •'■to ensure 
. that - /the -minute«vcltm© of - respired .air.‘is '''satisfactory#■',.
B^c^:^n^hool^lloea^.^tdf^^3■ to the 'difficulty; but.,.should-.be-‘.minimised /- . 
hy/tho /repeated' injection of - -stsdipihp- %uXphMp#;. This; should / 
-be:", given' - intravenously ;in,-‘doses of - 2mg.‘ /every" hour'/until- '• ,' ' '
.-'attsaarihic- ;signa abate.- or /signe of atropine _ '•. toxidty- appeauv/ /
' The'- latter.•-. pcss^iibitl^ityjr'ssl^^ju^^^t^- be. .considered-. :if - restlessness / . 
or - oomfu-sion ''develop /int.-the. well / oxygenated, pMlent 9' ■ '--,■.'•, •-•- , ■ • .
. Ouy&re’ as j antidote's;/ . - ."■/-.•/ ' ,./
/•- . ; .Atropine /-nais- no significant aatipn- on.ithe',-'-;'■ .••'/;-- ' :
neuromusehlaf •junction' 'of a skeletal; muscle * There: '-'are < < '.
't^Wo;ppos’s.^b/le approaches.to: the -problem/-at ‘this.sit©-1) to •;.';'• 
. r.e%tjvate ohPlinosterase,', ‘ii) .to; displace - come ' ;of’ the. "'■ ■ ‘
';ace,tyIe.ftl.Xino' fr.omi'endmpiate rie'eptorS''with d^tuboenrarine . -
./(19HXfe)o ■'{//The- latter Ja.paJX»ot^ch^?./'"Whlch' is similar' -
~ to/'fhe; ;us4.- of "'atropine /in ‘the ' . treatment /'of " muscarinic; effects, ■ 
has 'noti.been reported'. 'by other workers "Better result© ' ' '
might , bd'-jexpec ted /.-If -this"- - form - Of - treatment cduId - /be -.-•/ h ‘ . '
; controlled/ . .. . , - . ■•' ■ •,.••' - .. ' •'" . / .;. .-.. ;. ", ■’ ■
■_dohtrdlied''-by..iel©ctr6^dgr4Phy.*''- / //ifi///'! . ‘-'/t ■' :.’-'
; ■ -" - OasoJHMTTSB#,- /hhis ;i^'year’did - gi3^3;yesc^mp^^ai^»^d -of-/-V . ; V... \
' •■_- -x'-’©wiling® -.'of; Mr eyelids;-and '.'pain iM- the dalyes whoa -' ■
'■ .'"' ’ :waIk'iHg* - . Her -arms-;became weak" End'-aM" --notice# {{{_■•■. v ‘ , 
:- . 'ihereaaing-■ t:^^rd<ln0sa.;1aa''' "the-; day ‘wor'e'/on* .•;. Dr*. D*H#A/- Boyd ' ,
•" -Wad© .a'diagnosis -..of /.myasthenia 'grayis- -.which .Was; ... ". • '
; •Confitmsied- when site i wa.s " admitted '• to - the- " Bastern General -, ' -.
:V ■■{Kps;piVts^lLv{Kd:Ln^i^u^r^lh^';:^Dr^* 'Ai-Bube)*/' ■ The'ini'tiai, / ..- '■
-". "{ response 'td'. neostigmine was -'.‘exo ei 1 ©nt ypbu t -aft er/two . .,-
,.-" -.'■{ "'months when-1 - 'first Ww'/Mr .'ah©.;-hPd.’-becOme/ - extremely _ •-,.■: .
-.' ' '"■ "- /Wak" ’ requiring'-4 ■-tablets (bbrngr)-.of neostigmine .©Lxt» - ’
'■ ' '.fiiouiftyi/' ; • .'•■ .■ ''.'•■ . ... - ' 1/'; ■'..'• .
., ... ;, ' '-On , 1/5/57 'she' ■developed •pharyngitis, and - the ;’ , "
/ ■' f . myasthehia'- :be.e’ame {more -'severe "t {In -view,-of ..the '-increasing - ■ •
. ' ■''■deterioration - despite..ihcjreasLmg- ' the dose -of - neWtigmihe 
’.- • - / - to ,L^nt^i^«LniWoeiarijyi^^^ve3^5r--r>,^houf st it ..was. decided ' ' - .
" , • .'.v.dn '•9/5/57;to -remove - her /thypius/,/ tnitdiight she became . -
very ‘weak; and ronties©*'’/.Sh©: was 'given ;\.Omhppon 'gft.-X'/6' - • ■"
: -■.,'subcutaneously..at-i-lopp/m*t. At l*O*m?i-;- on the 10th V-ahe-- - ■
, •;-" ;;;fi^s^Uddei^,?iojBt.t?co^nnci^<^iu"sh©as{andfferdhthing.;stopped#. .'" The-
.. . . .. pp}uP^.fj;-;w.er;e<>nt;rra^'bed 'ah'd'-thferdwas apasm .of the 'jewy.-■■ t-", .;'
■/■ - muscles.- ond; excessive/salivation#/■ Opp trolled;., respiration ..
•' wast'&taated by an-"ana^©^£}iie^L^^.^;^';^Uutssh^>'■waa •• certainly{... • -/ "
' -;■'; apnooie -.for "dometilmpt - llrs.aw-Mr-"after respiration"-' ’ -•
; . -.was - reTotablish'ed -•'passively#'- • .The history-suggested- . . ;-
•/;; ' • myasthenic-'iritis/pP©e■■elPtatW - by,$'\r©$pirGttory '‘depressant 
. ' ..’drug/-but on questioning -.the --nursing■-staff- it-vaG found - ‘ •/• '
• ••.-.. /-'- that.'.-.the'- p'atient'.•had complained Of -'''ahaomn&i 'ph-in‘<^nd . '"-' ' .
-. - headache " -'earli.priin-the- evening*/ttSihco -these-symptoms . '
. {pointed, '.to - -'a- -uhpiinorgio :orisis and - the- small -.pupil's. ' ,' '
- ■-could 'be.; due " to ''neostigmine poiso'nipg-- -''rather than - - to -. opium! /'
• "••"•.dr/ {.'' ■.!-' "t - '" J. "t ; - - V :4 -' . " - '.
or'Oiypoiia ’lb{. ■decided ■ to,.ueq’• .•the • edropheMw:teat...-. - • {
as .described"'above*;, ‘.She’’'was.'given-1» Sag* of • atropine’ :...
.'then .-edrophoniw. ‘.XOmg* • intavyeneiasly-^ This" 'had -.no - '• ' {{‘
...., { obvious-/effect•-but" aine.e ho -•voluntari /a^o^<^i^ea^^e;^Bould•' . , ' 
{-be, tested/ihe- 'i-ajeotion was ' .repeated-with’ lomg *. - .--. {* ’•'{■'.,
yAs' there W^c3.''aiiiltih.n<^.''pW,ibus {-' . ; '- ' •
'■’•■ ... ■±RiaPGvem'eae'"the ..teat was ooXlderedlto'indicate a'.. . ; .. ■
'•-f.,,cholinergic" state#-\ ■ ••-{'- /{ • {?': {’’ "•-"-’'{
'- '■ •••.-'."' ' . .'stimulator .could/be "obtained • at = ={, . ■
' . 'that • time’ 'of • night’ 'butiaf' 'apparetuW "' -for’'' elbc trioal •' • '
I. ,, defi.bx*iila’tion • -of’the -.heart ’ waasi^x^iizL^Lable. » , lb was’ ■
, •£ound{:that ' ' this {ihstrua en t - c.opld; • '.evoke -a.-'tw tch {of ‘the , .
. f ingesrs, ’ when - the. large ‘ Hec trode " wao - applied- ,'direc tly . •
■ " to {.the flekor /.•mesGlea ’..in ’ the’ forearm' 'but {not "when• 'the ’ 
ulnar .. .nerv.e'was s’ tlemXabGd at '• the'-ebbow.;. . . / { • -
■ {{IP• 1957 {there was hp .’.antidote-’ {to,.n0Qsfigpine{so ■
•. .' : ;I•’.d'ec.ided- ta 'attempt-tp ■"iapilaaee'e^oett^I-'oh’^l.ine from end*’' 
plate receptors "'by {ind acting ’ ditubocurax*ii&. . ISls had .
'••; ."'never■'been'done ••before- so-’ there-‘.w^s'tne of• assessing
{•/gthe-required'' dose* {.{ ’ Intravenous '-injection .of • • l^ag*•’■of - 
-,- a {.did {not’’'cause- 'any ., obvious, . clinical , change’ .
■ _ ‘.'‘.{but" muscle. ’ twitches -could ’''now • ’be 'evoked’ by ’ stimulation’- of" ’
, {, the' •••'ulnar ’’.nerve*.-.. ,.{{{hxs' -wap" taken’ .as •••cohffadt!on that • . ’'
. . '’tlle' {previous {•blockihad’-'beeanof ;{d^^ext>o^£rttat^3^?>»t' 'typo*# '•.... '/
" ■ {•- {'Having--'no. . n -
■■ of {the • .effect - of', ; d^tubocuurnihe. ’ .-in"{this {condition ’{I .did {
.' - •-- ‘not • ;?give,• {&ny\mop.'e .but■■ • continued.’,ihrbpghont • the• night -xjith ’ 
{ •-•, • {'ihterai-ttent -positive '.pressure • reaplration ud • atropine*! '
( {-.{ '{ ’-'-'.-:• " Duri^pg the..’ following {day{:©he-'-'.r*ibbver'ed■,,.co'^se'^^o^usness.•." ,
"and- regained• voluntary- ao'yeaen-t - of ';hex^<{iaibs bP t -.a’ hor« ' .
..{ •:''{; adrenaline ’ .^drip;- was '’'required ’•to" • main tain {her blood-;.{ ' ...{•
;■/'•/- • ' : .319. ; •' ... -f . ,/ J'-/// , . '
."r-pressures <\S&yeateen;}h©;urs. after /she:,.',had/ UollMsse'd , ‘ 
,'/ dier-pond! tin - - 'dbterloratb& ’.again-,and.:ahe/died# .•' 'At-/-.' .. ■ . 
,./ autopsy;' (Dr# A*/ ' MacFarlamt©' ) -the ".bradhv ©h^oweh no '.' ’"' '- /„• •
•■'■. .• fixaerosdopie - alterations but ' on - histology - ■ the - :cel£s -' of- ■
. .-.'' tha granular, - -layer. o f the - -p erebellum . were - ballooned -"'id th
// 3pykh0.ei.a;- of -nuclei* • 3/ These - ohangOs'hntt /oihore huoh - ,as ■.'
//-- 'petechial' haemorrhages .and eechymoeeai'.Xn :tha:- epicardium 
Were - .attributed-/to - ’’the episode - of '.respiratory, arrest. - . 
'Tie -thymus ‘-^^43 "considered to -be 1 normal t.but soiae,- of - ■,
/‘..•/the/muscles, showed - . -Russell * s', type-.1 lesions*. 33'The
/^/thyroid W^-- not . examined* .' '/:■' ■.■•/ ,: "'“ ;/■ ; / ■ /hh/-/ ’
/ 'Oase '«M309’3»-' -Tie nearly . history - of this patient " id ’•/-’• ' 
;/'• ;• deboribad. in.., Chapter - He- had ' - s eye re-;myas th eni a, .gravi- 
/• ‘with .partial/.'removal of- -.a ^h^y^:to.?.^^u^mei^'r Ijg,years: .' ,/3 ;
- , •,preyiouely;.and-was referred - to. me on -■alcount "of- /. ?• •
.y//increasing' ‘/leoiiigmihe^resistnnce t" ' t Xh/additioh- to - /, 
/ / /RiyadShenia gravis/he had •;'., . ’, -
. '/••••hepatomegaly- and'ssI)W^^maef;o.ly» /'Hi’s -tongue/ was - 'smooth ..
' /and red ’(Fig* w^ioh might- have accounted, .for,- .7 , ;
' . disturbance /of ■.•..taste -Esejus&t±on --though.'.- he' also had - .-, ' /
, ••• paraestheMu---6f - •all- /limbs.’-C-see '-((^s^i^l^'er- 4)* / - .- ,-///" '
. ... , On, admission/to ?, the Northern /CWnrhl Hospitaly '// - " '
- Edinburgh^', .he- ’was taking. -46- /tablets', of neoatigmino'/dafly 
. . but /found . great difficulty- - • in - ,. ch.exwing and, swallowing ," . ■ 
... . hie/food.',7''and; -speech was - very - difficult .although, the -,.% -. 
'•.. .distal muscles, of- his •••limbs .were.powerful# " -.'• • . ; /■ •
.3 ■ /St.Cgd^- --1.- .Cdays. -. 1-19).After- two days -/on .Ap/ tablets' daily 
. ■ / his condition - "h'a^d'-./deteridi'a'tes^d » - On;/the. -seventh- '.ds^y..",.'-'. - -
r, /there -ww^-Zbri^^^f -‘improvement -after .intravenous' injection
.. of' edrophonium-'- (lOrng*) so- some - of'd^he neostigmine - •dose ’
. ; .was ‘ continued .but- given -■p&renieraXXy - in. a use . he was/not ■ 
swallowing/ ■
yy-^SOhy.
',3 wallowing .’^he-''fr^30^y;«^^<^^i^jem'yyv^rechoc>£^m>ey< Wa-3 porforitaed' '33 •
' ;'-'(Plgt .’• ; ■■GaVhlihiiVday’'; he 3ha& 'hieosiigmino, v ; 3 •■.
0200*.. .08OO "'and.yl'600 ’hours* 1 iansdci; .. ■ y./..-- -
' --pyridosilgntih©. ! (Metinoa) • ;3. ■ 'table te -by? mauW'&b; 13OO. • :'/ . ■ ■ '...'
■ hour©#' V; Tftro'e"' br^i'difcoe’sr dfiMrbpiho suiph'ato' ,CQ#0m&* .).-. 3 
y.wohe' given - in■ that . "'-periods.. • • -At ..'700'. .ho.itre pupils ■ - _ _ -'
,. ws*d/nha3Ply^^ pdiln'i^iLngBSgo" C?ii%y'.19?3^0^:X;:'feit:i .' y
.-• eurO "that ,"he• was . in." ohollnorgic • oriel©' .but"/.ayrepeat.'• ' ■ y”
; -,. edrophonlumy tee t at yldJO yh'mw'S". o aueed iHhecirlyoo&iy 'j3 ■ .' '■
Vtmpr*ovem35^'t ' of /-ye^Xid1 " -raising" and • yex'trapqMai’: -moyconexits • ' ■ 
-•'do/" a' further. ■ ' 5w * -.-neon ilgmine ' waa " . iuOdoteV/ intraumscularly. 
3’ at -that.-tim'd§ -causingthe • paiienh/tp.-ifeel -much-happfet1 :.
•■ ■ At" ,2100 " hours" the ''r©opdhe o -ytofedrop]fh>niii#' ""was" equivocal •'/•' i 
•but;'.the " eye, "movements " were"'again?" thought: to. improve.. "'so *3' ■
• dosplte.. continuing hfiiojsiiBg--Smg- ■ .of " 'ne;ostx£mihe' was- y... , ... '
3piij}O0t©d" AntrpmW'cnlarly. ' •.every" tW-hourS" (with ; apparent :.- 
-w dnip'roVeffiehi: in ymuscular "power.#:- ■ ...y / y -fyy 'ly..’’. -• -', - 3 • ' -'' i 
- ' On' the eighth 'day "/finger twitching was noted’. but"' •_
.••. •j^^n^Wr’>^y^aa^.■.^mintt^^L.in^d^, th.e/. "PUpili-waG sl:tglit3v3p;'la-rge^r'." and ‘;.
/edropKomxum"'still . XaUs.e'd(slight 'improvement-" in eye. . .3
/y -movement" so... the high ' dosage . was...continued' in the' belief '
' ' " that-, this■ must' indtCat.e yuboplimal -dosage'* /■■ On -that-" day ■ ■
, ‘ he. .had 2^mg» of. yi^jat^i?i:U^u©ci^l'ar3;y and ■ .J -tablets
(X80mg«')• .ofy/pyridostlgmine Orally/-'.'-:; iph-the/ " hinth 'day".-"/ '- ' 
ith'dre was no clinical .change 'on ",J->7-&gf no os. tigmihe- . -,.. ■
-• .intramuscularly -but-' any-edrophonuumy test gave ' no / -y -3"
:'• -yslghifie'ont-increase''in' powery ■ i_ Itywas'repeated  '' on -the ■ • 
yyytohth..day .t67mghtheoetigiRing#. '/There .wre -no-hadverso.‘ , .
, "'.effect" sy&nd' . hand grip seemed'/© tronggry/ype'' tuw'.otho.Vr : •' •'• .
ilat'er" lie had become very ' weak',3 " th'erp iweus" fa.sci'culatio.n '•.
... ’of/ ' S' , ‘ ,- 3,'v '.y.--"y-;y.."'' ..3-;.-,- .. -3
\ Of- forearm and calX ' -nudcies'- and'-"the-’'pupil - /measured 2mm* ;
:., /diameter/. ',/ Edrophonium. now .caused - xuU'aOj ec five change . '
■ ,huh oncd ’’again' 'the; patient' claimed’:tp -‘feel- --otrohge'r., - ' ; '•
’/Nevertheless, the-signs of cholinergic. .pr'isis/were'clearly. .. ...
' "/ - pre'sent /'■ miosis./’ ..sweating; /faacic.ulatidn and - pallor/../.-/..// / .'/
ThG/v'eens'were. /GonstmhLehed... (a.-feature,-I noted; in' ’• •>'"/.'/’ -■/ •-
' Subsequent cholinergic-. stales)* . ' He. 'was' -immediately'. ' //' '// ■ .
. ./. given- OOOmg* -of. . P'/A*M,,/hy /slow • iniaayenous inj action'/ ••■•' ; \ ;
< '■ ’(-'Tis io; one of./the qpimeidrug’S ’ ‘/ad-idiciussed' in the’.'•’« oxt --:. ;./. •
■ • soot .ion ) i': '.’ ’' ’ The re / was 'no' dramatic’ ' change iir’ tip ’ condition .
."/ '-but ••4o’’ minutees- Xai©r/sd^aphGiium- ,{2Q.mg» cauaod -/;•,./-'/’■/• '
/-,'. ; increased grip. /qtrGh'gnh■;<dhspihoincreasing'. fascicuid'tien - . / /p - ■ 
/-.;- ’of’ all' limb©/; '■ ihe/p&ticnt noticed'- no,';improvement/ until. ’ •.- -
■at ".least one hour -.■alter .injection .of ''PrA/M*' and' •'eontiftue'&/ ,
'.. ••i/io’ .fee!/ better --for about ’ 4 hoiurs». ■ '• Ninety minutes ’ ..after* /
/•>•; ’the --injection - -there ’-was - a, .'rapid-- 'drop/in. - .blood'- pressure ’ to - . /. 
,,/ ^Q/A’OmmHgo’^4-'.'i t.’-r emed.-ned/ iow- for' ’another.,. 21 hour©,* - .-. • •
. - Throughout this -period "the. pupil©.'-.remained robnetrio ted /(1^®)
-and. fasaiauXation- continued in the /dalves. - ,but not dln/;tl® - - / 
, : • upper . limbs 1.'/'- We .’felt'’ that : 'the: patient. ?d -condition -was’ ’..
/' ..'back. to/'that-';<^a^^-/./;hd..-proya^<)t^s}'-..^d;a^0-r’ / 'Parenteral' neostijmnine .
. / was 'restartcd’ as 'the, available information'- about ;/b:pimceis’
; ■ led me '.to -conclude that l Cholinesterase --had been’; . ’. /'■- /:/'
, . p - regenerated* ..-'" ' 1 wa&/ again influenced'-‘unduly by/ /the, .
■/'/:"edrophonium- test'-which- 'I .-interpreted as ’ indicating - that’'
.end-plat e©/-o£ -the .musclca/were’ again’’ responsive •
/■/•'to •ant±Qhol±h©st.er&ae. ’ .medication - although autonomic - . ■ . ' •
. synapses ' were'’ /.still'.markedly'-oyei'rsflmulated*'/'/.'Oh.--'day.-11 -'
. .the ’- pupils^remained/at’'S’*-gmm */■' but no t so - small as on ' the -- ■. ' 
/ •• day ’/beforie// fuBci<^u3*^'t3.oh .and/spoutaneous twitching ’.-of •• ’ / • 
/ x.pfinger© - /persisted'-, /.but .’/t^he/'-grip -.was ’••'g’bod’ and’•.definitely- / ' .
//' ©eemed/ -■>;- // ; -- '■ . ... '/ ’ ' ' : ' ■ .
e:522*( ■ ' ■' ■ '■ . yw*. ; ; ,
• seemed sfc^ongexv’after'darophonimm • (Pig* 19$3)<»\ ■.
,. ■ Nocturnal ; restlessness.'and .disorientation were ‘noted ,
- at;, this 'time ' and attribbuecd'. to' ..the frequent ..use' of . .
■ atropines On day IS-he seemed' stronger,. and fasciculation
.. was less, being confined to the. legs in/tho : mooning. and. - ..
/. ■ -absent alloge ther '".in '-the eyenint*' '’'.I was ' lulled ' by '- • ' ''
. . this ’ improvement* into 'ignoring increased bronch'orrhooi :
. ' '• -and .further constric -tion of, the pupil;(Xjnm> )* On day 139 ■
• won an. ; even ' bigger dose -of neosstimnin?^:.. intramuscularly)
.. •'••he 'seemed; well in' the morning', edrophonium 'otili .
. ■ ■‘improved'-tbe grip, and the movement of.'the 'e‘yes»\-; On that - '
' '.vy.'day 9 however, he'did not pass ..urine -and had oliguria for*. '
. .'.7,..the-next .1.0, days! . On the fourteenth' .day'air .hunger" ■
•• developed and it' :wae found, that acute haemooysis -'had. ■ .. •
, occurred', .He was given a, trans fusion of whole.. blood .• ■
, on .chy I* *?/* ■ ... .. , ; .....  ." '.' • ■ .
> 1* ; ' >Fpr the ''next - five days' yhe .s'e^med. to 'be .iye^lL', so far ■ ' ' ■'.
;. .. ' as muscle power was/concerne.d and' fasciciulation‘was slight • 
'. .. and. confined, .to the calves,' but the' ; pupils remained.. small
• :*-(!#3m.m»;)‘#. * W 'Gornjenfoatsd/On treating the • haemooytic
:'.- ' anaemia, and a.nuria«. ' ■ • ;.'*, ■*-■ *w - * .
.0omment ' . on^staje.: .,1: •• - • ■ ■ '' ' ■: ■' .
■ .During this" period' I .believed that . the patient’. '
■ .ieequirecl'large -doses ' of 'iudhsi±gm.iild par eh ter ally'and .. '.felt7 ' ' - ■ . "• .
confident '' ' that' he.' was - .being made- more powerful ;by it if -
•Viets .-.(1950) ' stated that l3mgf of ' .neostigmine ' bromide,.'by ■ .
mouth 'are ‘.eqtd.valent. too" l*3mg* „ of- the methy.lsulphatie/ injected' .'; 
'iit^amoscul^lrX■y *. ;'I Calculated ‘thie'.parenteral - dosage- on. this
•, basis tut 'as the 'result of expert one e.-in .this case' feel that . 
l^ing,'' 'oral ■ dose is equivalent toonly 1 * Omg;«. par en t oral» ; . '
^.Simpl0.n g. 1964b) * '.'. *y *. •/ •,. ' .<*’, ..' .'* . .
























■ . /.keemlts of testing with' edrophonium' appeared,; .• ....
■consistent — ;.FaeaOenlatiOn was ignored 'as -it-was 'confined'
'. to . muse lea "which . were no t weakened by ,• myasthenia*■ 1 • The ■ . ' '■
small pupils- w?ro''«oted: hut .discounted'in view .of the ■' 
.apparent 'improvement- .or ’the ■ grounds -that muscarinic ...
e f f ec tsneed . no t. parallel’-- the. ao ti on ■' on’- pathologic a!’■"-... 5 .••• • 
ixriso’lesi In -‘"retrospect- somer of the'improvement may■•••/' ■ .
have -been .the result ’ of5t.be blood- transfusion. on day ■ 13* ■
On the ■ one. occasion that’ I ’ had felt-, obliged itm doubt the, • 
snbj.ec. tive Improvement . on .edrophonium because muscarinic
effects were. so. ’gross* the.-injection of P-.A-.M, had not . .
given the iramediatt? • improvement ’I had ’ expected from .the- • • ■ '
’ lieeratiire*. . Indocd 5i ts. ■ most '-marked effect was ..a prompt’ ' '
and . alarming' .hypo tensionr '• The anuria end haemolysis ' . >
developing three day’'later wer e'a 11 ribu ted to this drug,
.pe.'r.hap.s ■ wrongly ’since ■ .there may have ’been renal 'ischaemia ' 
folOtvehdlinn^gi'c. poisoning! . = . \ ■. 1' • ' ‘ to- .
' ' ■ 1 was now faced.with a \di.imma»'''The -.only information
I’ could obtain about the fate of ingested .-neostigmine was .
that It■ was; /unknown, but ’ 'there; .is prosuimpivO evidence /that
it: is’ both .d.—3trryed“-I.n'.the' liver and .excreted in the urine **
(Goodman and Gilman5 ..1955)• ’ .Tie patieht’ .was known to have •
abnormality of ’ liver function and --now had ■ severe oliguria,.
■. ' - Stage ■ J.2■•.C..(bnff-iC ■ 5.20—41 )". ’ On the .morning -if day ’20 the ■ ■
■ condition ■ was that just described, .pupils l»5mm*, • ■ .
■ ' fascicula.tion slight and confined to the lower limbs, •
•• \ pawor. excellent. without --gross tiring and edrophonium■
. (20mg,) caused .increased grip. strength .without ■ increasing
.. fasci^cul^^tiit^j^A .■ Hov ertheless 20 aminut es.’ -1 at e r he was .. 
'weeacer- and lpr/■ hours’ after' the test ms very weak indeed—
'. perspiring^profusely’ with pin’point’ pupils but no ■ ,
. fascicula-tion/ . , '
/ fasciculatioa.-* ‘pulse rate was 84/mih* -Edrophonium
,2mgv intravenously' had . .no' ' effect*' - and "’a; ' further. ' 8mg» •.. .
/ did not increase strength (Fig* 19/4)'» .. Fasciculation-. 
was -possibly' increased* • Another l'Omg* '-given./within ■
- : .4 minutoa caused- definite fasOlauXatlon of interosseous 
. .- 'musdles; of - the ’hands'-’ but Arm' ' flexion- 'seemed 'more ■ ' •
‘ powerfilo ' : Venbspasra vdas agdin noted*' ' 'This. -'time 
? . there, was 'no- doubt ' that .'chollnei'gic' 'bloolfhad 'occurred* , .
'■ ' --Kootigmine' -was -discontinued/end PpA.M*- injected '• L -
.-'intravenously* - An ' initial dose - of - 1G* .'did- not -improve •<
■ the - clinical state and again there . waes a fall, in blood
pressure* 'Which commenced ' 13 minutes after ' the injection ’ 
■ -and .lasted for 4^1 hour. ' * One -hour later an -edrophonium ..
teat;' still indicated -a cholinergic state* A. further . ;' •
injection of P»A»M* ' was' given (300mg* intravenously*
wv'Smga,' intramuscularly)'* ■ About an ' hour 'after the ' second • 
•.'•-..'••'.'.dose/ar slow -improvement' in 'strength'.wad^.apparent
■ Atropine v/as injected and .further response '-observed*
..Four hours after the injection of -P..A..M*-, he was definitely 
••.stronger:-., and fasciculatioh. wasfless -but' the pupils ' '
'- remained' ' about' '1am•- - diameter ' .so /a? further 'It^Orng’*. P*A»M« '■ •
* was injected intramuscularly. On this occasion no .
hypotension occurred bub the clinical .state was not
-I- signifiodn' altered, and edrophphium/gave no -feepemse*
Two '-further doses offlOOCtog* 'P*A»M*' . weine injected 
intx'miuaculaiilLy. at ' intervals of throe ' hours* Some 
-twelve hours after the original injection of P»A*M* . 
(during which he ' had received a total' of 4a* of the drug 
in five doses) slight but .steady ' improvement was noted*
but '-two further injections of ' 10, ' intramuscularly were
required on the.following 't'Ay- 
, (Fig*'19/5)* - During much of 
was dxuowsy or unconscious and 
for/ ' '
to' prevent' relapse ’ ... '
this ' period the patient ' ■
there ' was subsequent Amnesia
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fr -,'the ..'/jhoie- ; period./- Hi’s ' temperature . ’dropped -' to ' • ••••
'• ;•?,?» $??; (rectal) - a&d .the. blood pressure/remained .very. , • -.•
■ • •^n.eeq&'Voeai;- improvement did .hot odour - .until: .•' ' - • ,
, 48 --hours: aitOr.-he' had- /doXXspas^d*- ' •'Obncbbiifaai- -with-/ ' ,
'. •; • '/returning -alertness- band - .•power, ' --'and - ' •
■ -• • ;the- .pupil - 'gra'dtislly increased to; ' 2mm#/ •ahd- ih-ahother - b' -
• • ’' -' ,• 12 hours; - to ' Juu * *. -’by '.which • time bpo Wen was good / •'■' ' ‘.. v.
, . hypotheeitiiv had; given; place to - .eli-git'pyrexia for -the - ... ■
' • ' -first -(time- and - .there - -'was -■• slight’?inrreused strength -after.­
, - i; - edrophonium - •(aOagg’);-' ' •/. < - ' h* ;; ' - ' 4 b.b; ,! . "
; ■ X.dichnot 'feel-.'•that -it • was./safe. to ’reinatitute- ' ' • ;• 
.nedstigmihe'' therapy .until - f^.houiM-fpQm the '---time ’of -the ;b
• . co Tl&jpe • although •- . obvioua .myasthenic.'.-;fatiguabili ty- had.,- - 
. • .•returned’ and. the-pupils -.had inc reamed- - to vSnn -’d isme ter #
. '■.•. ..Occasional■ fascic’ulaiiqn .was. still./present . - in the - l~o^#- “.
Gsmmoitit-os-estags^^ ^b-b - . wa,4. .?>••• •- 1
' . 1 v ;-Bttil-ng/this' .-period -(days 20/24-/inclusive') po- ; •. !
neostigmine was ..given -(-•ih2;amount-shown on. the.- chart - ’ ;- ' .
represents that part ‘of the previous - regime given before -,• ' ••• 
neostigmine /was /withdrawn - \bf d^e 20'));; b -There, wan there fore • , 
•a'-maintained - c'hoiinergid; -state ‘/for‘- 4bcompp/Ote - days•.-ami' 'b 
ano then . 8 hour a - el ap.s ed' - -before treatment' ‘ was res tar ted . '
ThO/period coincid'edw^thxa phase bafisever'e oliguria-./' ' . 
Cl30O*6OGml9-\urine --pSSSed•;.daily)# ' •'".‘/Thbupinary output ; ' -‘ .. 
i'ncr.ehsed to ‘98©ml»- on - the ‘ day ..of- -hisbrecoyery*- . but - some 
•'oliguria- pereisted'/UhtH- his-doa&h six wdeks -later* • • •
- •..• .'.-/•- .'../Two. conclusions may be. justifiable* i) neostigmine ■ 
is probably excreted'in the urine and •-•'it-in -not ‘significantly 
.destroyed- ..pr, excreted by -•‘Qfchher -.rOutteSt/ii)‘ the px’epai^atie.n, •­
'of P# A;M»- used Iwas ineffective'; ‘'.at; least in - the- presene-bb'of' - 
renal,•failure*! The /fail In body temperature'- ’was already -; '•; •
■ appment/.' ' < bi-''.;- ■ !' . . • ' •' -br- b 7
'apparent. .dn-'day' 19 and so ' was. considered /to' be Caused .. 
by. . central;,synaptic block » Hypotension was• probably .,
similarly caus'd but it was. . tempooarily" increased. after 
intravenous injection of P.A*M». (Fig,. 19,5}* ,
:3tagO',3/s '■ ■'•■•;- / • ■ - g . , - - • -
In • view of " the•continuing oliguria^treatment was
, restarted" with • a very small dose. on " the evening of
< -.'day.. 24. (Fig'} 19,4). . There’ ‘wa© ./slight'' sweating with, '
'"some. pyrexia and conjunctival . icterus which continued 
for three days, with biochemical evidence of haemolysis.
■ A \singl'e intramuscular injection 'of "l'iS3mg.* ’ ■ ■. / ' 
neostigmine did not improve the ■ myasthenic state, -which 
had bees allowed to' develop. and it .was repeated in an
; hour. , At midnight regular. medication''with' 2 tablets 
of neostigmine ' 'was restarted ''every .4 " hours and oh .the 
23th ' day; he. was quite well $ though ' still subop timaily 
treated as./judged" by ; edrophonium testing." - Nevertheless
■’•■.the'. pupils. which "had been . 4$3~.3ranu diameter" returned to 
2*.5r5m.m* The dose was cautiously Increased. pn
day ;29 " it; ws 4 tablets "'‘three" ho^i^^y (loss than .his. 
original. dose) , h.is. ..power..‘was"\now excellent but • the
. . pupils w^W sometimes as. small 'asf2;.'Omi, and upper limb
fasciculation ' had ■ returned so it ;was once . more ' reduced . /
..'.■''•to. 2^ tablets ' 4 ••hourly#. The first definite evldenc© " by 
edrophonium testing of a return to ' the myasthenic' state
• was oh ' day 53* '' Pyridostigmine■ was. substituted . for-
heostigmxne. '.but "-’on the 55th and' 36th ' days occasional. , 
sweating., and . Upper limb fasciculation recurred and. the 
'edrQphoniw:i tee! .was 'equlyocaiv■ • A' / •"' •'•.. ■ '
' The ' interval " between ' bach . dose of. pyridostigmine
g;;‘;w^s -increaseda to•'•'4J hours ' on. day . 36" and to 3 hours on
day'38< On ' that" day the pupil"-‘contracted to 2*2*5mrn.,
_ an&/ : •; -/ _ ’ . ' ' ; . . . ' ' •
-/ a ’ •. a -■ a/W* "m - ' '- a - -/ .
: a-and ‘ there - - was slight sweating 'but . no - fasciculation./
A iFaeaal -incontinence -. occurred without ' colic - , . :l.t may
; - have. 'been--hue- to"' potassium- citrate -’started ?on-.. that •
, date,.. but its '•continuation on, the next day with sight 
deterioration-in-power suggested that another -crisis - 
Was - impending ■ although he was .only ■ having '-12. tablets . of
. ; pyridos.tig®ine,!'.per- day- and the - pupil- diameter was 
approximately-in - the .yearly- morning of day 4o 
he became -difficult- to rouse, "weakened rapidly- - apd / 
collapsed. "--/The-pupil's-contracted - to - 1*0~l*5mm, 
sweating - was profuse - and -''•fasciculatiion- returned to - the
"...-hands- 'and fac e. - • .../ITere,. was spontaneous twitehing -of - - - :- 
the - fingers'* - ; - Atropine- was- - injected - immediitely, - -
A-f olio wed--by in'tr.^mseulaxil^I^- (1G)' which-was - now--, -.--.- . ' 
-, available,- '-'No-appreciable change occurred for one
hour then poWer -'■•/apiiiy-.; improved,- hand fasciculetlon 
?-and; sweating'-s. topped -/and,-he-regalhe d consciousness, - - ••
■' '-/''The" - pupils . ••'however^ vremmihod-'elmosi -/.pihrpoint ’in ' si&e • 
a (Fig. - 19,6)* ,A.Porty five minutes - later toxic - signs -
^-reappeared-and--15ymihutos. - after; that - (-two hours after 
!• ’the .'.first; ino'c^tion.) - a . further l'iOg>--ppA- wa£J 'injected .
intrtmmscuXarly,- ®iis time a - response - occurred - in
? 50 minutes but - seemed- to be .passing- off in - half an
-/-/ hour*- .• Meety/minutes' - after - the second -injec tian the 
'... -' --.pupil - .'diameter - was - -still - ■ 1*5*2.0mm # a - Faseiculati0i- -and
.....Sweating- had - .returned--but power was good and - so- i - 
decided to- continue with atropine*
- - He -had} no - ie.ostigeiie - -from - 0900 - on day - 59 - to- 2100
on day 41e(60 hours) - and only - then .was- power decreasing, 
-edrophonium- - c ausing- improvement, and the pupil - si'se -
, rn .larger/-A... /-'-e-'"..; -A A <•' .. A...-A...
larger than - /5rnm* Fawiculation was -minimal- throughout
.this period*. ‘ There ’was again oliguria during- this 
crisis - with greater output - on the day of rccovory*
..on- Stage - 3s ' ■ , ' - • - ■ ' ' ,
At the time -of these events' ''the renal ‘ failure - and -
haemolysis were attributed to - F,A.M.- ‘ /later examination 
of- fluid balance- charts suggests that the oliguria at least 
may -have been a ‘ result of-the cholinergic state*
Nevertheless - cholinergic crisis had onee- again occurred 
with a dose of anticholinesterase drugs substantially ‘ 
less - than that which he -h ad taken ‘-f our -.-year's- pr eviowsly * 
suggesting failure of an excretory mechanism* It is
possible - that potassium citrate, ‘ given by mouth (3g*b*d*) 
on - days /$8- and 39* /caused- faecal incontinence and/that the 
potassium ion precipitated ‘ this new crisis -but - this-ia 
unlikely, . ..The patient*s general state ‘was now deter±orati^g*
His - breathing had been -maintained by a posit! vo~pre.eeure . 
ventilator for five weeks* .and- tube - feeding had been - necessary 
throughout that time* Oesophageal ulceration was now
present - and - renal - ‘ function was poor, Haemooytic anaemia
Was added to a previous megaloblastic anaemia* The prognosis
seemed- hopeless but ‘ I felt obliged to persist with - attempts 
to- establish a satisfactory -balance despite apparently . 
Increasing sensitivity- to anticholinesterase drugs
Stage 4 (days 4g«»6l)r ' ' , ’ ' -
Since it, was now- clear that- tolerance for anticholinesterase 
drugs had decreased .-(whether from diminished excretion 
or other -reason) I decided to -restart - treatment with a 
very srnll dose- and to increase it . - gradually.*-, relying
: on - the ventilator -to- maintain respiration. Pyridostigmine
was/
 . . ' '■ ; 529,0 ; " ■ \ /
was • restarted in a dose of 60mg* (1 • tablet) 4 -.hourly* 
FaseicuXationand sweating persisted throughout day '42 
but- thereafter 'subsided, and the. pupil remained larger
- • than. 4mm The patient -was. alert and • strength was fair
but with . rapid' .fatigue* The dose was' gradually'
. increased after' confirmation that ' edrophonium caused •
unequivocal improvement but . op d&y 48 • wa still only
, 2 tablets 4 hourly by. day •-,and-l|' tablets 4 . hourly* by . 
night*- On day • 49 the patient ..bogged •for a bigger 
dose .but an • additional 0.5m'g* neostigmine intra*
. muucuX&aly-,before . a meal -made no. appreciable, difference 
..and for the first • time in '• a 'week: the• .pupil was .slightly
smaller' and'fascicuXationreappeared ■ in - jti&Bhan&8*(Fgr'/9$). 
, . On day 50 the ' serum potassium (which had been steady .
' at :4nEq/l±tr.o. )'"dropped ' to} 2.»9mmq/litre. . Potassium ■
, suppieffieehs/woxrr&gatn given and' continued until ' day 64.
Comment ' on . Stage 4; \ '
Throughout' this period It seemed- that the patient
was ' gradually improving'in his general condition though 
muscle power'was deliberately kept aubmaximal. Even so*
on ' day 54 an intravenous injection.of-edrophonium (XOmg.) 
improved the grip but caused.sweating*' hiccough and 
'•fasciculatidn of the eyelids. A change was gradually
taking place which' was difficult to define. power (measured
by a'dynamometer) wa no worse* fascicuXation was absent from 
the upper imbei the pupils were ' satisfactory but apathy and 
despair characterised the ' patient^s attitude in place'of 
his previous hopefulness. }
S tage; 5..' (days . 62-80); ' •• ' , ■ • . ' ’
During' this ' next stage it -was considered ' that ' further 
cholinergic crisis must be avoided at all costs by
•y ■ ' accepting/ . . . : ■ ' -
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accepting ■©ufarmqdmaX control ’ of .myasthenia; , .Anaemia
and inadequate gaseous/exchange ■ in the lung from
pulmonary-complications were now important factors in .
preventing adequate oxygenation.’ A trial.of AN? -235
(in addition to’two tablets of pyridostigmine 4 hourly)
was ' without any ■ effect.. The .megaloblastic anaemia
was' . now, -'shown to be accompanied by low . cyanoeobalamin
in .the ' serum (l45>~X3Uugmm* by ' cyanide . assay. normal
l7.0«100(Uytgm*)■• Injection of cyanoeobalemin. (XOOOyUg.
daily for 3 -■ days then weekly) gave a reticulocyte
response of' !7$ in - 5 days but without changing. the
gradually ..deteriorating clinical- course ’ (see Chapter 7) (Age/.9,8)?
By . this tim'e the unfortunate patient had been on 
the. respirator for 2 . ' months .during which .he had had many 
spells of. pulmonary collapse, pneumonitis and oesophageal 
ulceration. 'which. were only- relieved by '.the most devoted 
care ’of nurses and physiotherapists (Fig, 18.4). When .
he ’ collapsed,again on.day 68 the - ’ attack began ’ with 
breathlessness. ■ and sweating but there was ’no miosis ’or 
fasciculation. . Bronchial aspiration and changing the
tracheostomy tube relieved/ his air hunger. From day .
69 to 78 ’ the pulmonary pathology dominated the picture 
and oesophagitis . caused groat distress. On day 79 a
further . spell of air hunger caused ’ him to panic. Ho 
• seemed very weak but he could make strong muscular. 
contractions when persuaded to'make the effort and 
tetanisation. .of various . peripheral nerves produced 
strong contraction without demonstrable fatigue.. .
Sweating . was profuse ’and the pupils became . smaller.
Edrophonium. improved muscle power but reduced the’ 
pupil diameter to .. the. sise of a pin-point ’ and .^caused 
bronehorrhoea/ .
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bronchorrhoea*'• Urine output decreased again in the, 
latter part: of the day* It Was considered that 
pulmonary collapse and anoxia were again important 
/factors but the picture was,'now.. so like that occurring
■ in previous cholinergic crises that pyridostigmine 
must be discontinued and more atropine given despite 
the improved power after edrophonium*
He slept well, but was weak in the morning and the 
edrophonium test was equivocal* Pupils were now 
2*5*3*5mmy, sweating was profuse and there,/was an, odd- 
rhythmic jerking of the tongue* The blood pressure' 
had.dropped slowly to 82/5PmmHg< / , It did not drop 
further when (1G-) was injected intramuscularly 
(Fig. 19,JB)» In one hour power.was perhaps a little 
greater but the pupils were still I®-, in diameter»
The in j ec tion was rep eat ed twice-; at hourly intervals 
(3 in all) but, although the pupil became larger, 
sweating remained profuse, oliguria was severe, the 
hypotension never recovered end the pulse was rapid 
and thready (130-lhO/minute). When it was obvious 
that death -.was near, neostigmine 2,intramuscularly 
was tried without effect and still another dose of 
but all to no avail. The patient died on day 80 
(11 th February, X9&1)*
Cowent on .Stage g s
For whatever reason, the patient had shown in stages 
2 and '3 that he could no longer tolerate his previous, level 
of anticholinesterase medication. Paring this stage I 
deliberately allowed the patient to develop myasthenic 
weakness which was then slowly brought under control. 1 
was astonished when further collapse occurred with some 
signs/ '
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signs-common to .cholinergic crisis, but ' this time there, 
were important differences.*, . Tb® pupils-- remained large 
except after edrophonium, which caused miosis and ,
•fascicuXation, indicating that the anticholinesterase level 
was high despite the fimOtl dost*.. * Nevertheless FgS in. 
repeated ' doses (tfith ' atropine ) - vis without sign-5.fi.cant 
effect'* It , is net certain whether , anoxia due to
pneumoontis - was the cause of- the ' change but it was
. certainly an important -new factor confirmed at autopsy#
Even up-to the,time, of death,the - handmuueles still - 
responded well and without fatigue., when the ulnar nerve
•‘was, teicn/ise'&t at - the -.elbow# The ,post mortem findings
are summarised, in#Chapte.r 7# . ■. / •; ' ■- i# - .. ' ‘  . - . '■ -
. The - similarities and differences between respiratory
failureppv.ervontilation -and cholinergic - crisis are,
. suamarise.d in .Table ;i9,i# ?’ - ■
Urinary Excretion of Anticholinesterase Substances*
■ RH1WIM1 .................................................................................................................................. .. II II»*<W>-TV"W*** uriuiiWlM«MtiUUMbKiI vv ii k. •
*Amajor difficulty in the handling of this patient
who had both--hepatic- and renal- insufficiency, - was the 
uncertainty regarding - - the fate of neostigmine or 
pyridostigmine in - the body# - The current edition-of a
standard .work of reference (Goodman - and Gilman,- 1955)- 
stated that ’the - exact fate of- neostigmine in the organism 
is - unknown but: there is presumptive evidence that - it is 
both - destroyed -in the liver and - excreted in the urine*#
The - m^iufacturers (Roche Products Ltd#) were unable to . 
give more. information - biit - their biochemist, Mi*#- R#F#* Long, - 
kindly-assayed -the-urine excreted during - days 22*53,'the 
first - period of oliguria*- He was able -■ to recover from
the urine 5*8% of the - - amount of neosti{a'ine - taken by mouth 
from/ , , • ■' '. .
from day ’24, bit oven during the first’ two days a similar 
concentration was present in the urine though no drug.was 
administered. "• • ' - ■ • .. .
In.view of this evidence that neostigmine might be 
cumulative, the results wore discussed’ with Professor A. . Wilson 
of'Liverpool University. His previous studies on the .
metabolism of neostigmine had not ..shown such prolonged . 
secretion* The patient. was then’ having ’ pyridostigmine
and ’ Professor ’-Wilson found that 10% . of each day’s doser 
could. be recovered -from the urine, a result consistent ’ with 
his experience.of .the . elimination of single doses. Since
the drug . is still being excreted. two days later in persons 
with . normal renal function .it seems highly. ‘'probable that /• 
renal failure contributed to the difficulty of preventing 
the cholinergic. state in this case.
1 have ’‘.collaborated with . Professor Wilson and his 
colleagues in ’ studying the'urinary excretion of ’ neostigmine 
and pyridostigmine. ’in later eases. They have found that
up ’ to 67% of neostigmine is excreted unchanged . in the urine 
when it is giyen ’ by intramuscular injection. but . wheri . .
neostigmine or pyridostigmine is given orally the recovery 
in the .urine is only about ’ 3% (Nowell • et al, 1962-). . . They
haVe.also found evidence that pyridostigmine is absorbed 
more efficiently than. neostigmine from the . alimentary tract ’ 
but ’ ia.excreted . morn ’ slowly. Appreciable . amounts are still
detectable in’ the urine .two days ’ or more after the last 
dus.e.* ,
. ’/Neostigmine bromide taken by mouth is believed to
bo. metabolised to ’ m-hydroxyphenylti^imethylmlmunium bromide 
and. an unidentified quaternary ’ nitrogen compound. The' 
former metabooite is .known to have . an arrta-^curare action ’ 
(Nowd!/. 1 -
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(Nowell -et al, 19625 Scott et al, 19&2) <" It ia assumed 
that-‘the -' degradation after oral administration takes place 
in -the alimentary - tract/Goldstein et - - al, 1949) but - .the 
role - of 'the liver is uncertain. Injected - neostigmine, -
on the other hand, is-practically unchanged in the body.' - 
Some - of our -results obtained in 19&1-showed that the 
urinary - recovery was; relatively - independent of the - volume 
of - urine- excreted (Case MN54G9). : Me /considered - the - 
possibility’' that this - might be due - to tubular secretion .
of the drugs -and this has now -been shown by - Roberts et al,
(1963)< i/W / ■!' . . •
Oxime ;preparations i ■■ ' • ■ 7 / i; \';; ' ■ ' . . ' • '
Reactivation of - cholinesterase- can be achieved* when 
the en&yme is inhibited by-an organic phosphate drug,by the 
use -of oxime compounds, such as - pyridine-2 aldoxiao (2 PAM) 
or its methane/ sulphohate - PgB and diacetyl monoMme ; (DAiM * 
These -drugs may - bl - very effective antidotes to overdosage in 
myasthenic patients of - -(P3IPP and'/similar drugs (Wilson .and 
Gin'Sburg, 1935? Ohilds et - al, 1955)* The action of oximee 
and- related compounds-is considered to be a displacement of- 
phosphorus from the - phosphorylated cholineaieraese and - this 
action - is more or less powerful according to *'the nature of 
the alkyl group directly connected with - the phosphorus .'atom, 
being, relatively ineffective against with a
diaminoalkyl group such as OMPA (Kewlts- et - al, 1956)*.
Displacement of phosphorus cannot be the only 
mechanism involved-as Grob and Johns (1958a) showed that 
certain oximes are capable of reversing in - man the 
cholinesterase - inhibition and neuromuscular block due to - 
quaternary ammonium - anticholinesterase - compounds such as 
neostigmine/
nedstigrnine which contain no "phosphorus.’ -Those authors 
suggest that the oxlmes 'reactivate * muscle cholinesterase 
by some unspecified mechanism# I offer as .a working .
hypothesis that the oxime competes With either type of 
inhibitor. fox’ occupation ’of - the . esteratic site’ on the , > 
ch03-ineetlia'8e molecule.'... It . might then be expected to 
h&ve.sume affinity. fo’ ’ the similar. grouping of the end­
plate •receptur.'SulStanc.e» with the possibility’ of causing .> 
neurUmullClll^aX’ block.’’ Gnob and Johns (195oa) ■ ’ showed' ■ that
2 PAM produced a transient local neurumuseular block . ; , 
following the intra-arterial injection’ of. high concentrations# 
They.attribute': the. block'- to an anticholinesterase -effect ’ 
which can also be ’ dlmoust3^^ated with ’certain ’ concentrations 
of ’ 2 PAM. The block ’ is "potentiated” by. previous injection
of some apti'cholinest erase compounds but not by neostigmine.’ 
This would fit with” my suggestion that the . anticholinesterase’ 
substances ” occupy’ .esteratic sites ’on ch©^!^^©’'^© molecules 
and ..the 2 PAM -then occupies the less favourable sites on 
muscle receptors#. This would satisfactorily account for
their observation of progressive depression.of successive 
potentials evoked by repetitive nerve ’ stimuli during.the 
oxime ’ induced block, ’ and the .. transition , from. cholinergic to 
oxime block without a transitional phase of normal function# ’
Grob and Johns (195§a)' also measured the Inhibition 
by 8 .PAM and DM of. cholinesterase •ensymes. of human ’ plasma, ' 
lx^ythrucytes, muscle and brain and showed . that those ...'dkimis 
protected against’ the -inhibition of cholinesterase by 
urg&'norh0sph0ru3 compounds but the . protection and .reactivation 
of cholinestercoo’ inactivated by quaternary .ammonium.drugs 
(neostigminei pyridostigmine, '•ambla0hium) was slight; This’
conclusion was in keeping with previous opinion by
ph<arraacQO0UiJlts/
' /55
. pharmOoo.X'ogibt; Hohbigor- and •Sadler' ,( 1959) reported.- that,
;theID 50' of /.physostigmine or- neostigmine/ inexperimental
',i'©nimal,s-was -not raised by S PAM .in '..c.priyeptional -doses* ■■ .<
: . 5' . ; 'Pespitelthe. theoretical. objections, - -Grob .and Johns 
.'.. ( 3,958 a '.-and. h) ' claimed '••’that .2 PAM ''SncrWAM' were ■both effective '
}‘in .the ' /feroat-O-mt; of/the, ^ni©0tinie;/effddts '..'of neostigmine' ,, ,, ;
overdosage 'in . normal and 'myasthenic subjects though the ;/■
■ response ; was never ■ dramatic * = ' ■ ,The" musc arinie © ff ec ts ■'were .
'■ hot ' appreciably altered* //.-/ They - .found' that ' the .weakness ■•-., . - ' . ‘
' .. cause'd -by/Tjv^^irdose with ' /oximes''-was '©yen ' /.more/likely to •/. ' • - 
/ happen with'myasthenic patients ' this' _ to" an * ,
, ■ 'uncovering of .the /.’Vasal .'myasthenic W^^^kjdese^* 'by . removal of ■
./ /antic.hdli»©'steras.e". drugs* •'/‘On this account they ' .recommend ' •;./•''
■ - that ''myasthenic'patiOn'ts b.e tifi',at©d ' 'with 'successive ' .gpdhg* ’•/ 1
/ hoses' of"2/"'"(or DM)" at' 55-io'minute' interrain-until ■ , ,• ., ,
■ ' /strength? ia.' restored to ' the .maximum l.pvel attained following' ;
/ the ' administration' of' ;,dptim&ll•ddS©s' of ' anticholinesterase' -•- ■. "• .9 
compound*"//I/■/.,.;/• -f';/-I?'/ .'•'.•// . ; I...-.// .,1 ' /1 ‘ -■ /■■ 1 ’
- .in’• view of th© ' importance of this?claim for the , .
• treatment ' of ' the mmol' oommon form of death ' in fay&sthehia' - }
gravis ' it. be ' examined 'with. the' greatest care# /. As -■ I ' / -/’■
• have .shown /above ' .their V-bs'ervations' ''are open to .-alternative //
■ ■ ■' intprpretat.ioh..and or/e ' in '■ .•contrast .. to' the - Oeneyaiiy expressed ' ' . ’' 
: .opinion: '-of ' pharMi■coiogi^3bs,' working/in ' this field* - ' '.For this - /
reason' X have thought ' it.proper to give, ' detailed 'protoopis .
./ /of nay/oom .experience* on tlase '59?3-"'.wwich-.. haplbeeh-report;ed - -•:
/' 'to'/th'©;'British Pharmacological' Society/but -hot previously
, published (Simpson*' 1961 a)# It will Denoted that/.there
... /•-'was •.definite' /vidence,,Qf "'reversalof cholinergic ■'poisoning' - / l'
■' /although 'the '••'qxi.erit'''-©£' thip ' rVa//l<^.l,;{/u^i^^ff^^.i€^«^^":"td. '.b©;..of . . " -,//.' i•
great ' clinical ' value#.. This ' has; been/eaffirmed in /O-&©© MH&52#/
" Th©/ ' .'.•/''■/ •• ■•....'< , ■■./. .,/ .,
337.
•The' latency was . miwhh 'gi»<eafc0r' than. the lTlO minutes {. ,
deacribeeKby'. Grob. and Johns . .(-1958b.)*.-q'Gome of the• trials .. ,
were •■■aatWWi•’soluble . British drug -f^Sy; the;''■/ 
methane • sulphonate aalt of ' pyridinG^F^aidoxiffie..which- is. h‘. . ,, ■ 
.mo re.rapidly.,&bbox>bG& 'from • intrnffiuecnlan injection (Ladeil> . - 
..195?) • . ..-.Pespito -the limited. number .of; .observations the. .
'ppeceding report. of the first use-of P^G/in • Cholinesterase' . 
•poisoning'{of any.. kind ..has the advantages*of referring to ' .
investigations in the. unique. circumstances . hf ' full ‘-{control 
of '-respiration‘ and' - with ‘ hegligille'. •excretion. , of ' .. ■ ■ .
the . anticholinesterase*, q • These.{observation's ''cohfimmkfhq - ' ■
claims' of .• (ft*ob■and Johns (1938b) ' that, oxime{drugs have . , 
some {.effebt in . combatting' . ■ the nicotinic effects of neostigmine 
but. differ . in. showing, ail!ttle' activity- .-against--the ' ■
'muscarinic '.effects/ ‘ too*. .q'.Theee ..wbrlcors{'aO.sb' -euipgost .that ' :.
2 ’PAM’?and-<. pp *G act -With approximately .the , same ..latencies ■
-.when-injected. intramuscularly ‘though' Gribets et al . (i960) 
state that. pyfi&nh*r*.aXdo%ime• methiodide' (2 PAM) ‘ is too 
in soluble for ihirmusenuar'-'admini£:tx’ati0.n 'and . requires •':■ -A 
..-relatively ..large; quantities ' of . fluid' for. intravenous .. use* , 
This -.paper ■'was/published.after the first. of. the .above cases 
was. .treated. -and '{'the'--.preparation ' and ' •administration -.of ..PAM- ;
followed the advice. .of 'Ed'son (1959)* . (The drug supplied 
from .the . -Ministry' of Health ■■ emergency. . supply depot was* ^ {­
manufactured ' in 'Japan ' and •carried no. .instructions .in -Biggish)* 
It . is possible that ' .the ' --haemolytic acticn/ias/ duo . to .' the use ' 
of ' the drug in ‘too ■ •'{conc-entrate'd form* 'This .may aied account 
for- the abrupt hypotension . which followed intravenous { 
injection* : This wap also.; •uotedy>in. lesser; .degree.;. by IGrob 
and-;.Johns; (19^^^aj*< q Its' occurrence. doge treated with
oximes .for •organophosphorus poisoning by lubash et ■ . al . (196O) 
'•vaS/;- / q -- .... -.. ■..,•■ " •"- ’• ' ..%-'
was .attributed ’ :t'o" the • "effects of - hypoxia* }•. This ‘doe's • .not ’ 
s<hf» ' 'to'f be” a sdtisfabtf y/'0Xplanati‘on• forlmy•:observations. 
Neither• ' haemoXyeianiou hypotension” has "occurred• in. • my ■■ ■. 
reatricted' experience ’ of ''the ‘use ’ of the more • 'soluble'’PpS. . 
(fiW ’times ”'-in' -three patients)."'-:'; •• ft o •'
■, - /- ;’-©ie- • cdh£imation''0£ the • claim that oximea. •.•mmyn i • .
reverse” neoetigiiiihe; poisoning ;is • ’obviously important; ' '■■ . ;
Nverthciless it • must be • emphhsised ” that-/-in my experience.) . 
the ” delay of 30“45 ‘minutes and the. limited n'atlhe -.of. the- 
hsWficiul action'liec.” such ” as, • tot limit ’? their . clinical value 
intubation with cCntroi. of respiration1 should neverr ub •
delayed. in the hop© •that"” administration}oo‘ an.” oxime,', . ••>,•• • 
pre.paratioxj’ wall' render it •innocessaryi -Thb ;’shoet^anohor 




/dhabier/l*■/,/•-?■ :'''/e'-v .-. ’ ;- ••*.•.
' ; ,, • -'jA revi-W.of ;fche /c&Mier;WF±tiga*;bn; rayaathenxa ?f,rsvisA,, 
"shows /'that the/cohdept - -of.raV’biochemical- lesion*- of = A”'"/: ■ 
;ta'anami8sion'..'at; - the #©uromuecujar junction - - of skeletal muscles' - • 
has dominated ' thinkihg-- about the -nature- ofmyastlhnia, gp.ayi}‘ 
''for; tho/iast --thirty /years* - ' /- Prior - /tp.; the .discovery ■ of 'the - -• ' •
•restorative effect of 'physostigmine and -neostigmine it - was - 
accepted -. by - many that-, there --may -sometimes v.be..- A-onsopy- or- >?.. >• /•'•• 
mental -;disturbances * - / --An - analysis -' of - the . . natural - history /■ 
suggested/.'to- some - workers -.-that myasthenia-•gravio -was ’the- /.b - /•'
' result .-of.-';a toxin- -‘‘'from --’bacterial - infections - which ..affected - ' ■ • v; .- 
neuroMwcular - andJin - some - Way disturbed -the -
xymphhai,<5.systeHU /—Buzzard (19P5 ) -'demonstrated/--that, ' ; -•-/ } . - 
lymphorrhages - occurred in siiany - organs - besides -the skeletal 
muscles.- ..-.From that ' period it has been known that- the'
"thymus -gland - "is- of ten- enlarged in myasthenia .gravis and /is- 
sometimes; affected /by/ajiumour*-d .. . - / ■. • l - ... - • _ ■.'■■■ m," r
//-' •<- ,A;- new - era - waseiarted- with- the - suggestion--of -the - -writer 
that - -myas then! a -gravis - was the ..result of - --an - ,i^nmoo^o>ii^^^-l 
disturbance - of -muscle - and- ocoasiohally -'Of - other organs - and 
that - the thymus was- an - organ Of - the- reticuloondo thelial *
playing - a /ne'ce'spary- part- in the - ’autoimmune-’ reac tion,
Ghaptey • 2.’'~ /, - , - '. ■ ■- •".' -
-//-/- A - -.review -of- - ^X/cases - shows -that' myasthenia : gravio -'-occurs -
in-all - rases •'•'■--/-Ii-;'i$/; more common, in ' Women -..but--the; -mo'dial - -age ;
. (about ■. 20- -• years',,/ 1^, - 'the - - e - After- - 'M/years//
of- -age - an - increasing proportion- of - cases of bo th-soxes have a 
thymic , ./ tumour - and - - /■those cas es - hav e a - hi gher - - mortali ty - rate*
-^0/ / ,;-'.v--./';A;/^/A”' 'A. ' ■- ■ /
The-^age-distribution' . curve,- is mphomQddl;,' Sugges ting- t.hht-', 
myasthenia,-"gravis'-is.>a‘At.r.ue entity, *•. yy ;. ' , A Aaa-A. ■ , A
■'."..• -;y"' The .onset' -may ‘be' insidious or .'.sudden'- and the course ■ > ■■ .". 
is ‘.characterised-by/ydriabilityA... ".Long term ' remissions' Ay'*-' 
occiixyin . less 'than -ViaiX/hW ' .casesAand ' ' are; practically; ..yA ' • A ' •
confined'-to- the earlier1 years -of/the disease-., y ■DeathAfrdoA. ' '* .y 
myasthenia gravis ''( as diMinc t-fooo -acoia.en-fcai •complications). ' ‘ ,. 
or. ioproveOeni - .'after- ■ thymectomy; ‘^Oc mestfcommon 'in'' the ' '.first ■ ■ A 
seven years; • -Ali.ta'suggesteclthat this -period - is'.'' the Ay .A ■
"ac tivQ- - stage *•• of' the disease 'but that - peroaaent miGcaxlar ' - '■
.damage may - continue , - into- .a'-tburned-out*;.' stage* 'A. '■■■.; , .. .
' a-a ' "A Tie', initial; ■"Awet and'later, reiapeem. maybe. •" ■ . ■
pr ceipitated -'by. -.e motional- ups e ts - », -infoc tions; ' or, , by-. 'allergic ' ' .' 
disorders'* - -. ' yA - ' •'''•'••■ .? •-."'y-y. ‘,'Ay;\
Ghapteh--5$ ■ ■.■yAA""y”A- y; 'AAA A •■ - A Ay,: ;' A.--- • ' ; ;.., ■ ■.
A . yMyastheni'e weabnoss'; Is; defined; ‘andAlts' distribution -• -
s tudied. ,A;1i -is show 'that -certain muscles are. affected;.''' a" A A 
more; oftehAthan- .others- and- that .these -.tend - to -be''affected.' y ... 
parlies t-th- progressive cases, '., A. The - extraocular, bulbar - .■' ■ '
and'' neck-. m^Uc^3^^;s,s^J^^5'/m^^^;^‘'■c5C^Onm^rnLy' -affectedAandAin the-'- lAmbs ' . • ■
it -im mainly /theAproximal muscles;A-' ■*, Mlmltatioh- to- the;-- , -A."
extreo’ciuiar '.‘-muse 10 s?-was uncommon 'tu-thO/present; series .and • •' A '; 
it. ip be dueAto -
taken- ih;;exaralha tlon. ..of- other ' muscles, in-'..order to demoostrate ‘'.;' 
slight, - degrees of-, - myasthenic 'weaknhe;3£5*,A'' - • - ■ A A "y AAy.y- .;' ‘. .
■;,,; ' a‘"''PermanentA weakness- W.th-fail^uI^e-.to-.r^es^i^ond\tC,^^^^^^'A.- '.A-,-- , , 
neostigmine and-sosietimes-'muscular atrGphyA.{xmsrsthen^CA . ' -
•myopathy *) occurred in -7JT % of male and- /'&%. of female - c ases * .
•The '.'incidence;- was - much - higher . ( /$. • %) ’, l^^^.'l:^e^atIeh^c3." wihb,., - a;‘ '•' A . Ay 
thymoma*,1' '* ' 7-A'A-. ■ ■■ y .• ■-■■'"■ „'-y, A-AAA ,’A* A;A<;-, '■ ’ ' . .
The tendon reflexes .were usually - retained and- ...often- ,
exceptionally brisk* Abaonee-of tendon-jerks in a myasthenic '
.syndroma-- AA-A'- Ay< AAyA'-. / • ; v'-yAy, A'" -
 ;■< 'Syndl!PO«^© - should - , s'uggM.fc' <a ■diagnosis ' of - caroiriomatoxuo
;■•'ChQp|0r.;4 »'•••••••', •',- '■";•/ :.'L.'A-' ••’••.' ■<••••;,'■!
.: : '"Sonaory. aymPPtomti:coi^3^P^.ai^n^.ed of by. '--many' 'pptiehiC..±n “' ... ■ -
.- ihiss'eeriss7and'in - the / earlier' literature,z'are analysed# - • . Paini- „• . 
and,paraeatheoxae could usually be ’ attributed'to-the - "',7.7
" 1 mechanical 'effects /off muscular, 'weakness*'■'• zlntermittent '
.■ i-deafness is’. attributed-/to )‘eust^^<^S^i^^an';-biock'.assoo^^€^1te.d'..Vi,L;ii''-', A -
,/ pharyngeal - suggested’' -•- ■ ;
* m&y./be ' due-, -to; - par'alyeia. of.- -the tensor,' tympani*' -' /.-.SoMe 'cage's. •' ' '• 
of - sensory disturbance - ’.canz.h.ot be . accounted - for - on - &'■ basis; . - - ,
;: of - muscular''weakness 'it'io - '-possible '.’fthat^'soei^.o^^^'r^^heer'^© ■ „ .
fib'r 08 '- oriened/ organs';. ’may /'o c casipnaiXy'.-.fc'e. involved- by the - •'<;..- .
. / disease process* ; ' ' • Epilepsy ' occurs ' with ^greater.: frequency ' ■ ' :
. than would 'be^expectodaand .'meatal-'dispfdera - were noted* ' /•'
-■' •'Chapter ,-5« z^'llc'/' :l.-//-/zy /,z..7. : . •' ”
y'- 7 /-/../'. -'The'-'literatur;''associating myasthenic gravis .With ' /•’ ■
thyrotoxicosis'la reviewed* <,It. is'-shown ••from. the. Author’s.' ■
■ cramltpiaV’thui; .theref isya.-zhigh .• correlatlohzwi th- 'thyroiddisease’-,. r
.but/that -'the-/latter' 'goitre', orz.myxpo'doraa ''as’' -
' woli'ap'. t^^yf:^c>O^:i0cS^eJ;^■tat^^d-^ thothyrold .disease. - may '-precede,-' ' -' - ''
Z accompany/ ox* - follow-the ' myasthenia* - Simpson.\(1960h) drew.
' attention; tp -,• the - high-incidence' ''of; thyroid - disease - in - ’ the - " ' • /'
/ z ralatiyesr.of- myasthenic-patients *•-, "Xthispsuggested ztltat^•-•/i;"..'Z. •. ■
thyroid disease', ’and -are’ independent- results of. a 
. . .common,-genetic: - -factor.’ anC'tbatz - this --might /.act’ - through a. - '- ..
"1.hypethaX^WJlitbU£a^y- mechanism,-as -thOr0are.ppo&sionitl.’-; ■ ' fz 
'.' example's, of - disorders •- Of ' other- endocrine'- . glands ' asspoi^aitOd- -z'.' -•
y.../with- myasthenia--grayish-. z-■•■—i&bebe&.melliius ' may- also /be." ,z .. "...
■'/■ gei^^^e^:ich:i'l^y ’linked '-t^ti';tbJh-^z:^<^1^-Xoo^^^c^itt:lE^a/;';dl^s^<^^^^s<^• '• - •"';The^;■ -•'> •" ’/
.. effect --.of- ©motional/disturbance-'would- ..be'' .•compaaible-with - . '
;. a'il3rp6i;haJ^^^mo•*p;^^t^U'■^ary?'zi^^^^t^d^^^.n;i^£^m.and; thief would .also'/'/ • / '.a






account for the var.iablo effects >of men trust-ion / pregnancy 
and /.environmental 'extremes * ' -pp' - ■ ' p.-.p- ■' ' ... ■ P'
Cha:^jber.:;6*\-? . p\ p-f •;./•'•’ " CPPp’/..' ,' P':hA’- -p. ■
:;f ppp.p'.Wta3repare . no , 'consistent .■biooriemc&IbdiOord.ers* Pp ;/•->/• ■ ,.• 
8 erumpenzymmSerived • . from ' muscle /are : normal ■ and e rea tlhurla .'' 
is. absent. if • nutrition' is. maintained-#;//.- Endocrine fmxiciion
teats supplement and support the • clinical . conclusions of the 
last chapter* Attention is '"dawwnto a\high/incidenceJof'
hypOrgamraaalobblinaomia. which ' tends ' to. be associated', with 
.comXldatlo'na 'o'^'yah ^im8mnoXogieaXytypev' '- --.The ^protein content,} 
of the^perehrospihal. fluid /may, also. be inerearsd.p'p he pP\ 
incidence' of .this ' cannot be assessed ' owing to inadequate , 
data> : —;■•/• •'-' '!> P 'P-' - P,:'■ JrPP■ ' ‘ip
./../ • /•-■ ■■'Disorders of' other .systeme' 'in •tte/c■ases/rvviW^i^d '.are ' 
classified';and-.compared with--thoee of'-'other'/series.- /initho/v . - ; 
lit era tares' Gimpson (1960a j‘; nhd.we& that -,.hher e.' was surprising 
agreement between 'some 'Of 'them and .this -'has sineo '.beon---f'p' 
supported by other ' .authors.. . Although the '- figures are not
f statistically s it gn if leant; *.p;it is ' -clear that there 'is ' a . 
relationship between myasthenia-' gravis and ' /aplastic'anaemia, 
pernicious ''•■anaemia' (reported for 'the first time)’, ' , 
reficuioendq theiial"disorSersp systemic '.lhpus erythematosus, 
acrocyanosis,- ' ‘rheumatoid - * arthritis, 'nephritis, - asthma and 
'Other-'allergic disorders. . p, P. P'i •• P'- / ' • ■'
■ .p-p-PIt '10' 'suggested that --myasthenia - gravis -is '.part- of -a . . 
•disease,.process- involving- the\,petic.iiip£ndethelial - system ; 
■particularly' the as a-disorder of --irammUnlogieaXi' ' ,, ■ -
tOti^rahei- (Appendix- .6).. / Acrocyanosis -may be an indication- 
of a-poor prognosis . since it ..tend® to' be '-associated with- 
myooitis/PhP’’-hi.;’-■-■-■■.P:::/,'P/'- / ■;,‘P’P’-:-. '’•-?• - ; .
543'i.-.;
my ositis y. and/;*heos tigmine^resis'tano'e* # ’ ;■ V •/ /e’/'//•'/'.. "• • .
.Qhaptdr-yjk g ■■ , ' ') '• . ■ '. ,. /.-.■. ■ . , •
i • ■ .' - ' Thfe -infaM, bornto, 'a myasthenic- aether may ■have . .'. . •/'"•: '
.temporary. ’noohatal myasthenia*.-;even /'though the ;mother'’S ■ 
thymUs -has - - been . .romeved- /Thio .-'is' considered' to ..support , •' '
/the.''conbepibof - a- 'jnmaaShenic/. toxin'’ which •■can cross /.'the' ■ ■,,•?;? '■;- 
piacentaX'-barriorib..'././-. . ■/,. ' '• • V -/ /g)g--///'■ •'
•■- ;7,i;/■pape/caseB; of of myasthenia -'gravla, ' ’-
are'.described /boiyyObiy/one Of identical twins-’'Was/afioetOd#-; -• ; 
fhis-Vaugport© ,the ■ 'suggostiph; of , a genetic, factor _ withf;:g ' ?:,‘/i . 
/variableiexpiCees;ioR'';^^^]^^^i^n^^^^ng;partl^y.- .on /&eOondary; acquired ‘‘ ' •
factors1. -, ■ ,///'. '•’.//■■'y.ia- - /' i . '- ■■-.■ . b'- 'a/' a,.’ <■.
/?■ ' . '?hm«/'00bgenltai ■ myasthenia- is-. described .and '; ' It
.is;-suggested/:that)' this' I..-"a''di ff oreht -<c'oni'itoOn/ du’e'• -1 oy "' ../ y -- • , 
-delayed' /or.. arrestdd\®ittoraiion .-oF nenromusKuInr' juWiinpi# >.-?• .'• 
-An . ; unusual. o_hae . of.. . ’benign- congenita! - myopathy .-.with- - myy«istho.niO' 
' - features# do'sori^^bod previously- 'by --the /author.. '(Appendix: - 'tf);gis‘‘ " 
eohqi&ere'd te /be'' ;a/y'ariaht’/of}this .typeio'f- iiy&sthonia#/ -; ’ ? , ■
: ’ -g-g Myasthenic - syndrome© occur in a number of -'.diseases' 
•Including ’-polymyoostie, dermt ommyoitis kind - systemic ' lupus - , 
eryt^h^€^ l^ato^u^a» Xt is shown - that these -'/form- a' continuous - .
spectrum with J ’neostigmine-resietant ’ - types - of m^«^g^l;he^a i ' =-• 
gravi©*./. '</■,’■ ' ' ///. •;••..'' //'■' •• / ; ■
, /g’/Fatiguable’---''Weakness- may - also .-occur in carcinomatous;
yyasthesiia» disorders- of - the lower mo tor - neurones, (including 
peripheral neuropathy) and in toxic - tmd - nutritional- disorders. 
It '-is;' suggested ' that - - : these - have - a different' .mechanism - '.from •. ' ’ 
-bruey/ma©iheMa' gravis - ’but have;-S'oye- /ree©myianCi‘“With/W•y-^../ , •' 
^j^^enital m;J^asthen^ay g / . ‘ y/;y. b -•'.; "
- y//.yd.Ocular myopathy,/congenital .ptoqife and - ’.pseudoptosis'* 
'and/.'-; \
and.- encephalitis ure.' among':-th£ '".•cisordero which /may .he • ■■ ; ■- ••.
mistaken forimyastheMa-- gravis bnt;'"'they "are entirely ly _ ■ . . ••
different' in nature#-':','■ ? ’ ' ■ ’’. - '.-/-; >-'■ '
« v! !' - ,, -.";/■'• ' •' ' " >?--•>’ . ;'<•■>'''•• -/'-■,. ■'
•<•.•< •Bax’iy '-nlAima /.that .. Removal .-of the., thymus.. was /■■-■■-, : ‘
beneficial"'in;myasthenia- gravis /ware.:later •disputed*. h,- The ; ' 
-'confused ' -position waa" . resolved" by: .. ah’ .analysis-of , -part ■-off/ -' ■ ■'/■
the ‘present 'material '• .and’/ayoornjOurison With .other- ■ aeries. ■? ;' -
(Simpson '.l^Way""195B and Appendix /J£)« It . iS shewn " . that
.the 'coupae of .'.the-. • dlseaae;-^,a ■'fxvouumbly influenced .and the -'■ ' 
mortality reduced-if " the' .'.thymus - :is. removed .during - '•.th!? ■
tae tiye'''bt^£g^7«^*'/e.f■^il^"'dis3eaas^\^' / 'The benefit -ia" most " ?'< •,-• • '>
obvloua in youn^g^i'W^^men but duration of illness is 'more. 
■important 'than, age ..'©or'sex, i ••Removal■ 'of . ,a " ••thymoma loss■ 
cofmonly " . alters,.the "-unfavourable 'prognosis/’asso'otatcd'" with' . ' 
>hat "/yoidi'tiQft*”'-•; /' ; •. .'•• ■ . -" '. -
"'//■'-;.-„'■' "Contrary views. are .shown to be due "to failure "-to .... - 
analyse ■/separately 'the/ cases with' ,"’and" without " thymic tumours - ‘. 
'and, V'to/.a."leaser extent, "":to differences .ip'-response -of. each" 
sex #‘7/ it •. ' y-li'Ki.A • •' ", •<>*•'•/ “
’' ■ '., ,//• .is . concluded,.that the thymus plays.'an" -essential" ' " -
role "in-"ihe" -first ,9«7" .years .of the ..disease . but ""thereafter" " \ ■ /. 
..the " Ms'ease.."-is self-perpetuating or the other part's .'.of "the \ A 
reiiouXo'endotheiial system assume- greater -importance.-'A. . ''
Chap tpr.-11*.-. ■•. / ■ •?. ' 'ii \
, /’A brief outline "if the ", morbid- anatomy .show ''that the,-- .•
pur ely * biochemical * theories " of " myasthenia. . gravis .'have. - ,' " - 
'ignored.‘/the/"fact that ""'there .arcr :c6nt±stenttpathological ' A;. A'- 
'changes " In ..many " tissues#. ' - -It " is. auggeated' that; ,.IympbQrrhagea 
and " cytolytic -.■channes/’in ‘ skeletal.- are.-evidence-of / - ■ ■ 
'iuuU,nlX0Qiaal. damage#" ;<• Supravital staining. of ' the . motor . '' 
nerve/;,;.."/■
..ne.rvo ' torminals- /and ‘ eleeioonmieooso'opy. of • muscle /by 'other 
workers show that . there . is a ,pre- and ' ' :p0Btrjunct'ionai' ,
lesion in • the -majority 'of ' cases.'•••;, The nerve terminals’ ■ ;
ara characterised by -a - combination of.degeneration and• 
active regenerative. 'apron ting* . ■ /....?'• '• ? /./
•' ; *.■ /./Evidence- of'■immimolo.gicalldisovderst, may, be'. 'so®»- '
in. the heart,- adirenal and • thyroid' glands.. . . ‘ \ *
/, . The thymus shows a characteristic lymphoid. reaction .
(,* germinal. centres*. ) eyen • in - the glands -which.show/• . . .
/adenomatons; change - ( * thymoma *) . - ■ ■ It is-: s^^g^goa^.tpd ( Appendix ID) 
that - this is• -■evidence' of immunological activity,. though at
.the. time of -the original ; hypothesis (Simpson, 1960a) the 
/'function .of the. thymus... was unknown., /Some '.-.examples/ of. . ...
splenomegaly are reported. , ' ..•••’ -
Chapter 12,'•' - '/-■-% ' /-.';■'- f ' ' ■ • . • /
: ■' '.The. normal ' physiplogy/of the thymus is 'not fully .
understood. Earlier ' evidence is . reviewed suggesting ' that
it -.plays' a "'role ' -in- '-growth or, more' probably, maturation' 
undei* the .control of the pituitary 'gland. A possible
inhibitory effect on the ' thyroid ' and adrenal has also been ' 
discussed. The -’author’a suggestion' of -a' role for the,
thymus 'in 'autoimmune /diseases ’"'was ' soon given a firmer 
basis 'by the "work of MUlor (1961, , 1963) and of other '; , 
workers. It.is -suggested th&t ,'hhe •immunoiogica^'fu■ttction .
may .'be part of a wider mechanism of protein' differentiation 
.linking the recent work.with the earlier.studies, and further' 
that this is ' Under' .-hypothalamcopptuitary' control. This, ,
could ' provide 'the ho'meootatic mithhnnsnmrequi■r.ed'•by-some 
.current theories of i^iluuollgicaX tolerance,'(Simpsonn 0964$).
. There 'is no ' evidence ' that the thymus ' produces a ■
■ ■cti3rai^«»*-L'ike * substance' in, the ' conventional sonee. ■ . -
Chapter 13/ ' ‘ - i' '' . . ,• '
Chapter 3LJ5«,,; '' ; ■ • • ■ -.? 1' ? '' - '. ,. ' - •' :• '
American '' worker# int depon'd entiy reached .the Gohcppt a 
of an '/Immune logical,, meobanism '.I#, • myasthenia gravis "on" -; . '• • ••
observing the , .cytolytic; ' -effect ,on ..frQg-tm'ecl.a-'of ■' sOrmth. '"•
.from-:-some,• myasthenic, patients* . g/They Werelabl.e to -demonstrate-, 
.the\:$r,0SGnc'e '<o£,/muB'cl'eTbip.d.ing. compXomQnt-fi/tixg^ ;aOiio0&iea ■ ' ■■
/sera,and,this has,-be©A‘;eoh£&med .by,other',"?"/' '• '.'■ , 
Workers* , / ' .The, author .aiid'- his- .colleagues , have 'not';: 'been, ' able ” •' • 
■to"obtain- theaegroaialts /and;! ,t '.is .now suggested• that anti— '
muscle' anti bodies’..are,: ,only foiud , ,in, the blood ^of myasthenic•' 
patients who have a thymic tumour*, ' ’ , ' ■ ',
g,- — "-'OXtria.shoWi• -that. • many '-.patients ’Wth',my&ahenia< grayis; ., , 
have . ,raised_ ti tres. ••of ' antibodies' - uagainst thyroid asdvf^€lht^ric 
parietaltcolls i -ahd anti nuclear, factor but do -'not' have , a, ;/ --? ' ' 
.positive. reancnee 'to*,‘the; 'sensitised, ohe©p~c ell test' even - .When- 
/they have'a"/rheumatoid’"type 'c^ff art^hr±tif5ltl■;s_tr ?*/ cy'"-,,i..-' '
Haahimoto’s, disease is described in '4' caeee ; including, 
one in -'••Which-'thia- clinical' "pioture' developod after , ’removal of 
the ' 'thymus*'' ,lt; 'is shown ' that there ■ ia ' a elinii&.l and _ 
serological overlap between, myasthenia gravis and many ' diseases 
which are oonaidered,' to be ' due ' to ' defective -immmtioipgicaX .
tolerance •/; t .'•••.-"'p ' • ■ *.v
-In "this .chapter '/bl© evidence; is Gumnimrised' and ' the .
■ , hypothesis"istmade -thattinyas'thenia, gravis -;is - 'the - 'disord’er,
'resulting'' from ' immuni.dgio'al;' damage - to „ / the 'neuromuscular - 
Junctipno ashthe?"r.eWuit'iof'• abnormal. function -of. the thymus' 
/gland,'-.and ' ,-t^he^t-;■t^^tljJ•^^mry ''.be/iassociat©' ■ .with.'other? ■disorders - 
■.of' immunological 'toleranceIt "ia'/'suggested"that "the -.
abnormality' of • thymic'" fune tion is ' genetically determined' 
and ' involved a'do fecit. Of'' typcthaiamoa pituitary: control ' which
may -also. manifest itself '-'in; the 'sa^e“ patient or 'in hie ;
.'progenitors - ■"i’ aibii^n^gs/ae ."/'An/.- ./'I/ ' / "/- ' ;
al-onechsmi am Wraid-raoCounb ,for/neonatal;. mya.!3.thhnl& ' 
and ' 'ye t \.r en&ef-/midere tandable - the'.’fmLlur.e Jof. cross?*ye''""- / / ,
trans.•’ '•.• ;■’< • •'•''’-••• /•"•'•• ,• ' ;.
The - eymp timatid;- "rnybs theelae. * may - be; similar /ink.-; ,,' :: '
nature '(polymyGo'itis' ». &ermafcomyyoi‘fcia,) ‘systemic" - .lupus- -■’./'■ /• •-'•• 
erythom&tosue •)- ■ or": simply?-have -' a - - c ornmon - ." 'd’ipturbanc e " "of.I? '/ - . ' y ■ . ';. 
'neuromuscular - /phhsioiogy*. ." The" - irnmnOlOgle al’ disorder'. . . ; "■ ' { /
■ postulated, ifor myaGthoinua -/gravis- way-cause bloOkagokof'/end'-. -l/. , 
'plate" " rOadpiGrypi-tern" /(protein ) by - ■antihO'df f - •uubebo'u’i'd. " ? aff ecsV . 
•nerve" terminal^/" ! /■•,/- ' ' ' “' '“1 ’ '' ~
'Chapter.15 » •.-•■>'-,. / ■ / ?V ■ / ‘ ; /"
' ./' -"%«#' -’a/myasthenlc" " patient - •maintalhe" -a - postural "/."/
contraction of ,d; -mm©^'''!.'^’' 'the- "electromyographic registration, " •
of - summed-. .notion potentials- - is ? gradually" reduced"" by "•-motor,.-:/ ■ -•■ ■ ’ 
.units'." decrementing - in sipe - butt;.also - by " suddon/'c'eQs&hton of - - 
firing,'",,'; -.Many -of" the - motor - units (In. tha;ib^^e^c;tofUy■Ographi.c-' -• • 
£aense")lare - of. /■’3m■?rsUSS.e * typo; and ooGasionaXly• - spphta noons"-' 
activity may be recorded. at rest, "lliese- :find!ngs.-indicate"■ '' ■
' that - . in; addition' - to /W .'disorder- of ■ neuxO^r^imspul-a^.- • transmission • 
therO. in ./Often - electromyographic evidence of? "an abnormality - /. 
•of. muscle', fibres," .;. "/•rAin-/inidrmiasion "of " "a" .few ; seconds" '-la -■; ’ ,. - •/ 
•followed " by- renewed activity owing to - posirtei'anic"/facilitation 
and the a! t ©nation between * fatigue *■ and- facilitation " may - ?
' cause" .phaslc'/Con traction, ' / " . ""/'•■ / ", ■ '
I'//- -/'"";/ -;:if ■a.-motoy -nerve -is stimulated rej}et"it:3^v^el^;//lWit^h ". • ■■ .
, supram'estimal " '.a.tiranli ) ..the" uul<s^Xar" ' response decrementa".. bn t ;
/the- muscle. - will still , -rcapon'd- to 'direc -t - pos't-rjune- tiLcnicii. :■ . • r 
•stimulation.--'. /"This.-. la - -the ■-.Jolly - beat - .-which: -'di^^^nstt^j^-tba - !'•■'•••- .' 
that/ -there"!® - ••transmission /failure, " - The " integrated a'c’tOon.< ■
pot<antial/- . .//" /. "■.?/ " . ./. ••'
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- potential' of thejnusel#.may be used 7,as'‘the index of _ response t
, . - ( .Hary ey-Maland • -•‘test ). .- •• When ’ this - laid ope - i t -can,- b'e -seen .. ;•,'.
■ • '-- that. therevi.s'. &- facilitation reOpopso; ao/.iW3M'apfth.e'.'., ; •- ‘ - ,. -
decrementing ' reepopse* Usually. this causes- only temporary ' ;
■ •.•;recoyery?-but- 'in 'some muscles,. - .fast - rates' of - nerV'e -stimulation.
; 'eauso .anninepefflontiUg response* This,.-is ?.moot, striking: in . /•
carcinomatousMnyasiKenia .but-may- --- 4 • '
‘ myasthenia .gravis'* ' .It "is' suggested that'- muscles'- ‘showing, ■ • •. .'./
. the •'incrementing- .-response .are also rp©:i-o<;ant to -the action - ' •
4.'.' of-- depolarising--drug©,*., i--5*bWirtht^^^tet^e.iUa,t,io^ ^tdpp,i^5^-.:there,;- ;/■ ■ -­
x .--is-"a- -brief •-pOitt-ttttmic- -fwiXitationC;. but-according;to. . ; -, . • - ;
Deamedi/ - (,1957a)- this is ' followed by prolonged-. ’poot-activation 
'exhaustions. •.-■.• 4i ..4.■., - . ■ • • '■■- - • - - 4' ' . - v -44
-'4The anatomy and,- normal.'physiology/pfy-.tho. neuromuscular;
‘ •junc.tiohAkC .descriWedP./ip ■/' ---y 4 , - — -4444-' . ' •
' ■' Ohapter.-.i6*,. - \ , - /. '
■ :- ':Possible-■mechanisms'-of ^1^001x4001,^ blQ<k- in • -
It- - is- -shown' -'that; -there ■ ' '.’
, ’f is -•e.viiena.b .'.in -favour of -a-pre-. jumctional - disturbance'/but . • . . - 
also -'evidence, - of - post-junctional abnormality in the - altered - 
response of -myastheM’c, - muscle iHo.depolarizihg substancefc ..■
■ The ^.eieetrophysiolGgicaX- and'--pharmacologieal data are- - .■ ' ‘ /■ '••'
’comppaible- --withiseveral-of -the -mechanisms .-suggested.for- 4- “"•.•'
• ;-j^mass:l^<^^^iLa- .gravis/ - A personal -theory of the--nature - of- • ‘ 4
, '. .drug - - action - at 'the - end-plate- ‘of - muscle'.is discussed-' , •-■- •
(Appendix$)• ; ; Tt.ie ’-suggested -.that;; - a ^-sequence; .of/stimulation,.
. ' .depolarization-block, • refr’aotorinees and i competitive.’ihio.ck •
. .is common bo all - drugs --ac ting. on -‘th e- end’-pl at e- - . the intensity
..and - duration of eao h phase;, -depending .on"- the - .'.density; -of - - ionic -
charge^ on the end-plate Receptor,sites and-the, kinetics of-
•, . its -.breakdown -.and removal-. . Previous- reports 'on -the -4'44t ' .7 
.... • phenomena/ .4 ’■ . ■ - ' '• /.- -' ' ’ -
:.;y> > - i,y';y /. Wyyy ■ f.y. yiyf . /'/giyy,--, ; ,■ '
phenomena'.'- of " drug'1 ac tion . in myasthenia. fro,.'shoWnto- fbe:..,; '' - .... .
predietable on ’ this, .hypothesis''; and i t '-if -/ shown- that- anything 
which ' 'reduced - the ..density -of - ionic -charge ;at the end-pif.tey • • 
after each nerve imphlae - would-cause - -a-myasthenic phenomenon. 
...--•v. .-Two. -.possible ’theories '.are- .favoured, i ,). .competitive 7 y .
hipck-.by- -/a. .*^5^a^e^a^^'h'9Bic\'^^OKln,;< and - li)■ transmission. at, . 'yf-y. ,y ' ' '
_ - junctions*' '.Bee eht; - evldene e - oii ' - ' - - ? 
-the -■•X&tte:r -..rCi4WW-'€^<Sij^-- 196Q)’ysupp'ort 'this -' poo?c^^s^^l^ii^:ity-it ■'. < - / 
'±8 --'pointed otqt7-that..;no'thl^nigj.- ' is known' 'about - ‘the'/tr&ns®£s$ion- ‘
• from regenerating', -nerve-'terminals to. - pathological muscle•- ' — . 
-fibres. ;/ '-hhh’-./concept -of- a balancebe tween .degeneration, - ; and ••;. ' * 
regeneration - of motor - herveitte-rm^^^^^^ie assoclated with■- -'myo'sitis,- 
.described. ber<o4.for -the..- first'-tirne, la supported by .'the -.•. . . •­
•pathological ■ findings. ,'.. --h|i o' -le Sion, could - /be - of .iamuunlioic&i'. .­
origin-- . and - would - account. -for - the fluctuating - course - of 
myaathenia/gravis.. .//-// ' .• • ,• ■■
- The - pessibilityyof- a -..myasthenic - -toxin is. favoured by - 
the evidence - of neonatal?j.my<vB^tenil and /it - is pointed out 
that' the duration Of', the•/latter is'in keeping -with ,
persistence.- of/maternal/.aritibddi'es- in- the - blood - of the - newborn-- ■ 
chi'ld.'?-' hie- - author-.isi-unab^le to confirm - that some - muscle's'- .
. become'/weak if - -others -'..are/exercised- in---the /myasthenio - patient -'■ 
(Walker- - effect) - and -is critical of/previous - claims to .,- , 
demonssj^ate -such.an action. -' /-' y- • ■■. . ,
experiments, .on - isolated - ihbrvogmus.cle -preparations /shp.w/no‘ ./ 
.evidence - of - a -curareflike - substance in' the1' 'serum' of - • /. ; - '• .
myasthenic- patients.yy-'•'/, • "- ' •••••'...,,,. ' ■ . ./ /-'■ , ./
-/, - ..'-- e./I't-is - -suggested- /that/an--antibody '/against-' the;•protein'/•'-, • 
.'of - - end-plates ;'wgld/function as - l//cotlpetiiive blocking - y
'substance specific to fh - 'individual - or- to - a - genetically similar - 
infant# Aurd-oan - evidence for the presence of a substance -
ip•-.•myasthenie©eiUm - 'Which---causes -u'ytdiysici-'of - frog-musclii'is/' , 
cornside red/-- / -••••••' /'/- y •• - /- y . - yt"y- — .. • ’.yy- - ‘/- ' - . ’ .
considered ■ to- support- tho/hypothesis# , it ids concluded -that 
ohe-pi -.several. pp!^j^;i')bLe'ismntnale^^^i<sai mechanisms is ,- -- / ' '
eompp.aihlo. with ./of' ‘ndurpmusoular // ••.-.' ..!?
func txph »?/■.'•<,-■' ;?-•/ •/•.' ... - g •••••’. y . ' v
ghapter 1?» '; ; ■ . ■• ' >{ ./ . -'' ■ ' . ■ g -. '//-. '
/ - './- •■ .-The differ ential --die-gieeis- of . .myasthenia gravis - • 'Is/ :
discussed . and '-the Use of - diagnostic'- tests /based .on- -'the -• '
disorders of neuromuscular - and of- •reap'-onse io. .'• ,
drugs acting on the /end-plate '-region of . muscle.* 1 The -nature
of - drug"'action"as a /proliMnary ..to, .later. work*'' - 
on. t^wa-fcttienii 'and. •ojnt.i^e^^e^ogi^tig^m^^si'tar^c^’•*?./ v t-,'-. ' .
g-harter.- 18* '/.'.,.' ■ • ' .■■,././ - '// "-'; f
' Treatment is discucseci under the main '.headings ...of :■ .
a) ’ removal,/ destruction- 'ox*,-Inac tivation of the... thynmius-':h) -, ' 
pharmacologicaiooonpehs&tion f6r .tr'ausrnission afailure'-yh).' - .,... 
/general- mnag^aefb 9 e n ' . ■--- - .<■ ,. -/ "■?..-/- . _
- Thymectomy -is -advised- - for - all paii&nts, •'i-rre-'speo live 
of - -sex 9 if - til e. duration hom - myastheniV'is .{Less than
six ■-■yeiarSo the; weakness* .-is not’nonf-in©/!:t/o'/.Oh^i^y,extraocu;lar -, / ./. 
muscle© {/and ’ the. pationt la - - under- 40- years.Of - age . (-Appendix - -—) 
Wien -those' indie ations do - -•not.•/apply thymec to/my. /is-/still- g •; <.•-. 
advised,,/in •"cases •prpgreOeing' despite- .triatme'nO/':wi'.th- drugs, - ' 
and '-in-'/all .'patients-b^^d^^'th--- ■thymiog- tumOur* - ""•/ ■//■- -. -//, ii < ■
'•■ ' Hadis therapy:. is /not-a -ami -subsiOtuOe - for,;-; •{./ {% •
.thymeo'tomy by- a -skilled - Ohoraclc surgeon/ and -may be ' - - •• ' - ’;
dangerous* , It - is.- doubtful - whether - its - use -/before operation 
for /'thymoma 10- of - Value# - -’.' ’ Denervation of 'the - carotid .{sinus • . 
■ is discucsoOvwithout ••personal-'•'eXperiehcei:{'•- fit--is. not'-.:. .
rocQmminde& on - -the- grounds •/that it is-an inferior .method of - 
suppressing./the. 'function- -Of-ihe thymus#- -g ' The- a am e- obj .ecti on - - 
is/ '-/:'
is/made 'to':: the •' use • -Of, aidrepoeortieo ’trophiut an tire tiehlar .
- / cytotoxic ’‘"perum• and -plasma’/dialysis*’ •' .y/ty ■
'// - The antichvxLinesct;erv:^;c'do.n.g.s are • ■/reviewed,.' .,/ It • •,
; considered that/ the search ’/for/long*acting'" 'preparations is >■
•'misguided' /Sine e’' all, • those ■■•available/are -cumulative$ giving ' 
///rise/ to overdose • effects/*..'/ { Neostigmine and • pyridostigmine -
, - y aro' "satisfactory •for/routxne;• use/' the \ latter’ heiig/ the' -best ■
', ' for ./smoothness of ’ control/but 'neostigmine -.is valuable" • Where)-• :- 
•• • -ah’ •extra’ '’boost ’ is requ:ire,d#, '- , /f./v/vy. ;
'•■' • '• • ■ ’ •• {oi&S&iumyyphedrine and guanidine • ,' ’ /
have, .•.0cca8±0:ial ;';^fi^3^^e'..;«aP...adj^y^s^nt/\f<rm^s^- of i therapy/. but/the ’ ,
. .. author• 'does /not ’recommend /the -use .of • d'tub0cu^arii© to • ’rest ’•
/ " the /end“-plat eh 1 ,•. in• oaPos*’ o f • apparent ’ neos tigmine-r'esist ance * *
.Theeiatter’"^^^^e^rrtmf^6ni/Lp/;“B^^'c^ss^c^^;/a^l•"^/;Cfl^^^eidex^-^c^.• 'to /■ be • due :/.
. •ant ieho/XinePter&sO /oompOunds, ' ' // /' y/ •'//
• - /• -vyIn/.general/ avoidanoe’ "-of’ oertaih’ /drugs .:
' ; ' with' neUi'c^m^lscul./^^:‘ lb^;oclc^ng ’effect is advised and a '.warning ;.
' ' given •,<qf.< th.e ’■ danger '/of; ’.mdminiptraiion/- of: an 'enema'• to a /..-/ ’> -. • • '
, ' .myasthenic’'patient* Th/genem! management of’ the,patient ’s /
■ ../.' life' -Is -discussed. /■- " ' '■/ . ,/ '. • //,//.■■ /•.•-•. . .•/’ /y ..- '
' /'Chapter.' 19 * - • •—//’" : ’ •• : — // . : .. / -..• /'-?-.
' ... -./,.' The-- causes-of.death • ih myasthenic /patients’ are/;. /■
' ' discussed * ’ These //Ore-i.)'''unrel&t ed /causes-'-ii.) asphysctation. ■
. . by'Ooretgi-•bodiea or -saliva>: 'ill).• .myastHenic . - paralysis/o'f• ’ •
- ' respiration/iv) ’'cholinergic ’paralysis'/Of'respiration*- .-. /'
/ /"' •. t - it•■ is" "shown tapt/hhe -risk oof aap^^y^x^:^^t^On•vby;lihh^£^^.ed ,
. •,/ fnateri&X''may pprsist/Oven in the :*burned out’ -stage of ••••the’’••• ' 
’ / /'disease'' but that" the’• other /types :• of ;rq/bpirat6py/--failure ’ . --,
./// (mainly ’ inspiratory)-.’ 'arc • more • .probable, • duxiing/ the /active’ /. "’/ ;
-. //.-. stage '* / ' The • 'diagnosis' '•and • management o f ’ each - ie diso'ussod •
••',//and 'it/is ’ suggested ’ that Jchb-line^ig^^i^c- crisis * 'is-.’a/mo/re// common
- : 'eause/'' -.. /■' . '/,'/' ■ ''.•'/-•'/" •-/ • \ •
z ?■. /'■?,-'/ 77•;. 777*7.;;':' -. . ■ ;7.
chuse-pf/death . thanj/myasthCniC• crisis * /though -rarely/' - / /.'• '- 
recognised/ as{GUch.; /■ ■■/-:!,' g _/ .'/■.' '(j ; j '■■■//
/ ,•/,-/Ferspn&Xs' saudies<\onn\^Iie e -c.hoXinehgtc7®at te/,;sa?e/ reported 
laying, .emphasis, oh 'the fact '• that ■' ..differin'.t' •■ntuse lee••may' be• in’' 
a?’differont-'et ate • >as judged • .by■••■the• response.' 'to' '■/stimulation • o,r 
tojQdiObpl0oni:UUttiLl\-jXt..is /Sh.otWnfchat;.'home muscles• -may.'-be ' ■ •. ‘
oy<^ardo^^>a^^'■•-^lWhL^'^•-;h'ths.Sa,l^SL■li^'•ali0^w-a^!mzy^S^th^i35^^^> type • of - ,■/ 
wdakmets, //' -Precautions • .to' be ■ taken t while' ■ .tea ting/With { ' _• '•. • 
edrophonium /are'/deac^ribed in, the light ••.of. thece -rd^L4din^@^^^^:':’. ’ /
/• • •{. ’-he first ./British • report > on ^^h^^-.iu^*e/e^;-^'"oxame ■ drugs ’ -. ; 
f o r, /th a..tr ea a’tme hi- • o f word o.sage, WLW '•’c U le rnary ' ammonium • •-• • 
anti 0 holi nest e rase ? substance's • ‘ is - preachted# Pl /ft - is /epncluded 
that /—the action .jf’/drugs • at present • -available .-is, too /slow, • • 
and,too • limited' _ to/-be/ ' of "/pisiC• tical• 'valuey-/ . The- importance' - . 
.of giving • snfficihhbg&tfopine,toUzaup^resC ■mmucarinic /effects,
.and • • '.to.-., limit • -blockage • ,of•;cent^l^^a/^/•J^j^lls^s^O^,es';/±s emphasised''.and ’> 
'stress .is? laid .on ' ensure/ pillmonary -, /{/-■'7'/,/
ventilation/at/an,;early, stage* 7 -.'A• "te ntative • -tri al 'o f -/ 
artuboSurarlno • -as ah’ antido te• - to , cholinergic . poisoning' is ■'■• '•' - 
■described/■, / - \ :■/■/-/'/7_./--;,5 • /•/■A.;..'.-/ • • "jy/7 •■• ’■’■•-•'•
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Possible case from Byrom Bramwell’s Atlas.
Table 2,1 Age;and sex at onset of symptoms.
Fig.^2, 1 Age arid sex distribution.
Table 2, 2. Duration of myasthenic symptoms before death 
- non tumour.
Table' 2, 3 - with thymoma.
Fig. ^2, 2 ; Presentation as facial palsy and ocular myopathy
Fig* .2, 3 - Prominent-'supraorbital-pads.
Fig. 2, ; . .. ..Ptosis induced by. maintained, posture.
Fig. 3, 1 Eloctromyogram with sudden failure of 
contraction and brief restoration*
rig. 5^ 2 - Myasthenic facies. ; Triple grooved tongue.
Fig. 3, 3 Radiographs of thymic tumours.
Fig. 3, A Pneumo-mediastinography of thymic cyst.
ng. 3,5 Distribution of myasthenic weakness.
Fig. 3, 6 Myasthenic ptosis. .
Fig. 3, 7 Myasthenic facies. Effect of neostigmine.
.Fig,A 1 Post-neuritic myasthenia (E.M.G.)
Fig. *1-, 3 ' Smooth tongue of. patient with thymoma, 
megaloblastic anaemia and disordered taste 
sensation.
Fig. 3, 1 Exophthalmos, in euthyroid-myasthenic with 
previous history of thyrotoxicosis.
Table 3, 1 Clinical or autopsy abnormalities of thyroid 
gland - female, non tumour.
Table $, 2 . - male, non tumour.,.
Table 5» 3 - both sexes, with thymoma.
Fig, 5, 2 Transient thyrotoxicosis preceding myasthenia.
Fig. 5, 3 Transient thyrotoxicosis before myasthenia 
with recurrence as myasthenia responded to 
thymectomy.
Fig. 5i, Thyrotoxicosis after remission of myasthenia.
Table 9, Family history of thyroid disorder.
Table 5 Effect of pregnancy on myasthenia gravis.
Tabla 6, 1 Serum enzymes.
Table.6, 2‘ Plasma proteins.
Table 6, 5 Cerebrospinal fluid.
Table 6> 4 Thyroid function tests.
Table 6, 9 , Glucose tolerance test.
Table 6, 6 Serum calcium and inorganic x?hosphorus.
Table 6, 7 Urinary steroid excretion..
Fig. 7i 1 : Aplastic anaemia associated with thymoma.
Fig, ?, 2 Myasthenia gravis with ’rheumatoid9 arthritis.
Fig. 8y 1 Familial incidence.
ne. 8, 2 . Familial myasthenia.
Jig, 8, 3 Familial myasthenia, sisters.
Hg. 8, Family history, with other related disorders.
Fig. 8, 9 One twin with myasthenia gravis.
Fig, 8, 6 Congenital myasthenia.
Fig. 8, 7 Congenital myasthenia, neostigmine response.
Fig, 8,8 Becamethonium resistance in. benign congenital 
myopathy with myasthenic features.
Fig, 9» 1 Neostigmine-resistant myopathy
- arthritis and dermatitis.
Fig, 9> 2 - weakness of neck and jaw 
muscles.
Fig. 9, 3 * weakness of shoulder girdle
Fig. 9, A Harvey-Masland test in neostigmine-resistant 
disorder resembling myasthenia.
Fig. 9« 5 Harvey-Masland and edrophonium tests in 
dermatomyositis.
Fig. 9, 6 Carcinomatous myasthenia. Radiographs.
Fig, 9, 7 Carcinomatous myasthenia. Incrementing
response to tetanisation.
Fig. 9, S Ps eu d oray as t h e ni a.
Fig. 9, 9 Pseudomyasthenia.
Fig, '9t 10 Pseudomyasthenia.
Fig.-'9, 11 Myasthenic reaction in diabetic neuritis.
Fig, 9, 12 Myasthenic reaction in motor neurone disease.
Fig. 10, 1 Evaluation of thymectomy.
Fig. 11, 1 Muscle pathology - Russell type I,
Fig, 11, 2 - Russell type II.
Fig. 11, 3 - Russell type III.
Fig, 11, A- tymphorrhage. Myasthenic end-plates.
Fig, 12, 1 Germinal centres in thymus.
Fig, 12, 2 Thymoma and hyperplastic thymus*
Fig* 12, 3 Histology of thymoma.
Fig, 12, 4- ‘ Germinal centres related to a thymoma.
Mg. 12, 5 . Hypothalamo-pituitary control of thymus (hypothesis)
Table 13, 1 Organ-specific antibodies in serum.
Table 13, 2 Serum antibodies. Comparison with other 
series'.
Fig. 13, l Hashimoto’s disease after thymectomy.
Table 13, 3 Disorders associated with myasthenia gravis.
ng. 19, i Nouromuscnlar June ti on.
Fig. 15, 2 Myasthenic ’fatigue* of voluntary 
contraction (E.M.G*)
Fig* 15, 5 Myositic changes in »iay asthenic myopathy*,
Fig. 15, ** Harvey-Masland test.
- decremon.t&l response*
Mg,* 15 j 5 - decremental response with 
transient facilitation*
Mg, 15, 6 - incremental response*
Fig.* 15, 7 - post-tetanic facilitation.
Fig. 15, 8 -decremental response to slow
stimulation- and incremental to fast
Fig. 15, 9/ -positive test only after 
repeated trials.
Fig. 16, 1 Theory of action of drugs at the motor end-plate.
Fig. 17, 1 ; Ptos3.s, in'', rayxo edema.
Mg* 17, 2 / Decamethonium test.
Fig* 17, 5 Edrophonium test (clinical).
Fig* 17, Edrophonium test (S.M.G.).
Mg. 17, 5 Edrophonium test (B.M.G.).
Mg. 18, .1 Ergographic control of timing of dosage,
Fig. 18, 2 Trial of Hexadistigmin (DC-^D).
Fig. 18, 5 , . Surgical correction of ptosis*
Mg. 18, 4 Tracheostomy for ventilatory failure*
Fig., 18, 5 Leakage past cuffed tracheostomy tube.
Fig. 19, 1 Edrophonium test of cholinergic state.
Mg. 19, 2 Differential nicotinic action.
Fig. 19, 5 Treatment of cholinergic crisis
- effect of PiA.M. (1)
Fig. 19, - effect of P.A.M. (2)
Fig* 19, 5 .» effect of P.A.M. (3)
19» 6 - effect of PpS
Fig. 19$ 7 « control with low dosage during 
oliguria.
Fig. 19, 8 - pseudo-cholinergic states due 
to potassium or hypoxia*
Fig*-. 19»-9 - failure of response of pseudo- 
cholinergic state to P^S and 
atropine*
Table 19, 1 Comparison of symptoms of ventilatory failure 
in neuromuscular disease.
Appendix A Clinical trial of pyridostigmine and neostigmine*
Appendix B 1 Benign Congenital Myopathy with. Myasthenic 
Features®. (1996)*
Appendix C ’An Evaluation of Thymectomy in Myasthenia 
; Gravis(1958).
Appendix B ♦Myasthenia Gravis: a new hypothesis*. (I960).
ffig* lyl* < A child with remittent • ophthalmoplegia described 
' by-Byrom Bramwell (1892) in Volume 3 of his 'Atlas• of
Clinical Medicine *. The; aetiology was uncertain • and it
was attributed to syphilis, The bilateral ptosis, and 
dropping, of the mouth suggest that this • was an unrecognised 
case- of .myasthenia gravis (Simpson, 1960a)* ,
rMtntmn
TOSLS a, 1,■
Age at onset of sayaBthcftlc eywtoiiio . (488 caoce).
Age. Ueaxf
Non-timour* ■ ... '
. ' Female# Male#
Thymoma#
Fosvle# Male # .- .
0 - 5 ? 1 **- ■ «•
5-10 6 '2 ■■
11 - 15 ■ 33 6 4b '
16 — 20 49 83 ■ ' ** ' **
23. — 25 38 19 ' '• a ■ ' «W .
26 - 50 43 1? . ■ 3
31 '•* 35' . • H6 • ,13- ■ - 3 . 5 •
36 — 40 84 14 3 2
41 - 45 12 a • ' 6 . 3
46 - 50 10 ■ 11 3 3
51 - 55 ■ a a ■ a «*» -
56 - 60 ■ . 3 ■ ■ 4 - ■ a X
61 - 6.5 4 4 a **
66 - 70 2 2 • • - w
71* - 75 . • ■ 1 3 w **
?S — 8 2 «# . , 1#* ■ - *# .
Unknown ( 7 . a W» ‘ 2
.iMw ■ '■ n>K( ‘ ‘ —-
Total 299 14i ;,'. ■ '■ .29 ' - 19 ■ '
Over 40 - 44(14.?#) . 4o(a8.%) ■ . .. .17(38,6#) 9 (47.4#)
Mod&X ago 22 yreu 1? yr«# . 43 yra. ■ ' 44 yra*
Mean age ' • 27. yra# - 33yA'O# • ■ , 4a yra# ' ' 39 yr a.
Fig* 2,. 1. Distribution -of age at first myasthenic.symptom* 
“. , The• ordinate is calibrated in number of cases and; as
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Duration of myasthenia before death (excluding post-operative 
and other canoes of death) * Thymoma.
Females.
- Oaoe . ■ Yearn













MI '11406 ■ 5
MH 40934 . .... 4
MI 47064
HH 48570 1














ISH 5232 . 10
KH 17834 5
MM 5093 12
HH 6476 2 %-
3
a) Case Mg Presentation as recurrent paralysis
on either side of the face. She is attempting to 
show her teeth.
b) Case MN 6289. Presentation as a case of ’ocular 




. 2t 3. Prominent supraorbital pads*
a) Case MN 46g6. History suggested that she may have had 
mild thyrotoxicosis in the past but she was euthyroid 
when she became myasthenic though her eyes were 
slightly proptosed.
b) Case MN 3O5&» Note prominent supraorbital pads. No 
previous history of thyroid disease but she developed 
goitre with minimal toxic symptoms one year later.
See also Figs. 3$ 2j ?; and 2.

Fig, g), 4* . , • •
Case M.H . Induction ' of ptosis by fixing the
. gaze above head level for one minute.

jg. 3i X» Blectrorayograph recorded from the right deltoid
muscle by a co-axial needle electrode* The arm was held 
out until the posture could no longer' be maintained. The 
records read continuously. Note the . development of
hypersynchrony and tremor . leading to brief pauses of 
successively longer ' duration until further contraction is 
impossible, Each pause is followed by brief post-tetanic
potentiation* ' Tie pattern reduces.in amppitude but the
units firing at the end of the contraction apparently stop 
firing suddenly, without decrement in amplitude.
I itt
Case MN 1906. racial expression at rest shows slight 
ptosis and drooping 'of the cornel's of the mouth. On 
showing the.teeth the lips are not retracted but the 
elevators cause a typical ’snarl1. Note the prominent 
supraorbital pads. There was no history of thyroid 
disorder.^
Her tongue shows the ’triple grooved’ appearance.

ig. 3, 3a,
Case MN '6522* Cheat radiograph to shot*/ shadov; of a 
thymoma in the anterior mediastinum# Confirmed by- 
operation and histological examination*

Case MN 6^?6> .Radiograph of a large thymoma. In 
addition to. myasthenia gravis he had asthma which 
persisted after thymectomy#

a) Case MU 8l?0* Typical myaatbonia gravis, , .Paeuno-
- mediastinum radiography -demonstrates a rounded mass
near the lower - pole of the left lobe of the thymus 
gland, (Dr, M,D, Sumerling).
b) The thymus removed at operation, The rounded
mass proved to be cystic 9 containing brownish- 
yellow fluid* . No neoplastic changes were detected, 
(Dr, A.FJ, Maloney), ,
J
Frequency of involvement of different muscle groups. 
The 'scale. on the left of the key shows the frequency with 
Which these groups . are affected at the onset of myasthenia 
gravis. The scale 'on- the right of the key shows the
frequency with which they are affected at some <^^ae 
during the whole illness*
  
Pip, . 6* Myaathenic ptosis..- .
a) .Case MN 4603» Bilateral but asymmetrical ptosis#
b) Case MH 4$3g». Blateral. ptosis associated with
weakness - of"orbicularis . oculi causing epiphora.

c) ■ Case MK 5766, Left ptosis with bilateral facial 
■ weakness. .
a) Catse MH 6780. Bilateral ptosis*
Bee also Fig* 8» 2 for unilateral ptosis*

Case MH 7779* Myasthenic facies in a .middle-aged woman.
a) at rest
b) attempting; to show her teeth
c) the same twenty minutes after subcutaneous • injection
of neostigmine♦ .

.3, 7. ' '
, d) Typieal myasthenic_ facies at the characteristic age of
onset. Kote the bilateral ptosis, divergent strabismus
and absence of facial; -expression*

Fig, 4, . 1, .
Oaso MN 312-6, Positive Barv.oy-Hasland tost ,in a patient
■^npuifU»Bui * i<.WwgA<i Ti1 /! i<rWiTi«gt> '
with sensorimotor and reflex changes suggestive of 
peripheral neuritis., (Cie la tor history was compatible
with myastheniai gravis.
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Cage■ MH 5095, Myasthenla-gravis associated with a thymic
tumour. . Tie had ■sensory symptoms including temporary 
disturbance of taste sense. The illustration shows that 
the mucous membrane of the tongue was atrophic * He later
developed megaloblastic and haemooytic anaemia.

Fig. 5* 1* , ■ ' • ■
Case ...MB,,5652, Thyyotoxicosis in youth. Now euthyroid
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Clinical or autopsy abnormalities of thyroid gland* 
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Case MW Thyrotoxicosis in earlier life but now
euthyroid. Note supraorbital pads. Myrothenia gravis
is. now .'complicated by episodes of sudden loss of 
consciousness.

Case MN 4934# Thyrotoxicosis had been suspected
years previously but not confirmed by investigation*
When she developed myasthenia gravis• she was euthyroid but 
had a slight goitre (a), Six months later, after
thymectomy, the goitre was larger (b), and in another few 
months she had become thyrotoxic (c)* She has had a 
remission of myasthenia since one year after thymectomy 
but requires car.bimahOle for thyrotoxicosis*.

Case MN 7781.
a) 1955* Myasthenia gravis. Normal thyroid function*
b) !993j3 Thyrotoxicosis. Myasthenia gravis in i^emissoon
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♦ ' 2 '., Goitre.- ■/ ,
- 2 . Prominent-eyes.
. 7 ■'
- 1 Prominent eyes.
+ 9
-.37' Prominent eyes.
- i': • . P.H. of Thyrotoxicosis. ■
. Previous Thyrotoxicosis 
+ .4 / Prominent, eyes.
-6 .von Grsefe’s sign.t :
-6 ;; - 7 . <•'•., 7: .7.
• Thyrotoxicosis.
-10
+ 1 Proptosis : P.H. of
Thyrotoxicosis.
+14
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H ' VOtAHVO-CSVOvO • (APACjsOPAVD PACO X H UNO V> HO XOvo'OsoOO O PACO H H*r IACO O O UN VO KN X O AJ CO O' KS4H CXH lAOD C'XXO • X tA lA UN VC VC VC VC X4 -UN VC X'4h • 4h UN UN X<O' OS- UN KNnJ- HNNANXXXOM' ‘ UNUNUNUN VOVOVC VDVP VC VC X X- X X X X X X • XCO 00
Gaae.. MH 22713* . Thymoma with aplastic anaemia.
Effect of ACTH, thymectomy and splenecOomy* (from Chalmers 
and Boheimer,' 195^)*
  Fio. 1.—Case 1. Pure rctl-cell anaemia in a patient with myasthenia gravis and thymoma.
Haematological and therapeutic data over a period of three years.
Fi#, ^2,
Case MN 22.^4* Myasthenia gravis with ’i^heumt't^i.d'
arthx\iti.s of nietacarpo-phalangeal joints of left 
hand •

&)>.' Case ,W 1237^♦ .Pour eases of thyrotoxicosis in the 
previous generation (paternal-side). One of these
, • relatives also, had muscular weakness and wasting*
b) eau5as~MlL^9SS•'omd, HHH 6>2?Qj^ji wore distantly related
to tach, other. Ho details art known about other
relatives.
? <•> & 9 0?
9
9 9 i 9 9
Myasthenia Gravis
(•) Thyrotoxicosis










I Hl 62 033




ill I > I ' •
Case MN 427g. Typical myasthenia gravis with good
response to neoetigraino and to thymectomy* Her mo Other
is said to' have had neostigmine-responsive myasthenia 
gravis. ' ' ; ’

■Figi 8,
Case MN 46'?0.' Familial myasthenia gravis with aa)
previous history of pernicious anaemia and transient 
’rheumatoid! '‘arthritis* . ■
b) Sistefe-'-o'f Case IMF 46gO»/?. Typical history of
fflyasthen±a gravis.',T /Wot examined personally pwing 
to'death)*
See Fig;* 8, 4- for family history*

Fir?. 8,: 4.' Family history of Case MN 4650* In addition to
** nfrt-wlpmMV* , , , 1
a oister with myasthenia gravis there is a history of 
ptosis 'and blindness (apparently inherited as an autosomal






Ptosis in t i 1ln < n os s
PIo iii in Isi ptojnjncy
Thy rot oxIcosis
o' f foo 000 •
T + MN+4B58
d 0 Q Cf cJcCr®
rh I .
9 9 9
Fig. 8, g. .
Case NH g1559» on right of figure has myasthenia gravis• 





Case, MH/6l4O* Congenital myasthenia.
O, f ♦ . '
Case MM -6l39» Congenital myasthenia, younger sister of
the patient in Fig. 8, 6.
a) Before neosiimmirie.
b) After neostigmine « she is - now able to look at hie toy 
without holding her head back though, there is little
obvious decrease of ptosis.




ffig« 31 8* Resistance to decamethoninm- (0*10) in a case




















Fig* 9, . . 1*
a) Case MN 7^» Neostigraineeresistant muscular weakness 
, resemblling’ myasthenia 'gravis• (see also Fig* 9, 2)*
' Tie hands show arthritis, erythema, and
. desquamation*
h) Case ., HH. ?4* Radiograph, of right hand* Note localised
erosidns of metacarpophalangeal' and proximal





w* 9, a. ■ '
Case'MH 7^. Facies resembles myasthenia gravis* She 
sits with a hand supporting her jaw and head,.. Power, did 
not improve with anticholinesterase drugs.
Fig* ?> 5*












Case - .KN l?l4. Neosti tgpdiie-i'es3.stant myasthenic syndrome
with progressive improvement in voluntary contraction.
Hhrvey«MasXand test to show decrementing response to
supramaximal neural stimulation at 0.5 and 4.0/sgc.
Stimulation at 50/sec. • causes a decrementing'response to
. : the,first five stimuli then a progressive increment of the
muscular' • action-potential, associated with more powerful
contraction as ' in the sustained voluntary contraction
‘.(Simpson and henman,. 1959)*
a) A myasthenic reaction to the Harvey-Masland test in a 
case of dermatornyositis.
b) The myasthenic response is not significantly influenced 


















Case MN 7531 • Carcinomatous myasthenia.*
.•a) The -postero-antorior radiograph of the chest was
considered by the referring physician to.show a thymoma.
b) A la!;eral view shows that the abnormal mass is related
to the hilar region and does not encroach on the anterior 
mediastinum*
o) Tomography confirmed the peri-carinal localisation and 
showed encroachment on the right main bronchus (not 
visible on reduced reproduction).

 Fik* 9. ■ ?* ' ■
Case NN ?0g^., Carcinomatous .myasthenia.- . '
Harvey~MasIand test showing decrementing response of muscle to
supramaximal neural stimulation at 2.5/aec. and incrementing 
response at 20/sec. Note prolonged period of. post-tetanic 
potentiation.
1—I—I—I—I—t I (QQPV
llliiiiiiiiiimiMiiiiiiimiiiiiiiiiiini i (qq......... .
t '0 sec
Flg» . 9* . 8. ■
Pseudomyasthenia.
♦ 9_J; » '
. \ ' ‘ ''
Chee-MK 5765. Pseudornyasthenia.
Pig. 9, 10# Mrs. M.H.- (75)* Pseudomyasthenia.
This patient is not described in the. text. She stated that 
her eyelids had always been heavy. ■ For 5-^- years she had had
definite -.ptosis, occasional double vision and slight weakness 
of her left hand. On examination she had bilateral ptosis, 
failure of upward gasje, fatignabie weakness of both deltoid 
muscles, right triceps, and . the intrinsic muscles of the 
left hand. There .was' no response to edrophonium or
■ • neostigmine. .• v
(Courtesy of Dr. J.k. Slater).
Note the striking similarity of the facies and history of these 
three patients.

Pig. . 9, 11. Positive Hdrvey-Maaland test in diabetic neuritis
without clinical evidence of myasthenia '(Simpson, 1960b; 
1962a). . . ‘
' -Fig. 9, 12. Myasthenic reaction in motor neurone disease 
imps on, 1960b). ■
a) Case i» The co-axial-/needle electrode records only a single
remaining motor unit in the 1st dorsal' interosseous muscle. 
On maximum voluntary effort its amplitude decreases when the 
fii'ing rate increases. '.There is a marked decrement on
, electrical stimulation at tetanic • frequency. Subsequent
voluntary contraction is restricted :to brief bursts of
. innervation but' the muscle potential ho longer decrements.
b) Q&sb' -2» .■ .Marked- 'decrement of single motor unit action'
, potential on maximal voluntary effort (a) and supramaximal 
indirect totalisation (b).
J.L. 7-5.58 Diabetic Neuritis
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1st dorsal inteross. 
a Max effort 
b Supramax stimulation
b
mi aani—ttM--.' ir, T, ;j 11 1 >' -H’
7 secs
25OjuV | I sec
Table 10, 1$ Change of status frornfdatum point to time of
; follow-up in non-tumour patients, comparing operated with
non-operated series. , The diagram shows an increase in 
the proportions in categories A, B and C in the operated 
series, and a striking induction in deaths caused by 












A 40 22-0 15 19-7 9 15*3 7 17-5
B 24 13*2 8 10 -5 3 51 2 5-0
C 42 23 -1 18 23 *7 9 15-3 3 7-5
D 32 17-6 15 197 8 13-5 10 25 -0
Data incomplete 13 7*1 4 5 -3 9 15-3 9 22-5
Myasth. deaths 14 7-71 9 1181 17 28-81 8 20-01
Post.-op. deaths 14 7-7 U17-0 6 7 -9 V21-0 — V35-6 —:
Deaths, other 3 16 J 1 lJ 4 6-8 J 1 2-5J
Total 182 1 76 59 40






Operated 76 A + B ■ c D
Not-Opcrated ■0 A + B C D
Fig. 2.—Comparison of series (non-tumour) to show cumulative difference.
i Deaths, other 
causes
* 11, 1*. Russell’s type I lesion* Acute coagulative 
necrosis of muscle fibres with eosinophilic change, loss of 
cross striation, inflammatory cellular. reaction and 
phagocytic removal of the fragmented muscle fibre*
H & E 3C 280.
*11, 2* Russell’s typo XI lesion, the lymphorrhage, related 
to atrophy □£■ a ..single muscle fibre with basophilia of the 
cytoplasm and loss of cross striation*
. . H&E x 210*
* 11, 3* Russell’s type III lesion* Focal muscle change with 
eosinophilia and swelling of the fibre but without loss of 
strtation or inflammatory reaction*
H & B x 80
'• w
ntg. , 11. 4.
a) ' The lyrnphorrhage. The characteristic muscular Aesion
of myasthenia gravis*
. H & E x 280* .
b) Types of motor nene tex^rninals found in myasthenia 
gravis* The dystrophsic type is a reaction associated with 
muscular damage of various types5 the dysplasic type is 
considered to be specific for* myasthenia gravis* (Sketch 
based on the original papex’ by.-Goers and Desmedt, 1959)*
IO fi
D ys trophicys pla s i c
ffig. 12,1. , Photomicrograph of thymus from a patient with 
~ myasthenia gravis',to show lymphoid follicular hyperplasia
with Hassall*s corpuscles grouped round a germinal centre. 
. . ; , • . H & E x 52; .
I
a) Case MN 7784. Thymic tumour .fro .show capsule.
b) Gase MN 77$$ • Hyperplastic thymus. No tumour

g. 12, 3* Photomicrograph of thymoma from a patient with
■ myasthenia gravis. .Note the tubular arrangement of.
epithelial-type cells. This is only one of several types
of thymic tumour which may he associated with myasthenia 
gravis. ' ■
■ . : . ' ■ H ■& E X ^-2.
jg> 12, . Germinal centres in the thymic tissue surrounding
the tumour shown in .Fig. 12, 3*
■ . H & K x ,52.
I
Fig,. 12," . . 5. This ."figure is from Appendix .D where ' it is more
fully described* Prepared before the irmmnolcigical nature
of thymic function .was established, it suggests a . role for 
that organ in the differentiation of cells and plasma 
proteins, including immuuoOol;ically competent cells and 
antibodies. It is now suggested that the hypothal'amo-
pituitary control -shown may be a horneeotatic influence 
required 'by some immunological theories, (Simpson, 196*4&),
MUSCLE PLASMA PROTEINS
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 CaBe ■ 7290* H&shimoto*© disease developing after
thymectomy for myasthenia gravis. .
a) Photomicrograph of thyroid gland, .
: ' • H & E % 42. .
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 Fig. 15, ; 1. Diagram of -motor nerve termination and
”* neuromuscular junction.

Fig* 15,,-2. Case MN .5^01. , ' ’ ' ■
a) El.ectromyograph of sustained voluntary contraction of 
right deltoid muscle recorded by a co-axial needle 
electrode. The film has been stopped at three.points 
but the record is otherwise continuous. Note the 
progressive decrement and simplification of the record
- as ’myasthenic fatigue* occurs:but the single units, 
recognisable towards the end; of the contraction, stop 
firing suddenly without further decrement* There is 
temporary post-tetanic facilitation after a brief ’rest*
b) The; same muscle to show marked insertion activity and 
spontaneous fibrillation at rest.
Blgp 19, Myopathic motor units in myasthenia gravis.
a) Case MN 505^-, ;myopathic unit at slight contraction.
b) Seine case, stronger contraction.
c) Case NH 980, myopathic units at slight contraction.
d) Same case,' fullinterference pattern at maximal effort.









/ 00 -?»t j'ec
^«4 sop. v 
t O^^nsec
I 500/<V
MAAAAAAAAAAAAAAAAAAAAAAA  AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA b / 0 on Se c
. ............................ .... L ' ■ ‘ ■ 1 ■ 1 ■ 1 ■ L ■ ' ■ ■ ■ L - 1 ■ I ■ I ■ I ■ I --L. i
iOwsec
, • •’2941positive 'Harvey-Masland" tost • .with ■ '
■ ; • .. decrementa! response • to stimulation at. 50/sec* . but.not •
, at lO/aec.. , or slower. There is slight . post*tetanic
potentiation. .
Fig. 15, . ■ ;$. . • v.\> . ..
Case MN 582. beo'remental response in right abductor. .digiti
. minimi.• Immediate decrementa! • followed by prolonged
facilitation and; then delayed decrement in left • triceps 
' 'muscle. ‘ ■■ - • . ' ■
Myasthenia Gravis
thwmwwW
I N11 i u 11111111 11 i i H
'©’Tr, wrwitt
rrrwiprnTrr'^^ —rfw~-^Tn.,i-.r),  
rrr m I sec f 1"
L, Triceps 2
AAA A A A AAA AAA
5 10 15 20secs
Fig, 156-Early, and., sustained facilitation response to 
-'supramaximal neural- stimulation* ■ ■ ■ . .
■ : 49.' Case-. MH 5609? .Stimulation at ' 10/sec, -
b) . ■ ^se . ~'MN 4(66/. 'Stimulation at l6/sec.
15* ??»—' Post^totemO'' facilitation.. ,/'. ''' .
a) -.' - Odsd . MN‘3QgVd (The fourth line shows ' the improved
. ' maintenance of- the muscular action potential after
s Hexadistiginin l-.V.)
b) Case MN 5652,, - v, .. 'd •, . ' -
Case MN 2914 Decremental response - to stimulation at 10/sec


















GaafKH 214\3«' Tlie'fecoi’ds• read continuously* / .'Gaps in the 
rec or ding ar e lin'&i c at e d • (3Ki etc.) -but stimulation was not 
interrupted. \ The ‘ Harvey*M&slendi- test appeared to be 
negative until the, fifth burst of stimulation at 50/^ao.
V W W W A Z W S A A a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a a z v ^
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 Fig, .116$...:.!* Personal - theory of nature of drug action at the
neuromuscular junction (from Simpson, ' 1960a)*
Fig. 15. Time course (diagrammatic) of rise and fall of charge-density at motor end-plate of muscle for 
three doses of a depolarizing substance such as decamethonium to show the differing effects due to dose level, 
particularly in the recovery stages. The shaded area indicates the zone of competition w ith acetylcholine, 
increased from a to d by a hypothetical competitive substance. If the charge-density rises to the value between 
the horizontal lines (constant in each diagram), propagated action potentials occur. If the charge-density rises 
rapidly above this zone (dotted part of curves), the resulting twitch is brief and the muscle is then paralysed by 
depolarization block. As the drug is dispersed, the charge-density falls through the critical zone but ‘desensi­
tization’ prevents further response. If the dose is sufficiently high the prolonged effect may cause facilitation 
of test stimuli. When there is a substance competing for end-plate receptors (b—cl), only the biggest doses 
causes depolarization block, and this is succeeded by competitive block (mixed responses)'. A lower dose, 
sufficient to block the normal end-plate, causes only stimulation—'decamethonium resistance’. (Compare 
lower two curves in o and c.)
Ptosis in a case of my-xoedema* No response to
edrophonium. The upper photograph shows the patient before
she became myycoecdemmaons. . .

ffjg, 2* Decamethoni.ura . test* There is a clear difference in
the ability of athis drug to block neuromuscular transmission 
in the myasthenic patients* . The two patients with ’pseudo- 
'myasthenia* (Chapter 9) show initial resistance followed by
. a degree of block which’ is intermediate between true . 
myaa'theiiics and 'normal subjects.

Fig* 17,- Edrophonium test, Tie stopwatch was started When
lOmg* had been- injected into' the- vein. Ptosis is relieved
: ,in 4? seconds. ■ . ’ '

C&seMN ,, 1?14. Edrophonium ' test* . , A tetanus is we-H’ 
maintained 12-6O seconds after ■ intravenous injection of­
. • lOmg. The post-tetanic facilitation shows that the 
■ ■ ■■ response is not maximal* ■ - 'i ■ ’ ■
18. , 17, , 5. .. • - t ’ ?77 -A • , •
. .r:'..Case MH 3054* 7 . Edrophoniumutteii,;'’■ I positive' response.
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 M.g, , .... . •
a) ErgoggapPhLc - recording. of repeated flexion of right 
' index finger against-' a spring ' load ' at 'intervals' after* a dose
of -pyridostigmine, Note that the patient is capable of 
stronger contraction- while the drug ie active ■ but the rate 
of -fatigue la greater so that there is little -difference at 
the- end-of each- series of contractions. .
b)., • Diagram;of -duration - of effective - action of three
'anticholinestera&’e'dx’Ugsto hhow the ' nede&'sity-for suitable 
; timing of dosage'. '
° 1 '* Ml : 3
-------- Neo s t i g m i n e
--------- Pyr idostigmine
,-Mg. 13 Trial of Hexadistigmin 'Q,3mg, intravenously
(Case HM < Ptosis was decreased from 4^8 minutes
and borborygmi occurred at six minutes, A tetanus was 
better sustained from 10-18 minutes after the injection 





I , —ut • I
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.u ig» 18,, 3 *. . ,
• G&oe ..;6269. , Severe, ptosis which, no longer responds 
to' neostigmine, ’partially corrected by. plastic surgery.

X A.
Case MN 5095* Tracheostomy with positive-pressure 
respiration'and feeding by nasal tube or by gastrostomy 
may be - life-saving. The air pumped from the ventilator
pcasses - over a hurniddfier and is led by - a legged tube to a 
flutter valve. A pressure gauge is connected- between the
flutter valve ’ and,, the connection to the cuffed traoheostiily 
"'tube. =" . ' ■' . ' : ■ r ■ ■

Fig. 18, ,5 « • > .
Cas.e, MM g6g2. Even with a cuffed tracheos'fcomy tube, .
pharyngeal contents may enter the lungs, Lipiodol placed
in the mouth- is shown to enter the left main bronchus, 
having passed the inflated cuff. ’

 
Fig*LA99 F B^gograph used to record response to edrophonium
* ’ "two . 'hours' after oral dose of an anticholinesterase drug,
. Ihe 'response shows that the patient is underdosed*

Intravenous infusion of neostigmine may 
decrease, the power of some muscles while increasing the 
power of those more severely affected by myasthenia gravis* 
(Fig* 3 of Rowland et al, 1955)*
 HOURS
Fig. 3. Cose 2. Infusion 
started at zero time and 
discontinued because of 
muscarinic symptom* 
after 1.5 mg. prosttg- 
. mitie had been given in 
30 minutes ( atropin# ' 
omitted).
H.R. 38 d*
- Case MN ■ 55095 ° Stagel,.. ' '
Gradual onset,of’ cholinergic weakness, increasing .' 
fascicule tion,: miosis-and sweating. Equivocal results of 
edrophonium testing based on subjective response. -The 
neostigmine injected intramuscularly is charted bn an
. equivalence of Img. to lOmg. by mouth. Unsatisfactory 
response to P.A.M. 500mg. l.,V.
Hypotension soon after injection of P.A.M. Haemolysis and 
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Tig* 19, ;■ 4. ' Stages. 3 and ‘5* • g - / .
. ■ ■ , ' Continuation of Fig® 19, 3 showing- -onset of renewed 
■\ cholinergic crisis, delayed - response.io P* A.I.,' icterus 
: three days ' later. '. Neostigmine by injection resumed
■ : on day 24 and pyridostigmine on day 34. ' The latter was
® associated with gradual return of cholinergic signs, - ■
Sudden "crisis' on day 40' treated with. P^S.
Pjg».’ ,19.$' 3* Stage '2 - enlarged ' scale, ., -. / .
Poor response of secdnd'cholinergic' crisis (Stage ' 2) to 
.repeated injections . of P.A.M. Temporary increase of ' •
. slight hypotension ’
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Tig* 191 6. Stage 3 - enlarged scale.
Response to PgS In• one hour but pupils relatively 
unaffected. .
Tig. 19. 7* Stage 4. , , • , . ■
Relatively control on a email dose of pyridostggmine
OSOrng/day), Sweating and fasciculation persist,
especially when potassiim added, but pupils not constricted . 
Gradual deterioration starting at day • 38 despite absence 
of muucar.inic signs. .
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Stage 5*
Continuing olighria* General-deterioration.with 
aregenerative anaemia,, pneumonitisoesophagitis-, 'and 
attacks of. dyspnoea- Terminal deterioration with 
hypoxic -signs resembling the muscarinic signa;'of ..the 
cholinergic state* • '
Pig* 19, 9* Stage 9 * enlarged scale'* .
Terminal pseudo-cholinergic state not improved by 
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the manufacturer (Messrs. Roche Products Ltd.) revealed, -that tablet A contained neostigmine 
15*3g. and tablet- B.contained pyridostigmine, 60mg.
  
i ffend t'oc S
BENIGN CONGENITAL MYOPATHY WITH
MYASTHENIC FEATURES
BY
JOHN N. WALTON, NORMAN GESCHWIND, and J. A. SIMPSON
Reprinted from Journal ojf Neurology, Neurosurgery and Psychiatry
Volume 19, page 224, 1956
LONDON
BRITISH MEDICAL ASSOCIATION 
TAVISTOCK SQUARE, W.C.l
  
Neurol. Neurosurg. Psychiat., 1956, 19, 224.
BENIGN CONGENITAL MYOPATHY WITH MYASTHENIC FEATURES
BY
*JOHN N. WALTON, tNORMAN GESCHWIND, and jJ. A. SIMPSON
From the Neurological Research Unit and the Biochemical Department of the Institute of Neurology, 
the National Hospital, Queen Square, London
It has been increasingly apparent in recent years 
that in addition to cases which fall into recognizable 
categories of muscle disease, a number of less 
common disorders occur from time to time which 
do not correspond to the accepted descriptions. 
Some of these appear to be metabolic in origin and 
can be elucidated, at least in part, by modern 
methods of Investigation (McArdle, 1951) while 
others seem to fall into a borderland of either 
myopathy or myasthenia gravis. A case of the 
latter type is described and discussed below.
Case History
R. M. (N. II. case 4838), a female telephonist, was 
born in 1919; her mother was well during pregnancy, 
labour was normal, and the baby thrived well during 
ihe neonatal period. She seemed normally active and 
lively and sal up at 7 months; at 9 months she tipped 
over her pram by jumping vigorously and sustained a 
cut chin but no other injury. Shortly after this episode 
her mother noticed that the limbs and body tended to 
Hop limply when she was lifted and the head lolled as 
if she were totally unable to support it. The limbs were 
unusually flexible, like those of a rag doll, and she lay 
in her pram almost immobile, without kicking her legs 
or waving her arms. Nevertheless, at the age of a year 
she was able to crawl a short distance when put on the 
floor; her crawling improved steadily, although her 
limbs remained rather loose and “ floppy However, 
this was her only means of locomotion until she 
reached the age of 5 years, when she began to pull 
herself up with her arms and to walk around the furni­
ture. When she was 51 years old she was able to walk a 
few paces unaided and the limbs, though somewhat 
weak, were not so loose. The patient's mother suggested 
that at this age she was very little stronger but had 
learned to overcome her weakness. At the age of 7 
she was able to go to a school for disabled children and 
could walk about 20 yards, but would then have to rest 
for about a minute in order to regain her strength. She 
always tended to tire throughout the day and was much
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weaker in the evening than on waking. She had particular 
difficulty in climbing stairs or in rising from a low chair 
and showed a considerable tendency to trip and fall, 
after which she would find it difficult to get up again. 
Apart from her muscular disability the patient developed 
normally; the menarche occurred at 13 years and she 
had menstruated normally since.
As the patient grew older she was gradually able to 
extend her activities, although her muscular weakness 
was virtually unchanged. She attempted numerous 
occupations and finally worked (from 1948) for two 
years as a telephonist, but was compelled to give up this 
post because of her muscular disability; since 1950 she 
had helped her mother in the home. The patient had 
two sisters, one older and one younger than herself, 
both of whom were well, and there was no history of 
muscular disease in the family.
The patient was first admitted to the National Hospital 
in 1941 under the care of Dr. E. A, Carmichael, when 
generalized muscular hypotonia of moderate degree and 
diffuse atrophy of proximal limb muscles were discovered. 
She showed an accentuated lumbar lordosis and tended 
to waddle when she walked. There was also bilateral 
ptosis and weakness of the upper facial musculature. 
A diagnosis of atypical amyotonia congenita was made. 
She was readmitted on several occasions during the 
ensuing years, when her symptoms and physical signs 
were virtually unchanged. In 1944 she was seen by Dr. 
Gordon Holmes, who suggested that she was suffering 
from an unidentified defect of muscle metabolism. In 
1948 Sir Charles Symonds could demonstrate no 
myasthenic tiring of the eyelids, although there was 
pathological fatiguability of the deltoids; he agreed that 
the patient was suffering from an unusual metabolic 
disorder of muscle. On at least three occasions the effect 
of an intramuscular injection of 1-5 mg. prostigmine 
was tested. Each time the drug made the patient feel 
“ queer ” and dizzy, but nevertheless it produced some 
subjective improvement in muscular power, though there 
was little objective change. Twice the improvement in 
strength appeared to persist for two or three days after 
the injection and the drug was given by mouth in a dosage 
of up to 90 mg. daily. On each occasion there was a 
marked subjective improvement which, however, passed 
off after between one and two weeks and the treatment 
was discontinued. A similar improvement appeared to 
follow ephedrine, gr. L three times daily; the effect of
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Fig. I.—The bilateral ptosis and moderate atrophy of the shoulder girdle and arm muscles (particularly on the right side) are seen.
this drug was, in the patient's view, sustained, and she 
had been taking it continuously for several years. In 
1952 the patient was admitted to the Clinical Research 
Unit at Guy's Hospital and was investigated by Dr. B. 
McArdle; the results of these studies are given below. 
At that time she seemed to show doubtful improvement 
on treatment with oral potassium (dosage I g. KCl t.d.s.) 
and had continued to take this remedy, as well as ephe­
drine, until she returned to the National Hospital in 1955. 
Assessment of therapeutic results in this patient was 
always difficult as she was a suggestible, nervous indi­
vidual, who suffered numerous episodes of emotional 
instability, exaggerated by periods of conflict with her 
mother.
On readmission under the care of Dr. Carmichael on 
May 6, 1955, the patient's symptoms were virtually 
unchanged from those she had expressed on her previous 
admissions, save for the fact that she had experienced 
occasional dysphagia when tired. However, she was 
still able to do housework and to walk considerable 
distances (with many rest periods). She felt that the 
muscles of her legs seemed to “ let her down ” less often 
than they had done some years before, but there had 
been no striking change in the condition of the limbs 
for many years.
On examination (Fig. 1) the patient was thin and 
slightly built and walked with a distinct waddle and with 
a considerable increase in the lumbar lordosis. There 
was bilateral ptosis, with impaired ocular movement 
upwards, but not laterally or downwards: the ocular 
axes were parallel throughout and there was no diplopia. 
Both orbiculares oculi were strikingly weak, but the 
lower facial muscles, masseters, and temporales were 
strong. Palatal and pharyngeal movements were normal 
and the tongue showed no atrophy or fasciculation. 
The patient had a curiously long “ swan-like ” neck, but 
the sternomastoids were large and powerful as were the 
posterior cervical muscles; because of the ptosis she 
tended to hold her head backwards. There was un­
doubtedly atrophy of the sacrospinalis and other posterior 
spinal muscles, but those of the abdominal wall were 
good. The limbs were generally thin, particularly 
proximally, and there seemed to be a general moderate
atrophy, with considerable weakness, of all girdle and 
proximal muscles in the upper and lower limbs. The 
extensors of the wrist and fingers were also weak; the 
finger flexors were stronger but, nevertheless, consider­
ably weaker than would have been expected in a normal 
individual of the patient's age. In the lower limbs the 
anterior tibial and peroneal groups showed the same 
atrophy and weakness as the proximal muscles, although 
the calf muscles were more powerful. All deep tendon 
reflexes were present, though depressed, and direct 
muscle excitability was normal; the abdominal reflexes 
were brisk, the plantar responses flexor. The secondary 
sexual characteristics were normally developed and there 
was no abnormality to be detected on examination of the 
chest, abdomen, and cardiovascular system.
Electrodiagnosis.—In 1948, an intensity-duration curve 
from the right deltoid was normal: Dr. W. A. Cobb 
recorded an electromyogram from the same muscle, 
using a concentric needle electrode. He reported that 
there was no spontaneous activity and on voluntary 
contraction the motor unit action potentials were normal 
in amplitude and duration. In June, 1948, Dr. P. Merton 
found no decrement in the amplitude of a muscle action 
potential recorded with a surface electrode on the 
hypothenar eminence, on supra-maximal stimulation of 
the ulnar nerve at 3 per second.
Muscle Biopsy.—A specimen of muscle was removed 
from the right deltoid in 1950. There was no increase in 
perimysial connective tissue nor was there any accumula­
tion of fat between the fibres. Some of the muscle fibres 
were slightly enlarged, measuring 85 5 in diameter, 
while very occasional atrophic fibres were seen. In a few 
fibres sarcolemmal nuc'lei had migrated into the substance 
of the fibre and one or two short chains of nuclei, 
subsarcolcmmal in position, were seen. No segmental 
necrosis of fibres was evident and there was no cellular 
infiltration or evidence of muscle fibre regeneration. 
A number of nerve filaments were present in the section 
and appeared to be normal; two muscle spindles of 
normal appearance were also observed. Hence the 
histological changes were minimal. Although perhaps 
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much less than would have been expected considering 
the length of history and the comparative severity of the 
patient’s weakness.
Dr. J. N. Cumings reported that the potassium content 
of the muscle was 1-1 g. % by dry weight, a normal figure.
Metabolic Studies.—Studies carried out in June, 1948, 
by Dr. J. N. Cumings yielded the following results:—












1 900 0-73 0-18 1 0-51
2 820 0-84 027 , 0-53
3 940 0-86 012 ' 0-41
4 763 0-79 016 i 0-40
5 570 0-75 004 ( 0-51
6 1 940 j 0-87 008 i 056
i
Ephedrine medication and all other medicinal treat­
ment was discontinued from the third day of this test;
a creatine tolerance test was performed on the fourth 
day and gave results as follows :—
Creatine Tolerance Test.—Urinary and blood estima­
tions were carried out at the stated times before and 








Easting 35 007 001 0-03
1 hour 57 005 i 005 002
24 hours 121 j 0-10 | 0-04 003
RESULTS IN BLOOD
Time Creatinine (mg. %)
Creatine Inorganic
° Phosphate(me‘ (mg. %)
Potassium
(mg. %)
Easting 1-0 0-38 4-3 19-4
1 hour 112 1-63 4-7 20-0
2A hours 1-25 0-87 4-7 22-5
Response to Insulin and Glucose.—The patient was 
given 100 g. glucose by mouth and 25 units of insulin 
subcutaneously. Before the experiment was begun the 
serum potassium level was 20-0 mg./lOO ml., the serum 
inorganic phosphate level 4-5 mg./lOO ml., and the blood 
sugar level 100 mg./lOO ml. Thirty minutes after the 
injection, the serum potassium level was 18-3 mg./100ml., 
the inorganic phosphate level was unchanged, and the 
blood sugar level was 168 mg./lOO ml.
Dr. Cumings remarked that the urinary creatine was 
low and almost absent when the patient was taking no 
drugs, while the creatine tolerance and the potassium 
response to insulin and glucose were all normal.
Metabolic Activity of Forearm Muscles.—In January, 
1952, the following studies were carried out by Dr. B. 
McArdle in the Clinical Research Unit at Guy’s Hospital, 
London. The patient had received no drugs for about 
a week before the test. Blood was taken from the left 
antecubital vein before the test and again following the 
release of an occluding cuff after a period of ischaemic
work by the forearm muscles. The work consisted in 
raising and lowering (56 pulls) a 5 kg. weight by means 
of a gripping movement on an ergometer. A wrist cuff 
inflated to 200 mm. Hg ensured that blood taken from 
the antecubital vein came only from the forearm muscles. 


























Before 0-63 60 15-2 325 2-23 3-57
30 sec. after re-
lease of cuff 1-26 31-3 16-4 340 2-50 3-67
2 min. after re-
lease of cuff 0-91 29-4 15-6 — — —
6 min. after re-
lease of cuff 1-13 24-2 14-8 328 — 3-28
10 min. after re-
lease of cuff 1-01 16-3 14-7 330 —
20 min. after re- —
lease of cuff 0-86 12-7 14-5 329 — 3-18
Dr. McArdle remarked that all of these results were 
within normal limits.
Other Investigations.—Haemoglobin was 100% 
(14-8 g./lOO ml.); W. B. C. 4,000/c.mm. (63% polymor- 
phonuclears, 31% lymphocytes).
The E. S. R. was 8 mm. in one hour (Westergren). 
The Wassermann and Kahn reactions were negative.
The serum protein-bound iodine was 3y %. The 
total serum proteins were 7-9 g./lOO ml. (albumin 4-4, 
globulin 3-5).
A radiograph of the chest showed a slight dorsal 
scoliosis, convex to the right. The lung fields and heart 
were normal and the thymus did not appear to be en­
larged. An electrocardiogram was normal, and a basal 
metabolic rate was minus 11%. The urinary 17-keto- 
steroid excretion was 4-9 mg. in 24 hours.
Discussion and Experiments
It was clear from the information recorded that 
this patient fitted no clearly recognizable form of 
muscle disease as previously described. The non­
progressive nature of the disease and the diffuse 
rather than selective distribution of muscular 
wasting and weakness made it apparent that she 
was not suffering from any of the common categories 
of muscular dystrophy. Furthermore, the patho­
logical changes in the muscle were far less than would 
have been expected in a long-standing muscular 
dystrophy or polymyositis. She showed many 
characteristics reminiscent of the benign congenital 
myopathy or myopathic form of amyotonia 
congenita as described by Batten (1910) and by 
Aldren Turner (1940, 1949). Because of the general 
reduction in size of the skeletal muscles, the 
resemblance to Krabbe’s (1946) “congenital 
universal muscular hypoplasia ” was even more 
striking, since in Turner’s cases the muscular 
wasting and weakness affected selectively the 
proximal muscles of the limbs and the face was not
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involved. Despite these discrepancies, the results 
of a recent follow-up of cases of amyotonia con­
genita by one of us (Walton, 1956) have suggested 
that the disorders described by Krabbe and Turner 
may be the same. However, in this case there were 
additional unusual features: the variability of her 
weakness, the fatiguability, which had been a con­
sistent feature, and the apparent response to 
ephedrine, suggested that there might be some defect 
in neuromuscular transmission akin to that seen in 
myasthenia gravis. It was evident that the patient 
was not suffering from the latter disease, in view 
of the diffuse muscular wasting and the failure to 
show a sustained response to prostigmine therapy. 
Rowland (1955) has recently described a number 
of patients who appeared to be suffering from 
myasthenia gravis but who showed either a very 
variable response to prostigmine or none at all. 
However, from his descriptions it seems likely that 
some of his cases were examples of polymyositis, a 
condition which may show temporary improvement 
with this drug (Eaton, 1954). It is clear from the 
clinical and pathological findings that our case was 
not suffering from polymyositis. An alternative 
possibility seemed to be that she was suffering from 
an unidentified disorder of muscle metabolism, 
although Dr. McArdle’s results indicated that there 
was no serious defect in carbohydrate breakdown 
and utilization in the muscle.
In view of the apparent improvement which the 
patient had shown on potassium therapy it was 
decided to investigate the effect upon her muscular 
power of alterations in the serum potassium level. 
It was recognized that her symptoms were not like 
those of familial periodic paralysis, nor were they 
characteristic of those noted in chronic potassium 
deficiency (as in potassium-losing nephritis). It was 
also appreciated that the serum potassium level 
does not necessarily give a faithful indication 
of the intramuscular concentration of this ion. 
Nevertheless, since potassium is recognized to be 
one of the most freely diffusible ions, it was felt that 
if the patient’s condition were due to a deficiency 
of intramuscular potassium, she would become 
significantly weaker if the serum potassium level 
were lowered. Another possibility seemed to be 
that she might have some anomaly whereby her 
muscles required a higher than normal concentration 
of potassium in order to function properly. In this 
case, too, a fall in extracellular potassium would 
increase her weakness.
It was also decided to repeat the electromyogram 
and to study the effects upon the muscle action 
potential of repetitive nerve stimulation, first under 
normal conditions and secondly after increasing
doses of intravenous decamethonium iodide. Harvey 
and Masland (1941) found that in patients with 
myasthenia gravis, if the muscle action potential 
was recorded from the skin overlying a weak muscle 
during repetitive supramaximal stimulation of its 
nerve of supply at a rate of 3 per second, the poten­
tial often showed a rapid decrease in amplitude. 
This was suggested as a diagnostic test, and it has 
been conventional to take the recording from the 
hypothenar eminence during stimulation of the 
ulnar nerve at the elbow. If this muscle group is not 
clinically affected, however, another must be chosen. 
Recently, Churchill-Davidson and Richardson (1952) 
have shown that in the normal individual an 
intravenous injection of 2 mg. of decamethonium 
iodide will give a significant fall in amplitude of the 
motor unit potential recorded from the hypothenar 
eminence during stimulation of the ulnar nerve at a 
frequency of 10 per second. Patients with myas­
thenia gravis, however, in whom the hypothenar 
muscles were not weakened by the disease, were 
remarkably resistant to this drug and could often 
take 3 mg. or more without a significant decrement 
in the action potential.
Clearly it also seemed important in this patient 
to assess, under the conditions of a controlled 
experiment, the effect of ephedrine, prostigmine, 
tensilon, and potassium upon the muscular weak­
ness. It was decided in addition to study the effects 
of intravenous caffeine and of calcium, in view of 
the direct stimulant effect which these substances 
appear to have upon the muscle fibre.
Before carrying out these experiments all treat­
ment was stopped and the patient’s muscular power 
was assessed three times daily by one of us, at 
9.30 a.m., 1 p.m., and 5 p.m., in order to see whether 
there was any significant variation depending upon 
the time of day. The power of individual, muscle 
groups was assessed clinically and strength of grip 
was measured with a spring dynamometer, the 
value recorded being taken as the average of three 
maximal grips with each of the two hands. It was 
discovered that the latter test gave a satisfactory 
indication of general muscular power. Another 
useful test was to measure the time for which both 
arms could be held out horizontally in front of the 
body with the patient sitting in bed; the end-point 
was taken at the time when one hand touched the 
bed-clothes. Using these methods it was found that 
after five days in hospital, with approximately the 
same amount of activity carried out each day, 
consistent values for strength of grip and for holding 
out the arms were obtained from day to day. Each 
day there was a consistent slight decrease in these 
readings as the day advanced; for this reason it
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was decided to carry out ail experiments at approxi­
mately the same time in the mornings. All chemical 
estimations were carried out by one of us (N. G.) 
using a standard technique. The assessments of 
muscular power were made by J. N. W. and electro­
diagnostic tests were carried out by J. A. S.
Experiment I: Lowering of Serum Potassium Level.— 
On May 20, 1955, the patient was starved and 5 ml. 
of blood was taken from the right antecubital vein at 
9 a.m.; the serum potassium level, as estimated with a 
flame photometer, was 4-4 mEq./litre (17-2 mg./100ml.). 
At 9.5 a.m. the patient was given 150g. glucose orally 
and at 9.25 a.nt. 25 units of insulin were given sub­
cutaneously. At 10 a.m. muscular power was unaltered, 
but the serum potassium level was 4-1 mEq./litre 
{16 0 mg.; 100 ml.). Hence the fall in serum potassium 
level produced by this technique was inadequate.
On May 23, 1955, after a large breakfast, the serum 
potassium level was estimated at 9.10 a.m. to be 
4-0 mEq./litre (15-6 mg./lOO ml.). At 9.20 a.m., and 
again at 9.35 a.m. and 9.50 a.m. the patient was given 
15 g. sodium bicarbonate in 2 oz. water. At 10.30 a.m. 
the patient felt somewhat tired and nauseated but 
there was no objective change in muscle power. At 
1.15 p.m. the serum potassium level was 3-12 mEq./litre 
(12-2 mg., 100 ml.) and 1ml. of 1 in 1,000 adrenaline 
was administered subcutaneously. At 2 p.m. the serum 
potassium level had fallen to 3 0 mEq./litre (11-7 mg./ 
100 ml.) but there was still no significant change in 
muscular power. This technique for lowering the serum 
potassium level will be reported in detail by one of us 
(N. G.) in a subsequent communication.
Experiment II: Electromyography and Effect of 
Intravenous Tensilon and Ephedrine.—On May 24, 1955, 
the electromyogram from the right deltoid muscle was 
recorded at 9.30 a.m., using a concentric needle electrode. 
There was no spontaneous activity; on
voluntary contraction the interference 
pattern was sustained but contained an 
undoubted excess of polyphasic and 
short-duration potentials. After sustained 
abduction of the arm for 90 seconds, with 
the needle in situ, the proportion of short- 
duration and polyphasic potentials showed 
a significant increase. After assessment of 
voluntary power, 20 mg. "tensilon” was 
injected intravenously at 10 a.m. The 
patient immediately felt faint and dizzy 
and there was no increase in voluntary 
power, while the electromyogram was 
unchanged. At 10,50 a.m. ephedrine 
hydrochloride, gr. A, was given intra­
venously; the patient immediately felt 
stronger, and voluntary power, as assessed
Fig. 2.—Effect of dccamethonium on the action 
potential of abductor digiti minimi during 
supramaximal ulnar nerve stimulation in R.M. 
(upper curve) and in a control subject (lower 
curve).
with the dynamometer and by holding out the arms, 
increased to a level higher than any recorded since 
admission to hospital. The electromyogram now showed 
fewer polyphasic and short-duration potentials. The 
patient was unaware of the constitution of any of the 
injections she received.
Experiment HI: Supramaximal Stimulation of Ulnar 
Nerve before and after Injection of Decamethonium 
Iodide.—On June 4, 1955, a surface electrode was 
applied to the left hypothenar eminence (with the 
indifferent electrode on the fifth finger), and at 10 a.m. 
recording of the action potential produced by supra­
maximal stimulation of the left ulnar nerve at the elbow 
was begun. With a stimulation frequency of 2 per second 
there was no significant decrease in amplitude of the 
motor unit potential over a 10-minute period. Stimula­
tion was then discontinued but was restarted at 10.20 a.m. 
At 10.38 a.m. 1 mg. decamethonium iodide was injected 
over a two-minute period. Immediately the patient felt 
faint and dizzy (as after “ tensilon ”); her ptosis increased 
considerably and she developed diplopia, but the action 
potential of the hypothenar muscles was unchanged. 
At 10.44 a.m. and at 10,49 a.m. two further injections, 
each of 0-5 mg., were given; the patient felt subjectively 
weaker but there was no change in the action potential. 
A further injection of 0-5 mg. was given at 10.54 a.m. 
(total 2-5 mg.); at 10.59 the action potential showed a 
13 % decrease in amplitude; the patient felt weaker, was 
apprehensive, and refused to have further injections. 
The original amplitude of the action potential was restored 
by 11.25 a.m. With this dose of decamethonium, the 
action potential of a normal subject would decrease in 
amplitude by more than 50%, The results of this 
experiment are recorded graphically in Fig. 2, using the 
same ordinates as those utilized by Churchill-Davidson 
and Richardson (1952).
Experiment IV: Therapeutic Trials.—Five substances
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were used, namely, ephedrine, calcium, potassium, 
caffeine, and prostigmine.
Ephedrine.—For a period of seven days from May 25, 
1955, the patient was given tablets four times daily; for 
a part of this time the tablets were ephedrine hydro­
chloride (gr. I), and for the remainder nicotinamide 
25 mg. (which looked identical). This trial was designed 
by J. A. S. so that neither the observer testing muscular 
power (J. N. W.), the patient, nor the ward nurses were 
aware which tablet was being given at any one time, nor 
when the treatment was changed. At the end of this 
period it was clear that during the three-day period of 
treatment with ephedrine the patient was both sub­
jectively and objectively stronger than when she was 
receiving nicotinamide.
Calcium.—On successive days the patient received an 
intravenous infusion of 500 ml. of fluid over a two-hour 
period. One of these infusions consisted of 500 mg. 
of calcium (as the gluconate) in normal saline while the 
other was saline alone. The observer concerned with the 
measurement of the patient’s muscular power was not 
aware which infusion was being administered. After 
each infusion the patient claimed to be considerably 
stronger and showed a moderate increase in power as 
recorded dynamometrically and by holding the arms 
outstretched.
Potassium.—Over a seven-day period, from June 5, 
1955, the patient was given four times a day 1 oz. of an 
orange-flavoured preparation. For a part of this time the 
preparation contained 2 g. potassium citrate in each 
ounce and for the remainder sodium citrate. As with the 
trial of ephedrine neither the patient nor the observer 
was aware which remedy was being given at any one 
time nor when the change-over occurred. Throughout 
this period the patient’s condition remained unchanged; 
neither substance produced a significant change in 
muscular power.
Caffeine.—On June 12, 1955, the patient received three 
intravenous injections of comparable volume and 
appearance at intervals of one hour. One was caffeine 
sodium benzoate, 0-5 g., another ephedrine hydro­
chloride, gr. 2, and the other sterile saline. The injections 
were given by J. A. S, and neither the patient nor the 
clinical examiner (J. N. W.) was aware which injection 
was being given. It was discovered that the injection 
of saline had no effect, but both the ephedrine and the 
caffeine produced a distinct subjective and objective 
improvement in muscular strength of comparable degree.
Prostigmine.—On June 13, 1955, it was decided to 
study the effects of long-term oral prostigmine therapy, 
despite the fact that this treatment had proved ineffective 
in the past. Accordingly therapy with 15 mg. tablets of 
prostigmine four times daily was instituted, but was 
changed, at a time unknown to the patient and observer, 
to an inert tablet of identical appearance. This trial 
was continued over a five-day period. There was no 
doubt that both subjectively and objectively the patient 
was considerably stronger while on prostigmine. Indeed, 
she recorded higher dynamometer readings and was able
to hold out her arms longer than at any time since her 
admission to hospital. During the next five days prostig­
mine therapy was alternated with pyridostigmine in 
equivalent dosage, but there was little difference in the 
effect of the two remedies, although overall improvement 
was maintained.
Subsequent Progress.—As a result of the findings in 
the experiments outlined above it was decided to give 
the patient combined treatment with prostigmine, one 
tablet of 15 mg., four times daily, and ephedrine, one 
tablet of gr. 4, also four times a day. For three days the 
improvement in the patient’s strength was sustained: 
she moved about the ward more easily, could lift objects 
of considerable weight, and climbed three flights of 
stairs relatively briskly. Unfortunately she then developed 
follicular tonsillitis with a high fever and was compelled 
to take to her bed. This infection resolved within a few 
days but left the patient depressed, tearful and weak, 
though no weaker than she had been on admission. She 
asked to be discharged, feeling that she would pick up 
more quickly at home; she therefore left hospital, taking 
both ephedrine and prostigmine, on June 23, 1955. On 
discharge, physical examination revealed no significant 
change from her state on admission.
The patient was readmitted to hospital on August 9, 
1955. After returning home she had improved quickly 
and soon felt that her strength had returned to what it 
was after beginning combined prostigmine and ephedrine 
therapy in hospital. This improvement continued for 
three weeks but then she began to feel unaccountably 
weaker. Although she had experienced some fluctuation 
in her muscular strength as a result of emotional dis­
turbances, the present deterioration was quite different, 
being steadily progressive. In addition, she became 
short of breath and could no longer lie down in bed at 
night, or walk more than a few paces because of dyspnoea. 
On examination on admission the patient was unable to 
walk more than a few paces with considerable effort and 
she was quite unable to negotiate stairs. Her resting 
pulse rate was 120 per minute, but the heart and chest 
showed no abnormality on examination. She was severely 
breathless, with very poor abdominal and thoracic 
movement and striking activity of the accessory muscles 
of respiration, including the sternomastoids and scaleni. 
Her ptosis and facial weakness had not increased since 
her previous admission but her strength of grip was 
strikingly weak and she was quite unable to lift her arms 
from the bed. Her vital capacity could not be measured 
as she said she was unable to blow into the machine. 
An electrocardiogram was normal but for the tachycardia. 
Although an accurate assessment of her physical state 
was made difficult by emotional factors, there was no 
doubt that she showed persistent tachycardia and severe 
weakness of limb, trunk, and respiratory muscles, like 
that seen in severe myasthenia gravis. Intravenous ten­
silon and intramuscular prostigmine therapy produced 
no improvement in her condition; indeed, she insisted 
that these remedies made her worse. After each, some 
muscular fasciculation was seen but there were no 
abdominal symptoms. Accordingly, all therapy was
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discontinued and over the next two weeks there was a 
gradual improvement in her respiration and in the power 
of the limbs; her pulse rate returned to 80 per minute. 
The patient was finally discharged from hospital on 
September 16, 1955, receiving only ephedrine gr, i four 
times daily. Her condition was virtually the same as 
when she was first admitted in May, 1955.
Conclusions
There seems to be little doubt whatever that 
this patient was suffering from a relatively benign, 
probably congenital, non-progressive myopathy, 
showing certain features reminiscent of myasthenia 
gravis. Dr. McArdle's investigations revealed no 
apparent defect in carbohydrate metabolism, while 
we were unable to produce any evidence to indicate 
that alterations in serum potassium affected her 
muscular condition. Save for the “ myasthenic ” 
features, her condition corresponds closely to the 
“ benign congenital myopathy ” or myopathic form 
oT amyotonia congenita described by Batten (1910) 
and Aldren Turner (1940, 1949). However, Turner 
did not describe any fatiguability or apparent 
response to ephedrine or prostigmine therapy in 
his cases, nor were these features seen in the other 
cases of this type which were reviewed recently by 
one of us (Walton, 1956). On the other hand, it is 
evident that this patient was not suffering from true 
myasthenia gravis, in view of the failure to respond 
to tensilon, as well as the atypical clinical picture. 
Nevertheless, it must be admitted that she showed 
a considerable resistance to decamethonium iodide, 
while the sustained improvement on ephedrine 
therapy and the temporary response to prostigmine 
were suggestive of the latter disease. The apparent 
increase in strength following an injection of caffeine 
sodium benzoate was of doubtful significance.
Of great interest was the striking increase in 
weakness, particularly of the respiratory muscles, 
after prostigmine therapy had been in progress for 
some weeks. The associated tachycardia was 
suggestive of vagal inhibition but it is difficult to see 
how moderate dosage of prostigmine, which would 
be expected to give a bradycardia, could produce 
this effect. It seems most probable that the weakness 
could be attributed to this drug, despite the absence 
of other side-effects, and that the temporary im­
provement, perhaps due to its anti-cholinesterase 
effect, was subsequently overcome by a persistent 
depolarizing effect which appeared to be cumulative. 
It is well recognized that even patients with 
myasthenia gravis may become weak as a result of 
excessive dosage of this drug (Rowland, Korengold, 
Jaffe, Berg, and Shy, 1955), but the dosage adminis­
tered to our patient was only 60 mg. daily which 
could not be expected to produce such an effect in
an individual with true myasthenia. It is also difficult 
to understand the action of ephedrine in this case. 
Unlike adrenaline, this drug does not cause glycogen 
breakdown, hyperglycaemia, or a fall in the serum 
potassium level. We may ask whether its effect is 
unrelated to the energy metabolism of muscle and 
whether it may have a direct effect upon the muscle 
membrane or perhaps at the motor end-plate, We 
have no evidence which could help in deciding this 
problem.
The paradoxical responses which this patient 
showed to ephedrine, prostigmine, decamethonium, 
and “ tensilon ” suggest that in her case there may 
be some hitherto unrecognized defect in the muscle 
fibre and/or its end-plate or membrane. We can 
think of no better description for her condition than 
“ benign congenital myopathy with myasthenic 
features ” while recognizing that we do not under­
stand the essential nature of her disorder.
Although this patient, so far as we are aware, 
shows features which are unique, there is no doubt 
that other cases showing a resemblance to this 
clinical picture are seen from time to time. One of 
us (J. N. W.) in a previous communication (Walton 
and Nattrass, 1954) has referred to a number of cases 
of “ myasthenic myopathy This term is probably 
unsatisfactory, as it could be taken to refer to the 
irreversible muscular weakness and atrophy which 
may develop in the limb or ocular muscles of certain 
long-standing cases of myasthenia gravis. One of us 
(J, A. S.) in a recent study of a large series of cases 
of the latter condition has come to feel that such 
changes occur in a not insignificant proportion of 
cases and may follow a recognizable pattern, par­
ticularly in the limb muscles. However, the three 
cases briefly referred to by Walton and Nattrass 
(1954) were not of this type; rather, they were 
individuals with a long-standing weakness and 
atrophy of girdle and limb muscles who yet showed 
a somewhat phasic course and a definite, though 
sometimes temporary, response to ephedrine and/or 
prostigmine. Similar patients with a clinical picture 
like a combination of muscular dystrophy and 
myasthenia gravis have been reported by Laruelle 
and Massion-Verniory (1937), by Jezkova and 
Sachs (1939) and by Hosotte (1951). Hosotte’s case, 
however, may have been one of true myasthenia 
gravis with eventual amyotrophy. In none of the 
cases mentioned by Walton and Nattrass did the 
condition begin so soon after birth as in the patient 
described in the present report. It is of considerable 
interest that one of these patients, shortly to be 
reported by Griffin, Nattrass, and Pask (1956), was 
given increasing doses of prostigmine with apparent 
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with eventual respiratory paralysis, necessitating 
management with intermittent positive-pressure 
respiration. He was subsequently subjected to 
thymectomy with dramatic improvement.
It must be concluded that there exist a number 
of obscure disorders falling into the borderland of 
both myopathy and myasthenia gravis, of which the 
present case is a striking example. We have at 
present, however, no information to indicate the 
the nature of the basic muscular defect in such 
individuals.
Summary
The case is reported of a woman who developed 
muscular weakness and hypotonia in the first year 
of life ; she has shown subsequently persistent though 
non-progressive weakness, with moderate diffuse 
atrophy of the upper facial, trunk, and limb muscles. 
Her weakness has always become worse after 
exertion and she has had slight dysphagia but no 
diplopia.
Extensive metabolic, electrophysiological, and 
therapeutic experiments have revealed no defect in 
carbohydrate utilization or in potassium metabolism. 
She is more resistant to decamethonium iodide than 
the normal individual and shows improvement on 
ephedrine therapy but none following tensilon. 
Prostigmine produces definite improvement in 
muscular power, but if continued indefinitely in 
moderate dosage it appears to produce an increase 
in weakness, particularly of the respiratory muscles. 
A muscle biopsy revealed only slight, indefinite 
changes compatible with a myopathic disorder.
It is suggested that this condition falls into a 
borderland of myopathy and myasthenia and that 
it should be styled “ benign congenital myopathy 
with myasthenic features It was not possible to 
determine the nature of the biochemical or other 
defect in the muscle fibre and/or its end-plate or 
membrane which was responsible for this patient’s 
condition.
We wish to thank Dr. E. A. Carmichael for permission 
to report this case and for his encouragement and advice. 
We are also grateful to Dr. J. N. Cumings, Dr. B. 
McArdle, Dr. W. A. Cobb, and Dr. P. A. Merton for 
permission to quote their findings. Fig. 1 was prepared 
in the Department of Photography, the National Hospital, 
Queen Square, Fig. 2 in the Gardiner Institute of 
Medicine, University of Glasgow.
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THYMECTOMY IN MYASTHENIA GRAVIS
BY
JOHN A. SIMPSON1
{From The Neurological Research Unit of the Medical Research Councft9
The National Hospital, Queen Square,, London)
Few diseases have been more satisfying to the teacher of medicine than
myasthenia gravis for no better meeting ground exists for clinician,
physiolojpst and pharmacologist. Ten years ago the standard teaching
was that the myasthenic response must indicate one of three possible
“chemical lesions” at the neuromuscular junction; (i) insufficiency of
acetylcholine, (ii) excess of chohnesterase, or (iii) a “curariform” block of
transmission, presumably due to a substance carried in the blood. More
recently the logical fourth possibility of an abnormality of the motor end­
plates of muscle has been postulated. It seemed only a matter of time and
of refinement of physiological and pharmacological techniques before the
true lesion would be demonstrated. In that same period knowledge of the
physiology of the neuromuscular junction has made its greatest advances,
yet the solution of the problem of myasthenia evades us despite renewed
and world-wide interest as evinced by two recent symposia {Acta neurol.
psychiat, belg., 1955; Amer, J. Med, 1955),
Fundamental to any satisfactory theory is an explanation of the role of
the thymus gland. It is not the purpose of this paper to reconsider the
evidence that the thymus gland is implicated in myasthenia gravis; this has
been admirably reviewed by McEachern (1943) and by Eaton, Clagett and
Bastron (1953). The association of thymic pathology with myasthenia
gravis has been recognized for more than fifty years and is not in question,
but mere association is less important than the concept that it may be
causally related to the transmission defect in muscle. It is difficult to 
implicate the thymus in any “chemical pathology” of myasthenia gravis
with the possible exception of the neuromuscular block theory, and it is
significant that the exponents of the other theories make no serious efforts
to solve the dilemma. The evidence for causal relationship is of two types,
{a) thymic extracts may have neuromuscular blocking properties, and {b)
operative removal or radiotherapeutic destruction of the gland is followed
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by significant improvement in patients suffering from myasthenia gravis.
Evidence of the first type and its antithesis has been reviewed recently by
Wilson and Wilson (1955); the present paper is designed to review the
evidence of the second type and to present the results of an independent
survey of the largest series yet reported. A preliminary account has been
presented (Simpson, 1956).
Material and Methods
The records of all patients diagnosed as myasthenia gravis at the
National Hospital for Nervous Diseases since 1934 were scrutinized and
an attempt made to trace survivors and to determine the fate of those who
had died. Most of the cases seen after 1941 were subjected to thymectomy,
the majority by Sir Geoffrey Keynes. The survey was extended by kind
invitation of Sir Geoffrey to include his full series operated on at Saint
Bartholomew’s and New End Hospitals.
Criteria for inclusion of cases in the survey were :
(a) A firm diagnosis of myasthenia gravis by a consultant neurologist
to one of these hospitals.
(b) A convincing case history of loss of muscle power after exercise,
relieved by rest.
(c) Documented evidence of improvement with neostigmine (even if only
a test injection).
(d) Absence of evidence of central neurological disease.
A total of 404 cases was available for study. Where death was not
known to have occurred the patients were invited to attend the National
Hospital for examination. All were traced except 12 operated and 18
not-operated patients. Doctors and hospital records were consulted for
evidence of the cause of death in non-survivors. Where this was impossible
the certified cause of death was ascertained. Of the 245 known survivors
who could be traced, 181 were examined personally and 64 patients who
were unable to attend the hospital (mainly due to residence abroad) were
asked to complete a detailed questionnaire with the assistance of their
family doctor.
The operated cases were classified in the following categories in which
the essential feature is a comparison of the state at the time of follow-up
with the state before operation with respect to (i) presence of signs and
symptoms of myasthenia, (ii) exercise tolerance, (iii) drug requirements.
Category A: Full working life with no restriction. No neostigmine
required. No subjective weakness. A small degree of
permanent objective weakness, unrelieved by neostigmine,
is permitted. The present state must represent a marked
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Category B: Able to lead a full life with only minor myasthenic sym­
ptoms, requiring no neostigmine or controlled by not more 
than 4 tablets (60 mg.) daily. A significant improvement is
required.
Category C: Full life with few restrictions but (a) demonstrable myas­
thenia not requiring neostigmine, or (h) still requiring 
neostigmine but at least 40 per cent less than before and with
improved response.
Category D: (u) Improved, but neostigmine requirements unchanged or
increased, (b) unimproved, irrespective of neostigmine
dosage, (c) worse.
Post-operative death.—Death occurring within three weeks of operation.
Myasthenic death.—Death occurring at a later date where the history
suggested asphyxial death or death not explicable by other causes.
Death from other causes.—Death directly attributable to significant
disease where the history suggested that myasthenia was not a major factor
(e.g. cerebral haemorrhage).
Patients who had not been treated by thymectomy were assessed by
the same criteria with reference to the condition on first admission to
hospital. The essential feature is an assessment of change of status, hence
a patient with little disability (e.g. ocular myasthenia) does not qualify for
a high category if this state is not significantly better than at the datum
point. In case of doubt a patient was assigned to the lower category.
The data were analysed statistically with respect to sex, age at onset,
duration of symptoms before the datum point, and length of follow-up to
determine whether the two series (“operated” and “not-operated”) could
be accepted as representative samples of the population of myasthenics.
Cases known to have a thymoma were considered separately. These
analyses will be presented before comparing the natural history of the two
series.
Part I
Comparison of “Operated” and “Not-operated ” Series
The sex distribution and the frequency of thymic tumours in the two series
is shown in Table I. It is, of course, possible that some thymic tumours
Table I.—Distribution of Thymic Tumours
Operated Not-operated
Non- Non-
Sex tumour Thymoma % tumour Thymoma % All cases
Female .. 182 23 11-4 59 6 9*2 270
Male 76 13 14*6 40 5 11*1 134
Both 258 36 12-3 99 11 10*0 404
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have not been diagnosed in the not-operated patients, but the close resem­
blance of the two series suggests that this is not so. Table I does, however,
show a difference in the sex distribution. This is further analysed for non­
tumour cases in Tables II and III and in fig. 1.
Fig. 1.—Distribution of age at onset of myasthenia (non-tumour).
Table II.—Sex Distribution (Non-tumour Cases)
Operated Not-operated
Age at onset F M Rato F A4 Ratio
Years
0-10 9 2 4-5 1 1 1 1 1
11-20 62 20 3-1 1 8 8 1 1
21-30 67 24 2-8 1 21 8 2-6 1
31-40 23 17 1-4 1 16 6 2-7 1
41-50 11 10 1-1 1 6 6 1 1
51-60 2 1 (2 1) 4 8 1 2
61-70 2 1 2 1
71-80 2
Unknown 8 2 1
Total 182 76 2-4 1 59 40 1-5 1
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Table II and\fig. 1 showing the age at onset, reveal marked differences
between the two series. Inspection of the histograms of fig. 1 suggests
that there is an incidence of age-at-onset which has a skew distribution
about a modal value of 20 years (approx.) and that this does not differ
greatly with sex, although the males have relatively more cases in the older
age groups (causing a higher average age). This difference could be due
to the small numbers of males, and might disappear in a larger series, but
the same trend was reported by Grob and Harvey (1953). The regularity of
the distribution curves in the operated series alone and in the total series 
suggests that they must closely represent the true population of myasthenic
subjects if the age of onset is not randomly distributed. There is a
preponderance of females of 4-5-1 in the first decade which steadily,
decreases to unity in the fifth decade (numbers are too small to attribute
any significance to the possible reversal of sex incidence in later age groups).
On this interpretation the “not-operated” series is gravely deficient in
females under the age of 20 and contains relatively more males over 50
(hence the higher mean age for both sexes) (Table II). The series are
closely similar for the age period from 16 to 35 which contains two-thirds
of the operated series, though only half of the not-operated series (Table
III). It will be necessary to make all comparisons in this section of the case
TAbLE HI.-—The AGe-Gi<oup 16-35
Age at Not-
onset Operated operated
Years F M F M
16-20 36 15 6 6
21-25 37 13 12 5
26-30 30 10 9 3
31-35 13 11 8 2
Total 116 49 35 16
Ratio 2-3 1 2-2 1
material before accepting conclusions derived from comparison of the
whole of both series, since the value of thymectomy has been stated to be
most evident in women who develop myasthenia at an early age.
The length of survival from the onset of myasthenic symptoms (to April
1956) is shown in Table XV. It wili be more convenient to discuss the
breakdown into categories later. The mean survival is closely similar in
the two series, indeed despite the longer time at risk in the not-operated
series it is slightly lower than in the operated series, due to the long-
duration survivors being matched by a higher proportion of deaths within
a few years of the onset.
Associated phenomena of myasthenia gravis occurred with equal









































permanently weak wasted muscles not improved By neostigmine. “Goitre”
Includes simple non-toxic enlargement of the thyroid and thyrotoxicosis.
“Ocular myasthenia” Indicates the proportion of cases In which the
myasthenia remained confined to the extra-ocular muscles (including 
orBIiularls oculi) for the duration of the survey.
Part II
Results
The classification of Both series in April 1956 Is shown in Table V and
In percentage form in fig. 2. There are three questions to Be answered By
this survey: (I) Is there any significant difference In prognosis Between the
two groups ? (ii) If there is any Benefit to Be gained from thymectomy, Is it













A 40 22-0 15 19-7 9 15-3 7 17-5
B 24 13-2 8 10-5 3 5-1 2 5-0
C 42 23-1 18 23-7 9 15-3 3 7-5
D 32 17-6 15 19-7 8 13-5 10 25*0
Data incomplete 13 7T 4 5'3 9 15-3 9 22-5
Myasth. deaths 14 7-7"l 9 11-8"} 17 28-8^1 8 2001
Post.-op. deaths 14 7-7 U7O 6 7-9 >2T0 — V35-6 — >22*5
Deaths, other 3 1-6J 1 1-3 J 4 6-8 J 1 2-5j
Total 182 1 76 59 40
Sex Series No. Cumulative distribution
FEMALE
Operated 182 A 4- B c d , NS!
Not-Operated 59 A 4- B C D
Data Incomplete 
or too recent
0 20 40 60 80 100
% 1__ j___ I___ i___ I___ i---- 1---- 1---- 1___ i---- 1
Myasthenic Deaths
MALE
Operated 76 A -h B C
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Table VI.—Comparison of Treatments for Each Sex
Category
Female
Difference* S.E. of diff.
Male
Difference* S.E. of diff.
A+B + 14-8f 6-3 + 7-7 8-4
c + 6-8 5-6 + 16-2f 6-4
D + 4-1 5-3 - 553 8-2
Myasth. deaths -21-lf 6-2 - 8-2 7-3
All deaths -18-6f 6-8 - 1-5 8-1
*Per cent in operated series minus per cent in not-operated series. 
tUnlikely to occur By chance.
Operated Not-operated
Table VII.—Sex-difference m Each Series
Category Difference* S.E. ofdiff.
A+B + 5-0 6-3
c -0-6 5-8
D -2-1 5-4
Myasth. deaths -4-1 8-2















There is no significant
The first two questions may be investigated concurrently.
Comparison of results. Sex differences.—Vox further statistical analysis,
Categories A and B will be considered together as the distinction between
them is a fine one of doubtful validity. All cases in these categories are
for practical purposes without any disability due to myasthenia.
In Table VI the percentages in each category are compared separately
for each sex. The difference is expressed as -fve if the proportion is greater
in the operated series than in the not-operated, and —ve if otherwise. If
a difference in percentage exceeds twice the standard error of the difference
the odds are more than 20 : 1 against the difference being due to chance;
such a difference is accepted as statistically significant. In Table VII a
similar comparison is made between male and female in each series.
This analysis answers the first two questions. The operated series
contains a higher proportion of females in Category A and B than would
be likely to occur by chance (at the 5 per cent level), and the death-rate
from myasthenia is very significantly reduced (Table VI). Even when the 
operative hazard is added, the total mortality rate is significantly lower
than in the not-operated series. Males show a similar trend though the
difference is not statistically significant except in Category C. Table
VII suggests a possible explanation. Neither series shows a significant
difference between the sexes. In the not-operated series there is a higher
female mortality and fewer women than men reach Categories A and B,
in the operated series this trend is completely reversed. It may be that
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conclusions must be tentative as the analysis does not exclude the possi­
bility of the sex difference in either series having occurred by chance. As 
the benefit in favour of operation for women is unlikely to be due to chance
it is possible that a larger series would show that the similar trend for
males is equally significant. It is also possible that differences in compo­
sition of the series may be important. The following tables are of the
same type as Tables V-YII for the age group 16-35.











A 24 20*7 11 22-5 6 17-1 2 12-5
B 17 14-6 7 14-3 1 2-9 1 6-3
c 31 26*7 12 24-5 4 11-4 1 6-3
D 21 18-1 8 16-3 6 17-1 4 25-0
Data incomplete 4 3-4 1 2-0 7 20 -0 5 31-2
Myasth. deaths 9 7-7 7 14-3 10 28-6 2 12-5
Post-op. deaths 8 6-9 2 4-1 — — — —
Deaths, other 2 1-7 1 2*0 1 2-9 1 6*3
Total 116 49 35 16
Female
Table IX.—Comparison of Treatments for Each Sex (Age 16-35)
Male
Category Difference* S.E. of diff. Difference* S.E. of diff.
a+b + 15-3 16-8 + 18-0 25-2
c + 15-3 17-7 + 18*2 27-2
D + 1*0 17-5 - 8-7 2f*9
Myasth. deaths 20-9 16-8 + 1*8 26-8
All deaths -15-2 16-3 + 1-6 25-9
"Per cent in operated series Minus per cent in not-operated series. There 
is no significant difference.
Table X,—Sex-differencf, in Each Series (Age 16-35)
Operated Not-operated
Category Difference* S.E. of diff. Difeennce* S.E. of diff.
a+b -1-5 13*6 + +2 27-1
c +2-2 14-7 + 5-1 29*0
D + 1*8 15-5 - 7*9 23-4
Myasth. deaths — 6*6 15*9 + 16*1 27-4
All deaths -*1 15-3 + 12-7 26*5
*Per cent females minus per cent Males in each series, There is no 
significant difference.
Table VIII shows no essential difference from Table V except that the
male mortality rate is not apparently improved by thymectomy. This
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known. If only the known cases are considered the deaths from myas­
thenia form 18 per cent of the total, which is comparable with the figure
obtained in the full series. The poorer prognosis for women and its
reversal by operation are again suggested by this limited series but un­
fortunately none of the figures are significant in the statistical sense (Tables
IX and X). This is largely due to the small statistical population. The
proportion of not-operated patients in the “insufficient data” category is 
unfortunately high, but recalculation of the figures in terms of known
results only does not make enough difference to satisfy statistical criteria.
Failure to satisfy these criteria shows that the results could have occurred
by chance but, of course, does not indicate that they need have done so.
The close resemblance to the figures calculated from cases of all ages
(Table V) suggests that the trends disclosed are not chance ones and that
a larger series, by lowering the sampling errors, would confirm the validity
of the trends.
Factors affecting response to operation-—The third question to be
answered refers to the possibility that the response to operation may be
influenced by the patient's age at the time of onset of myasthenia or at the
time of operation; by the duration of illness prior to operation; or by the
severity of the myasthenia.















Operated F 182 Mean 22*8 23 -7 25*2 24*0 23*7
(s.e.) (1’2) (1-2) (1*8) (2-8) (0*5)
S.D. 9*6 7*6 10*4 10*7 6*5
P.* 0*1-0*05 1-0 0*01-0*001 > 0*1
M 76 Mean 26*2 27*7 31-0 22*3 27*9
(s.e.) (1*8) (2*1) (3*4) (2*9) (1*3)
S.D. 8-9 8*7 13-8 8*7 10*9
p * > 0*1 > 0*1 0-05-0*02 0*01-0*001























M 40 Mean 36*7 40*6 36*4 44*0 36*9
(s.e.) (6*7) (9*1) (4-1) (8*7) (2*9)
S.D. 20*2 15*7 12*9 24*6 18*2
p * > 0-1 >0-1 > 0*1 0*05-0*02
-ProBaBility, calculated By Student’s t test, that the mean age of the category is the 
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Age at onset.—It has been suggested that onset at an early age gives a
better chance of good operative results in contrast with a poor prognosis
without operation (Schwab and Leland, 1953 ; Eaton, Clagett and Bastron 
(1953), Table XIX). This factor is examined in Table XI for the present
series. The average age of the operated series is nine years younger than
the not-operated series owing to the larger representation of young people
.already shown in Table II but in each series the mean age of the female
patients is four years younger than the male average at the onset of
myasthenic symptoms. Examination of the breakdown into categories
•shows that of the surviving groups of not-operated patients only C-female
differs significantly from the mean age of the whole series. In the operated
series, group D is significantly older than the overall mean age in both sexes.
There is also a trend of increasing age from A and B through C to D
though the difference may not be significant. This analysis provides
slender evidence for the suggestion quoted that the earlier the onset the
better the response to operation. The suggested converse trend for not­
operated patients is not confirmed. The age difference is clearly too
•smaU to be of practical value in selection of cases for operation. If the
question asked is “in what respect do all other categories differ from
D (whichis that of ‘no change’) with respect to age of onset? the
answer is that none differs significantly. The age of onset of male patients
who died of myasthenia after operation was significantly younger than
die mean for the series or Category D, whereas myasthenic deaths in the
unoperated males occurred in patients whose average age at onset was
significantly older than the group mean or Category D. The very high
mean age at onset of the unoperated males who died of myasthenia has
too high a standard deviation to justify further discussion. The dis­
crepancy is not present in the 16-35 age group so it may be due to the
many older cases in the full series. Because the restricted group is
-speeially selected for age this factor has not been tabulated, but it may be
stated that within that group no effect of age at onset on the final result
■could be demonstrated. This question is discussed more fully in Part IV.
Pre-operative duration.—The possibility that the final state is inversely
proportional to the duration of myasthenia before operation is investigated
in Table XII. The female Category A+B has a mean pre-operative 
duration which is very significantly less than the mean of all the female
patients subjected to operation and significantly less than that of categories
C and D. Categories C and D have a significantly longer history than the 
group mean. (Category C does not differ significantly from Category D.)
A similar trend is disclosed by the males, though chance differences cannot
be excluded. The mean pre-operative duration of those who subsequently
died a myasthenic death despite operation was closely similar to the mean
for the group, and in fact was not significantly different from the A+B
■categories. There is thus no indication that those who die of myasthenia
122 JOHN A. SIMPSON
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THYMECTOMY IN MYASTHENIA GRAVIS 123
despite thymectomy differ in the length of history from those who survive.
This point will be returned to in a later section.
Age at operation.—The age at the time of operation may be more im­
portant than the previous duration of illness. The analysis (Table XIII)
for females shows that A+B are younger and D older than average, to a 
highly significant extent and that A+B are significantly younger than D
at the time of operation. In the males, group D is also older than the group
average though this is barely significant (at the 5 per cent level) and although
A+B is not much younger than the group average the difference from D
approaches the same order of significance. Those who subsequently died
of myasthenia were a little younger than the group average and consider­
ably younger than D (the “unchanged” survivors) and this difference is 
significant for males. Again the two sexes show the same trends.
It is not possible to say whether pre-operative duration or the age at the
time of operation is the more important factor. Obviously they are
interrelated. Formal analysis would require a series of cases aged less 
than 30 at the time of operation who had been myasthenic for, say five to
ten years, for comparison with a series of older patients with myasthenia
of recent onset. Individual patients of the present material could be
quoted with good or bad results in both these categories so that the analysis
would have no relevance in the assessment of a particular patient when
operation is under consideration.
Neostigmine requirements.—A major difficulty in an investigation
involving the comparison of large munbers of patients over a period of
many years is the classification of patients according to severity. Even
if it were possible for a single clinician to establish and maintain accurate
standards for twenty years, it would be impossible for a later examiner to
make such a decision, especially in a disease of widely varying manifesta­
tions, treated by numerous physicians during a period in which therapy
was changing. The amount of neostigmine required by the patient before
operation is a reasonably objective index of severity. The sexes do not
differ greatly in this respect (Table XIV) and those patients who have done
well after operation required little less neostigmine before operation than
















Operated .. F 10*0 12*6 19 -3 12-4 14*3 13-6
M 8*0 12 -6 19 -2 10-5 17-5 J. J u
Not-operated F 5-1 10 -0 7*2 10 -0 13*2 8-7
M 4-9 4-5 8-0 6*8 9*0 8 7
*15 mg.' tablets. Where parenteral injection was used the equivalent oral 





















124 JOHN A. SIMPSON .
death required more neostigmine than the survivors. The considerably
higher requirements in Category C cannot be explained. Ross (1952)
records the same trend but had too few cases in Category D to note the
anomaly. It is not found in the corresponding not-operated group. The
possibility must be considered that Category C is an artificial one and not
truly different from Category D in which the “improvement” due to 
operation could be explained if many had been given more neostigmine
than necessary before operation, but subsequently resumed their true
requirements. No patients have been included in Category C who did not
give a history suggestive of genuine improvement despite the decreased
dosage of neostigmine. Apart from this discrepancy the not-operated
series shows a trend similar to the operated series though the general dosage 
level was lower (lower dosage of neostigmine was then customary).
It is concluded that there is no clear evidence that the severity of
myasthenia materially affected the final state in survivors.
Survival.—A final question must be considered before the comparative
figures of Table V can be accepted. Is the follow-up period comparable
for all categories? This must be known to exclude the possibility that
immediate good results lapse with passage of time, or conversely, that if
an unoperated patient survives long enough there is a progressive tendency
to improve. Relapses do occur after operation, but in a minority of cases.
The author was, on many occasions, surprised to note how closely his
estimate agreed with that of Ross (1952) where the latter's note was avail-
Table XV.—Survival from Onset
All known Myasth.
survivors AyB C D deaths
Sex yrs. yrs. yrs. yrs. yrs.
Operated . . F Mean 13 -0 10 -9 14-2 15*8 6*7
(s.e.) (0-6) (0*7) (1*1) (1*4) (1*5)
S.D. 7*1 5*2 7-7 7*9 5-8
P.* 001-0001 >01 >005 0-001
M Mean 12-5 12 -1 10 -9 15*1 6-6
(s.e.) (1'0) (0*9) (1*1) (3-7) (2*7)
S.D. 7-4 4*3 4-8 11-8 8-0
P.* >0-1 0-05-0-02 >01 >0-05
Not-operated F Mean 14*7 16-6 14 -1 12-6 5-2
(s.e.) (1-2) (2*5) (2-7) (2*7) (1 '2)
S.D. 6-9 7-1 8-0 7-7 5-1
P.* >0*1 >01 >01 >0-001
M Mean 12-4 9 -4 15*2 14-5 4-0
(s.e.) (2-1) (2*3) (1*0) (3*8) (12)
S.D. 9-9 6-8 1*4 12-3 3*3
P.* >0 -1 >0-1 >0*1 <0*001
* ProBaBility, calculated By Student’s t test, that the mean duration of survival From 
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Table XVI.—Post-operative Survival
AU known Myasthenic
survivors A+B C D deaths
Sex yrs. yrs. yrs. yrs. yrs.
F 7-2 7-5 6-7 7*3 2-4
M 7-1 8-1 6-1 6-7 1-0
able in the case record. (Unfortunately, this was not always present
making an accurate review of the identical series impossible.)
Table XV shows the mean survival times from the onset of myasthenia
in both series and the survival after operation in the operated series (to
April 1956) is in Table XVI. The apparent shorter survival from onset
of operated group A+B must be taken along with the figures for post­
operative survival (Table XVI) which shows a longer post-operative follow­
up than the other categories, thus the lower figure in Table XV merely
reflects the fact that A+B tends to have a shorter pre-operative history.
There is nothing to indicate that the longer the series is followed the
more cases will move from Category A+B to C or D, confirming the
clinical impression. The further question regarding the possibility of
improvement with time in not-operated patients is not answered un­
equivocally since the sexes differ and no category differs significantly from
the mean for all survivors (Table XV). ' An interesting point emerges from
Table XV. Those patients who eventually died of myasthenia gravis did
so on average four to seven years after the onset of the disease whether
thymectomy was carried out or not. Deaths from myasthenia gravis
per se rarely occurred more than ten years after the onset of symptoms.
Conclusions,—Fewer women die of myasthenia gravis if their thymus is
removed than would be expected if they were treated with neostigmine
only, and a higher proportion of operated cases is very greatly improved
ten or more years after the onset of the illness. This difference is unlikely
to have occurred by chance. The greatest improvement tends to occur
in a group with myasthenia starting rather younger than average and with
a shorter pre-operative course than the less successful cases but the diff­
erences are not sufficiently marked to discount chance effects. The pre­
operative severity is probably not a significant factor. Similar trends are
noted in male cases. Though, considered in isolation, none of the diff­
erences noted in the operated male series are of such magnitude as to
exclude the possibility that they result from chance, the fact that all trends
after operation are in the same direction as in the female cases and that
a direct comparison between the sexes shows no significant difference
suggests that males do benefit in the same way as females. There is 
some evidence (Tables VI and VII) that the greater benefit obtained 
by thymectomy in women is due to the change from a prog­
nosis slightly poorer than the male to one better than the male.
Though the sex difference is not significant (in the statistical sense) in 

























126 JOHN A. SIMPSON
Part Ill
Thymomas
The number of patients in whom thymoma was known to be present was
not great (29 women and 18 men); the numbers are too small to make the
results statistically significant, but it is apparent from the breakdown
shown in Table XVII that the mortality rate is not strikingly lowered by
Table XVII.—Results—Thymomas
Operated Not-operated
F M F M
Category No. % No %/o No %/o No. %
A 1 4*3 3 23*0 0 0 1 20*0
B 0 0 0 0 1 16*7 0 0
C 4 17-4 1 7*7 1 16*7 0 0
D 3 13-0 1 7-7 1 16*7 0 0
Myasth. deaths 7 30*4 5 38*5 3 50*0 4 80*0
Post-op. deaths 7 30-4 2 15*4 —. — — —
Deaths, others 1 4-3 1 7*7 0 0 0 0
Total 23 13 6 5
operation. It is very much higher in both series than in myasthenia
unaccompanied by thymoma whatever form of treatment was used (Table
V). Of the 9 post-operative deaths, only 2 had been shown to have thy­
moma by previous radiography and each of these had been operated on
after a course of deep radiotherapy. In the other 7 the X-ray studies had
not revealed the tumour. The deaths recorded on the line for “other
causes” were a patient, described elsewhere by Chalmers and Boheimer 
(1954), who died of hemosiderosis without recurrence of myasthenia
gravis three and a half years after operation, and another who died of acute
mania complicated by bronchopneumonia. The circumstances of the
other deaths were investigated as fuUy as possible by retrospective inquiry.
In all cases the nature of the terminal illness was consistent with death due
to myasthenia gravis. In at least 7 of these patients the immediate effects
of operation were comparable with the non-tumour patients and indeed
three of them had long periods (two and a hah, six and seven years) of
complete remission from myasthenia before the relapse which led to death
in a short period.
Age at onset.—The mean age at onset of myasthenic symptoms was
higher than in comparable non-tumour groups but the small number of
cases and the wide scatter of ages make this of doubtful significance (Table 
XVIII). Tliis information was not available in two male patients who
have been omitted from the table.
The mean age at onset of myasthenia for all known cases of thymoma
was 40 -8 years for females and 39-3 years for males. The earhest onset
was in a woman of 24 (died) and the oldest a woman aged 64 who at the
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Operated 1 Not-operated
Table XVIII.—Age at Onset of Myasthenia (Thymomas)
F M F M
Cases No. 23 12* 6 4*
Mean age Yrs. 42-5 39-3 35-8 39*3
(s.e. of mean) Yrs. (6-3) (2-5) (4-5) (4-1)
S.D. Yrs. 30-1 8-5 I IM 8-2
-Age at onset unknown in one male of each group.





























Not-operated F 6 9-3 — 9 9*6 9 6-4
M 5 4-8 4-8 — — — 2-3




Cases survivors A B C D deaths
Sex No. yrs. yrs. yrs. yrs. yrs. yrs.
Operated .. F 15 5-3 5-8 — 3-9 6*9 2-6
M 10 5*5 4-6 — 9-3 4-5 1 2-1
a thymoma (with only post-operative radiotherapy). It does not appear
as if the patient's age when Myasthenia first manifests itself is of much
assistance in diagnosis or in prognosis But Keynes (1955) has remarked
on the absence of cases under 20 and the low incidence under 30 (4 per
cent).
Survival.—It has Been thought advisable to show the survival figure of
this group, though the numbers are too small for proper comparison with
the non-tumour series, as there is a common tendency to give a poorer
prognosis than is justified By the facts. The high mortality of this group
has Been discussed above, But many years of survival in a high category 
are possible (Table XIX). The post-operative survival is also shown for
comparison with Table XVI (Table XX).
The follow-up period is of the same order as in the non-tumour cases.
Furthermore Tables XIX and XX show that although myasthenic death
is more likely to occur in the presence of a thymic tumour, this event tends
to occur at much the same time from the onset or after operation, whether
tumour is present or not. In other ways, too, the patients with a thymoma
showed no obvious clinical difference from the others. The incidence of
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Myopathy* .. 8-7 23 *0 16*7 20-0
Goitre .. .. 21 -0 8-O 16*7 0
*As defined for Table IV.
Keynes (1955) thought that the tumour cases were nearly always associ­
ated with severe symptoms which were difficult to control. The average 
neostigmine requirements of the thymoma group was about 25-50 per
cent higher than the non-tumour series (Tables XXII and XIV) and
neostigmine resistance was more common. There is a marked discrepancy
in this index of severity when Category A is examined (Table XXII). In















Operated .. F 30 — 23 13 10-4 1 7-0
M 26 — 8+ 1 17-6 1 z u
Not-operated F — 24 10 10 40+ 20-0
M 27 — — — 5f
vZ
*15 mg. tablets. Parenteral dosage equated as before. 
I Not known in 2 cases.
the non-tumour series' this category had a slightly lower than average
pre-operative requirement for neostigmine, but in the tumour group the
mean dosage was much higher than average. Too much stress should not
be placed on this unexpected finding as the whole group includes only 4
cases, nevertheless, this observation once again underlines the fact that
excellent recovery may follow removal of a thymoma in a severely my­
asthenic patient. The 3 male patients in Category A had pre-operative
radiotherapy (which caused increased weakness). The female patient did
not have radiotherapy until after operation. Keynes (1955) stresses the
desirability of pre-operative radiation but records successful results in the
absence of this precaution. Of 20 patients with thymoma treated with
deep X-ray therapy followed by operation between 1948 and 1953, only 
4 (20 per cent) had died at the time of his report (1953, published 1955).
Part IV
Comparison with Published Series
Comparison of one published series with another cannot be made with
great accuracy. The most important reason for this is the failure to
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which no tumour can Be demonstrated. The numbers involved in most
of the series are small and their selection varies. Sir Geoffrey Keynes has
operated on almost every patient referred to him. (I have only found
3 patients who were rejected as "bad risks” so their inclusion in the not­
operated series does not introduce a significantly adverse factor.) The
number of patients who were not referred to a surgeon is not known, but
is believed to Be small. In his series of papers from 1946 to 1955 Keynes
has reported the cumulative results of his experience. In the present paper
(Table XXIII) his figures have Been recalculated in terms of the total
material instead of percentage survivors as reported. Ross (1952),
reporting an independent assessment of Keynes' patients, examined "100
consecutive patients” from the latter author's series. It seems implicit
that this means ‘TOO consecutive patients who survived thymiectoMy.”
To this extent the series is not representative of the total case material now
included. Keynes and Ross did not publish separate statistics for each
sex, nor did Viets (1945, 1950), Harvey (1948) and Eaton and Clagett
(1950), reporting the early results from Boston, Baltimore and the Mayo
Clinic. Furthermore, the American reports of that period included tumour 
and non-tumour cases in the one analysis. Indeed some of these centres 
considered that the presence of a thymoma was the main indication for
operation (Eaton and Clagett, 1950) and in other ways their series were
More "selected” than the London series. Viets (1950), for instance,
states that he had "deliberately avoided operating upon mild cases, or
those fully maintained under oral medication” and excluded most patients
under 40. He considered that less than half of 300 patients he had seen
since 1935 were proper candidates for thymectomy. Schwab and
Passouant (1952) and Schwab and Leland (1953) correlated the findings 
with sex and age, But still included cases with thymoma. In the last report
from Boston (Schwab and Leland, 1953) 22 per cent of 78 patients sub­
jected to thymectomy had thymomas. As tumours were present in 32
per cent of their male cases against 17 per cent of their females it is
apparent that their conclusion that males received no evident benefit from 
the operation requires further examination. The method of selection of 
patients for thymectomy by Schwab and Leland (1953) “depended partly
on chance, economic reasons and random persuasion in different periods 
by a number of different physicians, with a large number of variables.
There has Been, however, a trend towards selection of younger patients.”’ 
A like number of patients was selected from a group of 250 myasthenia
gravis patients as controls "that matched the thymectomy patients by sex,
age of onset (within five years), severity of disease and presence or absence
of thymoma.” The intention is most laudable, But considering the
“method of selection” of cases for operation and the virtual iMpossibility 
(to the writer) of matching many cases from such a small population, the
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The Baltimore series, starting with the famous paper of Blalock (1941),
was reported briefly by Harvey (1948) and more fully by Grob (1953) who 
discusses the sex difference, but unfortunately there is no report of this 
series in which the tumour material is separated from the non-tumour.
(20 per cent of 44 operated cases had thymomas ; 40 per cent of the deaths
in the operated series had tumours as compared with 10 per cent of the
deaths in the not-operated cases.) The criteria for selection for operation
are not reported but “the average severity of disease at the time of opera­
tion was slightly greater than in the other patients with myasthenia who
were hospitalized but who did not have thymectomy or irradiation.” The
incidence of ocular myasthenia was 4*5 per cent in the thymectomy series
and 29 " per cent in the remainder.
The failure to separate thymoma from non-tumour cases was also the
cause of confusion in the first reports from the Mayo Clinic by Eaton and
Clagett and their collaborators (1949, 1950). The sexes were not con­
sidered separately. It appears that “some patients were too ill or too old
for major surgical procedures to be recommended.” On the other hand
many cases of mild myasthenia gravis were included in the control group.
These authors also attempted the case-matching type of control in their
later papers (1950, 1953, 1955), nevertheless in 1950 Eaton and Clagett
concluded that “at present thymectomy in the treatment of myasthenia
gravis is recommended by us because of the potentially mahgnant
character of the thymomas and not because of anticipated improvement
in the myasthenia gravis. Thymectomy is seldom recommended except
when the following conditions prevail : (1) A thymic tumour can be demon­
strated roentgenologicaUy. (2) The condition of the patient is such that
the risk of operation is not considered excessive. (3) There is no roentgen­
ological or clinical evidence of inoperability of the tumour.” When their
material was redeployed to take account of presence or absence of tumour,
Eaton, Clagett and Bastron (1953) expressed surprise on finding statistic­
ally significant benefit from operation in the non-tumour cases. The
fullest discussion of the Mayo Chnic series including the sex factor, is
made by Eaton and Clagett (1955). This is the only American paper
which breaks down the material in such a way as to allow comparison with
the London series. It is apparent that the earlier views were based on a
surgical series in which 42 per cent of patients had thymomas against 7 per
cent of non-surgical cases. The criteria for operation after this recog­
nition was made are not reported, though it appears that the risk of
operation was accepted in more severely ill patients “on the basis that
thymectomy might prove to be lifesaving.” In view of the very marked 
differences between patients selected for operation and those not so
treated, Eaton and Clagett (1953, 1955) use the match-control method 
criticised above.
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is not made in any critical sense. The writer is well aware of the defici­
encies and lack of planned control in the present series, but the literature
has been so long bedevilled by conflicting claims it seems essential to
examine the basis of these claims with care before a comparison is made.
It is also necessary to examine the method of classification of results used
in the different centres. This has been done in Table XXV. Where the
authors define their criteria they have been quoted and this has been
amplified from internal evidence in the text or tabulated data. The
classifications differ widely, particularly in the large group in which
improvement short of complete remission is recognized. It is not always
made clear that the grading represents a change of status from some datum
point such as the pre-operative period rather than a classification of
physical status at the time of follow-up. Under the first system, used, in
this paper, a mild case of ocular myasthenia showing no spread but no
significant improvement would be classed in Group D. In the alternative 
scheme it would be in Group B. Table XXIII shows the apparent relation­
ship between the different reports and the further comparisons are based
on this assumption. Eaton and Clagett (1955) state that their criteria for
“complete remission” are stricter than those of Keynes. If a minor
degree of myasthenia gravis persists these authors classify the result as
“considerably improved.” The definition of Group A used in the present 
report is restricted in the same way, but it has been considered justifiable,
following Keynes (1954), to permit “myopathic” weakness (wasting, and
weakness not related to effort nor reversible by neostigmine). This point
is not discussed by the other authors, but since it cannot be expected that
thymectomy could reverse a myopathic lesion, such a concession seems
permissible. On the other hand my criteria for C and probably B are
stricter. The combined A and B groups are believed to conform to the
criteria of Keynes and Ross.
Table XXIV shows the relation between successive reports from London,
but it should be remembered that Keynes did not operate on a small
number of the present operated series which accordingly includes the “first
steps” mortality of several surgical units. It is evident that the present
author's assessment is similar to that made by Keynes in 1949 although the
proportion not included in the improved categories is some 10 per cent
higher. This is certainly attributable to the very rigid criteria adopted,
for instance Group D (a) were undoubtedly improved, and might well have
been in Group C in Keynes' classification, but they have been kept in the
lower group because the neostigmine dosage was not decreased. This 
decision is certainly open to argument, but the writer's aim is to present
the operative results in the least favourable light so that any result will not
be open to accusation of special pleading. The discrepancy with Ross's
results (which Keynes has described as “better than I have ever claimed 
myself”) is not understood. Though it is apparent that the criteria for
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Simpson, 1956
A. Full working life with no 
restrictions.
No neostigmine 
No subjective weakness. 
(Small degree of perma­




B. Full life. Minor symp­
toms, not requiring neo­
stigmine or controlled By 




Small dose of neo­
stigmine
C. Full life with few restric- 
trictions ;
(a) demonstrable myasth. 
But not requiring neo­
stigmine
(b) Still requiring drug 
But at least 40 per 
cent less than Before 
and with improved 
response
C. Some improvement, 
often consideraBle. 
Neostigmine still 









No symptoms or treat­
ment
B. Symptoms inconstant and 
minor e.g. only present at 
menses. The patient is 
aBle to carry on with full 
scale of activities. Treat­
ment minimal; signifi­
cantly less (mean post-op. 
dose 6*8 taBs. S.D,4-’8)
C. ConsideraBle improve­
ment. Fewer or less 
severe signs and symp­
toms, and responds to 
signif. smaller dose of 
neostigmine
D. (a) Improved, but on 
same or greater dose 
of neostigmine
(6) Unimproved, irres­
pective of dosage 
(even if in good 
health e.g. ocular 
myasthenia).
(c) Worse
died (a) Death due to myas­
thenia after three 
weeks
(6) Ppst-op. within 
three weeks
(c) Death dde t o ooher 
causes
D. No change D. Unchanged or worse
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Comparison of Criteria




Schwab and Leland (1953) 
A. Complete remission.
Nolongerrequiredany 
medication and had 
no symptoms
Grob (1953) 




(1) Subjectively well. Examination dis­
closes («) min. weakness due to 
myasthenia (6) Unequivocal sensi­
tivity to curare
(2) Marked subjective improvement. 
Verified by increased work and 
activity, plus great reduction in 
amount of neostigmine required
B. Significantly and ob­
jectively improved, 
took less medicament 
and had fewer symp­
toms. Medical referees 
would all agree as to 
the presence of im­
provement
Improved to a 
moderate degree
+2 Moderate improvement
(2) Same work and activity accom­
plished with signif. reduction of 
neostigmine
(1) Greater work and activity accom­
plished with use of same amount 
of neostigmine
+No essential change 
— 2 Worse
C. Various degrees of slight 
to mod. improvement 
which was subjective 
oftener than objective.
Difficult to evaluate 
quantitatively and would 
not convince referees
D. Unchanged or worse
Unchanged,
Worse
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Category B are less rigid (cf. neostigmine requirements) and Ross agrees
with Keynes in B. C. D. there is a difference between the proportions in
Category A which can only be attributed to fortuitous selection. The
apparent selection of survivors of the operation has already been pointed
out. Certainly the writer was frequently able to check his own assessment
with that made on the same case a few years earlier by Ross and there was
rarely disagreement; and 54 per cent of the* patients Ross had assessed as
A made up 56 per cent of these classified as A by Keynes in 1949 (Ross,
1952). This strongly suggests that the difference is a genuine one due to
examination of a consecutive series of cases which was not a true sample of
the whole operated population—a well-known risk in surveys of this type.
The present assessment in which no sampling is involved, should, therefore,
be taken as an expression of the writer's opinion of the latest state of the
whole London series when looked at in the most critical light. This can
now be compared with the other major series, bearing in mind the differ­
ences in composition and in the criteria of assessment which have been
presented above. The figures tabulated (Table XXV) are those most
recently reported.
The closest agreement with the results of the present survey is the much
smaller series of Schwab and Leland (1953). Unfortunately, 9 of the 53
females (17 -0 per cent) and 8 of the 25 males (32 per cent) in the operated
series had thymomas and the published data are insufficient to permit
computation of the non-tumour results though it is stated that exclusion
of the thymomas raised the A or B remission (A+B+C of the present
classification) to 68 per cent for females, but left the rate unchanged for 
males (24 per cent). On the other hand, exclusion of the tumours lowered
the mortahty rate for males from 32 per cent to 18 per cent (though not
stated it is assumed that the female mortality rate is little affected by the
adjustment). These authors, then, agree closely with the London results
except for the poor improvement rate in .males. Their control series
closely resembles the present one in all respects except for the larger 
number of females considered unchanged or worse. It should be remem­
bered that the control series was selected to contain the same incidence of
tumour as the operated series.
Eaton and Clagett (1953) also report results of the same order as the
present ones in their operated series, but agree with Schwab and Leland
(1953) in finding more females improved and more males unchanged or 
worse. The figures for their control series, however, are so .markedly
different from aU the other series (which are consistent with each other)
as to raise doubts about the validity of their matching technique. They
report the following assessment of 142 unselected controls : A 7*7 per cent,
B 9-9 per cent, C 10 -6 per cent, D 49-3 per cent, Died 22-5 per cent, but
9 per cent of this series were previously reported to be cases with tumour
(Eaton and Clagett, 1950). Nevertheless, the mortality rate is more
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Table XXIV.—Progressive Assessment of London Series 
(Non-tumour)
Keynes Keynes Ross Simpson
(1946) (1949) (1952) (1956)
No. 0/*/o No. % No. °/% No.f %
A 9 27-3 39 28-4 41 41 55 21-3
B 11 33-3 40 29-2 26 26 32 12-4
C 8 24-2 31 22-6 20 20 60 23-3
D 5 15-2 10 7-3 6 6 47 18-2
Data incomplete .. — 7 5-1 0 0 17 6-6
Myasth. Deaths .. — 0 0 1 1 23 9-0
Post-op. Deaths .. — 10 7-3 0 0 20 7-7
Deaths, others .. — 0 0 6 6 4 1-5
Total 33 137 100 258
-Per cent of survivors only. 
fBoth sexes comBineD.




























B 13-2 36-7 41-51 3601 5-1 14-8 20-71 2201
C 23-1 20-0 / 15-3 14-8 / J
D 17-6 16-7 22*6 24-0 13-5 57-4 37-7 34-0
Data Incomplete 7-1 — — — 15-3 .—. — —
Myasth. Deaths 7-71 6-6 7-61 28*81 7-4 28-3.. 30*0")
Post-op. Deaths 7-7 V 17-0 6-3 7-5 280 > — >35-6 — .—
Deaths, other 1-6 J — —J J 6-8 J — — J
Total cases 182 30 53 25 59 54 53 77
A M 19-7 17-7 8-0 22-0 17-5 13-0 16-0 17-0
B 10-5 17-7 16-0^ 16-0 } 5-0 17-4 10-01 12-0-s
C 23-7 17-7 f f 7-5 17*4 / • }
D 19-7 35-3 44-0 21-0 25-0 43-5 24-0 27-0
Data Incomplete 5-3 ■—• — — 22-5 — — ■—
Myasth. Deaths 11-81 0 8-0 1 20-01 8-7 20*0 I
Post-op. Deaths 7-9 V21-0 11-8 24-0 420 — >22-5 — — . 44-0 >
Deaths, others l«J — — J 2-5 J — — J
/ Total cases 76 17 25 19 40 23 25 41
*LonDon—present series. Mayo Clinic—Eaton and Clagett (1955). Boston—Schwab and 
LelanD (1953). Baltimore—GroB (1953).
Grob (1953) agrees with the present author in his grouping of male
cases with or without operation except for the considerably higher mort­
ality rate. Considering the numbers involved the female series are in
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higher. Unfortunately, no details are given to show how much of this
represents operative risk, but the high proportion of thymomas may be
responsible. 9 of the 44 operated patients (sex not distinguished) had
thymomas and 6 of these “died of myasthenia gravis.” Removal of these
would lower the combined sex mortality from 34 per cent to 10 per cent.
On the contrary, only 4 of the 41 not-operated deaths were thymomas (and 
2 surviving tumours were known) giving a corrected combined-sex
mortality rate of 33 per cent (37 of 112). These figures are again similar 
to those reported here.
To summarize, there is general agreement on the mortality rate and
extent of remission in operated and not-operated series and that differences
in assessment of the remainder can be attributed to differences in methods
of classification or to errors of sampling in small series. All four centres
agree that thymectomy results in a worth-while improvement in prognosis
for women, particularly in the reduced mortality rate, but the three
American centres do not consider that males are significantly benefited by
operation. On first glance at Table XXV this conclusion would appear
justified, but close inspection suggests that the conclusion may be pre­
mature since the male mortality in the operated series of Eaton and Clagett 
(1955) is entirely an operative mortality and in Schwab and Leland’s ((955) 
it is ptrdomsdadtly so. It will further be recollected that 32 per cent of
the operated males in the latter series had thymomas (double the incidence
in females), Grob (1953) does not detail the distribution of the thymomas
which formed 20 per cent of his entire operated series and contributed
60 per cent of the deaths. In the light of these considerations, the American
position cannot be sustained until analyses of their non-tumour series are
provided. Their conclusions are in line with those in Part II of this study
and all four series show identical trends (in favour of operation) though no
single series reaches statistical certainty. The identical trends in all series
are unlikely to be fortuitous. With regard to the influence of age, Eaton
and Clagett (1955) since removing thymomas from their series, now agree
with Keynes and Ross (1952) and return to their opinion (of 1950), that
the age at onset does not significantly affect the response to thymectomy,
though earlier (Eaton, Clagett and Bastron, 1953) they had agreed with 
Schwab and Leland (1953) that the younger the patient at onset, the better
the response to thymectomy. The latter authors, however, state that “the 
high proportion of thymomas in older females (in their series) probably
explains their poorer result.” The present study now provides further 
evidence that the non-tumour patients who show the poorest response are
a little older than the average, although a direct comparison between the
good results and the failures shows no difference sufficient to be of practical
value.
An unexpected finding is that the myasthenic deaths occurring despite
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operation and duration of symptoms before operation are substantially
similar to those of the group deriving most benefit. From Table XV it
appears that the crucial period is four to seven years from the onset,
whether operation is carried out or not, and it is possible that these
patients are more difficult to control by neostigmine (Table XIV). The
available data do not suggest any method of selecting this unfavourable
group. .
The beneficial effect of shorter prr-rprratsee duration demonstrated in
this paper confirms the findings of Keynes (1946 and 1949) and Ross
(1952). Schwab and Leland (1953) agree so far as females are crdcrtded,
but not for males. The high sdcidrdce of tumours again invalidates their
findings. The Mayo Clinic and Baltimore groups have not commented
on the influence of ptr-rprtatser duration of myasthenia. Eaton and
Clagett (1950) also agree that the ptr-opetatsee duration is, on average,
slightly shorter in those showing marked post-operative improvement
(without distinction of sex). Nevertheless, the inference that the incidence
of deaths due to myasthenia despite thymectomy would be reduced by
selecting young patients with a short ptr-oprtatsve history is not borne out
by the present survey since the average age at onset and at operation and
the average pre-rprratsee duration in these patients is actually lower than
in the unimproved (D) patients, and sometimes lower than the average of
the whole group or even of Group A+B. One would expect that the
response to any form of therapy would be a function of the severity of the
illness at the time treatment was started, that is to say that the final
category would bear some simple relation to the initial severity of myas­
thenia. The method of assessment used in this and in the other surveys
reviewed does not permit deductions of such a nature since the factor of
change of status selected for analysis takes no cognizance of the severity
of the disease from which that change occurred. The necessity for this
approach has been discussed already, but it is worth re-emphasizing that
the bald classification of a case as Category C or even B according to the
rigid definitions used does not convey how truly dramatic the change may
be. Some measure of the severity of myasthenia at the datum point is
given by the neostigmine requirements of the patient at that time. It was
found (in agreement with Ross, 1952) that the requirements in those
ultimately achieving Category A were little lower than the remainder, but
certain possible fallacies (discussed in Part II) make this conclusion only
tentative. None of the American series allows direct comparison.
Eaton, Clagett and Bastron (1950) give criteria for classification of severity,
but do not state how it correlates with the final outcome. It is, however,
relevant to note that the re-analysis of their non-tumour material which
forced them to acknowledge the value of thymectomy was based on cases
selected as being of “average severity.” Indeed a method of classification 






































138 JOHN A. SIMPSON
case in which any change can only be of small amount. This limitation
was accepted in the present study as it was thought desirable that any bias
introduced should be against thymectomy on the grounds that the onus
of proof rests on the proponents of radical forms of treatment. The 
“devil's advocate” has nevertheless confirmed their claims that a significant
saving of life results from removing the non-malignant thymus gland of
patients with myasthenia gravis and that the survivors have a better chance
of complete and lasting remission or of great improvement in myasthenic
symptoms, particularly if operation is performed within four years of the
onset of symptoms. It is perhaps not out of place to add that the extent
of this improvement may be very great. It is usually permanent, though
a few relapses have been noted, and it is common for improvement to be
progressive for several years after operation. For the present purposes
Category D has not been subdivided, but physicians considering subjecting
patients to operation should know that most of the patients in this category
were “unchanged,” very few became worse after operation. Unfortun­
ately, apart from duration of symptoms, this study (and parallel un­
published observations) has not shown criteria which would allow one 
to predict the effect of thymectomy in the individual case, but this writer
is satisfied that although the chances of significant improvement, or arrest,
are not overwhelmingly superior to those of non-surgical treatment, they
are sufficiently great and the extent of the improvement so potentially
spectacular that the operation should be seriously considered in all cases
in which myasthenia is not confined to the ocular muscles. This qualifica­
tion seems necessary in view of the report of Ferguson, Hutchinson, and
Liversedge (1955). These workers put forward the view that the prognosis
of myasthenia gravis is not unduly poor with medical management. They
traced 69 of 75 cases seen over a period of twenty-two years and only 9 of
these had died (2 with thymomas). Of the 60 survivors 42 were well
controlled with medical treatment. They pointed out that in 27 of these
(36 per cent of the total material) the myasthenia had remained confined
to the ocular muscles. It is apparent that they have seen a much higher
proportion of ocular myasthenia than occurs in the practice of the National
Hospital (Tables IV and XXI).
Discussion
Seventeen years have passed since Blalock (1941) reawakened interest
in the role of thymectomy in myasthenia gravis, yet the value of the
operation is still debated. The apparent lack of agreement between the
few centres with wide experience of thymectomy has caused those looking
for guidance to assume that the evidence was too equivocal to carry
conviction {Lancet, 1954). Keynes has pointed out on numerous occasions
that the apparently poor results in some of the American reports were due





































THYMECTOMY IN MYASTHENIA GRAVIS 139
remainder. Where such differentiation has been made (Eaton and
Clagett, 1955), the favourable results reported by Keynes have been
confirmed. t
Criticism has been made of the method used in this and the earlier
surveys. The deficiences of the method are clear and are freely acknow­
ledged. It is obvious that in a disease of protean manifestations without
measurable characteristics any assessment of disability on an absolute
scale would be misleading if not impossible. Nor would it be possible for 
even a single observer to maintain rigid standards of severity for a disease
of rare occurrence. It is, however, comparatively easy by the normal
means of clinical investigation for any physician to decide whether or not 
a patient has improved significantly from a given point in time and, if the
criteria are rigidly defined and the categories are not too narrow, any
experienced observer can assess the degree of improvement. Two difficul­
ties do arise. Firstly, there must be reasonable certainty that the original
diagnosis was correct. In the present study this was assumed if the
diagnosis was confirmed by an experienced neurologist and a record ful­
filling certain criteria was available for study. The second difficulty is
more serious : Since the basis of classification is a change in clinical status
it is obvious that the extent of this change may be little or great, depending
on the severity of the disease at the time used as reference point. A little 
consideration will show that this factor cannot influence Category A and 
probably would not materially affect Category D, but may substantially
affect the relative distribution between Categories B and C. As this effect
is a random one it should not be a serious matter in a large series, but it may
well explain some of the anomalies in the smaller series.
Further criticism encountered during this work has been the time-
honoured “you can't reduce a complex disease in a living subject to a
number.” Tins has been answered in an admirable way by Herdan (1955)
who writes :
“Some clinicians are not sympathetic to methods tending to condense
the information on a patient's hospital record by disregarding certain
details, in order to make the material amenable to statistical methods.
They consider this inferior to working with the complete picture of the
case. But such a view rests upon the illusion that our intellect is capable
of integrating all the data on a patient's card or even on a number of such
cards, into one clear-cut conclusion without neglecting any details.
Unfortunately, our mind is not made that way. Combination of observa­
tions—and without it no conclusion can claim the slightest degree of
generality—implies neglect of details. Since no two cases are completely
alike they can for the purpose of combination be made alike only by
dropping unnecessary detail. What statistics offer in tliis respect is a
legitimate method free from arbitrariness, by which to replace the highly










































140 JOHN A. SIMPSON
neglects a detail.” No other way of assessment is open. It is not
sufficient to quote a case of spectacular cure of myasthenia gravis or one
in which no benefit resulted without adding the (statistical) statement that
such a result may be expected to occur in a certain proportion of trials.
Nor would the statement be complete without the addition of the further
information of the extent to which such a result differed from that to be
expected from other modes of treatment.
The last statement raises the question of “controls.” For the present
purposes a srtsrs of patients treated medically by the same group of
physicians was, faute de mieux, regarded as an index of the expected out­
come of myasthenia gravis when treated without thymectomy, but in all
other respects in the same manner. In the event, it became clear that this
comparison could not be sustained since there were marked dissimilarities
in the composition of the two series (“operated” and “not-operated”).
This has been countered by demonstrating that the statistics of the total 
material are substantially the same as those of a selected sample of each
group in which age and sex were comparable. It was not, however,
possible to ensure that previous medical treatment was the same in both
groups as the majority of the not-operated series were patients treated
between 1934 and 1941 when neostigmine was customarily prescribed in
lower dosage than is now practised. Two of the American series have
attempted to obtain a control series of “not-operated” cases by selecting
for their unopened group a case brfieerd to match in every respect each
one in the “operated” series. The principle is good and it is probably the
best method where numbers are high and operation has been advised for
all cases without conscious selection. The writer does not believe that
the method is at all reliable where numbers are small, operation has been
selective, and the disease is so variable as to make matching in every
respect a virtual impossibility. Furthermore, the “control” series is
already selected by the fact of survival. It does not seem likely that if two
subjects had similar clinical manifestations, but one died at one year from
the onset of myasthenia, while the other survived to two years, the former
would be chosen to pair a third “identical” subject operated on at nine
months from the onset and still surviving at two years. Yet there would
seem no reason why at the relevant time—nine months—the second patient
should be considered a better match than the first. Without first-hand
evidence no more can be said, but it may well be that considerations of this
nature explain the very low mortality rate of Eaton and Clagett's (1955)
“controls” which differs so strikingly from that reported from the other
centres. These authors readily concede the tentative nature of their results
in view of the small size of their series. The only satisfactory method in
a disease with so many variable factors (e.g. do two paralysed limbs equal
one paralysed palate ?) is to allocate cases randomly to one or other series 
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to occur without statistically significant difference and thereafter until
sequential analysis shows that one series differs significantly in its natural
history from the other. Unfortunately this was not done in the present
instance. The physicians treating myasthenia gravis in London were
sufficiently impressed by the results of the early cases which they had
submitted to Keynes for thymectomy to wish to carry on in the belief that
it was in the interests of their patients to do so (Proc. Roy. Soc, Med.,
1946). No controlled trial was instituted at that time and it is doubtful if
such a measure would now be ethically justifiable. Though not scientific­
ally elegant the results reported here show that (in a series sufficiently large
to reduce the effect of random variations) there is a great saving of life in
patients subjected to thymectomy even when the hazards of operation are
included, and further that a greater proportion is greatly improved at the
end of a comparable period than is the case where the non-tumour thymus
is not removed. This difference has been shown to be greater than can be
attributed to chance in the female sex and the trend in males is the same,
although the level of statistical significance is not reached. No marked
sex difference could be established in either series. Slightly more women
than men were in Categories A and B after operation and fewer died of
myasthenia. Analysis shows that this could have occurred by chance and
so does not conflict with the impression of Keynes (personal communica­
tion) that the results are equally good in both sexes. On the other hand
though the sexes were again very similar in the not-operated series the
trend was quite different since women had a slightly poorer prognosis than
men. The change in prognosis for women when thymectomy is performed
is greater than can be explained by chance. This conclusion agrees with
Schwab and Leland (1953) and Eaton and Clagett (1955), thus reconciling
theirs with Keynes’ apparently conflicting point of view. The inclusion
of tumour cases in the Boston and Baltimore series and the small size of
the Mayo Clinic series have been shown to introduce fallacies which make
more direct comparison impossible, but it should be remembered that two
of these series agree with the writer that the benefit from thymectomy may
be shown by males though statistical analysis does not exclude the possi­
bility of chance. It would seem worth while appealing to other centres
to reclassify the small numbers involved according to the criteria stated
in this paper (since no others have been defined) in order that a unified body
of data might be available to test those points where statistical confirma­
tion is lacking because of shortage of cases.
Summary
A long term follow-up survey of 404 patients with myasthenia gravis is
reported and the value of thymectomy compared with medical treatment
alone. The 47 patients with thymic tumour are considered separately.







































142 JOHN A. SIMPSON
change of status from the pte-operatsvr period or the time of first entering
hospital in the not-operated series.
In Part I the “operated” and “not-operated” - series are compared with
respect to sex distribution, age sncsdedce at onset of myasthenia, length of
survival from onset of symptoms, and incidence of “myopathy,” “gosttr,”
and “ocular myasthenia” (as defined).
Part II analyses the assessment of non-tumour cases. It is concluded 
that significantly fewer women die of myasthenia gravis if their thymus is
removed than would be expected if they were treated with neostigmine
only. The number of women very greatly improved ten or more years
after the onset of the illness is significantly greater. , Similar trends are 
noted in men but the benefit in favour of operation is not so clear. It is
suggested that without operation women have a poorer prognosis than 
men but after thymectomy they have a better outlook and that the extent
of this change explains the more obvious advantage of thymectomy in
women.
No chnical indication of the type of cases likely to be helped by operation
is noted. It is confirmed that the best results are found in a group of
cases with younger mean age at onset, shorter pre-operative duration of
myasthenia, and younger mean age when operation was carried out. The
age differences were not sufficiently marked to be of clSdScal value. There
is strong evidence that a good result is most probable if the myasthenia
has been present for less than five years at the time of operation though
some excellent results were noted where the duration was much longer.
On the other hand, the pre-operative duration of those who subsequently
died of myasthenia (after the post-operative period) was no different from
the average. The age-at-onset and at operation was average in women who
died but lower than average in men. The female myasthenic deaths were
also of average age-at-onset in the ^operated group but the corresponding
males were significantly -older than average, due to a relative excess of
older men in the unoperated group. Death from myasthenia tended to
occur four to seven years from the onset in each series. During fife these
patients required more neostigmine than those who survived but there is
no clear evidence that the severity of myasthenia materially affects the final
state of survivors.
The duration of follow-up of both series was the same and did not
influence the category. There was no indication that a good response
was temporary (though a few relapses after early improvement were noted). 
The main conclusions were confirmed in part of the series omitting the
extremes of age in which the case material was more homogeneous.
The effect of thymic tumour is presented in Part HI. Myasthenia gravis
in the presence of thymoma differed from the non-tumour group in the later
age of onset (average 40 years) and the severity of symptoms which were
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thyroid disease was the same but myasthenia never remained confined to
the ocular muscles. The operative death-rate was high and combined with
a subsequent mortahty from myasthenia to give a poor prognosis which
was little better than that obtained without operation. Nevertheless
attention is drawn to the possibility of excellent response with long survival
(even without radiotherapy though Keynes (1955) stresses the desirability
of it). The total survival of those who died of myasthenia was closely 
similar to the non-tumour group.
In Part IV the other major series in the literature are analysed because
of apparent discrepancies. It is submitted that the differences are due to
(1) failure of other workers to report thymoma cases separately; (2)
different criteria for classification; (3) methods of selection for operation; 
(4) selection of unoperated cases for “controls?’ A tabulated comparison
of series is made with the original reports adjusted to match the criteria of
this paper as closely as possible. It is shown that the results of all series
are then similar, allowing for the sampling errors of small series.
Conclusions
(1) There is a substantial chance of improvement after thymectomy in
aU cases. This is most evident, and the saving in life is greatest, when the
duration is less than five years and no thymoma is present.
(2) After seven years from the onset considerable improvement after
operation is less Hkely though it may still occur, but the risk of death from
myasthenia is less whether operated or not.
(3) Improvement occurs in both sexes and the ultimate distribution of
categories is the same but the extent of improvement is most significant in
women as they would otherwise have a poorer prognosis than men.
(4) The prognosis for life remains poor if a thymoma is present, though
pre-operative radiotherapy may be beneficial. Only one case in three
survives but the improvement in myasthenia may then be as great as in
non-tumour cases.
(5) The maximum improvement occurs in patients who first show
symptoms at an earher age and who have their operation younger than the
average but the difference is insufficient to influence the selection of cases
for operation. Death from myasthenia is more probable in cases requiring
large doses of neostigmine but if they survive the ultimate category after
operation is not influenced by the pre-operative severity.
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MYASTHENIA GRAVIS; A NEW HYPOTHESIS*
John A. Simpson
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IN a part of the world which has now adop­ted more sophisstcated methods of brain 
washing, it was once the custom to expose 
those with unorthodox ideas to a trial by 
ordeal which consisted of the chewing of the 
Calabar bean. Today I wish to present you 
with some unorthodox ideas so let me start 
by asking you to throw away the Calabar 
bean, or at least to keep its active constituent, 
physostigmine, out of sight, for I believe that 
this magic bean, or its synthetic competitors 
may have blurred our vision of the true 
nature of myasthenia gravis.
First let me pay tribute to Mrs Honyman-
Gillespie who has made these lectures pos­
sible and the Post-Graduate Committee who 
invited me to contribute to this famous series. 
The first lecture was given by Edwin Bram­
well (1938) on the contributions of the Edin­
burgh school to the study of the reactions of 
the pupil of the eye. From him 1 learned that 
the mydriatic action of the Calabar bean was 
discovered by Sir Thomas Fraser in 1863 when 
he was professor of materia medica in Edin­
burgh and a physician to the Royal Infirmary, 
and introduced to ophthalmological practice 
in the same year by the young Argyll Robert­
son in a paper read before the Medico- 
Chirurgical Society of Edinburgh.
Collier (1930) attributed the first British 
recognition of myasthenia gravis to this same 
Edwin Bramwell when he was starting his 
illustrious neurological career as a house- 
physician at Queen Square. Though first 
described by the Englishman Thomas Willis 
in 1672, the syndrome was unrecognized until 
the magnificent papers of Erb (1879) and
*A Honyman-Gillespie Lecture delivered on 28th 
April 1960,
Goldflam (1893). Indeed, Bramwell's father, 
Byrom Bramwell, gives an excellent descrip­
tion of a case in his famous Atlas (1892#) but 
could not name it, and the illustration repro­
duced in Figure 1 is almost certainly a myas­
thenic child. Edwin Bramwell with Campbell 
reviewed the known cases in 1900 (Campbell 
& Bramwell, 1900) and recognition became 
more common from that time on. If some of 
the facts 1 shall present are unfamiliar it is 
humbling to record that almost all are present 
in that instructive review or in the interesting 
paper by their colleague Buzzard (1905). They 
have been ignored, and many later observa­
tions discarded because they are difficult to 
reconcile with views which have been current 
since attention was focussed on the pheno­
mena of neuromuscular transmission which 
is presumed to be disturbed in myasthenia 
gravis.
I would like you to forget all that you have 
been taught or presumed with regard to myas­
thenia and look with me at the symptoms and 
signs present in a series of 440 cases which I 
have been privileged to examine through the 
kindness of colleagues in Edinburgh, London 
and Glasgow. Let us not decide what is 
‘relevant’ until the whole picture is before us. 
I shall draw some novel conclusions from this 
analysis, leading to a new hypothesis. This 
will probably require modification in detail 
but has the double merit of incorporating all 
the clinical phenomena without exception, 
and of suggesting completely new lines of 
inquiry. In the closing part of the lecture a 
necessarily brief account of the pathophysio­
logy and pharmacology of myasthenia will be 
given to demonstrate that the hypothesis is 

















Ii«. I . Remittent. ophthalmoplegia of uncertain aetiology, attributed to syphilis. Note the bilateral 
ptosis and drooping of the mouth (Bramwell. 1892A). {Reproducedhy kind permission of Edinburgh
LIniversity Press).
Fig. 2. Distribution of age at first myasthenic symptom.
NATURAL HISTORY
Myaslhcnia gravis is twice as common in
women as in men. The ratio is higher in the
first three decades and reverses in the sixth
decade, being more common in males in the
later part of life, so that the mean age at onset
of the disease is slightly less in women (26 yr.)
than in men (31 yr.). but the modal age is
about 20 years for both sexes (Simpson. 1958).
The smoothness of the age distribution curve
(Fig. 2) does not suggest that we are dealing
with a miscellany of diseases with myasthenic
fatiguability as a common symptom.
The picture of generalized myasthenia is
well known (Fig, 3). There is ptosis (often
asymmetrical), diplopia, facial weakness with
a typical vertical ‘snarl' on showing the teeth.























Fig. 3. The myasthenic ‘snarl'.
the characteristic posture of the myasthenic,
sitting supporting head and jaw with her
hand. The limb and trunk muscles may be
weak. Weakness of the tongue and laryngeal
muscles causes dysarthria. Involvement of
skeletal muscle of the upper pharynx and
oesophagus causes dysphagia. Vocal cord and
respiratory paresis cause the voice to fade and
breathlessness to interfere with speech and
other activities.
Those areas shaded most heavily in Figure 4
are usually first to be involved. They are also
the most frequently affected altogether, and
usually the most severely involved when
myasthenia is generalized. Thus, though the
distribution is apparently random and usually
asymmetrical in the individual case, a distinct
pattern emerges when a large series is ana­
lyzed. The most frequently involved are the
extra-ocular muscles (including orbicularis
oculi) and then the muscles of the neck, should­
er girdle and hip flexors. The proximal limb
muscles are more severely affected than the
distal. Extensor muscles are more involved
Fig. 4. Percentage of cases in which 
various muscle groups arc affected at 
the onset (left of key) and at some 




than flexors in the upper limbs, but flexors 
more than extensors in the lower limbs which 
are usually less severely affected than the 
upper. Trunk muscles, other than erector 
spinae, are least affected. Fortunately few 
patients show the generalized distribution. 
It is much more common for the disorder to 
involve a group of muscles, a single muscle, 
or even part of a compound muscle (e.g.
extensor digitorum longus) and the initial 
weakness may affect any muscle. Seven pati­
ents had unilateral facial palsy which was 
considered to be BelFs palsy for several 
months until further weakness developed. 
Four patients had sudden severe inspiratory 
dyspnoea as the first symptom. Commonly 
the complaint is related to a muscle fatigued 
by a particular movement required by the 
patient’s work. Systematic examination may 
reveal unsuspected weakness or fatiguability 
of other muscles but examination must be 
thorough and include contraction main­
tained against resistance for an adequate 
period. If this rule is strictly followed 1 be­
lieve that myasthenia is less frequently con­
fined entirely to the extra-ocular muscles than 
other writers have claimed. Certainly the 
present series gives but scanty support to the 
statement that myasthenia is commonly con­
fined to these muscles. Grob (1953) states 
that if weakness has not spread from the 
extra-ocular muscles to others in 2 years it is 
unlikely to do so.
Weakness increases with repeated use of a 
muscle or with long-maintained contraction, 
if the patient is asked to gaze upwards the eye­
lids gradually droop. Eventually she blinks 
and immediately the ptosis lessens and may 
disappear. But it again reappears on refixing 
the gaze, and each time this happens the 
fatigue appears more rapidly until finally no 
improvement occurs. Exactly the same hap­
pens to the outstretched arms. The slow 
drooping followed by the cycles of sudden 
drop and renewed effort until fatigue is com­
plete, looks like a hysterical manifestation to 
the inexperienced. Electromyography shows 
that the patient is taking advantage of post­
tetanic facilitation accumulating during a 
brief rest to restore full activity temporarily. 
A similar phenomenon in the extra-ocular 
muscles causes coarse nystagmus which may be
monocular. The patient, if observant, will state 
that the object she is looking at ‘suddenly 
slips’. The reflexes are often unusually brisk 
(indeed ankle clonus is sometimes observed) 
but may be fatigued if elicited repeatedly.
This short-term fatiguability is highly char­
acteristic of myasthenia. It is not surprising 
that facilitative compensation should become 
less effective after the day’s activities, and 
most patients do complain of increased weak­
ness towards evening, but this is not so invari­
able as is often believed. Indeed one of the 
major difficulties in treatment is due to the fact 
that the patient is often extremely weak on first 
waking in the morning. This is not confined 
to those requiring frequent dosage who might 
be deprived of their drug during the night, as 
it occurs before treatment is started. Indeed 
I have had ten patients (eight of whom were 
males) who have noticed that they improved 
as the day advanced, and two actually used 
exercise as a means of increasing their 
strength. This is probably associated with the 
‘de-curarization’ phenomenon which will be 
described later (Simpson & Lenman, 1959).
Permanent weakness, not responding to 
neostigmine, and atrophy of muscle are much 
commoner than generally believed (10% in 
this series, [Simpson, 1958]). This is the so- 
called ‘myasthenic myopathy’. It may affect 
any muscle. The triple-furrowed tongue, 
named after Kinnier Wilson though pre­
viously described by Erb (1879) and Buzzard 
(1905), was only found in six cases (Fig. 5). 
The extra-ocular muscles quite frequently 
become unresponsive to neostigmine, and the 
triceps brachii and ilio-psoas next most com­
monly. Electromyographic and histological 
changes in these ‘myopathic’ muscles are 
indistinguishable from polymyositis.
The onset is often insidious and progress 
slow or rapid, but in some it has a very sudden 
beginning. It commonly follows a febrile 
disease, usually an upper respiratory infec­
tion. Only a little less common is precipitation 
by an emotional upset and this can be most 
dramatic. One patient, thrown to the ground 
by blast in the blitz, was unable to rise again, 
Another developed ptosis and diplopia the 
day after an accident at work, in which he was 
unharmed but was certain he was about to be 


































































Fig. 5. The triple furrowed tongue of myasthenia 
(same patient as Fig. 3).
time at their wedding, and one when she
found evidence of her husband's infidelity.
Very many attributed the onset to anger,
quarrels, worry etc. with details too circum­
stantial to discount. All had myasthenia from
then on, (as one woman ruefully remarked
‘girls with myasthenia shouldn't fall in love').
A few women first had symptoms during
pregnancy, and four cases were detected by
abnormal response to relaxant drugs used by
anaesthetists.
Later relapses were attributed to the same
factors, but other causes were the prc-men­
strual period, cold, warmth (especially a hot
bath) and allergy to shell fish (two cases) and
one case followed soon after inoculation.
Sunlight often caused ptosis and blurred
vision, and a few patients asserted that it also
caused generalized weakness.
There can be quite surprising variation
from day to day and even hour to hour.
Physical exertion is certainly a factor, but I
believe that the emotional state is more im­
portant. This raises the question of remissions.
Remissions are generally considered so char­
acteristic of myasthenia as to cause difficulty
in evaluating therapy. It is quite true that
sudden improvement can occur, but com­
plete remission lasting for more than a month
is seen in less than half of the patients, and
more than one long remission is very rare.
Furthermore, most of the ‘worthwhile' re­
missions occur during the first 3 years, though
there are notable exceptions to this rule. This
is the period which sees most of the deaths
from myasthenia (especially the first year of
the disease) and thymectomy, to be beneficial,
is best done during the first 5 years (Simpson,
1958). The impression 1 have is that the
‘active' stage of the disease is limited to this
period and the subsequent course depends on
the extent of the damage occurring then. This
is not to say that the patient is out of all dan­
ger if he survives for 5 years. On the contrary
1 am impressed with the ‘brittleness' of the
remissions and the delicate balance which
takes place. Sudden death may occur from
apparently trivial respiratory obstruction,
and many examples could be quoted. Never­
theless these catastrophes are due to the pre­
cariousness of an adaptation which is suffic­
ient for normal existence without permitting
mobilization of reserve muscular power in
emergency. They are not, in my opinion,
usually due to sudden relapses or to a pro­
gressive disease process, though second waves
of renewed activity do occur sometimes,
particularly after upper respiratory infection
or renewed emotional stress.
Pain is quite common in weak muscles,
usually an ache which is presumably due to
the extra effort required to maintain posture.
This often causes headache, pain round the
eyes, backache etc. Sometimes the muscles
are actually tender, and pain has been noted
to persist even while resting in bed. One is
irresistably reminded of polymyositis. A few
patients have complained of mid-sternal pain,
often on stooping, which is sometimes associ­
ated with palpitations. Other sensory symp­
toms are rare but cannot be ignored as they
have been present in other series (Harvey,
1948). Most often there is tingling of the
hands, thighs, or face, sometimes unilaterally.
I have usually considered that there was a
mechanical explanation, as from shoulder-
girdle drop, or a misinterpretation by the
patient of muscle ‘stiffness'. Deafness, often
variable, sometimes occurs, from Eustachian




deafness for low frequencies which may be 
caused by paralysis of the tensor tympani. If 
the stapedius muscle is weak the patient has 
hypcracusis. Some authors describe objective 
sensory changes including a few cases of loss 
of taste or altered olfactory sensation which 
are difficult to explain (Alajouanine et al.,
1957). Epilepsy was present in two of my cases 
and unexplained blackouts in another tJ'ree. 
These were thought to be coincidental, but 
Hoefer e/ al. (1958) found an unusually high 
incidence of epilepsy associated with myas­
thenia. Raised protein in the cerebro-spinal 
fluid was present in nine cases, but the fluid 
was only rarely examined. There is a sub­
stantial collection of similar cases in the litera­
ture.
Tables I and II list some disorders which 
were present in these cases, but it should be 
observed that they were noted in their case 
records by various observers or by myself 
when studying the value of thymectomy and 
no systematic attempt was made to record the 
true incidence of conditions to which I then 
attached no significance. For this reason no 
attempt was made to express the figures as 
percentages.





Carcinoma (present at onset of 
myasthenia) 3





Allergy (precipitating myasthenia) 3
Sensory phenomena, other than pain 11
Epilepsy and recurrent blackouts 5
Psychosis 3
Cerebrospinal fluid protein raised 9
If one defines myasthenia gravis as a dis­
order of neuromuscular transmission it is 
obligatory to consider these phenomena as 
irrelevant coincidences, especially as the fre­
quency of any one is too low to be statistically 
significant. But it may be more profitable to 
consider the possiblity that the various pheno­
mena are related to the muscular disorder.
Table II. Disorders of blood and reticulo-endothelial 
system in 440 patients with myasthenia gravis.
Disorder Number 
of patients








* No marrow smear but clinical diagnosis of perni­
cious anaemia based on peripheral blood, achlorhyd­
ria and therapeutic response.
It is interesting to note that all the disorders 
listed in Table I and many of those in Table 
II were noted as manifestations of diffuse 
lupus erythematosus by Harvey et al. (1954). 
Indeed the precipitating factors and the age 
and sex distribution already discussed are 
exactly those found in that disease by these 
authors. It may then be significant to note 
that Rowland (1955) found lupus erythema­
tosus cells in a case presenting as myasthenia 
gravis while Harvey et al. (1954) found myas­
thenic symptoms in three cases of diffuse 
lupus erythematosus. A list of cases is rapidly 
accumulating of myasthenic symptoms in 
other connective tissue-muscular disorders 
such as dermatomyositis, sarcoid and carcino­
matous neuropathy. One patient in the pre­
sent series had sarcoid at the onset, one had 
diffuse lupus erythematosus and three pati­
ents had neoplasm present or diagnosed soon 
after the onset of myasthenia. Can it be that 
myasthenia is a local manifestation of a dis­
order of the same type as diffuse lupus erythe­
matosus, in which other tissues may some­
times be involved?
Myasthenic phenomena have occurred 
after prolonged dietary deficiency (in the 
Japanese ‘Kubisagari’ and in prisoners-of- 
war [Denny-Brown, 1947J). An outbreak in 
France was attributed to the chewing of 
tobacco infected by Clostridium perfr ingens 
(Coulonjou & Salaun, 1952). This organism
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usually causes severe myositis (gas gangrene) 
but is related to Clostridium botulinum.
Myasthenic features in anterior horn cell, 
peripheral nerve and muscular disorders have 
been discussed by Simpson and Lenman 
(1959).
The evidence that myasthenia gravis is a 
local manifestation of a disorder of variable 
aetiology, but often allergic, which may occas­
ionally affect other tissues is too scanty to be 
dogmatic, but an interpretation of this type 
would satisfactorily account for all the clinical 
features so far discussed. Red cell aplasia 
(Table 11) is in a slightly different category. 
This has been noted in patients with thymic 
tumour even if unaccompanied by myasthenia 
though more often with it than without. The 
first case with myasthenia was described by 
Wintrobe (1946) and the present one was re­
ported in detail by Chalmers and Boheimer 
(1954). Some patients with thymoma have 
depression of other marrow elements and 
agammaglobulinaemia (Lambie et aL, 1957).
The erythrocyte sedimentation rate is usu­
ally normal in myasthenia, and total serum 
proteins are within the normal range. Low­
ered albumin and raised y-globulin may be 
demonstrated by electrophoresis (Lowenthal 
& van Sande, 1956), but there is some tech­
nical argument about the validity of the ob­
servation. Some of my cases have had slight 
elevation of b-globulin. Blood chemistry is 
otherwise normal, though some authors de­
scribe abnormal glucose tolerance. 1 found 
ten patients with glycosuria. Many of these, 
and others with normal glucose tolerance, had 
a family history of diabetes.
There have been many papers devoted to the 
relationship between myasthenia and thyro­
toxicosis. This has obscured the fact that most 
of the early reports stressed the presence of 
non-toxic nodular goitre, and the histological 
appearance of lymphadenoid goitre. My 
material has a higher incidence of thyroid 
disorders than usually reported (females 18%; 
males 10%) but most of these were either non­
toxic at all times, or had a very brief spell of 
toxicity, lasting only a few weeks or months, 
but often leaving traces of exophthalmos, with 
thick pu Ify eyelids. Some patients have the 
ocular changes usually associated with thyro­
toxicosis but without goitre or abnormal
basal metabolic rate at any time. There are 
cases reported with myasthenia gravis and 
myxoedema who had never had a thyrotoxic 
phase.
When toxic goitre does occur in myasthen- 
ics its appearance seems quite unrelated in 
time. They may coincide, but either may pre­
cede the other by many years and indeed 
antithyroid treatment may make myasthenia 
worse. These facts make it unthinkable that 
thyroxine can cause the myasthenia, but 
would strongly favour a pituitary factor, since 
all these thyroid states, toxic or otherwise, 
could be associated with excess pituitary sec­
retion. 1 have already commented on the fact 
that a family history of diabetes is not un­
common, but this is a common disorder. An 
observation which 1 believe to be new is 'that 
there is a high incidence of thyrotoxicosis in 
close relatives of myasthenies, even those 
without thyroid disorders. This relationship 
appears to be mainly, but not exclusively, on 
the maternal side. It is not, perhaps, well 
known that there is quite substantial evidence 
for a genetic factor in exophthalmic goitre. 
It would be reasonable to suspect that this 
acts by a pituitary hormone and perhaps, it 
may express itself in other ways such as myas­
thenia gravis. 1 do not say ‘thyrotrophin' 
since there is some evidence of a separate 
factor related to it which acts on muscles, 
especially the extra-ocular ones. It might be 
a growth hormone. Such a hypothesis would 
account for the reports of myasthenia gravis 
associated with acromegaly, diabetes, Addi­
son's disease, and perhaps for the effects of 
pregnancy, menstruation, and of the emotions 
acting via the hypothalamus.
Pregnancy has some sort of influence on 
myasthenia, but it is quite unpredictable. In 
general, remissions occur in the first trimester 
and relapses at the time of birth or during the 
puerperium, but some patients are worse 
during pregnancy and remit afterwards. Suc­
cessive pregnancies may have different effects. 
If a hormonal influence is present it must be 
only one of the factors involved. Schrirc 
(1959) has recently reported low pregnandiol 
excretion in myasthenia, which is corrected 
by thymectomy. As the recovery of pregnan­
diol in the urine after injection of proges­
terone was also low it is difficult to attribute
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the low levels to a decreased progesterone 
secretion. Preliminary results of similar in­
vestigations being carried out in my patients 
by Dr K. Fothcrby do not appear to confirm 
Schirc's findings.
Interestingly enough the endocrine disor­
ders referred to above are, like myasthenia, 
associated with lymphoid hyperplasia of the 
thymus. Comsa (1958) has confirmed that 
growth hormone causes enlargement of the 
thymus and suggests that it may be a neces­
sary target organ through which the pituitary 
acts in controlling growth. Everything points 
towards the pituitary, but, despite a few re­
ports of eosinophil changes or adenomas in 
that organ, most pathologists find it without 
abnormality.
If a genetic factor is involved—even if only 
for setting the stage for a myositic reaction— 
one would expect occasional evidence of famil­
ial myasthenia and this is indeed the case. I 
have seen three such families. One of these 
had the syndrome termed ‘congenital myas­
thenia' in which there is a high incidence of 
ptosis and ophthalmoplegia but rare involve­
ment of other muscles. Classical myasthenia 
rarely occurs in more than one person in a 
family, though 1 have examined two families 
with cousin and aunt involvement. On the 
other hand, one myasthenic girl in this series 
had an identical twin who is normal. Other 
workers have had the same experience.
These familial cases, like myasthenia occur­
ring in young people, show no special ten­
dency to remit.
The position is completely different in 
'neonatal myasthenia', which is the name 
given to the myasthenia which sometimes 
aflects the baby of a myasthenic mother. It 
may be serious and cause death if unrecog­
nized as a cause of weakness, but if the child 
survives, with or without treatment, the weak­
ness clears up within 6 to 7 weeks and never 
recurs. The suggestion of transplacental pas­
sage of a toxic substance is irresistable.
PATHOLOGY
The lymphocyte infiltrations of muscle de­
scribed by Weigcrt (1901) were termed lym- 
phorrhagcs by Buzzard (1905) to emphasize 
liis belief that they originated from small 
blood vessels. He showed, and others have
confirmed, that they are usually present if a 
search is sufficiently thorough, though they 
may decrease in number and size as time 
passes (Fig. 6). Buzzard’s demonstration of 
similar foci in other organs, including the 
adrenals and pancreas, is repeatedly confirmed 
in the literature and in my own material but 
dismissed by most pathologists as ‘non­
specific'. So too, the associated degenerative 
changes of muscle fibre described by Buzzard 
(1905) and recently re-investigated and classi­
fied by Russell (1953) are considered by the 
latter to be non-specific.
Fig. 6, Photomicrograph of skeletal muscle from 
patient with myasthenia gravis: lymphorrhage.
Haematoxylin & eosinx210
Professor Russell described three types of 
muscle change. Type 1 (Fig. 7) is an acute 
coagulative necrosis of the muscle fibre with 
eosinophilic change, loss of cross striation, 
and inflammatory cellular reaction leading to 
phagocytic removal of the fragmented muscle
Fig. 7. Photomicrograph of skeletal muscle from 




fibre. This process may be limited to one fibre 
or so widespread as to cause naked-eye changes 
in the muscle. Type II (Fig. 8) is the lymphor­
rhage, which the author considers to be secon­
dary to solitary muscle fibre atrophy with 
basophilia of the cytoplasm and loss of cross 
striation. Type III (Fig. 9) she considered to 
be the least specific, being a simple focal muscle 
change with eosinophilia and swelling but 
without loss of striation or inflammatory re­
action. Similar changes occurred in the myo­
cardium, but never in true smooth muscle. 
It is quite true that similar lesions are seen in 
other conditions, notably the rheumatic dis­
orders, connective tissue disease, chronic in­
fections, myositis and endocrine myopathies. 
The lymphorrhage is found in many of these 
besides being the characteristic lesion of aller­
gic reactions. Querido (1929) was impressed 
with a vasculitis which he found associated 
with lymphorrhages. ‘Non-specific' they may
Fig. 8. Photomicrograph of skeletal muscle from 
patient with myasthenia gravis: Russell's type II 
lesion and lymphorrhage related to atrophic muscle 
fibre. H. &E.XI80
Fig. 9. Photomicrograph of skeletal muscle from 
patient with myasthenia gravis: Russell’s type III 
lesion. H. & E. x 80
be, but in this list one notes many of the con­
ditions already discussed under the clinical 
aspects. Again one can choose to consider the 
muscle reactions as ‘non-specific’ or to look 
for a common factor.
Special staining techniques applied to the 
motor nerve endings by Coers and Desmedt 
(1959) have shown that the neuromuscular 
junctions may often be abnormal in myas­
thenia gravis. These authors describe two 
changes in the terminal arborization of motor 
nerves (Fig. 10). In one, the ‘dystrophic’ 
type, there is increased branching and the 
terminal knobs are distributed over a wider 
area of the muscle fibre than usual. This type 
is probably reactive as the related muscle fibre 
is usually abnormal and the same type of end­
plate has been found in other neuromuscular 
disorders. In the other type, the ‘dysplasic', 
there are few terminal knobs and these are 
arranged serially along a scanty number of 
terminal branches ending on a long end-plate
N orfflaf D ysplas ic D ysf rop.h>.g
Fig. 10. Types of motor nerve terminals found in myasthenia gravis 
(Sketch based on the original paper by Coers & Desmedt, 1959).
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region. In their limited experience the authors 
have not found this type in any other disease. 
Further work is required to confirm their 
results for, like the muscle fibre changes 
already described, they bear no direct rela­
tionship to the severity of the loss of function. 
Nevertheless, the evidence for structural 
changes in nerve and muscle is convincing and 
no ‘chemical’ theory of myasthenia is accep­
table which does not take account of them.
Now what of the thymus gland ? Weigert 
(1901) thought that the lymphorrhages of 
muscle were metastases from a thymic tumour 
but Buzzard (1905) soon disproved this. 
Nevertheless, the incidence of thymoma is 
remarkably high (15—20%) and most cases 
show some thymic pathology. There has been 
a great deal of misunderstanding about this. 
Some textbooks describe ‘thymic hyper­
trophy’, and others ‘failure of atrophy’ such 
as a normal thymus is assumed to undergo. 
Both descriptions are wrong. Some thymus 
glands removed from myasthenic patients are 
undoubtedly larger than normal limits but 
the majority are not, and those with wide 
experience agree that normal thymic regres­
sion may occur with age (Sloan, 1943). But 
whether large or small, the organ shows in­
creased content of lymphocytes (or thymo­
cytes) in cortex and medulla and there is evi­
dence of active formation of lymphocytes in 
the presence of ‘germinal centres’ (Fig. 11) 
This finding is very characteristic (Castleman
Fig. 11, Photomicrograph of thymus from patient 
with myasthenia gravis: lymphoid follicular hyper­
plasia with Hassall’s corpuscles grouped round a ger­
minal centre. H. & E. x 42
& Norris, 1949). The epithelial cells of the 
thymus are not proliferated unless there is a 
tumour but in thymomas they may be arran­
ged in cords or tubes, giving the appearance of 
a secretory tissue. Even then the surrounding 
non-tumour gland shows the typical ‘germinal 
centres’ (Fig. 12). It is interesting then to note 
the occasional presence (usually in young 
patients) of hyperplasia of lymph nodes and 
of lymphoid tissue in the spleen. One patient 
in the present series died of lymphosarcoma 
(Table II). Disorders of blood formation and 
of the plasma proteins have already been 
referred to. Each of these conditons is rare, 
but the total picture suggests that the thymus
fa) H. & E. 42 (b) H. & E.x 52
Fig. 12 Photomicrographs of thymus from patient with myasthenia gravis: 
la) 'I liymoma, with tubular arrangement of epithelial-type cells.




is participating in an activity of reticulo­
endothelial type rather than a glandular one 
in the conventional sense and certainly no 
evidence of glandular activity can be seen.
Myasthenia has occurred after a thymoma 
has been removed. A small thymoma associ­
ated with severe myasthenia may continue to 
grow while the myasthenia remits. Operative 
removal of a thymoma does not usually 
affect the course of the disease but occasion­
ally does so. Removal of the non-tumour 
gland, on the other hand, definitely improves 
the prognosis and saves may lives, but in 
general only if it is removed within the first 
5 to 7 years of the myasthenia and even then 
the results are unpredictable for the individual 
and improvement may be immediate or 
delayed (Simpson, 1958). 1 have seen patients 
improve immediately and others not till 
months later, but improvement may continue 
for 3 years or more. Why should this be? Why 
too should improvement be most marked in 
young women, to the extent of changing their 
prognosis from one which is poorer than men 
to one which is better? (Simpson, 1958). Men 
may improve too, although the statistics are 
equivocal and their gain is less obvious.
A HYPOTHESIS
These facts do not suggest that the thymus is 
the source of a toxic substance or an endo­
crine gland with some necessary function. 
Rather it may act as an accessory organ in 
some mechanism, perhaps as a storage organ 
or possibly (as suggested by Comsa [1958] in 
another context) as a target gland of pituitary 
growth hormone which might atrophy in later 
life. The thymic-inhibitory effect of the thy­
roid and adrenal described by that author 
could be manifestations of the well-known 
pituitary feedback inhibition. Unfortunately, 
we know too little about the thymus to do 
more than speculate. Certainly the organ 
does not impress one as an endocrine gland, 
but more as a reticulo-endothelial organ. 
Metcalf of Sir F. Macfarlane Burnet's labora­
tory in Melbourne has recently isolated a fac­
tor secreted by the epithelial cells of thymus 
(in tissue culture) which appears in the blood 
plasma as a lymphocyte stimulating factor’ 
(Metcalf, 1956). Though the main source of 
globulin antibodies is believed to be the
PLASMA PROTEFNS
Fig. 13.. Suggested role of pituitary and thymus in 
controlling growth and differentiation. Differentiation 
of blood cells and production of protein antibodies 
may be a surviving remnant of these functions in the 
adult. In myasthenia the thymus may produce an anti­
body against normal muscle, especially after upper 
respiratory infection.
plasma cells, the lymphocytes do seem to 
have some role in immunity reactions.
It is interesting to speculate on the possi­
bility that a genetically-determined pituitary 
hormone acting on muscles might do so via
a thymic secretion which releases an antibody 
carried by lymphocytes (Fig. 13) or alterna­
tively that the thymus reacts 'allergically’ to 
the breakdown products of muscle cells 
damaged by abnormal pituitary secretion or 
by a delayed-type allergy caused by infection. 
During the last 5 years Dr John Anderson of 
Glasgow and Dr Roland Alexander of Edin­
burgh have collaborated with me in a search 
for muscle antibodies in myasthenia gravis, 
but without success, perhaps because the sub­
stance sought is intracellular. We were en­
couraged to search for better methods on 
reading the recent report of Nastuk ef ah
(1959). Searching for a neuromuscular block­
ing substance, these authors found that blood 
from myasthenic patients (and a few control
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subjects in lesser degree) caused lysis of frog 
muscle cells. Following up this surprising 
observation they found that the serum com­
plement activity was within the normal range 
in most myasthenic patients, but was above 
or far below the normal range in a few cases 
and this tended to correlate with remissions 
and exacerbations respectively.
Last year Smithers (1959), studying the role 
of the thymus and lymphocytes in disease, 
concluded that they were implicated in auto­
immunity and that the thymus changes of 
myasthenia gravis were strongly suggestive 
of an auto-immune process. Perhaps, too, the 
occasional benefit to myasthenies from cor- 
ticotrophin or cortisone is further evidence 
of this. The muscle protein may be rendered 
antigenically 'foreign’ by the same type of 
association with upper respiratory infection 
as is believed to occur in the rheumatic dis­
orders and in acute nephritis. The postulated 
pituitary factor might predispose to this by 
disturbing cell membrane integrity and indeed 
if protein which is normally confined within 
the muscle cell were allowed to escape, the 
auto-immune process would be initiated. 
It is possible that we have here an example of 
the influence of the endocrine glands upon 
immune and allergic responses to bacterial 
infection demonstrated by Long (1955). Per­
haps the place of the thymus in growth is as 
a regulator of cell-differentiation, a function 
which becomes unnecessary in the adult 
except for the formation of blood cells and 
plasma proteins. This action would include 
the recognition of ‘foreign’ proteins, and the 
reactions appropriate to them, that is the 
function of the reticulo-endothelial system. 
One can only speculate where knowledge is 
incomplete, but I do so without apology 
because the purpose of this lecture is to suggest 
new ideas for research on myasthenia gravis.
PATHO-PHYSIOLOGY
I have taken you a long way from the current 
ideas on myasthenia, but not far from those 
of the earlier workers who knew nothing 
about neuromuscular transmission or auto­
immunity, and little about endocrinology. 
For my unorthodox ideas I must undergo the 
ordeal of the Calabar bean. How docs the 
notion of an endocrine or auto-immune dis­
order combine with the patho-physiology and 
pharmacology of the disease?
The resemblance of myasthenia to curare 
poisoning had occurred to Oppenheim (1887) 
and to Jolly (1895) but it was Mary Walker's 
(1934) demonstration of the dramatic relief, 
afforded by physostigmine coinciding with 
Dale and Feldberg’s (1934) confirmation of 
the role of acetylcholine in neuromuscular 
transmission which turned all thinking to­
wards transmission block. The effect of physo­
stigmine and a variety of related synthetic 
compotmds with anti-cholinesterase proper­
ties, suggested that a defect of acetylcholine 
transmission from nerve ending to muscle 
end-plate was present and would account for 
the weakness. Jolly (1895) had shown that the 
fatiguability could be reproduced by faradic 
stimulation of a motor nerve while the 
‘fatigued’ muscle would still respond fully to 
locally applied galvanism. Modern electro­
myography shows that the loss of power is 
accompanied by a decrelnent of the evoked 
action potential of the muscle (Fig. 14). This 
seemed explicable by three hypotheses:
(1) diminished acetylcholine synthesis or 
release; (2) increased acetylcholine destruc­
tion by cholinesterase; (3) competition for 
receptors by a curare-like substance.
Before discussing these I must describe the 
finding of the opposite effect—an incremental 
response to tetanic stimulation —which is not 
uncommon in myasthenia (Fig. 14) and in 
polymyositis (Simpson & Lenman, 1959). 
Both effects may occur in the same patient. 
One is reminded of the decurarizing effect of 
tetanic stimulation when the dose of curare 
is low. The phenomenon is most simply ex­
plained if neuromuscular block in myasthenia 
is competitive in type. Post-tetanic facilita­
tion, which is characteristic of true myas­
thenia gravis though not always present, is 
also strongly suggestive of a curare-type block.
It may be that one or more of the other mech­
anisms is responsible for the ‘symptomatic 
myasthenias’ found in motor neurone dis­
ease, polyneuritis, and polymyositis (Simp­
son & Lenman, 1959).
Perhaps more than one abnormality is pre­
sent in myasthenia gravis, for instance the 
histological findings might suggest that both 
nerve and muscle are abnormal. Normal
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Fig. 14. Electromyograms from patients with myasthenia gravis: (a) Ulnar nerve at wrist 
stimulated with supramaximal electric shocks repeated 4, 8 and 50 times per second. Action 
potential recorded from abductor digiti minimi muscle by surface electrodes shows decre­
ment (‘fatigue’) with fast tetanization only. Note post-tetanic facilitation at arrows.
(A) The classical response from abductor digiti minimi but the triceps shows a temporary 
incremental response.
physiology does not help one to predict the 
effects which would then occur, but it is desir­
able to attempt an explanation of the findings 
in disease in terms of the known normal 
mechanism. Pharmacological studies have 
recently added a new body of evidence which 
has first to be considered.
It has been recognized for some time that 
the myasthenic patient can be paralysed by an 
unusually small dose of <r/-tubocurarine or 
quinine, but Churchill-Davidson and Richard­
son (1952) showed that myasthenic muscle was 
extraordinarily resistant to the depolarizing
blocking drug decamethonium (CIO). A small 
dose might facilitate, or sometimes a depolar­
izing type of block might change to a com­
petitive type with response to neostigmine 
(a ‘mixed block’). Grob et al. (1956) showed a 
similar alteration of the response to choline— 
one of the breakdown products of acetyl­
choline. Zaimis et al. (1952) believe that these 
facts indicate an alteration in the motor end­
plate, which is one possible interpretation. 
Arguments about whether the myasthenic 
muscle is hypersensitive or hyposensitive to 
intra-arterially injected acetylcholine have
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been shown to be due to usage of massive test 
doses (Engback, 1951). With suitable dosage 
there is no doubt that the myasthenic muscle 
has a raised threshold. This, too, makes the 
acetylcholine deficiency theory unacceptable. 
The pharmacological results, often seemingly 
conflicting, are difficult to summarize, but 
can be harmonized by the following hypo­
thesis (Fig. 15).
It is proposed that the effective condition 
for depolarization of the end-plate membrane 
may be the density of ionic charges attached 
to the postulated receptor substance. Thus 
an applied substance will be effective only if 
(1) its ionic charge is adequate (Riker, 1953) 
and (2) there is an adequate charge per unit of 
receptor area. If this limiting charge density 
is not reached no depolarization occurs and
the attached charges merely block receptors 
If an adequate charge density appears (prob­
ably with certain time factors) the membrane 
permeability is altered and a ‘local response’ 
causes depolarization. If this reaches a ‘critical 
level’ it becomes self-completing, an action 
potential propagates and the muscle twitches. 
If the charge density rises too high, or the 
stimulating chemical is resistant to hydrolysis 
by cholinesterase, depolarization persists caus­
ing neuromuscular block of a type which is 
made worse by anticholinesterase compounds 
or by the addition of acetylcholine (‘depolari­
zation block’). As the concentration of depo­
larizing substance falls, charge is lost from 
the end-plate which repolarizes. ^excitability 
of the membrane due to ‘desensitization’ pre­
vents further stimulation (Axelsson & Thes-
Fig. 15. Time course (diagrammatic) of rise and fall of charge-density at motor end-plate of muscle for 
three doses of a depolarizing substance such as decamethonium to show the differing effects due to dose level, 
particularly in the recovery stages. The shaded area indicates the zone of competition with acetylcholine, 
increased from a to d by a hypothetical competitive substance. If the charge-density rises to the value between 
the horizontal lines (constant in each diagram), propagated action potentials occur. If the charge-density rises 
rapidly above this zone (dotted part of curves), the resulting twitch is brief and the muscle is then paralysed by 
depolarization block. As the drug is dispersed, the charge-density falls through the critical zone but ‘desensi- 
IizaIion' prevents further response. If the dose is sufficiently high the prolonged effect may cause facilitation 
of test stimuli. When there is a substance competing for end-plate receptors {b—d), only the biggest doses 
causes depolarization block, and this is succeeded by competitive block (mixed responses)’. A lower dose, 
sulficicnt to block the normal end-plate, causes only stimulation—‘decame^on^m resistance’. (Compare 




leff, 1958), but if the ionic charge remains 
within the ‘critical zone’ sufficiently long it 
may facilitate neuromuscular transmission 
for a brief spell (Grob et at., 1956) until the 
charge-density falls too low and it enters the 
zone of ‘competitive block’ where it will tend 
to inhibit response to indirect stimulation or 
to application of further depolarizing chemi­
cals until the ‘sticky molecules’ (Zaimis et at.,
1952) become slowly detached. The two latter 
phases would be more prominent with large 
doses and with compounds resistant to hydro­
lysis. This hypothesis would explain all the 
phenomena described.
If now, ionic charge-density (note tot
necessarily the total charge) is decreased, the 
‘critical ’level is raised. The competitive zone 
is passed too quickly at first to cause clinical 
signs, stimulation occurs at a higher dose level, 
‘depolarization block’ only occurs with the 
bigger doses and is soon followed by a pro­
longed ‘competitive block’ (the ‘mixed re­
sponse' of Zaimis). Smaller doses merely 
stimulate and drop rapidly through the com­
petitive zone (‘CIO resistance’ etc). Time 
factors will differ with different drugs and. 
animal species, but all the reported pheno­
mena can be fitted into the scheme. What 
light does it throw on the alternative hypo­
theses?
(1) Diminished acetylcholine production 
is unlikely unless the charge is dispersed 
spatially. Coers and Desmedt’s (1959) histo­
logical findings would be compatible with this.
(2) Increased cholinesterase would decrease 
the rate of rise, lower the crest and steepen
the falling phase of the curve. The observed 
results do not suggest that this occurs, and of 
course increased cholinesterase has never been 
demonstrated (in muscle or in circulation).
The remaining theories (i) alteration of the 
end-plate’s properties so that it requires a 
greater charge density and (ii) occupation of 
some receptor sites by molecules with a negli­
gible charge, would both fit the observations. 
The first is the ‘end-plate abnormality’ theory, 
the second the ‘curare-substance’ theory. The 
pharmacological results are compatible with 
each, or with dispersed acetylcholine recep­
tors. Further studies of this type are unlikely 
to settle the matter if the physics of the situa­
tion are those postulated. Selection between 
the alternatives must depend on other factors. 
It may be that more than one factor is present, 
but when the decurarization effect, the post­
tetanic phenomena, the natural history of the 
disease, and above all the probability of pla­
cental transmission of the disorder are taken 
into account the only satisfactory single 
theory is the ‘competitive-blocking’ substance 
(Table III). This substance must have the un­
usual property of persistence in the myasthenic 
baby for several weeks.
Despite claims to the contrary—especially 
Striipplers (1954) recent work—there is no 
satisfactory evidence that serum from myas­
thenic patients will cause block of normal 
neuromuscular junctions. Cross transfusion 
to normal subjects has no effect. Wilson and 
his colleagues in Liverpool have tried for 
years to isolate such a substance from the 
thymus (Wilson et at., 1953). Their early
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results with extracts of glands removed 
from myasthenic patients were most pro­
mising but have been eriIieized as being 
attributable to potassium in the extract. 
They have recently isolated a series of sub­
stances from the thymus of whale foetuses but 
they seem to block by depolarization (Nowell 
e( af.. 1959). In view of the warning I have 
given of the different effects occurring with 
varying dose levels of quaternary onium 
compounds it would be unwise to dismiss 
these extracts from further consideration, but 
they do not seem to have the desired proper­
ties. (For instance a sudden relapse should 
cause spontaneous twitching or a depolariza­
tion block and be aggravated by anticholin­
esterase compounds).
Where, then, are we to look for a blocking 
substance which must be of competitive type, 
transmissible through the placenta, with per­
sistence in the child for a few weeks only, but 
not transmissible to another adult? If one 
looks at the mechanism of attachment of acet­
ylcholine to receptor protein (Fig. 16) one is 
immediately reminded of the Ehriich theory 
of antibody action. Let us suppose that anti­
body was developed against the 'receptor
Fig. 16. Two molecules of acetylcholine and one of 
antibody have similar configuration, based on end­
plate receptor ‘templates’. They will compete for 
receptor sites.
substance’ of the end-plate protein. Would 
not this substance have exactly the properties 
described? All that is required of it is that it 
should be detachable and should only occasi­
onally lead to lysis of the muscle cell. That is, 
it should have the properties of an incomplete 
antibody (odd that the alternative name of 
‘blocking antibody’ should have been coined 
by the haematologists!). Perhaps a ‘complete’ 
antibody, or one modelled to the rest of the 
muscle membrane gives rise to ‘polymyositis’.
SUMMARY AND CONCLUSIONS
In summary then, my suggestion is that myas­
thenia is an ‘auto-immune’ response of muscle
in which an antibody to end-plate protein may 
be formed. This would have the properties of 
an acetylcholine-competitive-blocking sub­
stance, specific to the individual, and occa­
sionally to the foetus of a myasthenic mother. 
Nerve endings, muscle fibres, and on occasion 
the central nervous system might sometimes 
be involved, in close analogy with diffuse 
lupus erythematosus and dermatomyositis. 
Myasthenia gravis is, therefore, a restricted 
form of myositis. It may be the result of an 
auto-immune response to an infection, usually 
of the upper respiratory tract, or the reticulo­
endothelial system, specifically the thymus, 
may react to muscle end-plate protein as if it 
were ‘foreign’ in disorders of the thymus. The 
latter is probably under the influence of the 
pituitary gland, probably by a growth hor­
mone, and this may be a necessary condition 
for the allergic response to infection. A fami­
lial incidence of thyrotoxicosis or diabetes is 
reported for the first time.
These conclusions have been reached from 
a detailed analysis of 440 cases and of the 
literature. No other theory of myasthenia 
gravis attempts to explain all the phenomena, 
clinical and experimental. The present attempt 
is speculative, but I hope it is justified by the 
many new lines of research immediately sug­
gested by it. Let me close by quoting Hugh- 
lings Jackson (Taylor, 1958):
‘The use of hypotheses is the method of science. 
To suppose we can make discoveries by the Baconian 
method is a delusion. A hypothesis or supposition is 
not a conclusion; it is only a starting point for 
methodical observation and experiment, the endeavour 
being not only to prove it, but to disprove it’.
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